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ABSTRACT
This thesis records my involvement in bacterial cell surface
research which began in 1971 during my PhD programme with early
studies on the biosynthesis and chemistry of klebsiella polysac¬
charides. A detailed study of the chemistry of the pneumococcal
teichoic acid followed and here I was introduced to immunochemis-
try. The structure and immunochemistry of the surfaces of anaero¬
bic bacteria, particularly of the Bacteroides species and the
Clostridia, then become a major interest. Clostridium difficile
played an important part in this section, where the most signifi¬
cant contribution showed conclusively that it was an infectious
agent. Links with the Moredun Research Institute have resulted in
collaborative studies on the important veterinary pathogens Pas-
teurella haemolytica and P. multocida, and a study of the bacteri¬
ology of periodontal disease in sheep. Concurrent with this have
been other collaborative studies on bacterial surfaces, in partic¬
ular the group B streptococci. The major current interest is on
the chemistry and immunochemistry of bacterial lipopolysaccharide
(LPS) with a particular interest in its interaction with anti¬
bodies (leading ultimatly to immunotherapy of septic shock and
Gram-negative sepsis) and the environmental influence on LPS
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thanks must go to Ian Sutherland, my PhD supervisor, who was
instrumental in much that followed. Jim Lomax was also an impor¬
tant help during these early years in propagating my interests in
carbohydrate chemistry and "techniques". It was during my post¬
doctoral research in Newcastle that the long-term aims were to be
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Peter Lambert, John Coley and David Powell were all important
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Nelson all feature as co-authors on one or more publications and
their contributions were essential. At Moredun the collaboration
with Neil Gilmour, Willie Donachie and their Pasteurella group has
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broken mouth work is gratefully acknowledged.
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field of study.
Lastly but by no means least all the junior technical staff and
honours students doing project work who have passed through the




My first interest in bacterial cell surfaces began in the
summer of 1970 when I was given the opportunity, during the
vacation prior to my honours year, of working in the
Microbiology Department, University of Edinburgh with Dr Ian
W Sutherland. The project involved an investigation of the
biosynthesis of the exopolysaccharide of Klebsiella aerogenes
by following the incorporation of C-14 labelled sugar
nucleotide precursors via a lipid intermediate into
polysaccharide.
A year later I was awarded a PhD studentship by the Science
Research Council to continue the project under the
supervision of Ian Sutherland. A thesis entitled 'Carrier
lipids involved in the biosynthesis of polysaccharides in
Klebsiella aerogenes' was submitted in 1974 and the degree of
PhD awarded in 1975. During the course of my PhD programme
the techniques were concerned primarily with the biochemistry
of the biosynthetic reactions. There was however a necessity
to do a certain amount of preparative chemistry in order to
produce the enzymes and substrates involved in the reactions.
Much of this was done with the help and guidance of Jim
Lomax. I also became interested in the chemical analysis of
the various polysaccharides synthesised by the mutants that
were isolated (1-4).
At the end of my PhD in 1974 I was fortunate to be able to
continue and extend my interests in the structural chemistry
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of bacterial cell surface carbohydrates by being appointed as
a Research Associate on a Medical Research Council grant
under the direction of Professor Sir James Baddiley in the
Microbiological Chemistry Research Laboratory, Chemistry
Department, University of Newcastle upon Tyne. The project
was to determine the structure of the C-teichoic acid of
Streptococcus pneumoniae. During my three years in Newcastle
I began for the first time to become aware of the fascination
and the complexity of the chemistry of the bacterial cell
surface. Under the expert guidance of Sir James and Ron
Archibald I began to get to grips with the intricacies of the
chemistry of the pneumococcal teichoic acid, a molecule of
great biological interest which offered a challenge to
attempt to unravel its structure. With the arrival of Ted
Tarelli in Newcastle I was able to use such modern analytical
techniques as 13C nuclear magnetic resonance spectroscopy and
methylation analysis by combined gas chromatography/mass
spectrometry to help elucidate the complex structure which
was defying solution by more classical chemical methods (5).
As well as learning chemistry in Newcastle I was able to
follow my interests in biosynthesis and, with the aid of two
MSc students, David Leak and Mavis Thomas, make some inroads
into the biosynthetic incorporation of choline into the cell
wall of the pneumococcus (6, 7). It was also in Newcastle
that my first interests in immunochemistry began. The
teichoic acids of the pneumococcus are important antigens and
it seemed appropriate that immunological techniques should be
exploited for their study. Antibodies were raised in rabbits
and simple precipitation-in-gel and inhibition of complement
induced haemolysis techniques were used.
In 1977 I was appointed, by Professor B P Marmion, to a
Lectureship in Bacteriology in the University of Edinburgh
Medical School and given space in the Microbial Pathogenicity
Research Laboratory which was headed by Professor J G Collee.
At this time the work that I had begun on pneumococcal cell
wall carbohydrates was terminated as my new department did
not have the necessary facilities for me to progress further.
I was therefore looking for new areas of research to follow
where I could apply the techniques that I had learnt during
the preceding six years. The area of the Bacteriology
Department in which I found myself had an international
reputation as a laboratory in which the relatively new
discipline of anaerobic bacteriology was being developed.
This is the field that was to become my major area of
research for the next 10 or so years.
Anaerobic bacteriology, in 1977, was at the stage of
development where it was well recognised that the anaerobic
bacteria, especially the non-sporing, Gram-negative rods,
were a major cause of abdominal sepsis. The organisms could
be isolated, cultured in the laboratory and identified to
genus and usually species level by conventional
bacteriological techniques. Very little however was known of
their structure or how they interacted with the host during
the pathogenic process. These were the areas that I decided
to concentrate on initially.
Organisms belonging to the genus Bacteroides were the first
group of anaerobes to be investigated, especially the B.
fragilis group which comprises the major pathogens of the
genus. Both cell surface chemistry and immunochemistry have
been investigated in detail. Powerful, modern immunochemical
methods such as enzyme-1 inked immunosorbent assay (ELISA) and
immunoblotting were exploited (8-11). Robert Brown our chief
MLSO, and Madeleine Ip and Gary Cousland, two postgraduate
students, made significant contributions to these studies.
In the late 1970s it became apparent that the best known
group of anaerobes, the Gram-positive, spore-forming rods, -
the Clostridia, still played a major role in serious
infections and were in fact responsible for some 'new'
infections. A study in which I was ably assisted by Marie
Byrne resulted in several publications dealing with the
antigenic make-up of Clostridia (18-19), in particular
Clostridium botulinum and related organisms (20) and
C.difficile the organism recently identified as being the
cause of antibiotic-associated colitis. The work on Cj_
difficile included some fundamental studies on the
microbiology, structure and immunochemistry of the organism
(18, 21-26), and a consequence of this was the development of
a fingerprinting method (27-28) which could be used for the
debated epidemiology of C. difficile infections. This
technique has been applied to a number of collaborative
investigations some of which have been published (27, 29-30).
We have concluded that C. difficile is an infectious agent
that can be transmitted from person to person. A detailed
study of the culture, epidemiology and virulence factors of
C. difficile has been completed, with Jacquie Sharp
submitting a PhD thesis of her contributions to the work.
Several reviews and contributions to books have resulted from
my interest in anaerobes (31-36).
Anaerobes have been by no means my only interest in
Edinburgh. The interests in cell surfaces of Gram-positive
cocci which began in Newcastle have continued and I have been
involved in several collaborative projects on streptococci.
The most significant was on the carbohydrate antigens of
Group B streptococcus where I supervised Chris Cumming on
this aspect of his PhD thesis (37-40). A small part was also
played in collaboration with Jeremy Bagg and Donald Weir in
the investigation of the lectin-mediated adherence mechanisms
of some other Gram-positive bacteria (41,42).
Links with the Moredun Research
my return to Edinburgh and
veterinary microbiology. This
Pasteurella haemolytica and
immunochemistry and vaccine de
Willie Donachie and colleagues
Institute began shortly after
engendered an interest in
has been predominantly on
P. multocida cell surface
relopment with Neil Gilmour,
(43-48). More recently this
collaboration was extended to an intensive study of the
microbiology of periodontal disease in sheep (broken mouth)
with Jane McCourtie and John Spence, combining my anaerobic
and veterinary microbiological interests (49-51).
In 1985, a major collaboration with Robin Barclay and
colleagues in the Edinburgh and SE Scotland Blood Transfusion
Service was begun. The primary aim of the project was to
develop antibodies, either from blood donors or monoclonal,
which could be used in the prevention and or treatment of
Gram-negative sepsis and endotoxaemia. At the time of writing
this thesis the project is extremely active and much of the
work is unpublished (because of commercial sponsors).
However, several papers either directly or indirectly related
to the main thrust of the project have been published
(52-56).
The major linking theme throughout all of my work has been an
interest in the structure and function of the bacterial cell
surface in relation to its role in interactions with the
host. Of especial interest has been the 'techniques' side of
the work: immunochemical and biochemical methods. This
interest has led to several invited chapters and reviews (35,
36, 57, 58) and the production of a book (59) entitled
'Bacterial Cell Surface Techniques', co-authored with Ian
Hancock of the University of Newcastle. This is a practical
manual for the preparation and analysis of bacterial cell
surface components. A final publication worthy of note is a
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chapter, co-authored with John Arbuthnott of the University
of Nottingham, entitled 'Determinants of Bacterial Virulence'
for the latest edition of Topley and Wilson's Principles of
Bacteriology, Virology and Immunity (60).
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1. Introduction
The bacterial cell membrane is the site of synthesis
of several polymers which are composed, at least in
part, of oligosaccharide repeating units. In capsulate
Gram negative bacteria such as Klebsiella aerogenes
these products are mucopeptide, lipopolysaccharide
and exopolysaccharide (capsule and slime). In biosyn¬
thesis of each such polymer, formation of the oligo¬
saccharides involves transfer of monosaccharides from
nucleoside diphosphate sugars to a carrier lipid identified
as a phosphorylated C55-isoprenoid alcohol [1—3].
Exopolysaccharide synthesis in K. aerogenes follows
this pattern [3], the first two reactions in the biosyn¬
thesis of the capsule of type 8 strains being [4]:
Lipid—P + UDP—glucose -*■ Lipid—P—P—glucose + UMP
Lipid—P—P—glucose + UDP—galactose Lipid—P—P—
glucose—galactose + UDP
The enzymes responsible for these reactions form part
of the membrane complex and earlier attempts to ob¬
tain soluble transferases were unsuccessful [4], They
are probably highly hydrophobic molecules resistant
to extraction with aqueous solvents except under dras¬
tic conditions under which enzyme activity is destroyed.
A possible technique for the extraction and purifi¬
cation of hydrophobic proteins from bacterial cell
membranes was provided by the acid—butanol method
of Strominger and others [5]. Use of this extraction
procedure on cell membranes from Staphylococcus
aureus solubilised a number of proteins from which
an isoprenoid alcohol kinase was purified by low
temperature precipitation from butanol followed by
chromatography on DEAE-cellulose [6], Preliminary
experiments in our laboratory with K. aerogenes in¬
dicated that 4—5% of the membrane protein could be
extracted with acid butanol (H.A. McArthur, un¬
published results). We now report the extraction of
two glycosyl transferases from K. aerogenes type 8
and the reconstruction of an active enzyme system.
2. Materials and methods
The bacterial strain used was a non-mucoid deriva¬
tive of K. aerogenes A4 (type 8) known to be active in
glucose transfer to lipid and in galactose transferases I
and II [7], It was used in preference to the wild type
cells when extracellular polysaccharide was absent. It
was grown overnight in 30 2 of trypticase soy broth
(Baltimore Biologicals Laboratories, Baltimore, Md.,
USA) containing 1% (w/v) glucose in 15 2-fermenters
(L.H. Engineering Ltd., Stoke Poges, England), har¬
vested by centrifugation at 10 000 g for 20 min and
washed in saline (pH 7.5). The bacteria were broken
by passage through a French pressure cell (Aminco-
American Instrument Co., Inc., Silver Spring, Md.,
USA) suspended in Tris buffer (600 ml, pH 7.5) and ,
nucleic acids were destroyed by the addition of RNA-
ase and DNAase and gentle shaking for 30 min at 30°C.
'Cell membrane' material was recovered by centrifuga¬
tion at 50 000 g for 1 hr and extracted with acid
butanol as described [6],
Ficaprenol for use as glycosyl acceptor was pre¬
pared from the leaves of Ficus elasticus [8]. Reverse-
phase chromatography on silica gel revealed a mixture
of C50-, C55- and C60-isoprenoid alcohols. Crude iso¬
prenoid alcohol kinase was prepared from a culture of
Staphylococcus [6],
Incubation mixtures contained: 100 pg ficaprenol,
0.6% Triton X-100, 0.1 mM dimethyl sulphoxide,
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10 mM CaCl2, 10 mM MgS04, 50 mM Tris buffer
(pH 8.0), 5 mM ATP and UDP-[14C]glucose (50
nmoles, 0.2 pCi) in a total volume of 450 /ul. They
were prepared by adding the prenol dissolved in light
petroleum to each tube and evaporating the solvent
under reduced pressure. This was repeated after addi¬
tion of the butanol solution of protein. Triton, di-
methylsulphoxide and buffer were then added and
thoroughly mixed with a fine rod. All the other com¬
ponents except the nucleoside diphosphate sugars were
added and thoroughly mixed on a gyratory mixer. Im¬
mediately after the addition of the UDP-glucose, and
at intervals thereafter, samples (50 jul) were withdrawn
and pipetted into 4 ml of chloroform/methanol (2:1,
v/v).-Jixtraction of lipid-bound monosaccharide and
scintillation counting were performed as described
previously except that Whatman IPS papers were used
to separate the organic phase from aqueous material.
To detect galactose transferase activity, radioactive
glucose was omitted from the incubation mixtures and
UDP—[14] galactose (50 nmoles, 0.2 /ctCi) was added.
3. Results and discussion
3.1. Protein extraction
The initial extraction of the bacterial membrane
material yielded 4.1—4.8% of the membrane protein
in several experiments. Much of this protein precipi-
Fig. 1. Transfer of [14C]glucose to lipid by butanol soluble
enzyme. Ordinate: Incorporation/mg protein (pmoles).
Abscissa: Time (min). Incubation mixtures prepared as
described were held for 30 min at room temp, after addition
of ATP. UDP-glucose was added and samples (50 pi) with¬
drawn at 5 min intervals to measure incorporation into chloro¬
form extractable material.
Table 1
















BSE* - butanol soluble enzyme.
The incubation mixtures were prepared as described in the
Methods and incubated for 30 min at room temp, after addi
tion of the nucleoside triphosphate. Thereafter the UDP-
glucose was added and samples extracted with chloroform/
methanol 0, 15 and 30 min after incubation at room temp.
(18°C). Each reaction mixture contained 4 mg butanol soluble
protein.
tated along with other material when the soluble
extract was held at 0°C for 36 hr. It was removed by
centrifugation. Cooling of the resultant supernatant
fluid to —20°C for 16—24 hr yielded a small amount
of brownish precipitate which was recovered by rapid
centrifugation at —20°C and 8000 g. The yield was
approx. 0.4% of the membrane protein in the best
preparation. Lower yields were obtained when cell
breakage was sub-optimal, suggesting that the acid
butanol solution only extracts significant amounts of
protein from bacterial membranes and not from whole
bacteria. The coloured precipitates were redissolved in
butanol and kept at 2—4°C. A small amount of material
precipitated from the butanol solution after 1—2 weeks
at this temperature. The mixture was normally homo¬
genised gently before use.
3.2. Enzymatic activity
The ability of the bacterial extracts to transfer
glucose and galactose from the UDP-monosaccharides
to lipid was tested at all-stages-of the preparation. The
initial activity of the cell lysates from the pressure cell
was confirmed for both glucose and galactose transfer.
Activity was also found in the butanol extracts even
though organic solvent was present. On the basis of
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activity per mg protein, there was a considerable loss
of enzyme function at this stage, transfer being approx.
55—60% less than in the original cell lysates. This may,
in part, be due to the presence of butanol in the
aqueous incubation mixtures. The procedures used,
in which some protein is precipitated and the active
protein can only with difficulty be resuspended in
aqueous solutions, also prevent accurate comparisons.
The expected reaction is the transfer of glucose-1-
phosphate to prenol-phosphate. Transfer to free prenol
was not expected and no glucose was found in the
organic phase following incubation of UDP—glucose
with ficaprenol and the butanol soluble protein. The
addition of ATP permitted transfer of glucose to
chloroform-soluble material. Consequently, incubation
mixtures were kept for 30 min at room temp, to allow
phosphorylation of the lipid prior to addition of the
UDP—monosaccharides. Although other nucleoside tri¬
phosphates could replace ATP, none were as effective
as judged by subsequent glucosyl transfer (table 1).
These observations indicate that the butanol extracts
contain an isoprenoid alcohol kinase resembling that
reported by Higashi et al. [5]. The addition of a crude
preparation of this enzyme from Staphylococcus [6]
stimulated the incorporation of glucose but was unable
to replace the Klebsiella preparation as a source of
glucosyl transferase.
Incorporation of glucose from the nucleoside
diphosphate monosaccharide into lipid increased with
time to a maximum after 25 min (fig. 1). Thereafter a
decrease occurred. The reason for this is not known
although similar results have been obtained with mem¬
brane preparations prior to butanol extraction. The
glucosylated lipid may be unstable under the experi¬
mental conditions, or other enzymes present in the
butanol extract may affect this product. Galactose in¬
corporation resembled that of glucose and in a typical
experiment, replicate tubes in which labelled substrates
were UDP—[14C] glucose and UDP—[14C] galactose
respectively, incorporated 107 pmoles of glucose and
87 pmoles of galactose after 10 min. We have not yet
obtained the ratio glucose:galactose 1:2 found in mem¬
brane preparations of type 8 strains [4, 7]. The galac¬
tosyl transferase II [7] may therefore be absent from
the soluble proteins. The reproducibility of hexose
incorporation has varied considerably between experi¬
ments and this can almost certainly be ascribed to
failure to achieve uniform suspension of the hydro¬
phobic protein and lipid.
Recovery of glucosylated lipid from the incubation
mixtures by the standard chloroform methanol extrac¬
tion procedure was followed by chromatography on
paper and on silica gel (TLC). On paper, after
descending chromatography in ethanol/1 M ammonium
acetate, pH 7.3 (7:3, v/v) 1 cm strips of the paper were
counted in scintillation fluid. Most of the radioactivity
moved with ^t,aiactose 1-21 but a small amount was
also detected with 7?„al 0.4 and 0.1. The major peak
corresponds well to the position of glucosylated lipid
from normal incubation mixtures with membrane
material [4]. On TLC in diisobutyl ketone/acetic
acid/water (20:15:2) most of the radioactivity had
Rj- 0.2 with a smaller amount having R^ 0.47. Prepara¬
tions of mannosyl lipid showed a similar mobility to the
major product [9],
Further attempts to separate and purify the glycosyl
transferases from K. aerogenes, which are involved in
the synthesis of the exopolysaccharides of this genus,
are continuing. It is of interest that in earlier studies,
using a different strain of K. aerogenes, extraction of
membranes with neutral butanol at —25°C left the
glycosyl transferases of this strain in the residual
particulate material [3],
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Isoprenoid alcoholsfunction in bacteria as the acceptors on which polysaccharide molecules
are assembled. In this role they are involved in the biosynthesis of mucopeptide (Anderson,
Matsuhashi, Haskin & Strominger, 1965), lipopolysaccharide (Wright, Dankert & Robbins,
1965), teichoic acids (Anderson, Hussey & Baddiley, 1972) and extracellular capsular or
slime polysaccharides (Sutherland & Norval, 1970; Troy, Frerman & Heath, 1971). In
growing Klebsiella aerogenes three of these polymers are formed, but only the extracellular
polysaccharide continues to be synthesized after the bacteria have reached the stationary
phase of growth. This indicates that there must be some kind of control to ensure that the
isoprenoid alcohol of the organism is available for manufacture of the essential wall poly¬
mers during growth but can also function in capsule formation during and after active
growth. There is some indication that conditional mutants presumed to be defective in
isoprenoid lipid content synthesize only the wall polymers until growth has ceased, when
capsular polysaccharide synthesis commences (Sutherland, 1972).
A possible control mechanism for isoprenoid alcohol in Staphylococcus aureus was sug¬
gested by Strominger and his colleagues following the discovery of an isoprenoid alcohol
kinase and a C55-isoprenoid alcohol phosphatase in that species (Sandermann & Strominger,
1972; Willoughby, Higashi & Strominger, 1972). The two enzymes were thought to control
the carrier lipid - the kinase making it available, and the phosphatase removing it from the
systems requiring it. The isoprenoid alcohol enters the biosynthetic cycle for mucopeptide or
for lipopolysaccharide as the phosphate. Subsequently, it accepts a monosaccharide-1-
phosphate moiety from a nucleoside diphosphate sugar. After addition of various other
monosaccharides or similar compounds, transfer of the oligosaccharide formed to an
appropriate acceptor molecule leaves isoprenoid lipid as a pyrophosphate. It is unable to
re-enter the biosynthetic cycle for the polymers until it has been dephosphorylated by the
specific phosphatase. A second enzyme accomplished further dephosphorylation to yield the
free isoprenoid alcohol. The kinase described by Sandermann & Strominger (1972) rephos-
phorylated free isoprenoid alcohol to the active monophosphate form. If this control oper¬
ates, such systems will be widely distributed among bacteria and may have an even more
important role in those species which possess extracellular polysaccharides in addition to
wall polysaccharides.
In general, membranes can be prepared more readily from Gram-positive than from
Gram-negative bacteria to permit extraction of the membrane-bound enzymes by the acid-
butanol technique of Sandermann & Strominger (1972). Extraction of whole Klebsiella
aerogenes with acid butanol yielded little protein and none with detectable enzymic activities.
When the K. aerogenes were broken in an Aminco pressure cell the membranes (contaminated
with wall material) could be separated from unbroken bacteria. Acid butanol extraction then
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Fig. i. C55 alcohol phosphokinase activity in crude butanol-soluble enzyme (BSE). The activity of
crude butanol-soluble extracts was tested by removing 50 jul samples from the incubation mixture
and applying them directly to paper, as described by Sandermann & Strominger (1972). After
development of the chromatograms for 4 to 5 h, the front area was cut out and its radioactivity
estimated directly in a toluene-based scintillation fluid.
dissolved up to 5% of the membrane protein. Two enzymic activities, a glucosyl-phosphate
transferase and a galactose transferase, both essential for synthesis of the capsular poly¬
saccharide of K. aerogenes type 8, were detected (Lomax, Poxton & Sutherland, 1973). In
whole bacteria, the glucose-i-phosphate transferase requires the presence of C55 isoprenoid
alcohol phosphate as acceptor in the reaction:
Isoprenoid alcohol phosphate + UDP-glucose -> Isoprenoid alcohol-P-P-glucose + UMP.
Two non-mucoid mutan ts of K. aerogenes type 8 were used as sources ofmembrane material,
because membranes from capsulate bacteria were recovered with lower yields. After breakage
of the bacteria, membranes were recovered by differential centrifugation and extracted
three times with acid butanol [butanol-6 M-pyridinium acetate (8:3), pH 4-2, at room
temperature]. Partial purification was achieved by precipitation from solvent solution at
0 °C (inactive material) and then at —20 °C (active protein). The brownish precipitate from
each preparation was redissolved in butan-i-ol and held at o°C. This was used as 'enzyme'.
It lacked endogenous acceptor and this was normally replaced with added ficaprenyl
phosphate prepared by chemical phosphorylation of ficaprenol (Stone, Wellburn, Hemming
& Pennock, 1967). Alternatively, ficaprenol or the C55-isoprenoid alcohol from bacteria
(bactoprenol) and ATP could replace the alcohol phosphate, suggesting that the 'enzyme'
contained a kinase with similar specificity to that described by Sandermann & Strominger
(1972). When 'enzyme' and bactoprenol, which had been dried together under vacuum,
were suspended in a buffer containing: 50 mM-tris-HCl pH 8-5, 10 mM-Mg++, 100 mM-P„
600 mM-dimethyl sulphoxide, o-i % 2-mercaptoethanol and 0-3% Triton X-100, addition of
0-05 /id (o-i Amol) of ATP-y32-P yielded a radioactive product soluble in chloroform. This
product moved at the solvent front on paper chromatography in isobutyric acid+i m-
ammonia (5:3). Results from the two mutant strains were identical. Assay of lipid phosphate
formation by this technique (Sandermann & Strominger, 1972) showed that the reaction
increased with time over a period of about 30 min.^Thereafter, a slight but reproducible
decrease in product occurred (Fig. 1). This may have been due to the presence of a specific
phosphatase in the reaction mixture. Similar results were obtained when ficaprenol was used
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as acceptor instead of the bacterial C55 isoprenoid alcohol. Controls without added acceptor
did not transfer phosphate to lipid-soluble material. Paper chromatograms of complete
incubation mixtures scanned in a 4 n scanner showed three peaks, two of which were un-
reacted ATP and inorganic phosphate, while the third, at the solvent front, was assumed to
be isoprenoid alcohol phosphate.
To test the identity of the product of enzyme action, incubation mixtures were extracted
with chloroform + methanol (2:1, v/v). The chloroform solutions were thoroughly washed
with 0-9 % (w/v) NaCl and separated from the aqueous phase by passage through Whatman
iPS papers. Thin-layer chromatography of the chloroform solution in diisobutyl-ketone
+ acetic acid + water (40:25:5, by vol.) revealed a single radioactive product with RF o-6.
This is similar to the mobility in this solvent of chemically prepared ficaprenyl or bacto-
prenyl phosphate run on the same chromatograms and stained with a solution of 5 % (w/v)
p-anisaldehyde in a solution of concentrated H2S04 + 90% ethanol (1:18). Some other
isoprenoid alcohols of various chain lengths may also act as substrates, although less effec¬
tively than ficaprenol or bactoprenol.
The presence of an isoprenoid alcohol kinase, the third butanol-soluble enzyme isolated
from K. aerogenes membranes, supports the suggestion of Sandermann & Strominger (1972)
that enzymic phosphorylation and dephosphorylation of C55 isoprenoid alcohols provides a
regulation mechanism for the synthesis of polysaccharides by bacterial membranes. If this is
the role of the kinase, it should prove to be an enzyme of widespread occurrence. As yet, it
has been found only in one Gram-positive and one Gram-negative bacterial species, but
preliminary results (K. Jann, H. Kopmann and I. W. Sutherland, unpublished results)
suggest that it can also be isolated from Escherichia coli by the techniques described here. It
is probable that although a common means of enzyme extraction can be used for membranes
from Gram-positive and Gram-negative bacteria, there are sufficient differences in the
enzymes from different bacteria to require distinct purification procedures.
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summary
Two mutants which lacked both capsular and lipopolysaccharide O-antigen
polysaccharides were isolated from Klebsiella aerogenes serotype 2 by phage
selection; these were designated rough mutants. The polysaccharide fractions solu-
bilized by partial acid hydrolysis of the lipopolysaccharide from both the wild type
and mutants were chromatographed on Sephadex G-50. Analysis of the fractions
obtained confirmed that the rough mutants lacked the galactan portion of the
molecule, which is analogous to the Salmonella O-antigen polysaccharide.
Membranes prepared from wild-type K. aerogenes, from a non-mucoid strain
(lacking capsule only), and from one of the rough mutants were used in incubation
mixtures to compare the biosynthesis of polysaccharides by these organisms. The
incorporation of sugar nucleotides into both lipid intermediates and polymer was
followed. Results show that the transferases were apparently present in all mem¬
branes, while the polymerases were absent in both the non-mucoid and rough
mutants.
introduction
The lipopolysaccharides (LPS) of K. aerogenes do not appear to have the same relatively
simple basal structure as those of Salmonella spp. and Escherichia coli. The polysaccharide
is a complex mixture of fragments varying in both molecular weight and monosaccharide
content (Sutherland & Wilkinson, 1966; Koeltzow, Epley & Conrad, 1968). A branched
galactan has been proposed to be analogous to the O-antigen region of the Salmonella LPS,
and other fragments of polysaccharide may represent intermediate structures in the
biosynthesis of the complete LPS (Koeltzow & Conrad, 1971).
During biosynthetic studies on the capsular polysaccharide of K. aerogenes, Sutherland
& Norval (1970) found that sugar nucleotide precursors for the capsular poly¬
saccharide could also be incorporated into lipopolysaccharide. If the O-antigen region
of the K. aerogenes LPS is synthesized in an analogous manner to that in Salmonella
(Nikaido, 1973), then it must be assumed that lipid intermediates isolated from poly-
saccharide-synthesizing cell-free systems are a mixture of both LPS and capsular poly¬
saccharide precursors.
The aim ofLthis study was to isolate mutants from non-capsulate strains, which lacked
the O-antigen, and to use such mutants, together with non-capsulate strains, to obtain
information on the possible fate of sugar nucleotide precursors in cell-free systems.
Klebsiella aerogenes serotype 2 was chosen for this work because its capsular polysaccharide
contained mannose, but no galactose - the major O-antigen component. The structure
* Present address: Microbiological Chemistry Research Laboratory, School of Chemistry, The Uni¬
versity, Newcastle-upon-Tyne NEl 7RU.
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of the K. aerogenes serotype 2 capsule has been elucidated by Gahan, Sandford &
Conrad (1967):





Strains and media. Klebsiella aerogenes serotype 2, NCTC5055, a non-capsulate mutant
M4 which had been isolated previously in this laboratory (using a method similar to that
described below) from nitrosoguanidine-treated NCTC5055 bacteria by visual examination
for non-mucoid colonies, and the two rough mutants (isolated as described below) were
grown in 1 1 BBL trypticase soy broth in 2 1 Erlenmeyer flasks incubated at 30 °C on an
orbital shaker.
Bacteriophage F418, a strain from the departmental collection, was isolated from local
sewage by the method described by Sutherland & Wilkinson (1965). It was maintained as
a high-titre suspension, filter-sterilized, in nutrient broth at 4 °C.
Materials. Sugar nucleotides were purchased from the Boehringer Corp., London, and
UDP[14C]glucose and GDP[14C]mannose were obtained from The Radiochemical Centre,
Amersham, Buckinghamshire.
Mutagenesis. Portions (100 ml) of exponential-phase cultures of non-mucoid strains were
washed once in 0-85 % (w/v) sodium chloride, resuspended in 10 ml o-i m-citrate/phosphate
buffer, pH 6-i, containing 1 mg A-methyl-A'-nitro-A-nitrosoguanidine (Koch-Light), and
left at room temperature for 75 min. The bacteria were then washed twice with 10 ml 0-85 %
NaCl, resuspended in a further 10 ml, and 1 ml of the suspension was inoculated into 100 ml
trypticase soy broth and incubated for 12 h.
Phage selection. Portions (5 ml) of the 12 h cultures which had undergone mutagenesis
were used to inoculate broth (100 ml). After incubation for 4 h, samples were spread on to
plates of Oxoid nutrient agar supplemented with 1 % (w/v) glucose. The excess was removed
with a sterile pasteur pipette, and the plates were allowed to dry. Drops of phage L418
(4X 1 o8 plaque-forming units/ml) were spotted on to the plates, the plates were dried, and
then incubated at 30 °C overnight. Colonies of phage-resistant mutants were picked from
the centre of the zones of clearing and streaked out for single colonies. Colonies which still
appeared to be non-mucoid were tested for autoagglutinability by inoculation into io ml
trypicase soy broth in a test-tube. Those which autoagglutinated (a property of Salmonella
rough mutants) after 12 h incubation were grown in 1 1 trypticase soy broth for the prepara¬
tion and analysis of their lipopolysaccharide.
Preparation of lipopolysaccharide. Lipopolysaccharide was extracted from freeze-dried
bacteria by the hot aqueous-phenol procedure of Westphal & Liideritz (1954). The upper
aqueous phase was dialysed against running water for 16 h, concentrated to a small volume
by rotary evaporation, and centrifuged at 100000 g for 4 hr. The lipopolysaccharide, which
pelleted as a clear gel, was washed, suspended in distilled water and freeze-dried.
Hydrolyses. (i) Total hydrolysis of the glycosidic bond was achieved by treatment with
1 m-H2S04 at 100 °C for 3 h in a sealed tube. Neutralization was carried out by adding
excess Dowex 2 (HCO7 form) resin, washing the resin free of hydrolysate in a small no. 1
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sintered glass-funnel with distilled water, and finally concentrating the aqueous solution
to a small volume by rotary evaporation.
(ii) For partial hydrolysis, 10 to 20 mg LPS was dissolved in 2 ml 1 % (v/v) acetic acid,
sealed in a glass tube and hydrolysed for 90 min in a boiling water bath. The coagulated
lipid A was removed by centrifuging and the soluble polysaccharide solution was filtered
through a no. 4 sintered-glass funnel and freeze-dried.
Paper chromatography. Hydrolysed polysaccharides were analysed by descending chroma¬
tography on Whatman no. 1 paper, irrigating with butan-i-ol/pyridine/water (6:4:3,
by vol.) for 24 h. Saccharides were detected using the alkaline silver-nitrate reagents of
Trevelyan, Procter & Harrison (1950). Pentoses and hexoses were differentiated by spraying
with saturated aniline oxalate in water and heating to 105 °C.
Column chromatography. The polysaccharide fraction of partially hydrolysed LPS was
chromatographed on Sephadex G-50 (Pharmacia). The eluting buffer was pyridinium
acetate (4 ml pyridine and 10 ml acetic acid made up to 1 1 with distilled water; Schmidt,
Jann & Jann, 1969). Fractions (0-25 ml) were tested with the phenol-sulphuric acid reagents
of Dubois et ah (1956).
Ceil-free incubation mixtures. Cell suspensions (30%, wet w/v; 5 ml) in 0-85% NaCl
contained in glass tubes surrounded by an ice/ethanol mixture, were disrupted in an M.S.E.
100 W ultrasonic distintegrator set at maximum amplitude for 3 x30 s.
Unbroken cells were removed by centrifuging at 5000 g for 5 min at 4 °C. The membranes
were sedimented at 100000 g for 1 h at 0 °C, suspended in ice-cold distilled water at a con¬
centration of 20 to 30 mg protein mf1 and stored as 1 ml portions at -20 °C.
The incubation mixture, for following the incorporation of sugars from their nucleotide
precursors into lipid intermediates and polymer, contained: 200/d 50 mM-Tris/HCl buffer,
PH 8 ; 25/d o-i m-MgCI2, 10/d each of unlabelled sugar nucleotides (40 itim); 20 /d re¬
labelled sugar nucleotide (0-1 or 0-25/iCi); and 200 /d membrane suspension (4 to 6 mg
protein).
Assay ofproducts from incubation mixtures. Incorporation into lipid intermediates was
followed by extracting samples (50 /d) with 4 ml chloroform/methanol (2:1, v/v) at 60 °C
for 5 min. This was partitioned with 1 ml 0-85 % NaCl and vortexed. After separating the
phases with Whatman iPS (phase separating) papers, the organic phase was evaporated
and its radioactivity was measured in a Packard Tricarb liquid scintillation spectrophoto¬
meter, model 3330 (Packard Instruments, Caversham, Berkshire), using 10 ml Triton
scintillation fluid (9-1 g PPO, 0-22 g dimethylPOPOP and 500 ml Triton X-100 in 1 -16 1
toluene).
Incorporation into polymer was followed by spotting samples (5 /d) from the incubation
mixtures on to Whatman no. 1 paper and irrigating with ethanol/i m-ammonium acetate,
pH 7'3 (7-'3> v/v)- The origins were cut out and counted in a toluene scintillation fluid
[°'5 % (w/v) PPO in toluene].
Protein was determined by the method of Lowry et al. (1951), heptose and 2-keto-3-
deoxyoctonic acid (KDO) by the methods of Osborn (1963), and glucosamine by the method
of Strominger, Park & Thompson (1959). Glucose was determined using the glucose oxid¬
ase reagents (Boehringer) and galactose by the 'Galactostat' galactose oxidase reagent
(Worthington Biochemical Corp., Freehold, New Jersey, U.S.A.).
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Table 1. Sugar composition of K. aerogenes LPS (expressed as % dry wt LPS)
Strain Yield* KDO Heptose Glucose Galactose Glucosamine
.NICTC5055 2-5 1-5 56 7'5 23-2 5'2
(wild type)
M4 2-3 1-4 5'6 7-0 307 67
I OB i'3 1-7 7-6 14-2 0-2 7-8
36B 1-2 1-7 6-9 I2'5 0-2 10-3
* % dry wt bacteria.
Fraction no.
Fig. 1. Elution profiles of polysaccharide fractions obtained after partialTiydrolysis of LPS from:
(a) wild-type (NCTC5055) K. aerogenes serotype 2; (6) M4 non-mucoid strain; and (c) rough mutant
1 ob. A 250 x 20 mm column of Sephadex G-50 was eluted with pyridinium acetate buffer (described
in Methods). Fractions (1 ml) were collected, and 0 25 ml of each was analysed for carbohydrate by
the phenol-sulphuric method of Dubois et al. (1956). Fractions 18 to 25 (peak 1) and 36 to 42
(peak 11) were pooled.
results
Selection and characterization of mutants
After mutagenesis, phage-resistant mutants were selected from the non-mucoid strains of
K. aerogenes. Mutants designated iob and 3613 were both non-mucoid and autoagglutinable
and both could possibly be rough mutants. Other phage-resistant mutants were isolated, but
these appeared to be revertants to the capsulated form.
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Fig. 2. Incorporation of radioactivity from UDPglucose (•) and GDPmannose (O) into chloro-
form/methanol soluble material by serotype 2 K. aerogenes cell-free systems: {a) wild-type
(nctc5055); (b) mutant m4; (c) mutant iob. Incubation mixtures were set up as described in
Methods. Samples (50 /d) were removed, extracted with chloroform/methanol (2:1, v/v) and the
organic phase was assayed for radioactivity.
The LPS was extracted from wild-type bacteria, mutants iob and 36b, and from a non-
mucoid strain (m4) of K. aerogenes which has apparently normal LPS. Acid hydrolysis
(1 m-H2S04, 3 h, 100 °C) of the intact LPS, followed by paper chromatography, showed
that the normal LPS from wild type and M4 was composed of glucose and galactose, with a
minor amount of glucosamine. The LPS from mutants iob and 36b totally lacked galactose.
Quantitative analysis (Table 1) suggested that mutants iob and 3613 were of ihe required type
i.e. they apparently lacked the O-antigen (galactan).
Partial acid hydrolysis was carried out on the LPS from wild-type, m4 and iob strains,
and the soluble polysaccharides were fractionated on Sephadex G-50. The elution profiles
are shown in Fig. 1. The fractions corresponding to peaks I and II were pooled, reduced in
volume and hydrolysed in 1 m-HCI for 3 h at 100 °C. Paper chromatography of the products
showed that the peak I fraction was composed almost entirely of galactose; a trace of a
pentose which appeared to be xylose, co-chromatographed with it. The peak II fraction
appeared to consist entirely of glucose. Gluosamine was absent from both peaks. Quantitative
analysis of both iob and m4 LPS peak II fractions showed that the heptose content of
each was approximately 2 % while both preparations contained 1-5 % KDO.
Incorporation of sugars into lipid intermediates
Earlier work (Sutherland & Norval, 1970) showed that membrane preparations from
K. aerogenes possess a very active UDPgalactose-4-epimerase. This meant that if either
UDPglucose or UDPgalactose was added to an incubation mixture they could be inter-
converted. If the UDPgalactose and UDPglucose were labelled with 14C in the hexose part
of the molecule and added to an incubation mixture containing membranes of K. aerogenes
serotype 2, then it would be expected that the radioactivity would be incorporated into both
lipopolysaccharide and exopolysaccharide lipid intermediates. Radioactivity from labelled








Fig. 3. Incorporation of radioactivity from GDPmannose into polymer. Samples (5 /tl) from the
same incubation mixtures as in Fig. 2 were spotted on to paper and run in ethanol/l m-ammonium
acetate (7:3, v/v). The origins were assayed for radioactivity, O, Wild-type (nctc5055) membranes;
□ , mutant M4 membranes; A, mutant iob membranes.
GDPmannose, however, would be expected to be incorporated exclusively into exopoly-
saccharide lipid intermediates.
Figure 2 compares the incorporation of radioactivity from 14C-labelled UDPglucose and
GDPmannose into material soluble in chloroform/methanol (2: i,v/v) by cell-free incubation
mixtures prepared from wild-type (nctc5055), non-mucoid (m4) and rough, i.e. lacking
both O-antigen and capsule, (iob) strains of serotype 2 K. aerogenes.
Much of the radioactivity from UDPglucose is known to be incorporated into glycogen in
the cell-free systems described above (unpublished results), and so its incorporation was
not followed in this study. Figure 3 shows the incorporation of radioactivity from GDP¬
mannose (in the same incubation mixtures as in Fig. 2) into polymeric material.
The O-antigen and LPS structures of Salmonella are now well defined as heteropoly-
saccharides attached to a defined core structure (Wright & Kanegasaki, 1971). These
polymers are the receptors for various bacteriophages, but the receptor sites for the bacterio¬
phages of K. aerogenes are not very well understood. Many of these phages can induce
capsule degrading enzymes, while others require the capsule as a receptor site (Sutherland,
1972). Phage F418, however, cannot attach to encapsulated bacteria (unpublished
observation) and resistance to this phage by non-capsulated bacteria could occur in one of
three ways: (i) by reversion to capsulation (mucoid); (ii) by development of immunity
through the bacterium becoming lysogenic for that phage; or (iii) by loss or alteration of
the phage receptor site through mutation.
Tn the K. aerogenes mutants iob and 36b, it appears that (iii) has occurred. The galactan
(which is analogous to the O-antigen in Salmonella spp. or Escherichia coll) has been lost.
Other phage-resistant mutants appear to be revertants to mucoidness and apparently the
capsule protects the receptor sites.
Incorporation of mannose into polymer
discussion
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Gel filtration of the polysaccharide fraction obtained from partially hydrolysed normal
LPS (from wild-type bacteria or strain M4) resulted in the separation of two fractions.
A similar separation into two fractions was obtained with E. coli LPS (Schmidt et ah, 1969)
and with Pseudomonas aeruginosa LPS (Fensom & Meadow, 1970). The larger molecular
weight fraction, excluded from the gel, represents the O-antigen (galactan). The material
included on the column, by analogy with the other bacteria studied, probably represents
core polysaccharide. This core is not of the Salmonella type - it does not contain galactose.
We found no evidence for a heterogeneous LPS as reported by Koeltzow & Conrad (1971)
for NCTC243, serotype 2 K. (Aerobacter) aerogenes. Nimmich & Korten (1970) studied the
chemical composition of lipopolysaccharides from 12 different O serotypes of Klebsiella.
Several strains had a high proportion of galactose in their LPS whilst others almost entirely
lacked this sugar. In these galactose-deficient strains, mannose or rhamnose apparently re¬
placed the galactose. It is possible that all Klebsiella O-antigens are homopolysaccharides.
When the incorporation of radioactivity from the sugar nucleotides into lipid inter¬
mediates was followed (Fig. 2), it was seen that both mannose and glucose (or galactose)
were incorporated regardless of the sources of the membrane. The wild-type (NTCC5055)
cell-free system showed an initial high rate of incorporation of radioactivity from
GPDmannose followed by a decrease, then a steady state; this was typical of the formation
of a lipid intermediate which was turning over into polymer [see, for example, Anderson
et al. (1965) for peptidoglycan lipid intermediates; Nikaido, Nikaido & Nakae (1971) for
LPS O-antigen formation; or Schultz & Elbein (1974) for mannan synthesis in Myco¬
bacterium smegmatis]. The initial peak was not so apparent in the incorporation of
GDPmannose by M4 and iob membrane preparations, but these both showed a definite
formation of lipid intermediates.
The observed incorporation of radioactivity from both UDPglucose and GDPmannose
into lipid by M4 cell-free preparations could be explained if lipid (i.e. undecaprenyl
phosphate) were present in 'normal' amounts and the enzymes responsible for the addition
of sugars from their nucleotide sugar precursor to the hpid (transferases) were still present,
but turnover into polymer was somehow prevented. This might result in the accumulation
of sugars on the lipid. In the case of mutant iob, lipid would presumably be required only
for peptidoglycan synthesis and might be at a lower than normal level. The transferases,
however, still appear to be present. The results suggested that the defects in these mutants
might be at the level of assembling the oligosaccharide units, which have been assembled on
the lipid, into completed molecules outside the membrane. The increased incorporation of
sugars on to lipid, as observed for M4 membranes, is characteristic of many of the non-
mucoid mutants of K. aerogenes (Norval & Sutherland, unpublished results). An accurate
assessment of the lipid intermediates which were being formed is still not possible, because
of the very low levels of sugars which are assembled on to the lipid. So far no system has
been developed for K. aerogenes in which the different lipid intermediates can be separated.
Attempts with concanavalin A have proved unsuccessful.
It should be noted that the incorporation of radioactivity from GDPmannose into lipid
in Fig. 2, especially by M4 membranes, was dependent on the presence of UDPglucose in
the incubation mixture and there is no evidence for a polymannosyl-lipid or any mannose-
containing polymer other than the expopolysaccharide in K. aerogenes.
Confirmation that no mannose-containing polymer (exopolysaccharide) was being
synthesized by the cell-free system from either mutant is provided in Fig. 3. As mentioned
above, the incorporation of radioactivity from UDPglucose or UDPgalactose into polymeric
material was greatly confused by much of the label being accumulated into glycogen. A
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further examination of the problem of simultaneous glucose incorporation into glycogen
and wall material has been made and the results will be published elsewhere.
REFERENCES
Anderson, J. S., Matsuhasi, M., Haskin, M. & Strominger, J. L. (1965). Lipid-phosphoacetylmuramyl-
pentapeptide and lipid-phospho-disaccharide-pentapeptide: presumed membrane transport inter¬
mediates in cell-wall synthesis. Proceedings of the National Academy of Sciences of the United States of
America 53, 881-889.
Dubois, M., Gilles, K. A., Hamilton, J. K., Rebers, P. A. & Smith, F. (1956). Colorimetric method for
determination of sugars and related substances. Analytical Chemistry 28, 350-356.
Fensom, A. H. & Meadow, P. M. (1970). Evidence for two regions in the polysaccharide moiety of the
lipolysaccharide of Pseudomonas aeruginosa 8602. FEBS Letter 9, 81-84.
Gahan, L. C., Sandford, P. A. & Conrad, H. E. (1967). The structure of the serotype 2 capsular poly¬
saccharide of Aerobacter aerogenes. Biochemistry, New York 6, 2755-2767.
Koeltzow, D. E. & Conrad, H. E. (197 i). Structural heterogeneity in the lipopolysaccharide of Aerobacter
aerogenes nctc243. Biochemistry, New York 10, 214-224.
Koeltzow, D. E., Epley, J. D. & Conrad, H. E. (1968). The lipopolysaccharides of Aerobacter aerogenes
strains A3 (si) and nctc243. Biochemistry, New York 7, 2920-2928.
Lowry, O. H., Rosebrough, N. J., Farr, A. L. & Randall, R. J. (1951). Protein measurement with the
Folin phenol reagent. Journal of Biological Chemistry 193, 265-275.
Nikaido, H. (1973). Biosynthesis and assembly of lipopolysaccharides and the outer membrane layer of
Gram-negative cell wall. In Bacterial Membranes and Walls, pp. 131-208. Edited by L. Lieve. New
York: Dekker.
Nikaido, H., Nikaido, K. & Nakae, T. (1971). Glucosylation of lipopolysaccharide in Salmonella-. Bio¬
synthesis of O antigen factor I22. Journal ofBiological Chemistry 246, 3902-3911.
Nimmich, W. & Korten, G. (1970). Die chemische Zusammensetzung der Klebsiella Lipopolysaccharide
(O-Antigene). Pathologia et microbiologia 36, 179-190.
Osborn, M. J. (1963). Studies on the Gram-negative cell wall. I. Evidence for the role of 2-keto-3-deoxy-
octonate in the lipopolysaccharide of Salmonella typhimurium. Proceedings of the National Academy of
Sciences of the United States of America 50, 499-506.
Schmidt, G., Jann, B. & Jann, K. (1969). Immunochemistry of R lipopolysaccharides of Escherichia coli.
European Journal of Biochemistry 10, 501-510.
Schultz, J. & Elbein, A. D. (1974). Biosynthesis of mannosyl- and glucosyl-phosphoryl polyprenols in
Mycobacterium smegmatis. Archives of Biochemistry and Biophysics 160, 311-322.
Strominger, J. L., Park, J. T. & Thompson, R. E. (1959). Composition of the cell wall of Staphylococcus
aureus: its relation to the mechanism of action of penicillin. Journal of Biological Chemistry 234, 3263-
3268.
Sutherland, I. W. (1972). Bacterial exopolysaccharides. Advances in Microbial Physiology 8, 143-213.
Sutherland, I. W. & Norval, M. (1970). The synthesis of exopolysaccharides by Klebsiella aerogenes
membrane preparations and the involvement of lipid intermediates. Biochemical Journal 120, 567-576.
Sutherland, I. W. & Wilkinson, J. F. (1965). Depolymerases for bacterial polysaccharides obtained from
phage-infected bacteria. Journal of General Microbiology 39, 373-383.
Sutherland, I. W. & Wilkinson, J. F. (1966). The composition of lipopolysaccharides of Klebsiella
aerogenes and Aerobacter cloacae. Biochimica et biophysica acta 117, 261-263.
Trevelyan, W. E., Procter, D. P. & Harrison, J. S. (1950). Detection of sugars on paper chromatograms.
Nature, London 166, 444-445.
Westphal, O. & Luderttz, O. (1954). Chemische Erforschung von Lipopolysacchariden gramnegativen
Bacterien. Angewandte Chemie 66, 407-417.
Wright, A. & Kanegasaki, S. (1971). Molecular aspects of lipopolysaccharides. Physiological Reviews 51,
748-784.
4
The butanol-soluble proteins of Klebsiella aerogenes
I. R. Poxton* and I. W. Sutherland
Department of Microbiology, University of Edinburgh, West Mains Road, Edinburgh EH9 3JG,
Scotland, Great Britain
* Present address: Microbiological Chemistry Research Laboratory, School of Chemistry, University
of Newcastle, Newcastle upon Tyne NE1 7RU, Great Britain
Abstract
Membranes of Klebsiella aerogenes were extracted with acid butanol at pH 4.2 and the solubilized
proteins were fractionated by precipitation at 0°C and —20°C. The —20°C precipitate was examined
by polyacrylamide gel electrophoresis in sodium dodecyl sulphate.
Several enzyme activities associated with polysaccharide biosynthesis have been identified in
the crude — 20°C precipitate and an attempt was made to separate the enzymes from other protein.
The role of certain of these enzymes in a control mechanism for polysaccharide synthesis in K.
aerogenes has been postulated.
Introduction
The biosynthesis of peptidoglycan, lipopolysaccharide and exopolysaccharides (capsules
and slime) by the Gram-negative bacterium Klebsiella aerogenes, involves the formation
of oligosaccharide repeating units which are assembled on an isoprenoid alcohol phos¬
phate carrier lipid prior to polymerization (Rothfield and Romeo, 1971; Lennarz and
Scher, 1972; Troy et al., 1971). These reactions are catalysed by membrane-bound
(particulate) enzymes and solubilization by conventional means has proved difficult
(Sutherland and Norval, 1970). Sandermann and Strominger (1972) used acid butanol
solubilization and precipitation at low temperature, to purify the highly hydrophobic
enzyme isoprenoid alcohol phosphokinase from membranes of Staphylococcus aureus.
This provided a possible method for extracting other hydrophobic proteins from bacterial
membranes.
The solubilization by the acid butanol technique of two glycosyl transferase involved
in exopolysaccharide biosynthesis (Lomax et al., 1973) and an iosprenoid alcohol kinase
(Poxton et al., 1974) from membranes of K. aerogenes have been briefly described.
This report describes activities present in the crude butanol-soluble extract, an analysis
of the soluble material and the attempted fractionation and purification of the isoprenoid
alcohol phosphokinase, which differs in some properties from the corresponding enzyme
isolated from the Gram-positive bacterium S. aureus (Sandermann and Strominger, 1972).
Materials and methods
A non-mucoid strain of K. aerogenes A4 (type 8) was grown and 'membranes' prepared
as earlier described (Lomax et al., 1973). Extraction of the butanol-soluble material
was by a method similar to that of Sandermann and Strominger (1972). The bacterial
'membranes' (equilavent to approximately 60 g dry weight) were suspended in a final
volume of 500 ml 50 mM Tris-HCl buffer, pH 7.3 containing 1 mM MgCl2. This suspen¬
sion was stirred in acid butanol (120 ml 6 M pyridinium acetate, pH 4.2 + 320 ml
butan-l-ol) at room temperature for 40 min. The phases were separated by centrifuga-
tion at 6,000 x g for 20 min at room temperature and the upper butanol phase was
pipetted into a separating funnel containing 250 ml butanol-saturated water. The
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residual aqueous material was extracted twice more with 300 ml butanol; the butanol
layers, after washing, were combined. The butanol solution was concentrated by
rotary evaporation at 25°C until all the azeotrope had distilled over and stored in ice
at 0°C for 24—72 h, then centrifuged at 10,000 x g for 15 min. The butanol solution
held at —20°C in centrifuge tubes for 24 h was centrifuged in a pre-cooled rotor at
—20°C by accelerating to 13,000 x g then immediately stopped. The crude butanol
enzyme was resuspended in butanol and stored at 0°C.
Preparation of polyprenols
Ficaprenol was prepared by the method of Stone et al. (1967) from leaves of the deco¬
rative rubber plant (Ficus elasticus). Bactprenol was extracted from Lactobacillus plan-
tarum by the procedure of Thome and Kodicek (1966). Geraniol and farnesol were
purchased from Koch Light Ltd, Colnbrook, Buckinghamshire, England; geranylgeraniol
was a gift from Ciba-Geigy,- Basel, Switzerland and solanesol from the Tobacco Research
Laboratories, Bristol, England.
Assay of polyprenol phosphates
Incubation mixtures were prepared by drying under vacuum: 20 jul butanol-soluble
enzyme (350 /ig protein), 30 /d Span 20 (0.1% solution in methanol) and the polyprenol.
25 gi of a buffer containing 50 mM Tris-HCl, pH 8.5, 10 mM MgCl2, 100 mM NaH2P04,
600 mM dimethyl sulphoxide, 0.1% 2-mercaptoethanol and 0.3% Triton X 100 were
added and mixed with a fine capillary tube. The reaction was started by additon of
0.05 /tCi (0.1 pmoles) of ATP-7-32P in a volume of 1 or 2 p\. The reaction was stopped
by either (1) extracting with 4 ml chloroform/methanol (2:1), partitioning with 1 ml
saline and running the concentrated organic extract on thin layer plates in di-isobutyl
ketone, acetic acid, water (40:25:5) and scanning in a Tracerlab 4tt Scanner (Tracerlab
Ltd, Weybridge, Surrey, England), or (2) adding 30 jul tetrahydrofuran and running the
whole mixture as a 3 cm strip on Whatman 3MM paper (18x6 cm) by ascending paper
chromatography in isobutyric acid, 1.0 M aqueous ammonia (5:3). Radioactive poly-
prenyl phosphates which run at the solvent front in this solvent, were either detected
in the Tracerlab scanner or cut out and counted in 0.5% PPO (Diphenyloxazole) in
toluene in a Packard Tricarb liquid scintillation spectrometer (Packard Instruments Ltd,
Caversham, Berkshire, England).
Polyaciylamide gel electrophoresis as modified from Weber and Osborn (1969)
Proteins were solubilized in gel buffer containing 1% sodium dodecyl sulphate (SDS)
and 1% 2-mercaptoethanol for 4 h at 37°C or overnight at 20°C with vigorous shaking.
For application to gel, 10 /tg of protein standard or 100-200 /.d of unknown solubilized
protein in 10 pi buffer, were mixed with 1 drop of 10% (w/v) sucrose and 1 yul tracking
dye (0.05% bromophenol blue).
Ten per cent acrylamide gels with 0.27% b/sacrylamide were prepared in 65 x 5 mm
stoppered glass tubes. Electrophoresis was performed in Quickfit and Quartz (Stone,
Staffordshire, England) equipment at a constant current of initially 5 mA per tube
until the samples had entered the gel, then at 8 mA until the tracking dye had migrated
about 75% through the gel (2.5—3 h).
' Staining and destaining
Gels were immersed in (1) to (5) [according to the method of D. F. Wallach (personal
V: communication)]. The solutions were made up as follows: solution (1) 1.25 g Coo-
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massie brilliant blue R, 1625 ml water, 625 ml propane-2-ol, 250 ml acetic acid for
1 12 h; solution (2) 125 mg Coomassie blue, 2000 ml water, 250 ml propan-2-ol,
250 ml acetic acid for^—l^ h; solution (3) 63 mg Coomassie blue, 2250 ml water,
250 ml acetic acid.fot,J—12 h; solution (4) 1000 ml water, 800 mj methanol, 200 ml
acetic acid for 4—6"h; and solution (5) 10% acetic acid for 12 h. The mobility of the
proteins was calculated as indicated by Weber and Osborn (1969).
Protein was estimated in the presence of SDS by the method of Lowry et al. (1951).
Phosphorus was determined by the method of Barlett (1959). Thin layer chromato¬
graphy of the lipids found in association with crude butanol-soluble proteins was per¬
formed on silica gel H in chloroform, methanol, ammonia, water (65:25:0.5:3.6).
Amino acids were assayed qualitatively on Whatman number 1 paper developed in
the upper phase of butanol, acetic acid, water (4:1:5), by descending chromatography
and stained with ninhydrin. Quantitative analysis was performed in a Beckman Model
120 amino acid analyser by Dr R. P. Ambler (Department of Molecular Biology,
University of Edinburgh).
Results
Extraction of membranes with acid butanol
Washed bacteria (63.5 g dry weight) were disrupted and membranes prepared and ex¬
tracted as described in the Methods. Of the 19 g of protein in the crude membrane
Figure 1 Polyacrylamide gel electrophoresis in 0.1% sodium dodecyl sulphate of (a) crude mem¬
branes of K. aerogenes, and (b) the —20°C precipitate after acid-butanol solubilization of the
membranes. This was performed as described in Materials and methods. Molecular weights were
determined from the following protein standards — bovine serum albumen, deoxyribonuclease,
catalase, ovalbumen, lactate dehydrogenase, trypsin, lysozyme, ribonuclease and cytochrome C,
run under identical conditions.
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Figure 2 Synthesis of undecaprenyl phosphate. Scans of radioactive product on paper chromatograms.
Incubation mixtures were prepared with ficaprenol, crude BSE and 50 mM tris-HCI (pH 8.5) buffer
(see text). Span 20 detergent was omitted from (a) but added to (b). After 30 min incubation
with 32P-7-ATP the whole mixture was applied to paper, developed in iso-butyric acid: 1 M aqueous
ammonia (5:3) and scanned as described in text, using the Tracerlab 47t scanner with a full scale
range of 100 cpm and a time constant of 150 sec. O = origin; SF = solvent front.
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Table 1 Phosphokinase activity with isoprenols of varying chain length as substrates























Incubation mixtures were set up as described in Materials and methods. After 30 min incubation
each reaction was terminated by the addition of 30 pi tetrahydrofuran and chromatographed on
paper in isobutyric acid: 1 M ammonia (5:3). The solvent fronts were cut out and assayed for
radioactivity.
pellet, 60 mg (0.32%) was soluble in acid butanol. After the —20°C precipitation, 28 mg
crude butanol soluble enzyme (BSE) was obtained (0.15% of the total membrane protein).
A comparison between the proteins in the unextracted membranes and those in the
butanol soluble fraction was made by polyacrylamidc gel electrophoresis in the presence
of sodium dodecyl sulphate (0.1%) (Figure 1).
Enzyme activities associated with crude BSE
The presence of two glycosyl transferases and a Css isoprenoid alcohol phosphokinase
in crude BSE preparations has already been reported and was confirmed. Incubation
mixtures prepared as in the Methods were made with and without the detergent Span 20
to tost the effect on synthesis of isoprenyl phosphates. After separation of the products
by paper chromatography, the results were as shown in Figure 2. It was possible to
resolve the large peak shown in Figure 2 into two separate peaks. These corresponded
in their mobilities, to inorganic phosphate and unreacted ATP. Several isoprenoid
alcohols of chain length less than 11 isoprene units were tested to determine whether
they would act as substrates for the phosphokinase present in crude BSE. The results,
after 30 min incubation and assay of the material running at the solvent front on paper
chromatography (solvent — isobutyric acid: ammonia), are given in Table 1. The identity
of the radioactive material was chocked by thin layer chromatography of the chloroform/
methanol soluble material from duplicate incubation mixtures (Figure 3).
Attempted purification of BSE
Crude BSE (28 mg protein) from K. aerogenes membranes was extracted with 3 x 10 ml
butanol at room temperature for 20 min with shaking and the pellet removed by centri-
fugation at 20,000 xg for 2 min. Soluble material (fraction 1) was removed and the
pellet (fraction 2) retained. Fraction 1 was evaporated with about 5 g of 3 mm diameter
glass beads in a round-bottomed flask, then extracted with 25 ml methanol by shaking
at room temperature for 1 h. After centrifugation in a bench centrifuge for 5 min the
soluble material (fraction 3) was removed. The pellet was sequentially extracted with
25 ml each of 5% butanol in methanol (fraction 4); 10% butanol in methanol (fraction




















Figure 3 Synthesis of shorter chain length prenyl phosphates. Chloroform/methanol (2:1)
extracts of incubation mixtures with (a) geraniol, (b) farnesol, (c) geranyl-geraniol, and (d) solanesol
as substrates, were incubated and chromatographed as described in the text (solvent was diiso-
butylketoneiacetic acid:water, 40:25:5). Instrument settings were as for Figure 2.0= origin;
SF = solvent front.




















Figure 4 Protein and phosphorus solubilized from crude BSE during attempted purification.
Fraction 1, butanoi soluble material from crude BSE; fraction 2, butanol insoluble material;
fraction 3, methanol soluble material from butanol-solubilized crude BSE; fraction 4, 5% (v/v)
butanol in methanol solution from BSE; fraction 5, 10% (v/v) butanol in methanol solution;
fraction 6, 30% (v/v) butanol in methanol solution; fraction 7, 50% (v/v) butanol in methanol
solution; fraction 8, 100% butanol; fraction 9, residual insoluble material. Procedure as in Results.
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finally 25 ml butanol (fraction 8). The pellet was designated fraction 9. Each fraction
was analysed for protein, total phosphorus (Figure 4) and isoprenoid alcohol phospho-
kinase activity (Table 2). An attempt to examine the fractions by polyacrylamide gel
electrophoresis was unsuccessful as the large amounts of lipid present interfered.
The activity of the isoprenoid alcohol phosphokinase was apparently lost during the
organic solvent fractionation procedure, although Span 20 and cardiolipin were added
as possible activators. Attempts to purify this enzyme further were unsuccessful. The
failure of this procedure to yield active enzyme indicates that there is a difference in
this enzyme from K. aerogenes when compared with that from S. aureus.
Amino acid analysis of BSE
Although the isoprenoid alcohol phosphokinase could not be fractionated further from
the —20°C precipiatate, an examination of the amino acids present would provide an
indication of the overall composition of the constituent proteins and also of their hydro¬
phobic nature. Paper chromatography of BSE after hydrolysis in 6 M HC1 for 18 h at
100°C showed that the protein contained all the normal amino acids with alanine, gly¬
cine, phenylalanine and leucine/isoleucine in the highest concentrations. From quanti¬
tative amino acid analysis (Table 3), the content of hydrophobic amino acids as defined
by Sandermann and Strominger (1971), is 54.5%.
Discussion
Extraction of membranes of K. aerogenes with acid butanol and precipitation at —20°C
yielded 0.15% of the membrane protein, containing a number of different proteins
(Figure 1). The membrane of Gram-negative bacteria thus contains a number of proteins
soluble in butanol and presumably resembling the isoprenoid alcohol phosphokinase
Table 2 Isoprenoid alcohol phosphokinase activity in fractions of crude
butanol-soluble enzyme











Incubation mixtures were set up as described in Materials and methods. Similar amounts of
protein (200—400 /ig) from each fraction were added as enzyme, and Span 20, bactoprenol and
buffer were added as in text. The whole incubation mixture, after 30 min was treated as in Table 1
and radioactivity at solvent front assayed.
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* Results expressed as nmoles of amino-acid per 0.500 A280
from S. aureus in their general amino acid composition (Sandermann and Strominger,
i 1972). Not all these proteins need possess enzymatic activities, but, as we have already
identified three distinct enzyme reactions associated with the BSE preparations, more
may be present. Attempts to fractionate the crude mixture, using methods applicable
to a Gram-positive bacterium, were unsuccessful, and indicate that the prenol kinase
may be differently organized within the Gram-negative membrane. Protein, together
with phosphatidylethanolamine and cardiolipin was removed during fractionation, but
the high content of hydrophobic amino acids (Table 3) amounting to 54.5% compared
with the 57.8% reported for the S. aureus enzyme apoprotein (Sandermann and
Strominger, 1972) may account for the butanol solubility of these proteins.
The incubation mixture for phosphokinase assay contains a large excess of inorganic
phosphate. Despite this, incubation mixtures produced 32P-labelled inorganic phos¬
phate. This taken together with the evidence for a reproducible dephosphorylation
of isoprenoid alcohol phosphate on prolonged incubation (Poxton et al., 1974), suggests
that BSE contains a phosphatase. Slight activity against nitrophenylphosphate was
demonstrated, but the specificity of the phosphatase is not known, nor is it certain that
the same enzyme dephosphorylates the isoprenyl phosphate. E. coli alkaline phosphatase
is inactive against polyprenyl phosphates synthesized by Micrococcus lysodeikticus
(Keanan and Allen, 1974) under conditions where nitrophenyl phosphate is hydrolysed.
Other prenols act as substrates for the phosphokinase with lower efficiency than
bactoprenol. Solanesol, the nearest in chain length to bactoprenol of those tested, is
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the poorest substrate. This probably due to the isoprene units being in the trans con¬
figuration; all the other prenols tested have the cis configuration at the -OH terminal
isoprene unit. Higashi et al. (1970) using a wide variety of isoprenoid alcohols as potential
acceptors in tests with a phosphokinase from S. aureus, reported maximum activity with
C50 and C55 ficaprenols. Solanesol was a very poor acceptor, which did not stimulate
the formation of peptidoglycan lipid intermediate when added with ATP to incubation
mixtures. The lower phosphorylation of geranylgeraniol than isoprenols of shorter
chain length cannot be explained, but thin layer chromatography of replicate incuba¬
tion mixtures showed peaks of comparable magnitude to the values in Table 1. There
may be two different kinases within the crude BSE, one for CS5 alcohols and one for
shorter chain length prenols. In the synthesis of polyprenyl pyrophosphates from
A 3-isopentenyl pyrophosphate byM lysodeikticus (Allen et al., 1967) and Salmonella
newington (Christenson et al., 1969), the shorter chain length prenyl pyrophosphates
were synthesized by one enzyme and had the longer chain length compounds by a
second enzyme. Allen et al. (1967) also showed that in M. lysodeikticus the shorter
chain length pyrophosphates are more susceptible to alkaline phosphatase than are the
longer chain length products.
From the results discussed above and the fact that free isoprenoid alcohol has been
isolated from K. aerogenes (J. A. Lomax, unpublished results) as well as Streptococcus
faecalis (Umbreit et al., 1972). it seems likely that the control mechanisms postulated
by Sandermann and Strominger (1971, 1972) for S. aureus are not unique to that bac¬
terium but also exist in K. aerogenes. This would provide a useful mechanism for con-
tolling the level of available isoprenoid alcohol phosphate for use in polysaccharide
synthesis. If the phosphokinase-phosphatase system controls the gross level of isoprenyl
phosphate carrier lipid in the bacteria, a second mechanism may be required to control
which polymer — peptidoglycan, lipopolysaccharide or exopolysaccharide — is synthesized.
The control of this system is not yet understood but may depend on spatial separation
of the enzymes and substrates involved.
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The Structure of C-Polysaccharide from the Walls of
Streptococcuspneumoniae
By IAN R. POXTON,* EDWARD TARELLIf and JAMES BADDILEY
Microbiological Chemistry Research Laboratory, University ofNewcastle upon Tyne,
Newcastle upon Tyne NE\ 1RU, U.K.
(Received 5 May 1978)
The well-known immologically active component of pneumococci, C-polysaccharide, is a
teichoic acid that can be isolated from the cell walls and purified by Sephadex and ion-
exchange chromatography. Further details of the structure of C-teichoic acid were
established by chemical degradation, including hydrolysis in acid and alkali, treatment
with HF, periodate oxidation and methylation. In addition, the use of 13C n.m.r. has
confirmed some of these structural features and resulted in a proposal for the order of
substituents, the location of positions of substitution and the configuration of anomeric
centres in the repeating unit of the polymer.
The C-teichoic acid (C-polysaccharide) of
Streptococcus pneumoniae is receiving renewed atten¬
tion in immunology. It is mitogenic for T lympho¬
cytes; thus, as it is a widespread contaminant in
most pneumococcal capsular polysaccharide prep¬
arations, its presence might affect the use of the
preparations in studies on their effect on the immune
response (J. H. Humphrey, personal communication).
It possesses choline phosphate haptenic groups and
binds both to idiotypic determinants on immuno¬
globulins produced against other molecules pos¬
sessing choline phosphate residues, and to certain
myeloma proteins with binding sites specific for
choline phosphate (Brown & Crandall, 1976;
Glaudemans et al., 1977). C-reactive protein, an
acute-phase protein that is found in human serum
during several pathological conditions including
tissue injury, carcinoma and the febrile stages of
infections with various micro-organisms, is pre¬
cipitated by C-teichoic acid. This again probably
involves the choline phosphate determinant and
complement is consumed in vivo (Kaplan &
Volanakis, 1974). An homology has been noted
between human and rabbit C-reactive proteins,
immunoglobulins and histocompatibility antigens
by amino acid sequencing (Osmand et a/., 1977).
I The physiological importance of choline phosphate 4
residues in the cell wall of the pneumococcus is also
noteworthy and well documented. The biosynthetic
replacement of choline with analogues such as
Abbreviation used: Dnp, 2,4-dinitrophenyl.
* Present address: Bacteriology Department, Medical
School, University of Edinburgh, Edinburgh EH8 9AG,
Scotland, U.K.
f Present address: National Institute of Biological
Standards and Control, Holly Hill, Hampstead, London
NW3 6RB, U.K.
ethanolamine affects the organism in a number of
ways; the cells are unable to separate, genetic trans¬
formation is inhibited, and the organism becomes
resistant to autolysis, phage infection and the lytic
action of penicillin and other cell-wall antibiotics.
These altered properties are probably the results of
defects in the autolytic system of the organism
(Tomasz et al., 1975). A knowledge of the structure
of C-teichoic acid is therefore important in under¬
standing the nature of its association with immuno¬
globulin, myeloma, C-reactive protein and also the
autolytic enzyme system of the pneumococcus.
Since the first description of a species-specific
somatic antigen (fraction 'C') of the pneumococcus
by Tillett & Francis (1930) several structural studies
have been made, notably by Goebel et al. (1943) and
Gotschlich & Liu (1967). Brundish & Baddiley (1968)
first showed the polymer to be a teichoic acid com¬
prising a repeating unit containing ribitol phosphate,
.^-acetylgalactosamine, 7V-acetyIdiaminotrideoxy-
hexose, choline phosphate and glucose residues.
More recently, Watson & Baddiley (1974) studied the
action of HN02 on the polymer and proposed a
partial structure. In the present paper we describe an
improved method of preparation and further work
on the structure of C-teichoic acid resulting in the




Streptococcus pneumoniae A.T.C.C. 12213 was
grown in 15-litre batches as previously described
(Poxton & Leak, 1977). HF (60%, w/w) was pur¬
chased from Hopkin and Williams, Chadwell Heath,
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Essex, U.K. The glucose oxidase reagents were from
Sigma Chemical Co., London KT2 7BH, U.K.,
alkaline phosphomonoesterase was from Boehringer
Corp., London BN7 1LG, U.K., and KB3H4 from
The Radiochemical Centre, Amersham, Bucks.,
U-K- All other chemicals were purchased from local
suppliers.
Analytical methods
Phosphate was determined by the method of
Chen et at. (1956), choline by the method of Appleton
et al. (1953), glucose by the method of Dubois et al.
(1956) and also by the glucose oxidase reagents,
hexosamine by the method of Strominger et al.
(1959) and amino groups by the ninhydrin method
(Rosen, 1957). Amino sugar analyses were carried out
on a JEOL amino acid analyser.
Methylation analysis, by preparing partially
methylated alditol acetates by the method of Jansson
et al. (1976), was investigated in a Varian 1400 all-
glass gas-liquid chromatograph and a Micromass
(V. G. Micromass, Altrincham, Cheshire, U.K.)
model 12B2 mass spectrometer operating at 70eV
and 4kV accelerator voltage. Capillary columns were
used, coated with SP1000 resin for derivatives of
neutral sugars and SE30 resin for derivatives of
amino sugars (both liquid phases were supplied by
Phase Separations, Queensferry, Clwyd, U.K.)
Proton-decoupled 13C-n.m.r. data were deter¬
mined at 22.63 and 50.3 MHz in 2H20 solution at
32°C. External tetramethylsilane was used as
reference.
Immuno-gel diffusion on agarose plates was by the
method of Ouchterlony against C-antiserum kindly
given by Dr. Michael Heidelberger (New York
University Medical Center, New York, NY, U.S.A.).
Paper chromatography and electrophoresis
Both were carried out on Whatman no. 1 paper'
or, on a preparative scale, on Whatman 3MM paper
(washed with 2M-acetic acid and water). Descending
paper chromatography was used with the following
solvent systems: A, propan-l-ol/aq. NH3 (sp.gr.
0.88)/water (6:3:1, by vol.); B, ethyl acetate/
pyridine/acetic acid/water (5:5:1:3, by vol.).
Electrophoresis was carried out with a Shandon
Southern (Camberley, Surrey, U.K.) apparatus,
model L24, with the following buffers: C, 8.0%
(v/v) formic acid, pH1.8; D, pyridine/acetic acid/
water (1:1:38, by vol.), pH4.7; E, pyridine/acetic
acid/water (5:2:93, by vol.), pH5.3.
Compounds were detected by the following
methods: reducing sugars by the alkaline silver
nitrate reagents (Trevelyan et al., 1950), a-glycols
by the periodate/Schiff spray reagents (Baddiley
et al., 1956), amino compounds by ninhydrin,
phosphate esters by the acid molybdate spray
(Hanes & Isherwood, 1949) and choline and choline
phosphate by the Dragendorf spray reagent (Bregoff
et al., 1953).
Preparation of C-teichoic acid
Washed bacteria were suspended in ice-cold water
to a concentration of about 30% (w/v) and disrupted
for 2.5min in a Braun homogenizer with no. 11
Ballotini beads. Walls and unbroken bacteria were
collected by centrifugation at lOOOOg- for 30min at
4°C. The walls were carefully removed from above the
pellet of unbroken cells and suspended in water.
The suspension was heated rapidly to 80°C and kept
at that temperature for 3 min to destroy autolytic
enzymes. The walls were then washed three times in
water. Protein and membrane components were
removed by pouring a 30% (w/v) suspension of ceil
walls into an equal volume of boiling 5% (w/v)
sodium dodecyl sulphate and stirring for 4h at room
temperature (20°C). The cell walls, which were still
slightly contaminated, were washed by centrifugation
at lOOOOg for 20min in six changes of water at
20°C.
Cell walls were suspended in ice-cold water to a
concentration of about 2.5 % (w/v) and trichloro¬
acetic acid was added to a final concentration of
10% (w/v); C-teichoic acid was extracted by stirring
for 48 h at 4°C. The cell walls were removed by
centrifugation at lOOOOg for 30min at 4°C and the
trichloroacetic acid was removed from the super¬
natant fluid by six extractions with equal volumes of
diethyl ether. Water was removed by rotary evap¬
oration and nucleic acids by fractionation on a stacked
column of Sephadex G-25 and G-75 similar to that
described by Slabyj & Panos (1973), except that
0.2M-NaCl was used instead of LiCl. The fractions
containing phosphorus, but which did not absorb
at 260nm, were combined, decreased in volume and
desalted on a Sephadex G-25 column (60cm x 1.5 cm).
A final purification was carried out by ion-exchange
chromatography on a column (30cmx 1.5cm) of
DEAE-cellulose (Whatman DE-52), eluting with
a continuous gradient (0-1 M) of pyridinium acetate,




C-teichoic acid (2mg) was hydrolysed in 2m-HC1
for 3h at 100°C in a sealed tube. Acid was removed
in vacuo over NaOH and the products were examined J
by paper chromatography in solvents A and B.
The following were identified: ribitol, anhydroribitol,
galactosamine, glucose, galactosamine phosphate
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and isomeric ribitol phosphates. Electrophoresis in
buffer C reyealed choline, but not choline phosphate.
Molecular proportions of the constituents were
determined with both hydrolysed and unhydrolysed
material. After hydrolysis (2m-HC1 at 100°C for 3h),
the proportions of phosphorus/hexosamine/glucose/
choline/amino groups were 2:1.8:0.2 (by glucose
oxidase):0.66:2.6. Unhydrolysed material had a
molar ratio phosphorus/hexose (phenol/H2S04
method) of 2:0.2. A more accurate value of
phosphorus/galactosamine was obtained from the.
amino acid analyser. C-teichoic acid (5mg) was
dissolved in 1.2ml of water; 0.5ml samples were
adjusted to a final concentration of 4m-HC1 and
hydrolysed in vacuo for 6 and 24h at 100°C. After
removing the HCI over NaOH, samples were
examined in the analyser. Total galactosamine was
calculated by summation of the free galactosamine
and the galactosamine phosphate. The remaining
0.2ml of sample was used for phosphorus determi¬
nation. Molar ratios of phosphorus/galactosamine
were 2:0.87 after 6h and 2:0.95 after 24h. This
showed that the true ratio of phosphorus/galactos¬
amine was 2:1 and the anomaly in the hexosamine
value was probably due to the diaminohexose, which
is a known constituent, being decomposed to a
pyrrole that reacts with hexosamine reagents. The
presence of three amino groups/two atoms of phos¬
phorus agrees with this conclusion.
Alkaline hydrolysis
C-teichoic acid (20mg) was dissolved in 4ml
of 1 m-NaOH, sealed in a plastic tube and hydrolysed
for 3h at 100°C, cooled, desalted through 20 ml of
Dowex 50 (NH4+ form) resin, evaporated to dryness
and redissolved in 2 ml of water. Less than 5 % of the
total phosphorus was present as Pi. A portion (1 ml)
was treated for 16 h at 37°C under toluene with
alkaline phosphomonoesterase (10//g of Boehringer
suspension) at pH9 [adjusted with (NH4)2C03j.
In several experiments, 50-60% of the phosphorus
was converted into Pj. Thus about half of the
phosphorus was phosphomonoester after alkaline
hydrolysis.
The product of alkaline hydrolysis was hydrolysed
in acid (2m-HC1, 3h at 100°C) before and after the
phosphatase treatment. With solvents A and B, it was
found that before phosphatase treatment ribitol,
anhydroribitol, galactosamine, ribitol phosphates and
galactosamine phosphate were present. After phos¬
phatase treatment, all but ribitol phosphates were
present and the amount of ribitol appeared to have
increased. This suggests that the ribitol is attached to a
phosphomonoester and galactosamine to a diester
after the alkaline hydrolysis.
If choline had been produced in the alkaline
hydrolysis, it would have been bound to the Dowex
50 resin during desalting. In a control experiment,
choline phosphate was treated with 1 m-NaOH for
3 h ait 100°C. After cooling and neutralization with
dilute HCI, both organic phosphate and Pi were
determined. No P, was produced, but electro¬
phoresis of the.products showed that choline phos¬
phate had been destroyed and a smell resembling
trimethylamine was noted. Presumably choline
phosphate undergoes a Hofmann elimination to
trimethylamine and possibly vinyl phosphate under
the experimental conditions. Similarly, when C-
teichoic acid was hydrolysed with alkali a charac¬
teristic smell of a tertiary amine was observed. The
phosphate associated with the choline residue
remained as a diester bound to galactosamine. When
the hydrolysate was subsequently hydrolysed with
acid, chromatography in solvent B revealed a fast-
moving product that was not characterized, but was
probably derived from the vinyl group attached
through the phosphodiester to galactosamine.
Reaction with 1 -fluoro-2A-dinitrobenzene
To detect the diaminohexose, C-teichoic acid was
treated with fluorodinitrobenzene to dinitrophenylate
the free amino groups. The reaction was carried out
by the method of Distler et al. (1966); 12mg of
material was used and the final purification was by
dialysis in several changes of water for 24h. The
resultant dinitrophenylated material (Dnp-C), and
C-teichoic acid itself, were examined with C-anti-
serum on a gel-diffusion plate; a sharp yellow pre¬
cipitin band was obtained continuous with the band
given by the C-teichoic acid.
The number of dinitrophenyl groups was deter¬
mined at A360 and compared with a standard curve
derived from £-dinitrophenyl-lysine. A molar ratio
of phosphorus/dinitrophenyl groups of 2:0.76 was
found, i.e. about one free amino group to two phos¬
phates. Acid hydrolysis (4m-HC1, 4h at 100°C) of
Dnp-C (2mg) and electrophoresis in buffer D for
30min at 55 V-cirr1 gave a single yellow product that
strained with the ninhydrin reagent and migrated
about twice as far as dinitrophenyl-lysine. This was
similar to the properties observed by Distler et al.
(1966) for the Dnp-diaminohexose.
Degradation with HF
HF (60%, w/w) converts phosphomono- and
phosphodi-esters into P, and phosphorofluoridates
without significant hydrolysis of glycosidic linkages
(Lipkin et al., 1969). To protect the sensitive diamino¬
hexose, the C-teichoic acid (20 mg) was dinitrophenyl¬
ated as described above and a dry sample in a plastic
tube was treated with 1ml of 60% (w/w) HF at 0°C
for 16h. After neutralization with 60 ml of Dowex 2
Vol. 175
1036 I. R. POXTON, E. TARELLI AND J. BADDILEY
(COV form) resin by the method of Anderson et al.
(1977), the resulting material was examined by
electrophoresis in buffer E; a single yellow spot
remained at the origin, and a spot corresponding
to choline was detected by the Dragendorf spray.
On paper chromatography in solvent A a single
yellow spot, 7?ribitoi 1-3, was seen; in solvent B it had
glucose 1-6. The yellow material was purified by
preparative electrophoresis in buffer E on Whatman
3MM paper, where it remained at the origin. It was
eluted in water and hydrolysed with acid. Under
vigorous conditions (4m-HC1 for 6h at 100°C) a
yellow spot was observed on electrophoresis in
buffer D corresponding to Dnp-diaminohexose.
Galactosamine, ribitol, anhydroribitol and glucose
were also observed on paper chromatograms. Under
less vigorous conditions (2m-HC1 for 3h at 100°C) an
additional yellow spot was detected, migrating 1.5
times as far as the Dnp-diaminohexose; this was a
disaccharide of galactosamine and the diaminosugar,
both of which had been de-A-acetylated. This
disaccharide is discussed below.
When the yellow product obtained by treatment of
Dnp-C with HF was treated with 0.1 m-HCI at 100°C
for 30min and the mixture examined by paper
chromatography, ribitol and glucose were detected
together with two yellow products in roughly equal
amounts; one had Rgiucose 1.1 (solvent B), which was
the same as the starting material, and the other had
glucose 1.5. This second product was eluted from the
paper and a portion hydrolysed in 2m-HC1 at 100°C
for 3 h; the major products were Dnp-diaminohexose
(Rgtucose 1.7), galactosamine (in solvent B) and a
yellow component with RgiUQOse T3, which was de-N-
acetylated starting material (this was identical with
the disaccharide described above). After more
vigorous hydrolysis (4m-HCI for 6h at 100°C) only
galactosamine and Dnp-diaminohexose were
observed.
Reduction of the disaccharide with KB3If
The disaccharide (1 mg) prepared as above was
treated with 0.2ml of 0.2m-KBH4 [containing
14.8 MBq (0.4mCi) of 3H] for 2h in a fume cupboard.
Excess of BH4~ was destroyed by adding 50% (v/v)
acetic acid dropwise until the pH was below 5. The
solution was freeze-dried, the products were treated
with 2M-HC1 for 3h at 100°C and, after desiccation
over NaOH, dissolved in 0.5 ml of water, desalted
through Dowex 50 (H+ form) resin and eluted with
20 ml of 1m-NH4OH. Borate was removed by distil¬
lation with methanol (5 times) and CD and reducing
sugars were removed by passage through 2 ml of
Dowex 2 (OH~ form) resin. The colourless solution
contained a radioactive alditol that was indistinguish¬
able from galactosaminitol in solvent A and on
electrophoresis in buffer E. This confirmed that
galactosamine was the reducing component of the
disaccharide.
Order ofsubstituents in the repeating structure
The present results, together with those obtained
before (Brundish & Baddiley, 1968; Watson &
Baddiley, 1974) enable a partial structure to be
derived for the main repeating unit, i.e.:
-[Diaminotrideoxyhexosyl
*
jY-acetylgalactosaminyl ->■ ribitol phosphate],-
I
choline phosphate
The diaminosugar and ribitol were known to be in
the polymer chain because of their respective
destruction by HN02 (Watson & Baddiley, 1974) and
by periodate (Brundish & Baddiley, 1968), causing
simultaneous fission of the chain. Moreover, N-
acetylgalactosaminylribitol was characterized as a
degradation product (Watson & Baddiley, 1974).
The isolation in the present work of a disaccharide
containing the diaminosugar attached to a reducing
galactosamine confirms the above sequence.
Although the study by Watson & Baddiley (1974)
and the present work demonstrate the presence of
glucosyl substituents in the polymer, the amount is
insufficient for one glucose to each repeating unit.
It is likely then that either only a few of the repeating
units are glucosylated or that the glucose is localized
at the end of the chain. It is not attached through a
phosphodiester at its 1-position because it remains
attached to the unit obtained by HF treatment, and
reduction of this with B3H4~ gives no labelled
glucitol residue. Watson & Baddiley (1974) suggested
that the glucosyl substituent might be associated with
phosphate, since a product tentatively identified as
glucitol phosphate had been detected, but it now
seems likely that this identification was incorrect.
Although the location of glucose is still inadequately
established, the methylation and n.m.r. studies
described below indicate the presence of a glucosyl-
glucosyl (/?-isomaltosyl) substituent.
Periodate oxidation
Substitution of the galactosamine residue was
examined by the action of periodate. Aqueous
solutions (1 ml) of polymer and the Dnp/HF product
(lmg of each) were mixed with 5mM-NaI04 (1ml)
in O.lM-acetate buffer at pH4.5. After 16h at room
temperature under toluene, excess of periodate was
destroyed by adding ethylene glycol (5/d), solvent
removed in vacuo and the residue hydrolysed in
4m-HC1 for 6h at 100°C. After removal of acid over
NaOH in vacuo galactosamine was determined with
the autoanalyser. In neither experiment was a
decrease in aminosugar detected after the periodate
1978
PNEUMOCOCCAL C-POLYSACCHARIDE 1037
treatment, whereas galactosamine itself was com¬
pletely destroyed under similar conditions.
It follows that the diaminohexose must be attached
to the 3- or 4-position on the ^-acetylgalactosamine
residue. If it had occupied the 6-position then the
removal of the choline phosphate residue by HF
from the 3- or 4-position would have created an
oxidizable glycol structure.
There is strongjustification for the assumption that
the phosphodiester substituent on ribitol must
occupy the D-5-position. All of the many ribitol
teichoic acids examined are derivatives of D-ribitol
5-phosphate that, in the form of CDP-ribitol, is the
biosynthetic precursor of these compounds. It
follows that, as the ribitol residues in the polymer are
destroyed by periodate, causing chain fission, the
A-acetylgalactosaminyl substituents should occupy
the D-l- or -2-positions on ribitol.
Preparation of N-acetyl/HFproduct
For the following methylation and 13C-n.m.r.
studies the HF product was prepared from fully
A-acetylated C-teichoic acid. This was preferable to
using dinitrophenylated polymer.
The C-teichoic acid (120mg) was dissolved in
10 ml of water and 2 ml of saturated NaHC03
solution was added. This was cooled in ice and 2ml
of fresh ice-cold aq. 5 % (v/v) acetic anhydride was
added. Incubation was for 25 min at room temperature
and then excess of acetic anhydride was destroyed by
heating to 100°C for 3 min. The TV-acetylated polymer
was first desalted through a 20 ml column of Dowex
50 (NH4+ form) resin, decreased in volume, then
further purified by passage down a column (60cm x
1.5 cm) of Sephadex G-25 and finally freeze-dried in a
plastic tube. A yield of 114mg was obtained. This was
treated with 60% (w/w) HF as for the Dnp-polymer.
After HF treatment, the products were again N-
acetylated as above. The oligosaccharide products
were fractionated on a column (60cm x 1.5cm) of
Sephadex G-10 and the highest-molecular-weight
fraction was freeze-dried. A yield of 25 mg of pure
7V-acetylated HF product was obtained, which
contained ribitol, ^-acetylgalactosamine, A-acetyl-
diaminohexose and glucose.
Methylation studies
The position of substitution on ribitol and the
nature of the glucosyl substituents were studied by
methylation followed by hydrolysis, reduction,
acetylation and examination by g.l.c.-mass spectro¬
metry. The method of Hakomori (1964) as developed
by Jansson et al. (1976) was used with minor modifi¬
cations. The A-acetyl/HF product (4mg) from C-
teichoic acid was dissolved by ultrasonic treatment
in dry dimethyl sulphoxide (2ml) under N2. Prep-
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aration of the partly methylated alditol acetates
was as described (Bjorndal et al., 1967; Jansson et al.,
1976), except that hydrolysis was with 2m-HCI for
3 h at 100°C, followed by removal of acid over NaOH
in vacuo. The partly methylated alditol acetates of
neutral sugars were examined on a column of SP1000
resin, the results being given in Table 1. Products
(C)-(F) were identified by comparing their mass
spectra with the published data on authentic standards
(Jansson et al. 1976). Product (A) had a similar
retention time (approx. 7 min) to the isomeric 4-0-
acetyl-l,2,3,5-tetra-0-methylribitol and ions of mle
71, 89, 101, 117, 145 and 161 were identified. These














The mass spectrum was significantly different from
that of the above-mentioned isomer. Product (B) had
a slightly longer retention time than did authentic
2,3,5-tri-0-methyl-l,4-anhydroribitol, and both the
molecular ion {m/e 204) and the ion from the ring
(positions C-l to C-4) with m/e 131 were identified.
It follows that in the A-acetyl/HF product ribitol is
monosubstituted at a terminal position, and con¬
sequently the A-acetylgalactosaminyl substituent
must occupy that position.
The structure of the glucitol derivatives arising
from the glucosyl substituents was also established.
1,5-DirO-acetyl-2,3,4,6-tetra-0-methylglucitol must
represent a glucose residue at a non-reducing
terminus, and l,5,6-tri-0-acetyl-2,3,4-tri-0-methyl-
glucitol represents a glucose substituted at its 1- and
6-positions. These results agree with the presence
of a glucosyl(l 6)glucosyl substituent in the polymer
and this is supported by the n.m.r. data.
Although partially methylated derivatives from
the amino sugars might have been expected, in fact
g.l.c.-mass spectrometry studies of these proved
unsatisfactory. They are known to be difficult to
investigate by this method and a very complex
profile was obtained, probably because of their poor
volatility and complex fragmentation in the mass
spectrometer arising from their thermal instability.
Methyiation of C-teichoic acid itself seemed less
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Table 1. Partially methylated products from neutral sugars obtained from C-teichoic acid and its N-acetyl/HFproduct
Samples were examined on a capillary column of SP1000 resin and the temperature was controlled between 100 and
200°C at 2°C/min. Abbreviations: +++, >30%; ++, 10-30%; +, 5-10%; tr, <5% of the sum of peak heights.
Present in:
, —■ , Relative
Derivative C N-Ac-HF retention time
(A) 5-0-Acetyl-l,2,3,4-tetra-0-methylribitol — +++ 0.39
(B) 5-0-Acetyl-2,3-di-0-methyl-l,4-anhydroribitol +++ tr 0.56
(C) l,4-Di-0-acetyl-2,3,5-tri-0-methylribitol ++ tr 0.73
(D) l,5-Di-0-acetyl-2,3,4-tri-0-methylribitol tr tr 0.76
(E) l,5-Di-0-acetyl-2,3,4,6-tetra-0-methylglucitol + ++ 1.00







Fig. 1. Proton decoupled l3C n.m.r. spectrum of C-teichoic acid at 50.3 MHz in 2H20
attractive, since the presence of hydroxy groups in
the vicinity of the phosphodiester linkages might be
expected to facilitate cyclization during methylation
and consequent fission of diesters. This problem has
been long recognized in nucleic acid chemistry.
Nevertheless, an unpublished report cited by Conrad
(1972) suggested that methylation by the Hakomori
(1964) method might leave phosphodiester group's
intact. Consequently, C-teichoic acid (7mg) was
methylated and products were hydrolysed as de¬
scribed for the TV-acetyl/HF product. The hydrolysate
was treated with alkaline phosphatase (10//g in 1 ml)
under toluene after adjustment to pH9 with aq. NH3.
After 16 h at 37°C, all of the phosphorus had been
converted into Pj. Reduction and acetylation was
followed by examination with g.l.c.-mass spectro¬
metry. Results are given in Table 1; these suggest that
fission of phosphodiester linkages might well have
occurred, giving anhydroribitol derivatives. However,
even in this case the glucitol derivatives were easily
detected, suggesting the presence of the glucosyl-
(I -^6)glucosyl substituent in the polymer.
13C n.m.r. spectroscopy
Proton-decoupled 13C n.m.r. spectra of C-teichoic
acid and of its A-acetyl/HF product were determined
in 2H20 solution. Fig. 1 shows the spectrum (50.3
MHz) of C-teichoic acid and Table 2 gives the
calculated and observed chemical shifts relative to
internal tetramethylsilane together with the assign¬
ments for both the polymer and the A-acetyl/HF
product. Chemical-shift values were calculated from
the reported values of the individual units by allowing
increments for the formation of glycosidic and
phosphodiester bonds (see Table 3). The spectrum of
the polymer, although not fully interpreted (owing in
part to the lack of data for 2-acetamido-4-amino-
2,4,6-trideoxyhexose), nevertheless provided im¬
portant structural information, including positions
of glycosylation, anomeric configurations and
confirmation of the nature of the amino functions.
Two separate signals were observed at low field
(approx. 175 p.p.m.) and high field (approx. 23 p.p.m.)
portions of the spectrum of the polymer, readily
attributable to the carbonyl and methyl carbons of
two acetamido functions. In addition, three signals
I I
characteristic of the -C-N group were observed at
I I
49.3, 50.7 and 52.Op.p.m., that at 49.3 p.p.m. being
assigned to C-4 of the diaminotrideoxyhexose on the
basis of the difference observed for this region in the
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Table 3. 13C n.m.r. chemical shifts (in p.p.m. from tetramethylsilane) of components of C-teichoic acid with increments
expectedfor substitution, thereby giving the calculated chemical shift values for(i) the polymer and (ii) the N-acetyl/HFproduct
Increments are given the following values: +7p.p.m. for the formation of a glycosidic bond at the anomeric carbon,
I 9 p.p.m. for the formation of a glycooidic bond at other carbons, —1 p.p.m. for the introduction of an adjacent bond
(Hamer & Perlin, 1976); +4.6 p.p.m. for the formation of a phosphodiester; —1.6 p.p.m. for adjacent phosphodiester in
ribitol (Branefors-Helander et ah, 1977); +3.4p.p.m. for the formation of a phosphodiester at position C-6, —0.5 p.p.m.
for an adjacent phoophodioster in her.opyranosidos (Bundle ct ah, 197J). (a) Unsubstituted with choline phosphate
at C 6 of GalN; (b) substituted with choline phosphate at C-6 of GalN. Values for the reported shifts were from Usui
et al. (1973) for isomaltose, Branefors-Helander et ah (1977) for ribitol, Bundle etal. (1973) for TV-acetylglucosamineand
Johnson & Jankowski (1972) for choline chloride.
Isomaltose (I)
Carbon 1 2 3 4 5 6 1' 2' 3' 4' 5' 6'
Reported shift 97.7 75.9 77.7 71.3 75.9 67.4 99.4 73.3 75.0 71.3 73.8 62.5
Increment +7 -1 0 0 0 0 0 0 0 0 0 0
Calculated shifts 104.7 74.9 77.7 71.3 75.9 67.4 99.4 73.3 75.0 71.3 73.8 62.5
ibitol (R)
Carbon 1 2 3 4 5
Reported shift 63.2 72.9 72.9 72.9 63.2
Increment +9 -1 0 -1.6 +4.6
Calculated shift 72.2 71.9 72.9 71.3 67.8
Increment +9 -1 0 0 0
Calculated shift 72.2 71.9 72.9 72.9 63.2
-Acetylgalactosamine (G)
Carbon 1 2 3 4 5 6 OIIUA ch3-
Reported shift 96.5 54.9 72.3 69.0 76.3 62.2 175.8 23.4
Increment +7 -1 -1 +9 (a)—1 (a) 0 0 0
(b)—1.5 (b)+3.4
Calculated shift 103.5 53.9 71.3 78.0 (a) 75.3 (a) 62.2 175.8 23.4
(b) 74.8 (b) 65.6
Increment +7 -1 -1 +9 -1 0 0 0
Calculated shift 103.5 53.9 71.3 78.0 75.3 62.2 175.8 23.4
Choline chloride (C)
Carbon 1 2 ch3
Reported shift 56.6 68.3 54.8
Increment +4.6 -1.6 0
Calculated shift 61.2 66.7 54.8
function was acetylated. The highest field signal
(16.7p.p.m.) was clearly due to the 6-deoxy group of
the same moiety. In the anomeric region of the
spectrum, four separate signals were observed; two
of these (105.0 and 99.6p.p.m.), of equal area, were
about 0.6 times that of either of the others (102.5 and
94.8 p.p.m.). (Quantification of components on the
basis of peak area may be inaccurate because of
variations in saturation effects, nuclear Overhauser
enhancement etc.) The former pair of resonances were
in close agreement with the expected values (104.7
and 99.4p.p.m.; Usui et a/., 1973) for C-! and
C-l' of a /(-isomaltoside but significantly different
from those (103.8 and 100.3p.p.m.) expected for
an a-gentiobioside and were assigned accordingly.
Of the remaining anomeric signals, that at 102.5
p.p.m. was close to the calculated chemical shift of a
/(-/V-acetylgalactosaminyl group, and indeed C-l of
such a group has been observed at this value in
several polysaccharides (Hamer & Perlin, 1976;
R. Lifely, E. Tarelli & J. Baddiley, unpublished work)
The remaining signal in this region was assigned to
the anomeric carbon of the diaminotrideoxyhexose,
the chemical shift (94.8 p.p.m.) supporting the a-
configuration.
Resonances caused by the choline phosphate
substituent could be assigned to those observed at
55.2, 55.9, 60.8 and 68.Op.p.m., in good agreement
with the calculated values, the signals in the region of
55p.p.m. being assigned to the trimethylammonium
group, as has been proposed (Bennett & Bishop, 1977).
This set of resonances was essentially absent from the
spectrum of the (V-acetyl/HF product.
The intermediate section of the spectrum (70.2-
78.1 p.p.nr.) was difficult to assign unequivocally to
individual carbon atoms; however, it was significant
that after the anomeric signals the next highest
chemical shift observed for either the polymer or the
(V-acetyl/HF product was that at 78.1 p.p.m. Two
important points arise from this, (i) Position C-3 of
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the ^-acetylgalactosamine residue cannot be in¬
volved in a glycosidic linkage since, had this been so,
a signal for this carbon at chemical shift 81-82p.p.m.
would have been present; this value would be ex¬
pected both from calculation and from studies with
chondroitins A, B and C and similar polysaccharides
containing (1-*3)-linked /1-A-acetylgalactosamine
residues (Hamer & Perlin, 1976; R. Lifely, E. Tarelli
& J. Baddiley, unpublished work). Therefore in
C-teichoic acid the linkage of the diaminotrideoxy-
hexose must be to the C-4 position ofA-acety lgalactos-
amine (bearing in mind the results obtained from
the periodate oxidation study), (ii) Ribitol is most
probably substituted at its C-l position by A-acetyl-
galactosamine, since if a secondary carbon of the
pentitol were glycosylated then a signal for this
carbon atom would have been expected at a chemical-
shift value above 80p.p.m., both from calculation
and from studies on similar systems (Branefors-
Helander eta/., 1977). Thus4-0-/?-D-gIucopyranosyl-
ribitol and related teichoic acids give respectively
resonances at 81.7 and 80.1 p.p.m. attributable to
position C-4 of the ribitol moiety. The signals
observed in the region 70.2-78.1 p.p.m. can then be
assigned generally as shown in Table 2.
Structural conclusions from chemical and n.m.r. data
It is possible to propose the following detailed





From the chemical evidence already presented, the
choline phosphate could occupy either position C-3
or C-6 of A-acetylgalactosamine. It is probable,
however, that this group is substituted at position
C-6 of the amino sugar since a resonance was observed
at 65.7p.p.m. in the spectrum of the polymer, which
is in accord with the chemical shift expected for a
phosphorylated primary carbon of a hexose (Bundle
et a/., 1974). Further, a signal at this value was absent
from the spectrum of the A-acetyl/HF product that,
in addition, gave a resonance of increased relative
intensity at 62.2 p.p.m. (unsubstituted hydroxy-
methyl carbon), as would be expected after removal
of the phOsphodiester.
The remaining feature is the location of the /?-
isomaltose residue. The low glucose content of the
polymer suggests that the residue does not contribute
to the main repeating structure, but might be located
at one end of the chain. The substitution of isomaltose
at a secondary position on ribitol is unlikely for
reasons similar to those proposed above in connection
with the A-acetyIgalactosaminy Iribitol linkage. More¬
over, the methylation study indicates that the ribitol
in the A-acetyl/HF product is only monosubstituted.
A more likely possibility is that position C-3 of the
chain terminal diaminotrideoxyhexose is glycosylated
with /1-isomaltose, although in the absence of t3C
chemical-shift data on this residue no more than a
tentative suggestion can be made. Nevertheless, if a
glycosidic linkage of this nature were present, then
the chemical shift of the carbon involved in the
linkage would be expected to be sufficiently low
(owing to the shielding effect of the adjacent amino
function) as to be within the range of chemical shifts
observed. A further possibility is that position C-6 of
those galactosamine residues that do not have a
choline phosphate substituent is substituted by an
isomaltose residue. The present data do not enable
us to distinguish between these possibilities.
The spectrum of the A-acetyl/HF product (Table
2) agrees with the structure proposed for the polymer;
the differences are accounted for by the absence of
phosphate substituents in the former. It is note¬
worthy that both give signals corresponding to four
anomeric centres in glycosyl substituents; these are
the two amino sugars and two glucose residues.
Disregarding the isomaltose residue, and assuming
that the stereochemistry of the ribitol phosphate is
the same as that in CDP-ribitol, the structure of
C-teichoic acid is given in Fig. 2. The chain length
of the polymer prepared by us has been examined by
measuring the choline phosphate-binding sites with a
specific antiserum (Glaudemans et al., 1977). It was
concluded that there were 4-5 binding sites/molecule,
and as about 66% of the A-acetylgalactosamine
residues in the polymer are substituted with choline
phosphate the chain would comprise about 8 re¬
peating units. From the amount of glucose in the
polymer a chain of this length would possess about 1
isomaltose residue. It is possible, however, that in the
wall itself the teichoic acid might be larger, as the
preparations examined were extracted from walls
with trichloroacetic acid and this might well have
caused a decrease in chain length through hydrolysis.
There is an apparent anomaly in the molar ratio
of glucose/phosphorus, the published values being
0.36:2 (Brundish & Baddiley, 1967), 0.74:2 (Brundish
& Baddiley, 1968) and 0.2:2 (the present paper),
whereas the 13C-n.m.r. data might seem to suggest a
yet higher value for glucose. This last evidence should
be discounted, however, as peak area is not necessarily
proportional to the amount of that carbon atom
present owing to differences in shielding of different
carbon atoms. In many determinations of the glucose/
phosphorus ratio in several different preparations of
C-teichoic acid, and by two different methods, we
consistently obtained values of about 0.2:2. The
present method for the preparation of C-teichoic
acid gives a much purer product than hitherto and
this might be reflected in the values obtained for
Vol. 175
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Fig. 2. Repeating structure in C-teichoic acid
The isomaltose substituent is not shown.
glucose. It is also possible that culture conditions
might influence the amount of substitution by glucose.
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summary
Choline, a component of the wall teichoic acid of Streptococcus pneumoniae,
was converted to cytidine diphosphocholine via choline phosphate by enzymes
which were identified in cell-free extracts of the pneumococcus. The first enzyme,
choline kinase, was investigated in some detail. It appeared to have a pH optimum
of 7-3 to 7-4 and was stimulated by Mg2+. Kinetic studies gave an apparent
Michaelis constant (Km) for ATP of 1 mM, and for choline of 0-19 mM, with
Emax values of 3 nmol min-1 (mg protein)-1 and 0-5 nmol min-1 (mg protein)-1
respectively. The second enzyme, CDPcholine pyrophosphorylase was specific
for CTP and had a requirement for Mg2+ with an optimum at 7 mM.
INTRODUCTION
Choline, a nutritional requirement of Streptococcus pneumoniae, is essential for the
normal functioning of the bacterium (Rane & Subbarow, 1940; Tomasz, 1968). It is utilized
as a structural component of the wall (C-) teichoic acid (Tomasz, 1967; Brundish & Baddiley,
1968) and of the pneumococcal Forssman antigen (Briles & Tomasz, 1973) but not in
phospholipid biosynthesis. Structural analogues of choline, such as ethanolamine, can
replace it as a growth requirement but several properties of the organism then become
altered, e.g. (i) the daughter cells become unable to dissociate completely, forming chains of
several hundred cells, (ii) the bacterium becomes resistant to both autolysis and detergent-
induced-lysis, and (iii) it is unable to undergo genetic transformation (Tomasz, 1968; Tomasz
et a!., 1975).
This study reports the biosynthesis of cytidine diphosphocholine (CDPcholine) from
choline in a cell-free system of S. pneumoniae. A similar pathway has been proposed in
brewers' yeast which utilizes choline as a component of phosphatidylcholine (lecithin),
one of the major phospholipids of this organism. This first enzyme of the pathway in yeasts,
the choline kinase, has been investigated in some detail (Brostrom & Browning, 1973) and
is compared here with the pneumococcal enzyme.
METHODS
Materials. [mc//)j7-3H]Choline chloride was purchased from The Radiochemical Centre,
Amersham. [mc,/7;>7-3H]Choline phosphate was synthesized chemically from [methyl-:iH]-
choline chloride by the method of Riley (1944), except that it was purified by preparative
electrophoresis on Whatman 3MM paper in buffer B instead of by precipitation and
* Present address: Molecular Sciences Department, University of Warwick, Coventry CV4 7AL.
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recrystallization of the calcium salt. Unlabelled choline chloride and CDPcholine were
from Sigma, and choline phosphate from Boehringer.
Growth of organism. Streptococcus pneumoniae ATCC12213 was maintained on blood agar
slopes at 4 °C and subcultured at monthly intervals.
For preparation of the crude enzyme, batches of the organism (15 1) were grown in a
laboratory fermenter (L.H. Engineering, Stoke Poges, Berkshire) in a medium containing
450 g brain heart infusion and 35 g neopeptone (both Difco). The inoculum was 50 ml of
an overnight culture. Incubation was at 37 °C with gentle stirring (1-5 rev. mim-1) and
automatic addition of 5 M-NaOH to maintain the pH at 7-2. After 16 h, sterile glucose was
added to give a final concentration of 1 % (w/v), and incubation was then continued with
stirring at 3-5 rev. min-1. Growth was monitored spectrophotometrically at 600 nm and
cultures were harvested at an E600 of 2-0 in a Sorvall continuous flow centrifuge at 4 °C.
Cultures (100 ml) were also grown in the synthetic medium of Tomasz (1964) using
°'5 % (w/v) casein hydrolysate instead of individual amino acids.
Preparation of crude enzyme. Harvested bacteria were washed with 0-7 % (w/v) NaCl in
10 mM-Tris/HCl buffer, pH 7-5, and disrupted with no. 11 Ballotini beads in a Braun homo-
genizer in 0-9 % NaCl. Walls and unbroken cells were removed by centrifuging at 6000 g
for 10 min at 4 °C. The supernatant fluid was used as the crude enzyme.
Analytical methods. The protein content of cell-free extracts was determined by the method
of Lowry et al. (1951). Choline phosphate and CDPcholine were detected on paper by the
Dragendorf spray reagent (Bregoff, Roberts & Delwiche, 1953). High voltage electrophoresis
was performed in a Shandon Southern HVE apparatus model L24 (Shandon Southern
Instruments, Camberley, Surrey) on Whatman no. 1 or 3MM papers using the following
buffers: buffer A, 8-0% (w/v) formic acid, pHi-8; buffer B, pyridine/acetic acid/water
(5:5:190, by vol.), pH 4-7. Descending paper chromatography on Whatman no. 1 paper
was carried out in solvent C: ethanol/o-5 M-ammonium acetate, pH 3-8 (15:6, v/v).
Assay of [methyl-3H]choline phosphate. Reactions in incubation mixtures (see Results)
were terminated by adding 3 vol. ethanol, mixing thoroughly and cooling in ice, and the
insoluble material was removed by centrifugation. The supernatant fluid, which contained
almost all of the 3H, was dried by rotary evaporation in a small tube. The dried material
was redissolved in 30 /zl ethanol/water (1:2, v/v) and 10 /<1 samples were applied to What¬
man no. 1 paper. Electrophoresis in buffer A was carried out for 30 min at 45 V cm-1. Areas
of the paper corresponding to standard choline phosphate were cut out and assayed for
radioactivity in a scintillation fluid [containing 0-4 % (w/v) 2,5-diphenyloxazole (PPO) and
o-oi % (w/v) i,4-bis(4-methyl-5-phenyloxazol-2-yl)benzene (dimethyl POPOP) in toluene]
using a Packard Tri-Carb model 3385 liquid scintillation spectrometer.
Assay of [methyl-3H]C DPcholine. Incubation mixtures were treated as for the choline
phosphate assay except, instead of electrophoresis, samples were chromatographed in
solvent C and areas corresponding to standard CDPcholine were assayed for radioactivity.
RESULTS
Metabolites of [3H]choIine in whole bacteria
The defined medium of Tomasz (1964) (100 ml, containing 10//Ci [met/2y/-3H]choline
chloride) was inoculated with one loopful of S. pneumoniae and incubated statically for
16 h at 37 °C. The bacteria were then washed twice with ice-cold 0-9 % NaCl, once with
distilled water and then extracted with 20 ml 5 % (w/v) trichloroacetic acid (TCA) for
30 min at 4 °C. The extract was separated by centrifuging at 10000 g for 15 min and the
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Fig. 1. (a) pH profile of choline kinase. Incubation mixtures (10 ml) containing 0-5 ml crude
enzyme (8 mg protein), 0-2 ml 80 mM-veronal/HCl buffer, and (final concentrations) 0-04 % (w/v)
2-mercaptoethanol, tomM-Na.HPO,, and 10 min-ATP, were incubated at 37 °C with o-i ml4oniM-
bue?/ij'/-3H]choline chloride (0-5 /tCi /tmol-1). After 20 min, duplicate 0 2 ml samples were
assayed for choline phosphate and the pH value of the remainder was determined, (b) Magnesium
ion dependence of choline kinase. MgCl2 was added at (final concentrations) 0,10,15, 30 and 50 ium
to 0 25 ml of an incubation mixture similar to that in (a). The whole incubation mixture was
assayed for choline phosphate.
TCA was removed by six extractions with an equal volume of ether. Finally the extract was
concentrated by rotary evaporation and chromatographed as a 2 x 0-5 cm band on What¬
man no. 1 paper in solvent C. The distribution of radioactivity on the chromatogram was
investigated by cutting the paper into 1 cm strips and measuring their radioactivity in
a scintillation spectrometer. Results showed that 85 % of the radioactivity co-chromato-
graphed with an authentic choline phosphate standard, 11 % co-chromatographed with
CDPcholine and 4 % remained at the origin. No free choline was observed.
Choline kinase (EC 2.7.1.32). In a preliminary experiment, choline, ATP and the crude
enzyme were incubated together in a buffered system under conditions similar to those
described in Fig. 1. Samples, taken at intervals over 60 min, showed a plateau for choline
phosphate formation after about 30 min. This incubation mixture was then used as a basis
for determining the optimum reaction conditions for the choline kinase. The enzyme had
a pH optimum of between 7-3 and 7-4 (Fig. 1 a), and its activity reached a maximum when
incubated with about 30 mM-Mg2+ (Fig. 1 b).
The kinetic properties of the pneumococcal choline kinase were examined for comparison
with the corresponding yeast enzyme. Under the previously determined optimum condi¬
tions, the reaction choline -> choline phosphate did not proceed any further (i.e. to the
choline nucleotide). The enzyme's dependence on choline concentration was therefore
investigated as follows: [m£,//7j/-3FI]choline chloride, at between 0 and 3 mM, was incubated
with the crude enzyme suspension for 20 min at 37 °C with 3 mM-ATP. Choline phosphate
was assayed and the enzyme activity was related to the substrate concentration by both
direct and double reciprocal plots (Fig. 2a). A Vmax of 0-5 nmol min-1 (mg protein)-1 was
obtained, with an apparent Km of 0-19 mM. Using a constant choline concentration, and
varying the ATP between 0 and 20 mM, the two plots of enzyme activity (Fig. 2b) showed
that the substrate (ATP) strongly inhibited the enzyme at above 2-5 mM. Identical results
were obtained with either 5 or 20 mM-Mg2+, so the effect was not due to magnesium
Cell-free studies on the enzymes of choline metabolism




Fig. 2. Kinetics of pneumococcal choline kinase. Incubation mixtures (0-25 ml) contained 125 /d
crude enzyme (2 mg protein) and (final concentrations) 40 mM-veronal/HCl buffer, pH 7-4, o-oi %
2-mercaptoethanol, 2 mM-Na2HP04 and iomM-MgCl2. (a) [met/;>7-3H]Choline chloride was
varied between 0 and 3 mM with ATP constant at 3 mM. After 20 min at 37 °C, the whole mixture
was assayed for choline phosphate. Results are plotted directly and as a double reciprocal plot
(inset), (b) and (c) Similar incubation mixtures were used except the concentration of [methyl-3H]-
choline chloride was kept constant at 10 mM and ATP was varied between o and 20 mM (Fig. 2 b)
and 0 and 1 mM (Fig. 2 c).
Choline nucleotide synthesis by S. pneumoniae 27
Mg2+ concn (ma)
Fig. 3. Magnesium ion dependence of CDPcholine pyrophosphorylase. MgCl2 was varied between
o and 50 mM in incubation mixtures (0-25 ml) containing 60 /<1 crude enzyme, 120 /d 80 mM-veronal/
HC1 buffer, pH 8 4, and (final concentrations) o-ot % 2-mercaptoethanol, 2 mM-Na2HP04,
10 mM-CTP and 10 mM-|>?!e//y/-3H]choline phosphate (0-06 /(Ci /<mol-1). After 20 min incubation
at 37 °C, the whole incubation mixture was assayed for CDPcholine.
limitation. In a further experiment, in which ATP was varied between 0 and 1 mM, more
accurate determinations gave Fmax as 3 to 3-2 nmol min-1 (mg protein)-1 and Km as 1 mM
(Fig. 2 c).
Although no steps have been taken to purify the choline kinase in this study, we found
that if the crude enzyme was centrifuged at 100000 g for t h, about 90 % of the enzyme
activity per unit protein remained in the supernatant fluid.
CDPcholine pyrophosphorylase (EC 2.7.7.-). The experiment summarized above indi¬
cated that a choline nucleotide, with the same RF as CDPcholine, was one of the metabolic
products of choline. A preliminary experiment showed that CDPcholine could be syn¬
thesized in a cell-free system from choline phosphate and CTP: a mixture (1 -o ml) contain¬
ing 0-5 ml crude enzyme, 20 mM-veronal/HCl buffer, pH 8-4, 0 01 % 2-mercaptoethanol,
2 mM-Na2FIP04, 10 mM-MgCl2, 10 mM-[mef/*y/-3H]choline phosphate (0-06 /tCi /rmol-1) and
10 mM-CTP was incubated for 50 min at 37 °C and 0-2 ml samples were taken at intervals
and assayed for CDPcholine. The level of CDPcholine was observed to increase, reaching
a plateau after about 30 min incubation.
CTP was a specific requirement of this enzyme. When it was replaced in the above incuba¬
tion mixture by UTP, GTP or ATP at 10 mM and, after 30 min incubation, the whole
mixture was assayed for choline nucleotides by chromatography in solvent C, no radio¬
activity was detected in the region between the origin and choline phosphate (where a
choline nucleotide would be expected to run).
Using the incubation mixture described in Fig. 3 and varying Mg2+ between o and
50 mM, the maximum activity of the CDPcholine pyrophosphorylase was found with
7 mM-Mg2+ (Fig. 3).
No kinetic experiments were carried out on the CDPcholine pyrophosphorylase. Pre¬
liminary experiments on the crude enzyme system indicated that the reaction was not a
simple one-step reaction. A variable amount of radioactivity, which could possibly be
polymeric material, was always found at the origin. However, no free choline was found
indicating the absence of a phosphatase.
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discussion
The pneumococcus appears unique among bacteria in having choline in its cell wall.
Choline is found widely in eukaryotic organisms as part of the phospholipid phosphatidyl¬
choline (lecithin). This phospholipid is, however, relatively uncommon among bacteria
(Hagen, Goldfine & Williams, 1966). Phosphatidylcholine is synthesized by two pathways
in eukaryotes (Kennedy, 1962): (i) from CDP-d-i,2-diglyceride via phosphatidyl serine
and phosphatidyl ethanolamine; or (ii) from choline via choline phosphate and CDPcholine
plus d-i,2-diglyceride. There is evidence that both pathways occur in yeasts (Hunter &
Rose, 1971; Brostrom & Browning, 1973), while the latter seems to be predominantly found
in mammalian and plant systems. The metabolism of choline in the pneumococcus appears
to be similar to the first two steps in pathway (ii). Tomasz (1967) has shown that ethanol¬
amine cannot be methylated to choline by the pneumococcus.
The kinetics of the yeast choline kinase have been investigated by Brostrom & Browning
(1973). The results obtained for the pneumococcal choline kinase, however, differ to some
extent; the apparent Michaelis constant (Km) with respect to choline was 190 /im for the
pneumococcus and 15 /<m for the yeast, whereas Km with respect to ATP was i-o mm for the
pneumococcus and 0-14 mm for the yeast. The pH optima also differ, that for the yeast being
8-5 to 9 5 compared with 7-3 to 7-4 for the pneumococcus. Both enzymes require magne¬
sium. It should be noted that the yeast enzyme was partially purified and that Km for the
pneumococcal enzyme, especially with respect to ATP concentration, will be inaccurate as
ATP will be metabolized in other ways. The assay procedure for the pneumococcal enzyme
was simple and perhaps more reproducible than that used for the yeast enzyme.
Possibly the uptake of choline by S. pneumoniae involves the action of the kinase as there
is no pool of free choline inside the cell. This could, however, be due to the bacteria being
in the stationary phase of growth.
We propose that CDPcholine, which is synthesized from choline phosphate, is the direct
precursor of the choline which is incorporated into pneumococcal C-teichoic acid. As not
every repeating unit of C-teichoic acid is substituted with choline (I. R. Poxton & J. Baddi-
ley, unpublished results), the control of choline substitution is probably at the level of the
choline kinase or the CDPcholine pyrophosphorylase, possibly in combination with the
phosphorylcholine esterase described by Holtje & Tomasz (1974).
In an independent study, Bean & Tomasz have shown that choline phosphate and CDP¬
choline are metabolic products of choline in the pneumococcus (B. Bean & A. Tomasz,
unpublished results).
This work was supported by the Medical Research Council. D. J. Leak acknowledges the
award of a Science Research Council studentship. We thank Professor Baddiley, in whose
laboratory this work was carried out, for his interest.
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The Uptake of Choline by Streptococcus pneumoniae
By A. MAVIS THOMAS,* PETER A. LAMBERTf and
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Uptake of choline, a structural component of pneumococcal C- and F-teichoic acids,
into bacteria growing in a defined medium was very efficient with an uptake constant
([S]05) of 3-2 /iM. It was inhibited by iodoacetate, dinitrophenol and oligomycin but not by
structural analogues of choline. Ethanolamine, however, was transported in the absence of
choline but with a reduced affinity ([S]0.5 71-4/tM). The same constitutive system was
probably used by both ethanolamine and choline. It is suggested that this system required
ATP and probably involved choline kinase.
introduction
We recently demonstrated that choline, a nutritional requirement of Streptococcus
pneumoniae, was metabolized into CDPcholine via choline phosphate by a cell-free extract
of this organism (Poxton & Leak, 1977). This has also been shown independently by Bean
& Tomasz (1977). Choline is utilized as a structural component of the wall teichoic acid or
C-substance (Tomasz, 1967; Brundish & Baddiley, 1968) and of the membrane teichoic
acid or F-antigen (Briles & Tomasz, 1973) of the pneumococcus.
We suggested that the first step in the metabolism of choline, i.e. its conversion to choline
phosphate by the ATP-dependent choline kinase, may be involved in the transport mechan¬
ism for choline, as no pool of free choline was found in the cell. In the present study we have
investigated this suggestion and attempt to suggest the mechanism whereby choline is taken
up into the cell.
The uptake of ethanolamine, an analogue of choline, was also investigated. It is known
that ethanolamine can replace choline in the pneumococcal cell envelope but that this alters
some properties of the organism; for example, the daughter cells become unable to dissoci¬
ate forming long chains, which are resistant to autolysis, detergent-induced lysis and
infection by a bacteriophage, and also become unable to undergo genetic transformation
(Tomasz et ah, 1975).
methods
Materials. [me//;>7-3H]Choline chloride and [l-3H]ethanoIamine hydrochloride was purchased from The
Radiochemical Centre, Amersham; the unlabelled compounds were from Sigma. Hemicholinium-3 was
obtained from The Aldrich Chemical Co., Milwaukee, Wis., U.S.A.
Growth of organism. Streptococcus pneumoniae atcc 12213 was periodically subcultured from freeze-
dried stocks and maintained on blood agar plates at 4 °C for up to 14 d. It was grown statically in 25 ml
Universal bottles at 37 °C with 20 ml filter-sterilized medium, similar to that used by Tomasz (1964) but
* Present address: Glaxo Research Ltd, Biochemistry Department, Sefton Park, Buckinghamshire.
t Present address: Glaxo Research Ltd, Microbiology Division, Greenford, Middlesex.
+ Present address: Bacteriology Department, University Medical School, Teviot Place, Edinburgh
EH8 9AG.
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containing 0-5 % (w/v) casein hydrolysate instead of individual amino acids. This medium contained
choline at 28 km. Cultures were routinely inoculated from plates into liquid medium, grown overnight at
37 °C, without shaking, then diluted into fresh medium to give an Am of 0-05. After further incubation at
37 °C for approximately 1-5 h, Asoo reached 0-1 (mid-exponential phase). At this density, cells were used for
uptake experiments. Viable counts on blood agar plates indicated that 4-5 x 107 colony-forming units (c.f.u.)
ml-1 were present. If ethanolamine, at the same concentration, was used instead of choline, 9-1 x 106 c.f.u.
ml-1 were present at an Aeoo of 0-1. Total counts with a haemocytometer chamber showed that there were
approximately twice as many individual cocci in ethanolamine medium as in choline medium for a given
absorbance, with chains of, on average, about 30 cells in ethanolamine and 1 to 6 cells in choline.
Analytical methods. Descending paper chromatography was carried out on Whatman no. 1 paper using
either ethanol/0-5 m-ammonium acetate, pH 3-8 (15:6, v/v) or ethanol/1 0 m-ammonium acetate, pH 7-5
(15:6, v/v) as the solvent. High voltage electrophoresis was performed on a Shandon electrophoresis
apparatus (model L24) using Whatman no. 1 paper with either 8 % (v/v) formic acid (pH I -8) or pyridine/
acetic acid/water (5:5:190, by vol.; pH 4-7) as buffer.
Detection of compounds on paper. Choline and choline phosphate were detected by the Dragendorf spray
reagent (Bregoff et al., 1953). Ethanolamine was detected by ninhydrin and nucleotide derivatives by ultra¬
violet light.
Determination of incorporation of radioactive label. Radioactivity in choline phosphate and CDPcholine
from cell-free extracts was determined as previously described (Poxton & Leak, 1977). To determine radio¬
activity in whole cells, 1 ml of the culture was filtered through a cellulose acetate membrane (13 mm diam.,
0-45 /im pore size) held in a Swinnex holder, and the membrane was air-dried for 10 min at 37 °C. Instead of
washing the membrane, which would introduce inconsistent results due to cell lysis, a background reading of
medium containing the same concentration of label, without cells, was subtracted. Radioactivity was
measured by counting the membranes in toluene scintillation fluid [8 g 2,5-diphenyloxazole and 200 mg
l,4-di-2-(4-methyl-5-phenyloxazolyl)benzene in 21 toluene] using a liquid scintillation spectrometer.
Determination o/[S]0.5 values. The value of [S]0.5 is the solute concentration giving one half of the maximum
rate of uptake. This constant is preferred to the Michaelis-Menten constant for the measurement of uptake
by whole cells as there are many metabolic controls on the transporting proteins in the system (Rose, 1976).
Lineweaver-Burk graphs were constructed to calculate [S]0.5. In addition, linear regressions were calculated
to obtain the equation of the straight line (y = nu + c) of the Lineweaver-Burk plots; 1/[S]0.5 is the value
of .v when y = 0.
RESULTS AND DISCUSSION
When S. pneumoniae was grown overnight in a medium containing [wef/;>'/-3H]choline
chloride there was no free choline present in the intracellular pool of choline metabolites
(Poxton & Leak, 1977). To confirm that no choline was free inside the bacterium, even in an
actively growing culture with excess choline still present extracellularly, an overnight
culture was inoculated into fresh medium with 28 /<M-[3H]choline chloride (5 //Ci) to give an
^eoo °f 0'05 and incubated statically until Aeoo reached OT (about 1-5 h). The culture was
then harvested and extracted with trichloroacetic acid as described by Poxton & Leak
(1977). After removal of the trichloroacetic acid into ether, all of the 3H was found in the
aqueous phase. The chromatogram of the extract was similar to that obtained previously
(except the amount of label at the origin, possibly due to polymeric teichoic acids, was much
lower) with no trace of free choline. This confirmed that there was no free choline inside the
cell.
In a similar experiment, bacteria were incubated in a medium containing 1% (v/v)
toluene to make the membrane permeable to choline and other small molecules up to a few
thousand molecular weight (Schrader & Fan, 1974). Again there was no pool of choline in
the cells and no stimulation in production of choline phosphate or CDPcholine.
Choline uptake by whole cells
Preliminary experiments to find the optimum specific activity of [3H]choline to add to the
incubations indicated that choline concentrations up to 1 pM containing 0-5 //Ci mmok1
were suitable and the rate of uptake was linear over 30 min. Cells grown in the defined
choline medium were harvested in mid-exponential phase (/4600 0-1) and resuspended in
fresh medium without choline to give an A600 of about 0-05. After 30 min at 37 °C, when
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Fig. 1. Effect of inhibitors on the uptake of choline. Mid-exponential phase bacteria were sus¬
pended in synthetic medium containing [mcr/tyZ-'Hlcholine chloride (0-25 /tM, 0125 /tCi mf1) and
the following additions were made: A, 1 mM-iodoacetate; B, 1 mM-dinitrophenol; C, no addition;
D, 0-25 mM-dinitrophenol; E, 0-25 mM-oligomycin; F, no addition. At intervals, 1 ml samples
were taken and assayed for uptake of choline.
any choline intermediates would have been utilized, [3H]choline was added up to 1 /<m
(0-5 /tCi ml-1). After a further 30 min the incorporation of choline into whole cells was
measured. Results of uptake versus substrate concentration were plotted directly and as
double reciprocal plots; these gave an [S]0.5 value of 3-2 //m for choline and an uptake
capacity Umax ' of about 3 nmol choline min-1 (ml cell suspension)-1.
Seven identical cultures, in choline-free medium as above, were preincubated for 30 min
at 37 °C and then either hemicholinium-3, betaine hydrochloride, N,iV-dimethylethanol-
amine, A-methylethanolamine, choline chloride (each at 5 //m) or an equivalent volume of
choline- or analogue-free medium was added. Immediately after these additions, [3H]choline
chloride was added to give 0-5 //M (0-25 //Ci ml J). After 30 min incubation at 37 °C, three
1 ml samples were assayed for incorporated 3H. None of the analogues had inhibited the
uptake of choline. Only with unlabelled choline was there a decrease of 50% due to dilution
of the label.
These results indicate that there is a very specific transport mechanism for choline, with
no inhibition when the analogues were present at 10 times the concentration of choline.
This should be compared with the uptake of choline by a marine pseudomonad (apparently
having no use for choline) which is inhibited by more than 50% in the presence of betaine
hydrochloride and iV,./V-dimethylethanolamine (Snipes et al., 1974).
Using mid-exponential phase cells harvested and suspended in choline-free medium as
above, the uptake of [3H]choline at 0-25 //m over 70 min was inhibited completely by iodo-
acetate (1 itim) and inhibited by 64% by dinitrophenol at 1 mn and 31% at 0-25 mM.
Oligomycin (0-25 mM) inhibited uptake by only 12% (Fig. 1).
lodoacetate is a general metabolic inhibitor which acts by alkylating thiol groups in a
large number of enzymes. Oligomycin interferes with membrane ATPase and dinitrophenol
reduces the proton-motive force across the cell membrane by destroying the proton gradient.
The proton-motive force provides the energy for transporting certain sugars and amino
acids and produces ATP in conjunction with membrane ATPase. The complete inhibition of
choline uptake by iodoacetate and the comparative lack of sensitivity to dinitrophenol and
oligomycin suggests that choline uptake is not dependent solely on the amount of ATP or the
maintenance of the proton-motive force. We have, however, previously shown a require¬
ment for ATP by the choline kinase (Poxton & Leak, 1977).
Effect of choline analogues on choline uptake
Effect of metabolic inhibitors on the uptake of choline
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Fig. 2. Effect of chloramphenicol on the uptake of choline by choline-grown (A, B) and ethanol-
amine-grown (C, D) bacteria. Mid-exponential phase bacteria were suspended in medium free from
choline and ethanolaniine and I mM-chloramphenicol was added to tubes B and D. All tubes were
incubated for 30 min before adding [methyl-3Hjcholine chloride (0-25 /m, 0-125 pd ml-1). At
intervals, 1 ml samples were taken and assayed for uptake of choline.
We investigated the uptake of ethanolamine as it led to altered properties of the organism
when it replaced choline in the growth medium (see Introduction). Streptococcus pneumoniae
was grown in medium containing ethanolamine (28 //m) overnight at 37 °C. The culture was
diluted into fresh medium containing ethanolamine and harvested in mid-exponential phase.
The kinetics of uptake were followed as for choline-grown organisms. The uptake constant
was found to be much higher for ethanolamine than for choline ([S]0.5 7-14/;m) and the
uptake capacity was correspondingly lower [Kmax 4 nmol ethanolamine min-1 (ml cell
suspension)-1]. This suggests that the organism has a much greater affinity for choline than
for ethanolamine.
Bacteria were cultured in both choline-based and ethanolamine-based media and
harvested in mid-exponential phase. Each culture was then resuspended and preincubated
in a choline- and ethanolamine-free medium with or without 1 mM-chloramphenicol. After
30 min, [3H]choline (0-25 //M, 0-125 //Ci ml-1) was added and incubation was continued for
65 min at 37 °C. Throughout this period samples (1 ml) were assayed for choline uptake
There was no evidence from this experiment of induction of a choline transporting
system in the ethanolamine-grown cells as the choline-grown control cells were similarly
affected by chloramphenicol. The fact that chloramphenicol inhibited the uptake of choline
suggests that protein synthesis is required to maintain choline uptake capacity.
As there was no evidence for induction of choline transport, and as we had earlier shown
a difference in affinity for choline and ethanolamine when the organisms were grown on the
homologous substrate, we investigated the change in uptake constants and capacities when
the cells had been grown on one substrate and then changed over to the other substrate to
follow uptake.
When the uptake of choline was assayed after bacteria had been grown on ethanolamine,
[S]0.5 was 1-4 /fm-choline and Fmax was 12 nmol choline min-1 (ml cell suspension)-1. For
the uptake of ethanolamine by choline-grown cells, [S]05 was 14-2 /rm-ethanolamine and
Fmax was 6 nmol ethanolamine min-1 (ml cell suspension)-1. These results suggest that a
maximum amount of enzyme is present in cells grown on ethanolamine thus giving an
increased uptake capacity. When cells are grown on choline, however, a 'normal' amount
of enzyme is present but this has a lower affinity for the uptake of ethanolamine.
Ethanolamine uptake by whole cells
Investigation of choline-inducecl transport system
(Fig- 2).
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Metabolism of ethanolamine
In an attempt to show the intermediates in ethanolamine metabolism, cells grown in
[3H]ethanolamine were extracted with trichloroacetic acid and treated as for choline-grown
cells (Poxton & Leak, 1977). Regardless of incubation time and extraction procedure, we
could not detect any intermediates. We therefore conclude that intermediates were being
rapidly metabolized.
We conclude from this study that choline is transported into the pneumococcus by a
highly specific constitutive enzyme which may be ATP-dependent. Choline kinase is prob¬
ably involved. Choline analogues are transported by the same enzyme system but with a
much lower affinity.
A.M.T. thanks the Science Research Council for an Advanced Course Studentship. This
work was financed by a grant from the Medical Research Council to Professor Sir James
Baddiley, FRS, in whose laboratory it was carried out.
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summary An enzyme-linked immunosorbent assay was used to titrate antisera raised against live
cultures of eight type species (biotypes) of Bacteroides with the EDTA-released outer-membrane
complex from 29 characterised strains of Bacteroides species. With only minor exceptions, the
strains investigated reacted to titre with the antisera raised against the homologous type species
and not against the heterologous type species. Cross-reactivity between heterologous species and
antiserum was only significant between closely related biotypes. This cross-reactivity could be
removed by absorption of the antisera with whole cells. Significant correlation was found between
serotype and biotype with this technique.
Most serological studies of Bacteroides have so far
been limited to the sero-identification of selected
species of Bacteroides by direct fluorescent antibody
methods (Lambe and Jerris, 1976; Abshire et al.,
1977) and direct agglutination methods (Lambe and
Moroz, 1976; Elhag <?t a/., 1977; Elhag and Tabaq-
chali, 1978a). These studies were concerned with the
O-antigens of the strains in purified lipopolysac-
charide (LPS) extracts or in preparations of heated
or formalinised bacteria. Results suggest that there
are a large number of serotypes within a given
biotype (species or subspecies). The system is
complex: the B. fragilis species alone includes 13
serotypes with different LPS antigens (Elhag and
Tabaqchali, 1978a).
There is much interest in the possible use of
serological techniques for the titration of serum
antibodies to establish the involvement of a Bacte¬
roides species in an infection, or to show the normal
levels of antibodies directed against commensal
strains of Bacteroides in healthy or compromised
individuals. Several attempts have been made,
mostly by isolating the organism from an established
infection and using it as a source of the antigen
(eg, Danielsson et al., 1972), or by using type
cultures of the Bacteroidaceae as sources of antigen
(eg, Quick et al., 1972; Rissing et a!., 1974). Many
negative results were obtained from cases of proven
infections involving identified Bacteroides species.
These studies all suffer from a basic lack of
knowledge of the immunogenic structures of the
Received for publication 18 October 1978
Bacteroides cell. There is an apparent need for an
antigen preparation that is both immunogenic and
representative of a group of Bacteroides (either
species or biotypes) rather than an individual strain.
The disadvantages of the LPS molecule are that it
is poorly immunogenic and that the O-antigen
serotypes are so numerous within a given species or
biotype (Hofstad, 1977; Elhag and Tabaqchali,
1978a). Kasper and co-workers have investigated
the cell-surfaces of certain species of Bacteroides
(Kasper and Seiler, 1975; Mansheim and Kasper,
1977) which appear to be typical Gram-negative
organisms with an outer membrane and often a
capsule. In a related study, Poxton and Brown
(unpublished results) examined the outer membrane
and associated proteins of several strains of Bacte¬
roides by sodium dodecyl sulphate-polyacrylamide
gel electrophoresis and showed that similar biotypes
(species) of Bacteroides possess many common
polypeptides in their surface layers.
The present study exploits the group specific
antigenicity of the cell-surface outer membrane
complex together with the sensitivity of the enzyme-
linked-immunosorbent-assay (ELISA) procedure




Twenty-nine strains representing eight species of
Bacteroides are listed in Table 1. They were obtained
from culture collections or from laboratory stock
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Table 1 Titration of homologous and heterologous antigens against representative antisera
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Antigen preparedfrom* Titre ofgiven antigen when titrated against antiserum raised against:
NCTC9344 NCTC10582 NCTC10583 ATCC8483 ATCC8503 VPI4196 NCTC9338 NCTC9337












B. vulgatus NCTC 10583 — 800 102400 — — — — —
GNAB107 6400
B. ovatus ATCC8483 — — — 12800 — — — —
B. distasonis ATCC8503 — 1600 — — 51200 1600 — —
GNAB26 — 1600 —
B. melaninogenicus VPI4196 — 6400 — — — 51200 6400 —
ss. melaninogenicus ATCC 15930 3200 800 —
WPH62 6400 3200 —
WPH67 25600 6400 —
WPH97 25600 3200 —
B. melaninogenicus NCTC9338 — — — — — 3200 25600 —
ss. intermedius WPH4 6400 25600 —
WPH 22 3200 12800 —
WPH24 3200 12800 —
WPH31 3200 25600 —
B. asaccharolyticus NCTC9337 — 800 — — — — — 51200
WPH57 — — 12800
♦NCTC National Collection ofType Cultures.
ATCC American Type Culture Collection.
VPI Virginia Polytechnic Institute and State University, Blacksburg, Virginia.
GNAB and WPH Bacteriology Department, University ofEdinburgh—Stock Cultures,
t = Titre of less than 400
tAntigens from these strains were tested against homologous species antiserum only.
cultures (GNAB and WPH series) and characterised
by the procedures of Duerden et al. (1976) and
Holbrook et al. (1977).
growth of organisms and preparation
of antigen for elisa
One millilitre of a 48-hour cooked meat broth
culture (Watt, 1973) was used as an inoculum for
20 ml proteose peptone, yeast extract (PPY) medium
(Holbrook et al., 1977). After incubation at 37°C
for 16 hours by the standard anaerobic procedure
of Collee et al. (1972) the bacteria were harvested
and washed twice in phosphate-buffered saline,
PBS (0-1 5m NaCl containing 50 mm phosphate
buffer pH 7-4) by centrifugation for 30 minutes at
4000 g. The pellets were resuspended in 2 ml PBS
containing 10 mm ethylenediamine-tetraacetic acid
(EDTA), incubated at 45 °C for 30 minutes, and
treated in an ultrasonic bath (Model 6441 A, Dawe
Instruments Ltd, Western Avenue, London W3 0SD,
UK) for 60 seconds. The treated cells were removed
by centrifugation at 6000 g for 30 minutes leaving
the outer membranes and associated molecules in
suspension. After dialysis for two successive periods
of 2 hours in 2 litres of PBS this was used as the
antigen preparation. The amount of protein in each
antigen preparation was measured by the method of
Lowry et al. (1951).
preparation of antisera
Antisera were raised against whole live bacteria in
New Zealand white rabbits which weighed about
2kg. Livemillilitres of blood were removed from each
rabbit to provide control sera just before the first
injection. Bacteria were cultured in 10 ml volumes
of PPY medium, as described above, and washed
three times in sterile PBS. They were finally resus¬
pended in PBS to a concentration of 109 organisms/
ml. The rabbits received 1 ml injections of this
suspension intravenously according to the follow¬
ing schedule, with freshly cultured cells: weeks 1
and 2, daily injections for three days; week 3,
no injection; week 4, one injection; week 5, test
bleed (5 ml) then two or three days later the rabbits
were exsanguinated by cardiac puncture. Sera were
stored at — 20°C (modified from Kasper, 1976).
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absorption of antisera
Cross-reacting antibodies were absorbed from sera
by incubating 1 ml of a 1 in 10 dilution (in PBS) of
the serum with 1 ml of a suspension of washed
bacteria prepared from 10 ml of an overnight culture
in PPY medium, at 37°C for 30 minutes. After
removing the bacteria by centrifugation (1000 g,
30 minutes) the serum was again added to an equal
volume of washed bacteria and reincubated at 37°C
for 30 minutes. The supernatant fluid obtained after




This was essentially the same as that described by
Engvall and Perlmann (1972) but adapted for
microtitre plates (flat-well plates supplied by
Sterilin Ltd, Teddington, Middlesex, UK) as
described by Voller et al. (1976). Fifty microlitres
of antigen in 50 mm carbonate buffer pH 9-6,
containing 0 02% sodium azide were added to each
well and incubated at 37°C for 4 hours, then held
at 4°C overnight. The plate was washed three times
with 01 5m NaCl containing 0 05% Tween 20 by
directing the nozzle of a wash-bottle into each well
and filling it to the top. The plates were shaken dry
between each wash. Antiserum, diluted in PBS
containing 0 05% Tween 20 and 002% sodium
azide, was added to each well (50 ^1) and incubated
at room temperature for 4 hours. The plates were
washed as before and anti-rabbit IgG conjugated
to alkaline phosphatase (Miles Laboratories (UK)
Ltd, Stoke Poges, Slough, Bucks, UK), diluted in
the same buffer as the antiserum, was added to each
well (50 fj,1) and incubated overnight at room
temperature. After again washing the plates, 50 yd
volumes of the enzyme substrate—1 mg ml-1 solution
of p-nitrophenylphosphate (Sigma) in 50 mM
carbonate buffer, pH 9-8, containing 1 mm MgCU
—were added to each well. After 1 hour's incubation
at room temperature the colour was read visually
on a + + +->- — scale. The end point of the titration
was judged as + +, that is, when the intense yellow
colour had just started to decrease.
To determine the amount of outer membrane
complex (antigen) required to coat the wells of a
microtitre plate and to determine a suitable dilution
at which the anti-rabbit IgG-alkaline phosphatase
should be used, a chequer-board titration of doubling
dilutions of antigen (1 mg protein/ml) against serial
I-5-fold dilutions of conjugate was carried out. An
excess of homologous antiserum (1 in 100 dilution)
was added to each well. A 1 in 16 dilution of antigen
and a 1 in 500 dilution of conjugate were found
to be suitable minimum values to give an optimum
yellow colour and were the standard dilutions used
for all subsequent experiments, each well being
coated with antigen equivalent to ca 3 jug protein.
In trial experiments, antigens were titrated with
homologous antisera, and titres between 6400 and
and 102400 were obtained.To standardise conditions,
all subsequent titrations started with an antiserum
dilution of 1 in 400. At this dilution all preinocu-
lation sera when titrated against antigen gave no
trace of colour.
Results and discussion
titration of unabsorbed sera
Sera that had been raised against eight type species
of Bacteroides were titrated with antigens prepared
from both homologous and heterologous strains.
The results are shown in Table 1. Significant cross-
reactivity occurred between B. fragilis and B.
thetaiotaomicron, B. thetaiotaomicron and B. dista-
sonis, B. melaninogenicus subspecies melaninogenicus
and B. melaninogenicus subspecies intermedins. A
little cross-reactivity was observed between B.
melaninogenicus subspecies melaninogenicus and
B. thetaiotaomicron. It was possible to identify
almost all of these strains to species or subspecies
level without difficulty, the cross-reactive strains
reaching an end point several dilutions below the
titre of homologous strains and antiserum. All the
strains of B. fragilis reacted to the same titre as the
type species (NCTC 9344) against homologous
antiserum. Similarly, most of the other species,
where several strains were available for testing,
reached titre with the antiserum raised against its
type strain. Notable exceptions were B. distasonis
(GNAB 26), which failed to react with its type strain
antiserum but reacted significantly with B. theta¬
iotaomicron antiserum,and two strainsof B.melanino¬
genicus ss. melaninogenicus (ATCC 15930 and WPH
62), which reacted only weakly with the antiserum
raised against the type strain. In the latest VPI
anaerobe manual (Holdeman et al., 1977) it is stated
that ATCC 15930 is an atypical B. melaninogenicus
subspecies melaninogenicus. Another significant
feature of these results is that the B. asaccharolyticus
strains (previously B. melaninogenicus subspecies
asaccharolyticus) do not cross-react at all with either
of the B. melaninogenicus subspecies investigated
and therefore appear to be unrelated serologically.
titration of absorbed sera
It was possible to distinguish most of the species
with unabsorbed sera, but there could be some
confusion between certain B. fragilis and B. theta¬
iotaomicron strains and between the subspecies of
B. melaninogenicus. An attempt was made to remove
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Table 2 Titration of antigens prepared from B. melaninogenicus subspecies melaninogenicus and subspecies
intermedius with absorbed and unabsorbed sera raised against the type strains of these subspecies
Antigen preparedfrom: Titre ofgiven antigen when titrated against antiserum raised against:
VP14196 VP14196 Absorbed NCTC 9338 NCTC 9338 Absorbed
Unabsorbed with NCTC 9338 Unabsorbed with VPI 4196
B. melaninogenicus ss. melaninogenicus VPI4196
ATCC
51200 51200 6400 —
15930 3200 400 800 —
WPH 62 6400 400 3200 —
WPH 67 25600 12800 6400 —
WPH 97 25600 3200 3200 —
B. melaninogenicus ss. intermedius NCTC9338 3200 — 25600 25600
WPH 4 6400 800 25600 6400
WPH 22 3200 — 12800 3200
WPH 24 3200 — 12800 3200
WPH 31 3200 — 25600 6400
— less than 400
cross-reacting antibodies from sera raised against
these four strains. Thus NCTC 9344 antiserum was
absorbed with NCTC 10582 cells and vice versa,
while VP1 4196 serum was absorbed with NCTC
9338 cells and vice versa. Results showed that all
cross-reactivity between B.fragilis and B. thetaiota-
omicron could be removed by using absorbed sera,
with no decrease in titre with homologous strains.
Similarly, cross-reactivity between B. melanino¬
genicus ss. melaninogenicus and ss. intermedius
could be removed by using absorbed sera (Table 2),
but this was accompanied by a decrease in the titre
of the absorbed sera when compared with the
unabsorbed sera for some of the strains belonging
to the same subspecies. This suggests a sharing of
some major antigenic determinants between some
members of both subspecies.
The species and subspecies investigated in this
study have all been characterised by a variety of
conventional biochemical tests and are therefore
biotypes. Evidence presented here shows that
similar biotypes also possess similar immunogenic
surface components. As strains that belong to the
same species or subspecies tend to react to titre, it
should be possible to use the EDTA-released outer
membrane complex as an antigen in a converse study
to titrate serum antibodies, either in patients with
a possible bacteroides infection or in normal or
compromised individuals. If selected carefully and
possibly pooled, a few antigen preparations could
cover a very broad range of Bacteroides species.
These should prove more suitable than the antigens
used previously (see Introduction) which include
LPS, and undefined heated, formalinised, or dis¬
rupted whole cells.
During the preparation of the manuscript Elhag
and Tabaqchali (1978b) have published results of
a survey of O-serotypes in the B. fragilis group (ie,
B.fragilis, B. thetaiotaomicron, B. vulgatus, B. ovatus
and B. distasonis). They found no correlation
between O-serotype and biotype. This differs from
the present finding that there is a close correlation
between biotypes and serotypes as determined by
reactions with antigens of the outer-membrane
complex.
This work was supported by the Medical Research
Council (grant No. G977/951/S). I am grateful to
Professor J. G. Collee for his interest and helpful
assistance in the preparation of this manuscript,
to Dr D. M. Weir for introducing the ELISA
technique to me, and to Mr R. Brown and col¬
leagues for skilled technical assistance.
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Sodium Dodecyl Sulphate-Polyacrylamide
Gel Electrophoresis of Cell-surface Proteins as an Aid to the
Identification of the Bacteroides fragilis Group
By IAN R. POXTON and ROBERT BROWN
Bacteriology Department, University of Edinburgh Medical School,
Teviot Place, Edinburgh, EH8 9AG, Scotland
(Received 30 November 1978)
The outer-membrane complexes from 40 strains of Bacteroides, representing eight of the
species included in the Bacteroides fragilis group, were released by EDTA treatment. The
component polypeptides were examined by sodium dodecyl sulphate-polyacrylamide gel
electrophoresis on slab gels. Within a species (biotype) the patterns produced indicated
marked similarities in the structures of the surface proteins among the strains examined. The
patterns produced by strains belonging to different species, however, showed fewer similari¬
ties. An unknown organism could therefore be identified to species level using this technique
and a few selected biochemical tests.
introduction
Bacteroides fragilis, B. vulgatus, B. distasonis, B. thetaiotaomicron, B. eggerthii, B. ovatus,
B. uniformis and B. splanchnicus are species included in the B. fragilis group. They are
characterized as being obligately anaerobic, non-pigmented, bile-tolerant, glucose-
fermenting, Gram-negative rod-shaped bacteria. These organisms are frequently isolated
from clinical specimens, predominantly from wounds, intra-abdominal infections, the blood
and perirectal or pelvic sites (Finegold, 1977; Willis, 1977; Wren et al., 1977). Bacteroides
fragilis, a minor component of the faecal flora, is the member of the group most commonly
isolated from infections, whereas B. vulgatus, B. thetaiotaomicron and B. uniformis are pre¬
dominantly faecal isolates.
After an organism has been identified as a member of the family Bacteroidaceae by
culture and microscopic examination, and is distinguished from the fusobacteria by gas-
liquid chromatography of the volatile fatty acid metabolic products, at least eight, some¬
times variable, biochemical tests have to be performed for identification to species level
(Holdeman et al., 1977).
Recently, polyacrylamide gel electrophoresis (PAGE) of cellular proteins has been em¬
ployed in attempts to sub-classify the Bacteroides genus. Strom et al. (1976) used discon¬
tinuous gradient PAGE and examined proteins solubilized by sonication of whole cells of
several species of Bacteroidaceae. Swindlehurst et al. (1977) used the SDS (sodium dodecyl
sulphate)-PAGE procedure to examine members of the species B. melaninogenicus; these
workers used hot SDS extracts of whole cells. It was possible to identify members of the
Bacteroidaceae to species, subspecies and strain levels.
The present study evaluates the use of SDS-PAGE in examining the cell-surface proteins
released from the bacteria by controlled treatment with EDTA at 45 °C followed by mild
ultrasonic disruption. When this is used in conjunction with a few selected biochemical
tests it becomes a relatively rapid, simple aid to identifying the species within the B. fragilis
group.
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Table 1. Strains of Bacteroides examined by SDS-PAGE and results ofselected
biochemical tests
Indole Fermentation of:
Strain pro¬ , * ,
Species no. Source duction Rha Tre ManOH Sue
B. fragilis NCTC 9344 NCTC — — _ _ nt
NCTC 8560 NCTC — — — — nt
NCTC 10581 NCTC — — _ _ nt
NCTC 10584 NCTC - — _ _ nt
GNAB 4 Wound swab RIE — — — nt
GNAB 8 Wound swab RIE - — — — nt
GNAB 49 Skin RIE — — — — nt
GNAB 101 Wound swab WGHE — — — _ nt
GNAB 102 Wound swab WGHE — — — — nt
GNAB 104 Wound swab WGHE — — — — nt
GNAB 105 Wound swab WGHE - - - - nt
B. vulgatus NCTC 10583 NCTC — + — — nt
GNAB 25 Faeces — + — — nt
GNAB 30 Faeces — + — — nt
GNAB 31 Faeces — + — — nt
GNAB 34 Faeces — + — — nt
GNAB 35 Faeces — + — — nt
GNAB 37 Faeces — + — — nt
GNAB 38 Faeces — + — — nt
GNAB 44 Faeces — + — — nt
GNAB 107 Wound swab WGHE — + — — nt
GNAB 120 Wound swab WGHE - + - - nt
B. distasonis ATCC 8503 ATCC — + + nt
GNAB 22 Faeces — + + - nt
GNAB 27 Faeces — + + - nt
GNAB 39 Faeces - + + - nt
B. thetaiota- NCTC 10582 NCTC + + + nt
omicron GNAB 1 Wound swab RIE + + + - nt
GNAB 2 Wound swab RIE + + + - nt
GNAB 7 Wound swab RIE + + + - nt
B. eggerthii NCTC 11155 NCTC + + — — —
GNAB 21 Faeces + + — — _
GNAB 24 Faeces + + — — —
GNAB 41 Faeces + + - - -
B. uniformis ATCC 8492 ATCC + + — — +
VPI 11227 VPI + — + - +
GNAB 18 Wound swab RIE + + — — +
VPI 11368 VPI + + - - +
B. ovatus ATCC 8483 ATCC - + + + +
B. splanchnicus NCTC 10825 NCTC + - - nt
+ , Positive; —, negative; nt, not tested.
Non-standard abbreviations: VPI, Virginia Polytechnic Institute, Blacksburg, Virginia, U.S.A.; RIE,
Royal Infirmary, Edinburgh; WGHE, Western General Hospital, Edinburgh; GNAB, Lab. strain no.
Rha, Rhamnose; Tre, trehalose; ManOH, mannitol; Sue, sucrose.
METHODS
Growth ofbacteria andpreparation ofprotein extracts. Freeze-dried inocula of the strains listed in Table 1
were cultured in 10 ml of Robertson's cooked meat broth (modified by Watt, 1973) and incubated for 48 h
at 37 °C by the standard anaerobic procedure of Collee et at. (1972). One ml of this culture was inoculated
into 50 ml proteose peptone/yeast extract (PPY) medium (Holbrook et at., 1977). After incubation for 20 h,
3 ml of the culture was removed for purity checks and biochemical testing (Table 1) while the remainder was
harvested by centrifugation at 3000 g for 30 min and washed three times in phosphate buffered saline (0-15
M-NaCl in 50 mM-NaoHP04/NaH2P04 buffer, pH 7-4). The bacteria were resuspended in 2 ml phosphate
buffered saline containing 10 ium-EDTA and transferred to a glass test tube. To remove the outer membranes
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and associated molecules, the suspension was incubated for 30 min at 45 °C, then vortex-mixed, treated in an
ultrasonic bath (model 6441 A; Dawe Instruments, Western Ave, London) for 1 min and again vortex-
mixed. After two centrifugations (6000 g for 30 min) the supernatant fluid contained outer-membrane
vesicles together with released proteins and other molecules. The above conditions were standardized to
give optimum release of protein without lysis of the bacterial cytoplasmic membrane. EDTA was removed by
dialysis for 4 to 5 h in two successive 1 litre volumes of 0 01 M-Tris/HCl pH 7-4 containing 0-01 % (v/v)
2-mercaptoethanol and the samples were concentrated by dusting the dialysis bags with a fine layer of
Sephadex G-100 and leaving at 4 °C for 16 h. The concentrated extracts were freeze-dried and dissolved in
SDS-PAGE sample buffer to give a protein concentration of 2 mg ml"1. Sample buffer was 0-0625 M-Tris/
HC1 pH 6-8 containing 2 % (w/v) SDS, 10 % (v/v) glycerol, 1 % (v/v) 2-mercaptoethanol and 0-001 % (w/v)
bromophenol blue. Samples were heated in a boiling water bath for 3 min just prior to application to the gel.
Polyacrylamide gel electrophoresis. This was adapted from the method of Laemmli (1970). Slab gels
(170 x 140 mm) of 10 % (w/v) acrylamide with a 10 mm 4 % (w/v) stacking gel were used to run up to 12
samples in a Raven (Haverhill, Suffolk, CB9 7UU) slab gel apparatus. Buffers were as described by Laemmli
(1970). Samples (100 /d) of extract containing 200/tg protein were electrophoresed at constant voltage, first
at 50 V until the sample had entered the separating gel (approx. 1 h) then at 150 V until the bromophenol
blue was near the bottom of the gel (approx. 4 h). Staining was carried out overnight and de-staining was done
over 4 h with the solutions described by Poxton & Sutherland (1976).
Protein estimation. Samples of EDTA extracts were assayed for protein using the method of Lowry et al.
(1951).
Characterization of strains used. All test strains had previously been characterized by the procedures of
Duerden et al. (1976). Selected biochemical tests, however, were performed on each strain after growth in
PPY medium (Table 1). These served as a check on the previous results. They included tests on indole pro¬
duction and the fermentation of rhamnose, trehalose, sucrose and mannitol by the methods described by
Duerden et al. (1976).
RESULTS AND DISCUSSION
The EDTA-extracted proteins from eight different type species included in the B. fragilis
group were examined on the same gel (Fig. 1). The patterns of bands were quite different;
only a few matching lines were shared and there was no possibility of picking out diagnostic
bands typical of the B. fragilis group as a whole. Flowever, the individual species within the
group showed species-specific patterns.
For 11 strains of the species B. fragilis (syn. B. fragilis subs p. fragHis) there were many
matching bands in all of the extracts (Fig. 2), perhaps with the exception of NCTC 8560
(track 2) which did not share many bands with any of the other strains. The double high
molecular weight and triple low molecular weight sequences of bands (arrows) appeared to
be common to the other 10 strains. There were close similarities between tracks 1 and 5 and
between tracks 3, 7, 8, 9, 10 and 11.
Ten strains of B. vulgatus (syn. B. fragilis subsp. vulgatus) gave similar patterns with many
matching bands (Fig. 3). The sequence of five or six high molecular weight bands (arrow)
appeared to be characteristic of this species. Many other sequences of bands were shared by
these strains and an overall similarity of patterns was observed.
Four strains of B. distasonis (syn. B. fragilis subsp. distasonis) were examined with a strain
of debated identity (Fig. 4). All four strains of B. distasonis gave a strongly staining, high
molecular weight band of similar, but not necessarily identical, molecular weight (arrow).
The dubious strain (track 2, Fig. 4) had been received as B. vulgatus but the results of sub¬
sequent biochemical re-testing (Table 1) and the pattern produced on the gel confirmed that
it was B. distasonis. It was, in fact, identical with strain ATCC 8503 (track 1, Fig. 4). Strains
GNAB 27 and GNAB 39 (tracks 4 and 5, Fig. 4) showed almost identical patterns. These
were faecal isolates taken several days apart from the same person.
Three indole-positive species of Bacteroides which were originally regarded as B. theta-
iotaomicron (syn B. fragilis subsp. thetaiotaomicron) are now grouped into at least three
separate species: B. thetaiotaomicron, B. eggerthii and B. uniformis. Their patterns on gels
(Fig. 5) showed that they share several common polypeptides but there are closer similarities
between strains from the same species. The four strains of B. thetaiotaomicron (tracks 1 to 4)
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Fig. 1. SDS-PAGE of EDTA-extracted cell-surface proteins of Bacteroides species on 10%
acrylamide slab gels (for details, see Methods). Track 1, B. fragilis NCTC 10584; 2, B. vulgatus
NCTC 10583; 3, B. distasonis ATCC 8503; 4, B. thstaiotaomicron NCTC 10582; 5, B. eggerthii
NCTC 11155; 6, B. ovatus ATCC 8483; 7, B. uniformis ATCC 8492; 8, B. splanchnicus NCTC 10825.
1 2 345 6789 10 11
Fig. 2. SDS-PAGE of EDTA-extracted cell-surface proteins of strains of Bacteroides fragilis on
10% acrylamide slab gels (for details, see Methods). Track 1, NCTC 9344; 2, NCTC 8560; 3,
NCTC 10581; 4, NCTC 10584; 5, GNAB 4; 6, GNAB 8; 7, GNAB 49; 8, GNAB 101; 9, GNAB
102; 10, GNAB 104; 11, GNAB 105. Arrows indicate bands characteristic of the species.
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Fig. 3. SDS-PAGE of EDTA-extracted cell-surface proteins of strains of Bacteroides vulgatus on
10 % acrylamide slab gels (for details, see Methods). Track 1, GNAB 25; 2, GNAB 30; 3, GNAB
31; 4, GNAB 34; 5, GNAB 35; 6, GNAB 37; 7, GNAB 38; 8, GNAB 44; 9, GNAB 107;









Fig. 4. SDS-PAGE of EDTA-extracted cell-surface proteins of strains of Bacteroides distasonis
on 10 % acrylamide slab gels (for details, see Methods). Track 1, ATCC 8503; 2, mis-labelled B.
vulgatus; 3, GNAB 22; 4, GNAB 27; 5, GNAB 39. Arrow indicates a band characteristic of the
species.
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Fig. 5. SDS-PAGE of EDTA-extracted cell-surface proteins of strains of indole-positive Bacteroides
species on 10 % acrylamide slab gels (for details, see Methods). Bacteroides thetaiotaomicron: track'
1, NCTC 10582; 2, GNAB I; 3, GNAB 2; 4, GNAB 7. Bacteroideseggerthii: track 5, NCTC 11155;
6, GNAB 21; 7, GNAB 24; 8, GNAB 41. Bacteroides uniformis: track 9, ATCC 8492; 10, VPI
11227; 11, GNAB 18; 12, VPI 11368.
showed many matching bands. Similarly, the four strains of B. eggerthii (tracks 5 to 8)
closely matched each other. The strains of B. uniformis (tracks 9 to 12), however, showed
variation: strains ATCC 8492 (track 9) and VPI 11227 (track 10) matched very closely, and
strain VPI 11368 (track 12) shared several common polypeptides with these two; however,
strain GNAB 18 (track 11) was very different from these although the results from standard
biochemical tests showed it to be identical with VPI 11368. Tracks 2 and 4 were unfortun¬
ately weakly stained although the amount of protein was the same in all the samples applied
to this gel. A duplicate gel, using freshly prepared samples, gave the same result. In the
original gel the bands in tracks 2 and 4 could be easily compared with 1 and 3.
This study presents much evidence that similar biotypes of Bacteroides possess similar
polypeptides in their surface layers. The patterns of B.fragilis NCTC 8560 and B. uniformis
GNAB 18 show, however, that organisms indistinguishable by biochemical tests can differ
significantly in their surface chemistry; thus the results of biochemical tests alone can be
misleading and should be used with caution. Due to our present lack of knowledge of the
cell-surface chemistry and serology of Bacteroides we are not in a position to re-classify
strain GNAB 18.
The characterization of the Bacteroides genus by conventional biochemical techniques is
time-consuming and some of the tests are unreliable. SDS-PAGE of surface proteins in
conjunction with a few selected biochemical tests offers a rapid, reproducible approach to
the demonstration of relatedness between an unknown and a type species. It is hoped that
the fine degree of accuracy of this analysis will make it possible to distinguish small differ¬
ences between strains, so that it might even be possible to distinguish between a newly
acquired organism and a resident strain in a patient.
This work was supported by the Medical Research Council (grant no. G977/951/S). We
are grateful to Professor J. G. Collee for his interest and helpful advice, to Professor B. P.
Marmion who initially suggested the approach and to Mr G. Hay and Miss M. D. Byrne for
skilled technical assistance.
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Characterization of the surface immunogens of
bacteroides and their use in sero-identification




Until recently the characterization of bacteroides organisms to species level depended
almost exclusively on conventional biochemical tests and simple microscopic observations.
There have been difficulties in the development or acceptance of serological tests. Those based
on lipopolvsaccharide antigens appear to be of little use in species identification as the
O-serotvpes are numerous and not species-specific'. Recent reports, however, suggest that
some capsular antigens may be species-specific and useful in sero-identification of some
Bacteroides species3'3.
Bacteroides organisms appear to be morphologically and chemically typical Gram-negative
bacteria. Our preliminary analyses of the cell-surface (outer-membrane) proteins of a number
of strains of different species of bacteroides by sodium dodecvl sulphate-polyacrvlamide gel
electrophoresis have shown that the patterns of peptides were very similar within a species but
were significantly different between species5. This suggested that it might be possible to
develop a sero-identification system based on cell-surface protein antigens. An indirect
enzvme-linked immunosorbent assay (ELISA) has been used for this investigation4. Antisera
were raised against live, untreated organisms. The antigens used for coating the polystyrene
wells of microtitre plates prepared by treatment of the bacteria with EDTA, heat and mild
ultrasonic shearing. When the antisera were titrated in ELISA tests against these antigens,
species-specific reactions were clearly obtained (Tables I and II). Cross-reactions could be
removed by absorption of the sera with whole bacteria.
At present this ELISA procedure has made it possible to use type-specific antisera to
identify B. fragilis, B. thetaiotaomicron, B. eggerthii. B. vulgacus, B. melaninogenicus ss.
melaninogenicus and ss. intermedins. B. asaccharolyticus. B. bivius and B. disiens. Other
species of bacteroides are more complex and it appears that some, such as B. distasonis, might
contain at least two serogroups within the species.
In order to define the numbers and types of immunogenic molecules from the cell surface
reacting in the ELISA procedure, characterization of the immunogens was attempted. This has
been achieved by the three methods outlined below. The ELISA procedure was used as the test
system for the first two methods which exploited the ability of a variety of agents to denature or
modify the antigens.
1. The antigens to be used for coating the polystyrene wells were treated with the agents
specified in Table III and the changes in titre were observed. The results shown in
Table III indicate that the denaturing agents had different effects on the two species
investigated. The findings suggest that the major immunogenic molecules of B. vulgatus





Titre when antigen was titrated with antiserum raised against:
Antigen prepared from:
B. fragilis B. th. i. o. B. eggerthii B. vulgatus
NCTC 9344 NCTC 10582 NCTC11155 NCTC





























— Less than 400
2. To confirm that the change in titre was due to the inactivation of the antigens, and not
the result of a non-specific effect such as inhibition of the binding of the antigen to the
polystyrene wells, an ELISA-inhibition test was used. The wells were coated as usual
with whole outer membrane complex, but before addition of the antiserum (at a
dilution equivalent to half of its titre) the antiserum was preincubated with various
antigen preparations. A 100% inhibition (positive control) was achieved by preincu-
batine the serum with whole outer membrane complex. Results are summarized in
Tabic iV. This confirmed that the major immunogens of B. vulgams are protein whereas
carbohydrate antigens other than lipopolysaccharide and capsular polysaccharide seem
to be significant in B. melaninogenicus ss. melaninogenicus.
3. A crossed immunoelectrophoresis (CIE) procedure has also been developed to assist
quantitation and characterization of the immunogenic molecules of Bacteroid.es spp.
Results so far show that in each of a few species investigated there are three or more
major antigens on the cell surface together with several minor antigens.
With ELISA and CIE procedures it should be possible to define the immunogens of the ceil
surface of bacteroides organisms. These findings are promising in relation to sero-
identification within the genus and determination of antigenic molecules that may be shared by
closely related species or subspecies.
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Titre when antigen was titrated with antiserum raised against:
Antigen prepared from:
B. mel. mel. B. mel. intermed. B. asaccharolyticus
VP1 4196 NCTC 9338 NCTC 9337
B. melaninogenicus VP1 4196 51200 6400 —
ss. melaninogenicus ATCC 15930 3200 800
WPH 62 6400 3200
WPH67 25600 6400
WPH 97 25600 3200
B. melaninogenicus NCTC 9338 3200 25600 —
ss. intermedius WPH 4 6400 25600
WPH 22 3200 12800
WPH 24 3200 12800
WPH 31 3200 25600





— Less than 400
Table HI Effect of pre-treatment of coating antigen on titre
of homologous antiserum
Titre of homologous serum with
antigen from
Treatment of antigen
B. vulgatus B. mel. ss. met.
(NCTC 10853) (VPI4196)
None 12800 25600
0.1M NaI04 (overnight) 12800 400
20% HCHO (overnight) 3200 6400
121°C 15 min. 400 6400
Table TV Inhibition of ELISA
Inhibitor
Inhibition (%)
B. vulgacus B. mel. ss. mel.
Outer membrane (OM)* 100 100
Heat-treated OM 0 0
Urea-treated OM 0 ND
Formalin-treated OM 50 50







ND = not determined
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The Cell-surface Antigens ofBacteroides vulgatus
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The cell surface of Bacteroides vulgatus was examined by electron microscopy. The outer
membrane complex was removed by EDTA and mild sonication and the antigens of this
complex were characterized by enzyme-linked immunosorbent assay and crossed immuno-
electrophoresis. The species-specific antigen was identified and was shown to be the major
outer membrane protein with a molecular weight of 100000.
introduction
Bacteroides vulgatus, an obligately anaerobic, Gram-negative, rod-shaped bacterium is
the predominant bacteroides organism in the human colon (Finegold et al., 1975; Duerden,
1980). It is occasionally isolated from clinical specimens (Holland et al., 1977). Recently, it
was shown that the sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-
PAGE) profiles of the outer membrane (OM) polypeptides of several B. vulgatus strains were
extremely similar (Poxton & Brown, 1979); and the antigens of the OM complex of
bacteroides appear to be species- or subspecies-specific when detected by an enzyme-linked
immunosorbent assay (Poxton, 1979).
It is becoming recognized that proteins of the OM of other Gram-negative bacteria may
include group- and species-specific antigens that might be useful in serological identification
(e.g. Hofstra & Dankert, 1980; Sippel et al., 1978).
The present study characterizes the antigens of the OM complex of B. vulgatus and
investigates the species-specific antigens. The recognition of species-specific antigens of
bacteroides would greatly aid the development of more rapid methods for their identification.
methods
Culture of bacteria and preparation of EDTA-outer membrane complex. Bacteroides vulgatus NCTC 10583
and NCTC 11154, and six laboratory strains (GNAB 9, 25, 30, 107, 120 and WPH 116) which had been
characterized in detail according to the criteria of Duerden et al. (1980), were cultured anaerobically from
freeze-dried inocula in PPY medium (Holbrook et al., 1977) and outer membrane (OM) complexes were prepared
by the EDTA-heat-mild sonication treatment previously described (Poxton & Brown, 1979).
Electron microscopy. This was based on the method of Springer & Roth (1973). Bacteria were harvested from
blood agar plates (5% human blood in Columbia base; Oxoid) or from PPY medium, and suspended in a mixture
of 1 ml ruthenium red (1-5 mg ml-1) in water, 1 ml 3-6% (w/v) glutaraldehyde and 1 ml 0-2 M-sodium cacodylate
buffer pH 6-5 and held at 0 °C for 1 h. After three washes in 0-07 M-cacodylate buffer, the pellet was suspended in a
mixture of 1 ml ruthenium red (1-5 mg ml-1), 1 ml 4% (w/v) osmium tetroxide and 1 ml 0-2 M-cacodylate buffer
and incubated for 3 h at 27 °C. The pellet was washed once in 0-07 M-cacodylate buffer and dehydrated in
successive 10 min steps in 25%, 50%, 75% and 90% (v/v) ethanol, then in absolute ethanol for two periods of
1 h. Propylene oxide was added for two 10 min periods and the pellet was then kept in a propylene oxide/Epon
Araldite (1:1, v/v) mixture. The pellet was embedded in fresh Epon Araldite in disposable capsules and maintained
at 45 °C for 24 h then at 60 °C for 48 h. Sections were cut and placed on rhodium-coated copper grids. The thin
sections were stained with saturated uranyl acetate in 75% ethanol in the dark for 30 min, then washed once in
0022-1287/81/0000-9616 $02.00 ©1981 SGM
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75% ethanol and once in distilled water and stained for 2 min with Reynolds' lead citrate (Reynolds, 1963). They
were then washed once in 0-02 m-NaOH and three times in water, blotted dry, and viewed in a Hitachi Model HU
12A electron microscope.
Thin sections of the OM vesicles were prepared as above except that they were initially pelleted at 100000 g for
1 h and ruthenium red was omitted from the fixation procedure.
Capsule preparation. Blood agar plates were flood-seeded with a 16 h PPY culture of B. vulgatus NCTC 10583.
To enhance capsule production, this strain had been passaged for two 6 h periods in the peritoneum of a mouse.
After 72 h anaerobic incubation at 37 °C the cells were harvested by scraping, with a glass slide covered with
adhesive tape, into 0-15 m-NaCl in 0-05 m-phosphate buffer pH 7-4 (PBS) containing 0-08% (v/v) formaldehyde.
The suspension was mixed vigorously in a Waring blender for 30 s. Bacteria were removed by centrifugation
(6000 g. 30 min) leaving the capsular material in solution. This was precipitated by the addition of 4 vol.
acetone at —18 °C. The precipitate was recovered by centrifugation (4000 g, 30 min), washed once in acetone,
dissolved in water and dialysed against distilled water. To purify the carbohydrate fraction from the crude
capsular material it was extracted with aqueous phenol: an equal volume of 90% (w/w) phenol was added to the
solution of capsular material and stirred vigorously for 15 min at 20°C. The phases were separated by
centrifugation (6000 g, 30 min) and the upper phase was dialysed for 16 h against running tap water, then against
distilled water, and finally freeze-dried.
Lipopolysaccharide (LPS) preparation. LPS was extracted from freeze-dried bacteria that had been grown for
18 h in PPY medium, by the aqueous phenol procedure developed by Westphal & Liideritz (1954). It was purified
and washed by centrifugation at 100000 g for 3 h.
Treatments of OM complex. Separate samples of the EDTA-released OM complex at a concentration of
0-5-1-0 mg protein ml-1 were subjected to one of the following denaturing or modifying agents: (i) heat (121 °C
for 15 min); (ii) formaldehyde (20% at 20 °C for 16 h); (iii) sodium periodate (0-1 m at 20 °C for 16 h; excess
periodate was consumed by the addition of ethylene glycol); (iv) urea (8 m at 20 °C for 16 h); (v) pronase
(0-1 mg ml-1 in PBS at 20 °C for 16 h); (vi) trypsin (as for pronase). Excess formaldehyde, urea and the
periodate reagents were removed by dialysis against PBS and enzymes were inactivated by the addition of
formaldehyde to a final concentration of 0-2%. Controls were included, in which the OM samples were treated as
above except that the agent was omitted.
Antiserum. Antiserum was raised against washed live cells of B. vulgatus NCTC 10583 in New Zealand White
rabbits as previously described (Poxton, 1979).
Enzyme-linked immunosorbent assay (ELISA). Both the indirect ELISA described by Poxton (1979) and an
ELISA-inhibition test were used. The ELISA-inhibition was performed as for the indirect test, except that the
antiserum was pre-incubated with the potential inhibitor: antiserum (50 pi), diluted to a concentration twice that of
its titre. was incubated with an equal volume of doubling dilutions of treated OM complex (see above) or LPS
(1 mg ml-1) for 30 min in a 37 °C water bath; 50 pi volumes of this pre-incubated serum were added to each well.
Inhibition was observed by comparing the test with a positive and negative control.
SDS-PAGE. This was performed on 10% (w/v) acrylamide slab gels, with the buffer system of Laemmli
(1970), by the method described by Poxton & Brown (1979).
Crossed Immunoelectrophoresis (CIE). EDTA-OM complexes and isolated LPS and capsular polysaccharide
were examined by CIE according to the method developed by Weeke (1973), as described by Poxton & Byrne
(1981). CIE was also performed, as indicated, with SDS-PAGE in the first dimension.
Analytical techniques. Protein concentrations were estimated by the Lowry method, and carbohydrate as
glucose equivalents was estimated by the method of Dubois et al. (1956).
RESULTS AND DISCUSSION
Electron microscopy of thin sections of B. vulgatus NCTC 10583 demonstrated the typical
appearance of the cell envelope of a Gram-negative bacterium (Fig. 1). The inner or
cytoplasmic membrane and the outer membrane were clearly visible, and separated by a
dense layer corresponding to peptidoglycan. On the outer surface of the outer membrane
there was a thin capsule layer. Electron microscopy of the bacteria after the EDTA-
heat-sonication treatment did not reveal any dramatic differences from the untreated
organisms, except that the capsular layer was absent. There were no obvious examples of
organisms with part of the outer membrane removed as shown for B.fragilis by Kasper &
Seiler (1975). When the material released by EDTA was examined in the electron
microscope, after sedimenting at 100000 g for 1 h, vesicles of varying size bounded by a
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Fig. 1 Fig. 2
Fig. 1. Thin section of B. vulgatus NCTC 10583 stained with ruthenium red. Inner (I) and outer (O)
membrane, peptidoglycan (P) and capsule (C) are visible. The bar marker represents 0-1 pm.
Fig. 2. Thin section of EDTA-released outer membrane vesicles which were deposited by
ultracentrifugation at 100000 g for 1 h. The bar marker represents 0-1 pm.
single trilamellate membrane were observed (Fig. 2). This suggests that after fragments of
outer membrane had been removed the outer layer of the organism was re-formed.
Chemical analysis of the EDTA-released OM complex showed it to be predominantly
protein with a small proportion of carbohydrate (protein : carbohydrate, approximately 14 : 1
by weight). SDS-PAGE revealed at least 30 polypeptides, with two major bands at 100000
and 70000 molecular weight. After ultracentrifugation (100000 g, 1 h), the pellet was very
similar to the whole EDTA-released complex except that the polypeptide of 70000 molecular
weight was predominantly in the supernate (Fig. 3).
When the EDTA-released OM complex from eight strains of B. vulgatus was titrated with
antiserum raised against B. vulgatus NCTC 10583 by the indirect ELISA technique, titres of
25 600-102400 were obtained, whereas titres of less than 400 were obtained when EDTA
antigens from 17 other species of bacteroides were titrated with the B. vulgatus antiserum.
The homologous antigen-antibody reaction was visualized by crossed Immunoelectro¬
phoresis (CIE). At least seven precipitin lines, including line 3, were visible (Fig. 4). When this
CIE profile was compared with a CIE profile of the ultracentrifuged pellet, only lines 2 and 5
appeared not to be membrane bound. When antigens from the other seven strains, which
strongly react with the NCTC 10583 antiserum in ELISA, were reacted with this antiserum
in CIE, line 3 was produced by all; in addition, antigens prepared from two of them
(NCTC 11154 and GNAB 120) produced line 7. No other precipitin lines, either anodic or
cathodic, were produced by these seven strains. This indicates that the cross-reaction
demonstrated by ELISA is due to one major species-specific antigen associated with
precipitin line 3 in CIE.
Several approaches were made to determine the identity of the antigens of the OM complex
of strain NCTC 10583 and the major species-specific antigen which forms precipitin line 3 in
CIE. Initially, a crude screening determination was made by ELISA-inhibition (see Methods).
Complete inactivation of the antigens could only be demonstrated by heating the OM
complex for 15 min at 121 °C. Treatment with 8 M-urea resulted in almost complete













Fig. 3. SDS-PAGE of EDTA-released outer membranes of B. vulgatus NCTC 10583 on 10%
acrylamide gels: (a) whole EDTA extract; (b) ultracentrifuged pellet (100000 g, 1 h); (c) ultracentrifuge
supernate. The arrows indicate the major membrane-bound (i) and unbound (ii) polypeptides.
1st dimension
Fig. 4. Crossed immunoelectrophoresis of EDTA-released OM complex (20 pg protein) from B.
vulgatus NCTC 10583 against homologous whole cell antiserum (0-25 ml in 3-5 ml agarose) on
50 x 50 mm glass slides. Electrophoresis was at 12-5 V cm-1 for 1-5 h in the first dimension and
12 V cm'1 for 16 h in the second dimension, both at 4 °C. Note that precipitin lines 1 and 5 each form
a double peak. O, origin.
inactivation, whereas formaldehyde, trypsin, pronase and periodate produced only slight or
partial inactivation. Inhibition by isolated LPS was minimal under circumstances that we
cannot claim to be quantitative.








Fig. 5. SDS-PAGE/crossed immunoelectrophoresis of OM complex (50 pg protein) from B. vulgatus
GNAB 25. Outer membrane complex, after SDS-PAGE on a 10% acrylamide gel in the first
dimension, was run into 3-5 ml 1% (w/v) agarose containing 0-25 ml whole cell antiserum of B.
vulgatus NCTC 10583 and 1 % (w/v) Triton X-100. The original first dimension gel has been removed
and replaced by a stained duplicate (a). Note the single precipitin arc produced by the 100000 mol. wt
polypeptide. No other precipitin arc was detected (see drawing, b).
(iv) —*■
Fig. 6. SDS-PAGE of four pooled excised replicates of the single precipitin line produced by CIE of B.
vulgatus GNAB 25 OM complex. The arrows indicate (i) 100000 mol. wt major OM polypeptide; (ii)
94000 mol. wt product of IgG; (iii) 55 000 mol. wt IgG Fl-chain; (iv) 23 000 mol. wt IgG L-chain.
Visualization of some of the inactivated antigen preparations that reacted with antiserum
was performed by CIE. Heat treatment removed all but one precipitin line (line 1). Periodate
treatment removed line 1; the other lines remained, but the peak heights of lines 4 and 5 were
reduced. Purified LPS gave rise to a double peak that co-precipitated with line 1. There
appears to be no cross-reaction between the LPS of B. vulgatus NCTC 10583 and the LPS of
the other B. vulgatus strains examined, i.e. line 1 is produced only by NCTC 10583 antigen.
This is in agreement with the observations of Elhag & Tabaqchali (1978) who showed that
the O antigens of the B. fragilis group (which includes B. vulgatus) are extremely
heterogeneous within a species. The phenol-extracted capsular polysaccharide produced a
small line that appeared to be similar to line 6.
To determine the molecular weight of the species-specific antigen, CIE was performed on
B. vulgatus GNAB 25 OM complex with SDS-PAGE for the first dimension. GNAB 25
produced only one precipitin line (line 3) in the CIE described earlier in which agarose was
the material of the first dimension. By reference to a stained duplicate SDS-PAGE profile, it
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was seen that the single line was produced from the major membrane-bound protein of
molecular weight about 100000 which was described earlier (Fig. 5). To confirm that the
antigen which was demonstrated by CIE was in fact the same antigen that was detected by
SDS-PAGE/CIE, the single precipitin line that was produced by GNAB 25 OM complex in
CIE was excised from the gel and examined by SDS-PAGE. The immunoprecipitate in
agarose from four gels was dissolved in 100 pi SDS-PAGE sample buffer by heating at
100 °C for 5 min and applied molten to a well in an SDS-PAGE gel slab. This produced four
major bands, of molecular weights 23000, 55000, 94000 and 100000 (Fig. 6). Bands (iv)
and (iii) correspond, respectively, to the L and FI chains of IgG. Band (i), of molecular weight
100000, is the major OM protein and band (ii), of molecular weight 94000, is a degradation
product of IgG which is produced from purified IgG under the electrophoresis conditions
used and is probably a dimer of H chains. It was not derived from the antigen as there was
no corresponding band in the GNAB 25 OM complex. From these observations it appears
that the species-specific antigen is heat-labile, periodate-stable and is the major outer
membrane protein with a molecular weight of about 100000.
Our studies with B. vulgatus suggest that it might be possible to define OM protein
antigens of other Bacteroides species which might be used in serological identification. Such
protein antigens would probably be much more constant characters than the capsular
antigens that are currently being investigated for B.fragilis (e.g. Kasper et al., 1979).
This work was supported by the Medical Research Council (grant no. G977/951/S). We are grateful to
Professor J. G. Collee for his advice and encouragement.
REFERENCES
Dubois, M., Gilles, K. A., Hamilton, J. K.. Rebers,
P. A. & Smith, F. (1956). Colorimetric method for
determination of sugars and related substances.
Analytical Chemistry 28, 350-356.
Duerden, B. I. (1980). The isolation and identification
of Bacteroides species from the normal human
faecal flora. Journal of Medical Microbiology 13,
69-78.
Duerden, B. 1., Collee, J. G„ Brown, R.. Deacon,
A. G. & Holbrook, W. P. (1980). A scheme for the
identification of clinical isolates of Gram-negative
anaerobic bacilli by conventional bacteriological
tests. Journal ofMedical Microbiology 13, 231-245.
Elhag, K. M. & Tabaqchali, S. (1978). The distri¬
bution of Bacteroides fragilis serotypes amongst
clinical strains. Journal ofHygiene 81, 89-97.
Finegold, S. M., Flora, D. J., Atterbery, H. R. &
Sutter, V. L. (1975). Faecal bacteriology of colonic
polyp patients and control patients. Cancer
Research 35, 3407-3417.
Hofstra, H. & Dankert, J. (1980). Major outer
membrane proteins: common antigens in Entero-
bacteriaceae species. Journal of General Micro¬
biology 119, 123-131.
Holbrook, W. P.. Duerden, B. I. & Deacon, A. G.
(1977). The classification of Bacteroides
melaninogenicus and related species. Journal of
Applied Bacteriology 42, 259-273.
Holland, J. W., Hill, E. O. & Altemeier, W. A.
(1977). Numbers and types of anaerobic bacteria
isolated from clinical specimens since 1960. Journal
ofClinical Microbiology 5, 20-25.
Kasper, D. L. & Seiler. M. W. (1975). Immuno¬
chemical characterisation of the outer membrane
complex of Bacteroides fragilis subspecies fragilis.
Journal ofInfectious Diseases 132, 440-450.
Kasper, D. L., Fiddian, A. P. & Tabaqchali, S.
(1979). Rapid diagnosis of bacteroides infections by
indirect immunofluorescence assay of clinical speci¬
mens. Lancet i, 239-242.
Laemmli, U. K. (1970). Cleavage of structural proteins
during the assembly of the head of bacteriophage
T4. Nature, London 227, 680-685.
Poxton, I. R. (1979). Serological identification of
Bacteroides species by an enzyme-linked immuno¬
sorbent assay. Journal of Clinical Pathology 32,
294-298.
Poxton, I. R. & Brown, R. (1979). Sodium dodecyl
sulphate-polyacrylamide gel electrophoresis of cell-
surface proteins as an aid to the identification of the
Bacteroides fragilis group. Journal of General
Microbiology 112, 211-217.
Poxton, I. R. & Byrne, M. D. (1981). Immunological
analysis of the EDTA-soluble antigens of
Clostridium difficile and related species. Journal of
General Microbiology 122,41-46.
Reynolds, E. S. (1963). The use of lead citrate at high
pH as an electron-opaque stain in the electron
microscope. Journal of Cell Biology 17, 208-212.
Sippel, J. E., Mamai, H. K., Weiss, E., Joseph, S. W.
Bacteroides vulgatus cell-surface antigens 109
& Beasley, W. J. (1978). Outer membrane protein
antigens in an enzyme-linked immunosorbent assay
for Salmonella, enteric fever and meningococcal
meningitis. Journal of Clinical Microbiology 7,
372-378.
Springer. E. L. & Roth, I. L. (1973). The ultra-
structure of the capsules of Diplococcus pneumoniae
and Klebsiella pneumoniae stained with ruthenium
red. Journal of General Microbiology 74, 21-31.
Weeke, B. (1973). Crossed immunoelectrophoresis.
Scandinavian Journal of Immunology 2, Suppl. 1,
47-56.
Westphal, O. & LOderitz, O. (1954). Chemische
Erforschung von Lipopolysacchariden Gram
negativer Bakterien. Angewandte Chemie 66, 407-
417.
J. MED. MICROBIOL.—VOL. 15 (1982) 223-231
© 1982 The Pathological Society of Great Britain and Ireland
0022-2615/82/0534 0223 $02.00
DETECTION OF SPECIES-SPECIFIC AND CROSS-REACTIVE
CELL-SURFACE ANTIGENS OF BACTEROIDES SPECIES
BY AN INDIRECT ENZYME-LINKED IMMUNOSORBENT ASSAY
I. R. Poxton, R. Brown and J. G. Collee
Department of Bacteriology, University of Edinburgh Medical School, Teviot Place,
Edinburgh EH8 9AG
Summary. EDTA-released outer-membrane antigen complexes were
prepared from 172 laboratory and reference strains and 43 fresh clinical
or faecal isolates representing 20 species or subspecies of Bacteroides,
together with 13 species of other genera. These antigens were titrated
against antisera to whole, live cells of 21 species or subspecies of
Bacteroidaceae in an indirect enzyme-linked immunosorbent assay
(ELISA). The presence of species-specific antigens was investigated
and cross reactions between species were noted. Results showed that a
high proportion of the species possess species-specific antigens with little
significant cross reactivity.
We believe that the ELISA system described here detects antigens
that represent the whole cell surface of bacteroides organisms. We have
exploited the sensitivity of the system and its quantitative potential to
define approaches for those wishing to use serological approaches for
either the identification of Bacteroides species or for the titration of
serum antibodies in patients with a possible bacteroides infection.
Introduction
In the laboratory investigation of infections involving anaerobes at mucosal
surfaces, estimation of the numbers of the various organisms present, and a distinction
between commensals and potential pathogens, could influence clinical assessment and
management. In the development of this expertise, it would be helpful if diagnostic
laboratories could identify bacteroides organisms to specific or subspecific level as a
routine, but this is still a complex and time-consuming exercise. Although the direct
observation of fluorescence of a specimen in ultraviolet light and the direct
examination of pus by gas chromatography may be useful adjuncts to direct
microscopy and may expedite the detection of anaerobes and the determination of the
genera involved, more detailed identification still generally rests upon an extended
series of biochemical and other tests (see Duerden et al., 1980).
Serological approaches to detailed identification of Bacteroides species and
subspecies have been explored by several groups of workers (Beerens et al., 1971;
Received 26 Aug. 1981; accepted 19 Oct. 1981.
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Lambe and Jerris, 1976; Abshire, Lombard and Dowell, 1977; Elhag and Tabaqchali,
1978). Commercial kits have been developed (Holland, Stauffer and Altemeier, 1979;
Labbe et al., 1980) and an immunoperoxidase method has been described (Hsu et al.,
1979). Other workers have explored the possibility of detecting specific antibodies in
the serum of patients with bacteroides infections (Hofstad, 1979; Sonnenwirth, 1979).
Our lack of knowledge of the significant surface antigens of these organisms in
relation to existing and evolving taxonomic groupings limits the development of
serological approaches to the characterisation of gram-negative anaerobes.
Outer membrane (OM) complexes released by EDTA from several species of
Bacteroides have been shown to contain species-specific antigens that can be
demonstrated by enzyme-linked immunosorbent assay (Poxton, 1979). The present
study extends this investigation and examines cross reactions that may occur between
species.
Materials and methods
The test bacteria included 172 strains representing 20 species or subspecies of Bacteroides,
five strains of Capnocytophaga ochracea, six strains representing four species of Fusobacterium,
and eight strains representing eight genera of aerobic or facultative gram-negative bacteria.
The following strains were obtained from the National Collection ofType Cultures (NCTC),
Central Public Health Laboratory, Colindale Avenue, London NW9 5HT: Bacteroides fragilis
NCTC nos. 9343, 9344, 8560, 10581 and 10584; B. thetaiotaomicron NCTC10582; B. vulgatus
NCTC10583; B. eggerthi NCTC11155; B. splanchnicus NCTC nos. 10825 and 10826;
B. melaninogenicus ss. intermedius NCTC nos. 9336 and 9338; B. asaccharolyticus NCTC9337;
B. corrodens NCTC10939; Fusobacterium necrophorum NCTC nos. 10576 and 10577; F.
necrogenes NCTC10723; F. polymorphum NCTC10562; F. varium NCTC10560; Proteus
mirabilis NCTC6197; Salmonella abortus equi NCTC5727; Shigella sonnei NCTC8220;
Escherichia coli NCTC10418; Pseudomonas aeruginosa NCTC10662; Enterobacter aerogenes
NCTC8172; Branhamella catarrhalis NCTC3622 and Haemophilus influenzae NCTC4560.
B. melaninogenicus ss. melaninogenicus ATCC15930 was obtained from the American Type
Culture Collection (ATCC), 12301 Parklawn Drive, Rockville, Md 20852. B. distasonis
ATCC8503, B. ovatus ATCC8483 and B. uniformis ATCC8492 were from Dr Ella M. Barnes,
Agricultural Research Council Food Research Institute, Colney Lane, Norwich. B. variabilis
VPI11368, B. bivius VPI6318 and VPI6822, B. disiens VPI8057, B. melaninogenicus ss.
melaninogenicus VPI4196 and B. melaninogenicus ss. levi VPI3300 were obtained from the
Virginia Polytechnic Institute and State University (VPI), Blacksburg, Va. 24060. B. oralis
strain 1210 was obtained from Dr S. Socransky, Forsythe Dental Center, Boston, Mass, and
B. ruminicola NP333 was obtained from Dr G. H. Bowden, London Hospital Medical College.
B. ureolyticus WPH58 was obtained from Dr A. L. James, Newcastle Polytechnic, Newcastle
upon Tyne. Capnocytophaga ochracea (Ristella ochraceus) strain 1956c was obtained from Dr
M. Sebald, Institut Pasteur, 25 Rue du Docteur Roux, Paris.
Other strains were received in connection with collaborative studies initiated by the ICSB,
Taxonomic Sub-committee on Gram-negative Anaerobic Rods (see Holbrook, Duerden and
Deacon, 1977; Deacon, Duerden and Holbrook, 1978), or were isolated in this laboratory from
clinical material; 43 strains of Bacteroides spp. were isolated for use in the fresh isolate study (see
below). All strains were identified by the methods of Duerden et al. (1976, 1980).
Growth of organisms and preparation of OM antigens was modified from the method of
Poxton (1979). Cultures in 50 ml of PPY medium were incubated for up to 48 h to yield good
growth. The suspended, washed cells were incubated with 10mM EDTA at 453C for 2-5 h; after
removal of cells by centrifugation, the undialysed supernate was used as the OM antigen.
Antisera were prepared as described by Poxton (1979).
Absorption ofantisera. Cross-reacting antibodies were removed by incubating 1 ml ofserum
with bacteria harvested from 50 ml of an 18-h PPY culture and washed with phosphate-buffered
saline. The suspension was shaken during the absorption period of 30 min at 37°C on a
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blood-cell suspension mixer. Cells were removed by centrifugation at 20 000 cj for 30 min at
4°C. The absorption procedure was repeated once.
Micro indirect enzyme-linked immunosorbent assay (ELISA) was modified from that of
Poxton (1979). Considerable loss of protein can occur during dialysis and, because dialysed and
undialysed OM antigens behaved similarly in the ELTSA assay, undialysed preparations were
used. No difference in homologous titre was generally found when the OM antigens were used
at 30 pg protein/ml or 60 pg protein/ml, so the lower concentration was used. However, for
comparison with results already published by Poxton (1979) the 60-^g concentration was used in
cross-reactivity studies. The results were read on a Titertek Multiscan Spectrophotometer
(Organon Teknika, St Neots, Cambs); the highest dilution of serum that gave an E405 value > 1 0
was recorded as the titre.
Study offresh isolates. Primary isolation plates from clinical specimens that contained
anaerobic gram-negative rods, were kindly supplied from the Bacteriology Laboratory, Royal
Infirmary of Edinburgh, and the Central Microbiology Laboratories, Western General
Hospital, Edinburgh. When possible, a single colony was subcultured into 50 ml of PPY
medium and incubated for 18-48 h. This culture was checked for purity, then 5 ml were
lyophilised and the remaining 45 ml were used for the preparation of OM antigen. If it was not
possible to pick a single colony pure from the primary isolation plate, a subculture was made on
BM-based lysed-blood agar containing kanamycin 75 ^ig/ml and vancomycin 2-5 /rg/ml
(Holbrook, Ogston and Ross, 1978). After incubation for 48 h, a single colony was subcultured
to PPY medium and processed as above.
OM antigens prepared from the fresh isolates were tested initially in a screening assay with
selected pools of rabbit antisera before they were titrated against individual sera within any
pool. A pool of antisera was prepared by mixing different volumes of soveral sera so that, when
the pool was diluted and tested against its homologous OM antigens, they all reacted to the same
titre. The pools were: 1, B. fragilis group (BFG) comprising 11 sera; 2a, B. melaninogenicus
group (BMG, pigmented) comprising four sera; 2b, B. melaninogenicus group (BMG,
non-pigmented) comprising six sera and 3, asaccharolytic group (AG) comprising three sera.
OM antigens that reacted significantly in screening tests with the BFG pool were further
screened against two other pools of BFG sera. They were: la, four sera representing three
indole-negative Bacteroides species and lb, seven sera representing six indole-positive
Bacteroides species.
Results
Studies with OM antigens and homologous sera
Outer-membrane antigen preparations from 28 strains representing 23 species or
subspecies of non-sporing anaerobes and one strain of Capno. ochracea were included
in the indirect ELISA with antisera raised against the same strains, except for three of
the Fusobacterium species, in rabbits and referred to here as species reference sera. OM
antigen preparations from the eight control aerobic or facultative species were
included in the study. The results are summarised in table I and the figure. Titres in
the range 3200-51 200 were recorded for strictly homologous interactions, i.e., when
an OM preparation was tested against a reference serum raised specifically against the
same strain. Minor heterologous cross reactions were observed in some cases and are
indicated as fractions of the homologous titres. When OM antigens from a range of
strains within the same species were tested against the species reference antiserum, the
results indicated the antigenic homogeneity or heterogeneity of the species (table I).
Results obtained with reference and laboratory stock strains are analysed separately
from those obtained with freshly isolated strains.
Results with reference and laboratory strains. OM antigen preparations from all
B. fragilis, B. vulgatus, B. eggerthi, B. uniformis, B. splanchnicus, B. melaninogenicus ss.
TableI
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intermedins, and B. disiens strains reacted strongly with their respective species
reference antisera. Two strains of B. ureolyticus reacted less strongly, but the reference
serum did not cross react with any other species. Two strains labelled
B. asaccharolyticus and later shown to be B. gingivalis did not react with the
B. asaccharolyticus antiserum.
When it became apparent that some strains did not react with an antiserum
prepared against the same species, sera were raised against other strains in an attempt
to find a more representative strain or to determine whether more than one serogroup
existed within the species. For example, strains of B. thetaiotaomicron reacted more
uniformly and more strongly with GNAB11 serum than with NCTC10582 serum, but
one strain failed to react with either serum. Two strains of B. distasonis reacted with
ATCC8503 serum, and four other strains reacted with GNAB26 serum, but one strain
failed to react with either serum. These findings indicate that there are two or more
serogroups in each of these species. For some species or subspecies the small number
of available test strains limited our study.
OM antigens from a significant proportion of the strains of B. melaninogenicus ss.
melaninogenicus, B. oralis and B. ruminicola failed to react with their species reference
antisera. Six of 11 strains of B. melaninogenicus ss. melaninogenicus, 12 of 17 strains of
B. oralis and eight of 14 strains of B. ruminicola failed to react with their species
reference antisera.
Results with freshly isolated strains. After the OM antigens prepared from fresh
isolates had been screened against pooled sera (see Methods) the following results were
obtained with appropriate species reference sera (table I): 23 out of 24 strains of
B. fragilis, one strain of B. vulgatus, two of three strains of B. thetaiotaomicron, one
strain of B. ovatus and seven out of nine strains of B. bivius reacted to a titre one-eighth
or greater of the respective homologous titres. However, one strain each of B. fragilis,
B. distasonis, B. thetaiotaomicron and B. disiens, and two strains of B. bivius failed to
react with their species reference sera. Three strains that failed to react with any group
of pooled antisera were later identified as B. capillosus for which we do not have an
antiserum. The OM antigen prepared from B. bivius GNAB136 reacted significantly
with more than one serum; it reacted to half of the homologous titre with the species
reference serum (VPI6318) and to one-eighth of the homologous titres with the
B. disiens VPI8057 serum and the B. oralis 1210 serum.
Cross reactions between species
B. fragilis group (BFG) OM antigens. When OM antigens from 11 strains
representing the nine species comprising the BFG were titrated with rabbit antisera
raised against washed whole bacteria, homologous titres were significantly greater and
usually at least 16-fold greater than any heterologous cross reactions (figure).
However, there were four reactions between BFG OM antigens and BFG sera, in
which the difference was 16-fold or less; there were significant cross reactions between a
B. ovatus antigen and the two B. thetaiotaomicron antisera, a B. uniformis antigen and a
B. fragilis serum and a B. variabilis antigen and a B. eggerthi serum. In addition, three
BFG OM antigens cross reacted with B. melaninogenicus/B. oralis/B. ruminicola group
antisera to one-sixteenth of the homologous titre. Serum raised against Capno.
ochracea cross reacted with the OM antigen from B. distasonis GNAB26.
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OM antigen
prepared from :
Titre of reaction between OM antigen and antiserum raised against whole cells
of the following strains, indicated* as a fraction of the homologous titre































B. mel. ss. int. NCTC9338
B. mel. ss. levii VPI3300
B. mel. ss. mel. ATCC15930

























Capno. ochracea 1956c •
F. necrophorum NCTC 10577
F. polymorphum NCTC10562
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Fig.—Specificity of the interaction of OM antigens and antisera prepared from bacteroides and other
organisms in an indirect ELISA system. BFG = B. fragilis group; BMG = fi. melaninogenicus/oralisl
ruminicola group; AG = asaccharolytic group.
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B. melaninogenicusforalis/ruminicola group (BMG) OM antigens. The OM
antigens of this group did not cross react with antisera raised against species in the
BFG or the asaccharolytic group. When these OM antigens were titrated against
antisera raised against the BMG species there was usually at least a 16-fold difference
between the homologous and cross-reacting titres, but there were 12 cross reactions
where the difference was 16-fold or less (figure).
Asaccharolytic group (AG) OM antigens. OM antigens of this group did not cross
react with antisera raised against species in the BFG or AG series, but there were some
minor cross reactions with antisera raised against the BMG species (figure).
OM antigens of aerobic andfacultative gram-negative bacilli. OM antigens from
these organisms usually failed to react with the bacteroides antisera or reacted to less
than one-sixteenth of the homologous titre. The exception was the OM antigen from
Esch. coli NCTC10418 which reacted with some of the BFG and AG antisera and the
Capno. ochracea antiserum to a titre one-sixteenth or greater of the homologous titre,
but did not react with the BMG antisera.
Cross reactions with Fusobacterium necrophorum antiserum. Serum raised against
F. necrophorum cross reacted with many OM antigens prepared from Bacteroides spp.
but not with the OM antigens of other Fusobacterium spp.
Reactions with absorbed antisera. After absorption of cross-reacting antibodies
(see Methods) the heterologous titres of 10 out of 13 cross-reacting sera were reduced to
<400 with no more than a twofold decrease in the homologous titres (table II).
Table II
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whole cells of cross-
reacting strain
NCTC9344 ATCC8492 6400 3200 400 <400
NCTC10582 ATCC8483 25600 25600 1600 <400
GNABI1 ATCC8483 3200 3200 400 <400
NCTC11155 VPI11368 6400 3200 400 <400
ATCC8492 NCTC 10418 12800 12800 3200 <400
NCTC9338 VPI4196 25600 25600 6400 <400
VPI4196 NCTC9338 51200 51200 3200 <400
VPI4196 ATCC8503 25600 12800 1600 800
VPI4196 GNAB26 25600 12800 1600 800
VPI4196 VP13300 25600 25600 1600 800
VPI4196 1210 25600 12800 1600 <400
VPI4196 VPI8057 25600 12800 800 <400
1210 VPI8057 25600 12800 1600 <400
VPI6318 VPI4196 12800 6400 1600 <400
VPI8057 NCTC9338 12800 12800 400 <400
Discussion
We have shown here, and previously (Poxton, 1979), that Bacteroides species
generally have cell-surface antigens that are species specific. The cross reactions that
do occur are mainly between similar species; cross-reactive antibodies can be absorbed
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with whole cells of the cross-reactive species. Our results suggest that it will be
possible to define species-specific surface antigens for many species of Bacteroides
especially within the B. fragilis group. This has already been done for B. vulgatus
where the species-specific antigen is the major outer-membrane protein (Poxton and
Ip. 1981) and for B. fragilis where the "capsular" polysaccharide, which appears to be
membrane bound and is thus amenable to investigation by ELISA, is the species-
specific antigen (Kasper et al., 1977). More strains within the species B. bivius, B.
melaninogenicus ss. intermedins, B. asaccharolyticus and B. ureolyticus also appear to
possess species-specific or subspecies-specific antigens. Some species such as B.
melaninogenicus ss. melaninogenicus, B. oralis and B. ruminicola, are as yet ill defined
and there were significant cross reactions within the group; more taxonomic studies
must be made before this group can be investigated serologically. For other species,
we have not been able to obtain sufficient strains to make a full serological
investigation.
In any identification scheme based on serological techniques, the antigens that are
to be detected must be clearly defined; their predominance within a species, subspecies
or serogroup should be known, and their cross reactions with related and unrelated
species must be determined. Moreover, the stability of these antigens and their
expression in laboratory-passaged strains must be ascertained. Only one of 24 fresh
isolates of B. fragilis failed to react with the B. fragilis species reference serum. More
work is needed to evaluate the significance of the few non-reactors when small numbers
of fresh isolates of other species were tested against apparently appropriate species
reference sera. A cautious approach to the identification ofwild strains by sera raised
against stock strains is clearly advisable on principle, but the results with B. fragilis
strains are particularly encouraging.
The indirect enzyme-linked immunosorbent assay that we used has provided useful
results in our investigation ofmaterial released from bacteria by mild heat, EDTA and
sonication. Our system appears to provide a valid representation of all of the antigens
present at the surface of whole cells. The antigens detected could include protein,
lipopolysaccharide (LPS) and capsular material; because extremely high dilutions of
serum are used, the system will detect the more immunogenic molecules, which have
the greatest affinity for the antibodies that we raised against whole cells. Less
immunogenic molecules which may be more cross reactive, such as LPS (Elhag and
Tabaqchali, 1978), will not be detected at such high dilutions of serum. The extreme
sensitivity of the system, its specificity and its quantitative potential will be of use in
defining approaches that might exploit immunofluorescence methods for the direct
examination of clinical specimens, or might allow the titration of serum antibodies in
patients with a possible bacteroides infection.
This study was supported by the Medical Research Council (Grant No. G977/951/S).
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1. SUMMARY
Lipopolysaccharides (LPS) from three strains of
Bacteroides fragilis were run on SDS-polyacryla-
mide gels and stained with silver. Each LPS pro¬
duced a similar pattern, consisting of a series of
regularly spaced discrete bands which decreased in
intensity as they increased in A/r value. Electroblot
transfer from duplicate SDS gels onto nitrocellu¬
lose membrane were reacted with antisera raised
to whole cells of two of the strains and antigens
were visualised with horse-radish peroxidase-anti-
rabbit-IgG conjugate and colour reagent. Results
revealed that the two lowest Mr bands of the LPS
preparation (rough LPS) represented common an¬
tigens.
2. INTRODUCTION
B. fragilis, the most commonly isolated
anaerobic bacterium from clinical specimens, pos¬
sessed surface factors, often referred to as "caps¬
ule", which appear to confer it with a greater
pathogenic potential than that of closely related
species [1],
In 1976 Kasper suggested that the capsular
polysaccharide may be a species-specific antigen
[2] but a recent report has suggested that the
earlier preparations were contaminated with LPS
and this may have been the species-specific anti¬
gen [3]. The presence of several distinct surface
carbohydrate antigens has been demonstrated by
Hofstad [4] and more recently he has shown by gel
filtration that LPS preparations are contaminated
with non-LPS carbohydrates [5].
The.investigations into the roles of surface com¬
ponents as virulence factors and species-specific
antigens have therefore been compromised by at¬
tempting to use preparations of unknown purity.
In this study we show that LPS prepared by
classical aqueous phenol technique from B. fragilis
can be analysed by sodium dodecyl sulphate poly-
acrylamide gel electrophoresis (SDS-PAGE) and
stained with silver. It can also be transferred to
nitrocellulose membrane and probed with antisera
raised against whole cells of B. fragilis. From the
results obtained we have been able to comment on
the purity of the LPS and suggest the nature of the
species-specific antigen.
3. MATERIALS AND METHODS
3.1. Bacterial strains and growth conditions
B. fragilis NCTC9344, and two clinical strains
0378-1097/83/$03.00 © 1983 Federation of European Microbiological Societies
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GNAB4 and GNAB92 which were isolated in our
own laboratory, were cultured to late exponential
phase in proteose peptone, yeast extract (PPY)
medium supplemented with haemin (5 jug. ml-1)
menadione (1 jug. ml-1), sodium bicarbonate
(0.04%) and cysteine HC1 (0.075%) [6] anaerobi-
cally with 10% C02 at 37°C.
3.2. Preparation of LPS
LPS was extracted from washed, freeze-dried
whole bacteria by the aqueous phenol procedure
developed by Westphal and Luderitz [7]. It was
purified and washed by two cycles of centrifuga-
tion at 100000 X g for 3 h and stored freeze-dried.
3.3. Preparation of antisera
Antisera were raised to whole live washed cells
of B. fragilis strains GNAB4 and GNAB92 in New
Zealand White rabbits by the method of Poxton
[8],
3.4. SDS-polyacrylamide gel electrophoresis
(SDS-PAGE)
This was performed on 10% slab gels with the
buffer system of Laemmli [9] by the method de¬
scribed by Poxton and Brown [10]. Gels were
stained with silver after periodic acid treatment by
the method of Tsai and Frasch [11] and also with
Coomassie Blue [12].
3.5. Electro-blot transfer and enzyme immunoassay
This was essentially by the method of Towbin
et al. [13], Material was transferred to nitrocellu¬
lose membrane (Transblot™ Transfer Medium,
BioRad) in Tris, glycine, methanol buffer, pH 8.3
[13] over a 16-h period at 12 V, 40 mA.
The transferred antigens were detected with the
ImmunBlot™ immunoassay (BioRad). Briefly, the
membrane, after washing for 10 min in Tris-
buffered saline (20 mM Tris, 500 mM NaCl, pH
7.5, TBS) was placed in 3% gelatin TBS for 45 min
to block any unbound sites. It was then trans¬
ferred into the B. fragilis antiserum diluted 1 :100
in 1% gelatin TBS and incubated for 3 h at room
temperature. After two-min washes in 0.025%
Tween-20 TBS the membrane was placed into goat
anti-rabbit IgG-horse radish peroxidase conjugate
(BioRad) diluted 1:3000 in 1% gelatin TBS and
incubated for 1 h at room temperature. After a
further two 10-min washes in Tween TBS it was
placed into HRP colour development solution
(BioRad) which contains 4-chloro-l-naphthol and
hydrogen peroxide. Colour development took place
between 5 and 15 min. The reaction was stopped
by placing into distilled water and washing with
several changes of water over 1 h. All of the above
steps were performed in clean glassware and with
gentle agitation throughout.
3.6. Carbohydrate assay
This was performed on the LPS preparation by
the method of Dubois et al. [14] with glucose as
the standard.
Fig. 1. SDS-polyaclyamide gels of LPS (20 fig) from B. fragilis
NCTC9344 (track 1), GNAB92 (track 2) and GNAB4 (track 3)
stained with silver after periodic acid oxidation. S represents
possible smooth LPS and R is rough LPS. R + l, 2, etc.




The three LPS preparations were run on SDS-
PAGE: the gel was loaded with 20 /ig (based on
carbohydrate assay) of each LPS and stained with
silver; the final development proceeding for no
more than 5 min. A significantly shorter develop¬
ment resulted in clearer definition of the heavier
staining bands but the finer bands were not visi¬
ble. Conversely a longer development time in¬
a 1 2 3
creased the sensitivity but results were difficult to
read. The results are shown in Fig. 1. Each LPS
preparation gave a similar pattern. At the front of
each track there was an almost clear area where
stain had not penetrated and just behind this there
was a series of regularly spaced discrete low-Mr
bands which decreased in staining intensity as they
approached the middle of the gel. This is best seen
in track 1 (NCTC9344 LPS). At the top half of
each track there were three high-Mr diffuse-stain-
b 1 2 3
Fig. 2. Electroblots of LPS (20 jug) from NCTC9344 (track 1), GNAB92 (track 2) and GNAB4 (track 3) which had been separated on
SDS gels as in Fig. 1 and transferred to nitrocellulose membranes. Reaction with antiserum raised against (a) GNAB4 and (b)
GNAB92, followed by anti-rabbit IgG and HRP colour development (BioRad). Faint reactions are arrowed.
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ing bands. On closer examination the middle dif¬
fuse band in track 2 (GNAB 92 LPS) can be seen
to be composed of a series of closely spaced dis¬
crete bands (arrowed —> S).
To estimate the protein in the LPS preparations
the amount of sample on the gels was increased
from 20 /xg to 50 /xg (carbohydrate) and stained
with Coomassie Blue. (We have found the Lowry
protein estimation to be of little use on LPS pre¬
parations from bacteroides due to the interference
from amino sugars and other unidentified compo¬
nents. Apparent high protein levels give no
Coomassie Blue bands on gels). After staining with
Coomassie Blue a grey-blue region was visible at
the front which corresponded to the clear area in
the silver stain and just behind this there was a
faintly stained band which may have been protein.
Other than this no definite bands were visualised.
Electroblot transfer was performed from two
duplicate gels which contained 20 /xg of each LPS.
One blot was probed with B. fragilis GNAB4
antiserum (Fig. 2a) and the other with B. fragilis
GNAB92 antiserum (Fig. 2b). In Fig. 2a the
GNAB4 antiserum reacted strongly with both high
and low-Mr bands in the homologous reaction
(track 3) and also in the reaction with NCTC9344
LPS (track 1). However, with GNAB92 LPS only
the two lowest Mr bands reacted strongly, but
several faint bands of increasing Mr were visible
(track 2). In Fig. 2b the homologous reaction
(track 2) demonstrated a reaction between both
high and low-Mr components, but with the two
heterologous reactions only the two lowest Mr
weight bands reacted strongly but, as in Fig. 2a,
faint higher-Afr bands were just discernible!
5. DISCUSSION
The silver-stained SDS-polyacrylamide gels of
LPS from the three strains of B. fragilis show
similarities to those previously reported for E. coli,
Salmonella typhimurium, Neisseria meningitidis and
Bordetella pertussis [11.15]. They are also similar to
the SDS gel profiles revealed by autoradiography
of LPS from E. coli and S. typhimurium [16,17],
The presence of multiple, regularly spaced bands
has been interpreted as LPS molecules possessing
increasing numbers of O-antigen-repeating units.
The heavily stained low-Mr component represents
rough LPS (i.e. lipid A and core) and each band of
increasing Mr represents the addition of one more
repeating unit (these have been indicated on Fig.
1, track 1 as R, R+l, R + 2, R + 3, etc.). This
interpretation probably also applies to the LPS of
B. fragilis. The material at the absolute front of the
gel, which did not stain well, may represent the
lipid A component which does not stain with silver
[11].
The diffuse-staining high-Mr bands have not
been so apparent in PAGE analyses of the enter¬
obacterial LPS preparations. The middle of the
three high-Mr bands in Fig. 1, track 2, labelled S
may be a series of smooth LPS molecules. It may
be possible that the other bands represent con¬
taminating non-LPS carbohydrates; either capsu¬
lar polysaccharide or the high-Mr carbohydrates
described by Hofstad [5]. In preliminary work in
our laboratory, capsule preparations have been
shown to have apparent high Mrs on SDS gels.
Electroblot transfer of the three LPS prepara¬
tions and subsequent detection of antigens by
antisera raised to whole cells of the two clinical
isolated revealed that the only components which
reacted significantly with both antisera were the
two lowest-Mr bands (R and R + 1) although faint
reactions were visible with some of the higher-A/r
bands (arrowed). The homologous reactions also
detected the high-Mr components. Some of the
high-Mr bands of the reference strain (NCTC9344)
also reacted with the GNAB4 antiserum. These
observations demonstrate that the probable core
region of the LPS is an antigen common to the
three strains of B. fragilis and may represent a B.
fragilis common antigen. If we assume that the
middle high-A/r band (S in Fig. 1) represents
smooth LPS then a likely explanation for only the
rough and semirough LPS reacting with antiserum
is either because of a concentration effect i.e. there
are only sufficient core determinants present in the
first two bands to be detected, or the presence of
many repeating units mask the core. The high-Mr
carbohydrates are not species-specific antigens but
may be shared by more than one strain. This is in
agreement with the work of Kasper et al. [3] who
have found LPS from two strains of B. fragilis to
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have an extremely similar chemical composition
and to be identical antigenically by use of inhibi¬
tion of an enzyme-linked immunosorbent assay.
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Antisera were raised to whole, live cells of a reference strain (NCTC 9344) and two clinical
isolates (GNAB 92 and GN AB 4) of Bacteroides fragilis. Each antiserum was reacted in crossed
line immunoelectrophoresis (CLIE) with EDTA-heat-sonication-prepared outer membrane
(OM) complex from 10 B. fragilis strains. In addition, the antisera were reacted with these
antigens in an enzyme-linked immunosorbent assay (ELISA). In CLIE, the antisera raised to the
reference strain and one of the clinical isolates (GNAB 92) demonstrated a heat labile antigen
which was common to all 10 of the test strains. Lipopolysaccharide (LPS) prepared from both
the clinical isolates produced three major precipitin lines when reacted with their homologous
antisera in crossed immunoelectrophoresis (CIE). In both cases, these three antigens were
present as major components of the OM complex. Each antiserum reacted significantly in
ELISA with all test OM complex preparations. Inhibition of ELISA showed that carbohydrates
were the predominant cross-reactive antigens in ELISA and that in the case of the clinical
isolate GNAB 4, most of the cross-reactive antigenic activity was present in the homologous
LPS preparation.
introduction
Bacteroidesfragilis is the most common anaerobic organism isolated from clinical specimens
(Wren et al., 1977). It is a significant pathogen in various wound infections, especially those of
the abdomen (Finegold, 1977). It can be found either in pure culture or more frequently together
with facultative organisms. Bacteroides fragilis has surface components, usually referred to as
capsule, which apparently make it more virulent than the more common faecal commensal
bacteroides, e.g. B. vulgatus, to which it is closely related (Onderdonk et al., 1977). These
observations, and the subsequent need for a rapid and more reliable sero-identification scheme,
have led to several studies of the cell surface of the species.
Methods used to examine the surface antigens of B. fragilis have most often concentrated on
heat stable carbohydrate components and have included tube agglutination of whole, boiled
cells (Lambe & Moroz, 1976; Elhag & Tabaqchali, 1978) and immunodiffusion of cell extracts
(Abshire et al., 1979; Cherniak et al., 1979). The antigenic properties of purified
lipopolysaccharide (LPS) have also been studied (Hofstad, 1975, 1977; Meizel-Mikolajczyk et
al., 1981). All investigations have shown complex patterns of cross-reactions and thus
considerable antigenic diversity associated with heat stable antigens.
The role of individual cell surface components as antigens is uncertain. Kasper & Seiler (1975)
and Kasper (1976) isolated a high molecular weight, species-specific capsular polysaccharide
antigen, but Kasper et al. (1983) have reported that the purified substance was a mixture of LPS
and capsule. Recent studies have also indicated that LPS purified from B. fragilis by the aqueous
phenol method of Westphal & Luderitz (1954) may be contaminated with non-O-antigenic,
carbohydrate precipitating antigens (Hofstad, 1981, 1982).
Abbreviations: CIE, crossed immunoelectrophoresis; CLIE, crossed line immunoelectrophoresis; ELISA,
enzyme-linked immunosorbent assay; OM, outer membrane.
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An enzyme-linked immunosorbent assay (ELISA) has been developed which detects species-
specific antigens in B.fragilis outer membrane preparations (Poxton, 1979; Poxton et al., 1982).
However, the relationship of the ELISA antigens to LPS, other carbohydrate antigens and outer
membrane proteins is not known. In this study, the nature of the antigens detected by ELISA
was investigated by the inhibition of ELISA technique. Crossed immunoelectrophoresis (CIE)
was also performed to investigate the relationship between precipitating antigens and the
antigens detected by ELISA.
METHODS
Culture ofbacteria and preparation ofEDTA-ouler membrane complex. Bacteroides fragilis NCTC 9344 and nine
laboratory isolates (GN AB 4, 85, 86, 87, 88, 90, 92,97 and 98) that had been previously characterized according to
the criteria of Duerden et al. (1980) were cultured anaerobically from freeze-dried inocula in PPY medium
(Holbrook et al., 1977). Outer membrane (OM) complexes were prepared by the EDTA-heat-sonication treatment
previously described (Poxton & Brown, 1979), except that incubation with EDTA buffer was extended from
30 min to 2 h and all samples were concentrated in an ultrafiltration cell with a PM-10 membrane (Amicon Corp.,
Lexington, Mass., USA).
Lipopolysaccharide (LPS) preparation. LPS was extracted from freeze-dried bacteria that had been grown in
PPY medium for 18 h by the aqueous phenol procedure developed by Westphal & Luderitz (1954). It was purified
and washed by centrifugation at 100000# for 3 h.
Treatment ofOM complex. Separate samples of EDTA-released OM complex at a concentration of 0-5— 1 -0 mg
protein ml"1 were treated with: (a) Heat (121 °C) for 15 min.; (b) 0-1 M-sodium periodate in sodium acetate buffer
(pH 5) at 20 °C overnight. Excess periodate was consumed by the addition of ethylene glycol and samples were
dialysed against 0-15 M-phosphate buffer pH 7-4 (PBS). A control sample was taken through each stage with the
omission of sodium periodate. (c) A mixture of pronase (BDH) and trypsin (Sigma) both at a concentration of
01 mg ml"1, overnight at 37 °C. A control sample was also incubated at 37 °C without the enzymes.
Preparation of antisera. Antisera were raised against washed live cells of B.fragilis NCTC 9344, B. fragilis
GNAB4 and B.fragilis GNAB92 in New Zealand White rabbits as previously described (Poxton, 1979).
Enzyme-linked immunosorbent assay (ELISA). Indirect ELISA was carried out as previously described (Poxton
& Byrne, 1981). Briefly, OM complex was diluted to 30 pg protein ml"1 in pH 9-6 carbonate buffer and coated
onto wells of microtitre plates. After reaction with rabbit antiserum, anti-rabbit-IgG-alkaline phosphatase
conjugate (Miles Laboratories, Stoke Poges, Slough, UK) and substrate (p-nitrophenyl phosphate, Sigma) results
were read in aTitertek Multiskan (Organon Teknika, St Neots, Cambs., UK). The end-point of the titration (titre)
was the first dilution of serum with an A405 value of less than 1 -6. An ELISA inhibition test was performed by pre-
incubating antisera with potential inhibitors: antiserum at four or eight times its titre, depending on strength of
heterologous reaction, was incubated with an equal volume of doubling dilutions of untreated, heat treated or
periodate treated OM complex (2 mg protein ml ~1) or LPS (400 pg carbohydrate ml ~1). A 1 in 2 dilution of OM
complex or LPS was the first inhibitor concentration used. Absorbance (A405) readings for each inhibited reaction
were expressed as a percentage of the normal uninhibited reaction.
Crossed immunoelectrophoresis (CIE) with intermediate gel. The procedure was essentially that described for CIE
by Weeke (1973). OM complexes were adjusted to a concentration of 2 or 3 mg protein ml" 1 in PBS containing 1 %
(v/v) Triton X-100. These antigens (16 pi) were examined against homologous antisera in CIE on sheets (5x5 cm)
of GelBond (Marine Colloids, Rockland, Maine, USA). Gel and electrophoresis buffer composition were as
previously described (Poxton & Byrne, 1981). Electrophoresis was at 12-5 V cm" 1 for 1-5 h in the first dimension
and at 12 V cm" 1 for 16 h in the second dimension, both at 4 °C. Gels were washed, pressed and stained with
Coomassie blue. A 5 x 1 cm agarose strip (intermediate gel) containing antiserum (or nothing in controls) was
incorporated between the first and second dimension gels.
Crossed line immunoelectrophoresis (CLIE). The conditions for CLIE were as described above for CIE except
that the intermediate gel contained heterologous OM antigen preparations (150-450 pg protein). This technique
detects cross-reactions between the homologous antigens run in the first dimension and heterologous antigens
contained in the intermediate gel (Krall, 1973).
Analytical techniques. Protein concentrations were estimated by the Lowry method, and carbohydrate as glucose
equivalents was estimated by the method of Dubois et al. (1956).
RESULTS
CIE and CLIE
Crossed immunoelectrophoresis ofOM complex from B.fragilis strains NCTC 9344 (reference
strain), GNAB 92 and GNAB 4 (clinical isolates) was performed against homologous antisera.
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Fig. 1. CIE and CLIE reactions of 9344 antiserum: (a) CIE of 9344 OM complex with blank
intermediate gel; (fc) CLIE of 9344 OM complex with GNAB 85 OM complex in the intermediate gel;
(c) as in (b) except with GNAB 90 OM complex in the intermediate gel. In the first dimension 16 pi
NCTC 9344 OM complex (48 pg protein) was run, against 500 pi antiserum in the second dimension.
Intermediate gels (b and c) contained 450 pg protein in 0-75 ml agarose gel. The numbers indicate the
precipitin arcs of cross-reacting antigens.
The presence of cross-reacting precipitating antigens in heterologous strains was detected by
inclusion of heterologous OM complex in an intermediate gel (CLIE).
Reactions with NCTC 9344 antiserum. The homologous reaction with NCTC 9344 OM
complex produced several precipitin arcs (Fig. 1 a), and those that were subsequently proved to
be cross-reacting antigens are numbered. CLIE was done with OM antigens from the nine
heterologous test strains. The results obtained with OM complex from GNAB 85 and GNAB 90
in intermediate gels are shown in Fig. 1 (b, c). Appearance of a horizontal precipitin line
indicated a reaction between the NCTC 9344 antiserum and a heterologous antigen, and the
joining of such a line with a homologous precipitin arc indicated a cross-reaction between the
antigens. Cross-reaction of the GNAB 85 OM complex with antigen 1 can be seen in Fig. 1 (b)
(arrowed). This strain also cross-reacted with a faint precipitate that was not visible in the
control reaction but which became apparent in CLIE reactions (arrowed). This antigen was
numbered 4 (Fig. 1 b). In Fig. 1 (c) it can be seen that the OM preparation from GNAB 90 cross-
reacted with antigens 1 and 3 (arrowed). The nine test strains varied in their cross-reactions with
antigens 2, 3 and 4, but all strains possessed an antigen that cross-reacted with antigen 1,
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(a)
(c)
Fig. 2. CIE and CLIE reactions of GNAB 92 antiserum: (a) CIE of GNAB 92 OM complex with blank
intermediate gel; (b) CLIE of GNAB 92 OM complex with GNAB 87 OM complex in the intermediate
gel; (c) CIE of heated GNAB 92 OM complex with blank intermediate gel; (d) CIE of GNAB 92 LPS
with blank intermediate gel. In the first dimension 16 pi GNAB 92 OM complex (48 pg protein) or LPS
(4 pg carbohydrate) was run, against 375 pi antiserum in the second dimension. Intermediate gel (b)
contained 150 pg protein in 0-75 ml agarose gel. L and X mark the cross-reacting antigens.
indicating the presence of a B.fragilis common antigen. Periodate treatment of the NCTC 9344
OM preparation had little effect on the homologous picture and the antigen 1 precipitate was
unmodified. Heating the OM complex (121 °C for 15min) destroyed most of the antigens
although some ill-defined precipitates remained. It was unclear which of the antigens these faint
reactions represented. The damage to antigen 1 by heat and its resistance to periodate suggested
that it may be a protein. When the OM complex was treated with pronase and trypsin, the
antigen 1 precipitate became faint and cross-reacted poorly in CLIE indicating that antigen 1 is
a protein.
Purified NCTC 9344 LPS did not react strongly with the antiserum, but did produce faint
precipitates representing at least two distinct antigens.
Reactions with GNAB 92 antiserum. The homologous reaction with GNAB 92 OM complex is
shown in Fig. 2(a). Outer membrane complexes from the nine heterologous test strains were
included in intermediate gels and an example of the CLIE pattern obtained with GNAB 87 is
shown in Figure 2(b). A cross-reaction with the antigen marked X in Figure 2(a) occurred
(arrowed). The antigen X precipitate joined up with the horizontal precipitin line and was
positioned higher in the gel than in the control. The OM antigens from the other eight
heterologous strains also cross-reacted with antigen X. Most of the strains only showed cross-
reaction with this single antigen. Periodate treatment of the GNAB 92 OM complex destroyed
all the major antigens, including antigen X. Several antigens were resistant to heat (Fig. 2c),
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although antigen X was destroyed. This is difficult to see from Fig. 2(c), but the destruction of
antigen X was confirmed by running a CLIE with untreated homologous antigen in the first
dimension and heated heterologous OM complex in the intermediate gel (i.e. as Fig. 2c but
unheated): no line precipitate occurred. Treatment with pronase and trypsin hardly affected the
picture, although the mobility of antigen X towards the anode increased slightly.
The results indicated that there are several distinct carbohydrate antigens associated with the
GNAB 92 OM complex. Also, a heat labile, periodate sensitive common antigen (X), possibly a
glycoprotein, exists. Purified GNAB 92 LPS produced three distinct antigens in CIE (Fig. 2d).
When LPS was incorporated into the intermediate gel of the homologous OM complex reaction,
it cross-reacted with the three antigens marked 'L' in Figure 2(a).
Reactions with GNAB 4 antiserum. The homologous reaction with GNAB 4 OM complex
yielded several precipitates (Fig. 3a). In contrast to the results obtained with the NCTC 9344
and GNAB 92 antisera, CLIEs with GNAB 4 antiserum did not demonstrate a common
antigen in the ten test strains. The OM complex from strain GNAB 86 cross-reacted with
antigen A (Fig. 3b, arrowed) as did strain GNAB 97. Strains NCTC (Fig. 3c, arrowed) and
GNAB 87 cross-reacted with antigen C and appear to have cross-reacted weakly with antigen
A. Strain GNAB 98 was the only strain to cross-react with antigen B. Cross-reactions of OM
complexes from strains GNAB 85, GNAB 88, GNAB 90 and GNAB 92 could not be
demonstrated by CLIE, even when levels of 600 (ig protein were included in the intermediate
gel. Periodate treatment destroyed most of the antigenic activity of the GNAB 4 OM complex
and at least three of the antigens were resistant to heat (Fig. 3d).
Purified GNAB 4 LPS was run against homologous antiserum (Fig. 3e): two heat resistant
antigens were detected. The GNAB 4 OM complex was run against homologous antiserum with
LPS in the intermediate gel. The CLIE pattern obtained confirmed the presence of antigens A
and C in LPS but also detected two other antigens. One of these cross-reacted with antigen B but
the other showed no cross-reaction with the OM complex precipitates.
The results indicated that GNAB 4 antiserum reacted with several carbohydrate antigens in
the homologous OM complex. Four precipitating antigens were detected in the LPS
preparation, three of which were the major cross-reacting antigens. The presence of four
precipitating antigens in ultracentrifuged LPS indicates co-purification of antigens other than
LPS.
The antisera to NCTC 9344 and GNAB 92 had demonstrated a common antigen in the ten
test strains (antigen 1 and antigen X). They were both heat labile but their sensitivity to
periodate differed. In an attempt to determine if they were in fact the same antigen, CIEs with
antiserum-containing intermediate gels were run. Antigen from GNAB 92 was run through an
intermediate gel containing GNAB 9344 antiserum into GNAB 92 antiserum (Fig. 4). When
compared to the control CIE without antiserum in the intermediate gel (Fig. 2a) precipitin line
X is seen to have precipitated in the intermediate gel. In the converse experiment, NCTC 9344
antigen run through GNAB 92 antiserum, a similar effect was seen with line 1 (result not shown
due to difficulty in reproduction). This demonstrated that there were antibodies to the common
antigens in both heterologous antisera, suggesting circumstantially that these common antigens
shared determinants.
Enzyme-linked immunosorbent assay (ELLSA)
The three test antisera were reacted in ELISA with OM complex from each of the ten test strains
(Table 1). In only three instances did a heterologous reaction fall below an eighth of the
homologous titre, thus indicating strong ELISA reactions of the three antisera with heterologous
strains.
Inhibition of ELISA. Inhibition studies«were performed to investigate the nature of the
antigens that reacted in ELISA. Potential inhibitors of the ELISA reactions were (a)
homologous untreated (i.e. positive inhibition control), (b) heat treated and (c) periodate treated
OM complexes. Antisera were incubated with doubling dilutions of potential inhibitors prior to
Fig.3.CIEandLIEreactionsofGNAB4ntiserum:( )ABOMcomplexwithbla kintermediag l;(b)CL1ofGNABOcomplexwith GNAB86OMcomplexinthentermediateg l;( )asbexc pwith9344complexithntermediatg ;(d)CIEofh ateGNAB4OMcompl xwith blankintermediategel;( )CIEofGNAB4LPSwithr ediateg l.Inhfi sdimension16pGNABOMco plex(32gp t i )rLPS6 carbohydrate)wasrun,again t375piantiserumithsecodime si .Intermediateg ls(ba dc)ont ined150gpro eii0- 5ofa rosg l.A,BandC markthecross- eactingantigens.
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Fig. 4. CIE of GNAB 92 OM complex with NCTC 9344 antiserum in intermediate gel. 16 pi (48 pg
protein) of GNAB 92 OM complex was run in the first dimension, through an intermediate gel
containing 125 pi NCTC 9344 antiserum (in 0-75 ml agarose), into 375 pi of GNAB 92 antiserum in the
second dimension. X marks the precipitin line which precipitated in the intermediate gel.
Table 1. Reactions of Bacteroides fragilis OM antigens with the three test antisera
The titre is defined as the first dilution of serum with an A405 value of less than 1-6. The titre of the
homologous reactions is marked (T).
Titre of given antigen when titrated
against antiserum raised against:
Antigen prepared t * \
from strain no.: NCTC 9344 GNAB 4 GNAB 92
NCTC 9344 12800 (T) 6400 3200
GNAB 4 3200 25600 (T) 6400
GNAB 85 3200 6400 6400
GNAB 86 6400 6400 6400
GNAB 87 3200 6400 6400
GNAB 88 1600 1600 800
GNAB 90 12800 3200 6400
GNAB 92 6400 6400 25600(T)
GNAB 97 6400 3200 3200
GNAB 98 12800 1600 6400
addition to the ELISA plate wells. In all experiments, each of the uninhibited reactions (as in
Table 1) was included as a control. Absorbance readings in the inhibited reactions were
expressed as a percentage of the normal uninhibited ELISA reaction.
Inhibition ofNCTC 9344 antiserum reactions. The extent to which heat or periodate treatment
reduced the capacity of NCTC 9344 OM complex to inhibit the ELISA reactions of NCTC 9344
antiserum varied, depending on the test antigen. However, three trends occurred in the results
and examples of each trend are shown in Fig. 5 (a~c). Inhibition of the reaction with GNAB 87
OM complex produced results (Fig. 5a) representative of those obtained with five other strains
(GNAB 4, 85, 87, 90 and 98). The weak inhibition by periodate treated antigens showed that
carbohydrates were the major antigens in these reactions. The position of the curve showing
inhibition by heated OM complex indicated that both heat resistant and heat labile antigens
took part in the reactions. Inhibition of the homologous (NCTC 9344) and GNAB 92 reactions
exhibited a second trend (Fig. 5b): inhibition by heated antigens was similar to that found in the
first trend, but periodate treated antigens inhibited to a greater extent than in the first trend. The
third trend occurred in the reactions with strains GNAB 88 and GNAB 97 (Fig. 5c) and showed
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Fig. 5. Inhibition of ELISA reactions of NCTC9344 antiserum by untreated (O), heated (0) and
periodate treated (□) homologous OM complex, (a), reactions with GNAB 87 OM complex; (b),
reaction with GNAB 92 OM complex; (c), reaction with GNAB 97 OM complex. 100% absorbance
was that obtained in the control reaction, i.e. no inhibitor added to antiserum.
Fig. 6. Inhibition of ELISA reactions of GNAB 92 antiserum by untreated (O), heated (0) and
periodate treated (□) homologous OM complex, (a), reactions with GNAB 98 OM complex; (6),
reactions with GNAB 88 OM complex.
that heat labile antigens were of greater importance than in the reactions with other strains. The
results suggested that reactions showing the second and third trends may have involved
important protein antigens as well as carbohydrates.
Inhibition ofGNAB 92 antiserum reactions. Two general trends were found in the reactions with
GNAB 92 antiserum. The results of the reactions with OM complex from strain GNAB 98 (Fig.
6a) are an example of the pattern obtained with seven other strains, including the homologous
strain. In the GNAB 98 reaction, negligible inhibition occurred with periodate treated
inhibitor. In four of the reactions showing this trend, some inhibition occurred at the two lowest
inhibitor dilutions, but this became negligible on further dilution. The position of the curve
showing inhibition by heated antigens indicated that heat resistant antigens were very
important in ELISA, while heat labile antigens were involved to a lesser extent. It is unclear why
the heated antigens inhibited ELISA less than untreated antigens at low dilutions and more at
high dilutions, but this was a consistent finding in the eight reactions. These results indicated
that in eight out of the ten ELISA reactions of GNAB 92 antiserum, carbohydrates were the
major antigens.
A second trend occurred in the reactions with strains GNAB 88 (Fig. 6b) and GNAB 97.
Heat labile, periodate resistant antigens had a significant role in ELISA, suggesting importance
of protein as well as carbohydrate antigens.
3 5 7 9 1 1
0;)
3 5 7 9 11
('0
Inhibitor dilution (1 in 2")
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Fig. 7. Inhibition of ELISA reactions of GNAB 4 antiserum by untreated (O), heated (®), periodate
treated (□) homologous OM complex and homologous LPS (■). (a) and (c), reactions with GNAB 86
OM complex; (b), reaction with GNAB 97 OM complex.
Inhibition of GNAB 4 antiserum reactions. Figure 7(a) shows the results obtained in the
reactions with OM complex from GNAB 86. This trend occurred in the reactions with nine
strains, including the homologous strain. The strong inhibition by heated antigens indicated
that carbohydrates were the predominant antigens in ELISA. Only the reaction with GNAB 97
(Fig. lb) differed, but still showed that the most important antigens were carbohydrate.
Inhibition of GNAB 4 antiserum was also carried out with the homologous LPS preparation,
with untreated homologous OM complex providing a positive inhibition control. The results
obtained in the reactions with strain GNAB 86 (Fig. 7c) indicated strong inhibition by LPS. A
very similar picture was obtained in the reactions with five other strains. In the reactions with
the strains GNAB 88, 97 and 98, inhibition by LPS was slightly less than in the GNAB 86
reaction, but was still very significant. Inhibition by LPS was weakest in the homologous
reaction.
DISCUSSION
Throughout this study, an EDTA-45 °C-mild ultrasonication extract of whole cells was used as
the OM complex antigen. From previous work (Poxton & Ip, 1981; Poxton et al., 1982; Kasper
& Seiler, 1975), we know that this type of preparation represents the outer membrane and
associated molecules, including capsule, and contains species-specific antigens.
The techniques of CIE and CLIE have been useful in showing the array of antigens that exist
at the cell surface of B. fragilis. By these methods, we have detected certain cross-reactions
between strains and have examined the antigens present in extracted LPS in relation to OM
complex antigens. Most previous studies of the cross-reacting precipitating antigens of B. fragilis
have used immunodiffusion methods. Immunodiffusion has been applied to the analysis of
various extracts of B. fragilis and has shown complex patterns of cross-reaction (Abshire et al.,
1979; Cherniak et al., 1979; Meisel-Mikolajczyk et al., 1981). It had been concluded that
considerable antigenic heterogeneity exists between strains of B. fragilis. In the present study,
although variations in cross-reacting patterns were observed, two of the test antisera
(NCTC 9344 and GNAB 92) each detected heat labile, precipitating antigens common to all
strains tested. Such heat labile common precipitating antigens have not previously been
reported but Schwan et al. (1981) have demonstrated a heat labile surface antigen associated
with non-homogeneous immunofluorescence staining. The reactions of the GNAB 4 antiserum
were similar to those observed by previous workers in that no common antigen was
demonstrated, heterologous strains cross-reacted with any one of three carbohydrate antigens
and no cross-reactions could be demonstrated in some strains. The reason that GNAB 4
antiserum did not detect the single common antigen may have been because this organism has a
well defined large capsule which masked, or was dominant over, the common antigen. This is
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supported by the CIE results with GNAB 4 antiserum and homologous LPS and EDTA
preparations where the major antigens in both preparations were found to be heat stable and
periodate labile. We know from other studies (unpublished results) that the LPS preparation of
GNAB 4 contains much high molecular weight capsular polysaccharide.
The nature of the heat labile, common, precipitating antigen(s) detected by the antisera to
NCTC 9344 and GNAB 92 strains is not yet fully characterized, but attempts are being made to
purify it. Both these strains apparently express this antigen when injected into rabbits. They do
not exhibit obvious capsules.
An ELISA has been used to detect largely species-specific reactions of B. fragilis antisera with
OM complex from heterologous strains (Poxton, 1979). SDS-PAGE of OM complex has shown
marked similarities in the polypeptide profiles of different B. fragilis strains (Poxton & Brown,
1979; Kasper & Seiler, 1975), suggesting that proteins could act as species-specific antigens in
ELISA. Alternatively, the species-specific carbohydrate antigen(s) isolated from OM complex
(Kasper & Seiler, 1975; Kasper, 1976) and aqueous phenol extracts (Kasper et al., 1983) may be
the major cross-reacting antigen(s) in ELISA. The nature of the antigens reacting in ELISA was
investigated in the present study by ELISA inhibition. The results indicated that the
predominant cross-reacting antigens were in most cases periodate sensitive and heat resistant
and were therefore carbohydrates. The extent to which protein (heat labile, periodate resistant)
antigens appeared to be involved in ELISA reactions depended on the individual cross-reacting
strain. Although protein antigens were of some significance in ELISA for at least two cross-
reacting strains (GNAB 88 and GNAB 97), carbohydrate antigens still contributed to these
reactions.
There was clearly limited correlation between the CLIE and ELISA results: in the reactions of
GNAB 4 antiserum, heat stable carbohydrates were the important cross-reacting antigens in
both systems; however, CLIE did not detect cross-reactions with certain strains that cross-
reacted strongly in ELISA. Heat stable carbohydrates were also predominant in the ELISA
reactions with GNAB 92 antiserum, yet CLIE detected only a single, heat labile, cross-reacting
antigen with this antiserum. The limited correlation between the two techniques is not
unexpected considering the far greater sensitivity of ELISA over CLIE. Also, CLIE only detects
precipitating antigens, while ELISA will detect monovalent antigens.
It is not clear which of the carbohydrate components of the OM complex were reacting in
ELISA. Inhibition of ELISA reactions of GNAB 4 antiserum with homologous LPS indicated
that LPS contained most of the cross-reactive antigens. The nature of the antigens present in the
LPS preparations is currently under investigation in this laboratory.
This study was supported by a grant from the Medical Research Council (no. G8106873). G. C. gratefully
acknowledges the award of a studentship from the Medical Faculty of the University of Edinburgh.
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Immunochemistry of the Surface Carbohydrate Antigens of
Bacteroides fragilis and Definition of a Common Antigen
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The components extracted by aqueous phenol from whole cells of Bacteroides fragilis were
analysed by SDS-PAGE and immunoblotting and shown to consist of a series of strain-specific,
cross-reactive and common antigens. Regularly-spaced ladder patterns on silver-stained gels
indicated that in most strains the LPS was present as a predominantly smooth type, but with
chain lengths of varying molecular mass, ranging within each particular strain from essentially
rough forms to long chain-length smooth forms. The rough form of the LPS at the gel front
possessed an antigen common to most of the strains investigated. Another antigen, which
migrated behind the rough LPS on SDS gels, was common to all strains of the species. The
smooth LPS forms and the other high molecular mass components were strain-specific antigens.
Previously published methods are not capable of producing pure LPS or capsular polysaccharide
for this organism.
introduction
Bacteroides fragilis, the most frequently isolated anaerobic bacterium from clinical specimens,
appears to have a greater pathogenic potential than its close relatives, e.g. B. vulgatus and other
members of the B. fragilis group. Surface structures have been associated with this virulence
(Onderdonk et al., 1977). Much has been published on the chemistry and immunochemistry of
structural components but confusion exists. Many workers (e.g. Kasper et al., 1983) assume that
the surface carbohydrates of this Gram-negative bacterium consist simply of lipopolysaccharide
(LPS) and 'capsular polysaccharide'. Hofstad (1981) and Cousland & Poxton (1984), however,
have demonstrated a complex set of surface carbohydrates. Much of the apparent confusion
stems from the difficulty in preparing pure surface components. Kasper et al. (1983) and
Weintraub et al. (1985) claimed to have developed methods for the preparation of pure capsular
polysaccharide free from LPS, and of LPS free from capsular polysaccharide, protein and
nucleic acid. Starting with an aqueous phenol extract of whole cells, capsular polysaccharide was
prepared by gel filtration in the presence of a detergent, whereas LPS was prepared by further
extraction with a phenol/chloroform/petroleum spirit mixture. The authors suggested that the
LPS of B. fragilis is a rough-type molecule and is both chemically and antigenically similar in all
the strains investigated.
The development of a method for demonstrating the heterogeneity of LPS on polyacrylamide
gels (Tsai & Lrasch, 1982) has been applied to many species of Gram-negative bacteria. In a
preliminary report (Cousland & Poxton, 1983), we showed that B. fragilis possesses a complex
mixture of aqueous phenol-extractable surface carbohydrate antigens. A series of closely spaced
bands in a ladder pattern on the silver-stained polyacrylamide gel was reminiscent of the pattern
produced by the smooth form of LPS from other bacteria. This led us to suggest that B. fragilis
possesses smooth type LPS. We also showed that a common antigen ran at the gel front and was
associated in some unknown way with the rough form of the molecule.
0001-3246 © 1986 SGM
2476 I. R. POXTON AND R. BROWN
In the present paper we extend our earlier work by studying aqueous phenol extracts of a
range of B.fragilis strains with a combination of SDS-PAGE and immunoblotting. We report on
the complexity of the carbohydrates of the cell-surface of B. fragilis and we define the common
antigen.
METHODS
Bacterial strains and growth conditions. B.fragilis strains NCTC 9343 and 9344 were obtained from the National
Collection of Type Cultures, Colindale Avenue, London, UK. Clinical strains of B.fragilis, GNAB 4, 82, 85, 90
and 92, were from our laboratory collection.
All strains were cultured in 2 to 6 litre batches of proteose peptone/yeast extract (PPY) medium (Deacon et al.,
1978) statically for 18 h in an anaerobic atmosphere (80% N2, 10% C02 and 10% H2) at 37 °C.
Preparation of aqueous phenol extract. Lyophilized bacteria were resuspended to a concentration of
approximately 5% (w/v) in distilled water and heated to 67 °C. An equal volume of 90% (w/w) aqueous phenol at
67 °C was added to the suspension and the mixture was stirred for 15 min at 67 °C. After cooling to 4 °C the phases
were separated by centrifugation at 10000# for 10 min. The upper aqueous phase was dialysed against running
water for 18 h, concentrated to approximately 20% of the original volume by rotary evaporation and centrifuged at
100000# for 3 h to sediment the insoluble fraction. This was washed once by suspension in water with the aid of a
syringe fitted with a no. 26 gauge needle, and recentrifugation. The pellet was finally resuspended in water and
lyophilized.
Fractionation of aqueous phenol extract. The lyophilized pellet from the aqueous phenol extract (5 mg) was
solubilized in deoxycholate buffer and fractionated on a column (55 x 1 -6 cm) of Sephacryl S-300 by the method of
Kasper et al. (1983). Fractions (50 x 2 ml) were analysed for precipitating antigen by fused rocket
immunoelectrophoresis in the presence of 1 % Triton X-100 (Svendsen, 1973), and for total antigen by dot-blotting
onto nitrocellulose membrane and reaction with antiserum to strains of B. fragilis as described below.
Preparation of rough LPS. Lyophilized, dialysed aqueous phase from the aqueous phenol extraction of B.fragilis
NCTC 9344 was extracted with phenol/chloroform/petroleum by the method used for LPS extraction by
Weintraub et al. (1985). The material remaining insoluble after phenol/chloroform/petroleum extraction was
resuspended in distilled water, re-extracted with an equal volume of 90% aqueous phenol as described above and
the aqueous phase dialysed and lyophilized.
Preparation of antisera. Antisera were raised in New Zealand White rabbits to whole, live, washed cells of B.
fragilis strains NCTC 9344, GNAB 4 and GNAB 92 by the method of Poxton (1979).
Monospecific polyclonal antiserum was raised to the B.fragilis common antigen by a method briefly referred to
in a Bio-Rad pamphlet (no. 48EG, 1984). The aqueous phenol extract (containing 112 pg carbohydrate) was
separated as a band on SDS-PAGE and transferred to nitrocellulose as described below. This was done in
duplicate. Guide strips were cut from the nitrocellulose and reacted with whole cell antiserum to locate the
common antigen. Strips 2 mm wide containing the common antigen were cut from the unreacted nitrocellulose
membranes. They were dried in a stream of compressed air, cut into small pieces and dissolved in dimethyl
sulphoxide (100 pi cm-2). This was mixed with an equal volume of Freund's complete adjuvant (Difco) and
injected subcutaneously in approximate 0-1 ml volumes into several sites on the back of a rabbit. This procedure
was repeated four times but with Freund's incomplete adjuvant over a period of two months. Test bleedings taken
at intervals during the injection schedule were screened by dot-blotting against homologous aqueous phenol
extract. The antiserum reached its highest titre one month after the last injection.
SDS-PAGE. This was done on both 10% and 12% slab gels with the buffer system of Laemmli (1970) by the
method described by Poxton & Brown (1979). Gels were oxidized with periodate and stained with silver by the
method of Tsai & Frasch (1982).
Electrophoretic transfer and immunoblot. This was done by the method described by Cousland & Poxton (1983),
with the Bio-Rad Immunoblot reagents, except that the nitrocellulose membrane was 0-2 pm pore size (Sartorius).
Antigens were either electrophoretically transferred, or applied directly in 1 pi volumes as dots for dot-blotting.
The antiserum raised against whole cells was used at a dilution of 1 in 250 while that raised against the common
antigen was used at a dilution of 1 in 40.
Analytical methods. Carbohydrate was measured by the method of Dubois et al. (1956) with glucose as a
standard. Protein was measured by the Lowry method.
RESULTS
The bacteria grew well in PPY medium to yield 0-5-1 -0 g dry weight l-1 after overnight
incubation. After aqueous phenol extraction and ultracentrifugation, yields of extract were 0-4%
to 0-9% of the bacterial dry weight. All strains were grown on more than one occasion; yields
were similar and subsequent analyses were identical.
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Fig. 1. Silver-stained SDS-polyacrylamide (12%) gels of aqueous phenol extracts (10 gg carbohydrate)
of seven strains of B. fragilis. Track 1, NCTC 9343; track 2, NCTC 9344; track 3, GNAB 4; track 4,
GNAB 82; track 5, GNAB 85; track 6, GNAB 90; track 7, GNAB 92. H, High molecular mass band;
S, multi-banded pattern typical of smooth LPS; C, common antigen; R, rough LPS at gel front.
Samples of dry extract were resuspended in distilled water to a concentration of 5 mg ml"1 and
assayed for carbohydrate and protein. There was a negligible amount of protein, and
phenol/sulphuric acid positive carbohydrate (Dubois et al., 1956) accounted for about 20% only
of the dry weight of the extract. No further chemical assays were done.
SDS-PAGE and immunoblotting of aqueous phenol extracts
Each extract was dissolved to a concentration of 400 pg carbohydrate ml"1 in the SDS/2-
mercaptoethanol solubilization buffer of Laemmli (1970), and heated to 100 °C for 3 min.
Samples (25 pi) were applied to a 12% SDS-polyacrylamide gel. Fig. 1 shows examples of
patterns obtained after separation and silver staining of aqueous phenol extracts from seven
strains of B. fragilis. In all tracks there is a multi-banded pattern (labelled S), of varying
intensity, which is similar to smooth LPS of other Gram-negative bacteria. In some tracks (3, 4
and 5) the fine banding pattern is extremely faint and the general appearance is more like that of
rough LPS. There is material of high molecular mass with a characteristic dumb-bell shape in
most of the tracks (labelled H). A pronounced band (C) is present behind the main front band
(R). No Coomassie-blue-staining material was observed.
Three separations identical to that shown in Fig. 1 were done, and the components from each
were transferred to a sheet of nitrocellulose and probed with antisera raised to whole cells of
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Fig. 2. Immunoblots from SDS-polyacrylamide (12%) gels of aqueous phenol extracts of the strains
used in Fig. 1. The blots were probed with antiserum raised against whole cells of B.fragilis GNAB 92
and anti-rabbit horseradish peroxidase conjugate. See Fig. 1 for abbreviations.
three of the strains: NCTC 9344, GNAB 4 and GNAB 92. An example of the results (with
GNAB 92 antiserum) is shown in Fig. 2. All strains have one antigen in common, a discrete
band migrating behind the front (labelled C). The band migrating at the front (R) is an antigen
common to all strains except GNAB 4, whereas antigens in the upper part of the gel were
detected only in the homologous strain (track 7) and weakly in strain GNAB 82 (track 4). With
the NCTC 9344 antiserum, a similar pattern was seen: an antigen common to all strains was
detected just behind the gel front, a band at the gel front was common to all except GNAB 4 and
a series of higher molecular mass bands were common to the homologous strain, NCTC 9343
and GNAB 4. With the GNAB 4 antiserum, the common band behind the gel front was
apparent, and a series of higher molecular mass bands common to the same three strains as with
the NCTC 9344 were visible, but the band at the front was specific only to the homologous
reaction. Pre-immune sera gave no reactions.
Fractionation of aqueous phenol extract
As the aqueous phenol extract consisted of a series of different antigens demonstrable by SDS-
PAGE and immunoblotting, the whole extract was subjected to gel filtration in the presence of
deoxycholate by the method developed by Kasper et al. (1983) for the production of capsular
polysaccharide free from LPS. The extract from B. fragilis GNAB 92 was solubilized and
fractionated on Sephacryl S-300. Analysis of the fractions by fused rocket immunoelectrophore-
sis with homologous whole cell antiserum showed that only fractions eluted at the void volume of
the column contained precipitating antigens. When the fractions were analysed by dot blotting,
Fig. 3 Fig. 4
Fig. 3. Immunoblots from SDS-polyacrylamide (10%) gels of an aqueous phenol extract of B.fragilis
GNAB 92 after fractionation on Sephacryl S-300. Track 1, pooled void volume antigenic fractions;
track 2, pooled included antigenic fractions; track 3, fractions from between two antigenic peaks; track
4, unfractionated aqueous phenol extract. All tracks contained 10 pg carbohydrate. The blots were
probed with homologous whole cell antiserum and horseradish peroxidase conjugate. See Fig. 1 for
abbreviations.
Fig. 4. Silver-stained SDS-polyacrylamide (12%) gels of extracts (10 pg carbohydrate) of B.fragilis
NCTC 9344. Track 1, aqueous phenol extract; track 2, phenol/chloroform/petroleum extract of
aqueous phenol extract; track 3, material remaining insoluble after phenol/chloroform/petroleum
extraction.
two groups of antigen-containing fractions were detected, one corresponding to the column void
volume which was the same as that detected by fused rocket immunoelectrophoresis and one
containing lower molecular mass material. With the two other antisera (GNAB 4 and NCTC
9344), only the lower molecular mass material reacted. These findings indicate that the first peak
contained strain-specific antigens while the second contained cross-reactive antigens.
The fractions that corresponded to each of the two peaks of antigen as demonstrated by dot
blotting, and the fractions between the two peaks, were combined into three pools, lyophilized
and examined by SDS-PAGE and immunoblotting; both techniques gave identical results. The
patterns produced with homologous antiserum are shown in Fig. 3. The void volume fractions
(track 1) contained a series of antigens of which the central group (labelled S), on close
examination of the original, consisted of a series of discrete fine bands. The included fractions
(track 2) produced only two bands corresponding to the common B.fragilis antigen (C), and the
front band (R). The pooled fractions between the peaks (track 3) contained a mixture of the
antigens in both of the peaks. Track 4 is of the aqueous phenol extract before fractionation;
fractionation of the aqueous phenol extract of GNAB 4 gave similar results.
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Fig. 5. Immunoblots from SDS-polyacrylamide (12%) gels of aqueous phenol extracts of the strains used
in Fig. 1. The blots were probed with monospecific antiserum raised against the common antigen
excised from nitrocellulose.
Comparison of rough LPS with aqueous phenol extract
The pattern produced on SDS-PAGE of the phenol/chloroform/petroleum-extracted fraction
of the aqueous phenol extract of NCTC 9344, i.e. the fraction corresponding to the LPS studied
by Weintraube/a/. (1985), was compared with that of the aqueous phenol extract and that of the
material that remained insoluble after the phenol/chloroform/petroleum treatment (Fig. 4). A
ladder pattern typical of smooth LPS was found with the aqueous phenol extract, with the dumb¬
bell shaped high molecular mass band. Track 2 shows the PCP fraction, which was typical of
rough LPS, with only a single heavily staining band at the front. Track 3, containing the
insoluble material remaining after PCP treatment, had a strongly staining dumb-bell shaped
band at the top, a faintly staining ladder pattern that became stronger after longer development,
an intensely stained band running behind the front (subsequently shown by blotting to be the
common antigen) and also a band at the dye front.
Demonstration of the antigenic specificity of the B. fragilis common antigen
Common antigen, purified by SDS-PAGE, immunoblotting and extraction from nitrocellu¬
lose membranes, was injected into a rabbit to raise monospecific antiserum. In immunoblots
against aqueous phenol extracts prepared from the seven strains used in Figs 1 and 2, the serum
reacted strongly with the common band of the B. fragilis strains (Fig. 5).
DISCUSSION
In this study we have shown that aqueous phenol extracts of B. fragilis contain a series of
antigens that can be detected by silver-staining and immunoblotting. Most strains possess
antigens that include (i) a rough type LPS which runs at the gel front, (ii) a common antigen
which runs behind the front, (iii) a smooth LPS which runs as a series of closely spaced bands,
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and (iv) one other antigen, with a high molecular mass and with a characteristic dumb-bell
pattern, which we suggest is the capsular polysaccharide.
The recent studies of Weintraub et al. (1985) on the chemistry and immunochemistry of the
LPS of B. fragilis were based on the assumption (shown here to be false) that the species
produced only a rough form of LPS; the system used selectively extracted rough LPS and the
fraction that would have contained the smooth form was discarded. In the earlier studies of these
workers (Kasper et al., 1983), the Sephacryl S-300 chromatography separated the aqueous
phenol extract into two major fractions; the higher molecular mass fraction consisted of
'capsular polysaccharide', while the second fraction contained LPS. In our studies, the first peak
consisted of smooth LPS together with another high molecular mass antigen, probably capsular
polysaccharide, and the second peak contained rough LPS and the common antigen.
The nature of the common antigen is not known. The monospecific antiserum raised against it
shows that it is antigenically distinct from the rough form of the LPS, although in some
immunoblots a weak reaction was seen with some of the front material. Studies are currently in
progress to purify and characterize the antigen with monoclonal antibodies, but at present we
can only speculate on its nature. It may either be totally distinct from the LPS and be analogous
to the enterobacterial common antigen (Mannel & Mayer, 1978), as it is purified in a similar
way, or be related to the rough LPS but with a unique and dominant epitope: it could be lipid A
plus a complete core - the unique epitope, distal from the lipid end, being normally substituted
with O antigen. The material that runs at the gel front, which is common to all but one of the
strains of B. fragilis that we have investigated, may be lipid A with an incomplete core. Its
epitopes would be expressed along the linear core portion of all or most LPS molecules. The
smooth LPS and the high molecular mass 'capsular' antigen are not common antigens. There is a
certain amount of cross-reaction between the strains of the species but there appear to be type-
specific antigens which could be used in serotyping.
This study was funded by a grant from the Medical Research Council. We are grateful to J. Keen for producing
Fig. 3, C. Patrizio for expert technical assistance and to Professor J. G. Collee for encouragement and interest.
REFERENCES
Cousland, G. & Poxton, I. R. (1983). Analysis of
lipopolysaccharides of Bacteroides fragilis by sodium
dodecyl sulphate-polyacrylamide gel electrophoresis
and electroblot transfer. FEMS Microbiology Letters
20, 461^165.
Cousland, G. & Poxton, I. R. (1984). Crossed
immunoelectrophoresis and enzyme-linked im¬
munosorbent assay of the cell-surface antigens of
Bacteroides fragilis. Journal of General Microbiology
130, 645-655.
Deacon, A. G., Duerden, B. I. & Holbrook, W. P.
(1978). Gas-liquid chromatographic analysis of
metabolic products in the identification of Bacteroi-
daceae of clinical interest. Journal of Medical
Microbiology 11, 81-99.
Dubois, M., Gilles, K. A., Hamilton, J. K., Rebers,
P. A. & Smith, F. (1956). Colorimetric method for
determination of sugars and related substances.
Analytical Chemistry 28, 350-356.
Hofstad, T. (1981). Precipitating carbohydrate anti¬
gens of Bacteroides fragilis NCTC 9343. Acta
pathologica et microbiologica scandinavica B89, 215-
219.
Kasper, D. L., Weintraub, A., Lindberg, A. A. &
Lonngren, J. (1983). Capsular polysaccharide and
lipopolysaccharide from two Bacteroides fragilis
reference strains: chemical and immunochemical
characterisation. Journal of Bacteriology 153, 991-
997.
Laemmli, U. K. (1970). Cleavage of structural proteins
during the assembly of the head of bacteriophage T4.
Nature, London 111, 680-685.
Mannel, D. & Mayer, H. (1978). Isolation and
chemical characterisation of the enterobacterial
antigen. European Journal of Biochemistry 86, 361—
370.
Onderdonk, A. B., Kasper, D. L., Cisneros, R. L. &
Bartlett, J. G. (1977). The capsular polysaccharide
of Bacteroidesfragilis as a virulence factor: compari¬
son of the pathogenic potential of encapsulated and
unencapsulated strains. Journal ofInfectious Diseases
136, 82-89.
Poxton, I. R. (1979). Serological identification of
Bacteroides species by an enzyme-linked immunosor¬
bent assay. Journal ofClinical Pathology 32, 294-298.
Poxton, I. R. & Brown, R. (1979). Sodium dodecyl
sulphate-polyacrylamide gel electrophoresis of cell-
surface proteins as a guide to the identification of the
Bacteroides fragilis group. Journal of General Micro¬
biology 112, 211-217.
Svendsen, P. J. (1973). Fused rocket immunoelectro¬
phoresis. Scandinavian Journal of Immunology 2,
supplement 1, 69-70.
Tsai, C.-M. & Frasch, C. E. (1982). A sensitive silver
stain for detecting lipopolysaccharides in polyacryl-
amide gels. Analytical Biochemistry 119, 115-119.
Weintraub, A., Larsson, B. E. & Lindberg, A. A.
(1985). Chemical and immunochemical analyses of
Bacteroidesfragilis lipopolysaccharides. Infection and
Immunity 49, 197-201.
J. Med. Microbiol. — Vol. 28 (1989), 267-273
© 1989 The Pathological Society of Great Britain and Ireland
0022-2615/89/0028-0267/$ 10.00
Immunochemistry of the cell surfaces of Bacteroides
bivius and Bacteroides disiens
R. BROWN, KAREN E. HORNETT and I. R. POXTON*
Department of Bacteriology, University of Edinburgh Medical School, Teviot Place, Edinburgh EH8 9AG
Summary. Outer membranes were extracted from seven strains of Bacteroides bivius
and six strains of B. disiens by the Sarkosyl method. Lipopolysaccharides (LPS) were
extracted from the same strains by the Proteinase K method, and from three strains
of each species by an aqueous phenol method. Analysis of the outer-membrane
proteins by SDS-PAGE demonstrated that, within a species, very similar patterns
with many shared or common bands were produced, but there were sufficient
differences between species to allow separation. Immunoblotting with antisera raised
against whole cells of each of the type strains showed that many antigens were shared
between species. Smooth LPS was present in both species. By immunoblotting, the
O-antigen of B. disiens was shown to be common to all six strains, and there was no
cross-reaction between the B. disiens antiserum and B. bivius LPS. The O-antigen of
B. bivius was not detected by immunoblotting with homologous antiserum, but
antiserum to B. bivius reacted with a series of common low molecular mass antigens
that were present in LPS preparations from strains of both species.
Introduction
Bacteroides bivius and B. disiens are closely related
species of anaerobic, gram-negative bacteria that
share the same main ecological niche, being most
commonly isolated from the vagina and cervix in
both health and disease and from genital infections
in the male (Holdeman and Johnson, 1977; Duer-
den, 1980). Both species are non-pigmented, bile
sensitive, weakly saccharolytic and proteolytic, and
do not produce indole. They are differentiated by
the ability of most B. bivius strains to produce acid
from lactose and galactose whereas no strains of B.
disiens ferment either of these sugars. DNA
hybridisation has shown that they are distinct
species (Holdeman et al., 1977; Holdeman and
Johnson, 1977).
Sodium dodecyl sulphate-polyacrylamide gel
electrophoresis (SDS-PAGE) of cell-surface pro¬
teins has been a useful aid in the identification of
species and sub-types of a range of bacteria,
including anaerobes (Poxton and Brown, 1979;
Moore et al., 1980). The aim of the present study
was to use SDS-PAGE in conjunction with immu¬
noblotting to compare the outer-membrane proteins
and lipopolysaccharide (LPS) of several strains of
B. bivius and B. disiens to determine any inter- or
Received 20 Sept. 1988; accepted 26 Oct. 1988.
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intra-species similarities or differences. The Sarko¬
syl method for the preparation of outer-membrane
proteins and the Proteinase K method for LPS were
chosen for their simplicity and applicability to
small culture volumes; these advantages make the
methods particularly useful for diagnostic or tax-
onomic investigations. LPS extracted by the Pro¬
teinase K method was compared with that extracted
by the classical aqueous phenol method.
Materials and methods
Bacterial strains
B. bivius strains VPI 6822 and VPI 6318, and B. disiens
strains VPI 8057 and VPI 7582 were obtained from the
Virginia Polytechnic Institute and State University,
Blacksburg, VA, USA. Strain GNAB 12 was isolated
from a high vaginal swab in this department. The MW
series of strains was supplied by Dr B. Watt, City
Hospital, Edinburgh. Identity of strains was confirmed
by the method of Brown et al. (1989). Tests included bile
tolerance, indole production, fermentation of glucose,
lactose, sucrose and maltose, and gelatinase activity.
Preparation ofouter membrane
Cultures were prepared by seeding 500-ml volumes of
pre-reduced proteose peptone-yeast extract (PPY) broth
(Deacon et al., 1978) with 25 ml of 48-h starter cultures
267
268 R. BROWN, K. E. HORNETT AND I. R. POXTON
in the same medium. They were incubated anaerobically
(H2 90%, CO, 10%) for 24 h at 37°C. The cells were
harvested and washed once in 200 ml of phosphate-
buffered saline (50 mM phosphate buffer, pH 7-4, contain¬
ing 015 m NaCl; PBS). The centrifuge tubes were
drained and the pellet was suspended in 5 ml of distilled
water. The cells were broken by passage through a French
pressure cell (Aminco, Silver Springs, MD, USA) at
6000 psi (42 MPa) at 0°C. Unbroken cells were removed
by centrifugation at 6000 g for 10 min at 4°C. A
modification of the method of Filip et al. (1973) was used
for Sarkosyl treatment. One volume of a 7% w/v solution
of sodium N-lauroyl sarcosinate was added to nine
volumes of the broken-cell suspension. The insoluble
outer membrane was harvested and washed once in 5 ml
of distilled water by centrifugation at 50 000 g at 4°C for
1 h. The pellet was resuspended in 0-5 ml of distilled
water by repeated aspiration into a syringe through a 26-
gauge needle. The suspension was stored at — 20°C.
Protein was assayed by the method of Lowry et al. (1951).
Preparation ofLPS
The Proteinase K method for LPS extraction was
modified from Flitchcock and Brown (1983). Volumes
(5 ml) of the cultures prepared for Sarkosyl extraction
were harvested and washed twice in PBS by centrifuga¬
tion at 4000 g at 4°C for 15 min. The pellet was suspended
in PBS to an A525 of 0-6 and 1-5-ml volumes were
centrifuged at approximately 10 000 g for 90 s (Microfuge
Beckman Model B). The pellet was solubilised in 50 g\ of
PAGE sample buffer (00625 m Tris-HCl, pH 6-8,
containing sodium dodecyl sulphate 2% w/v, glycerol
10% v/v, 2-mercaptoethanol 1% v/v and bromophenol
blue 0-001% w/v) and heated in a boiling water-bath for
10 min. Proteinase K (25 gg) (Sigma Protease XI) in 10 g\
of sample buffer was added to each tube and then
incubated at 60°C for 1 h. Samples were stored at
— 20°C.
The aqueous phenol method for the extraction of LPS
was that of Poxton and Brown (1986).
Carbohydrate was assayed by the method of Dubois et
al. (1956).
SDS-PAGE
SDS-PAGE was performed on 10% slab gels with the
Laemmli buffer system (Laemmli, 1970) by the method
of Poxton and Brown (1979). Samples (25 pi or 100 pi) of
the Proteinase K LPS extracts, 50-/d or 100-//1 samples of
the aqueous phenol extracts containing 10 ^g or 20 gg of
carbohydrate respectively, or 50-^1 samples containing
9-25 pg of protein of the Sarkosyl preparations were
loaded on to the gels. The LPS separating gels were
stained by a modification of the silver stain methods of
Tsai and Frasch (1982) and Hitchcock and Brown (1983).
The gel was fixed in 200 ml of propan-2-ol 25% v/v, acetic
acid 7% v/v overnight, and then oxidised in freshly
prepared periodic acid 1-05 g in 150 ml of distilled water
containing 4 ml of the above fixative for 5 min. The gel
was then washed in at least four changes of 200 ml of
distilled water over 4 h, drained and added to fresh
ammoniacal silver nitrate solution—1-4 ml of ammonia
solution (SG 0-88) was added to 21 ml of NaOH 0-36%,
and 4 ml of AgN03 19-4% solution was added with
vigorous agitation; after the brown precipitate had
disappeared, the volume was made up to 100 ml with
distilled water. After 15 min, the gel was washed in at
least four changes of distilled water over 40 min and then
transferred to a fresh solution of citric acid 0-005% in
200 ml of formaldehyde 0-019% at 25°C. When the
desired staining intensity was reached, the gel was
washed repeatedly in large volumes of distilled water.
The Sarkosyl outer-membrane gels were stained with
Coomassie blue by the method of Poxton and Sutherland
(1976).
Immunoblot transfer
This was based on the method of Towbin et al. (1979)
as described by Cousland and Poxton (1983) with BioRad
immunoblotting reagents, but the nitrocellulose mem¬
brane was of 0-2-pm pore size (Sartorius). For dot
blotting, 2 g\ of aqueous phenol-extracted LPS was
applied directly to the nitrocellulose. Antisera were used
at a dilution of 1 in 100.
Preparation ofantisera
Antisera were raised in rabbits against washed whole
cells of the type strains—B. bivius VPI 6822 and B. disiens
VPI 8057—and against B. bivius VPI 6318 by the method
of Poxton et al. (1982).
Samples of the antisera raised against the type cultures
were absorbed with their homologous aqueous phenol-
extracted LPS. Serum (2 ml) was mixed with 1 ml of a
solution containing 1 mg of LPS (0-2 ml of an aqueous
solution ofLPS 5 mg/mlw/v + 0-8 mlofPBS)and agitated
on a blood-cell mixer at 15°C for 1-5 h. After centrifuga¬
tion at 10 000 g at 15°C for 5 min, the supernate was re-
extracted as above. Unreacted LPS and immune com¬
plexes were removed by two cycles of centrifugation at
100 000 g at 4°C for 3 h, and the supernate was collected
and stored at — 20°C. The absorbed sera were shown by
dot blotting not to react at a final dilution of 1 in 100 with
their homologous aqueous phenol LPS.
Results
SDS-PAGE and immunoblotting ofSarkosyl outer-
membrane preparations
Fig. 1 shows examples of the patterns obtained
after separation and Coomassie-blue staining of
Sarkosyl extracts of seven strains of B. bivius and
six of B. disiens. The patterns produced by the B.
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Fig. 1. S DS-PAGE of Sarkosyl outci-nieiubiune preparations of B. bivius and B. disiens strains separated on aeiylamide 10% slab
gels stained with Coomassie blue. Track 1, B. bivius VPI 6822; 2, MW 1; 3, MW 3; 4, MW 6; 5, MW 8; 6, MW 15; 7, VFI 6318; 8,
B. disiens VPI 8057; 9, MW 20; 10, VPI 7582; 11, GNAB 12; 12, MW 19; 13, MW21. Molecular masses are in Kda.
bivius strains (tracks 1-7) show much similarity to
one another with many shared or common bands
and only a few strain-specific bands, and have in
particular four major common bands of approxi¬
mately 31, 27, 26 and 21 Kda. The patterns
produced by the six B. disiens strains (tracks 8-13)
show less similarity to each other with more strain-
specific bands but still have a great many shared or
common bands. One major common band of
23 Kda, and a common duplex of 32-33 Kda are
seen. Several bands appeared to be shared by both
species, and bands of approximately 90, 66, 53 and
41 Kda appear to be common to all strains of both
species.
Three gels identical to those shown in fig. 1 were
run and each was transferred to nitrocellulose
membranes. One of these blots was probed with
antiserum raised against whole cells of B. bivius
VPI 6822 (fig. 2a) and the second was probed with
antiserum to B. disiens VPI 8057 (fig. 2b). The third
blot was cut to separate the two species and each
was probed with its homologous antiserum which
had been absorbed with its own LPS. Fig. 2a shows
that all the B. bivius strains (tracks 1-7) have almost
identical profiles except for slight quantitative
differences and a few strain-specific antigens. There
are many common antigens and the general profile
bears some resemblance to the pattern in fig. 1, all
the major protein bands being antigenic. A greatly
elongated high-molecular-mass band partially ob¬
scuring the separated protein bands and clearly
seen in the upper half of the homologous reaction
(track 1) and faintly in track 2 were also seen in
immunoblots of Proteinase K extracts of the same
two strains (see fig. 4a later). Curved bands seen
clearly at the front of tracks 1, 3 and 6, and less
clearly in tracks 2, 4, 5 and 7, were not seen in the
Coomassie blue-stained gel. When these seven
Sarkosyl preparations were probed with LPS-
absorbed B. bivius antiserum, the latter two de¬
scribed bands were not seen, indicating that they
were LPS antigens. Antigens of 53, 46 and 29 Kda
were also not detected with the absorbed serum.
The heterologous reactions in tracks 8-13 show
that there are a considerable number of B. disiens
antigens that cross-react with B. bivius antiserum.
Again, some of these antigens correspond to the B.
disiens outer-membrane-protein bands in fig. 1. A
few of the bands (122, 72 and 27 Kda) appear to be
common to B. bivius and B. disiens but three of the
four major common protein antigens of B. bivius
appear to be species specific. The 23- and 33-Kda
common protein bands were detected by the B.
bivius antiserum.
Fig. 2b shows the same strains as in fig. 1, probed
with the antiserum raised against B. disiens VPI
8057. The six B. disiens strains (tracks 8-13) share
common antigens of 122, 118, 72, 52 and 33 Kda.
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Fig. 2. Immunoblot of Sarkosyl outcr-mcmbrane preparations of B bivius and B disiens after separation as in fig. 1 and transfer to
nitrocellulose membrane. Tracks were loaded with the same samples as in fig. 1. Gels were probed with (a) B. bivius VPI 6822 and
(b) with B. disiens VPI 8057 whole cell antisera, followed by anti-rabbit IgG-horseradish peroxidase conjugate and colour
development. Molecular masses are in Kda.
Several antigenic bands, seen most clearly in track
11, of 118, 52 and 33 Kda correspond to the protein
bands in fig. 1. In the upper half of the other tracks,
several extra bands, not revealed by the Coomassie
blue-stained gel, have largely obscured the protein
bands. These are shown to be LPS antigens below.
When these six Sarkosyl preparations were probed
with LPS-absorbed B. disiens antiserum, all tracks,
with the exception of a few strain-specific bands,
were identical to each other and to the pattern
produced by strain GNAB 12 (track 11) in fig. 2b.
Some of the low-molecular-mass protein bands,
including the major 23-Kda common protein, are
not apparently antigenic.
The heterologous reactions (tracks 1-7) again
reveal a considerable number of cross-reacting
antigens that are identical to the corresponding
tracks in fig. 2a. However, in fig. 2b many of the
bands in the lower half of the gel are either absent
or gave very weak reactions. The elongated high-
molecular-mass band seen in tracks 1 and 2 in fig.
2a were absent in fig. 2b.
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SDS-PAGE and immunoblotting ofaqueous phenol
and Proteinase K LPS extracts
Fig. 3 shows examples of patterns obtained after
separation and silver staining of aqueous phenol
extracts of three strains of B. bivius and two of B.
disiens. With the exception of B. bivius strain MW8
(track 3) even when overloaded, smooth LPS ladder
patterns, resembling those found in some Entero-
bacteriaceae, were seen. A considerable amount of
material was seen at the front of all tracks. The B.
bivius tracks had in common a series of four or so
low-molecular-mass bands which may be a low-
molecular-mass ladder pattern, and an elongated
high-molecular-mass band. The B. disiens tracks
had two common bands in addition to the ladder
pattern. The first was a high-molecular-mass dumb¬
bell shaped band, and the other was a low-
molecular-mass band (both arrowed).
When B. bivius aqueous phenol extracts were
probed with antisera raised against B. bivius strains
VPI 6822 and VPI 6318, no smooth LPS ladder
pattern was seen. All other bands seen in the silver-
stained gel were antigenic; at least three of the
series of four low-molecular-mass bands were
common antigens and the front material and
elongated high-molecular-mass material appeared
to be strain specific. Ladder patterns common to all
three B. disiens aqueous phenol extracts were
demonstrated when probed with antiserum raised
against B. disiens VPI 8057 (data not shown). These
results are identical to those described below for
Proteinase K extracted LPS (see fig. 4a and b).
Proteinase K extracts of all strains belonging to
both species were separated by SDS-PAGE, trans¬
ferred to nitrocellulose and probed with homologous
and heterologous antisera. With B. bivius VPI 6822
antiserum (fig. 4a), all seven extracts of B. bivius
(tracks 1-7) showed reactions with the series of
low-molecular-mass LPS antigens. An elongated
high-molecular-mass band in tracks 1 and 2, and
an antigen at the front in tracks 1, 3 and 6
correspond to antigens seen in the immunoblot of
the Sarkosyl extracts of the same strains probed
with the same serum (fig. 2a). Marked cross-
reactions are seen with the series of low-molecular-
mass antigens from five of the six Proteinase K
extracts of B. disiens (tracks 8-13); strain GNAB
12 (track 11) showed no heterologous reaction.
Faint high-molecular-mass smooth LPS ladder
patterns are visible in tracks 8 and 10 (VPI 8057
and VPI 7582 respectively).
In the reaction between B. disiens Proteinase K
extracts and homologous antiserum (fig. 4b), all six
strains were seen to have a smooth LPS ladder
pattern (tracks 8-13); the bands in track 11 (GNAB
12) were fainter and more widely spaced than in
the other tracks. The low-molecular-mass bands
that cross reacted strongly with the B. bivius
antiserum have reacted only weakly with homolo-
1 2 3 4 5 6
Fig. 3. SDS-PAGE of aqueous phenol extracts of B. bivius and B. disiens strains stained with silver. Tracks 1 and 6, B. bivius VPI
6822; 2, VPI 6318; 3, MW 8; 4, B. disiens VPI 8057; 5, VPI 7582. Tracks 1-5 were loaded with 10 fig of carbohydrate. Track 6 was
loaded with 20 fig to demonstrate ladder pattern.
B
Fig. 4. Immunoblots of Proteinase K extracts of B. bivius and B. disiens strains, arranged as in fig. 1, probed with (a) B. bivius VPI
6822 and (b) B. disiens VPI 8057 whole cell antisera.
gous serum. A strain-specific dumb-bell-shaped
antigen is seen near the top of track 8. The B. bivius
Proteinase K extracts have not cross-reacted with
the B. disiens antiserum.
Discussion
The Sarkosyl method for the preparation of outer
membranes, when applied to B. bivius and B.
disiens, gives protein patterns on SDS-PAGE that
are similar to those produced by most gram-negative
bacteria. Many different bands of protein are
visualised and there are a few strongly staining
bands which are usually classified as the major
outer-membrane proteins. The patterns produced
by strains belonging to the same species are
sufficiently similar to each other but different from
other species to allow identification to species level.
Gram-negative bacteria that are closely related
have cross-reactive outer-membrane antigens (Hof-
stra and Dankert, 1980) and these two closely
related Bacteroides spp. have several protein anti¬
gens in common.
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Immunoblotting of LPS with two B. bivius
antisera detected a series of low-molecular-mass
antigens that were common to that species and that
also cross-reacted with a similar series of antigens
of slightly different molecular mass in strains of B.
disiens. These B. bivius antisera reacted with their
homologous high-molecular-mass antigens but no
clear ladder pattern was revealed. They did how¬
ever, react weakly with high-molecular-mass ladder
patterns in two strains of B. disiens. Antiserum
raised against the type strain of B. disiens detected
smooth LPS ladder patterns in all strains of that
species, but did not cross-react with B. bivius LPS.
The LPS of gram-negative bacteria, especially
the O antigenic part, is usually considered to be
highly variable within a species. The core, however,
is often much more conserved and there are regions,
especially in the inner core, that are common within
a species and even among species. This may explain
the shared series of low-molecular-mass LPS anti¬
gens of these two species which consist of LPS
molecules with a relatively higher proportion of
core oligosaccharide than O antigen repeating
units. The B. bivius strains appear to have produced
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It is now well established that anaerobic bacteria, especially the black pigmented Bactcroides species are involved in the
aetiology of chronic periodontal disease (1). Bacteroides gingivalis (formerly oral B. asaccharolyticus) is one of the
predominant species isolatod from advancod periodontal disease (2) and recent evidence suggests it may bo playing an
important pathogenic role (3, 4). As well as the enzymes and toxic metabolites that such bacteria produce,
immunopathologic mechanisms which are stimulated by bacterial antigens may be important in the disease process (5).
Recent reports have described the measurement of serum antibodies to B. gingivalis (6, 7) and Kagan (3) has assessed
local immunity by demonstrating the specificity of plasma cells in the gingival tissue to B. gingivalis by
immunofluorescence technique. These results suggest that it might be possible to assess the activity of periodontal disease
by measuring the immune response to potentially pathogenic organisms.
The study reported here explores the possibility that the detection and quantitation of antibodies produced locally in the
ginigival crevicc against B. gingivalis and B. melaninogcnicus os. intcrmcdius another species implicated in periodontal
disease, might give an indication of the disease activity. Bactcroides organisms have been shown to possess species specific
antigens in their outer membranes and these can bo detected quantitatively by an enzyme linked immunosorbent assay
(ELISA) (8).
Methods: Eighty two pationts presenting with varying degrees of gingivitis and poriodontotis, woro included in the
survey. Details of age, sex, recent or current antimicrobial therapy and other treatment were noted, but the major clinical
criteria were measurement of Pocket Depth and Bleeding Index by the criteria of the WHO Technical Report (9). These
measurements were performed after sample collection.
Samples were collected by washing the gingival crevice using a technique similar to that described by Skapski and
Lehner (10). The site was isolated and dried. A microsyringe (SGE Ltd., Melbourne, Australia, Model 50A, 50 p.\
capacity) fitted with a dome tipped needle was used to introduce 15 p.\ of buffer (50 mM Na phosphate buffer pH 7.4
containing 0.15 M NaCl and 0.05% Tween 20: PBST) into the gingival crevice. Washings were withdrawn and more buffer
added until 100 p\ of fluid had been collected. The sample was centrifuged for 1.5 min at 9500 gin a Beckman Microfuge B
and the pellet was discarded. The antibody-containing supernate was stored at —20 °C.
The enzyme linked immunosorbent assay (ELISA) was similar to that described earlier for assay of rabbit
immunoglobulins (8). Outer membrane complex antigens were prepared from B. gingivalis ATCC 33227 and B.
melaninogenicus ss. intermedius NCTC 9338 by the EDTA, 45 °C, sonic bath treatment and used without dialysis at a
concentration of 30 pg/ml to coat wells (50 //I) in a microtitre plate as described previously (8). Dilutions (1 in 10, 20, 40
and 80) of crevice washing in PBST were added to the wells and incubated for 4 h at room temperature. After washing,
anti-human IgG, IgM and IgA alkaline phosphatase conjugates (Miles, Slough, UK) were added and incubated for 16 h at
room temperature. The dilutions of Ig conjugates used were the highest dilution that gave an A405 reading (Titertek
Multiskan, Organon Teknika, St Neots, Camb , UK) of 14 when titrated against IgG, M and A myeloma sera diluted to
200 /ag/ml (supplied by Blood Transfusion Service, Royal Infirmary, Edinburgh) by our standard ELISA method (8).
Results were read in a multiskan and expressed as matrix values of 0 — 9 where one matrix unit corresponded to a range of
0.2 absorbance units at 405 nm.
Results and discussion: In preliminary experiments the background level in the ELISA was investigated: dilutions of
crevicular washings which gave apparently high levels of IgG to B. gingivalis or B. melaninogcnicus ss. intermedins were
reacted aginst antigens prepared from the non oral B.fragilis (NCTC 9344). An A405 reading of less than 0.2 (matrix value
0) was found if a dilution of 1 in 10 was made of the gingival washing. In subsequent assays a reading of greater than 0.2
(matrix value 1 or more) for a 1 in 10 dilution of crevicular fluid was judged as a significant level of Ig.
In the 109 samples taken from 82 patients no IgA could be detected and IgM was present in trace amounts in only a few
patients (ELISA reading approaching A405 of 0.2). Significant levels of IgG were detected in 103 (95%) of samples. Specific
IgG for B. gingivalis was found in 95 samples (87% of total) and for B. melaninogenicus ss. intermedins in 82 (75% of total).
The Ig levels ranged between matrix values of 1 — 9. Most fell in the lower end of the range (values of 1—4) but 30
samples had a level of IgG which gave a matrix value of 5 or greater. These high levels of IgG to B. gingivalis were found in
11 samples (10%) and to B. melaninogenicus ss. intermedius 19 samples (17%). In the samples which had a high level of
antibody to one species there was a correspondingly low level of antibodies to other species. Of the 30 samples which gave
an ELISA level of 5 or greater for one antibody all but 2 of these had a level at least two-fold that of the other antibody.
Nine samples had four-fold or greater variation between the antibody levels. This suggests that it is uncommon to have
high antibody levels against both of these Bacteroides species in the same individual. There was no correlation between IgG
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level and the clinical parameters of pocket depth and bleeding index. Within the same mouth there were local differences
between the sites sampled. Examples of five patients showing this variation are summarised in the table. These results
confirm that the tochniquc is measuring antibodies in a local exudate rather than simply a serum exudate.












1 Upper right 7 5 1 8 4
Upper left 7 4 1 5 2
Upper right 2 2 0 0 1
2 Upper right 3 3 0 0 3
Upper left 2 2 1 0 1
3 Upper right 3 4.5 1 1 4
Upper right 2 5 1 1 2
4 Upper right 4 4 1 1 2
Lower right 5 10 1 1 4
5 Upper right 5 7 1 9 + 1
Upper right 2 5 1 3 1
a; Counting from the centre, k: I — bled on gentle probing; 0 — did not bleed, c: IgG level expressed as a matrix value of the A4m leading uf the 1
in 10 dilution ofcrevicular washing in the standard ELISA.
In this pilot study, most patients had samples taken on only one occasion. One patient from whom samples were taken
more than once may be worthy of note. A patient (female, 23 years) presented with juvenile periodontitis in 1974 and has
received periodontal treatment extensively since that time. Two samples taken at intervals of 12 weeks had ELISA levels
of antibodies to B. gingiva lis and B. mclaninogcnicusss. intcrmcdius of 1 and 9 respectively for the first sample and 1 and 7 fur
the second sample, indicating high levels of B. mclaninogcnicusss. intcrmcdius antibodies present.
Although these results are of a preliminary nature, there appears to be an indication that the measurement of the local
antibody response to bacteria which may be involved in the aetiology of periodontal disease might give a quantitative and
reproduciblo indox of the activity of the organisms in the disease process. So far, an investigation has been made into the
levels of only two antibodies. Many other species of bacteria have been implicated in the aetiology of periodontal disease
and antibody levels to these should be assayed. Recently a report has been published showing increased levels of serum
antibodies to Treponema dcnticola, an anaerobic spirochaete, in cases of advanced periodontitis (11).
We suggest that this assay for specific local antibodies secreted into the gingival crevice/periodontal pocket should be
extended to a controlled study and results might shed more light onto the complex pathologic mechanisms that exist in
periodontal disease.
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Immunological Analysis of the EDTA-soluble Antigens of
Clostridium difficile and Related Species
By IAN R. POXTON* and MARIE D. BYRNE
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{Received 7 May 1980)
Antigens were extracted with EDTA from 32 strains representing 10 species of Clostridium.
When these antigens were examined by an enzyme-linked immunosorbent assay, marked
cross-reactions were observed between C. difficile, C. sordellii and C. bifermentans. The
cross-reactive antigen, visualized by crossed immunoelectrophoresis, was carbohydrate.
introduction
Until recently Clostridium difficile was regarded as an uncommon, non-pathogenic
organism. It is part of the normal faecal flora of many neonates but is rarely found in adults
(Larson et al., 1978). Since 1977, however, there has been an increasing number of reports to
suggest that this organism is the major, if not the only, cause of antibiotic-associated colitis
(Larson, 1979; Bartlett. 1979). There have also been recent reports that C. difficile is involved
in chronic inflammatory bowel disease (Lamont & Trnka, 1980; Bolton et al., 1980).
Two methods are currently available for the detection of C. difficile in the faeces: (i) it can
be cultured on a highly selective medium (George et al., 1979); (ii) its toxin can be
demonstrated in a faecal filtrate by a cytopathic effect on tissue monolayers. This effect can
be neutralized with C. sordellii antitoxin (Rifkin et al., 1977). There is a need to develop an
immunological method for the identification of C. difficile in faecal smears by direct
microscopy. Before such a technique can be developed, cross-reactions between serologically
related species must be investigated. Furthermore, a knowledge of the antigens of this species
might allow the development of a serotyping scheme to elucidate the epidemiology of C.
difficile (see Larson, 1979).
The present study examines serological relationships of C. difficile, C. sordellii and C.
bifermentans by enzyme-linked immunosorbent assays and crossed immunoelectrophoresis.
Clostridium sordellii and C. bifermentans, regarded by many as the same species, are
commonly encountered in soil, sewage and the large bowel of man and animals. They are
uncommon pathogens, but are occasionally associated with gas gangrene (Willis, 1969,
1977).
methods
Organisms and growth conditions. The strains of bacteria used were: C. difficile, Nl, N3, N4, N5 and N6
(obtained from Dr S. Hafiz, University of Sheffield Medical School), MPRL2, 15. 40, 50 and 59 (isolated in the
Bacteriology Department, University of Edinburgh), RIE11831 (isolated in the Royal Infirmary, Edinburgh),
FAL11456 (isolated at Fife Area Laboratories, Kirkcaldy) and NCTC 11223; C. sordellii, NCTC 1340,
NCTC 2914. NCTC 6800, NCTC 6801, NCTC 6927, NCTC 6929 and NCTC 8780; C. bifermentans,
NCTC 1341, NCTC 6928 and three laboratory strains; C. perfringens, NCTC 1869, NCTC 3110, NCTC 3180,
NCTC 8237, NCTC 8239 and one laboratory strain; C. paraperfringens, a laboratory strain; C. fallax,
NCTC 8380; C. sporogenes, NCTC 8594; C. novyi, a laboratory strain; C. chauvoei, NCTC 8070; C. absonum, a
laboratory strain.
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All strains were cultured from a stationary phase broth culture in modified Robertson's cooked meat medium
(Watt, 1973). Proteose peptone/yeast extract broth (Holbrook et al., 1977) was inoculated (2%, v/v) and cultured
for 16 h at 37 °C by the standard anaerobic procedure of Collee et al. (1972). Sporulation was negligible under
these conditions.
Extraction of antigens. Bacteria, cultured in 100 ml medium (see above), were harvested by centrifugation at
2400 g for 20 min at room temperature and washed twice in phosphate buffered saline (PBS, 50 mM-sodium
phosphate buffer, pH 7-4 containing 0-15M-NaCl). The pellet was suspended in 4 ml PBS containing
10 mM-EDTA and incubated for 30 min at 45 °C. The extracted cells were removed by centrifugation (10000 g.
10 min, 4 °C) and the supernatant fluid was dialysed twice against 2 1 volumes of PBS over 20 h at 4 °C. Protein
concentrations, after dialysis, were measured by the Lowry method. Antigens were stored at —20 °C.
Preparation of antisera. Antisera against u.v.-killed, whole, washed bacteria were raised in New Zealand White
rabbits as described previously for Bacteroides spp. (Poxton, 1979). Clostridium difficile NCTC 1 1223 and C.
sordellii NCTC 1340 were used at the standard doses of 10' cells throughout the injection schedule. However, for
the toxigenic C. sordellii NCTC 8780, the first three doses were 106 cells, increasing to three doses of 107 cells in
the second week and boosted by one dose of 107 cells in the fourth week.
Absorption of sera. Cells for absorption were cultured on blood agar for 18 h at 37 °C. They were carefully
scraped from the surface, suspended in PBS and washed twice in PBS. Undiluted serum was added directly to the
washed pellet at a ratio of 1 ml of serum to bacteria from ten plates. The mixture was gently homogenized and
incubated at 37 °C for 30 min. Bacteria were removed by centrifugation at 2400 g for 20 min at 20 °C.
Micro-enzyme-linked immunosorbent assay (ELISA). The EDTA-extracted antigen was diluted to a
concentration of 30 pg protein ml-1 in antigen buffer just prior to coating wells of microtitre plates. The method
was as described previously (Poxton, 1979) except that the results were read in a Titretek Multiskan (Organon
Teknika, St Neots). The end-point of the titration of antiserum (titre) was the first dilution with an Aioi value of less
than 1-6.
Crossed Immunoelectrophoresis (CIE). The procedure was essentially the same as that described by Weeke
(1973 a). The EDTA-extracted antigens were made up to 2 mg protein ml"1 in PBS and equilibrated by dialysis in
CIE sample buffer (see below). Triton X-100 was added to the dialysed antigen at a concentration of 1% (v/v).
Antigens (\2 p\) were examined by CIE on 5 x 5 cm glass slides using barbital/glycine/Tris buffer pH 8-8 (Weeke,
1973 A). Buffer was used undiluted (ionic strength 0-08) in the electrode reservoirs, but in the gels and sample
buffer it was diluted 1 in 4 with distilled water, and Triton X-100 was added to a concentration of 1 % (v/v). Gels
contained agarose (BDH electrophoresis grade) at a concentration of 1% (w/v). Electrophoresis was at
12-5 V cm-1 for 1-5 to 2 h in the first dimension and at 12 V cm"1 for 16 h in the second dimension, both at 4 °C.
Gels were pressed, washed and stained with Coomassie blue as described by Weeke (1973 6), or stained with the
periodate-Schiffs reagents (Segrest & Jackson, 1977).
Treatment of antigens. The following treatments were performed on the antigens and the effects on the CIE
profiles were examined: (i) heat, 121 °C for 15 min; (ii) formalin, 20% (w/v) formaldehyde for 16 h at 20 °C
followed by dialysis against PBS for 18 h at 4 °C; (iii) periodate, 0-1 M-NaI04 for 16 h at 20 °C in the dark;
excess periodate was consumed by the addition of ethylene glycol and this was followed by dialysis against PBS
for 18 h at 4 °C. Untreated controls were included for treatments (ii) and (iii).
RESULTS
EDTA extracts were prepared from 32 strains representing ten species of Clostridium.
Antisera raised against whole, washed cells of C. difficile NCTC 11223, C. sordellii
NCTC 1340 and C. sordellii NCTC 8780 (a toxigenic strain) were titrated with the extracts
in an enzyme-linked immunosorbent assay (ELISA). Cross-reactions were observed only
between C. difficile, C. sordellii and C. bifermentans strains. The antigens extracted from
these three species gave titres ranging between 3200 and 25 600 when reacted with the
antisera raised against the C. difficile strain and the two C. sordellii strains. A titre of less
than 100 was obtained when antigens prepared from C. perfringens Types A to E, C.
paraperfringens, C. fallax, C. sporogenes, C. novyi, C. chauvoei and C. absonum were
reacted with C. difficile or C. sordellii antisera. It was impossible to differentiate beween C.
difficile, C. sordellii and C. bifermentans when EDTA-extracted antigens were titrated with
unabsorbed sera. In an attempt to reduce the cross-reactions between species the sera were
absorbed with whole cells of the cross-reactive species. This resulted in a more specific
reaction but it was accompanied by a marked reduction in the titre of homologous
0 ; >"©
1st dimension
Fig. 1. Crossed Immunoelectrophoresis of EDTA-extracted antigens from C. difficile NCTC 1 1223 and
C. sordellii NCTC 8780 against homologous whole cell antisera: (a, and drawing b) 12ft\ antigen from
C. difficile, after electrophoresis in the 1st dimension, was run into agarose containing 63 /A antiserum;
(c, and drawing d) 12 //I antigen from C. sordellii was run into agarose containing 500 iu\ antiserum.
antigen/antibody reaction. This suggested that there were some species-specific antigens in
the EDTA extracts but that other antigens were shared between these three species.
The antigen/antibody reactions demonstrated by ELISA were visualized by crossed
immunoelectrophoresis (CIE). Figure 1 shows that the homologous antigen/antibody
reactions for C. difficile NCTC 11223 and for C. sordellii NCTC 8780 are quite different
from one another. Clostridium sordellii NCTC 1340 gave a reaction that was almost
identical with that of strain NCTC 8780. In similar tests with C. bifermentans antigens run
against C. sordellii antisera, the patterns were indistinguishable from those obtained with C.
sordellii antigens.
Table 1 indicates the number and position of precipitin lines obtained with antigens
prepared from 13 strains of C. difficile run against C. difficile NCTC 11223 antiserum. The
positions of these precipitin lines are given by reference to the lines shown in Fig. 1 (b). Line 2
is common for all strains tested, line 4 occurs frequently and lines 1 and 3 are less frequently
demonstrable.
Clostridium difficile antigens reacted with C. sordellii antisera to give line 2 on all














Fig. 2. Intermediate-gel crossed immunoelectrophoresis of C. difficile NCTC 11223 EDTA-extracted
antigens: (a, and drawing b) 12 //I antigen, after electrophoresis in 1st dimension, was run through a
1 cm intermediate gel containing 63 //I antiserum to C. sordellii NCTC 8780 into a gel containing 48 /A
C. difficile NCTC 1 1223 antiserum; (c, and drawing d) as above except the intermediate gel did not
contain any serum. Peaks are numbered as in Fig. 1 (b).
Table 1. Variation in EDTA-extracted antigens from 13 strains of C. difficile run against
NCTC 11223 antiserum in crossed immunoelectrophoresis
Strain of C. difficile Precipitin lines in EDTA extract*
NCTC 11223 12 3 4






FAL11456 1 2 4
MPRL2 234
MPRL15 2 4
MPRL40 1 2 4
MPRL50 2 4
MPRL59 2 4
* Precipitin lines numbered as in Fig. 1 (b).
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occasions. No other precipitin line occurred in these tests. However, C. sordellii antigens
reacted with the C. difficile antiserum to give two lines in positions A and B shown in Fig.
1 (d). This suggested that line 2 and line A are lines of cross-reaction and may be identical.
This was further investigated by exploiting the intermediate gel procedure of Axelsen (1973).
Clostridium difficile antigen was run through an intermediate gel containing C. sordellii
antiserum and then into a gel containing C. difficile antiserum (Fig. 2 a, b). In a control, the
intermediate gel contained no antiserum (Fig. 2 c, d). Lines 1, 2, 3 and 4 developed in the test
and control. However, the presence of the C. sordellii antiserum in the intermediate gel held
back the precipitin line 2. The other lines were identical in the test and the control. The
position of line 3 at the intermediate gel level is explained by back diffusion of the antiserum.
The converse experiment was done with C. sordellii antigen run through an intermediate gel
containing C. difficile antiserum into gel containing C. sordellii antiserum. In this case both
lines A and B (see Fig. 1 d) were held back by the serum in the intermediate gel.
The EDTA-extracted antigen of C. difficile used in these studies contained approximately
90% protein and 10% carbohydrate as estimated by the Lowry method and by the method of
Dubois et al. (1956), respectively. Examination by sodium dodecyl sulphate-polyacrylamide
gel electrophoresis showed that it contained at least 25 polypeptides. In an attempt to
characterize the antigens that were visualized by CIE a number of chemical and physical
treatments were performed (see Methods for details), (i) After heating, only line 2 remained,
(ii) After treatment with formalin, only line 2 was unchanged; lines 3 and 4 were lost and line
1 was diffuse and changed in shape, (iii) After treatment with periodate, lines 2 and 4 were
lost. In an untreated control, which was dialysed in the same way as in treatments (ii) and (iii),
line 4 was also lost. This suggested that the antigen which precipitated in line 4 was either
extremely labile or was lost during extensive dialysis. All lines except line 4 stained with the
periodate-Schiff s reagents in an untreated control that had not been dialysed.
DISCUSSION
If the composition of the clostridial cell surface is similar to that of other Gram-positive
bacteria, the surface antigens will include a range of proteins and possibly capsular material,
and teichoic acid components or their analogues associated with the cell wall and cytoplasmic
membrane. In the present study, EDTA was chosen to solubilize antigens from C. difficile
and related species because it should solubilize protein and perhaps membrane teichoic acid
without the breakage of any covalent bonds and without the extraction of wall teichoic acids;
a considerable advantage is that autolysis is apparently inhibited by EDTA (unpublished
observation).
All of the strains of C. difficile, C. sordellii and C. bifermentans examined share a common
EDTA-extractable antigen which is probably carbohydrate; it is thermostable, inactivated
by periodate and stains with the periodate-SchifPs reagent. In addition, all the strains of C.
difficile had at least one other protein or possibly glycoprotein antigen complex that appears
to be specific for C. difficile. It should be possible to exploit this finding to raise a specific C.
difficile antiserum that will not cross-react with the C. sordellii-bifermentans group. In
addition, the EDTA-extractable antigens may provide a basis for a sero-typing system of
epidemiological value in tracing C. difficile infections.
The known serological relationships between C. bifermentans and C. sordellii (Huang,
1959, cited by Willis, 1977) are reflected in our finding that the EDTA-extracted antigens of
these two species were indistinguishable by ELISA and CIE procedures. The relationship of
C. difficile to the bifermentans-sordellii complex, suggested by the cross-neutralization of its
toxin by C. sordellii antitoxin, is therefore paralleled by the somatic antigenic relationships
that our studies have revealed.
This study was supported by a grant (no. K/MRS/50/C247) from the Scottish Home and Health Department.
We are grateful to Professor J. G. Collee for his interest and advice.
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DEMONSTRATION OF SHARED ANTIGENS IN THE
GENUS CLOSTRIDIUM BY AN ENZYME-LINKED
IMMUNOSORBENT ASSAY
I. R. Poxton and Marie D. Byrne
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Teviot Place, Edinburgh EH8 9AG
Summary. Antigens prepared from several strains of each of 10
Clostridium species were used in an indirect enzyme-linked immunosor¬
bent assay with antisera raised against whole cells of a representative
strain from each of the 10 species killed by ultra-violet irradiation.
With the exception of C. cadaveris, the antisera gave similar results with
antigens prepared from all strains of the homologous species. Antigens
prepared from 13 other clostridial species were then investigated in an
ELISA system with the 10 representative antisera. The results showed
many cross-reactions, particularly in the C. perfringens group, the C.
difficile/sordelli group and the C. botulinum/novyi/sporogenes group.
Introduction
Bacteria in the genus Clostridium are subdivided into species according to a range
of morphological and biochemical criteria that include shape, position of spore, the
ability to digest proteins and ferment various sugars and the production of a range of
extracellular enzymes and toxins. Several identification schemes are available, e.g.
those of Holdeman, Cato and Moore (1977) and Willis (1969), but in practice a number
of isolates prove difficult to identify. Many species are closely related, and
morphological and biochemical variations occur within strains of the same species and
even within a subculture of the same strain. Toxigenic and non-toxigenic variants of
the same species occur and some species can be distinguished only by differences in the
toxins they produce (Cruickshank et al., 1975).
In human and verterinary medicine, immunological methods have been exploited
to detect and identify Clostridia. Immunofluorescent antibody (IFA) kits are
commercially available for C. botulinum types A, C and E, C. septicum, C. chauvoei, C.
novyi and C. tetani (Wellcome Diagnostics, Dartford, England), for the detection of C.
botulinum types A, B and F in suspected infant botulism (Hatheway and McCroskey,
1981) and for C. difficile in cases of antibiotic associated pseudomembranous colitis
(Hubert, Ionesco and Sebald, 1981). Several studies of antigenic relationships in the
genus Clostridium have been based on agglutination tests (Mandia, 1955) or empirical
immunofluorescence reactions (Walker and Batty, 1964; Batty and Walker, 1965;
Lynt, Solomon and Kautter, 1971) with a range of antisera raised against heat-killed or
Received 4 Aug. 1983; revised version accepted 28 Sep. 1983.
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formalin-killed organisms. More recently, we presented evidence for antigenic
relationships between C. difficile and C. bifermentans and C. sordelli (Poxton and
Byrne, 1981a) based on surface antigens extracted by EDTA. These were demon¬
strated by an enzyme-linked immunosorbent assay (ELISA) and crossed immunoelec-
trophoresis and we were able to provide guidelines for the detection of C. difficile by
immunotechniques (Poxton and Byrne, 1981b).
The work reported here extends these studies to the majority of medically
important species of Clostridium.
Materials and methods
Bacterial strains. The following strains were obtained from the National Collection ofType
Cultures (NCTC), Central Public Health Laboratory, Colindale Avenue, London NW9 5HT:
Clostridium bifermentans NCTC1341; C. butyricum NCTC7423; C. chauvoei NCTC8070; C.
difficile NCTC 11223; C.fallax NCTC8380; C. histolyticum NCTC nos. 503, 7123 and 7124; C.
novyi type A NCTC538, type C NCTC9747 and type D NCTC8350; C. perfringens type A
NCTC8237, type B NCTC3110, type C NCTC3180 and type E NCTC8084; C. septicum
NCTC547, C. sordelli NCTC8780; C. sporogenes NCTC8594; C. tertium NCTC541 and C.
tetani NCTC249. C. irregularis NCIB11830 (ATCC25756) was obtained from the National
Collection of Industrial Bacteria, Torry Research Station, Aberdeen. The strains of C.
botulinum were from the collection in the Botulinum Laboratory, Unilever Research,
Sharnbrook, Bedford: type A, strain nos. 1,7, 8,9; type B (proteolytic) strain nos. 25,26, 27; type
B (non-proteolytic) strain nos. 188, 194, 229; type C, strain no. 205; type D, strain no. 154; and
type E, strain nos. 34, 118, 126, 250. Other strains included our own laboratory cultures of C.
cadaveris MPRL34, MPRL506, 50233; C. irregularis 4403; C. nexile MPRL39; C. novyi type A
GR2A, GR3A; C. novyi type B GR2B; C. paraputrificum CP3; C. perenne MPRL95; C.
sporogenes 24, 33; C. subterminale MPRL303; and C. tertium CT1, CT2. Others were obtained
from the following sources: C. absonum Ha 9103 and C. paraperfringens 2227 from Professor S.
Nishida, Kanasawa University, Japan and C. perfringens type D, L85 from the late Professor
C. L. Oakley, University of Leeds. All strains were fully authenticated by performing the
biochemical tests described in the Virginia Polytechnic Institute Anaerobe Laboratory Manual
(Holdeman et al., 1977).
Culture ofstrains and preparation of EDTA extracts. Lyophilised cultures were inoculated
into Robertson's Cooked Meat Broth (10 ml) and incubated anaerobically with CO: 10% for 16
h at 37°C. These cultures (0-2 ml volumes) were used to inoculate 100-ml volumes of proteose
peptone-yeast extract broth (Holbrook, Duerden and Deacon, 1977) which were incubated
anaerobically with CO210% for 16hat37°C. Spore formation, as determined by phase contrast
microscopy, was negligible under these conditions. Antigens were prepared from the 100-ml
cultures by extraction with 10mM EDTA by the method described previously (Poxton and
Byrne, 1981a) except that the dialysis step was found to be unnecessary and was omitted.
Preparation ofantisera. Antisera were raised in New Zealand White rabbits by intravenous
injection of whole, washed, killed bacteria during a 5-week period (Poxton, 1979). The bacteria
were killed by ultraviolet irradiation and 109 organisms were used for each injection except for
the toxigenic strain of C. sordelli, NCTC8780 (106— 107 organisms, see Poxton and Byrne, 1981a).
Indirect enzyme-linked immunosorbent assay (ELISA ). The EDTA extracts were diluted to
contain protein 30 pgffiX in antigen buffer and used to coat wells in flat-bottomed microtitre
plates. The ELISA technique was performed as described earlier (Poxton, Brown and Collee,
1982).
Reading and presentation of results. In all titrations, a homologous reaction was included
and heterologous reactions were compared directly with this. A reaction was considered
significant if the titre was within six doubling dilutions (T/32) of the titre of the reference reaction
obtained between a reference antiserum and the homologous antigen preparation. The results
are expressed as a fraction of the homologous reference titre. The size of the symbol in the figure
is proportional to the degree of the reaction or cross-reaction, on this basis. A reaction at a titre
of less than 1/32 of the homologous titre was considered insignificant.
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Results
Reference homologous reactions
Initially, EDTA extracts prepared from 10 species of Clostridium were used as
antigens in an indirect ELISA system with their homologous antisera. During the
course of the study, these homologous reactions were included as controls whenever a
specific antiserum was used and the range of titres (table) reflects the variation found in
repeated titrations.
Table
Reactions of EDTA antigens with homologous antisera in an indirect ELISA system
Range of Number of strains reacting to a titre of Total number
Reference antiserum raised homologous of strains
against (species and strain no.) titres (T) T T/2 T/4 T/8 T/16 T/32 <T/32 tested
C. cadaveris (MPRL34) 12800-25600 1 113
C. chauvoei (NCTC8070) 12800-25600 1 1 2
C. difficile (NCTC11223) 25600-51200 6 25 3 34
C. histolyticum (NCTC503) 6400-51200 2 1 3
C. novyi, type A (NCTC538) 25600-102400 1 11 3
C. perfringens, type A 12800-51200 2 4 1 7
(NCTC8237)
C. septicum (NCTC547) 12800-25600 3 2 5
C. sordelli (NCTC8780) 12800-25600 8 8
C. sporogenes (NCTC8594) 6400-25600 1 2 3
C. tertium (NCTC541) 1600-3200 1 2 3
Tests with representative strains
Antigens were prepared from 61 other strains of Clostridium belonging to the 10
species listed in the table; they were then used to compare the titres with these antigens
and the 10 antisera (now referred to as reference antisera) with those of the
homologous reactions. The results indicated that most of the antigens gave titres
within one or two doubling dilutions of the homologous reaction (table). Only the
antiserum against C. cadaveris failed to react significantly with either of the other two
strains tested. The reactions of the C. novyi type A strains were not as strong as those
of the other species but a reaction was considered significant if the titre was within six
doubling dilutions (T/32) of that of the homologous reaction (see Methods).
Studies of cross-reactions
With the knowledge that nine of the reference antisera reacted strongly with
antigens prepared from several strains of the same species, all 10 reference antisera
were used to investigate cross-reactions with antigens from at least two strains of 13
other clostridial species, including five different types of C. perfringens and C.
hotulinum, and four of C. novyi. The results are summarised in the figure. They are
expressed as a fraction of the titre obtained with the reference antiserum and the
homologous antigen (see Methods). Three areas of major cross-reactions were
identified: in the C. perfringens group, in the C. difficileIsordelli group, and in the C.
botulinum/novyi/sporogenes complex.
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Titre* of reaction between EDTA antigen and antiserum raised



















a. 0 CO 4-> °
a 0 a CJ CJ CJ CJ O O O
C. perfringens A-e « • • •
C. paraperfringens • • • • • •
C. absonum • • • • «
C. chauvoei • a • •
C. septicum • • •
C. tertium • • •
C. fallax « • •
C. butyricum • • • • •
C. perenne •
C. cadaveris • . • • •
C. sordelli • •
C. bifermentans • •
C. difficile • •
C. irregularis • •
C. histolyticum •
C. sporogenes • •
C. novyi A • •
C. novyi B •
C. novyi C •
C. novyi D •
C. botulinum A •
C. botulinum pB •
c. botulinum npB • • • »
C. botulinum C •
C. botulinum D •
C. botulinum E • • • »
C. tetani • •
C. ramosum
C. paraputrificum
C. subterminale • .
C. nexile
* Titre indicated as a fraction of the homologous titre.
#T #T/ •T/ •?/ •T/ •T/w '2 '4 '8 16 32
Fig.—Cross-reactions within the genus Clostridium in an indirect ELISA test with EDTA-extracted
antigens and whole cell antisera.
Discussion
The C. perfringens group included the first 10 species listed in column 1 of the
figure. From previous work, some of the cross-reactions might have been expected,
although others were not. All types of C. perfringens (A-E) were indistinguishable by
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this test and they reacted strongly with C. chauvoei, C. septicum and C. tertium antisera
as well as with the C. perfringens type A reference antiserum. C. perfringens, C.
paraperfringens and C. absonum are related biochemically and antigenic relationships
could be expected. C. chauvoei and C. septicum are also inter-related but it was
unexpected to find that these species reacted strongly with the reference antisera
against C. perfringens and C. tertium. The strong reactions of the above species,
together with those of C.fallax and C. butyricum with the first four reference antisera,
and to a lesser extent with the C. cadaveris and C. sporogenes antisera, confirmed the
cross-reactions. Antigens prepared from C. botulinum type B (non-proteolytic) and
type E were also included in this group.
The C. sordelli/bifermentans and C. difficile group were studied in detail before
(Poxton and Byrne, 1981a) but in this extended survey we included the species C.
irregularis. We have been able to obtain only two strains of C. irregularis, one isolated
in our own laboratory, strain 4403, and one from the NCIB (strain no. 11830, which is
the same as ATCC25756). Both strains were indistinguishable from C. difficile, C.
sordelli and C. bifermentans in our ELISA system and shared the same major
carbohydrate antigens as these strains (I. R. Poxton, unpublished results). The
antigens from these four species did not cross-react with any other antisera, nor did the
C. sordelli or C. difficile antisera cross-react with any other antigen.
It is well established that organisms in the C. botulinum/novyi/sporogenes complex
possess some biochemical and cultural similarities (Smith, 1977). C. botulinum type A
and type B (proteolytic) are biochemically and culturally indistinguishable from C.
sporogenes; only the toxins separate them. This relationship was confirmed by the
ELISA technique which showed the presence of shared antigens. Three of four type-A
strains and all of three proteolytic type-B strains reacted with the C. sporogenes
reference antiserum. Similarly, C. botulinum types C and D are indistinguishable from
C. novyi type A (except by toxin), and this was borne out in this study. The unexpected
result in this group was the demonstration of cross-reactions between C. botulinum
type B (non-proteolytic) and type E antigens with the first four reference antisera.
Taken in isolation this result may be questioned; however, non-proteolytic type B and
type E C. botulinum are distinguished only by toxin production (Smith, 1977) and all of
three strains of non-proteolytic type B and all of four strains of C. botulinum type E
gave identical results with the four reference antisera, indicating that the result was
consistent.
The antisera prepared from C. sporogenes and C. cadaveris antigens had
remarkably similar patterns of specificity. The C. cadaveris antiserum, however, may
be atypical as antigens prepared from the other two strains did not react significantly
with it.
This study has demonstrated some unexpected shared antigens in the genus
Clostridium but has confirmed others. The EDTA preparation used as antigen for the
C. difficileIsordelli group contained proteins and carbohydrate extracted from the cell
surface (Poxton and Byrne, 1981a; Poxton and Cartmill, 1982); the previously
unrecognised cross-reactions demonstrated in this study were presumably due to the
presence of heat- and formaldehyde-labile antigens not detected in earlier studies. It is
difficult to compare our results with those obtained in previous studies which have been
used to separate Clostridia by immunofluorescent antibody techniques, for such tests to
be satisfactory they must be specific, and cross-reacting antibodies were removed by
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absorption. The assay system we have used is relatively non-selective and highly
sensitive. We suggest that the results presented here may provide useful guidelines
when designing immunological methods for the detection of Clostridia and may also
help to define taxonomic relationships in the genus. A detailed investigation at the
molecular level of some of the more important areas of cross reactions is currently
being made.
This study was supported by a grant from the Biomedical Research Committee of the
Scottish Home and Health Department (Grant no. K/MRS/50/C247). We gratefully
acknowledge the help and advice given by Dr J. S. Crowther and Mr C. Grimes of Unilever
Research, Bedford, to I.R.P. during culture of the C. Botulinum strains at Unilever. We also
thank Professor J. G. Collee for his continuing encouragement and advice in the preparation of
the manuscript. Part of this study has been included in a thesis submitted by M.D.B. for the
award of Fellowship of the Institute of Medical Laboratory Sciences.
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Demonstration of the Common Antigens of Clostridium botulinum,
C. sporogenes and C. novyi by an Enzyme-linked Immunosorbent Assay
and Electroblot Transfer
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Bacteriology Department, University of Edinburgh Medical School, Tebiot Place,
Edinburgh EH8 9AG, UK
(Received 19 October 1983)
EDTA extracts were prepared from whole cells of 16 strains of Clostridium botulinum (types A-
E), 6 strains of C. novyi (types A-D) and 3 strains of C. sporogenes. They were reacted in an
enzyme-linked immunosorbent assay (ELISA) with antisera raised against whole, UV-killed
cells of C. sporogenes and C. novyi type A. Results showed significant cross-reactions between C.
sporogenes antiserum and the C. botulinum type A (three out of four strains), proteolytic type B
(all strains) and one type E strain, and between C. novyi type A antiserum and C. botulinum types
C and D. All the C. sporogenes and C. novyi strains reacted with their homologous antiserum;
these two species showed no cross-reactions. All the reactions were investigated further by
running the EDTA extracts on SDS-polyacrylamide gels. The separated molecules were electro-
phoretically transferred to nitrocellulose membranes, reacted with antiserum and complexes
visualized with horseradish peroxidase conjugate reagents. Only those extracts that reacted
significantly in the ELISA gave a pattern of cross-reactive antigen bands and the number of
bands and intensity of stain closely paralleled the strength of the ELISA reaction.
INTRODUCTION
The heterogeneous group of Clostridia collectively known as Clostridium botulinum are alike in
that they all produce toxins with a similar pharmacological action. In taxonomic terms, how¬
ever, strains of C. botulinum can be divided into four reasonably distinct groups: Group I,
proteolytic strains with serologically distinct A and B toxins; Group II, non-proteolytic strains
producing toxins of types B, E and F; Group III, strains producing toxins of types C and D; and
Group IV, proteolytic, non-saccharolytic, toxigenic type G strains (Smith, 1977). In culture and
biochemistry, excluding toxin production, Group I strains are indistinguishable from C.
sporogenes; accordingly C. sporogenes is considered by some workers to be a non-toxigenic
variant of C. botulinum (Iida et al., 1981). Various degrees of cross-reactivity between the two
species have been revealed by immunofluorescence procedures (Walker & Batty, 1964;
Hatheway & McCroskey, 1981) and by numerical taxonomy; for example, Kiritani et al. (1973)
grouped 20 proteolytic strains of C. botulinum and 14 strains of C. sporogenes in the same phenon.
Similarly Group III C. botulinum strains (i.e. types C and D) are indistinguishable from C. novyi.
Type C C. botulinum can be cured of the prophage that codes for toxin production and converted
by another phage to a C. novyi type A strain, and C. botulinum types C and D can be inter-
converted by phage (Eklund & Poysky, 1981).
Our extensive study of cross-reactive antigens in the genus Clostridium (Poxton & Byrne, 1984)
demonstrated shared antigens between C. botulinum types A and B (proteolytic) and C.
sporogenes. Moreover, antigens from types C and D cross-reacted with antiserum to C. novyi type
A. The present study extends the investigation of these cross reactions.
Abbreviations: npB, type B non-proteolytic strain; pB, type B proteolytic strain; TBS, Tris-buffered saline.
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METHODS
Bacteria. All strains of C. botulinum were from the collection in the Botulinum Laboratory, Unilever Research,
Sharnbrook, Bedford, UK: type A, strain nos 1, 7, 8, 9; type B (proteolytic, pB), strain nos 25, 26, 27; type B (non-
proteolytic, npB), strain nos 188, 194, 229; type C, strain no. 205; type D, strain no. 154 and type E, strain nos 34,
118, 126, 250. The C. novyi strains NCTC 538 (type A), NCTC 9747 (type C) and NCTC 8350 (type D) and C.
sporogenes NCTC 8594 were obtained from the National Collection of Type Cultures, Central Public Health
Laboratory, Colindale Avenue, London NW9 5HT, UK. Other strains from our laboratory culture collection
were: C. novyi GR2A and GR3A (type A strains) and GR2B (type B), and C. sporogenes strains 24 and 33. The
strains of C. botulinum were checked for toxin type by Mr C. Grimes of Unilever Research at the time of EDTA
antigen preparation. The culture supernates were used in mouse toxin-antitoxin neutralization tests as outlined by
Willis (1977). Neutralizing antitoxin was obtained from the Pasteur Institute, Paris, France. The identity of all
strains was confirmed. The strains of C. novyi and C. sporogenes were fully characterized by the method of
Holdeman et al. (1977).
Growth conditions. Stationary phase bacteria (0-2 ml) which had been cultured in Robertson's cooked meat broth
and incubated anaerobically with 10% C02 for up to 48 h at 37 °C, were used to inoculate 100 ml proteose
peptone/yeast extract broth (Holbrook etal., 1977). Cultures were incubated anaerobically with 10%CO2 for 16 h,
or 40 h for C. botulinum types C and D, at 37 °C. Spore formation as judged by phase-contrast microscopy was
negligible under these conditions.
Antigen extraction. Extraction with 10 mM-EDTA of washed bacteria from the 100 ml cultures was as previously
described (Poxton & Byrne, 1981) except that the dialysis step was omitted after it was shown to be unnecessary.
Preparation of antisera. Antisera to C. novyi type A NCTC 538 and C. sporogenes NCTC 8594 were raised in
New Zealand White rabbits by intravenous injection of whole, washed UV-killed bacteria over a 5 week period as
detailed by Poxton (1979). A standard dose of 10® organisms per injection was used. These sera are referred to as
reference species antisera.
Indirect enzyme-linked immunosorbent assay (ELISA). The EDTA extracts were diluted to 30 pg protein mL1 in
antigen buffer (50 mM-sodium carbonate buffer, pH 9-6) and 50 pi volumes were used to coat wells in flat-
bottomed polystyrene microtitre plates. They were incubated for 4 h at 37 °C and overnight at 4 °C. After washing
three times with0-15 M-NaCl containing 0-05% (v/v) Tween 20 (Tween saline), doubling dilutions (1 in 400 to 1 in
102400) of rabbit antiserum in Tween PBS (50 mM-sodium phosphate buffer pH 7-4 containing 0-15 M-NaCl,
0-05% Tween 20 and 0-02% sodium azide) were added to each well (50 pi) and incubated for 4 h at room
temperature. The plates were washed three times in Tween saline, and anti-rabbit IgG-alkaline phosphatase
conjugate (Miles, Slough, UK) diluted 1 in 500 in Tween PBS was added to each well (50 pi) and incubated over¬
night at room temperature. After washing three times in Tween saline, 50 pi p-nitrophenyl phosphate (Sigma) at a
concentration of 1 mg mf in 50 mM-sodium carbonate buffer pH 9-8, containing 1 mM-MgCl2, was added to
each well. After incubation for 1 h at room temperature, the plates were read in a Titertek Multiskan (Organon
Teknika, St Neots, UK): the highest dilution of serum that gave an A405 > 1-0 was recorded as the titre.
Polyacrylamide gel electrophoresis and electroblot transfer. SDS-polyacrylamide gel electrophoresis was done on
10% slab gels with the buffer system of Laemmli (1970) as described by Poxton & Brown (1979). Approximately
50 pg protein (based on the Lowry method) was run in each track.
Electroblot transfer was essentially by the method of Towbin et al. (1979). Material was transferred to nitro¬
cellulose membrane (Transblot Transfer Medium, Bio-Rad) in Tris/glycine/methanol buffer, pH 8-3 over a 16 h
period at 12 V, 40 mA. The transferred antigens were detected with the ImmunBlot immunoassay (Bio-Rad).
Briefly, the membrane, after washing for 10 min in Tris-buffered saline (20 mM-Tris, 500 mM-NaCl, pH 7-5; TBS)
was placed in 3% (w/v) gelatin TBS for 45 min to block any unbound sites. It was then transferred into the C.
sporogenes or C. novyi antiserum diluted 1 in 200 in 1 % gelatin TBS and incubated for 3 h at room temperature.
After two 10 min washes in 0-025% Tween 20 TBS the membrane was placed into goat anti-rabbit IgG-horse-
radish peroxidase conjugate (Bio-Rad) diluted 1 in 3000 in 1% gelatin TBS and incubated for 1 h at room
temperature. After a further two 10 min washes in Tween TBS it was placed into HRP colour development
solution (Bio-Rad) which contains 4-chloro-l-napthol and hydrogen peroxide. Colour developed within 5-15 min.
The reaction was stopped by placing into distilled water and washing with several changes of water over 1 h. All of
the above steps were done in clean glassware and with gentle agitation throughout.
RESULTS
ELISA studies
EDTA extracts of all of the test strains were reacted in an ELISA system with our reference
antisera to C. sporogenes and C. novyi (Table 1). All the proteolytic type B, three out of four of the
type A and one type E strains reacted strongly with the C. sporogenes reference species
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Table 1. Reactions obtained with EDTA extracts of C. botulinum, C. sporogenes and C. novyi in
ELISA with antisera to C. sporogenes and C. novyi
The figures presented are typical of results obtained in repeated experiments. Titre of less than
400.
Titre of reaction of the stated antigen with
antiserum raised to whole cells of:
EDTA antigen























A NCTC 538 - 12800
A GR2A - 800
AGR3A - 1600
B GR2B - 1600
C NCTC 9747 - 1600
D NCTC 8350 - 1600
antiserum. The type A strain that did not react (A9) was not even a weak reaction; no colour was
detectable by the ELISA plate reader at the lowest dilution (1 in 400) used. The two heterologous
C. sporogenes strains reacted significantly with the reference C. sporogenes antiserum. No
reaction was demonstrated between the non-proteolytic B, the C, the D, three out of four of the E
strains and all of the C. novyi strains with the C. sporogenes antiserum.
With the C. novyi antiserum only C. novyi strains and C. botulinum strains of types C and D
showed a reaction.
Polyaerylamide gel electrophoresis and electroblot transfer
Initially, EDTA extracts from one strain of each type of C. botulinum and from one strain each
of C. sporogenes and C. novyi were run on 10% SDS-PAGE slab gels and stained with Coomassie
blue (Fig. 1 a). All patterns were complex but there were marked similarities between those of C.
botulinum types A and B (proteolytic) and those of types C and D (tracks 2 and 3, and 5 and 6
respectively).
Two duplicates of this gel (unstained) were electrophoretically transferred to nitrocellulose
membranes and were probed with the C. sporogenes and C. novyi antisera. The results, after
development with the horseradish peroxidase conjugate reagents, are shown in Fig. 1 (b, c). The
antiserum to C. sporogenes (Fig. 1 b) reacted significantly with C. botulinum type A1 (track 2) and
proteolytic type B25 (track 3) and the homologous C. sporogenes (track 8) EDTA extracts. In the
cross-reaction with the C. botulinum proteolytic type B25 extract many strongly staining bands
were visible, the overall intensity being stronger than with the homologous reaction. The cross-
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Fig. 1. SDS-polyacrylamide gel electrophoresis and corresponding electroblot transfers of EDTA
extracts of strains of C. botulinum, C. novyi and C. sporogenes. Approximately 50 ug protein in 50 pi
sample buffer were run on each track of a 10% acrylamide gel. Track 1, C. novyi type A NCTC 538;
track 2, C. botulinum A1; track 3, C. botulinum pB25; track 4, C. botulinum npB 188; track 5, C. botulinum
C205; track 6, C. botulinum D154; track 7, C. botulinum E34; track 8, C. sporogenes NCTC 8594. (a)
Coomassie blue-stained gel. (b) Electroblot transfer of (a) reacted with antiserum to C. sporogenes
NCTC 8594. (c) Electroblot transfer of (a) reacted with antiserum to C. novyi NCTC 538.
reaction with the type A extract was less strong but several bands, which were common to the
type B, were stained. Single faint cross-reacting bands were also apparent in the C. novyi and the
C. botulinum non-proteolytic type B extracts. The antiserum to C. novyi (Fig. 1 c) only cross-
reacted with extracts from C. botulinum types C and D, one major antigen being present in each.
Antigenic cross-reactions in Clostridium spp. 979
1 2 3 4 5 6 7 8 9 10 11 12
Fig. 2. Electroblot transfers of EDTA extracts of strains of C. botulinum and C. sporogenes separated as
in Fig. 1 (a) and reacted with antiserum to C. sporogenes NCTC 8594. Track 1, C. botulinum A1; track 2,
C. botulinum A7; track 3, C. botulinum A8; track 4, C. botulinum A9; track 5, C. botulinum pB25; track 6,
C. botulinum pB26; track 7, C. botulinum pB27; track 8, C. botulinum El 18; track 9, blank; track 10, C.
sporogenes NCTC 8594; track 11, C. sporogenes 24; track 12, C. sporogenes 33.
In order to demonstrate fully the cross-reactions revealed by ELISA between C. botulinum
strains and the two antisera and also to compare these inter-species cross-reactions with the
reactions within C. sporogenes and C. novyi strains, two further electroblot transfers were done.
EDTA extracts of all the strains of type A and proteolytic B, strain El 18 (see Table 1) of C.
botulinum and the three C. sporogenes strains were run together on an SDS polyacrylamide gel.
They were transferred to nitrocellulose and reacted with the C. sporogenes antiserum (Fig. 2).
Extracts from A1 and A7 (tracks 1 and 2) showed almost identical patterns with a series of
diffusely staining bands at the bottom of the gel and three common bands at molecular weights
of approximately 90000, 77000 and 47000. The A8 extract (track 3) was similar to A1 and A7
except that the bands were weaker in staining intensity and some high molecular weight bands
were faintly visible at the top of the gel. The proteolytic type B strains (tracks 5-7) produced a
much more variable reaction than the type A strains. The extract from B25 (track 5) produced a
very complex pattern of strongly staining bands as already described. Reactions with extracts
from B26 and B27 were much weaker but the patterns produced were similar to each other. A
significant reaction was also produced by the extract from strain El 18 (track 8). A series of
strongly staining low molecular weight bands at the front of the gel was the main feature of this
pattern with a few faint higher molecular weight bands. When compared with the homologous
reaction (track 10) the two other strains of C. sporogenes produced much less complex patterns
(tracks 11 and 12). Again the series of low molecular weight bands was common, while there
were other common bands with molecular weight of approximately 47000 and 31000.
Similarly the type C and D strains of C. botulinum and all the C. novyi strains were run together
and reacted with the C. novyi type A antiserum (Fig. 3). The C. botulinum types C and D (tracks 1
and 2) both produced similar patterns. A band with a molecular weight of approximately 47000
was the major cross-reacting antigen, but several high molecular weight bands were apparent at
the top of the gel and there was a series of regularly spaced cross-reacting low molecular weight
bands at the bottom of the gel. The reactions between the three type A C. novyi strains were very
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Fig. 3. Electroblot transfers of EDTA extracts of strains of C. botulinum and C. novyi separated as in
Fig. 1 (a) and reacted with antiserum to C. novyi type A NCTC 538. Track I, C. botulinum C205; track 2,
C. botulinum D154; track 3, blank; track 4, C. novyi A NCTC 538; track 5, C. novyi A GR2A; track 6,
C. novyi A GR3A; track 7, C. novyi B GR2B; track 8, C. novyi C NCTC 9747; track 9, C. novyi D
NCTC 8350.
similar to each other (tracks 4, 5 and 6). The major cross-reacting antigens had molecular
weights of 48000 and 31 000 with a series of regularly spaced bands at the bottom of the gel. The
C. novyi types B, C and D produced similar patterns (tracks 7, 8 and 9): there was a major band
with a molecular weight of 47 000 and a series at the bottom of the gel which was similar to all the
other tracks on the gel.
DISCUSSION
The results obtained with the ELISA and the electroblot procedures agree closely and show
conclusively that most strains of C. botulinum types A and proteolytic B (Group I) share antigens
with C. sporogenes, whereas types C and D (Group III) share antigens with C. novyi. This
provides further evidence of the close taxonomic relationships between these species. In view of
the limited number of strains investigated, it is not yet certain how widely these cross-reactions
occur and how many exceptions there may be to the general rule demonstrated here. For
example, one of the strains of C. botulinum type A did not react, whilst one of the type E strains
did react with C. sporogenes antiserum. Moreover, varying degrees of cross-reactivity could be
demonstrated with the three type A and three proteolytic type B strains that cross-reacted with
the C. sporogenes antiserum. This was also true for the three strains of C. sporogenes investigated,
and indicates antigenic heterogeneity. Reactions within the C. novyi strains were much more
uniform. No major differences were seen between the three C. novyi type A strains. The C. novyi
strains of types B, C and D showed close antigenic similarity with each other and with the C.
botulinum strains of types C and D.
The patterns of cross-reactivity revealed by electroblot transfer all showed some similarities.
Most of the major cross-reactive bands corresponded to predominant protein bands on the
Coomassie blue-stained gels. All strains that reacted with antiserum, however, also showed
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patterns of regularly spaced bands at the bottom of the gels. These bands did not appear to
correspond to any of the protein bands on the Coomassie blue-stained gels. They were
reminiscent of the patterns produced by lipopolysaccharides of Gram-negative bacteria when
stained with silver (Tsai & Frasch, 1982). It is possible that these cross-reacting antigens were
lipocarbohydrate molecules from the cytoplasmic membrane (lipoteichoic acid analogues). We
know that, at least for C. difficile and C. sordelli, the membrane lipocarbohydrates are cross-
reacting antigens and that they are solubilized by EDTA treatment (Poxton & Cartmill, 1982).
There was no attempt made in this study to use antiserum raised to any C. botulinum strain.
The aim was to use antisera raised against cells that were as close as possible to living organisms:
washing and killing with a minimum dose of UV light were the only treatments used. Obtaining
undenatured cells of toxigenic C. botulinum devoid of toxin is not possible. No attempt was made
to work with C. botulinum types F and G as the author was not protected against these types.
This study was funded by a grant from the Biomedical Research Committee of the Scottish Home and Health
Department (grant no. K/MRS/50/C247). I am extremely grateful to Dr J. S. Crowther and Mr C. Grimes of
Unilever Research, Sharnbrook, Bedfordshire for the advice, assistance and facilities made available during my
visit to their laboratory. Professor J. G. Collee's interest and encouragement is gratefully acknowledged.
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Detection of Clostridium difficile Toxin by
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Recent methods for detection of Clostridium difficile toxin by counterimmu-
noelectrophoresis might lead to errors. False-positives may be attributable to
soluble cell surface antigens reacting with impure antitoxin.
Several workers have recently attempted to
develop a counterimmunoelectrophoresis (CIE)
method for the detection and quantitation of
Clostridium difficile cytotoxin in both fecal and
culture filtrates (3, 4). If valid and successful,
such a system would have obvious advantages
over the cytotoxic assays that are currently in
use for investigation of antibiotic-associated co¬
litis. We are convinced, however, that the anti¬
gen that is being detected by CIE and reported
in these two papers is not necessarily the C.
difficile toxin and could be a cell surface antigen
of C. difficile. Our evidence for this is as follow.-:.
(i) We have recently shown that C. difficile,
Clostridium sordcl/ii, and Clostridium bifer-
mentans, but no other clostridial species tested,
have at least one surface carbohydrate antigen
in common (1). Welch et al. (4) show that cyto¬
toxic assay-negative strains of C. sordcllii and
C. bifermentuns arc both positive by CIE. Sim¬
ilarly, in both papers (3, 4) all C. difficile strains
tested are CIE positive, although some are cy¬
totoxic assay negative.
(ii) Although we arc unable to test any of the
conditions available in the United States, out-
own C. difficile antitoxin and the C. sordellii
antitoxin supplied by the Wellcome Research
Laboratories (Bcckenhant, England) have anti¬
bodies to the common cell surface antigens.
Commercial preparations of antitoxin are usu¬
ally raised against relatively impure toxin prep¬
arations.
(iii) In attempting to purify the C. difficile
toxin by the method of Rolfe and Finegold (2)
we found that the cell surface carbohydrate an¬
tigen copurified with the toxin.
(iv) C. difficile in culture, especially if any cell
lysis has occurred, releases much cell surface
antigen into the medium.
While agreeing with the other authors (3, 4)
as to the importance of identification of toxigenic
strains of C. difficile for the management of
cases of antibiotic-associated colitis, we suggest
the need for caution in interpreting the results
of CIE studies in this area. The absorption of
the antitoxin with whole cells of C. sordellii, C.
bifcrmentans, or C. difficile will remove the
anti-surface immunoglobulins and may allow
more specific results. Similarly, antitoxin raised
against absolutely pure toxin will give specific
results.
There is still much that is not understood
about the roles of both toxigenic and nontoxi-
genic strains of C. difficile as enteropathogens;
possibly erroneous reports of toxin-positive
strains will increase our confusion.
Our studies on C. difficile are supported by the Scottish
Home and Health Department, grant no. K/MRS/50/C247.
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Two carbohydrate cell-surface antigens were extracted from Clostridium difficile. One was
extracted from pure cell walls by NaOH and contained glucose, mannose, galactosamine and
phosphate in the approximate molar proportions of 2:0-65:1:0-63. The other antigen was
extracted with phenol from the disrupted contents of whole cells and purified by
chromatography on Sepharose 6B and an immunoabsorbent column; it contained glucose,
glucosamine, phosphate and fatty acid in the approximate molar proportions of
2:1:1-6:0-04. Both antigens showed partial immunological identity and both cross-reacted
with Clostridium sordellii antiserum. They are analogues of the wall and membrane teichoic
acids of other Gram-positive bacteria.
introduction
Clostridium difficile is a Gram-positive, motile, spore-forming, rod-shaped bacterium
which, until recently, was regarded as an uncommon, non-pathogenic organism. In 1977 it
was shown to be involved in the aetiology of antibiotic-associated colitis; it may also be
involved in a significant number of antibiotic-associated diarrhoeas (Larson, 1979; Bartlett,
1979). A recent analysis of the EDTA-soluble antigens of this and related species by Poxton
& Byrne (1981) showed that a carbohydrate antigen is shared by C. difficile and C. sordellii.
The present study investigates the cell-surface carbohydrate antigens of C. difficile with a view
to showing the location and nature of the common C. sordellii/C. difficile antigen, and also
reports the first investigation of the secondary cell wall polymer (teichoic acid or analogue)
and of the membrane lipocarbohydrate polymer (lipoteichoic acid or analogue) of a
Clostridium species.
methods
Culture of organism and preparation of cell walls. Clostridium difficile NCTC 11223 was cultivated in 16-litre
batches in an L.H. fermenter (L.H. Engineering, Stoke Poges, Berks.). Oxygen-free nitrogen was bubbled at the
rate of 300 ml min ' 1 through PPY medium (Holbrook et al., 1977) which contained 0-4% (w/v) sodium carbonate
and 0-75% (w/v) cysteine hydrochloride, for 16 h at 37 °C. The medium was inoculated with 100 ml of a 16 h
culture of C. difficile in PPY medium and incubated for 18 h at 37 °C with nitrogen bubbling. Sporulation was
negligible under these conditions. Bacteria were harvested by centrifugation at 2000 g for 40 min and washed once
in phosphate-buffered saline (PBS: 50 mM-phosphate buffer pH 7-5 containing 0.15 M-NaCl). The wet pellet was
suspended to a concentration of approximately 30% (w/v) in PBS and the bacteria were disrupted by passage
through a French Pressure Cell (Aminco, American Instrument Co. Inc., Silver Springs, Md., U.S.A.) at
6000-7000 lbf in-1 (41-48 MPa). The suspension was centrifuged at 45000 g for 20 min at 4 °C. The supernate
was removed, freeze-dried and retained for subsequent extraction of membrane antigen. The upper white layer of
cell walls was carefully removed from the small pellet of unbroken cells, suspended in a small volume of water and
heated to 80 °C for 5 min to inactivate the autolytic enzymes; it was then purified by treatment with 2-5% (w/v)
sodium dodecyl sulphate (SDS) as described by Poxton et al. (1978).
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Extraction of cell-wall antigen. Freeze-dried SDS-treated cell walls were extracted with 0-5 m-NaOH for 4 h at
20 °C by the method of Archibald et al. (1969). The NaOH was neutralized with dilute HC1 and salts were
removed by extensive dialysis against distilled water. The extract was freeze-dried.
Extraction of membrane antigen. The freeze-dried supernate (8 g) obtained after a cell breakage was defatted
with 2 x 200 ml chloroform/methanol (2:1, v/v), over 24 h, extracted with cold 80% (w/w) phenol and partially
purified on a Sepharose 6B (Pharmacia) column (65 x 1 -6 cm) by the method of Coley et al. (1975).
Preparation of antisera. Antisera against u.v.-killed, whole, washed cells of C. difficile NCTC 11223 and C.
sordellii NCTC 8780 were prepared as described previously (Poxton & Byrne, 1981).
Immunoelectrophoresis. Crossed immunoelectrophoresis (CIE) was performed by the procedure of Weeke
(1973) as described for C. difficile by Poxton & Byrne (1981). Fused rocket immuno-electrophoresis (FRIE) was
done by the method of Svendsen (1973), with the same buffer system as used for CIE.
Preparation of immunoabsorbent column. Immunoglobulin G (IgG) was prepared from 3 ml antiserum to C.
difficile NCTC 11223 by batch treatment with DEAE-cellulose (Whatman DE 52) by the method of Hudson &
Hay (1976). IgG (50 mg) was coupled to 10-5 ml swollen CNBr-activated Sepharose 4B (Pharmacia) by the
method recommended by Pharmacia in 'Affinity Chromatography, Principles and Methods'. The immuno¬
absorbent was packed in a column (10 x 1 cm) and equilibrated for storage in 0-1 m-phosphate buffer pH 7-0
containing 0-5% (v/v) Tween 80 and 0-01 % (w/v) Merthiolate (thimerosal).
Analytical techniques. Phosphorus was estimated by the method of Chen et al. (1956); sugars, as glucose
equivalents, were estimated by the method of Dubois et al. (1956); sialic acid was estimated by the method of
Aminoff (1961).
Paper chromatography. Acid hydrolysates of carbohydrates (2 m-HCI, 100 °C, 2 h) were dried several times in
vacuo over NaOH pellets and phosphorus pentoxide. They were chromatographed on Whatman no. 1 paper in
solvent A [butan-l-ol/pyridine/water (6:4:3, by vol.)] for reducing sugars and stained with the alkaline silver
nitrate reagents (Trevelyan et al., 1950) and in solvent B fpropan-l-ol/aqueous ammonia (S.G. 0-88)/water
(6:3 :1, by vol.)] for polyols and stained with the periodate-Schiff's reagents (Baddiley et al., 1956).
Gas chromatography. (a) Sugars. Dry hydrolysates of carbohydrates were converted to alditol acetates by a
method modified from that of Lindberg et al (1978). The hydrolysate (1-20 mg) was dissolved in 1 ml distilled
water, and 10 mg sodium borohydride was added. After 1 h at 20 °C, excess borohydride was destroyed by the
addition of a few drops of glacial acetic acid. After drying by rotary evaporation, borate, as methyl borate, was
removed by three distillations with methanol. The dry alditols were acetylated in 1 ml pyridine/acetic anhydride
(1 :1, v/v) at 100 °C for 1 h. Excess reagents were removed by several co-distillations with toluene in a rotary
evaporator, and the alditol acetates were taken up in 1 ml chloroform, washed twice with water, dried by rotary
evaporation and finally dissolved in 0-5 ml chloroform. Samples (1 pi) were examined on columns of 3% OV225
on Gas-chrom Q (for amino sugar derivatives) and 3% SP2330 on Supelcoport (for pentose and hexose
derivatives) in a Pye-Unicam model 104 gas chromatograph, with the temperature controlled between 190 °C and
240 °C by 2 °C min-1.
(b) Fatty acids. Membrane antigen which had been eluted from the immunoabsorbent column was dried and
methanolysed by heating with 0-5 m-HCI in methanol (1 ml) in a sealed vessel for 2 h at 65 °C. Water (2 ml) and
ether (4 ml) were added; after mixing, the phases were separated. The ether phase was brought to dryness in a
rotary evaporator, redissolved in ether (0-5 ml) and examined for methyl esters of fatty acids on a column of 3%
SP2330 on Supelcoport at 150 °C.
RESULTS
Cell wall antigen
From 50 mg lyophilized cell walls, 20 mg was solubilized by 0-5 M-NaOH. When this wall
antigen extract was examined by crossed-immunoelectrophoresis (CIE) against antiserum to
whole cells of C. difficile NCTC 11223, one precipitin line was observed (Fig. 1 a). This line
did not correspond to any of the lines produced by the EDTA extract of whole cells (see
Poxton & Byrne, 1981) but it did correspond to one produced by an autolysate of whole cells
of C. difficile (Fig. 1 b). When this wall antigen was run against antiserum to C. sordellii
NCTC 8780 in CIE, an identical precipitin line was produced.
Chemical analysis of the wall antigen showed it to contain sugar (phenol/sulphuric acid
assay method) and phosphorus in the molar ratio of 4-2:1. Analysis of the constituent sugars
by paper chromatography of acid hydrolysates showed the presence of glucose, mannose and
galactosamine. No ribitol or glycerol was detected. Gas chromatography of alditol acetate
derivatives showed the presence of the same three sugars in the molar ratio







Fig. 1. Crossed immunoelectrophoresis of (a) NaOH-soluble cell-wall antigen (6 pi of 5 mg ml-1
solution) and (b) soluble fraction of autolysed whole cells of C. difficile (6 pi of supernate from cells
allowed to autolyse in PBS for 24 h at 37 °C) run against 65 pi C. difficile NCTC 11223 antiserum. The
precipitin line X is common to both preparations.
glucose :mannose :galactosamine of 2:0-65:1. As galactosamine does not react in the
phenol/sulphuric acid assay this suggests a ratio of total sugar:phosphorus of 6:1 or
glucose :mannose :galactosamine:phosphorus of 2 :0-65 :1:0-63. Sialic acid was absent. The
polymer (1 mg) was treated with 4 units of phosphomonoesterase (Boehringer, Grade I) for
3h at 37 °C in 0-5 ml 0-05 m-ammonium carbonate pH 9-5 under toluene. All the phosphate
was shown to have been present in the monoester form. The dephosphorylated product and
the untreated control gave an identical precipitin line when run in CIE against C. difficile
antiserum.
Membrane antigen
The crude phenol extract of the lyophilized supernate from the broken cells was run in CIE
against C. difficile whole-cell antiserum. Two precipitin lines were present and they appeared
to be joined (Fig. 2). After fractionation on a Sepharose 6B column, fractions were analysed
for carbohydrate, phosphate and nucleic acid and by fused-rocket immunoelectrophoresis
(Fig. 3). The fractions corresponding to the two antigens were pooled and each was examined
against C. difficile whole-cell antiserum by tandem CIE with an EDTA extract of whole cells
of C. difficile NCTC 1 1223 (Poxton & Byrne, 1981) and with the wall antigen according to
the method of Kroll (1973). The antigen that eluted from the Sepharose 6B column in the void
volume (Peak I) gave a precipitin line that was identical with line 2 in the EDTA extract, i.e.
the carbohydrate antigen that is common to C. difficile and C. sordellii. The antigen that was
included by the Sepharose column (Peak II) gave a precipitin line that was identical with the
purified wall antigen.
The material in Peak I contained one antigen, but as there was extensive contamination
with nucleic acid, further purification was necessary before a chemical analysis could be
made. The immunoabsorbent column, prepared as described in Methods, was equilibrated in
borate-buffered saline (BBS: 0-1 m-NaCl, 0-2 m di-sodium tetra borate, pH 7-3). This was to
remove any phosphate buffer that might subsequently contaminate the eluted antigen. The
material from Peak I (2-5 mg) was dissolved in BBS, applied to the column and washed with
20 ml BBS. The flow was reversed and the antigen was eluted with sodium carbonate buffer
pH 9-6/ethylene glycol (1 :1, v/v). Ten 4 ml fractions were collected and screened for antigen
by fused-rocket immunoelectrophoresis. The fractions containing antigen were pooled and
concentrated to 2 ml in an Amicon (Lexington, Mass., U.S.A.) ultrafiltration cell (PM10
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Fig. 2. Crossed Immunoelectrophoresis of phenol extract of C. difficile cell contents (6 pi of 5 mg
carbohydrate mf solution) run against 65 pi C. difficile antiserum. Lines A and B correspond to the
antigens separated in Fig. 3.
Fig. 3. (a) Purification of phenol extract of C. difficile cell contents run on a Sepharose 6B column (60 x
1-6 cm). Fractions (3 ml) were collected and screened for nucleic acid at 260 nm (O): 0-1 ml of each
fraction was screened for phosphorus (#) and carbohydrate (□).
(A) Drawing of fused rocket immunoelectrophoresis of fractions run against antiserum to C. difficile
NCTC 11223. Lines A and B correspond to the same lines in Fig. 2.
membrane). Paper chromatography of acid hydrolysates showed the presence of glucose and
glucosamine. No glycerol or ribitol was detected. Gas chromatography showed the presence
of the same sugars in the molar ratio glucose: glucosamine of 2 :1. After methanolysis (see
Methods) the ether phase was analysed by gas chromatography and the fatty acids were
shown to consist of C16:0, 25-1%; C16:l, 7-1%; C18:0, 8-6%; C18:1, 43-8% and
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C18:2, 15-3%. Percentages were calculated by measuring the area of the peaks of the
gas-chromatography trace. Total fatty acid was calculated by comparison with methyl
stearate. Phosphate and carbohydrate (phenol/sulphuric acid) were estimated on the aqueous
phase of the methanolysate. Results showed the overall composition of the antigen to be
glucose, glucosamine, phosphate and fatty acid in the molar proportions 2:1:1-6 :0-04.
Treatment of the membrane antigen with mild alkali (5 mM-lysine, 140 mM-KCl, pH 11-5)
for 2h at 20 °C released the lipid moiety for the carbohydrate portion, which then
became indistinguishable from the wall antigen in crossed immunoelectrophoresis.
DISCUSSION
Clostridium difficile possesses two carbohydrate cell-surface antigens. The secondary cell
wall polymer or teichoic acid analogue is a major component of the cell wall (40% by weight
of SDS-purified walls). It was not released by EDTA but was solubilized during autolysis.
This is similar to the behaviour of teichoic acids, which appear to be released but not degraded
by autolytic enzymes (Duckworth, 1977). Its composition is unusual but it resembles the wall
polymer described by Partridge et al. (1971), which was found in the walls of a Micrococcus
species. After extraction with alkali all the phosphorus was present as monoester and its
removal by phosphomonoesterase did not alter its antigenic properties in crossed
immunoelectrophoresis. This means that the phosphorus is not part of the antigenic
determinant; as structural determinations have not been possible, the location of the
phosphorus is as yet unknown.
The other carbohydrate polymer was extracted by methods developed for the isolation of
membrane or lipoteichoic acids. The material excluded by Sepharose 6B and further purified
by immunoabsorbent chromatography was the polymer analogous to the membrane teichoic
acid. Its composition is unlike any polymer previously described. It is the common C. difficile,
C. sordellii/C. bifermentans EDTA-soluble carbohydrate antigen (Poxton & Byrne, 1981)
which was released due to the loss of membrane integrity following chelation of divalent
cations by EDTA. The antigen in Peak II from the Sepharose column was immunologically
identical to the wall carbohydrate antigen. This agrees with the observation of Coley et al.
(1975) that the wall teichoic acids of several Gram-positive bacteria are often found in Peak
II. When the lipocarbohydrate was deacylated with mild alkali, the carbohydrate fraction
became immunologically identical to the wall polymer. It is therefore reasonable to ask
whether the antigenic material in Peak II from the Sepharose 6B column is wall antigen or
deacylated membrane antigen.
As both wall and membrane carbohydrate share immunological determinants, and both
react with C. sordellii antiserum, they cannot be exploited for the detection of C. difficile by
immunological means. A specific serological system for detection of C. difficile and distinction
from C. sordellii would require an antiserum devoid of antibodies directed against either wall
or membrane carbohydrate antigens.
C. difficile thus appears similar to aerobic Gram-positive bacteria in possessing a
secondary cell wall carbohydrate and a membrane-bound lipocarbohydrate. These polymers
are not strict teichoic acids as they do not contain ribitol or glycerol phosphate. They are,
however, phosphate-containing carbohydrates. Their composition is more complex than any
related phosphorylated carbohydrates yet described.
This study was supported by a grant (K/MRS/50/C247) from the Scottish Home and Health Department. We
are grateful to Miss Marie Byrne for preparing the immunoabsorbent column, to Dr J. Coley for useful discussions
and to Professor J. G. Collee for his encouragement and advice.
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DETECTION AND ISOLATION OF CLOSTRIDIUM
DIFFICILE
IAN R. POXTON
Department of Bacteriology, University of Edinburgh Medical School, Teviot Place, Edinburgh, EH8 9AG,
UJC.
SUMMARY
Methods are described for the detection of Clostridium difficile cytotoxin in faecal extracts
by tissue culture methods, and isolation of the organism on selective medium.
Characterization steps include microscopy and biochemical tests, supplemented with gas
chromatography of metabolic products. Biotyping and serotyping have possible epidemio¬
logical applications. New approaches for the detection of the organisms include the
development of direct immunofluorescence assays and the determination of enterotoxic
activity.
INTRODUCTION
Clostridium difficile is a Gram-positive, anaerobic, spore-forming, rod-shaped bacterium.
Until recently, it was regarded as a commensal occurring in the faeces of 40-50% of
neonates, but rarely in adults. It has been detected with increasing frequency since 1977,
when it was shown to have a causative role in pseudomembranous colitis (PMC), and
subsequently in antibiotic-associated colitis (AAC). It appears to be involved in a spectrum
of conditions ranging from AAC through to antibiotic-associated diarrhoea (AAD), and
also in exacerbations of chronic inflammatory bowel disease, post-operative diarrhoea and
non-antibiotic-associated diarrhoea (Anonymous, 1981).
Our increasing awareness of the range ocircumstances in which C. difficile can be
found has been greatly advanced by the development of a highly selective medium (CCFA
medium) by George et al. (1979). The development of an assay for C. difficile cytotoxin,
the effect of which can be neutralized by Clostridium sordellii antitoxin, has allowed us to
detect the presence of toxigenic organisms in faecal filtrates by observing a cytopathic
effect on tissue monolayers.
The epidemiology and pathogenic mechanisms of C. difficile are still poorly understood.
Animal studies and the clustering of some cases suggest that cross-infection can occur. The
production of cytotoxin is circumstantia"y associated with severity of disease, but
organisms that do not produce cytotoxin have been associated with enteropathies. Many
questions have still to be answered. Only when C. difficile can be routinely detected,
isolated and typed, and the nature of its extracellular products defined, can some of these
questions be answered.
This paper reviews the methods currently available and others that are being developed
for the detection, isolation, characterization and typing of C. difficile, and for the detection
of its cytotoxin and presumptive enterotoxin (see below).
\
124 Ian R. Poxton
METHODS AND RESULTS
1. Detection ofcytotoxin
(a) Tissue culture assay for cytotoxin. Since Larson et al. (1977) first described a
heat-labile cytotoxin in the stools of patients with AAC which could be neutralized in vitro
by C. sordellii antitoxin (Chang et al., 1978; Rifkin et al., 1978), tissue culture assays have
been developed for the detection of C. difficile cytotoxin. Bartlett (1979) has reviewed the
methods available—a summary of our own method is given here.
A liquid stool, or the homogenate of a solid stool in physiological saline, is centrifuged at
27,000 g for 10 min. Four-fold serial dilutions of the supernate are prepared in
physiological saline and 10 ft 1 volumes are added to 90 fi\ of Eagle's modified maintenance
medium containing penicillin (200 units/ml), streptomycin (200 /rg/ml), gentamicin (10
/*g/uil) and amphotericin B (20 /rg/ml) over monolayers of human embryo fibroblasts in
Microtitre plates. The titre of cytotoxin is the highest dilution that produces complete
rounding of more than 50% of the cells after incubation for 24 h at 37°C. Neutralization is
performed by C. sordellii antitoxin (obtained from Dr. P. D. Walker of Wellcome
Research Laboratories, Beckenham, U.K.). Antitoxin (10 /ft of a 1 in 25 dilution) is added
to a duplicate series of wells. A positive control, cither a known positive stool extract or a
purified C. difficile toxin, should be included. In our hands, there is no loss in potency if the
toxin control is frozen and thawed several times.
There seems to be little correlation between cytotoxin titre and severity of disease.
Although Burdon et al. (1981) have shown a significant correlation between a titre of
greater than 6400 and pseudomembrane formation. It may be that the duration of exposure
to the cytotoxin is a more valid criterion, but severity of the disease is best judged on
clinical grounds. See, however, note on presumptive enterotoxin.
(b) Other methods for detecting toxin. Two groups (Welch et al., 1980; Ryan et al.,
1980) have recently described a counter-immunoelectrophoresis method for detection of C.
difficile toxin. We are certain, however, that this technique will result in many
false-positives by the detection of a soluble cell-surface antigen common to C. difficile, C.
sordellii and C. bifermentans. This technique should be used with the utmost caution
(Poxton and Byrne, 1981a).
2. Isolation of C. difficile
Since the development of the highly selective cycloserine, cefoxitin, fructose agar
(CCFA) medium by George et al. (1979), this has become the medium of choice for the
isolation of C. difficile. It exploits the resistance of C. difficile to D-cycloserine (500 /jg/ml)
and cefoxitin (16 /tg/ml) and its ability to ferment fructose. In our laboratory, and in many
others, this medium has proved invaluable. After 24 h incubation at 37 °C in anaerobic
conditions, C. difficile produces a large (5 mm) flat to low umbonate yellow colony with a
ground-glass appearance and a slightly filamentous edge. The selectivity of this medium is
such that only after 24 h or 48 h incubation do other colonies appear. They are usually
small, white and raised; these arc usually lactobacilli and cannot be confusec with the
typical C. difficile colonies. In pilot studies, we have found no difference in isolation rates
from faeces whether we. use an anaerobic cabinet or bench technique. In quantitative
platings from pure cultures we find that CCFA and blood agar give approximately equal
yields. We do, however, find that colonies on CCFA are extremely sensitive to oxygen and
should be sub-cultured without delay.
Hafiz and Oakley (1976) utilized the organism's resistance to p-cresol and developed a
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selective medium containing 0.2% p-cresol. George et al. (1979), however, found that 0.2%
p-cresol in reinforced clostridial agar inhibited all 16 of their stock strains, and
concentrations below 0.2% were not selective.
3. Characterization of the organism
(a) Microscopy. In the light microscope C. difficile appears as a large (4-8 pm x 0.5-1
/im) Gram-positive rod with non-bulging sub-terminal to terminal spores. Under
phase-contrast it exhibits a characteristic oscillating motility. In the electron microscope it
is seen to have a rather sparse arrangement of peritrichous flagella.
(b) Biochemical tests. Most strains of C. difficile ferment glucose, fructose and mannitol;
they hydrolyse aesculin and some produce gelatinase. All are indole and lecithinase
negative. Some of our strains vary markedly in their biochemical reactions and this is
summarized below. All strains can be conclusively characterized by gas chromatography
(GC) of their volatile fatty acid metabolic products after culture in PPYSG medium
(Deacon et al., 1978). A typical GC profile together with an atypical profile from an
asaccharolytic strain is shown in Fig. 1. The atypical profile could, however, not be
\N
Typical profile Profile from aeaccharolytic strain
Fig. 1. Gas chromatograms of volatile fatty acid metabolic products from 18 h PPYSG cultures of a typical
and an asaccharolytic strain of C. difficile on columns of SP 1220.
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confused with any other Clostridium species. The significant peaks of acetic, butyric,
iso-butyric, iso-valeric and iso-caproic acids are diagnostic.
Phillips and Rogers (1981) have recendy developed a gas-chromatographic method for
rapid identification of C. difficile. They used a modified CCFA medium supplemented with
p-hydroxyphenyl acetic acid. This substrate is metabolized by C. difficile to p-cresol.
P cresol is assayed by extracting it from the agar below several presumptive colonies into
ether and injecting the extract into a gas chromatograph. Results appear promising.
4. Typing of C. difficile
(a) Biotyping. We have investigated the biochemical properties of 43 of our isolates of C.
difficile. These strains can be divided into seven different biotypes based on their reactions
in six biochemical tests (Table 1). When several isolates were made from the same patient,
Table 1. Results of biochemical tests performed on 43 isolates of C. difficile
Biotype
Test 1 2 3 4 5 6 7
Aesculin hydrolysis + + + + — + —
Glucose fermentation + + + + + — —
Fructose fermentation + + + + + + —
Mannitol fermentation + + + + + + —
Mannose fermentation + + — - — — —
Gelatinase production + — + — — — —
No. strains (patients*) 10(10) 10(7) 3(3) 12(12) 4(2) 2(1) 2(1)
* Figure in parenthesis refers to the number of patients from whom the strains were isolated.
they were almost invariably shown to belong to the same biotype; however, in apparently
two instances, type 2 and type 4 strains were isolated from the same patient. The only
property that these two types differ in is their ability to ferment mannose, but strains that
ferment mannose do so only weakly. Perhaps this test should be excluded from a biotyping
scheme.
(b) Serotyping. Poxton and Byrne (1981b) have shown that four cell-surface antigens
can be extracted from C. difficile NCTC 11223 with EDTA and visualized by crossed
immunoelectrophoresis (CIE) (Fig. 2). Two EDTA antigens (producing precipitin lines 2
and 4) are found in all strains of C. difficile so far investigated. Line 4 is often difficult to
observe. The antigens that prodt ce lines 1 and 3 may occur together, or singly, or not at all
in preparations from some strains. The antigen that produces line 2 is common to C.
sordellii/C. bifermcntans and is a membrane associated lipo carbohydrate (Poxton and
Cartmill, unpublished work). A fifth antigen, producing line 5, can be extracted from pure
cell-walls by NaOH, or by autolysis of whole cells; this is the secondary cell wall polymer
(teichoic acid analogue), and it is also common to C. sordellii/C. bifermcntans (Poxton and
Cartmill, unpublished). It is possible, therefore, to serotype C. difficile by detecting lines 1,














Fig. 2. Diagram of precipitin lines produced by cell surface antigens of C. difficile NCTC 1 1223 in
crossed-immunoelectrophoresis. Lines 1-4 are produced by EDTA-extract. Line 5 is produced by the
secondary cell wall polymer.
3 and 4 by CIE of EDTA extracts. Isolates from the same patient give the same profile.
When sera have been raised against other strains, and when more antigens including the
flagella have been investigated, a more complete serotyping system may be developed.
When biotyping and serotyping are used in tandem it should now be possible to
investigate the epidemiology of C. difficile infections.
5. New approaches
The direct visualization of C. difficile in clinical specimens would be an obvious
advancement in our investigation of C. difficile infections. An immunofluorescence assay
(IFA) or immunoperoxidase assay would be useful. Hubert et al. (1981) have developed an
IFA technique for identification of isolated C. difficile colonies. They have raised an
antiserum against one strain of C. difficile. In our studies, antiserum raised against one
strain (a different strain from that of the French workers) does not detect all our isolates.
We are developing a mixed antiserum to detect all our strains. It is, of course, necessary to
absorb C. difficile antiserum with C. sordellii cells to make it specific.
Problems that we have encountered in IFA applied directly to faeces include the
presence of Fc receptors on much of the cellular debris in faeces and the possibility that the
bacteria may be antibody-coated.
During the preparation of this paper, a reference has been made to an unpublished
finding that many of us have predicted. Bartlett et al. (1980) have shown that C. difficile
produces an enterotoxin as well as a cytotoxin. This enterotoxin appears to be the major
virulence factor of the organism. It can be detected in tests with ligated ileal loops in the
rabbit or by injection into the caecum of the hamster. It will be necessary to develop simple
tests for the detection of the enterotoxin before this can become a routine procedure. The
significance of the finding is already clear and it may explain some of the difficulties that we
have encountered in relating apparently non-toxigenic strains to disease.
128 Ian R. Poxton
CONCLUSIONS
In so short a period of time, great advances have been made in the isolation and detection
of C. difficile. This has resulted in an evolving awareness of the range of enteropathies in
which it may play a role. Its pathogenic mechanisms are debated, but it is encouraging that
the procedures outlined in this short paper promise to make further significant
contributions to our understanding and management of conditions in which C. difficile may
be involved.
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Abstract
A total of 154 patients admitted to an infectious diseases
unit were included in a year's prospective survey of
sporadic diarrhoeal disease. Stools from 19 of them
yielded Clostridium difficile, generally on more than
one occasion. Twelve of these patients were assessed as
having a severe or moderately severe gastrointestinal
illness: CI difficile was the only pathogen isolated from
10 of them, and two had an associated salmonella
infection. Seven had had a recent course of antibiotics,
but five had not taken antibiotics. Faeces from seven
patients with moderate or mild gastrointestinal illness
yielded CI difficile, and two of these patients also had an
associated salmonella infection. Two patients in this
group had no antibiotic history.
From these findings, the occurrence of C difficile in
faeces could not be described as antibiotic-associated.
Faecal CI difficile cytotoxin was detected in only six
patients, and generally at low levels. In such patients a
more relevant pathogenic index might take account of
the numbers of CI difficile present and of their toxigenic
potential.
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Introduction
Though a pathogenic association between Clostridium difficile
and pseudomembranous colitis is accepted, the role of this
organism in intestinal health and disease in infants and adults
is still uncertain.' The development of better selective culture
procedures has greatly facilitated the isolation of CI difficile
from stools.2 We have therefore conducted a prospective study
to determine the range of circumstances in which CI difficile
may be detected and possibly implicated in sporadic cases of
diarrhoea in adults admitted during one year to an infectious
diseases hospital.
Patients and methods
We included in the survey all patients admitted to the infectious
diseases unit during November f979 to October 1980 who presented
with diarrhoea or developed diarrhoea. During the study period
there was no recognised epidemic of gastroenteritis or diarrhoeal
disease. Diarrhoea was defined as three or more loose stools daily for
one day or more. The stools of patients with diarrhoea were examined
for intestinal pathogens, including Salmonella., Shigella, and
Campylobacter spp and for CI difficile; a sample of faeces was also
referred for virological examination but not for direct electron
microscopy. Patients whose stools yielded CI difficile were graded
retrospectively according to the severity of their illnesses on clinical
grounds alone.
BACTERIOLOGICAL INVESTIGATIONS
Specimens of faeces—Samples were taken with care to avoid
contamination and submitted in sterile plastic containers without
transport medium. When CI difficile was isolated follow-up specimens
were submitted.
Microscopy—Suitable preparations of each specimen were examined
by phase-contrast microscopy; a Gram smear tf?as prepared and
examined by light microscopy. Pus cells, red blood cells, and Gram-
positive rods with spores were noted.
Culture—Approximately 0 1 g or 0 1 ml of faeces was plated on
cefoxitin cycloserine fructose agar medium (CCFA)2 and incubated
anaerobically in 90",, hydrogen and 10% carbon dioxide for 24 hours
at 37"C. Another, similar sample was inoculated into Robertson's
cooked meat broth and incubated in the same way. The CCFA plate
was examined for typical colonies, and the number of CI difficile in
the faeces estimated semi-quantitatively: -(- - growth in well only
(102-103 organisms/g faeces), F f ~ growth in well and on primary
streaks (10:'-104), and + (- + = growth in well, primary streaks, and
secondary streaks (>105). The cooked meat broth culture was plated
on CCFA medium and this plate subsequently examined for
CI difficile and scored | if positive only after enrichment. All CCFA
plates were incubated for 48 hours before being discarded as negative.
All presumptive isolates were confirmed by gas chromatography
of the volatile fatty-acid products of metabolism. The acidified
supernate from a 24-hour culture in proteose peptone, yeast extract,
serum, and glucose medium3 was examined on a column of 15 %
2
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Supclco SP1220, 1"„ H3PO, on chromosorb W acid washed in a
Pye Unicam model 104 gas chromatograph. A typical fatty-acid
profile with pronounced peaks of acetic, N-butyric, isobutyric,
N-valeric, isovaleric, and isocaproic acids was taken as diagnostic.
Toxin assay—Toxin was assayed essentially according to Bartlett4
by observing a cytopathic effect on monolayers of human embryonic
fibroblast cells. All faecal assays were performed retrospectively on
specimens that had been stored at -18"C. Before centrifugation,
solid faecal specimens were mixed with a minimum of physiological
saline to give a fluid suspension; liquid specimens were used without
further dilution. Neutralisation tests were performed with CI sordellii
antitoxin (10 /d of a one in 25 dilution added to 90 /il medium over
the monolayer just before adding 10 /si of faecal extract). The toxi-
genicity of fresh isolates of CI difficile was estimated by assaying the
supernate from five-day cultures in 3-5% (w/v) brain-heart infusion
medium supplemented with 1 % (w/v) proteose peptone (both from
Oxoid).
Results
A total of 154 patients were included in the survey, 145 of whom
were referred by their general practitioners and nine transferred
from other hospitals. All were admitted for investigation and treatment
of illnesses that either presented with or developed a diarrhoeal phase.
Of these, 39 had medical or surgical conditions that might reasonably
be associated with diarrhoea and not regarded as primarily infective.
Of the remaining 115 patients, 27 (23%) yielded enteropathogenic
bacteria, 12 (10%) had salmonella infections, and 15 (13°,,) yielded
Campylobacters. A reovirus may have caused another one diarrhoeal
episode. From four of our 115 patients a Salmonella sp and CI difficile
were isolated together. Eighty-seven patients had diarrhoea that
might have been infective and was unexplained; from 15 of these we
isolated CI difficile alone.
During the survey 35 patients were admitted who did not fulfil
the criteria of the study—that is, they did not produce three or more
loose stools daily for one day or more. Stools from these patients were
also investigated and contained no CI difficile. Since other patients
resident in hospital are not entirely equivalent, the 35, like the study
patients, were in the main admitted directly from the community,
were regarded as matched controls.
CI difficile was isolated from a total of 19 patients (group 1). Of these,
17 came from their homes and two were from other hospitals. The
age range was 19 to 88 years, with a mean of 56; the male to female
ratio was 1:4; two patients died; 15 of the patients presented during
May to October: and one had travelled abroad recently. There was
no case-to-case spread of CI difficile. On only one occasion were two
patients with the organism in the ward at the same time. A check on
the ward area and clean bedpans during the survey yielded no
CI difficile.
Toxin that could be neutralised by CI sordellii antitoxin was detected
in the faeces of six patients in group 1. No cytotoxin was detected in
any of the specimens that were available for testing (106 tested out
of a possible 135) from patients who did not have CI difficile in the
faeces (group 2). Twelve of the 19 patients in group 1 and 17 of the
135 in group 2 had had courses of antibiotics during the six weeks
before their admission to hospital, whereas only one of the 15 patients
4
with Campylobacter diarrhoea and none of the eight with salmonella
infections alone had received antibiotics during that time.
There was no appreciable difference between the two groups in
age, sex, mortality, seasonal incidence, contact history, or travel
abroad, and the groups were indistinguishable in terms of presentation,
biochemical and haematological profiles, and clinical course. Group 2
included a wide variety of acute surgical cases (appendicitis, perforated
viscus, obstructed hernia, ischaemic ileitis, and colitis) and medical
conditions (diverticular disease, carcinomatosis, pneumonias, ulcera¬
tive colitis, and chronic renal failure). There was no obvious correlation
with faecal excretion of CI difficile in patients with diarrhoea other
than recent antibiotic treatment, which was not an invariable
association.
Clinical assessment—The table summarises relevant data for the
19 patients in group 1. The patients were divided retrospectively
into four groups based on the severity of their illness; duration,
frequency, and persistence of diarrhoea; occurrence of blood in the
stools; fever; signs and symptoms of dehydration; increased white
cell counts; and low serum albumin concentrations. The four groups
were clinically severe (1 Ft), moderately severe (If f),
moderate ( -f + ), and mild ( + ). We considered that 12 patients had
appreciable enteropathy, and it was among these that the high white
cell counts and low serum albumin values were recorded. The
symptoms included diarrhoea, vomiting, and abdominal pain; three
patients had frank blood in the stools.
Microbiological assessment—Semi-quantitative assessments of the
isolation of CI difficile from the 19 patients in group 1 showed many
examples of poor correlation with clinical severity. This was also
true of our assessments of in-vitro toxigenicity of the CI difficile
isolates and it was largely true of our estimations of toxin in the faeces
of these patients, though with one exception (case 16) all of those with
detectable faecal toxin were severely ill. Five non-cytotoxic strains
of CI difficile were isolated; four were associated with diarrhoea in
patients from whom no other presumptive pathogen was isolated.
Pathogens other than CI difficile were isolated from two severely ill
patients (cases 7 and 8). One of these (case 7) had an associated
salmonella bacteraemia, and presented with septicaemic shock initially
considered to be secondary to an Escherichia coli urinary tract
infection. With the exception of these two patients, 12 had a clinically
severe illness in the absence of any presumptive cause other than
CI difficile. Seven of the 12 had received antibiotics within the previous
six weeks, but the other five patients had not received antibiotics.
Management—Vancomycin was given to 10 of the 12 patients with
clinically severe and moderately severe disease and to one patient
with moderate disease. The decision to treat was clinical, though it
was influenced by finding CI difficile in the stools. At the time of each
patient's illness we did not have the results of the faecal toxin assays;
in retrospect it could be argued that several of our patients did not
merit specific treatment. Cholestyramine was used only twice; it
failed to improve one patient (case 12), who eventually received a
course of vancomycin.
Sigmoidoscopy was performed on 11 patients (cases 1-8 and 10-12).
Moderate inflammation with contact bleeding was seen in four
(cases 1, 3, 7, and 8), but none had pseudomembranes or ulcers; the
rest were normal. Rectal biopsy in six patients (cases 1, 3, 5, 6, 7, and
8) showed oedema with chronic or acute inflammatory infiltrates.




In a recent survey5 no CI difficile was isolated from a group
of 62 healthy adults, but in an earlier one up to 3% of healthy
adults were found to be carrying CI difficile.6 Most of this work,
however, was done before the introduction of the selective
CCFA medium.2 Hence these surveys may have underestimated
the carriage rate of CI difficile if some normal adults had carried
small numbers of organisms in their stools. Similarly, in our
35 controls we were unable to isolate any CI difficile on CCFA.
CI difficile has been isolated from the urogenital tract of men and
women,' occurs commonly in the faeces of neonates,5 8 and
has an accepted causative association with pseudomembranous
colitis in adults. The organism has been associated with 6-48%
of cases of antibiotic-associated diarrhoea'"; the assumed
association is based on faecal cytotoxin assays or isolations of
the organism on selected media. Twelve of our 29 patients with
antibiotic-associated diarrhoea yielded CI difficile, but none had
pseudomembranous colitis diagnosed. Mogg et al12 and
Keighley et al12 have demonstrated the inadequacy of sigmoido¬
scopy and rectal biopsy and the greater reliability of faecal
cytotoxin determinations in diagnosing pseudomembranous
colitis.
Evidence is now appearing implicating CI difficile in non-
antibiotic-associated colitis,14 16 exacerbations of chronic in¬
flammatory bowel disease," 18 and postoperative diarrhoea.10"
The clustering of some cases suggests that cross-infection may
occur."
Falsen et alu found that CI difficile was the second commonest
enteropathogenic isolate in a survey of many stool specimens
submitted to a laboratory. Our hospital-based survey would
have excluded many young patients with salmonella and
Campylobacter infections treated by general practitioners
without referral to hospital. In our series CI difficile was the
commonest presumptive enteric pathogen. Unknown or un¬
detected pathogens might have accounted for some of our
cases of presumed infective diarrhoea. For example, the
occurrence of rotaviruses and other enteropathogenic viruses
in an adult population has not been adequately assessed and
merits further consideration. With these provisos, CI difficile
seems to be associated with some cases of diarrhoea requiring
admission to hospital and may be acting as a primary pathogen
in a proportion of these. In common with the findings of
others,1! 20 we were able to isolate an accepted infective agent
from only 28 (24%) of 115 patients. Our suggestion that
CI difficile may be an additional accepted cause of infective
diarrhoea is supported by recent reports of hospital studies" 11
and animal studies." "
The titres of faecal cytotoxin detected in our survey (from
0-1024) were appreciably lower than those obtained in classic
cases of pseudomembranous colitis (500-400 000", 1000-5000,"
and 1000-2000"). Our patients may have had illnesses at the
6
lower end of the range of clinical severity. The CI difficile
isolates from five of our patients were non-cytotoxigenic, which
raises the question whether non-cytotoxigenic CI difficile is
invariably non-pathogenic. Recent work suggests that the
cytotoxin presently assayed is not the enterotoxin that causes
the diarrhoea.27
When CI difficile was isolated, a decision to treat was made on
clinical grounds with oral vancomycin2 8 or with cholestyramine.2"
That non-cytotoxigenic strains of CI difficile might be implicated
in diarrhoea led us to regard vancomycin as the first choice
when specific treatment seemed to be indicated. The criteria
required to implicate CI difficile as an enteric pathogen are not
yet clear. It may be helpful to avoid the terms toxigenic and
non-toxigenic until the role of the cytotoxin and enterotoxin in
relation to enterotoxicity is defined. It is important to determine
whether a relation might exist between the numbers oforganisms
excreted, their ability to produce one or more toxic factors,
the concentrations of these factors in the faeces, and the clinical
condition of the patient. The epidemiology is complex,30 and
the enteropathogenic range of CI difficile is as yet undefined.
We suggest that the range of illness produced by CI difficile
may include sporadic infective diarrhoea and that oral vancomycin
should be considered for patients whose clinical condition causes
anxiety.
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1. SUMMARY
The membrane lipocarbohydrate antigen (lipo¬
teichoic acid analogue) of Clostridium difficile has
been purified by aqueous phenol extraction and
Sepharose 6B chromatography. After analysis by
polyacrylamide gel electrophoresis (PAGE) and
immunoblotting it has been shown to consist of a
series of components of differing Mt. It appears as
a regularly spaced ladder pattern similar to those
shown for the lipopolysaccharide (LPS) of many
Gram-negative bacteria.
2. INTRODUCTION
C. difficile is a Gram-positive, spore-forming,
anaerobic bacterium and is well recognised as
being the major cause of pseudomembranous and
antibiotic-associated colitis [1], The structure of
the cell-surface appears to be typically Gram-posi¬
tive: components analogous to wall and membrane
teichoic acids have been demonstrated [2] and a
regular surface array of protein subunits has been
recognised [3]. The membrane teichoic acid ana¬
logue is not based on a poly-glycerol phosphate
backbone as in most other Gram-positive bacteria
so far investigated, but contains glucose, glucos¬
amine, phosphate and fatty acid in the molar
proportions of 2 :1 :1.6 :0.04 [2].
In Gram-negative bacteria the LPS has been
investigated by PAGE. After silver staining, it has
been shown to be made up of a heterogeneous
population of differing A/r, adjacent bands vary¬
ing by one repeating unit of polysaccharide [4],
It might be expected that the appearance on
PAGE of lipoteichoic acid molecules based on the
typical poly-glycerol phosphate backbone would
not show the characteristic ladder pattern of LPS.
If the chain lengths were variable they would only
differ by a single substituted glycerol phosphate
unit, which might not be resolved on PAGE.
This present study uses PAGE and immuno¬
blotting to investigate the immunochemistry of the
atypical lipocarbohydrate of C. difficile. Antigeni-
cally related species are also compared.
3. MATERIALS AND METHODS
3.1. Culture of organisms and cell breakage
The strains used were C. difficile NCTC11223,
and 3 clinical isolates, RIE1I83I, MPRLI6I and
MPRL597, C. sordellii NCTC8780 and C. bi-
fermentans NCTC506.
A 0.1% (v/v) inoculum of an overnight culture
0378-1097/86/S03.50 © 1986 Federation of European Microbiological Societies
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of bacteria in Robertsons' cooked meat broth was
added to 6 1 of pre-reduced proteose peptone yeast
extract medium containing 0.04% (w/v) sodium
carbonate and 0.075% (w/v) cysteine hydrochlo¬
ride [5] and incubated anaerobically at 37°C for
18 h in an anaerobic cabinet (Forma Scientific).
The bacteria were harvested (8500 X g for 10 min
at 4°C) and broken as described previously [2],
After removal of the cell walls at 45 000 X g for 20
min, the supernate, containing the membrane anti¬
gen, was lyophilized prior to further extraction.
3.2. Extraction of membrane antigen
The lyophilized supernate was defatted with
2 X 200 ml chloroform/methanol (2 :1, v/v) over
24 h and extracted with cold 80% (w/w) phenol as
described by Coley et al. [6]. The membrane
material (about 0.8 g) was suspended in distilled
water to about 10% (w/v), mixed with an equal
volume of 80% aqueous phenol (w/w) and stirred
at room temperature for 30 min. This was centri-
fuged at 2500 X g for 20 min at 4°C. The upper
aqueous layer, after dialysis, was mixed with an
equal volume to 0.2 M acetic acid/acetate buffer,
pH 5.0, containing 0.02 M MgCl2. Ribonuclease
and deoxyribonuclease (Sigma) were added and
the mixture incubated under toluene at 37°C over¬
night. Phenol/water extraction was repeated, the
upper aqueous layer dialysed and finally lyophi¬
lized. This was the crude membrane antigen.
Further purification of the MPRL161 sample
(13 mg in 500 jul of distilled water) was carried out
by fractionating on a Sepharose 6B column (30 X 1
cm) by the method of Coley et al. [6],
3. J. Immunoelectrophoresis
Crossed Immunoelectrophoresis (C1E) was per¬
formed by the procedure of Weeke [7] as described
by Poxton and Byrne [8] with antiserum raised to
MPRL161. Samples (10 jal) were applied at a
concentration of 10 mg/ml in distilled water.
Fused rocket Immunoelectrophoresis (FRIE)
was done with antiserum raised to NCTC11223 as
described by Svendsen [9] with the same buffer
system as used for CIE. The pooled fractions were
desalted on a 10 ml Sephadex G25 column.
3.4. Preparation of antiserum
Antisera against UV-killed, whole, washed cells
of C. difficile NCTC11223 and MPRL161 were
prepared as described previously [8].
3.5. PAGE and immunoblotting
The buffer system of Laemmli [10] with 10%
slab gels as described by Poxton and Brown [11]
with and without SDS was used. Samples (50 /xl)
containing 250 /xg crude antigen or 25 \xg purified
antigen were run on each track. Gels were stained
with silver [4] for 10-15 min. For immunoblotting
gels without SDS were used. Materials were trans¬
ferred to nitrocellulose membranes (0.2 jam pore,
Sartorius) and treated with antiserum raised against
NCTC11223 and anti-rabbit HRP conjugate, as^
previously described [12], except that Tween 20
was omitted from the washing solutions.
4. RESULTS
Crude aqueous phenol-extracted membrane an¬
tigens from 4 strains of C. difficile and one strain
each of C. sordellii and C. bifermentans were
analysed by SDS-PAGE and stained with silver.
The results (Fig. 1) showed that the patterns pro¬
duced by the C. difficile strains all appeared as a
regularly spaced ladder pattern reminiscent of the
pattern produced by the LPS of Gram-negative
bacteria. The patterns produced by the other two
species were indistinct, and even when more
material was applied to the gel no ladder pattern
could be demonstrated. Imnrunoblots of the C.
difficile extracts with antiserum raised to C. dif¬
ficile MPRL11223 revealed patterns of faint anti¬
genic bands similar to those of the silver stain
(results not shown).
One of the crude antigens (from C. difficile
MPRL161) was analysed by CIE and produced a
pattern identical to that previously produced by
NCTC11223, i.e., two precipitin arcs showing par¬
tial identity [2]. After fractionation of the
MPRL161 crude phenol extract on a Sepharose 6B
column, two antigens were detected with FRIE,
one eluting in the void volume, the other with a
A"av of 0.71. This was similar to that previously
shown for NCTC11223 [2]. The fractions corre¬
sponding to the two antigens were pooled, de¬
salted and analysed further by PAGE and im-
Fig. 1. Silver-stained SDS-PAGE of crude aqueous-phenol
extracts of C. difficile. Lane 1, NCTC11223; lane 2, MPRL161;
lane 3, RIE118311; lane 4, MPRL597. Samples (50 fi\) contain¬
ing 250 /^g crude antigen were applied to each lane.
munoblotting. Initial attempts to obtain good pho¬
tographs of immunoblots were hampered by the
apparent lack of sensitivity of the procedure. Sub¬
sequently, sodium dodecyl sulphate (SDS) was
omitted from the gels but retained in the sample
and electrode buffers. This resulted in greater
sensitivity of detection by immunoblotting, and
the silver-stained gel was extremely similar to the
SDS-containing gel, except that the bands ran
slower when SDS was omitted. The results of the
PAGE and corresponding immunoblot of the crude
membrane antigen and the two antigenic fractions
after Sepharose 6B treatment are shown in Fig. 2.
The material in fraction 1 gave an identical band¬
ing-pattern to that seen with the crude material. In
the silver stain there was nothing apparent in the
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Fig. 2. (a) Silver-stained PAGE (without SDS) of crude aque¬
ous-phenol extract of MPRL161 (lane 1) and the two antigenic
fractions detected by FRIE from the Sepharose 6B column
(lane 2 is first antigen and lane 3 the second). Lane 1 contained
250 /xg crude antigen, and lanes 2 and 3 25 /ig purified antigen,
(b) Corresponding immunoblot with antiserum raised against
NCTC11223.
sample corresponding to fraction 2. In the im¬
munoblot of fraction 2 an antigenic band was
detected just behind the gel front.
Immunoblotting with antiserum toNCTC11223
of the crude extracts of the four C. difficile strains
and the other two species was repeated, omitting
SDS. The patterns produced by C. difficile were
identical to those obtained with the silver stain.
There was distinct cross-reaction of the C. difficile
antiserum with the extracts from Clostridium
sordellii and Clostridium bifermentans, part of the
pattern in the mid-region of the C. sordellii and C.
bifermentans gels being series of fine lines which
appeared as a smear in the silver stain (not shown).
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5. DISCUSSION
Previous work has shown that a phenol extract
of lyophilized supernate from broken cells of C.
difficile NCTC11223 contained two antigens when
studied by CIE. These antigens, which appeared to
be antigenically related, were proposed to corre¬
spond to (a) the lipoteichoic acid moiety found in
all Gram positive organisms and (b) a deacylated
form of this antigen which cross-reacts with the
cell wall antigen (teichoic acid) [2], In this present
study the membrane carbohydrate has been shown
to be extremely similar in appearance to the LPS
of Gram-negative bacteria when examined by
PAGE, giving a ladder pattern; each rung ap¬
parently differing by one repeating unit of poly¬
saccharide. Relatively high concentrations of the
antigen were applied to the gels to ensure that the
silver-stained material developed rapidly, thus
avoiding problems with high background staining.
The identity of the second antigenic peak from the
Sepharose 6B column is uncertain. This rather
heterogeneous low-A/r material may be frag¬
mented wall antigen or deacylated membrane anti¬
gen.
As far as we are aware this is the first report of
the analysis of a lipoteichoic acid (or analogue) by
PAGE. It has however been speculated that a
ladder pattern seen in immunoblots of crude cell
surface extracts of Clostridium Botulinum might be
due to such a molecule [13]. We do not know if
this ladder pattern is produced by the LTA ana¬
logues of other Clostridia or indeed of other
Gram-positive bacteria.
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1. SUMMARY
The proteins which can be released by 6 M urea
treatment from the cell walls of Clostridium dif¬
ficile represent the major cell surface proteins. In
the 5 strains examined there are one to three of
these major proteins. They appear to be strain-
specific antigens being detected in immunoblots
only with homologous antiserum. A common cell-
surface protein of Mr 73 kDa has been identified
as a minor component of the urea extract.
2. INTRODUCTION
Clostridium difficile is the anaerobic, spore-for¬
ming organism responsible for most, if not all
cases of antibiotic-associated pseudomembranous
colitis [1]. Molecules analogous to the teichoic
acids and lipoteichoic acids found in typical
Gram-positive organisms have been identified in
the cell envelope [2,3]. An outer cell wall layer has
also been identified consisting of two major pro-
Correspondence to: Ian R. Poxton, Bacteriology Department,
University of Edinburgh Medical School, Teviot Place, Edin¬
burgh, EH8 9AG, U.K.
tein molecules organised in a regular array [4], By
SDS-PAGE all isolates examined could be divided
into two different groups based on the molecular
mass (Mr) values of these major wall proteins
which had been extracted with urea [4].
In the development of a fingerprinting system
for epidemiological investigations of outbreaks of
C. <7(//i'c/7e-associated infection [5,6] we have ob¬
served an apparently infinite number of EDTA
extractable cell-surface protein profiles. Tabaq-
chali and coworkers [7,8] have developed a typing
scheme based on radiolabelling of major cell pro¬
teins and the patterns produced have allowed re¬
cognition of at least 9 types. Immunoblotting
studies with whole cell antiserum showed that the
major radiolabeled proteins were antigenic when
probed with homologous antiserum. They did not
cross-react with heterologous antiserum and might
correspond to major cell surface proteins [8],
However, by both radiolabelling and immunoblot¬
ting there was an indication that all strains could
be divided into many more groups than the two
originally defined by SDS-PAGE of the urea-ex-
tractable regular array proteins [4],
The aim of this study was to investigate the
urea-extractable cell wall-associated proteins by
SDS-PAGE and immunoblotting and relate them
to the fingerprinting/typing schemes.
0378-1097/88/$03.50 © 1988 Federation of European Microbiological Societies
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3. MATERIALS AND METHODS
3.1. Strains and culture conditions
Five strains of C. difficile, which from previous
work were known to produce very different surface
protein fingerprints, were selected for this study:
NCTC 11223, MPRL 604, MPRL 683, MPRL
1123 and MPRL 1128 (MPRL numbers refer to
our departmental culture collection). Organisms
were cultured anaerobically for 17 to 18 h at 37° C
in pre-reduced proteose peptone, yeast extract
medium (PPY) containing 0.04% (w/v) sodium
carbonate and 0.075% cysteine hydrochloride [9],
3.2. Preparation of EDTA extracts
These were prepared from 100 ml of bacterial
culture in PPY medium as described previously
[6],
3.3. Cell wall preparation and urea extraction of
proteins
Cells were cultured in 10 litres of PPY medium,
harvested and washed once (10000 X g, 10 min,
4°C). The wash buffer consisted of 0.05 M
Tris/HCl, 0.025 M MgCl2 and 0.85% NaCl, pH
7.4. All steps were done on ice. Cells were resus-
pended in 40 ml of buffer, DNase and RNase
(Sigma—both proteinase free) were added and the
cells disrupted by French Pressing as previously
described [2]. After centrifugation at 20000 Xg
(30 min, 4 ° C) the resulting pellet was washed four
times in ice-cold distilled water (centrifuging
30 000 X g, 15 min). The pellet was resuspended in
10 ml of distilled water and stored at — 20 °C.
The crude cell wall preparation was purified
and extracted with urea as described in [4], The
cell wall suspension (1 ml) was separated into
pellet and supernate by centrifugation (50 000 X g,
10 min, 4°C) and the pellet resuspended in 1 ml
of 2% (v/v) Triton-XlOO in distilled water. This
was left at room temperature for 30 min. Follow¬
ing two washes in distilled water it was resus¬
pended in 1 ml of 6 M urea and again kept at
room temperature for 30 min. Following sep¬
aration into pellet and supernate (50000 Xg, 10
min, 4°C) the supernate was retained and stored
at -20°C.
3.3. SDS-PAGE and immunoblotting
The buffer system of Laemmli [10] with 10%
slab gels was used. Samples (50 /rl) containing 25
iu,g of protein (determined by the method of Lowry
[11] with bovine serum albumin as standard) were
run in each track. Gels were stained with Coomas-
sie blue. For immunoblotting, extracts were
transferred to nitrocellulose membranes (0.2 /im
pore, Sartorius), probed with both absorbed and
unabsorbed whole cell antiserum raised in rabbits
(see below) and visualised with anti-rabbit HRP
conjugate as previously described [5],
3.4. Preparation and absorption of antisera
Antiserum was raised in rabbits by intravenous
injection of U.V.-killed whole cells, without ad¬
juvant, of the five strains listed above (3.1.) by the
method of Poxton and Byrne [12].
Absorption was as follows: bacteria harvested
from 50 ml of culture were washed twice in phos¬
phate buffered saline (50 mM phosphate buffer,
pH 7.4 containing 0.15 M NaCl). Each antiserum
was absorbed with the four heterologous bacteria
at the same time by mixing the pooled pellets with
1 ml of antiserum. The suspensions were mixed
for 30 min at 37 °C on a blood-cell suspension
mixer. Bacteria were removed by centrifugation at
5 000 X g for 30 min at room temperature. This
absorption procedure was repeated once.
4. RESULTS
From previous epidemiological studies it was
known that the five strains selected each produced
a different profile when whole-cell EDTA extracts
were examined on SDS-PAGE. When the urea
extracts of the walls of these five strains were
examined by SDS-PAGE the patterns produced
were again all different (Fig. 1). All strains pro¬
duced between 1 and 3 major protein bands all
differing from each other in Mr. Several other
bands of weaker intensity were also present in the
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Fig. 1. Coomassie blue stained SDS-PAGE (10% gel) of the
proteins (25 pg) extracted from the cell walls of five strains of
C. difficile with 6 M urea. Track 1, NCTC 11223; track 2,
MPRL 604; track 3, MPRL 683; track 4, MPRL 1123; track 5,
MPRL 1128.
urea extracts. In general the major bands in the
urea extract corresponded to the major bands of
the more complex EDTA extracts (Fig. 2). The
exception being strain NCTC 11223 where only
one of the three major urea extracted bands was a
major component of the EDTA extract.
When the urea extracts were electrophoretically
transferred to nitrocellulose and probed with ho¬
mologous antiserum, the major protein bands were
revealed as the major antigens. However, a band
of Mr 73 kDa which stained only weakly with
Coomassie blue was also revealed as a major
antigen and it was present in all of the strains. On
probing with heterologous antisera the major
urea-extracted proteins were not cross-reactive, but
the apparently common major antigen at 73 kDa
was detected. Also many of the minor antigens
cross-reacted. Examples of the five strains probed
with antisera raised against MPRL 604 and MPRL
1123 are shown in Figs. 3a and 4a respectively.
The reactions between MPRL 1128 antigen and
the MPRL 1123 antiserum was complicated by the
strong cross-reaction of the antigen at 37 kDa
(Fig. 4a, track 5) which was not apparent in the
Coomassie blue stained gel of MPRL 1123 (Fig. 1,
track 4), When the homologous immunoblot is
examined (Fig. 4a, track 4) there is, however, a
corresponding antigen in the MPRL 1123 track.
When homologous serum that had been ab¬
sorbed with the four other heterologous strains
was used (Figs. 3b and 4b), the patterns became
much simpler because of the removal of the
cross-reactions. The major antigens were generally
strain-specific and retained their prominence. The
exception was the common 73 kDa antigen. In
most tracks there was no obvious reduction in its
staining intensity as might have been expected if it
was common. On close examination this band of
approximately 73 kDa varies slightly in MT and in
strain MPRL 683 (track 3 in Figs. 3a and 4a) it is
made up of two closely spaced bands.
5. DISCUSSION
From the work presented here it is apparent
that the major proteins of the surface of C. difficile
are highly variable in their Mr. This disagrees with
the previously published work where it was re¬
ported that only two SDS-PAGE patterns could
be produced by the proteins which are extracted
by urea and are responsible for the regular arrays
found on the surface of C. difficile [4], With the
exception of the series of major antigens of ap¬
proximately 73 kDa, the major proteins extracted
by urea are strain specific antigens. This might
form the basis of the typing scheme developed by
Tabaqchali and coworkers [7] where the patterns
of 35S methionine incorporation reflect the major
cell surface protein patterns. In our own
fingerprinting method [6] we have observed an
apparent infinite number of patterns of surface
proteins by SDS-PAGE. By extending our ex¬
amination of the fingerprinting by immunoblot-
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Fig. 2. Coomassie blue stained SDS-PAGE comparing the urea-extracted cell-wall proteins (left-hand track) with the proteins
extracted by EDTA from whole cells (right-hand track). Lanes 1-5 are as in Fig. 1.
ting we can, with the use of one carefully chosen
antiserum (raised to whole cells of NCTC 11223),
detect differences between strains by observing
the fingerprint which results from detecting the
minor surface antigens. This appears to result in a
simple, possibly unique fingerprint for each strain
of C. difficile.
That the common (73 kDa) antigen was not
removed by absorption might have been for several
reasons: between strains it varies slightly in Mr
Fig. 3. Immunoblots of SDS-PAGE of the five strains of C.
difficile as in Fig. 1 probed with (a) unabsorbed antiserum
raised to MPRL 604 and (b) the antiserum after absorption
with whole cells of the four heterologous strains. The ho¬
mologous reaction is in track 2.
5
Fig. 4. Immunoblots of SDS-PAGE of the five strains of C.
difficile as in Fig. 1 probed with (a) unabsorbed antiserum
raised to MPRL 1123 and (b) the antiserum after absorption
with whole cells of the four heterologous strains. The ho¬
mologous reaction is in track 4.
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but it may have sufficiently different epitopes to
appear distinct, or, perhaps more likely, it is be¬
cause it cannot absorb the antibody because it is
present in such small amounts or it is masked at
the cell surface of the whole bacteria.
From the work of Tabaqchali and coworkers [8]
and of Delmee and coworkers [13] it appears that
only certain of their types of C. difficile are com¬
monly associated with disease, while other types
are more associated with asymptomatic carriage.
If, as appears likely, our cell wall-associated pro¬
tein patterns correlate with the 35 S patterns of
Tabaqchali [7], and if the serotyping system of
Delmee [13] is due to cell-surface protein antigens,
it may be that these proteins represent as yet
undefined virulence factors of the organism.
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Summary. Twenty eight strains of Clostridium difficile, isolated from
an outbreak of antibiotic-associated colitis and diarrhoea in an
orthopaedic ward and from sporadic cases throughout Sweden, were
sent to Edinburgh for immunochemical fingerprinting without informa¬
tion about their origin. EDTA extracts of the organisms were examined
by crossed immunoelectrophoresis (CIE), polyacrylamide gel electro¬
phoresis (PAGE) and electroblot transfer. Two patterns were revealed
by CIE: group A (18 strains) and group B (10 strains). PAGE and
electroblot transfer revealed one major group of 10 strains (group 1), six
small groups of two or three strains and six strains which were unlike any
other strain. The CIE group B and PAGE-electroblot group 1 were
identical. Nine of the 10 strains in this group were from patients in the
outbreak. These findings indicate that a single strain spread in the
orthopaedic ward as a nosocomial infection and that this strain differed
from most other strains investigated. The PAGE-electroblot technique
should, therefore, greatly aid investigations into the epidemiology of C.
difficile infections.
Introduction
Clostridium difficile is now well recognised as the major cause of antibiotic-asso¬
ciated pseudomembranous colitis (Larson et a/., 1978; Bartlett, 1979; Mollby, Nord
and Aronsson, 1980) and appears also to be responsible in part for a spectrum of
related bowel conditions, such as antibiotic-associated diarrhoea, post-operative
diarrhoea, exacerbations of chronic inflammatory bowel disease and sporadic
non-antibiotic-associated diarrhoea (British Medical Journal, 1981; Brettle et al.,
1982). Carriage of C. difficile by healthy adults is extremely uncommon but high
isolation rates of up to 40% have been reported for infants (George, Sutter and
Finegold, 1977).
The epidemiology of C. difficile is still poorly understood. Animal studies (Larson,
Price and Borriello, 1980) and the clustering of cases (Howard, Sullivan and Troster,
Received 17 Nov. 1983; accepted 2 Dec. 1983.
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1980; Greenfield et al., 1981; Rogers et al., 1981) suggest that the organism may be
transmitted from person to person or from the environment (Mulligan et al., 1980;
Kim et al., 1981) rather than being a simple overgrowth of a minor component of the
normal flora in a compromised bowel. Even healthy carriage by infants appears to be
associated with case-clustering (Larson et al., 1982). More thorough investigations
into the modes of transmission of C. difficile have been hampered by the lack of a
reliable typing system for this species. The aim of the present study was to show by the
use of immunochemical fingerprinting that isolates of C. difficile obtained from a
nosocomial outbreak of antibiotic-associated colitis and antibiotic-associated diarr¬
hoea in an orthopaedic ward were identical. These isolates were also different from 15
isolates from other sources. Crossed immunoelectrophoresis, SDS-polyacrylamide
gel electrophoresis and electroblot transfer were used to identify the various strains of
C. difficile.
Materials and Methods
Patients. During a period of 14 days, stool samples from patients on antibiotic therapy in
two different wards were analysed for the presence of C. difficile cytotoxin and organisms. In an
orthopaedic ward at Huddinge Hospital, Stockholm, where there was an outbreak of C.
difficile-associated colitis and diarrhoea during this period, 34 patients (20 females, 14 males;
mean age 74 years) were investigated, and during the same period 29 patients (17 females, 12
males; mean age 59 years) in the Department of Infectious Diseases, Karolinska Institute,
Roslagstulls Hospital, Stockholm, with only sporadic incidents of this disease, were investi¬
gated. Patients were regarded as having antibiotic-associated colitis (AAC) on the basis of
endoscopic examination, or as having antibiotic-associated diarrhoea (AAD) if they had more
than five loose stools daily and endoscopy was negative or, as was the case for the majority of
these cases, if endoscopy was not performed. The antimicrobial agents used in the two wards
were clindamycin, cephalosporins and /Mactamase-stable penicillins, and the patterns of use
were roughly comparable between the wards.
Bacterial isolates. Isolation and identification of C. difficile and testing for toxin production
were done as previously reported (Aronsson, Mollby and Nord, 1981). Fifteen isolates of C.
difficile from 13 patients in the orthopaedic and infectious diseases wards were fingerprinted
immunochemically along with two isolates from another two patients in the orthopaedic ward,
one sampled 4 months before and the other 2 months after the outbreak in the orthopaedic ward.
Another 11 isolates from 10 patients with AAC or AAD in four other hospital wards in Sweden
were also included. All strains were toxigenic and they were stored as cooked-meat-broth
cultures. They were sent to Edinburgh for fingerprinting without information about their
origin.
Environmental sampling. Stool samples from 37 members of the staff at the orthopaedic
ward at Huddinge Hospital were collected and assayed for C. difficile and its toxin. Plastic Rodac
plates (Falcon, Oxnard, CA) were used to culture environmental samples from beds, toilets,
washing rooms, treatment rooms and floors.
Culture oforganisms and antigen preparation. Stationary-phase cooked-meat-broth cultures
(OT ml) were inoculated into 100-ml volumes of PPY medium (Holbrook, Duerdenand Deacon,
1977), which contained sodium carbonate 0 04% w/v and cysteine hydrochloride 0-075% w/v,
and incubated anaerobically with COi 10% for 16 h at 37°C. Spore formation was negligible as
judged by phase-contrast microscopy. Antigens were extracted with EDTA by a method
simplified from that of Poxton and Byrne (1981). Bacteria were harvested by centrifugation
(20 000# for 8 min), washed twice in phosphate-buffered saline (PBS; 50 mm sodium phosphate
buffer, pH 7-4, containing 015 m NaCl). The drained pellet was resuspended in 1 ml of PBS
containing 10 mM EDTA and incubated for 30 min at 45°C. The extracted cells were removed
by centrifugation (20 000 g for 10 min) and the supernatant fluid was used undialysed as antigen.
Protein content of the preparation was measured by the method of Lowry et al. (1951).
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Antiserum preparation. Antisera against u. v.-killed cells of C. difficile NCTC11223 and two
clinical isolates not from the present study were raised in New Zealand White rabbits by the
method of Poxton and Byrne (1981).
Crossed Immunoelectrophoresis. This was performed by the procedure of Weeke (1973) as
described by Poxton and Byrne (1981). EDTA antigens were prepared in duplicate from all the
strains. Protein concentrations in the preparations were c. 1-3 mg/ml.
SDS-polyacrylamide gel electrophoresis (SDS-PAGE). The buffer system of Laemmli
(1970) was used with 10% slab gels and the method was that of Poxton and Brown (1979). A
20-track gel was used to run two sets of nine EDTA antigens at the same time. One set was
stained with Coomassie Blue and the other was used for transfer to a nitrocellulose membrane.
Electroblot transfer. The method of Towbin, Staehelin and Gordon (1979) was followed.
Briefly, the EDTA extract that had been separated on SDS-PAGE was transferred to
nitrocellulose membrane (Transblot ™ Transfer Medium, BioRad) in a Tris, glycine, methanol
buffer, pH 8-3 (Towbin et al., 1979) at 12 V and 40 mA for 18 h. The antigens were probed with
the antiserum raised against C. difficile NCTC11223 by the Immun-blot™ immunoassay
(BioRad): after washing for 10 mm in Tris-buffered saline (TBS; 20 mM Tris, 500 mM NaCl,pH
7-5), the unbound sites on the membrane were blocked by treatment with gelatin 3% in TBS for
45 min. The membrane was transferred to the C. difficile antiserum diluted 1 in 200 in gelatin 1%
in TBS and incubated at room temperature for 3 h. After two 10-min washes in Tween 20
0 025% in TBS, the membrane was placed into goat anti-rabbit IgG-horseradish peroxidase
conjugate (BioRad) diluted 1 in 3000 in gelatin 1% in TBS and incubated at room temperature
for 1 h. After two more washes as above, the membrane was placed into HRP colour
development solution (BioRad) which contains 4-chloro-l-naphthol. The colour developed
between 5 and 15 min. Several changes of distilled water were used to stop the reaction. All of
the above steps were performed with gentle agitation.
Results
In the infectious diseases ward with only sporadic cases of AAC or AAD, no
patient on antibiotic treatment developed serious diarrhoea during the time of
investigation, and only two of 29 patients were found to be colonised. In the
orthopaedic ward, six (four females, two males; mean age 75 years) out of 34 patients
developed serious colitis that needed vancomycin therapy. Another seven patients
(five females, two males; mean age 72 years) colonised with C. difficile showed no or
minor intestinal symptoms (table I). In total, 15 strains from these two wards were
submitted for immunochemical fingerprinting without information about their
origins.
Initially, a sample of each antigen was run in CIE against three different
antisera—one raised against the reference strain C. difficile NCTC11223, the others
Table I
Acquisition of C. difficile by patients on antibiotic therapy in two different wards
Number of patients (%)
Number who developed who were colonised
Ward of patients colitis but asymptomatic
Orthopaedic ward 34 6 (18) 7 (20)
with C. difficile
outbreak
Infectious diseases 29 0 (0) 2 (7)
ward with sporadic
cases
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Table II
Groups of C. difficile identified by CIE and SDS-PAGE-electroblot analysis
SDS-PAGE-electroblot Number
CIE group group of strains Source
B 1 9* O.W.
B 1 1 S
A 2 3(2)t S
A 3 2 S
A 4 3 S
A 5 2(1)+ O.W.
A 6 2 s
A - 2(1)+ O.W.
A - 2 I.D.
A - 2 s
O.W. = orthopaedic ward; I.D. = infectious disease ward; S = from hospital wards throughout
Sweden.
* Four patients with AAC and five carriers,
t Two strains were isolated from the same patient.
Fig. 1.—Examples of CIE patterns ofEDTA extracts of C. difficile run against antiserum to whole cells of C.
difficileiACXCX 1223. Approximately 15 pg of protein in 10 p\ in the first dimension was run into 250 pi
of antiserum in the second dimension; (a) and (b) are examples of group-B patterns and (c) and (d) are
examples of group-A patterns.
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against two clinical isolates. Only the patterns of precipitin lines produced by the
NCTC11223 antiserum were considered suitable for further investigation. The
patterns produced by the antisera to the clinical isolates were ill-defined. Only line 4
(see below) was at all clear; they were difficult to compare and were not used further.
After all the antigens had been tested with the reference antiserum, it was seen that
the duplicate antigen preparations gave identical patterns, but that two distinct
12345678 12345678
Fig. 2.—SDS-PAGE of EDTA extracts of 15 strains of C. difficile on 10% gels, and their corresponding
electroblot transfers probed with NCTC11223 antiserum. Approximately 45 /ig of protein in 50 /tl of
sample buffer was run on each track, (a) Coomassie Blue-stained SDS-polyacrylamide gel: track 1,
group-3 pattern; track 2, group-5 pattern; tracks 3-6, group-1 patterns; tracks 7 and 8, group-2 patterns,
(b) Electroblot transfer of fig. 2a. (c) Coomassie Blue-stained polyacrylamide gel: tracks 1 and 2,
group-2 patterns; tracks 3-7, ungroupable patterns, (d) Electroblot transfers of fig. 2c.
322 I. R. POXTON ET AL.
patterns had been produced overall. One pattern was produced by 18 strains (group
A). The rest of the strains (group B) gave a different pattern (table II). Examples of
the two patterns are shown in fig. 1. Several of the precipitin lines were shared by both
groups, but the group-B pattern had a characteristic, strongly staining, slow-moving
line (no. 1). The precipitin lines are numbered as in our previous publications (Poxton
and Byrne, 1981; Poxton, 1982). It should be noted, however, that in this study some
extra, weakly staining lines have been seen for the first time. This is a consequence of
using undialysed EDTA antigens. Extensive freezing and thawing also resulted in the
destruction of these antigens. The best results were obtained when antigens were used
immediately after preparation, without freezing and thawing.
In the Coomassie Blue-stained polyacrylamide gels, many common bands were
present, with identical patterns in some tracks. Duplicate antigen preparations gave
identical patterns. Groups of similar patterns could be assembled with some
difficulty, but the electroblot transfers immediately revealed groups of similar patterns.
Fig. 2 shows two sets of SDS-PAGE patterns and their corresponding electroblots.
When analysed in detail, the groups obtained with both techniques were identical
(table II). Although some of the patterns produced by other strains were similar to
those in groups 1-5, none were identical (group A6, table II). Others were
considerably different and unlike any other (group A — , table II).
Comparison of the groups identified by CIE with those based on SDS-PAGE or
electroblot analysis shows that group B and group 1 are identical. The isolates
belonging to this group were, with one exception, obtained from the orthopaedic ward
at Huddinge Hospital during the time of the outbreak of colitis and diarrhoea. Isolates
obtained from other sources in Sweden were different from the isolates in the B1 group
(table II). These data justify the assumption that the B1 isolates belonged to the same
strain of C. difficile which spread within this ward, colonising five patients and causing
severe colitis in another four patients. However, isolates from two patients with
diarrhoea in the ward during the 14-day period did not belong to the B1 group. Thus,
more than one strain of C. difficile was present in the ward during the period. Isolates
sampled after and before the outbreak in this ward were found to be different from the
B1-group strain of C. difficile.
None of the stool samples obtained from staff members or from the environment in
the orthopaedic ward yielded C. difficile or its toxin.
Discussion
Studies with a selective medium have shown that there is a very low carrier rate for
C. difficile in a healthy adult population (Aronsson et al., unpublished observations). It
has been suggested that such carriage is transient (Larson et al., 1978). However, the
immediate environment of infected patients has been found to be contaminated
(Mulligan et al., 1980; Fekety et al., 1981), and spread of the organism from the
environment and from person to person has been suggested (Kim et al., 1981; Kim,
Dupont and Pickering, 1983). Isolation of C. difficile has also been reported from
household pets (Borriello et al., 1983), seals, donkeys, camels, sewage, mud and sand
(Hafiz and Oakley, 1976) and recently from a Kodiak bear with pseudomembranous
colitis (Orchard, Fekety and Smith, 1983). Thus, exogenous sources of C. difficile are
being increasingly recognised.
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Our investigation is the first time that strains of C. difficile isolated from an
outbreak of C. difficile colitis have been fingerprinted immunochemically and shown to
be identical, and also different from other isolates in a control group (Wust et al., 1982).
With only one exception, the strains isolated from this 14-day outbreak were identical
with each other and different from other strains, as determined by CIE or
SDS-PAGE-electroblot methods. Strains isolated before and after the outbreak from
the same ward were also different.
In our experience, strains from diverse sources can have similar CIE profiles and it
is only when striking differences occur, as in this study, that this method proves useful
for typing. SDS-PAGE can be used alone; the patterns produced, however, are
complex and are difficult to analyse without the use of specialised equipment,
especially if tracks from different gels have to be compared. Electroblot transfer
immunoblotting has proved extremely satisfactory. The technique is simple to
perform in apparatus that can be made easily in the laboratory. The simplicity of the
patterns allows straightforward visual analysis, and we conclude that investigations
into the epidemiology of C. difficile should be considerably aided by this technique.
Our data strongly suggest that the same strain of C. difficile spread within a hospital
ward, infecting 38% of the patients and causing disease in susceptible patients. It is not
likely that this finding represents an overgrowth of endogenous C. difficile in these
patients, but we have not been able to determine the means of transmission in this
outbreak.
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The use of sodium dodecyl sulphate-polyacrylamide gel electrophoresis in association with electro-
phoretic transfer of proteins to nitrocellulose and subsequent probing with antisera appears useful as a
method for fingerprinting Clostridium difficile. Thorough testing of the stability of the antigenic nature of
isolates of the organism during subculture and antigen preparation has shown it to be remarkably stable
both in vitro and in vivo. Minor differences in the method of antigen extraction do not markedly alter the
immunoblot patterns produced. It has also been demonstrated that an individual may harbour more than
one strain of the organism at any one time. Results show the possible usefulness of this technique in
studying the epidemiology of diarrhoeal disease known to be associated with C. difficile. It is suggested
that for any serious study several colonies should be subcultured from the primary isolation plate.
Key words: Clostridium difficile - immunoblotting - fingerprinting
Introduction
Clostridium difficile is known to be associated with nearly all cases of antibiotic-
associated pseudomembranous colitis. The organism also appears to be involved to
some extent in a broad spectrum of other bowel conditions such as antibiotic-associ¬
ated diarrhoea, post-operative diarrhoea and chronic inflammatory bowel disease. It
has also been isolated from cases of sporadic non-antibiotic-associated diarrhoea
(British Medical Journal, 1981; Brettle et al„ 1982). Isolation of C. difficile from
healthy adults is uncommon although the organism can be cultured from a high
percentage of normal infants (George et al., 1977; Stark et ah, 1982). The epidemiol¬
ogy of C. difficile-associated disease is poorly understood at present (Mulligan,
1984). There have been several reports indicating possible cross-infection between
patients from whom the organism has subsequently been isolated. However lack of a
reliable typing technique has hindered more detailed studies of these outbreaks. Sell
et al. (1983) suggested that the use of bacteriophage could prove useful in typing of
C. difficile while Tabaqchali et al. (1984) have used radiolabelling of growing cells as
a possible means of studying the epidemiology of the organism. Since then Delmee
0022-1759/85/503.30 © 1985 Elsevier Science Publishers B.V. (Biomedical Division)
242
et al. (1985) have shown that strains of the organism can be serogrouped into 6
different groups using a variety of antisera. Recently, in this laboratory the use of
sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) in associ¬
ation with electrophoretic transfer of proteins to nitrocellulose and subsequent
probing with antisera has provided a useful method for fingerprinting the organism
(Poxton et al., 1984). Further studies have subsequently been performed to test the
reproducibility of results obtained with this technique. This paper provides a review
of the experimental work carried out and offers guidelines for the successful
application of the technique in the clinical situation.
Materials and Methods
Bacterial isolates
Isolation and identification of C. difficile was done as previously described
(Brettle et al., 1982). Four strains of the organism, MPRL 558, 559, 589 and 720,
which had been isolated from patients attending the Renal Unit in the Royal
Infirmary of Edinburgh (RIE) during 1983 were used in this study. They were picked
from the primary isolation plates as single colonies, cultured overnight in cooked
meat broth (CMB) and lyophilised. MPRL 558 came from a severely ill patient;
MPRL 559 from a patient with no diarrhoea while MPRL 589 and MPRL 720 came
from 2 different patients with moderate diarrhoea.
Standard technique for culture and isolation of surface protein antigens
Lyophilised organisms were cultured in CMB for 17 h and 0.1 ml of this was
inoculated into 100 ml proteose peptone yeast extract broth (PPY) supplemented
with 0.04% (w/v) sodium carbonate and 0.075% (w/v) cysteine hydrochloride as
described by Poxton et al. (1984). After 17 h incubation anaerobically at 37°C the
cells were harvested (20,000 X g for 5 min at 4°C) and the washed pellet was
resuspended in phosphate-buffered saline, pH 7.4, containing 10 mM EDTA and
incubated at 45°C for 30 min. The supernatant, containing the antigens, was
collected after 2 cycles of centrifugation at 10,000 X g for 2.5 min and used
undialysed as antigen. The protein content of the preparation was measured by the
method of Lowry et al. (1951) using bovine serum albumin as standard.
Enrichment broth and selective agar
C. difficile was isolated from mouse faecal specimens using cycloserine-cefoxitin
egg yolk agar (CCFA) (George et al., 1979). Enrichment was achieved using CCF
broth which was CCFA without the egg yolk and agar.
SDS-PAGE
The buffer system of Laemmli (1970) with 10% slab gels as described by Poxton
and Brown (1979) was used. EDTA extracts containing 25 jug of protein in 50 p\ of
sample buffer were run on gels in duplicate. One set of the separated proteins was




The method of Towbin et al. (1979) as described by Poxton et al. (1984) was
followed. This involved transfer of the SDS-PAGE-separated EDTA extracts to
nitrocellulose membrane in a Tris, glycine, methanol buffer pH 8.3 at 12 V and 40
mA for 18 h. After this the membrane was washed and probed with a rabbit
antiserum raised against UV-killed cells of C. difficile NCTC 11223. The method of
raising the antiserum was as described by Poxton and Byrne (1981).
Results
Work carried out with the standard technique for fingerprinting of C. difficile
isolates which was described earlier (Poxton et al., 1984) has raised questions as to
the reproducibility of the immunoblot patterns produced from one study to the next.
Minor variations occurred between blotting patterns produced from different clini¬
cal isolates. It was important to find out whether these differences were due to real
variations between strains or whether they arose simply because of differences in
growth conditions of particular strains or variation in antigen extraction. These
studies were therefore done to investigate the antigenic stability of isolates, both
during culture of the organism and subsequent antigen extraction.
Effect of variation in phase of growth at harvesting
In the standard technique the organisms were cultured for 16-17 h before
harvesting and antigen extraction. In order to find if culturing of the isolates for
differing periods would produce differences in the resulting immunoblot patterns
obtained, the following experiment was done. A 5% inoculum of MPRL 558 put into
PPY medium was incubated anaerobically at 37°C and 100 ml amounts were
harvested after 2, 4 and 8 h. Similarly a \% inoculum was harvested after 16, 18, 20,
24 and 40 h. All other conditions remained the same throughout. It can be seen from
the resulting immunoblot patterns produced (Fig. la) that there was a great degree
of similarity in the banding patterns. There were minor variations, especially in the
higher molecular weight polypeptides, but these may in part be due to slight
variations in the amount of protein actually loaded onto the gel as seen in the
corresponding Coomassie blue stain (Fig. lb).
Variations in antigen extraction
Another likely source of variation between isolates could be differences in the
actual method of antigen preparation. To investigate this 3 of the renal isolates were
grown up in PPY for 17 h, harvested, washed and resuspended in EDTA buffer as
described previously. The EDTA suspensions were then divided into 4 equal aliquots
and each was subjected to one of the following treatments, (a) 'normal' antigen
extraction at 45°C for 30 min, (b) extraction at 50°C for 30 min, (c) extraction at
45°C for 2.5 h, (d) freeze-thawing (— 20°C to 37°C) 3 times over a period of 3 h and
then 45°C for 30 min. These 4 EDTA suspensions were then centrifuged as
described in Materials and Methods.
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Fig. 1. (a) Immunoblot patterns produced by EDTA extracts of C. difficile MPRL 558 obtained 2-40 h
after inoculation of PPY medium. Tracks 1-8 contained extracts obtained after 2, 4. 8, 16. 18. 20. 24 and
40 h respectively. Extracts were probed using antiserum raised to NCTC 11223. (b) Corresponding
SDS-PAGE profile stained with Coomassie blue.
When these various extracts were run on gels it was found that MPRL 558 and
559 produced very similar banding patterns by Coomassie blue staining but there
were consistent differences between the isolates in the patterns produced on im-
munoblotting (Fig. 2a and 2b). There was a much stronger reaction involving the
high molecular weight proteins in MPRL 559 than occurred with MPRL 558 and
this remained consistent despite the differing treatments of the extracts during
extraction. However, MPRL 589 behaved differently. It was found that the extracts
which had been heated for 2.5 h produced a blot pattern which was different from
the others in the mid-region of the track (Fig. 2c). Why this occurred is not clear.
With all 3 isolates the EDTA/freeze-thawed extracts had more protein bands
apparent on theiCoomassie stained gel. However, the immunoblot patterns obtained
did not show up these additional bands indicating that they were probably intracell¬
ular proteins with which the antisera raised against whole UV-killed bacteria would
not react.
Variations on subculture of the organisms
Having found that no major variations in immunoblot patterns could be accounted
for by differences in culture or antigen preparation, further work was done to
investigate the stability of an individual isolate both in vitro and in vivo. MPRL 558
was used for both these areas of investigation. A CMB culture of the isolate was
passaged weekly into fresh pre-steamed CMB over the course of 7 weeks. An EDTA
extract of each of these broths was prepared in the standard way after each had been
incubated anaerobically at 37°C for 24 h. When these extracts were analysed by
SDS-PAGE and immunoblotting the patterns produced were identical.
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Fig. 2. SDS-PAGE and immunoblot patterns produced by (a) MPRL 558, (b) MPRL 559 and (c) MPRL
589 after various treatments during EDTA extraction. Track 1: extraction at 45°C for 30 min, track
2:50°C for 2.5 h, track 3:45°C for 2.5 h, track 4: freeze-thawed extract.
To study antigenic variation of the organism in vivo a spore suspension of MPRL
558 (100 /x 1 saline inoculated with 10 C. difficile colonies from a 72 h blood agar
plate) was given orally to a female BALB/c mouse which was known to be C.
difficile-negative. Faecal samples were collected weekly from the animal over a
period of 7 weeks. Each sample was inoculated into enrichment broth and the
organisms were recovered by plating of these broths onto CCFA. The isolates were
stored as CMB cultures and an EDTA extract of each isolate was prepared by the
standard method. Again it was found that there were only minor variations between
each of the isolates.
Another study was done with 3 strains where one colony from a CCFA plate was
streaked onto blood agar. Eight colonies were subsequently picked from this into
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Fig. 3. Analysis of EDTA extracts prepared from 8 different colonies picked from a CCFA primary
isolation plate, (a) SDS-PAGE, (b) immunoblot.
CMB and EDTA extracts prepared of each colony. When these extracts were
analysed it was found that the patterns produced were identical.
The only other possible source of variation during this work was in the composi¬
tion of the PPY medium used to culture the organisms. However, these studies were
done over a period of 4 months during which several different batches of media were
used and no variation in antigenic patterns was observed.
Different strains within one patient
It was now apparent that any one strain of C. difficile would remain antigenically
the same throughout any study. Further work was consequently done to see whether
an individual patient could harbour more than one strain of the organism at one
time. The original faecal sample from which MPRL 720 had been isolated was
spread onto CCFA. After incubation 8 different colonies were subcultured from this
plate. EDTA extracts were prepared from all of these isolates which were subse¬
quently analysed. It was found that from this primary isolation plate 2 different
banding patterns were produced by the isolates (Fig. 3). The pattern produced in
tracks 1, 2, 3, 6 and 7 was as expected for MPRL 720 (as indicated by other studies);
the pattern in the other tracks corresponding to that of another isolate cultured from
this patient 6 months previously. When this experiment was repeated with another 2
faecal samples one of these was also found to contain 2 different strains of C.
difficile.
Discussion
The immunochemical fingerprinting of C. difficile strains described here has been
used in this laboratory over the past 2 years to study various outbreaks of diarrhoea
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with which the organism was found to be associated. The first investigation involved
studying 28 strains of C. difficile sent from an outbreak in Sweden (Poxton et al.,
1984). With this technique it was possible to show the existence of a common strain
within one area of a hospital. The results of this study showed that this technique
could prove useful in tracing the epidemiology of C. difficile. Since then a further
study has been done involving renal patients attending the RIE who had differing
degrees of diarrhoea. In this particular group of 18 patients 13 different strains of
the organism appeared to be associated with their symptoms over a 9-month period
(Cumming et al., unpublished results). It was found however that in one or two
instances it was difficult to be absolutely certain whether or not 2 strains were the
same or different. For this reason it was felt necessary to investigate the stability of
the antigens that were being isolated and studied with this technique.
As we know from our previous studies, the Coomassie blue and immunoblot
patterns vary considerably from strain to strain although one or two major bands
and several minor bands are common to all strains. Some of the major bands in
Coomassie blue gels are antigenic while others are not, and this is also true for the
minor bands. In this study the variation in antigenicity of the bands can be seen by
comparing the patterns produced in Fig. 1 and 3. In Fig. 1 most of the major
Coomassie blue bands are also stained strongly in the immunoblot, while in Fig. 3
only one of the major Coomassie blue bands in tracks 1, 2, 3, 6 and 7 is strongly
immunogenic and most of the staining of the immunoblot is due to minor bands.
It is apparent from the studies done here that the antigenic nature of any
particular isolate of C. difficile will remain constant when analysed by this im-
munoblotting technique. The only major difference observed in an isolate was with
MPRF 589 when it was left to incubate for an extended period of time during
EDTA extraction of the antigens. It has been noticed that variations in the intensity
of banding seen on the Coomassie stain can lead to difficulty in interpreting the
immunoblotting patterns. Protein bands that are faint often do not show up on the
immunoblot. However, these minor problems do not detract from the usefulness of
this technique in the epidemiology of any outbreaks of diarrhoeal disease known to
be associated with C. difficile.
Recommendations for successful use of immunoblotting
(1) Pick several colonies (at least 10) from the primary isolation plate in case there
is more than one strain of C. difficile present in the patient.
(2) A standardised technique should be used for the culture and preparation of
the EDTA antigen extracts. Cells should be incubated for 30 min and at a
temperature of 45°C although minor variations in this do not appear to matter.
Since different strains may vary in their sensitivity to changes during antigen
extraction it is best to keep to a well-defined regimen. Freezing and thawing during
the EDTA extraction procedure releases more protein: this complicates the Coomas¬
sie blue pattern, adds nothing to the immunoblot and should be avoided.
(3) Only compare EDTA antigens run on the same gel. It is difficult to compare
one gel with another as it is impossible to reproduce running conditions accurately.
(4) When analysing the SDS-PAGE and immunoblot patterns produced by this
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technique minor variations should be overlooked if the general picture arising is of
similarity between the strains.
(5) Conclusions should be drawn using the information provided by both the gel
and the immunoblot since some patterns that appear similar on the blot can appear
quite different on the gel and vice versa. The advantage of doing an immunoblot as
well as a Coomassie blue-stained gel is that the blot is simpler and easier to read.
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Diarrhoea due to Clostridium difficile
associated with antibiotic treatment
in patients receiving dialysis: the role of
cross infection
Diarrhoea due to Clostridium difficile associated with treatment with
antibiotics has been described among patients receiving peritoneal dialysis,1
and cross infection is thought to be important.2 We describe an outbreak of
diarrhoea associated with C difficile in patients undergoing haemodialysis
and continuous ambulatory peritoneal dialysis in which a "fingerprinting"
technique of typing strains was used to investigate the possibility ofperson to
person spread.
the major mechanisms by which organisms were acquired during this
outbreak. Among patients undergoing dialysis who have uraemia the
frequent use of broad spectrum antibiotics, defective immunity, abnormal
nutrition, and perhaps other changes in gut flora or mucosal defence
mechanisms might combine to permit acquisition of C difficile or to promote
its selective growth.5 After this outbreak we tried to give as narrow a range of
antibiotic treatment as possible and avoided oral antibiotics, particularly oral
cephalosporins; the incidence of isolation of C difficile and related clinical
disease returned to a low level.
We recommend early selective faecal culture for C difficile in any patients
undergoing dialysis who have diarrhoea. Our findings suggest that cross
infection with C difficile may occur in patients receiving dialysis, although it
is not always the major mechanism of acquisition of this organism. It would
be unwise to abandon standard measures against cross contamination, and it
should be appreciated that patients undergoing dialysis may be particularly
prone to infection with C difficile.
Patients, methods, and results
The table gives details of 18 patients from whom C difficile was isolated on stool
culture. All developed diarrhoea while inpatients in the medical renal unit, Royal
Infirmary, Edinburgh, between July 1983 and April 1984. C difficile had been
isolated from only one patient with renal disease in the previous six months.
C difficile was cultured and identified as previously described'; strains
were identified by the fingerprinting method of Poxton et al, using SDS-
polyacrylamide gel electrophoresis of surface proteins extracted with edetic acid
followed by Coomassie blue staining and an immunoblot probe using rabbit
antiserum to cells of C difficile NCTC 11223 killed with ultraviolet light.4 When C
difficile was isolated patients were given oral vancomycin (500 mg every six
hours) and other antibiotics were withdrawn if possible. Diarrhoea resolved in 12
patients. Four patients died during or shortly after treatment; all were severely
debilitated by pre-existing medical conditions. The fingerprinting technique
identified 13 different strains of C difficile. One strain occurred in five subjects
(cases 12, 13, 14, 15, and 18) and one strain in two (cases 7 and 11); the 11 other
strains occurred in only one patient each.
We thank the Scottish Home and Health Department and Upjohn Co for
financial support; R Brown, A B Harris, and G Fleming for technical help;
Professor J G Collee for advice and support; and Professor J S Robson, Dr Anne T
Lambie, and Dr R J Winney for advice and permission to report on patients
under their care.
1 Gokal R, Ramos JM, Francis DMA, el al. Peritonitis in continuous ambulatory peritoneal dialysis.
Laboratory and clinical studies. Lancet 1982;ii: 1388-91.
2 Ritchie DBC, Jennings LC, Lynn KL, Bailey RR, Cook HB. Clostridium difficile-associated
colitis: cross-infection in predisposed patients with renal failure. NZ MedJ 1982;95:265-7.
3 Poxton IR. Detection and isolation of Clostridium difficile. European Journal ofChemotherapy and
Antibiotics 1982;2:123-8.
4 Poxton IR, Aronsson B, Mollby R, Nord CE, Collee JG. Immunochemical fingerprinting of
Clostridium difficile strains isolated from an outbreak of antibiotic-associated colitis and
diarrhoea. J Med Microbiol 1984;17:317-24.
5 Larson HE, Price AB, Honour P, Borriello SP. Clostridium difficile and the aetiology of
pseudomembranous colitis. Lancet 1978;i: 1063-6.
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Comment
Cross infection with C difficile in hospitals has been clearly shown
previously,4 and seemed likely in this series of cases among our patients
receiving dialysis; all had been inpatients in the medical renal unit, with
considerable overlap in their periods of stay in hospital, and the rate of
isolation ofC difficile increased abruptly over 10 months. Standard measures
to prevent spread of the organism were taken—namely, isolation when
feasible, use of gown and gloves when working with patient3, and careful
attention to personal hygiene.
Isolation of patients was limited by lack of space and the specialised
nursing that dialysis requires. The five patients from whom the same strain
was isolated were probably cross infected; all were nursed in one of two
adjacent cubicles, the first four within one month. The isolation of 13
different strains of C difficile appears, however, to exclude cross infection as
University Department of Medicine and Medical Renal Unit, Royal
Infirmary, Edinburgh EH3 9YW
ALLAN D CUMMING, MB, MRCP, lecturer
BRIAN J THOMSON, MB, MRCP, registrar
Departmont of Bacteriology, University of Edinburgh Medical School,
Edinburgh EH8 9AG
JACQUELINE SHARP, BSC, research student
IAN R POXTON, Bsc, phd, lecturer
ANDREW G FRASER, BSC, md, senior lecturer
Correspondence to: Dr Fraser.
Details ofpatients from whom C difficile was isolated
Case No
Age
(years) Sex Type of dialysis Type of infection Antimicrobials given
Month when
strain isolated Outcome
1 61 F CAPD Peritonitis None July 1983 Resolved
2 60 F CAPD Peritonitis Cephradine, flucloxacillin, tobramycin July 1983 Died
3 48 F Haemodialysis None None July 1983 Remained well
4 15 F CAPD Peritonitis Cephradine, tobramycin August 1983 Died
5 56 F Haemodialysis Wound Cefuroxime, metronidazole August 1983 Diarrhoea continued
6 59 F Haemodialysis Arteriovenous fistula Flucloxacillin, benzylpenicillin August 1983 Resolved
7 61 M CAPD Peritonitis Flucloxacillin, metronidazole, ticarcillin August 1983 Resolved
8 69 F CAPD Peritonitis Cephradine September 1983 Resolved
9 59 M Haemodialysis Mastoid Flucloxacillin, benzylpenicillin October 1983 Resolved
10 50 M Haemodialysis Pericolic abscess Cephradine, cefuroxime, metronidazole October 1983 Resolved
11 68 F CAPD Peritonitis Tobramycin November 1983 Resolved
12 71 F CRF None None January 1984 Resolved
13 73 M Haemodialysis (acute) Pneumonia Ampicillin, cefuroxime, erythromycin, metronidazole, January 1984 Resolved
gentamicin, benzylpenicillin
Resolved14 33 F Haemodialysis Urinary tract Co-trimoxazole February 1984
15 63 F Haemodialysis (acute) Ischaemic bowel Cefuroxime, metronidazole, tobramycin February 1984 Died
16 64 F CAPD Peritonitis Flucloxacillin February 1984 Resolved
17 60 M CAPD Peritonitis Flucloxacillin March 1984 Resolved
18 66 F Haemodialysis Arteriovenous fistula Cephradine, cefuroxime, tobramycin March 1984 Died
CAPD=Continuous ambulatory peritoneal dialysis. CRF- End stage chronic renal failure.
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Typing of Clostridium difficile causing diarrhoea in an
orthopaedic ward
IAN McKAY," JECOIA." I R POXTONt
From the * University Department of Bacteriology. Royal Infirmary. Glasgow, and the + Department of
Bacteriology. University Medical School. Edinburgh
summary In an outbreak of diarrhoeal disease in an orthopaedic ward Clostridium difficile was
isolated from all six patients with diarrhoea. Attempts were made to type these isolates by means of
anttbiogram. detection of pre-formed enzymes, analysis of surface proteins by sodium dodecvl
sulphate- polvacrylamide gel electrophoresis (SDS-PAGE) and immunoblotting, and plasmid profile
analysis. This showed that a single strain (type E) indistinguishable by the four distinct methods of
typing, was isolated from all six patients at some time during their episodes of diarrhoea. Relapse was
caused by the acquisition of a new strain in two patients, and by re-emergence or reacquisition of the
original strain in two patients. The immunochemical method was the most sensitive and
discriminatory of the typing strategies adopted.
Clostridium difficile was first implicated as the cause of
pseudomembranous colitis in 1978.'"' Since then,
numerous reports have documented that the organism
can cause a broad spectrum of bowel disorders which
include antibiotic-associated diarrhoea, chronic
inflammatory bowel disease, and non-antibiotic
associated diarrhoea.4"*
The role of C difficile in the pathogenesis of these
conditions is still the subject ofcontroversy. It has also
been difficult to define the epidemiology because of the
lack of reliable and readily available typing methods.
Several methods have been described. These include
antibiograms, analysis of surface proteins by
sodium dodecyl sulphate-polvacrylamide gel electro¬
phoresis (SDS-PAGE) and immunoblotting, plasmid
profiles, bacteriocin and bacteriophage typing,
autoradiograms of "S methionine labelled proteins
extracted from growing cells, and serogrouping by
agglutination.48"" In this study we used a combination
Accepted for publication 12 December 1988
Table 1 Summary ofclinical details
Previous
use of
Case No Sex Age Reason for admission antibiotics Outcome
I F 88 Fractured neck of femur Yes Infectious diseases unit
2 F 79 Dislocated Thomson's prosthesis Yes Died
3 F 79 Dislocated Thomson's prosthesis Yes Infectious diseases unit
4 F 82 Bone graft, right femur Yes Infectious diseases unit
5 F 75 Fractured neck of femur No Convalesced
6 F 72 Fractured neck of femur Yes Infectious diseases unit
of antibiograms. analysis of pre-formed enzymes.i;
SDS-PAGE/immunoblotting and plasmid profiles to
investigate an outbreak of diarrhoeal disease due to C
difficile in an orthopaedic ward in Glasgow Royal
Infirmary.
Patients and methods
The six patients (mean age 79 years; range 72-88) were
elderly women who had been admitted to an ortho¬
paedic ward of Glasgow Royal Infirmary. Due to their
underlying conditions the patients were all bedbound.
Individual details are given in table 1.
Faecal samples were taken from those patients who
developed diarrhoea. When the possibility of an
outbreak was suspected faecal samples from all the
patients in the ward, together with environmental
samples from the ward floor, bedpan wagon, "clini-
matic", toilets and from ward furniture, were cultured.
In addition to the isolates from the "outbreak", five
other strains of C difficile from sporadic cases of
Convalesced—patient transferred to another orthopaedic ward.
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diarrhoea in the hospital isolated during the previous
six months were kept to be used as controls for surface
protein analysis.
All samples were inoculated on to cycloserine
cefoxitin agar (CCFA)'3 and incubated anaerobically
at 37°C for 48 hours. Isolates were identified as C
difficile by colonial morphology, characteristic smell.
Gram stain, toxin production, biochemical reactions
and by gas-liquid chromatography.14 Faecal samples
were also cultured on MacConkey agar, deoxycholate
citrate agar (DCA), Campylobacter agar and in
selenite F broth for the presence of other enteric
pathogens.
TEST FOR TOXIN PRODUCTION
Faecal samples were centrifuged directly at 2000 x g
for 20 minutes or, if solid, first suspended in an equal
volume of saline before centrifugation. The super¬
natant was filtered through a 0-45 qm membrane filter
and then diluted 1 in 50 and 1 in 500 in tissue culture
growth medium before inoculation on to Vero cell
monolayers: the cells were then incubated for 18 hours
at 37CC. The presence of toxin was indicated by the
characteristic cytopathic effect. If a sample was found
to be positive at the screening dilutions, the concentra¬
tion of toxin present was established by testing serial
doubling dilutions from 1 in 50 to 1 in 6400. The
specificity of the toxin was confirmed by neutralisation
with Clostridium sordellii antitoxin.14
ISOLATION OF SURFACE PROTEIN ANTIGENS
Organisms were cultured in cooked meat broth (CMB)
overnight and 0-1 ml inoculated into 100 ml of
protease peptone yeast extract broth (PPY).
supplemented with 0-04% (w/v) sodium carbonate
and 0-075% (w/v) cysteine hydrochloride as described
by Poxton et aid After overnight incubation
anaerobically at 37°C the cells were harvested by
centrifugation at 20 000 x g for five minutes at 4°C
and the pellet resuspended in phosphate buffered
saline. pH 7-4. with 10 mM ethylene diamine tetra-
acetic acid (EDTA): the suspension was then
incubated at 45"C for 30 minutes. The supernatant,
which contained the concentrated antigens, was
collected after two cycles of centrifugation at
10 000 x g for 2-5 minutes and used without dialysis
as the antigen preparation. The protein content was
measured by the method of Lowry et al.'5 using bovine
serum albumin as standard.
ANALYSIS OF PROTEINS IN SDS-PAGE
The buffer system of Laemmli16 with 10% slab gels was
used as previously described by Poxton and Brown17.
Extracts in EDTA which contained 25 qg of protein in
50 ill of sample buffer were run in duplicate on gels.
One set of the separated proteins was stained with
McKay, Coia, Poxton
Coomassie blue and the other was used for transfer to
nitrocellulose membrane.
IMMUNOBLOT TRANSFER
The method of Towbin et al18 was used. SDS-PAGE
separated EDTA extracts were transferred to
nitrocellulose membrane in a Tris, glycine, methanol
buffer, pH 8-3, at 12 V and 40 mA for 18 hours. The
membrane was then washed and probed with a rabbit
antiserum raised against cells of C difficile (NCTC
11223) killed by ultraviolet light followed by applica¬
tion of an antirabbit IgG-horseradish peroxidase
(HRP) conjugate and appropriate colour reaeent
(BioRad).19
DETERMINATION OF PLASMID PROFILES
Overnight anaerobic cultures (18 hours) in pre-
reduced brain heart infusion broth at 37;C were
prepared. The cells were harvested by centrifugation at
2000 x g for five minutes, and the pellets resuspended
in 200 ql of Tris, EDTA, sodium chloride (TES)
dissolved in 50 mM sucrose to which 50 /d of lyso-
staphin (1 mg/ml) and 50 ql of lysozyme (40 mg/ml)
were added. After incubation for 45 minutes at 37'C
80 ill of 0-25 M EDTA was added before incubation at
56 C for 30 minutes, after which 400 /il of 10% w.v
sodium dodecyl sulphate was added to complete lysis.
Crude lysates were centrifuged for 15 minutes at
15 000 x g_ and the supernatants run on 0-7%
agarose gels, as described previously.;o:i Plasmids of
known size were used as molecular weight standards.
A strain of C difficile known to harbour an 80
megadalton plasmid was processed in parallel as a
positive control.
ANTIBIOGRAM TYPING
Antibiogram patterns were determined by estimation
of minimum inhibitory concentrations (MICs) of
erythromycin, tetracycline, chloramphenicol, rifam-
picin and clindamycin. This was done by an agar
dilution method with two-fold dilutions of antibiotic
incorporated in Wilkins-Chalgren agar.9" The
antibiotic concentrations tested ranged from:
erythromycin 1 to 64 mg/1; tetracycline 0-25 to
32 mg/1; chloramphenicol 8 to 128 mg/1; rifampicin
0-25 to 256 mg/1 and clindamycin 8 to 256 mg, 1. Plates
were inoculated with about 100 000 organisms/ml and
incubated anaerobically overnight at 37=C. Sensitive
strains were defined as those that did not grow at the
lowest antibiotic concentration, and resistant strains
as those which were not inhibited by the highest
concentration tested.
ENZYME PROFILES
Pre-formed enzymes were detected by the API ZYM
system. Overnight broth cultures of each isolate were
centrifuged and the pellet suspended in 2 ml sterile
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R = resistant; S = sensitive.
water to obtain a suspension with a turbidity which
measured between McFarland values No 5 and No 6.
Volumes (65 pi) of this suspension were then
inoculated into the 20 cupules of the test strip (one
control + 19 tests) and incubated in darkness at 37CC
for four hours.
The test strips were processed, and the results
interpreted in accordance with the manufacturer's
instructions. Each isolate was tested on two separate
occasions.
Results
In late May and early June 1987 six patients in the
orthopaedic ward of the Glasgow- Royal Infirmary
were involved in an outbreak of diarrhoea (table 2).
Three weeks earlier, one patient (case 1) had required
treatment for an isolated episode of diarrhoea
associated with C difficile. This patient was treated
with vancomycin for 10 days with good clinical
response but five days later she again developed
diarrhoea. Over the next 17 days five other patients
had episodes of diarrhoea due to C difficile.
Five of the six patients in the outbreak had received
antibiotics within the previous four weeks. These
included fiucloxacillin (four patients), ampicillin and
amoxycillin (two patients), fusidic acid (one patient),
erythromycin (one patient) and cephalexin (one
patient).
All patients were treated with oral vancomycin. One
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19
Fig 1 Initial 19 strains typed by immunochemical method (14 from outbreak: 10 patients,
four environmental. five from elsewhere in hospital).
Lanes: 1 A: 2 B: 3. 4 C: 5 G: 6 H: 7 D: 8 F: 9-19 E.
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Fig 2 Eight different stains A-H. Strains A. D, H, E
isolatedfrom patients in "outbreak". Strains B. C. G. Ffrom
elsewhere in hospital.
Lanes: I A: 2 B: J C: 4 G: 5 H: 6 D: 7 F: 8 E.
patient (case 2) died. The cause of death was not
directly related to C difficile diarrhoea, although this
may have been a contributory factor. Of the other five
patients, four had further episodes of diarrhoea from
which C difficile was isolated. The outbreak was
eventually controlled by closure of the ward to further
admissions and transfer of those patients with relapses
to the local infectious diseases unit.
C difficile was isolated from the six patients on the
ward (in some cases on more than one occasion) and
from the bedside locker, bedpan holder, and sur¬
rounding floor of one of the affected patients and from
the bedside locker of an asymptomatic patient in the
ward. C difficile was not isolated from any of the
patients without diarrhoea. No other enteric
pathogens were isolated from any patient.
The 15 isolates of C difficile from the six patients and
the four environmental isolates produced toxin. All
faecal samples from the six patients were also found to
contain high titres (> 1 in 6400) of C difficile toxin.
Antibiotic sensitivity tests separated the isolates
into two "antibiotypes" on the basis of clindamycin
sensitivity. Type 1 was resistant to clindamycin and
type 2 was sensitive. All the environmental samples
were "antibiotype" 1. A comparison between
antibiogram patterns and immunochemical types in
the patient samples is shown in table 2.
None of the C difficile isolates studied harboured
plasmids.
The following enzymes were present in all isolates
from patients and the environment: alkaline phos¬
phatase, esterase (C4), esterase lipase (C80), leucine
arylamidase, acid phosphatase and naphthol-AS-BI-
phosphohydrolase.
Nineteen strains of C difficile from the outbreak and
five sporadic isolates from elsewhere in the hospital
were submitted with no indication of source for SDS-
PAGE/immunoblot fingerprint analysis. Eight
immunochemical types, arbitrarily designated A-H,
were found (figs 1 and 2). Four of these, A, D, E, and
H. were found only in samples from the "outbreak".
The other four patterns, B, C, F, and G were produced
from the five strains isolated from elsewhere in the
hospital. Strains with pattern E were isolated at least
once from all the affected patients and from the
surrounding environment at some time during their
episodes of infection. Types A, D, and H were only
found sporadically and were present only in single
samples from four different patients (table 2).
Discussion
Results of this study suggest that a single common
strain (type E) of C difficile, isolated from all six
patients and from the environment, was almost cer¬
tainly responsible for the outbreak of diarrhoea.
These results support the observations of other
workers89"25 that C difficile can be responsible for
nosocomial infection in the hospital environment,
especially in elderly debilitated patients. It is clear
from this study that diarrhoea can relapse after
treatment with an appropriate agent (vancomycin)
and that the same strain may again be implicated. The
reasons for such relapses are not clear but for the first
time we have shown that relapse can be caused by
acquisition of a new strain (cases 1 and 4) or by re-
emergence. or reacquisition of the original strain
(cases 3 and 6).
The immunochemical method was shown to be the
most discriminatory of the typing strategies evaluated.
Antibiograms showed the presence of two types,
distinguishable only by their clindamycin sensitivity.
Type 1 (clindamycin resistant) was further divided into
the "outbreak" type E and another strain, type H, by
immunochemical methods. Type 2 (clindamycin
sensitive) was further divided into types A and D by
immunochemical methods.
The presence of four strains in the outbreak com¬
plicated the epidemiological investigation. Although
not as complex as a recent outbreak in a renal unit,24
this outbreak shows that multiple strains of C difficile
may be involved in a susceptible patient population.
Ideally, 10 colonies should be picked from primary
isolation plates for immunochemical analysis25
Typing of C difficile causing diarrhoea in an orthopaedic ward 515
because more than one strain may be present in
primary cultures from individual patients. Unfor¬
tunately, this was not done in this study, because it was
not at first clear that we were dealing with an outbreak.
A similar caveat, however, could equally be applied to
many other epidemiological studies of outbreaks
which have used this and other typing strategies.
Although types A, D, and H were isolated from four of
the patients at some time during their diarrhoeal
episodes, type E might well have been present on the
primary isolation plate.
Levett': used the API ZYM system to identify
C difficile from other clostridial species. He noticed
that a few strains had other enzymes present in
addition to the common enzymes found in all the
C difficile strains tested. We found that all our isolates
produced the same enzymes and that this result was
reproducible. Consequently this method is unlikely to
be useful as a typing method for C difficile, unless an
unusual enzyme pattern is found.
Plasmid profile data have been used to provide
useful epidemiological information in outbreaks of
infection caused by a variety of different bacterial
general6 Most strains of C difficile, however, do not
harbour plasmids and it is well recognised that absence
of plasmids or very limited plasmid diversity limits the
usefulness of this technique as an epidemiological tool.
Peerbooms et al have described the use of restriction
endonuclease digest patterns of C difficile
chromosomal DNA as a means of typing." and this
method may find wider application in the future.
Immunochemical and plasmid profile analysis can
be undertaken in a labortorv with standard electro¬
phoresis equipment, but technical expertise is required
to operate these systems successfully, so that these
techniques are likely to be restricted to specialist
centres. "Antibiotyping" is much less technically
demanding and is probably a useful initial step in the
investigation ofan outbreak but a more discriminating
technique should also be used.
We thank Robert Brown and Carol Whittaker for
their technical assistance in the preparation of the
surface protein analysis. We also thank Professor
Morag Timburv for her encouragement and advice.
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Current Approaches to the Classification, Characterisation and
Typing of Pathogenic Anaerobic Bacteria
J. G. COLLEE. R. BROWN. !. R. POXTON and A. G. FRASER
From tin1 Department ofBacteriology. University Medical School. Edinburgh. Scotland
ABSTRACT. Characterisation systems based on the demonstration of soluble antigens and toxins
are of much practical value but have clear taxonomic limitations. This is illustrated bv reference to
our work with some of the pathogenic Clostridia. The definition and classification of the anaerobic
cocci is a difficult and continuing challenge. Systems for the classification and characterisation of
the gram-negative non-sporing anaerobic bacilli are evolving well, though there are still some very
difficult areas. A selection of the most helpful tests is indicated. Biotyping systems are compared
with serotyping systems: the results of serological approaches to characterisation are encouraging.
The further exploration of bacteriocin ty ping seems to be merited. The challenge of characterisa¬
tion and classification of anaerobic spirochaetes commonly involved in human infections must now
be taken up.
INTRODUCTION
So much work is being done on the anaerobic bacte¬
ria thtit it is helpful to consider practical aspects of
classification and characterisation in 1981. to up¬
date our views expressed in 1979 (1). In this paper,
we review significant trends and we consider results
of our recent studies of various pathogenic anaer¬
obes. with special reference to practical approaches
to their prompt characterisation and effective clas¬
sification in relation to medical and dental bacteri¬
ology.
MATERIALS AND METHODS
Organisms: the strains studied are detailed in recent pa¬
pers published by past and present members of our re¬
search team: the relevant references are given in the text.
Biochemical tests were as described previously (5. 6). Gas
liquid chromatography: The procedures used were de¬
scribed by Deacon and colleagues (4). Neuraminidase as¬
says were performed as described by Fraser and Brown
(8. 9). Bacteriocin studies were as outlined by Watt and
Collee (22).
RESULTS AND DISCUSSION
The Clostridia. Two organisms provide interesting
examples of challenges to our existing systems of
classification and characterisation. These are Clos¬
tridium perfringens and C. difficile.
C. perfringens. Although strains of types Al and
A2 replicate very rapidly at 44-45°C with mean
generation times of less than 10 min (2.3) we found
that production of lecithinase (phospholipase-C) is
suppressed at these temperatures. As detection of
this enzyme is important in current primary identifi¬
cation tests, the organism's potential for very rapid
growth has not been exploited significantly in the
diagnostic laboratory.
C. perfringens-Wke organisms, including C. ab¬
sonant. C. paraperfringens and C. sardiniensis. dif¬
fer in relatively minor characteristics from typical
C. perfringens (14. 15). It is important to keep in
touch with developments in this area.
Any approach that might help to sub-divide the
C. perfringens complex merits exploration as our
present dependence on animals for toxin neutralisa¬
tion tests in the typing of the organism is a great
disadvantage. The use of agglutination tests for the
typing of strains involved in food-poisoning has
been very helpful (10).
C. difficile. Our experience with this organism
has recently been reviewed by Poxton (17). We
characterise the organism on the basis of its micro¬
scopic morphology, its ability to grow on CCFA
medium, its performance in biochemical tests, the
characteristic profile of end-products detected by
gas-liquid chromatography (GLC). and the detec¬
tion of characteristic antigens in crossed immuno-
electrophoresis systems when tested against rabbit
antiserum raised against whole cells of the type
strain (NCTC 11223). Antigenic cross-reactions
with the C. sordellilbifermentans complex can be
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IX J. G. Collee et al.
absorbed out. Some strains do not produce the typi¬
cal cytotoxin and it is clear that more work is need¬
ed on the debated role of the cytotoxin in the en-
teropathogenicity of this organism. Some of our
strains showed minor variations in the presently
accepted range of biochemical tests used for char¬
acterisation: several showed significant differences,
and two strains showed marked departures from the
recognised pattern for C. difficile published in the
VPI manual (12). Differences of this degree would
certainly qualify for separate species rank in the
Bacteroides genus (see below). We are anxious to
determine whether the variation offers a basis for
biotyping which may be of epidemiological value in
tracing infective strains.
Neuraminidase production as an aid to clostridial
taxonomy
The possible association of neuraminidase produc¬
tion with pathogenic potential is debated, but the
enzyme may be of taxonomic use (8). Table 1 lists
the neuraminidase-positive and neuraminidase-neg-
ative Clostridia. This appears to distinguish clearly
between C. sordelli and C. bifermentans and com¬
plements the case for regarding these as separate
species.
Amino acid utilization and production in relation to
taxonomy
Studies to explore the metabolism of amino acids by
Clostridia as an aid to our understanding of the
proteolytic group deserve our attention (7).
Bacteroides-Fusobacterium group. Presumptive
Table I. Neuraminidase studies with Clostridia
Neuraminiduse-positive Clostridia



















identification at genus level can be made by obser¬
vations on Gram smears, colonial morphology and a
few other tests. GLC analysis of short chain fatty
acid end-products of metabolism can also identify
to genus level, but further tests are required to
establish the species or sub-species of Bacteroides
and Fusobacterium (4). We select the observations
and tests indicated in Table II as the currently rec¬
ommended range (4. 5, 6, 11).
The experience of others (12. 13) encourages us
to replace mannitol with salicin. and we note prom¬
ising results with xylan (19). The range of organisms
indicated in Table II is not complete and is inten¬
tionally restricted to those species that might merit
specific recognition in the clinical laboratory. Den¬
tal bacteriologists may soon press for the inclusion
of Bacteroides gingivalis as an important species.
The restriction to genus level for Fusohacterium
species is unwise and merely reflects our present
lack of extensive experience with this group.
We now restrict the tolerance tests to taurocho-
late and to one dye only, in view of practical diffi¬
culties with Victoria blue. The two tests give infor¬
mation that helps significantly to compensate in a
laboratory that might not be able to afford the ex¬
pense of a GLC system.
Serological characterisation. In studies that ex¬
ploit the species-specific antigenicity of the cell sur¬
face outer membrane (OMl complex and the sensi¬
tivity of an indirect enzyme-linked immunosorbent
assay (ELISA), we are now able to identify many
Bacteroides strains to species and sub-species level
(16. 18). Table III summarises results obtained with
OM preparations from representative reference lab¬
oratory and freshly isolated strains with species
reference antisera that we prepared against whole
cells and tested in an indirect ELISA system. The
outer membrane preparations are obtained by treat¬
ment of bacterial suspensions with 10 mM EDTA at
45° C for 30 min and then holding in an ultrasonic
bath for 60 s. The antisera are raised in rabbits
against whole live bacterial suspensions. Heterolo¬
gous cross-reacting antibody can be removed by
absorption of the antiserum with whole cells. We
find very significant correlation between serotype
and biotype in this work. Results were clear-cut
with the B. fragilis complex, the asaccharolytic
group, and with B. melctninogenicus intermedins.
The results with the B. melaninogenicus-ruminicola
complex reflect the confusion that also afflicts con¬
ventional biotyping systems.
Scand J Infect Dis. Suppl. 35
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Table II. A practical approach to the characterisation of commonly encountered grant-negative non-
sporing anaerobic bacilli <>) clinical interest
+ = > 95 r? of strains give positive result. - = > 95of strains give negative result, v = variation 30-709?. +(-
) = positive with most strains. —( + ) = negative with most strains. For details see Duerden. Holbrook. Collee & Watt.




Pigment - - - - - + + - - - - + - -
Indole — — — -f + + — - — — + (-) — V
Aesculin hydrolysis + V + + + - V + (-) + - - - - -(+ )
Fermentation of
Glucose + + + + + + + + + + + - - V
Lactose + + + + + -( + ) + + + + - - - -( + )
Sucrose* + + + + + + + + + - - - - -( + )
Rhamnose - + +(-) + + - -( + ) V +(-)
Trehalose - - + + + -( + )
Xylose + (-) + + + + - - - + - - - - -
Salicin — -(+ > + -( + ) + — — -<+) +(-) — — — — -(+)
Significant FA
Produced'7 v"
Succinic + + + + ( + ) + -(+ )
Acetic + + + + + + + +
N-Butyric - - + + - + +
Tolerance of
Sod. Taurocholate + - - - V
Gentian Violet - - - - +
Resistance tol/
Neomycin 1000 ug R S S/R S S
Kanamvcin 1000 ug R R R s S
Penicillin 2 units R S/R S s S
Rifampcin 15 ug S S S S/R S/R
" Alternative reactions in this column relate to species
differences as well as strain variations.
GLC: + = 1 -10 umol/ml. ++ = > 10 umol/ml.
( + ) = variable amount of minor product.
' Tolerance: Taurocholate 0.59?. Gentian violet I in
100000. + = tolerant. - = inhibited.
*' Antibiotic resistance: R = resistant. S = sensitive.
S/R = variation I30-70T).
Neuraminidase studies. Table IV lists the neura-
minidase-negative and positive Bacteroides species
and may help in classifying the melaninogenicus-
ruminicola-oralis complex and the bivius-disiens
group. The few Fusobacterium species that we
have tested do not produce neuraminidase (9). Our
neuraminidase tests helped to discriminate between
closely related Bacteroides species that are present¬
ly differentiated by a small number of sugar fermen¬
tation reactions. As the results are consistent for all
strains of each of the species that we examined, the
findings might be of taxonomic value (9). In view of
the technical difficulties of neuraminidase assays, it
will be necessary to develop a simple test; for exam¬
ple, the enzyme's ability to confer panagglutinabi-
lity on human red cells might be exploited.
Bacteriocin typing. Bacteriocin-like substances
produced by Bacteroides species offer a possible
approach to typing and sub-classification (22). It
was first necessary to develop detailed characteri¬
sation studies and now it seems worthwhile to re¬
examine the "bacteroidicins" in which we were
interested some years ago, but now to recognise
them as fragilicins, etc. It has been possible to ana¬
lyse our earlier results in the light of our subsequent
characterisation of the organisms that we tested
St and J Infect Dis, Suppl. 35
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Table III. Results of serological studies with outer-









Species and strain(s) Autologous (out of number
used as antigen titre" tested)
B. fragilis
NCTC9344 12 800 34 (35)
B. vulgatus
NCTC10383 25 600 II (11)
B. distasonis
ATCC8503 12 800"
GNAB26 12 800 6 (8)
B. thio.
NCTC10582 25 600"





VP14196 25 600 6(11)
B. oralis
1210 51 200 5 (17)
B. ruminicola
NP333 25 600"
GA33 6400 6 (14)
B. asaccharoh ticus
NCTC9337 25 600 24 (25)
" The autologous titre denotes the titre obtained with the
strain used as antigen. When two antisera were prepared
for a species, the combined results are given.
Table IV. Results of neuraminidase studies with
organisms of the Bacteroides-Fusobacterium group
Neuraminidase-positive Bacteroides spp.
B. met. ss. melaninogenicus









(B. ochraceus = Capnocytophaga)
Neuraminidase-negalive Bacteroides spp.
B. eggerthii B. mel. ss. intermedins
B. uniformis B. ruminicola








(Table V). The indications are that most strains of
B. fragilis are both good producers and indicators,
whereas strains of B. thetaiotaomicron studied by
us were poor in this respect. Our experience with
the B. melaninogenicus group is presently inad¬
equate. The results obtained with the B. asaccharo-
lyticus strains seem to be promising, as the produc¬
ers showed their effect only against B. asaccharoly¬
ticus indicators. These are retrospective analyses
and a note of caution is needed: the agents responsi¬
ble for these effects have not been formally charac¬
terised as bacteriocins and a systematic study is
now indicated with a range of characterised strains.
The anaerobic cocci
We certainly confirm that "the clinical microbiolo¬
gist attempting to isolate and characterise the obli-
gately anaerobic cocci, and the clinician attempting
to treat infections caused by these organisms, both
suffer from a lack of useful data" (24). We accept
the provisional definition of Watt and Jack (23) that
anaerobic cocci grow under satisfactory conditions
of anaerobiosis and do not grow on suitable solid
media in 109c CO; in air even after incubation for 7
days at 37° C. These workers found that metronida¬
zole sensitivity is a reliable index: obligately anaer¬
obic cocci are all sensitive to metronidazole.
The detailed descriptions provided by Smith and
Holdeman (20) provide a helpful starting point for a
review of classification of this difficult group. We
find the inclusion of Streptococcus confusing. The
division of the streptococci into truly anaerobic and
facultative groups might be taxonomically proper,
but facultative strains are encountered in clinical
specimens that cannot be isolated initially unless
Table V. Results ofpreliminary studies of bacterio-
cin-like effects with gram negative anaerobic bacilli
Producers Indicators
Species
Number Number Number Number
Positive Tested Positive Tested
B. fragilis 34 37 28 34
B. thio. I 6 1 6
B. vulgatus 0 5 4 4
B. distasonis 0 1 0 1
B. mel. ss.
intermed. 2 -> 0 ->
B. mel. ss. mel. I 1 1 1
B. asaccharolyticus 4 4 4 4
B. ruminicola 0 1 0 1
Fusobacterium spp. 2 5 0 3
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anaerobic culture procedures are undertaken (2(1).
This may be explained on the basis of carbon diox¬
ide dependence and other exacting considerations
that merit further work. Thus, apparently anaerobic
cocci that are not true anaerobes still feature in our
collections, and sometimes in our clinical reports.
The anaerobic state and sensitivity to metronida¬
zole is of clinical importance, but it is inevitable that
the rules of convenience must bow to the stricter
rules of a system that might well include obligate
anaerobes and facultative organisms in one genus.
Accordingly, the clinical bacteriologist must be on
guard: we make the lighthearted but significant
comment that some of our organisms at the primary
isolation stage have not read the textbook.
The anaerobic spirochaetes
We are again indebted to Smith and Holdeman (20)
for a helpful outline. In addition to the well-known
human pathogenic associations of the anaerobic
species in the genera Spirochaeta. Borrelia and Tre¬
ponema. the association of spirochaetes with other
organisms in periodontal disease is of much inter¬
est. The occurrence of spirochaetes in the human
colon, especially noted in male homosexuals, also
merits further study. Smith takes the view that it is
doubtful whether any of the cultivable treponemes
are significantly pathogenic in the mouth. The in¬
crease in number of these organisms in areas of
gingival pathology has been recognised for years,
but the correlation of these organisms with degrees
of tissue destruction has stimulated interest among
dental bacteriologists and dental practitioners con¬
cerned with periodontal disease (21). There is
pathogenic synergy in these infections and. while it
may be that the spirochaetes are not a significant
component of the initial microbial attack and may
be merely secondary opportunists exploiting condi¬
tions that encourage their growth, many of us have
been slow to develop adequate investigations of
periodontal disease. It is likely that the significant
primary pathogens will include bacteroides organ¬
isms and fusobacteria and perhaps Capnocyto-
phaga-like organisms which abound in these le¬
sions. Recent developments in the classification
and characterisation of these organisms should now
allow us to make significant progress in this impor¬
tant field.
CONCLUSION
Our aim in this paper has been to consider the
Classification and characterisation ofanaerobes 2 I
degrees of precision regarded as necessary and
practical in the characterisation and classification of
some representative anaerobic bacteria of clinical
importance. It is paradoxical that the label of C.
perfringens presently applies to a remarkably wide
range of human and animal pathogens that can only
be distinguished by difficult toxigenic analyses,
whilst new species rank is afforded to relatively
minor variant biotypes. In this case, serological
analyses of soluble antigens have so far helped only
in typing food-poisoning strains. On the other hand.
C. difficile seems to embrace many biotypes: pre¬
sent confusion concerning the significance of the
cytotoxin and the enterotoxin in its identification
encourages us to develop somatic serological stud¬
ies. Further studies of amino acid metabolism might
also be helpful. The successful biotyping of the
Bacteroides-Fusobacterium group has been ex¬
tended to the point at which minor biochemical
variants qualify for species rank, and this seems to
be supported by serological analyses of species-
specific outer membrane antigens. Other possible
approaches include bacteriocin typing and this may
have epidemiological value. In contrast, the classifi¬
cation of the anaerobic cocci is still poorly devel¬
oped. and the oral spirochaetes merit more system¬
atic study.
ACKNOWLEDGEMENTS
We are indebted to many colleagues for helpful discus¬
sions and particularly on this occasion to Dr Brian Duer-
den. Dr Brian Watt. Professor Sidney Elsden and Mr
Torquil MacPhee. We thank Mrs Joan Collins for much
help in preparing the manuscript. We are very grateful to
the Scottish Home & Health Department (Grant K/MRS
50/C247) and the Medical Research Council (Grant
G8106873SB) for their financial support.
REFERENCES
1. Collee. J. G.: Current classification of anaerobic bac¬
teria. J Infection 1. Suppl. 1:3. 1979.
2. Collee. J. G.: Controlling the conditions of incubation.
In: Public Health Laboratory Service Quality Control
Manual, p. 17. PHLS England. 1980.
3. Collee. J. G.. Knowlden. J. A. & Hobbs, B. C.: Stud¬
ies on the growth, sporulation and carriage of Clostri¬
dium welchii with special reference to food poisoning
strains. J Appl Bacteriol 24: 326, 1961.
4. Deacon. A. G.. Duerden. B. I. & Holbrook, W. P.:
Gas-liquid chromatographic analysis of metabolic pro¬
ducts in the identification of Bacteroidaceae of clinical
interest. J Med Microbiol 11:81. 1978.
Scand J Infect Dis, Suppl. 35
-- J. G. Collee et al.
5. Duerden. B. I.. Ccllee. J. G.. Broun. R.. Deacon. A.
G. & Holbrook. VV. P.: A scheme for the identification
of clinical isolates of gram-negative anaerobic bacilli
by conventional bacteriological tests. J Med Microbiol
13:.31. 1980.
6. Duerden. B. I.. Holbrook. W. P.. Collee. J. G. &
Watt. B.: The characterization of clinically important
gram-negative anaerobic bacilli by conventional bac¬
teriological tests. J Appl Bacteriol 40: 163. 1976.
7. Elsden. S. R. & Hilton. M. G.: Amino acid utilization
patterns in clostridial taxonomy. Arch Microbiol
123: 137. 1979.
8. Fraser. A. G.: Neuraminidase production by Clostri¬
dia. J Med Microbiol 11:269. 1978.
9. Fraser. A. G. & Brown. R.: Neuraminidase produc¬
tion by Bacteroidaceae. J Med Microbiol 14:63. 1981.
10. Hobbs. B. C.: Clostridium perfringens gastroenteritis.
In: Food-borne infections and intoxications. 2nd ed.
p. 160 (ed. H. Riemann & F.L. Bryan). Academic
Press. New York 1979.
11. Holbrook. W. P.. Duerden. B. 1. & Deacon. A. G.:
The classification of Bacteroides melaninogenicns
and related species. J Appl Bacteriol 42: 259. 1977.
12. Holdeman. L.V.. Cato. E.P. & Moore. W.E.C.: Ana¬
erobe laboratory manual. 4th ed. Virginia Polytechnic
Institute and State University. Blacksburg. Virginia.
13. Johnson. J. L. & Ault. D. A.: Correlation of phenoty-
pic characteristics with DNA homology groupings for
Bacteroides fragilis and other saccharolytic Bacte-
roides species. Int J Syst Bacteriol 28: 257. 1978.
14. Mead. G. C.. Paez de Leon. L. & Adams. B. W.: A
study of rapid and simplified confirmatory tests for
Clostridium perfringens. J Appl Bacteriol 51:355.
1981.
15. Nakamura. S.. Shimamura. T.. Havase. M. & Ni-
shida. S.: Numerical taxonomy of saccharolytic Clos¬
tridia. particularly Clostridium perfringens-\ike
strains: Descriptions of C. absonum sp.n. and C.
paraperfringens. Int J Syst Bacteriol 23:419. 1973.
16. Poxton. I. R.: Serological identification of Bacte¬
roides species by an enzyme-linked immunosorbent
assay. J Clin Pathol 32: 294. 1979,
17. Poxton. I. R.: Detection and isolation of Clostridium
difficile. Eur J Chemother Antibiotics 2: 123. 1982.
18. Poxton. I. R.. Collee. J. G. & Brown. R.: Detection of
species-specific and cross-reactive cell-surface anti¬
gens of Bacteroides species by an indirect enzyme-
linked immunosorbent assay. J Med Microbiol 15:
223. 1982.
19. Salyers. A. A., Vercellotti. J. R.. West. S. E. H. &
Wilkins. T. D.: Fermentation of mucin and plant poly¬
saccharides by strains of Bacteroides from the human
colon. Appl Envir Microbiol 33: 319. 1977.
20. Smith. L. DS. & Holdeman. L. V.: The pathogenic
anaerobic bacteria, p. 91 and p. 325. Thomas. Spring¬
field 1975.
21. Socransky. S. S., Listgarten. M.. Hubersak. C.. Cot-
more J. & Clark. A.: Morphological and biochemical
differentiation of three types of small oral spiro-
chaetes. J Bacteriol 98: 878. 1969.
22. Watt. B. & Collee. J. G.: Practical approaches to the
isolation and identification of clinically important non-
sporing anaerobes. In: Infection with non-sporing ana¬
erobic bacteria, p. 16 (ed. 1. Phillips & M. Sussman).
Churchill Livingstone. Edinburgh 1974.
23. Watt. B. &Jack. E.: What are anaerobic cocci? J Med
Microbiol 10:461. 1977.
24. Watt. B.. Young. O. & McCurdy. G.: The susceptibi¬
lity of anaerobic cocci from clinical samples to six
antimicrobial agents. J Infection I: 143. 1979.
Address for reprints:






Scttttd J Infect Dis, Sttppl. 35
?
32
36 R- Brown, J. G. Collee, I. R. Poxton & M. G. Fraser
Bacteroides, Fusobacterium and related organisms:
anaerobic cocci: identification of anaerobes
This chapter deals with the Bacteroides!
fusobacterium group of organisms and. for
practical reasons, it embraces Mobiluncus and
the anaerobic cocci. Many of the principles
adopted for laboratory diagnosis and identifica¬
tion of these organisms are also applicable to the
Clostridia, which are covered in the next two
chapters. Some procedures basic to anaerobic
technology, such as anaerobic culture method¬
ology. have been detailed in earlier sections of
this book (Ch. 7). The first part of this chapter
outlines a general approach to the identifi¬
cation of anaerobic bacteria, relevant not only
to this chapter but also to the succeeding chap¬
ters on Clostridia.
General approach to the identification of
anaerobic bacteria
Table 36.1 at the end of this chapter outlines the
range of tests and media that are of value in
characterizing the different groups of strictly
anaerobic Gram-positive and Gram-negative
bacteria. As it is easy to presume that a
demanding aerobe or facultative anaerobe might
be an obligate anaerobe, it is most important to
subject isolates to a systematic screening
procedure as indicated in the first few steps of
Table 36.1.
Cell morphology and Gram-stain reaction
should be examined in films from blood agar
(BA) or cooked meat broth (CMB) cultures
incubated for 18-24 h. or longer for anaerobes
that grow slowly. Similarly, colonial morphology
on BA plates may be examined after 24 h. but
prolonged incubation is required for slow
2 rowers.
Some organisms, e.g. Bacteroides melanino-
genicus. produce dark brown or black colonies
on blood-containing media, by forming a haern-
protein complex. Up to 14 days incubation may
be required before this is seen: pigment
formation is less delayed if lysed blood is used.
Fluorescence of colonies can be detected bv
exposing BA cultures to long-wave UV light
(365 nm) from a Wood's lamp. Colonies of B.
melaninogenicus fluoresce brick-red. and Clostri¬
dium difficile colonies fluoresce green. Colonies
of fusobacteria fluoresce yellow on media
containing cysteine hydrochloride. Note that
other Clostridia may also fluoresce and that B.
asaccharolyticus and B. bivius colonies on blood
agar are pink. red. dark red and purple under
UV light at successive stages of growth over 1-4
days;
The further tests indicated in Table 36.1
extend into a range of biochemical and resistance
tests that may be of value for determining the
individual species within each of the broad
groups of organisms. Practical experience with
the characterization steps indicated in the
subsequent tables in this chapter (or Ch. 37 for
Clostridia) will allow a bacteriologist to discrimi¬
nate in the number of tests used for a particular
identification, e.g. depending on the nature of a
Gram-negative rod isolated, a short-cut approach
along the lines set out in Table 36.2 at the end
of this chapter might be adopted.
Detection and quantitation of fatty acid
end-products of bacterial metabolism by gas
chromatography (GC) is a useful aid to the
identification of anaerobic bacteria. When this
information is used in conjunction with details
of cell morphology and Gram-stain reaction, it
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is possible to establish the identity of anaerobes
to genus level (as in Table 36.3), and
occasionally to species level. The use of GC in
characterization of Gram-negative anaerobes is
included in the further tables in this chapter, and
accounts of GC for identification of the Clostridia
are given in Chapters 37 and 38. Technical
details are given in specialist manuals (or see
Deacon et al 1978); a brief account is provided
in the Methods section of this chapter.
freshly prepared or pre-reduced blood agar
Development of visible colonies of some strains
may require 48 h or more. Some have special
requirements for haemin and vitamin K3 (mena¬
dione). The presence of 10c/c CO; in the anaer¬
obic atmosphere often markedly enhances
growth. Colonial appearances vary, depending
on species and culture media, from tiny trans"
lucent colonies to large, grey, circular or irregu¬
lar colonies at 24-48 h.
BACTEROIDACEAE
The strictly anaerobic Gram-negative non-sponng
rod-shaped bacteria are abundantly represented
as commensals in the human gastrointestinal
tract, oropharynx and female genital tract and
these include many opportunist pathogens. It is
increasingly evident that these anaerobes are
involved in a very wide range of clinical
conditions and that characterization of individual
species concerned can be of clinical significance.
This section deals with the Bacteroides, Fuso-
bacterium and Leptotrichia organisms of clinical
interest. The description and laboratory guide¬
lines are closely linked with the information
given in the associated tables (see end of
chapter). Many laboratories find it necessary to
restrict the degree of characterization. The infor¬
mation given in Table 36.2 illustrates a short-cut
approach in this complex field.
Morphology
Range from short Gram-negative rods to fila¬
mentous and fusiform shapes. Pleomorphism is
common. All are non-sporing, but some may
produce swollen spherical bodies resembling
sporing forms when wet films are examined by
phase contrast microscopy. Most species of
clinical interest are non-motile.
Biochemical activities
Active saccharolvtic and some non-saccharolytic
species are described. Some are proteolytic and
a few produce other demonstrable exoenzymes
that facilitate their early characterization (see
below).
Sensitivity to physical and chemical agents
These organisms vary in their sensitivity to
oxygen; in general, colonies on solid media
should be picked promptly for subculture.
Species variations in sensitivity to dyes, bile and
antibiotics can be exploited in simple character¬
ization systems (Table 36.2).
Antibiotic sensitivity
In general, organisms of the B. fragilis group are
resistant to penicillin and produce potent
cephalosporinases and penicillinases. A signifi¬
cant proportion of organisms in the B. melanino-
genicus group are partially or markedly
resistant to penicillin. The fusobacteria are
generally sensitive to penicillin. All of these
anaerobes are resistant to clinically achievable
concentrations of the aminoglycosides. They are
often resistant to the tetracyclines. They are
generally sensitive to clindamycin, and virtually
always sensitive to chloramphenicol and
metronidazole.
Cultural characters
The nutritional requirements of this hetero¬
geneous group vary. Most of the species of medical
interest grow better on enriched media such as
Serological identification
Several different attempts pioneered by Beerens
et al (1971) to develop a serological scheme for
identifying Bacteroides spp. have been largely
\
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empirically based on heated or unheated whole
11 antigens and procedures such as aggluti¬
nation or immunofluorescence. In 1987. when
this chapter was written, no serological scheme
vsas widely in use. Two immunofluorescence kits
available commercially (Fluoretec F and
Fluoretec M: Pfizer) for the identification of the
B. fragilis group and B. melaninogenicus spp. do
not differentiate between the likely pathogens
and non-pathogens and are still being evaluated.
The F kit seems to react with the majority of B.
fragilis strains but gives variable results with
other species in the B. fragilis group. The M kit
reacts with some B. bivius and B. melaninogen¬
icus strains, but reactions within this group are
not sufficiently specific. As more is understood
of the antigens of Bacteroides spp.. more specific
serological schemes will be developed for the
identification of these organisms. At present,
capsular antigens and outer membrane protein
antigens both appear promising for exploitation.
The highly heterogeneous LPS antigens have
been used in exploratory epidemiological studies.
Other typing methods
Promising results are being obtained with bacte-
riocin typing, which is simpler than serotyping
and may be of diagnostic and epidemiological
value (Riley & Mee 1982).
Animal pathogenicity
Animal pathogenicity tests are not performed
routinely for any Gram-negative anaerobe. In
our limited experience with fusobacteria, F.
necrophorum is lethal for rabbits when injected
intravenously. Various animal models have
demonstrated that pathogenic synergy exists
between some facultative anaerobes such as
Escherichia coli and Bacteroides spp.
(Onderdonk et al 1977; Kelly 1978).
Classification of Bacteroidaceae
The Gram-negative anaerobic non-sporing bacilli
of clinical interest are essentially contained
within the Bacteroides/Fusobacterium group
(Bacteroidaceae). A spectrum of Gram-negative
rods in this range of organisms extends across
many genera, linked by unnamed and. as yet.
inadequately characterized groups. There are
associated non-anaerobic genera to add to the
confusion; recently described genera with
characterized species of medical and particular
dental interest include the Eikenella group which
is aerobic and includes capnophilic members,
and Wolinella which is a group of anaerobic or
microaerophilic species. The microaerophilic
capnophilic organism formerly known as
Bacteroides ochraceus is now in the genus
Capnocytophaga (C. ochracea). These 'associ¬
ated non-anaerobic genera' are not discussed
further in this chapter, but there is a note on
Mobiluncus. Gardnerella is described in Chapter
19.
By 1987, there were more than 30 species of
Bacteroides and 14 species of Fusobacterium.
Many species occur as normal commensals in
man. but some have much greater pathogenic
potential than others. B. fragilis is accepted as
the most commonly encountered pathogenic
member of the genus, but other pathogenic
associations are increasingly recognized.
Several schemes have been developed for the
identification of Gram-negative anaerobic rod-
shaped bacteria. Those most widely used are
based on publications of the Virginia Polytechnic
Institute (Holdeman et al 1977), the Center for
Disease Control, Atlanta (Dowell & Hawkins
1976) and the Wadsworth Hospital. Los Angeles
(Sutter et al 1975). A shortened, simple and
reliable scheme is that of Duerden et al (1980).
Bacteroides and Fusobacterium can be readily
separated into major groups by simple tests
(Table 36.2) and these groups can be subdivided
to species level by further biochemical tests
(Tables 36.4-36.7; all at the end of this chapter).
The Bacteroides organisms can be divided into
the B. fragilis group, the B. melaninogenicus!oralis
group, and an asaccharolytic group. In GC tests,
the fusobacteria characteristically produce major
amounts of butyric acid with varying amounts of
other fatty acids but generally excluding iso-
butyric and iso-valeric acids. On the other hand,
most Bacteroides organisms produce major
amounts of acetic and succinic acid; the few
species that produce butyric acid usually also
produce iso-butyric or iso-valeric acid or both of
these (see Table 36.3).
Note. In the tables that give differential
characteristics of important pathogens in this
group of organisms, key reactions are indicated
in bold and these provide a short-cut character¬
ization procedure of value to hard-pressed
clinical laboratories.
Bacteroides fragilis group
This comprises non-pigmented. strongly sacchar-
olytic and bile tolerant species of Bacteroides and
includes B. fragilis, B. vulgatus. B. distasonis, B.
thetaiotaomicron, B. ovatus, B. uniformis, B.
variabilis, B. eggerthi and B. splanchnicus (see
Table 36.4). They are non-motile, non-sporing,
small Gram-negative rods 1-4 x 0.4-0.8 gm
with rounded ends. Pleomorphism is common
and large bizarre rods with round or oval swell¬
ings can be seen if fermentable carbohydrate is
present. They grow well on freshly prepared
blood agar incubated anaerobicallv with 10%
CO: at 37°C to produce smooth, circular,
convex, opaque, light grey colonies 1-2 mm in
diameter at 24 h that are usually non-haemolytic.
All members of this group are resistant to
penicillin.
Bacteroides fragilis. This organism has the
characteristics of the group described above. It
is not the most numerous of the commensal
bacteroides but it is the most commonly en¬
countered member of the group in a pathogenic
role, occurring in postoperative infections asso¬
ciated with abdominal and gynaecological
surgery, and in a wide range of other infective
situations including cerebral abscess, lung
abscess and soft tissue infections, often in
concert with other pathogens. The infections are
usually endogenous, often assisted by debili¬
tating factors that operate locally or generally in
the patient.
It is thought that B. fragilis owes its special
pathogenic potential to its production of capsular
material, but the factor or factors primarily
related to the virulence of this organism are still
debated. In common with some other pathogenic
bacteroides organisms. B. fragilis can inhibit the
effective phagocytosis and killing of coliform
organisms in test mixtures with polymorphs: this
is a likely explanation of the pathogenic svnergy
exhibited in mixed infections with these organ¬
isms. Aggressins produced by B fragilis that
may contribute to virulence include a range of
proteases, neuraminidase. DNase. heparinase
and other enzymes. In addition to this range of
biochemical activity against complex substrates,
the organism has other activities including the
ability to hydrolyse aesculin and to ferment
several sugars actively; the latter characteristics
are of use in sub-classification (see Table 36.4).
B. fragilis produces very potent (^-lactamases and
these preclude the use of antibiotics of the
penicillin series and most of the cephalosporin
drugs, though cefoxitin has some activity. Some
strains are resistant to the lincomycins. All but
a very few strains are sensitive to metronidazole
which is most often the drug of choice.
Bacteroides melauinogeuicus/oralis group
This group (Table 36.5) comprises saccharolytic,
bile-sensitive species of Bacteroides. some of
which produce black-pigmented or brown
colonies on blood-containing media. The
pigmented species B. melauitiogenicus. B. inter¬
medins, B. corporis and related organisms not
specified here are non-motile, non-sporing. small
Gram-negative rods. 0.6-2 x 0.4 jim. often
coccobacillarv. and sometimes pleomorphic in
broth cultures. They grow well on freshly
prepared blood agar supplemented with mena¬
dione 1 Aig/ml incubated anaerobically plus 10%
CO: at 37°C. At 24 h colonies may be very
small: at 48 h they are 1 mm, smooth, circular,
convex and opaque. The colour of the colony
changes from light grey, through tan and brown,
to black. Speed of pigment development is
enhanced on lysed blood agar, or by spotting a
haemolytic organism on to an inoculated blood
agar plate before incubation. Detectable devel¬
opment of pigment by some species may take up
to 7 days or more. Colonies of B. melanino-
genicus on blood agar, and cells of the species
in pus or on wound swabs, will fluoresce brick-
red when subjected to long-wave (365 nm) UV
light (Myers et al 1969).
Non-pigmented members of this group include
B. oralis, B. ruminicola. B. bivius and B. disiens.
Several new species have recently been proposed.
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. cc11 u 1 ar and colonial morphology is similar
,t of the pigmented members, except that





j,rcv to light tan and do not fluoresce brick-
elaninogenicus and related organisms areB "i
viated vsith periodontal disease, gingivitis,
j^ntal abscesses, maxillo-facial sepsis, lung
jf>sce^s and cerebral abscess. The infections are
>jtcn mixed. In acute ulcerative gingivitis
(Vincent's infection) Bacteroides organisms
occur in pathogenic synergy with Vincent's
^pirochaete and a fusiform organism which may
^ Fusobacterium nucleatum or Leptotrichia
buccal'*- The appearances in a Gram smear are
diagnostic. Pigmented and non-pigmented
members of the melaninogenicus/oralis complex
are associated with infections of the female
gvnito-urinary tract. These are assumed to be
endogenous as the organisms are encountered
frequently (but not invariably ) as components of
the commensal flora of that site. However. B.
fragdis is still regarded as the commonest Gram-
nccative anaerobic pathogen in female genital
tract infections (see Duerden 1980. 1984).
Asaccharolytic bacteroides group
This group (Table 36.6) comprises non-
saccharolvtic or weakly saccharolytic. usually
bile sensitive, species of bacteroides, some of
which produce black pigmented colonies on
blood-containing media. The pigmented species.
B asaccharolyticus, B. endontalis and
B. gingivalis. are non-motile, non-sporing. small
Gram-negative rods. 1 x 0.6 gm. often cocco-
bacillary and pleomorphic. Colonies on freshly
prepared blood agar are similar to pigmented
members of the melaninogenicus/oralis group.
The non-pigmented asaccharolytic members
include a number of species, some of debatable
status. Cell and colonial morphology vary among
the species. B. praeacutus is motile, and colonies
of B. ureolyticus burrow into the surface of agar
plates.
Fusobacteria and Leptotrichia
Representative species of fusobacteria are listed
in Table 36.7.
These organisms tend to occur in mixed infec¬
tions such as putrefactive necrotic fusospiro-
chaetal conditions with much tissue destruction,
as in cancrum oris, other maxillo-facial infections
(sometimes following surgical excision for
neoplastic disease), septic abortion and lung
abscess. Sometimes a fusobacterial infection can
be fulminating and can advance with great
rapidity from a sore throat syndrome to a necro¬
tizing pneumonitis. Fusobaeteria are commonly
involved in dental and periodontal infections,
ulcerative gingivitis (see above), liver abscess
and cerebral abscess. Fusobacteria and bacter¬
oides organisms are often involved in concert or
separately in necrotizing conditions variously
described as anaerobic cellulitis, necrotizing
fasciitis and dermal gangrene. The occurrence of
these organisms in mixed infections with foul pus
is common in infected pilonidal cysts, perianal
abscesses, balanitis, and ulcers of the leg and
buttocks, including diabetic ulcers and bed sores.
Some species of fusobacteria produce long
slender Gram-negative rods that are wide at the
centre and taper towards the ends (fusiform),
but others produce cells that range from cocco-
bacilli to long slender rods with parallel sides and
these are indistinguishable from other members
of the Bacteroidaceae. Isolation is best on blood
agar plates containing neomycin and vanco¬
mycin.* They are strict anaerobes, sensitive to
metronidazole, and tolerant of gentian violet.
Most are non-motile. After incubation at 37°C
for 48 h colonies usually have a raised, irregular
or crenated edge, a peaked centre, and may be
striate and granular.
Fusobacteriarn nucleatum is the type species
of the genus. It is a slender spindle-shaped
Gram-negative rod. 5-10 x 1 /am. with tapering
pointed ends and often with central or eccentric
swellings. After incubation for 48 h on freshly
prepared blood agar, colonies are 1-2 mm. irreg¬
ular, low convex, translucent or opaque, grey
and non-haemolytic. The organism is weakly
saccharolytic. non-proteolytic and non-motile.
Fusobacterium necrophorum. This Gram-
negative anaerobe has a tendency to pleo-
morphism and irregular staining. Cells are
1-10 x 0.5 /am; long filaments are frequently
* Refer to Methods at end of this chapter.
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seen. They are non-motile and non-sporing. but
swollen areas sometimes occur. At 48 h. colonies
are 1-2 mm. circular, with a flattened edge and
raised or convex centre, translucent or opaque,
grey and often |3-haemolytic. Most strains are
lipolytic (see Methods. Ch. 37).
Leptotrichia buccalis. This organism is charac¬
teristically seen in Gram smears of clinical
specimens as long Gram-negative rods of
considerable width and with terminal tapering;
individual cells may be up to 15 x 1.5 ^m. It is
sensitive to metronidazole and tolerant of
gentian violet. Colonies on blood agar after
incubation for 48 h are 2-3 mm. very irregular
and often striate. Leptotrichia has been thought
of as essentially commensal in the human mouth,
but pathogenic associations with other bacteria
in the oropharynx are likely to be accepted.
Laboratory diagnosis of bacteroides and
fusobacterial infections
The specimens should ideally be of pus. wound
exudate, tissue or blood which has been trans¬
ported to the laboratory in a closed syringe or
in a container that has been flushed out with
nitrogen. Swabs are not ideal; if they must be
used, they should be inoculated on to the media
directly, or transported to the laboratory in a
reduced transport medium, or thrust into a semi¬
solid agar medium to avoid desiccation in transit.
On receipt, specimens must be processed
without delay. Clinical specimens containing
fusobacteria or bacteroides can be handled
briefly on the open bench and surface plating is
suitable, provided that it is expeditious. An
anaerobic cabinet (Ch. 7) is not essential, but
can be useful if single specimens arrive
sporadically or if cultures are to be checked
regularly. Freshly poured plates or pre-reduced
plates should be used. When seeded with a suit¬
able inoculum, media should be promptly placed
in an anaerobic environment with 1097 CO; and
incubated. The steps in a routine investigation
are as follows;
1. Make a direct examination of the specimen.
Note if it has a foul smell. Observe under a long¬
wave (365 nm) UV lamp for brick-red fluor¬
escence. which suggests the presence of B.
melaninogetiicus. Consider preparing an ether
extract of the specimen for direct examination bv
gas chromatography* (Holdeman et al 1977).
2. Prepare films for phase contrast microscopy
and Gram stain. Observe characteristic
morphology: non-motile, pleomorphic, cocco-
bacillary to fusiform or filamentous. Gram-
negative. Consider fluorescent antibody stains
for bacteroides. but note cautions (see above).
3. Plate on to two plates each of blood agar
(Columbia base containing 4 or 897 whole blood
and 1 or 297 freeze-thawed lysed blood and
menadione 1 /agml*) and two selective blood
agar plates*. Primary sensitivity tests can be
made at this stage by placing disks, e.g. metro¬
nidazole 5 pg and penicillin 1 or 2 units, on the
first series of streaks. Also seed a tube of pre-
reduced cooked meat broth (CMB).
4. Incubate one blood agar plate aerobically
and the rest anaerobically with 109c CO; at
37°C. Check the CMB. the blood agar and one
selective plate after 24 h. Leave the remaining
selective plate undisturbed for 48 h.
5. Examine plates for typical colonies. Examine
CMB enrichment by microscopy, and subculture
as in (3).
6. Pick colonies and subculture into pre-
reduced CMB, into PPY medium for subsequent
identification by biochemical tests, and into PPY
medium containing glucose 197 for gas chroma¬
tography,* and also to observe whether or not
glucose is fermented.
7. Identification to group level is by observing
the tolerance of the organism to bile and gentian
violet.* its resistance to a range of antibiotics*
and its ability to ferment glucose. Full identifi¬
cation to species level is by selecting the appro¬
priate biochemical tests as indicated in Tables
36.1-7. A more detailed approach is described
by Bennett & Duerden (1985).
MOBILUNCUS SPECIES
These are anaerobic or microaerophilic, curved.
Gram-negative or Gram-variable rods and they
are motile with two or more subterminal flagella.
Mobiluncus spp. have antibiotic sensitivity
profiles that are more typical of Gram-positive
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organisms, and some features of their cell wall
structure are more typical of Gram-positive cells,
but this is debated. The organisms may occur in
the vagina of apparently healthy women, but
seem to have an association with non-specific or
bacterial vaginosis. The organisms are fastidious
and grow slowly at 33-37°C. producing round,
entire, convex, smooth, translucent, colourless
colonies. 2-3 mm in diameter, after anaerobic
incubation on blood agar medium for 5 days. A
suitable selective medium is blood agar
supplemented with colistin 10 /xg/m' and nali¬
dixic acid 10 /xg/ml. Two species are currently
recognized. M. curtisi and M mulieris. Both
accepted species are saccharolvtic. but can be
differentiated as follows:
M. curtisi is 1.7 x 0.5 jum. Gram-variable,
metronidazole resistant, and gives positive
results in tests for hippurate and arginine hydro¬
lysis and ONPG. Small amounts of acetic acid
and major amounts of succinic acid are produced
in glycogen-containing media.
A/, mulieris is 2.9 x 0.5 /urn, Gram-negative,
metronidazole sensitive, and gives negative
reactions in tests for hippurate and arginine
hydrolysis and ONPG. Major amounts of acetic
and succinic acids, and sometimes small amounts
of lactic acid are produced in glycogen-containing
media.
ANAEROBIC COCCI
Strictly anaerobic Gram-positive cocci have been
assigned to the genera Peptococcus, Peptostrep-
tococcus, Ruminococcus and Sarcina\ strictly
anaerobic Gram-negative cocci are included in
Veillonella, Megasphera and Acidaminococcus.
This brief account is restricted to Peptococcus,
Peptostreptococcus and Veillonella, as these are
the genera most commonly associated with
clinical infections. Most of the peptococci have
now been reclassified as peptostreptococci.
Peptococcus niger is the only surviving member
of the genus Peptococcus (see Table 36.8 and
Ezaki et al. 1983)'.
Many species of anaerobic cocci are commonly
found as commensals on the human skin, in the
female genital tract, in the oropharynx, and in
the gastrointestinal tract. These commensal
organisms may contaminate clinical specimens.
Anaerobic cocci may nevertheless be significant
pathogens in intra-abdominal infections, brain
abscesses, empyema and aspiration pneumonias,
hepatic abscesses, infections of the female
genital tract, or infections following maxillo¬
facial surgery in debilitated patients. An associ¬
ation of anaerobic cocci with infected sebaceous
cysts is recognized, and anaerobic cocci may also
occur in many mixed infections of skin and soft
tissues.
The anaerobic cocci are generally sensitive to
metronidazole and penicillin, and to a wide
range of other antimicrobial drugs including
tetracycline, erythromycin, chloramphenicol,
clindamycin and the cephalosporins. However,
variations in sensitivity make it necessary to
check the susceptibilities of isolates in the
laboratory. Some cocci that may seem to be
anaerobic on primary isolation but are resistant
to metronidazole can be shown on subculture to
grow aerobically, or microaerophically, or in a
CCL-enriched atmosphere; these isolates are not
true anaerobic cocci (Watt & Jack 1977).
Laboratory diagnosis of anaerobic cocci
Table 36.8 indicates some of the representative
species and a range of useful tests. Metronida¬
zole sensitivity is used to differentiate true anaer¬
obic cocci from those that may seem to be
anaerobic on primary isolation. Vancomycin
resistance is typical of Gram-negative anaerobic
cocci. The peptococci and some species of
peptostreptococci are resistant to novobiocin.
Most strains of Peptostreptococcus anaerobius are
sensitive to sodium polyanetholsulphonate
(Liquoid), giving inhibition zones of more than
12 mm diameter with disks containing 100 pg
Liquoid/disk; most other anaerobic cocci are
resistant in this test. The species noted below
merit special attention.
Peptostreptococcus anaerobius. Spherical or
lanceolate Gram-positive cocci, diameter 0.8 /xm.
Short chains with some single and paired cocci
are seen in smears from broth culture. Abundant
gas produced in broth culture. Colonies on blood
agar after anaerobic incubation with 10% CO;
3
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for 24 h at 37CC arc 0.5-1.5 mm in diameter,
round, convex, shiny, opaque. grev and non-
haemolytic. After further incubation, colonies
may become slightly irregular in outline,
umbonate. with a light grey centre and darker
grey periphery.
Peptostreptococcus magnus. Spherical Gram-
positive cocci, diameter 0.8-1 /am Small and
large irregular masses with some single and
paired cocci are seen in smears from broth
culture. Slight gas production in broth culture.
Colonies on blood agar after incubation for 24 h
are very small, round, convex, shiny, opaque,
grey and non-haemolytic.
Peptostreptococcus asaccharolyticus is similar
to P. magnus. but colonies on blood agar after
incubation for 24 h are usually 0.8-1 mm in
diameter. Despite its name, it produces abun¬
dant gas in broth culture.
Veillonella parvula. Spherical Gram-negative
cocci, diameter 0.3-0.5 gm. Diplococci and
single cocci with some clusters are seen in smears
from broth culture. Abundant gas is produced
in broth culture. Colonies on blood agar after
incubation for 24 h are very small, round,
convex, shiny, opaque, light grey and non-
haemolytic.
METHODS
Growth factors for anaerobes
The inclusion of reducing substances (cooked
meat particles, cysteine hydrochloride, sodium
thioglvcollate. glucose) in culture media improves
the growth of anaerobic bacteria. Some anaer¬
obes have a requirement for other growth factors
that are not present in the basal media: the
addition of haemin and menadione (vitamin K.3)
enhances the growth of many species of bacte-
roides. There are claims that the growth of
anaerobic cocci is enhanced by Tvveen 80
(Holdeman et al 1977): the authors could not
demonstrate this effect in PPY medium.
Haemin and menadione
Haemin 500/ug ml. Dissolve 50 mg haematin
hvdrochloride in 1 ml of 1 mo!, litre NaOH
solution, and make up to 100 ml with distilled
water. Filter sterilize.
Menadione 100 /ugml Dissolve 10 mg mena¬
dione in 2 ml ethanol. and make up to UK) ml
with distilled water. Filter sterilize. Protect from
light.
Equal volumes of haemin and menadione
solutions can conveniently be mixed before
storage. They are added to all media for growth
of bacteroides. but can safely be added to all
media for growth of anaerobes with no apparent
inhibitory effect. The final concentrations in the
medium should be haemin 5 /xg ml and mena¬
dione 1 Mgml.
Cysteine HCl 3.75%
Dissolve 3.75 g L-cvsteine hydrochloride in
1(H) ml distilled water. Autoclave at 121°C for
20 min. The final concentration in the medium
should be 0.075%.
Sodium carbonate 2%
Dissolve 2 g Na:CO? in 100 ml distilled water.
Filter sterilize. The final concentration in the
medium should be 0.04%.
Tween SO 10%
Mix 10 ml Tween 80 and 90 ml distilled water.
Autoclave at 121°C for 20 min. The final concen¬
tration in the medium should be 0.02-0.1%.
Media for anaerobes
Many media in general use are given in Chapter
6. Here we list several media that are specially
modified for anaerobic work.
Thioglycollate medium
For fermentation and urease tests use Thioglv¬
collate medium, without glucose or indicator
(BBL). supplemented with 0.25% Yeast extract
(Oxoid) and 0.25% sodium succinate. Dispense
in 5 ml volumes and autoclave at 121°C for
20 min.
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Proteose peptone-yeast extract broth (PPY)
Proteose peptone (Oxoid) 2%
Yeast extract (Difco) 1%
NaCI 0.5%
Dissolve the ingredients in distilled water and
adjust the pH to 7.4. Dispense in 5 ml volumes
and autoclave at 121°C for 20 min. For use. drive
off dissolved oxygen by placing in boiling bath
for 10 min. then add:
L-cysteine HCI. sterile 3.75%
solution 0.1 ml
Na;CO;. sterile 2% solution 0.1 ml
Vore: PPY medium with glucose 1% (PPYG
medium is used for gas chromatography (see
below).
Blood agar for anaerobes
The basic medium is Columbia agar (Oxoid). It
is autoclaved at 121°C for 20 min and cooled to
about 50°C. when the following are added to
give:
Blood agar: 5% defibrinated horse blood.
Lysed blood agar: 51c saponin-lysed horse
blood, and menadione to 1
Combined blood/lvsed blood agar: 4% whole
blood. 1% freeze-thawed lysed blood and
1 /xg/ml menadione. (Use of this medium allows
haemolysis to be detected, and speeds up the
formation of pigment bv pigmented species of
bacteroides.)
Selective blood agar
A range of agents can be added to any of the
above blood agar media to make them selective
for anaerobes as follows (the concentrations
given are the final concentrations in the complete
medium):
Selective medium for anaerobes. Add genta-
micin 20 /xg ml.
Selective medium for bacteroides. Add kana-
mycin 75 /agml and vancomycin 7.5 /ugYnl.
Selective medium for fusobacteria. Add
neomycin 100 MS'm' an<J vancomycin 7.5 /xgYnl.
Selective medium for Clostridia. Add neomycin
70 /zg'ml.
Fermentation tests for anaerobes
Dissolve the carbohydrates in distilled water and
filter sterilize. Rhamnose. trehalose, melibiose.
aesculin. xylan. cellobiose. inositol and mannose
are prepared as 10% solutions, and used at a
final concentration of 0.5%; the other substrates
are prepared as 20% solutions, and used at a
final concentration of 1%. Add 0.25 ml amounts
of the appropriate test carbohydrate solutions to
5 ml amounts of reduced thioglycollate medium
or PPY broth.
After inoculating the test .organism, incubate
anaerobicallv with 10% CO; at 37°C for 24 h. or
up to 4 days until reasonable growth occurs. A
seeded tube of the test medium without carbo¬
hydrate is incubated as a reference control. Read
the results, preferably with a pH meter, or by
adding a suitable pH indicator solution (e.g. a
0.02 ml drop of a 0.1% aqueous bromothymol
blue solution). If a pH meter is used, the test is
regarded as positive if the pH falls 0.5 unit below
that of the carbohydrate-free reference control
culture. If the indicator is used, a yellow colour
indicates a positive result, and a green colour
indicates a negative result. It is not advisable to
incorporate an indicator in the culture medium
at the start as indicator dyes may be decolour¬
ized. sometimes irreversibly, under anaerobic
conditions. When equivocal results are obtained
with the indicator solution, they should be
verified with a pH meter.
Other tests modified for anaerobes
Urease
Dissolve the urea (10%) in distilled water and
filter sterilize. Perform this test in thioglycollate
medium or proteose peptone yeast extract (PPY)
broth containing 1% urea, and read the results
as for the fermentation tests. The test is regarded
as positive if the pH rises 0.5 unit above that of
the substrate-free reference control culture, or
if the indicator turns blue.
Indole production
Extract 5 ml of PPY culture with 0.5 ml toluene.
Slowly layer 0.5 ml Ehrlich's indole reagent on
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to the liquid interface. A red/purple colour in¬
dicates a positive result
Ehrlich's indole reagent. Dissolve 1 g
/?-dimethyl-aminobenzaldehyde in 95 ml absolute
ethanol, then slowly add 20 ml concentrated
HC1. Protect from light.
Nitrate reduction
Sterilize a solution of potassium nitrate (KNOi)
2% in distilled water bv autoclaving at 12UC for
20 min. Use this to supplement PPY medium
with KNO3 200 /xg/ml. To 5 ml of the test
culture in this PPY nitrate medium, add 0.25 ml
Reagent 1. then 0.25 ml Reagent 2. A red colour
indicates the presence of nitrites.
Reagent I. Add 100 ml distilled water and
30 ml glacial acetic acid to 0.5 g sulphanilic acid
and allow to dissolve.
Reagent 2. Dissolve 0.2 g Cleves acid (5-
amino-2 naphthalene sulphonic acid) in 120 ml
distilled water by warming in a waterbath. then
add 30 ml glacial acetic acid.
Gas chromatography (GC) of metabolic
products
This procedure can be used with cultures of test
organisms, or directly with pus or exudate. Grow
cultures for 24 h or longer in 5 ml of PPY
medium containing 1 % (w/v) glucose (PPYG).
After acidification to c. pH 2 with 0.1 ml of 50%
(v/v) H2SO4, remove the bacteria and insoluble
material by centrifugation at 5000 g for 15 min.
For analysis of volatile fatty acids (VFA) and
alcohols, prepare ether extracts by adding 0.2 ml
50% (v/v) H2SO4. 0.4 g NaCl and 1 ml diethyl
ether to 1 ml of the prepared culture supernate.
After mixing well and centrifuging at 500 g for
5 min, carefully pipette the ether layer on to
fine-mesh anhydrous CaCF to remove water.
The CaCF should be about one quarter of the
total volume, and the mixture should be left for
5 min before use (Holdeman et al 1977). Inject
samples (1 /xl) into the GC column. It is possible
to obtain VFA profiles by injecting samples
(1 /xl) of acidified culture supernate directly on
to some GC columns (Deacon et al 1978) but
these columns become contaminated and the
packing must be replaced. Ether extraction is
essential for samples of pus or exudate. For non¬
volatile fatty acids (lactic, succinic and phenvl-
acetic), methylate samples by mixing 1 ml of
prepared culture supernate, 0.4 ml of 50% (v;'v)
H2SO4 and 2 ml methanol in a stoppered tube
and either leave overnight at room temperature,
or heat at 60CC for 1 h. Add 1 ml distilled water
and 0.5 ml of chloroform and mix well by inver¬
sion. If an emulsion forms, centrifuge at 500 g
for 5 min. Inject samples (1 /xl) of the chloro¬
form layer on to the GC column.
A less hazardous solvent, methyl rm-butyl
ether, can replace both diethyl ether and chlo¬
roform for the extraction of volatile and non¬
volatile fatty acids (Thomann & Hill 1986).
Following separation of the acids in the
column, they are detected and then recorded as
a series of peaks on a chart recorder. Identifi¬
cation and quantitation of the substances
producing these peaks is done by comparing the
retention time and the peak area respectively
with peaks produced by standard amounts of
known acids.
Useful column packings for analysing meta¬
bolic products include; FFAP, SP 1220 (15%)
+ H3PO4 (1%). or SP 1000 (10%) + H3PO4
(1%) on 100/200 Chromosorb WAW (Supelco).
or Chromosorb 101. 100/120 mesh (Supelco. or
Phase Sep).
Aesculin hydrolysis
Aesculin cooked meat broth is prepared similarly
to CMB. except that aesculin is dissolved in
the broth component before autoclaving. Add
0.5 ml of a 1% aqueous ferric ammonium citrate
solution to the test culture in CMB containing
1% aesculin. or PPY containing 0.2% aesculin.
A black colour indicates a positive result. Note:
renew the ferric ammonium citrate solution
when it changes from green to brown.
Gelatin digestion
Observe a charcoal gelatin disk incubated in a
CMB culture of the test organism for up to 2
>
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weeks. Release of charcoal indicates digestion of
the gelatin.
Prepare disks by a modification of Kohn's
method (1953). Dissolve 12.5 g gelatin (Difco)
in 100 ml nutrient broth (Oxoid No. 2). Add 5 g
of finely powdered charcoal, pour the mixture
into flat dishes to a depth of c. 3 mm and allow-
to solidify at 4°C. Hold the charcoal gelatin in
4% aqueous formaldehyde solution at room
temperature for 5 days and then, after rinsing
briefly in tap water, cut 1 cm disks. Leave the
disks in running tap water for 48 h or longer,
until all the formalin is removed. Test this by
placing one of the disks on a nutrient agar plate
that has been flood-seeded with a 24 h culture
of the Oxford strain of Staphylococcus aureus.
When virtually no zone of inhibition occurs, the
disks are considered free from formaldehyde.
Place disks in sterile bottles, cover with sterile
distilled water and finally pasteurize by heating
at 70°C for 20 min. Store at 4°C. Test a random
sample of disks for sterility and stability by incu¬
bating in CMB at 37°C for at least 14 days.
Tolerance tests
Growth of the test organism is observed in solid
media containing the test agent. We recommend
separate plates, one containing sodium tauro-
cholate 0.5% and one with gentian violet.
Prepare the media as follows: 0.25% Yeast
extract (Oxoid) and 0.25% sodium succinate are
added to the Columbia agar base before auto-
claving. When cooled to about 50°C. add haemin
5 M&'ml and menadione 1 /xg/ml. Then add the
inhibitory agents as follows: bile medium. 0.5%
sodium taurocholate; gentian violet medium.
Gurr's gentian violet (BDH) to a final concen¬
tration of 1 in 100 000. Aqueous stock solutions
of the dye are prepared at 100x the final concen¬
tration. and the sodium taurocholate at 10x the
final concentration, and sterilized by autoclaving
at 121°C for 20 min. The control medium has no
further additives.
Each medium is seeded with 0.02 ml of starter
CMB culture, and this inoculum is spread with
a loop over about 1/6 of the area of the plate.
After incubation, plates are observed for growth
or inhibition. Set up known control organisms on
each batch of tolerance plates. Suitable control
strains, and the expected results are as follows:
Test organism
Growth on medium
Control with sodium with gentian
taurocholate violet
B fragilis




(NCTC10723) + + +
Antibiotic resistance tests
These tests are useful in the characterization of
some anaerobes. Note that some of the
substances are used at levels that could not be
safely achieved therapeutically; these tests
should not be confused with antibiotic sensitivity
tests.
Freshly prepared blood agar plates are seeded
by spreading 0.02 ml of starter CMB culture on
the surface with a glass spreader. The diameters
of zones of inhibition are measured after 24 h
incubation, or when satisfactory growth occurs.
A zone of <15 mm is considered to indicate
resistance.
The following antibiotic disks should be used:
neomycin. 1000 /ug'disk; kanamycin. 1000 jug/disk:
benzylpenicillin, 2 units/disk; metronidazole.
5 /xgMisk.
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Table 36.1 Tests required to identify anaerobic bacteria
Key. N. necessary: . . .. not necessary: U. use in some cases. For Methods see text. Chs 36 and 37. BA. blood agar plate.
EYA. egg-yolk agar plate; CMB. cooked meat broth. PPY. proteose peptone-yeast extract broth. TG. thioglycollate
medium; SSA. semi-solid agar.
Test required for identification of
Test Bacterotdes Fusobaclerium Clostridium Anaerobic cocci Media employed
Isee Key)
No growth in air N N N N BA
No growth in air + 10T CO: N N BA
Gram stain reaction N N N N CMB or PPY or BA
Cell morphology N N N N CMB or PPY or BA
Spore shape and
position N CMB
Motility U CMB or SSA or BA
Colonial morphology N N N N BA
Colony fluorescence
at 365 nm U U BA




Lipase U N EYA
Bile and dye tolerance Sodium taurocholate Tolerance test agar
Gentian violet '
Antibiotic resistance Kanamvcin 1000 Mg Metronidazole 5 ng
Neomycin 000 Mg Novobiocin 5 ^g BA
Penicillin 2 units Vanomycin 5^g
Metronidazole 5 /ig Liquoid 100 ^g
Indole production N N N N PPY
Aesculin hydrolysis N N N U CMB + IT aesculin or
PPT + 0.2T aesculin
Gelatin digestion 1 N N I CMB with charcoal
Meat digestion ) U \ gelatin disk
Fermentation" Glucose Glucose Glucose Glucose PPY or TG
Lactose Lactose Lactose Lactose
Sucrose Sucrose Sucrose Sucrose


















PPY + IT glucose
" The extended range of these useful sugars is not always necessary. The selection depends upon the degree of
characterization required (see following tables).
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Table 36.2 Typical patterns of results obtained in antibiotic-disk resistance tests and tolerance tests with anaerobic Gram-
negative rods
Key: R. resistant; S. sensitive; S R. 30-70T of strains give each result; R(S). few species give sensitive result; +. growth.
-. inhibited; -( + ), few species give positive result; +/-. result varies depending on species.
Test













Neomycin 1000 gig R S S "R S S
Kanamycin 1000 gig R R R(S) S s
Penicillin 2 units R S,R S S s
Tolerance of:
Bile salt'" + - - +/— -
Gentian violet* - - -( + ) + +
Fermentation of:
Glucose + - +/— +
J Amount of antibiotic in disk is given.
b See Methods.




a. Peritrichous flagella or non-
motile
1. Lactic acid only major
product
2. n-Butyric acid with no (or
only trace amounts of) iso-
butyric or iso-valeric acid
3. Not as (1) or (2) above, and
usually acetic and succinic
acid produced
b Polar flagella. motile
c. Spiral cells with axial fibrils
Cocci
1. Acetic and propionic acid
2. Acetic and butyric acid














a. No spores present
1. Lactic acid only major
product
2. Lactic and acetic acids in
ratio 1: > 1
3. Acetic and propionic acids as
major products
4. Acetic acid ± formic acid,
and lactic or succinic acid or
both as major products
5. n-Butvric acid + others, or




1. Lactic acid only major
product











' Although not strict anaerobes, these organisms are included because on primary isolation they may fail to grow
aerohicallv or mav grow onlv anaerobicallv. Thev are resistant to metronidazole.
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Clostridia of wound infection
The genus Clostridium is composed of anaerobic
large, straight or slightly curved Gram-positive
spore-bearing rods, 3-8 x 0.6-1 /urn with
slightly rounded ends. Gram-variable. Gram-
negative and pleomorphic forms are common. A
few species can grow poorly aerobicallv.
General recommendations for anaerobic culture
procedures are given in Chapter 7, and principles
for the identification of anaerobes are outlined
in the first part of Chapter 36. before the system¬
atic treatments of Gram-negative anaerobes and
anaerobic cocci. Details of special relevance to
the Clostridia are given in this chapter and in
Chapter 38. For convenience, we deal here with
the Clostridia that may be involved in wound
infections, with brief accounts of the histotoxic
group; Clostridium tetani and the laboratory
diagnosis of tetanus are dealt with separately at
the end of this chapter. Enteropathogenic Clos¬
tridia are discussed in the following chapter.
Identification of Clostridia
In practice the routine characterization of patho¬
genic Clostridia is often limited to a few tests
that will presumptively indicate the likely
species; this simple approach partly explains why
many laboratories have experience of a relatively
narrow range of clostridial species. Accurate
subdivision of the Clostridia to species level rests
upon morphological criteria, the results of
biochemical tests and gas chromatography (GC),
together with the identification of some specific
toxins (see. e.g. Table 37.1. and see Willis, 1969;
Willis. 1977; and Willis & Phillips, 1983). Our
approach parallels that adopted in Chapter 36
and is based on a series of simple tests that allow
precise characterization. Initial steps involved in
characterization of Clostridia and the range of
tests of value in detailed identification are given
in Chapter 36 (see Tables 36.1 and 36.3). There¬
after. the Clostridia can be divided into four
groups based on lecithinase production, and
lactose and glucose fermentation (see Tables
37.2-37.5. at end of chapter). Whenever poss¬
ible. the identity of toxigenic species should be
confirmed by specific toxin-neutralization tests,
although it should be borne in mind that non-
toxigenic strains may also occur. Even without
GC or animal tests, presumptive identification is
often possible. (Note: as in Ch. 36. key reactions
in the tables that give differential characteristics
of important pathogenic species are indicated in
bold and these provide a short-cut identification
system for the Clostridia.)
Many of the techniques used for identification
of Clostridia are also used for other anaerobes
and detailed instructions are given in Chapter 36;
tests and procedures of particular relevance to
Clostridia are included here.
All Clostridia produce spores but they vary
markedly in their readiness to do so; prolonged
incubation of cooked meat broth (CMB) cultures
may be required. The spores are most readily
demonstrated in wet films examined by phase
contrast microscopy. The shape of the spore and
its position in the bacillus is of some help in
classification. C. perfringens and the type species
C. butyricum produce capsules. Most Clostridia
are motile, but C. perfringens is not. Some
motile species do not show active motility under
the relatively aerobic conditions of the usual wet
film preparations and it may be advantageous
to use a semi-solid agar stab (see Methods
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section below). The active motility of species
such as C. septicum and C. sporogenes may be
of advantage or of distinct disadvantage in the
isolation of pure cultures on solid media (see
below).
Biochemical tests are important in the classi¬
fication of many Clostridia. C. perfringens. C.
septicum, C. tertium and C. fallax are predomi¬
nantly saccharolytic: C. sporogencs and C. histo
lyticum are actively proteolytic and C. tetani is
slightly proteolytic. These activities are reflected
in the cultural appearances in CMB (and also in
litmus milk medium). The saccharolytic Clos¬
tridia grow rapidly and vigorously in carbo¬
hydrate media with production of acid and
abundant gas: detailed recommendations for
specific sugar fermentation tests are given in the
Methods section of Chapter 36 (and see Table
36.1). When grown in CMB. saccharolytic Clos¬
tridia rapidly produce acid and gas but they do
not digest the meat: the cultures may have a
slightly sour smell and the meat is often
reddened. Gas production is not necessarily
indicative of sugar fermentation, as proteolysis
may be accompanied by evolution of gas
bubbles.
The proteolytic Clostridia digest protein and
liquefy gelatin and coagulated serum. Cultures
in meat medium produce blackening of the meat,
decomposing it and reducing it in volume with
the formation of foul-smelling products.
In litmus milk medium (Ch. 8). C. perfringens
produces acid and gas. The acid clots the milk
and the gas breaks up the clot, resulting in the
'stormy clot' reaction that is produced by almost
all strains of C. perfringens but is not specific for
this organism as various mixed cultures may
mimic the reaction. Litmus milk medium does
not support luxurious growth of some Clostridia.
It is of very limited usefulness in a diagnostic
laboratory.
Phospliolipase-C (lecithinase) and lipase activity
can be demonstrated when cultures are grown on
egg-yolk media (see Methods section below).
Zones of opacity produced in egg-yolk agar
cultures of phospholipase-producing Clostridia
can be neutralized by antisera prepared against
C. perfringens type A and C. novyi type A toxins
(the Nagler effect). The specificity of this
neutralization is valuable in identification of a
range of Clostridia (see Table 37.2 at the end of
this chapter).
Gas chromatography (GC) is also of value in
the identification of Clostridia. GC used in
conjunction with the Gram stain reaction and cell
morphology can identify anaerobes to generic
level (see Table 36.3). The production of butyric
acid by many species of Clostridia readily differ¬
entiates them from some other genera of anaer¬
obic Gram-positive rods (Lactobacillus,
Bifidobacterium, Actinomyces and Propionibac-
terium). However, it is necessary to demonstrate
spores to differentiate the non-butyric-acid-
producing Clostridia from these genera, and the
butyric-acid-producing Clostridia from Eubac-
terium species.
GC. used in conjunction with a suitable range
of phenotypic tests, can also help to identify
some Clostridia to species level. This is especially
so when the phenotypic characteristics are
similar for more than one species, or when
differentiation of the species depends on the
results of tests that require prolonged incubation
(gelatin liquefaction, spore production), or on
tests that give variable results if not done under
optimal conditions (motility). Thus, butyric acid
production differentiates lecithinase positive
strains of C. subterminale from C. limosum. and
C. butyricum from C. clostridiforme; C. irregu¬
laris, C. cochlearium and lecithinase negative
strains of C. subterminale can be differentiated
by butyric and isobutyric acid production: isobu-
tyric acid production differentiates C. difficile
from C. innocuum and C. putrificum from C.
novyi type C (see Tables 37.2-37.5, at the end
of this chapter). Recommendations for GC tech¬
nique are given in the Methods section of
Chapter 36.
CLOSTRIDIUM PERFRINGENS
C. perfringens (C. welchi) can be identified as
outlined in Table 37.2 (see end of this chapter).
Five types (A-E) are distinguished by the
different combinations of major lethal toxins that
they produce (Table 37.1). C. perfringens type
A occurs normally in numbers of about 104/g wet
3
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Table 37.1 The major lethal toxins and minor lethal or non-lethal factors produced by the various tvpes of Clostridium
perfringens (after Brooks et al 1957).
Key +. produced by >95rc of strains: +. produced by most strains: (-»-)■ produced bv some strains: -. not produced.
Major lethal Minor lethal or non-lethal factors
toxins
Type Occurrence a P € 1 V 6 n e k X V
i| Gab gangrene
al , Puerperal infection
1 Septicaemia + - - - - ( + ) ( + ) ( + ) - ( + ) ( + )
a: Food poisoning + " - - - - - (+) ( + ) - ( + )
b Lamb dysentery + + + - + (-) - + " + + +
|f 'Struck' in sheep + +
- - + - + + - - (*:
| Enteritis in other
C animals + + - -
•?
- - + + - - (+.
Enteritis necroticans
1I in man + - - - - - - - - +
1| Enterotoxaemia of
D i sheep and pulpy
( kidney disease + + - - - - + + + ( + ) < +
E Doubtful pathogen of
sheep and cattle + - + - - - + + + ( + ) ( +
weight of faeces in the large intestine of healthy
man and animals; this is a median figure and the
range is very wide (see Collee 1974). The
organism also occurs commonly in soil, water
and dust and is particularly associated with
manured cultivated soil. The classical C. perfrin¬
gens of gas gangrene belongs to type Al. Note
that C. perfringens food poisoning is dealt with
separately in Chapter 38.
Morphology and staining
A relatively large Gram-positive rod. about 4-6
x 1 /am. with stubby ends, occurring singly or
in pairs; often capsulate in tissues. In sugar
media the rods are shorter; in protein media they
may become filamentous. Non-motile. Spores
formed, usually in small numbers and not in the
presence of fermentable carbohydrates; typically
oval, subterminal or central and not bulging.
Spores are produced in special media such as
Ellner medium.* but here many bizarre forms
occur and sporulation is variable, even with
different cultures of the same strain. The
improved sporulation media described by
Duncan & Strong (1968)* and Phillips (1986)*
are now recommended.
" Refer to Methods at end of this chapter.
Cultural characters
Anaerobic, but may grow microaerophilicallv.
Optimum temperature range 37-45°C. Grows
best on carbohydrate-containing media such as
glucose blood agar. Surface colonies large,
smooth, regular, convex, slightly opaque disks.
On horse blood agar, colonies usually surrounded
by a variable zone of complete haemolysis and
a wider darker zone of incomplete haemolysis.
Other types of colonies include one with a raised
opaque centre and a flat radially striate trans¬
parent border. Rough flat colonies with an irregu¬
lar edge resembling a vine leaf may also occur.
A variant occasionally produces very mucoid
broth cultures and tenacious colonies on blood
agar.
Biochemical reactions
Actively saccharolytic. Ferments, with gas
production, glucose, lactose, sucrose, maltose,
mannose. inositol, starch and (some strains)
salicin, glycerol and inulin; mannitol and galac-
titol (dulcitol) not fermented (see Ch. 36 for
Methods). Acid and gas produced in litmus milk
medium gives the 'stormy clot' reaction; this is
produced by almost all strains but is not specific
for this organism. The culture has a sour, butyric
\
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acid odour. Gelatin liquefied; coagulated serum
not usually liquefied. In CMB the meat is
reddened hut not digested. Hydrogen sulphide
is produced; sulphite is actively reduced; most
strains reduce nitrates to nitrites.
Viability
Spores generally resist routinely used antiseptics
and disinfectants with the exception of formal¬
dehyde and glutaraldehyde. The spores of
classical type A1 strains do not survive boiling
for more than a few minutes, whereas the spores
of type A2 food-poisoning strains and certain
type C strains may be markedly heat resistant
(see Ch. 38).
Vegetative cells of C. perfringens are very
sensitive to heat and disinfectants. C. perfringens
is sensitive to penicillin, erythromycin, many
cephalosporins and metronidazole. Generally
sensitive to clindamycin. Typically resistant to
aminoglycosides.
Toxins
The five types of C. perfringens can be differ¬
entiated by their production of the four major
lethal toxins (Table 37.2). Typing is done by a
combination of in-vitro and in-vivo neutraliz¬
ation tests; for details see Volume 2 of the 12th
Edition of this book (p 474).
Alpha fa) toxin is produced by all types but
notably by type A1 strains; occasional negative
strains occur. It is lethal for laboratory animals
and necrotizing on intradermal inoculation. The
a toxin is a Ca2+ or Mg:~-dependent phospho-
lipase. or lecithinase-C (E.C. 3.1.4.3; phospha¬
tidylcholine choline phosphohydrolase). In the
presence of free Ca:* or Mg2+ it produces
opalescence in serum or egg-yolk preparations
by splitting phospholipid complexes. The reaction
can be inhibited by specific antitoxin; this is the
basis of the Nagler test.*
The enzyme is haemolvtic for the red cells of
most species except the horse and the goat. The
clear zones of haemolysis typically seen around
colonies of classical type A1 strains grown on
horse blood agar are produced by the theta (0)
toxin and not bv the a-toxin. With the red cells
of the sheep in particular, the a toxin provides
an example of a 'hot-cold' lysin. Activity may be
assayed by turbidity tests with egg-yolk emulsion
(lecitho-vitellin, LV) or human serum as indi¬
cator. or by haemolysis tests incorporating anti-
sera to other haemolytic toxins that may be
produced by C. perfringens.
Animal pathogenicity
Virulence for guinea-pigs can be demonstrated
by subcutaneous or intramuscular injection of
0.5-1 ml of a 24 h culture in CMB into the
thigh. A control animal can be protected by an
injection of 300-500 units of C. perfringens anti¬
toxin given intraperitoneally 24 h before chal¬
lenge. In the test animal, a spreading inflammatory
oedema develops with gelatinous exudate and
gas production in the tissue planes; the affected
muscles become pink, sodden and necrotic and
virtually liquefy at the site of injection. The
products of growth in a young culture increase
the organism's aggressiveness; washed organisms
are practically non-pathogenic. An equal volume
of a sterile 5% solution of calcium chloride
mixed with the inoculum just before injection
increases the pathogenicity of a strain.
CLOSTRIDIUM NOVYI
Four types of C. novyi (C. oedematiens) types A.
B, C and D are specifically differentiated on the
basis of the toxins or 'soluble antigens' that they
produce; they can be identified as outlined in
Tables 37.2 and 37.4 (at the end of this chapter).
Type A strains and occasionally type B strains
may be associated with a severe form of gas
gangrene in man.
Morphology and staining
Large Gram-positive rods (5-8 x 0.8-1 pm)
with rounded ends and peritrichous flagella.
Spores oval, central or subterminal.
Cultural characters
Type A strains are very strictly anaerobic. Type
\
CLOSTRIDIUM SEPTICUM 575
B and type C strains are even more exacting, and
type D strains are among the most exacting of
the strict anaerobes that can be cultured as a
routine on solid media. All types may be grown
satisfactorily in freshly made CMB. Special solid
media are required for reliable surface growth of
types B. C and D (see Collee et al 1971); these
types are not typically associated with human
disease. The following observations relate to
type A strains, which will grow on appropriate
solid media if the atmosphere is strictly anaer¬
obic; growth is enhanced by 109c CCK Surface
colonies are raised, opaque, sometimes dome-
shaped and circular in very young cultures, but
often flattened, large and irregular in older
cultures. The colonies tend to fuse and form a
spreading, sometimes swarming, growth; tracks
produced by motile daughter colonies may be
seen. Discrete colonies show two zones of
haemolysis on horse blood agar - a narrow inner
zone of complete haemolysis, and an outer zone
of partial lysis; this is not seen with spreading
growth. On egg-yolk media, the organism's
gamma (y) toxin produces a zone of opacity
caused by its phospholipase (lecithinase) activity
which can be inhibited by specific antitoxin. In
addition, the epsilon (e) toxin (a lipase)
produces a pearly layer effect that is more
restricted and overlies the colonies.*
Biochemical reactions
C. novyi type A is saccharolytic and mildly
proteolytic. Ferments glucose with gas production.
Some strains ferment maltose and inositol.
Various other sugars including lactose, sucrose,
fructose and mannose are not fermented.
Changes produced in litmus milk medium are
slight and indefinite. Gelatin is liquefied, but
milk agar, coagulated serum and cooked meat
are not digested. Hydrogen sulphide is produced.
Nitrates and nitrites reduced. Type A strains do
not produce indole or reduce sulphite (Rutter
1970).
Serology
All types seem to share at least one common
surface antigen and this is exploited in a direct
immunofluorescence procedure for the prompt
identification of C. novyi.*
Animal pathogenicity
An intramuscular injection of 0.2-1 ml of an
actively growing culture of C. novyi type A in
CMB into the thigh muscles of a guinea-pig may
cause overwhelming gas gangrene, with minimum
gas production but with massive oedema. With
some strains there may be difficulty in initiating
the infection and the procedure outlined above
for C. perfringens should be followed.
CLOSTRIDIUM SEPTICUM
C. septicum and C. chauvoei are very similar
(Table 37.3). Both organisms occur widely in the
soil and in animals in health and disease, but C.
septicum is also well recognized as a pathogen
of man. It may be involved in gas gangrene (clos¬
tridial myositis) on its own or in association with
other Clostridia.
Morphology and staining
Moderately large Gram-positive rods with rounded
ends. 3-20 x 0.6-1 gm. Pleomorphic; short
forms, swollen 'citron bodies' and long curved
filaments occur; degenerate Gram-negative
forms common. Actively motile with peritrichous
flagella. Spores readily formed; oval, central or
subterminal and distend the bacillus.
Cultural characters
Obligatory anaerobe but less strict than C.
tetani. Optimum temperature 37°C. Grows on
ordinary media, but glucose promotes growth.
Grows well on blood agar to produce irregular
transparent colonies, later becoming greyish and
opaque with fairly coarse projecting radiations;
often confluent spreading growth. Colonies on
horse blood agar may show a narrow zone of
haemolysis.
Biochemical reactions
Ferments various sugars including glucose.
\
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lactose, maltose and salicin. but not mannitol or
sucrose. Slight acid production in litmus milk
medium may cause slow clotting. Liquefies
gelatin but not coagulated serum: no proteolytic
effect on milk agar. The meat in CMB is
reddened but not digested. Hydrogen sulphide
is produced but not indole. Nitrates reduced to
nitrites. Sulphites reduced. C. septicum does not
produce a phospholipase or lipase effect on egg-
yolk agar.
Antigenic characters
Six groups distinguished on the basis of two
somatic antigens (1. 2) and five flagellar (H)
antigens (a-e). Marked cross-relationship with
C. chauvoei. which shares a common spore
antigen with C. septicum. There are good
reasons to consider C. septicum and C. chauvoei
as different types within the same species.
However, most C. chauvoei strains have a
distinct specific antigen and this is exploited in
a direct immunofluorescence procedure for the
prompt identification of these two species by
ultraviolet microscopy.*
Soluble antigens
The a toxin of C. septicum is lethal, haemolytic
and necrotizing. The (3 toxin is a deoxyribo-
nuclease. The y toxin is a hyaluronidase. and
the 6 toxin is an oxygen-labile haemolysin. A fibri-
nolysin is produced and the organism also
produces a haemagglutinin and a neuraminidase.
Animal pathogenicity
Intramuscular injection of cultures into guinea-
pigs produces gas gangrene. The organisms
invade the blood and the animal dies within a
day or two. Smears from the liver show long,
filamentous forms and 'citron bodies'.
CLOSTRIDIUM BIFERMENTANS AND
CLOSTRIDIUM SORDELLI
C. bifermentans and C. sordelli are closely
related, but C. bifermentans is non-pathogenic
whereas pathogenic strains of C. sordelli produce
a lethal necrotizing toxin and are occasionallv
associated with wound infections in man. Their
identification is outlined in Table 37.2.
Morphology
Short stubby Gram-positive rods with rounded
ends, often occurring in chains and showing large
oval central spores that do not typically bulge
but seem to make the whole organism look
bigger. Chains of these forms in Gram smears or
in wet films give the appearances of necklaces set
with bright beads.
Cultural characters
Grow readily and are relatively non-exacting
anaerobes. Growth on blood agar abundant and
may spread. Colonies grey-white, convex,
roughly circular with irregularly crenated edges;
more irregular colonies common. Colonies on
blood agar are often, but not invariably,
haemolytic.
Biochemical reactions
The name bifermentans refers to the ability to
decompose both sugars and proteins, and the
sordelli/bifermentans group shares this double
activity with variations: C. bifermentans ferments
glucose, maltose, mannose. sorbitol and salicin.
w hereas C. sordelli ferments glucose and maltose
but not the other sugars in this list; neither
ferments lactose nor sucrose. Both are strongly
proteolytic: they liquefy gelatin and decompose
milk protein, coagulated serum and cooked
meat. C. bifermentans does not decompose urea,
whereas C. sordelli usually produces an active
urease. Both produce indole and hydrogen
sulphide, and both produce a serologically
related phospholipase (lecithinase) that is
partially neutralized by C. perfringens antitoxin.*
A nimal pathogenicity
Experimental inoculation of 0.5-1 ml of an
actively growing CMB culture of a pathogenic
strain of C. sordelli into the thigh of a guinea-pig
\
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produces a rapidly lethal oedematous myone¬
crosis.
CLOSTRIDIUM H1STOLYT1CUM
This long slender Gram-positive rod is not a
strict anaerobe and can be cultured aerobically.
Proteolytic but non-saccharolvtic. In meat
medium, digestion occurs with the formation of
white, crystalline masses of tyrosine. Pathogenic
to experimental animals and man. When a
culture is injected into the muscle of an animal,
in-vivo digestion of the tissues results. Produces
a lethal necrotizing exotoxin, an active colla-
genase. a proteinase, an elastase. an oxygen-
labile haemolysin. and various other biologically
active products. It may be associated with gas
gangrene in man. Its identification is outlined in
Table 37.5.
CLOSTRIDIUM TERTIUM
This slender rod is also a non-exacting anaerobe
and will grow sub-optimally under aerobic
conditions. Weakly motile. Spores oval, terminal.
Actively saccharolvtic. In litmus milk, acid is
formed with gas production and slow clotting.
Meat is reddened but not digested. Neither
gelatin nor coagulated serum is liquefied. Its
pathogenicity is doubtful, but when present in
wounds it may give rise to gas production. No
exotoxin is produced. See Table 37.3 for an
outline of its identification.
CLOSTRIDIUM SPOROGENES
This Gram-positive motile bacillus is very widely
distributed. Generally regarded as a harmless
saprophyte, but frequently isolated from wound
exudates in association with pathogens. Its
identification is outlined in Tables 37.2 and 37.4.
Morphology and staining
Usually longer and more slender than C. perfrin-
gens. Forms abundant oval, central or
subterminal spores which may be highlv
resistant: hence the organism is frequently
encountered in mixed cultures in the laboratory,
especially after preliminary heating of these
cultures to select heat-resistant pathogens. Its
spores may survive boiling for periods of 15 min
up to 6 h.
Cultural characters
Relatively strict anaerobe. Grows well on simple
media, provided that anaerobic conditions are
maintained. Surface colonies may present a
medusa-head appearance (cf. Bacillus anthracis)
if the plate is dry. Young colonies small, circular,
raised and slightly opaque; soon produce
outgrowths and the spreading margin of the
colony becomes irregular with coarse feathery
projections. On horse blood agar colonies may
appear to be haemolytic but this is not caused by
a true haemolysin: they are usually irregular and
transparent with some central greyish opacity
where the colonies are raised. Colonies in shake
cultures show as 'woolly' balls of growth. A stab
culture develops with lateral spikes like that of
C. tetani.
Biochemical reactions
Actively proteolytic and saccharolvtic; produces
amino acids, ammonia, hydrogen sulphide, etc.
and cultures have an exceedingly putrid odour.
In milk media, casein is precipitated and
digested. In CMB. meat is blackened and di¬
gested. Gelatin and coagulated serum liquefied.
Acid and gas produced from some sugars,
including glucose and maltose: lactose and
sucrose not fermented.
Laboratory diagnosis of gas gangrene
The bacteriological diagnosis of gas gangrene is
usually combined with a general bacteriological
examination of the infected wound with which
this condition is associated. It is convenient here
to give special reference to the recognition of the
Clostridia, but see also references to bacteroides
infections in Chapter 36.
Take exudate from the wound, particularly
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from the deeper parts and from parts where the
infection seems to be most pronounced. Sterile
swabs rubbed over the wound surface and
soaked in the exudate are much less satisfactory
than pus and excised tissue fragments. If there
are sloughs or necrotic tissue or if there is an
adequate amount of exudate present in the
wound, place good samples of these in sterile
screw-capped bottles. If only swabbed specimens
are available, ask for at least two or three: one
for film preparations, one for aerobic, and one
for anaerobic culture. Prompt submission to the
laboratory is imperative; desiccation in transit
must be avoided. It is good practice to put a
swab directly into a screw-capped bottle of CMB
at the bedside. The steps in a routine investi¬
gation are as follows:
1. Prepare smears for Gram stain. If gas
gangrene is present. Gram-positive rods may
predominate. Thick, stubby. Gram-positive rods
suggest C. perfringens or C. sordelli: 'citron
bodies', boat- or leaf-shaped pleomorphic bacilli
with irregular staining, may indicate C. septicum;
slender rods with round terminal spores suggest
C. tetani; C. novyi occurs as large rods with oval
subterminal spores, but these may be relatively
scanty in the wound exudate, even in an active
infection. The direct immunofluorescence staining
procedure of Batty & Walker (1965) is a most
useful diagnostic aid for the prompt identifi¬
cation of C. septicum and C. novyi and some
other Clostridia, but not C. perfringens (see
Methods section below).
2. In addition to the media routinely used for
detection of aerobes, inoculate a tube of pre-
reduced cooked meat broth (CMB). a blood agar
(BA) plate and two plates of selective BA
containing neomycin 70-10(1 pg'm 1 (see Ch. 36).
Primary sensitivity tests can be made at this stage
bv placing disks, e.g. metronidazole and peni¬
cillin. on the first series of streaks.
Consider also the use of: plates containing
increased agar (4-6%) to prevent swarming by
some species of Clostridia:* a selective egg-volk
agar plate, with or without antitoxins, to detect
phospholipase- and lipase-producing Clostridia,
and to demonstrate any Nagler reaction;*
additional tubes of CMB, heated at 70°C for
20 min or at 100°C for 5-20 mm. to select
sporing forms.
3. Incubate the CMB. BA and selective BA
anaerobically with 10% CO; at 37°C. Leave one
selective BA incubating anaerobically
undisturbed for 48 h. Examine the other media
after 24 h incubation.
4. Examine plates for typical colonies.
Comparison of the aerobic and anaerobic plates
affords some indication of the presence of strictly
anaerobic organisms, but any suspect anaerobe
must later be tested in subculture to ensure that
it is unable to grow under aerobic conditions (see
Watt & Jack 1977). C. tertium, C. carnis and C.
histolyticum can grow to some extent aerobically.
5. Examine CMB enrichment by microscopy,
and subculture to plates. In CMB both aerobes
and anaerobes flourish: this growth is useful for
later subculture should the plate culture fail to
yield successful isolation of organisms present in
the wound. Film preparations also yield further
information on the morphological types of
vegetative organisms, and sporing forms that
may have developed can be seen.
Note: C. perfringens is a common environ¬
mental contaminant and. because of its capacity
for rapid growth in CMB. it may be present in
misleadingly large numbers on secondary plate
cultures seeded from primary broth cultures.
When it is truly involved in a clostridial myositis
(gas gangrene). C. perfringens is usually capsu-
late and can generally be recovered in large
numbers on primary plates.
6. Pick suspect colonies and subculture to pre-
reduced CMB or PPY medium for subsequent
identification by biochemical tests, and to PPY
medium containing glucose 1% for gas chroma¬
tography (GC; see Methods. Ch. 36).
CLOSTRIDIUM TETANI
C. tetani is a common saprophyte occurring in
cultivated soils throughout the world. Tetanus
occurs in man and animals when a wound is
infected with the organism and conditions permit
it to multiply and to produce tetanospasmin.
which begins to act on the central nervous
\
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strating the presence of tetanus neurotoxin in
culture supernates; a pair of mice is used for
each test. Protect one animal by intraperitoneal
injection of 500-1500 units (0.5 ml) of tetanus
antitoxin 1 h before the test. Inject 0.1 ml of a
48 h CMB culture supernate of the organism
intramuscularly into a hind limb of the test and
control animals. Signs of ascending tetanus
develop in the unprotected animal after several
hours: they begin in the inoculated leg and
extend to the tail: then the other hind limb is
affected and then generalized signs appear. The
animal responds to the slightest stimulus with
generalized spasms. If large doses of toxin are
injected, death may occur in 18-24 h without
any of the intermediate symptoms.
Tetanolysin. an oxvgen-labile haemolvsin. is
distinct from the true tetanus toxin.
Laboratory diagnosis of tetanus
The specimen will be wound exudate or tissue
removed from the wound.
1. Make a direct smear. Gram stain, and
examine for drumstick spore-formers. Caution:
only a minority of specimens will show these and
they are not an invariable index of the presence
of C. tetani. The use of immunofluorescence
staining should be considered here.*
2. Inoculate exudate or homogenized tissue
into CMB and on to a BA plate and two selec¬
tive BA plates (see Methods Ch. 36). Incubate
anaerobicallv with 107c CO; at 37°C. Consider
also seeding an antitoxin-controlled plate for
the presumptive identification of C. tetani. This
involves the use of a freshly prepared BA plate
half-smeared with tetanus antitoxin (Lowbury
& Lilly 1958). C. tetani produces haemolysis
which is inhibited by the antiserum. Although
there are several objections to this technique,
the method is convenient for the provisional
screening of large numbers of strains. Confirm¬
ation by mouse inoculation is recommended.
3. Leave one selective BA plate undisturbed
in the anaerobic atmosphere for 48 h. Check the
other plates after 24 h incubation, and daily for
up to 4 days. Examine the plates with a hand
lens or plate microscope for fine spreading
growth. (Note that C. tetani type 6 is non-
motile). If present, make a pure subculture from
the spreading edge to BA and pre-reduced
CMB. and incubate anaerobicallv for 48 h.
4. Examine the CMB enrichment culture daily
by microscopy. If clostridial forms are seen, do
the following:
a. Heat part of the culture at 8()°C for 10 min
and then subculture the heated and unheated
samples to BA. Incubate the plates anaerobic-
ally. (Note that some C. tetani spores are heat
sensitive.)
b. Direct immunofluorescence staining.
c. Although it is usual to wait until a pure
culture is available, toxicity testing can be done
with the supernate from the CMB enrichment
culture.
5. Check the subculture in CMB. If it is not
pure, subculture from the spreading edge of
growth on BA to pre-reduced CMB. If the CMB
is pure, set up toxin tests in protected and
unprotected mice (see above), set up a range
of biochemical tests, and examine the fatty acid
profile by GC (see Table 37.5).
METHODS
Identification of Clostridia by direct staining
with fluorochrome labelled antibody
This procedure (see Batty & Walker 1965) is of
use for the identification of C. septicum, C.
chauvoei, C. novyi, C. botulinum types A. B. F.
C, D and E. and C. tetani. Conjugated
immunoglobulins are commercially available
from Wellcome.
An air-dried smear is fixed by immersion of
the slide in reagent grade anhydrous acetone for
10 min. A drop of the conjugated immunoglobulin
is spread on the smear and left at room tempera¬
ture for 30 min in a humid atmosphere provided
bv a wet filter paper in a plastic box.
The excess conjugate is quickly rinsed off the
smear with phosphate buffered saline at pH 7.6
(NaCl 8.5 g. Na;HPOj 1.28 g. NaH:P04.2H;0
0.156 g. in 1 litre of distilled water): the smear
is held in several changes of this buffer during
the following 10-15 min. It is then gently blotted
dry and mounted with buffered glvcerol at
pH 8-9 (NaHCO, 0.0715 g. Na:c63' 0.016 g.
\
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water to 10 ml. glycerol to 100 ml) and a glass
(not plastic) coverslip for UV microscopy.
Preservation and storage of strains
Strains may be preserved by freeze-drying or by
storage in various media. Cooked meat broth
containing chalk and minced cooked egg-white
is a useful preservation medium (Ch. 6).
Germination of spores is sporadic, especially
following heat-resistance tests, and this is
considered to be partly due to fatty acids in the
subculture medium. The inhibitory effect may be
reduced by incorporating soluble starch or serum
in the medium when subcultures are made from
preservation media or from heat-resistance tests.
Media that induce sporulation
Ellner's (1956) medium
This medium is used to induce spore formation
in C. perfringens. Anaerobiosis may be ensured
by heating at 100°C for 10 min and cooling just
prior to inoculation. It is important that the
inoculum should be adequate; 0.5 ml of an
actively growing 4-12 h meat broth culture
should be introduced with a pipette into the
bottom of the tube of medium. Incubation is in
an anaerobic jar at 37°C.
Peptone (e.g. Proteose peptone.
Difco) 10 g
Yeast extract 3 g




Water to 1 litre
Steam briefly at 1(K)°C to dissolve, adjust to
pH 7.8 with sodium hydroxide 1 mol/litre.
dispense in tubes and autoclave at 121°C for
20 min. Tubes should be half to two-thirds full.
Medium of Duncan & Strong (1968)
This medium should be pre-steamed and then
cooled to 37CC just before being seeded with a
10% volume of a 4 h active culture of the strain
of C. perfringens in thioglycollate broth.
Addition of activated carbon (Iff) may increase
the sporulation of some strains. Although high
numbers of spores are produced by many test
strains, the medium is not invariably successful;
this reservation should be applied to all currently
developed media for the sporulation of C.
perfringens.
Proteose peptone 15 g
Yeast extract 4 g





Water to 1 litre
The pH of the medium is about 7.0. Steam at
100°C to dissolve, and dispense into screw-
capped bottles which should be at least two-
thirds full of medium. Autoclave at 121°C for
15 min. After inoculation and incubation,
sporulation should be evident within about 6 h;
maximum sporulation is likely to be achieved at
10-16 h.
Medium of Phillips (1986)
A plate of this sporulation medium for Clostri¬
dium perfringens should be seeded by rubbing
a dry swab charged with a blood agar culture of
the organism over the whole surface. Incubate
in an atmosphere of nitrogen 80%. CO: 10%
and hydrogen 10% at 37CC for 48 h.
Blood agar base No. 2 (Oxoid CM27) 39.5 g
Desiccated ox bile (Oxoid L50) 10 g
Sodium bicarbonate. NaHCO-, 5 g
Ouinoline (BDH No. 30012) 0.5 ml
Defibrinated horse blood 50 ml
Distilled water 1 litre
Dissolve the blood agar base, the ox bile and
the quinoline in 800 ml of the water and ster¬
ilize at 12I°C for 15 min. Cool to 50°C. Add the
sodium bicarbonate (dissolved in 200 ml of the
water and filter sterilized) at 50°C. Then add the
horse blood and pour plates. The pH of the
medium should be 8.5.
\
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Alkaline et;g medium
This medium promotes spore formation bv Clos¬
tridia. Clostridia remain viable in it for years.
Egg yolk 1
Egg whites 2
Sodium hydroxide. NaOH. 1 mo 1/1 it re 6 ml
Water to 500 ml
Beat the yolk and whites, add the sodium
hydroxide and water. Eleat slowly to 95CC for
90 min. filter through cotton wool and distribute.
Sterilize by autoclaving at 121°C for 15 min.
Reinforced clostridial agar
This medium is specially enriched with substances
that might promote the growth of Clostridia. Its
preparation involves the heating of cysteine in
the absence of any chemical that could protect
it substantially against prompt oxidation, but the
medium is nevertheless widely used for the
culture of various anaerobes in the following
form.
Peptone 10 g
Yeast extract 3 g
Meat extract 10 g
Glucose 5 g
Sodium acetate 3 g
Sodium chloride 3 g
L-Cysteine hydrochloride 0.5 g
Soluble starch 1 g
Distilled water to 1 litre
Steam the ingredients in a flask; filter when
dissolved. Adjust pH to 7.4. Add agar 10 g and
sterilize bv autoclaving at 121°C for 20 min.
Cysteine dithiothreitol blood agar
Moore (1908) described the use of the reducing
agents cysteine and dithiothreitol to improve
solid media for C. novyi. particularly of the more
fastidious types B and D. Collee et al (1971)
modified Moore's medium bv increasing the
concentrations of cysteine to 1 mg/ml, dithio¬
threitol to 0.0V mg'ml and of human blood to 3397
and later substituted 109r horse blood for the





Distilled water 3 ml
Prepare the solution immediately before use
and sterilize by membrane filtration.
Preparation of complete medium
Nutrient agar (Oxoid blood
agar base. No. 2) 88 ml
Cysteine-dithiothreitol solution 2 ml
Elorse blood 10 ml
Melt the nutrient agar, cool to 45-55°C and
add the remaining ingredients, mixing carefully
before pouring plates. Dry the plates briefly at
60CC for 10 min to protect the reducing agents.
Inoculate and incubate immediately.
Motility
Motility may be difficult to demonstrate with
some species and it is advantageous to use more
than one method.
1. With some species there is active swarming
of the culture on the surface of an anaerobic BA
plate.
2. Motility may be demonstrated directly by
examining freshly made wet films from log-phase
CMB cultures, preferably by phase contrast
microscopy under a sealed coverslip.
3. A semi-solid agar stab technique can also be
used for demonstration of motility (see Ch. 8).
Stab cultures in this medium, freshly prepared
with added IT glucose to enhance anaerobiosis,
should be examined frequently before excessive
gas production invalidates the test. A non-motile
species (e.g. C. perfringens) may show lateral
spikes of growth along faults extending from the
stab line, but the appearance is not likely to be
confused with the diffuse growth of a truly
motile species.
Control of spreading growth on anaerobic plates
Control of the swarming growth of unwanted
organisms in plate cultures presents various
problems. Pre-treatment of the proposed
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inoculum by differential heating may be effec¬
tive. but it carries the risk of killing vegetative
cells of likely non-sporing and sporing patho¬
gens. Moreover, the spores of some pathogens
are not markedly heat resistant and may be
inactivated, or their prompt germination may'be
inhibited. The use of firm agar containing 3-4^:
agar is recommended as a general control
method (see Ch. 8), but colonial morphology is
altered. Alternatively, some workers pay par¬
ticular attention to drying the surface of agar
plates to inhibit swarming; but the availability
of nutrients for the initiation of colonial growth
on a relatively dry surface may be critically im¬
paired. An 'alcohol' plate is sometimes used;
here the surface of the unseeded medium is
flooded with ethanol. the excess is removed and
the plate is exposed in an incubator to dry it at
37°C. The medium is then seeded in the usual
manner. If the pathogen to be isolated can grow
on MacConkey agar, it should be noted that
Proteus and Pseudomonas species do not spread
on this medium. It is sometimes possible to ex¬
clude these spreading species by exposing the
seeded plate to chloroform vapour for some
minutes prior to anaerobic incubation.
Specific serological control of the swarming
growth of C. tetani and C. septicum is possible
(see Willis & Williams 1972). When commercial
tetanus antitoxin 40-60 units/ml is incorporated
into the agar medium, motile strains of C. tetani
grow as discrete colonies. Similarly. C. septicum
does not spread on plates on which 0.2-0.5 ml
of a C. septicum antiserum prepared against
the two serological groups is spread.
Tests for phospholipase and lipase; Nagler's
reaction
Several Clostridia produce phospholipases that
give rise to a zone of opalescence extending
beyond the colony or line of growth on human
serum or egg-yolk media (see Ch. 8). Proteolytic
colonies produce zones of clearing on these
media, whilst opalescence restricted to the
medium underlying a colony and associated with
an overlying iridescent 'pearly layer' indicates
lipase activity. The phospholipase reaction
produced by C. perfringens is specifically
neutralized by C". perfringens antitoxin (Nagler
reaction), but the serologically related phospho¬
lipases of C. btfermentans and C. sordellt and
some other Clostridia are also inhibited. The
phospholipase of C. novvi type A can similarly
be inhibited by specific C. novyi antitoxin (see
Table 37.2).
For the presumptive detection of C. perfrin¬
gens in direct plate culture, prepare and dry a
plate of good quality digest agar containing egg-
yolk 59c. On one half of the plate spread 2-3
drops of C. perfringens antitoxin (Wellcome)
and allow to dry. Then seed with the test
organism or with the exudate under investigation,
stroking from the antitoxin-free on to the anti¬
toxin-bearing half, and incubate anaerobicallv at
37°C. On the section containing no antitoxin. C.
perfringens colonies show a surrounding zone of
opacity, i.e. the Nagler reaction, whereas
colonies of the organism on the remainder of the
plate do not. Parallel stroke cultures of different
strains or isolates may be done on one plate,
with a known positive control included, for
identification of pure cultures.
Lowburv and Lilly 's medium
An indicator medium for C. perfringens
containing Fildes peptic digest of blood to stimu¬
late the production of lecithinase. human serum
or egg-yolk to show lecithinase production and
C. perfringens antitoxin spread over the surface
of half the plate to show neutralization of the
lecithinase was devised by Hayward (1943) who
named it the Nagler plate. Nagler (1945)
observed the lipase in addition to the lecithinase
reaction in egg-yolk and proposed an egg-yolk
medium as indicator of the lecithinase and lipase
of C. novyi. Lowbury & Lilly (1955) modified
the human serum medium by increasing the
concentration of agar to prevent the swarming
of Proteus, making a double layer medium to
allow a clearer demonstration of leeithinase
reactions and adding neomycin (1 (JO /xg ml) to
inhibit lecithinase-producing aerobic sporing
bacilli. However in the description given here
the concentration of neomycin is only 70 /ag/ml.
the maximum that is not markedly inhibitory to
many Clostridia (Collee & Watt 1971). The
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neomycin potency of neomycin sulphate is
700 /ag/rng. This 70% factor is taken into account
in the following recipe.
Agar base
Agar 50 g
Peptone water (Ch. 6) 1 litre
This agar base autoclaved at 121°C for 20 min
is used for the lower layer of the medium and
as basal medium for the upper layer.
Preparation of complete medium
Agar base 100 ml
Fildes peptic digest of
sheep blood 6.5 ml
Human serum, sterile 40 ml
Neomycin sulphate (Upjohn),
sterile aqueous solution:
10 000 M&'tnl 1.47 ml
The serum may be prepared by treating
plasma with 5% of sterile 10% calcium chloride
at 37°C. Note: Special precautions must be taken
when human blood products are used (Chs 7,
15).
Heat the Fildes digest at 55°C for 30 min,
melt the agar base and cool it to 56°C. Add the
remaining ingredients and pour the medium as
the upper layer of double layer plates on a
nutrient agar base. Spread 250 international
units of C. perfringens antitoxin over half of the
agar surface.
Willis and Hobbs medium
This medium for the isolation of Clostridia (Willis
& Hobbs 1959) is a lactose egg-yolk milk agar
made selective for various Clostridia, particularly
C. perfringens, by the addition of neomycin. The
recommended concentration of 250 ps. neomycin
sulphate/ml inhibits some Clostridia, usually
inhibits strains of Bacillus and Staphylococcus.
and greatly reduces the growth of coliform
bacilli. As results of culture on Willis & Hobbs
medium can be variable and are occasionally
confusing, a simpler selective medium such as
egg-yolk agar with a good base and neomycin
70 /ag/ml is preferred for general use.
Egg yolk suspension. Break eggs with
precautions to keep their contents sterile, as
described for Lowenstein medium (see Ch. 6).
at the same time separating the yolks from the
whites. Discard the whites and dilute the yolks
with an equal volume of sterile 0.9% sodium
chloride solution.
Sterile stock milk. Remove the cream from
ordinary milk by centrifuging. Sterilize the





Neutral red, 1% solution 1.3 ml
Meat infusion broth,
pH 7.0 400 ml
Egg-yolk suspension 15 ml
Milk 60 ml
Dissolve the agar and lactose in the neutral
red and broth by steaming, and sterilize at 121°C
for 20 min. Cool to 50-55°C and add the egg-
yolk and milk. Pour plates.
Possible additions to basal medium
Neomycin sulphate (Upjohn) 250 /at^ml
Sodium thioglycollate 0.1%
Stock sterile solutions of neomycin may be
stored in the refrigerator with little loss of
potency. The antibiotic is not decomposed by
heating at 60°C for 20 min. Thioglycollate may
assist the growth of the stricter anaerobes.
Either or both of these reagents may be added
at the same time as the egg-yolk and milk.
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Table 37.5 Differential characters and Lev for the identification of the lecithinase negative, asaecharolvtic Clostridia
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C. botulinum type G
+(-) A p ib B iv (f ic 1 s) C. hasuforme
A ib b iv (f p 1 s) C. subterminale
A p B (IT s) C. cochlearium
A ib iv (f p iC I) C irregularis
" Fermentation test.
b S = subterminal: T = terminal.
c See Table 36.4 for standard key to fatty acid profiles.
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Enteropathogenic Clostridia and Clostridium botulinum
This chapter deals with the pathogenic Clostridia
that affect the bowel. Some of the disease associ¬
ations are definite and dramatic: others are less
clearly defined, and some are still debated.
CLOSTRIDIUM PERFRINGENS FOOD
POISONING
Food poisoning caused by C. perfringens type A
Strains of C. perfringens type A that produce
enterotoxin are associated with a mild form of
food poisoning (Vol. 1. 13th Edn, Ch. 36). The
so-called "typical food-poisoning strains' (type
A2) that are non-haemolytic or feebly haemo-
lytic on horse blood agar plates and have
markedly heat-resistant spores are most frequently
encountered, but classical (type Al) strains that
are (3-haemolytic and have relatively heat-sensi¬
tive spores can also be involved (see Table 37.1).
Many opportunities arise for spores of
C. perfringens to contaminate meat and meat
products at the abattoir, in transit to shops and
market places, and in catering establishments
and in the home. As the organism is encountered
so frequently and so widely, it is not usual to
attempt to trace the ultimate source in an
outbreak of food poisoning but rather to deter¬
mine the circumstances or conditions that
allowed the almost inevitable contamination to
be boosted during processing of the food
concerned. The heat resistance of type A2 spores
allows them to survive the whole cooking
procedure, whereas type Al spores are not likely
to cause trouble unless they are introduced by
faulty catering practice during the period
between cooking and serving.
The bacteriological investigation of C. perfrin¬
gens food poisoning must take account of the
findings of Collee et al (1961) and Sutton et al
(1971). Virtually 1009c of the healthy population
carries classical (3-haemolytic C. perfringens in
their gut. and 2-30% may be healthy carriers of
heat-resistant C. perfringens. The faecal counts
of C. perfringens just after food poisoning
caused by this organism are higher than the
counts for healthy people, or for people with
diarrhoea due to other causes (median counts
8.5 x KT/g; cf. 1.5 x 104/g in normal subjects).
However, it should be noted that the range of
counts for commensal C. perfringens in normal
subjects is wide. The spores of heat-resistant
strains often require heat treatment before they
grow quantitatively. A semi-quantitative procedure
for the isolation of C. perfringens from food and
faeces is outlined in Figure 38.1. Techniques for
identification of C. perfringens are discussed in
Chapter 37.
Samples of suspect foods should be examined
if possible but they are often not available by the
time the diagnosis is suggested. The organism
will be present as vegetative cells in food and the
samples should not be heated before culture.
Although the organism does not readily specu¬
late in routine culture media, it does so in the
human gut and considerable numbers of spores
of C. perfringens may occur in faeces of affected
persons. Faecal specimens should be examined
for vegetative cells and spores of C. perfringens.
If faecal samples are boiled before culture, heat-
resistant strains will be isolated but the spores ol
many enterotoxin-producing strains will be killed
by this treatment. Mild heating is, however, ol
value in recovery of heat-sensitive C. perfringens
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Food
Emulsify a representative
weighed sample in nutrient
broth
Quantitative counts (Miles & Misra)





the heat resistance of
spores of non-haemolytic
isolates of C. perfringens
after culture in cooked
meat broth
Faeces






Heat 1 ml at 80CC
for 10 min
(Heat activation)
Heat 1 ml at 100°C
for 30 min
(Heat resistance)
For each sample, prepare four serial ten-fold dilutions in
nutrient broth or sterile saline (i.e. 1 in 10J-1 in 105).
Spread 0.1 ml of each of the three highest dilutions
(1 in 103— 1 in 10s) over neomycin blood agar plates.

















Fig. 38.1 Isolation of C. perfringens from food and faeces after a food-poisoning incident.
Serotype
from faeces as heat shock activates the spores
and increases the rate of germination.
The demonstration of C. perfringens in the
faeces of affected people is of limited value. The
qualitative evidence requires to be substantiated
by quantitative evidence, because many foods
are contaminated with C. perfringens and the
organism occurs regularly in the faeces of normal
people. The count of organisms in remnants of
suspect food will depend on the conditions under
which the food has been kept and little reliance
can be put upon high counts unless the food was
held in the refrigerator after serving. Under
normal circumstances, counts of the organism do
not usually exceed 105 per gram of food or
faeces, whereas in C. perfringens food poisoning
the affected food may contain very high counts
of C. perfringens (up to 109 per gram) and the
faeces of affected people may contain
C. perfringens in counts of 105-108 per gram for
some days after the food-poisoning incident.
The approach outlined in Figure 38.1 for
examination of faeces includes a mild heat acti¬
vation step as well as a procedure for selecting
the very heat-resistant spores of type A2 strains.
The yield obtained from sample A (unheated)
represents vegetative cells and some of the
spores that may germinate, with either type A1
or A2 strains appearing. Sample B (heat acti¬
vated) will yield colonies, either type A1 or A2.
derived purely from spores, as vegetative cells
will not withstand heating at 80°C. Colonies of
>
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C. perfringens grown from sample C (boiled) are
derived from markedly heat-resistant spores of
type A2 strains.
If a faecal sample yields large numbers of type
A1 or A2 colonies, this is compatible with a
diagnosis of C. perfringens food poisoning, but
supportive evidence is really needed. If samples
from several people involved in an incident yield
the same colony type, the evidence is stronger.
If the suspected food yields a similar organism
in larger numbers, the case is virtually made.
However, the identity of isolates should be
finalized by serotyping, so that a relationship can
be established between them. The isolation of
classical type A1 (3-haemolytic C. perfringens
from food or faeces must be interpreted with
caution if this is not possible. Serotyping of food-
poisoning strains by slide agglutination tests is
done at the Food Hygiene Laboratory. Central
Public Health Laboratory, Colindale Avenue.
London NW9 5HT. Food-poisoning strains can
be assigned to serotypes 1-75 (Stringer et al
1980) but untypable strains also occur quite
frequently.
Send several colonies for each specimen, as
strains of more than one serotype of C. perfrin¬
gens may be present in the same specimen. If
only one single-colony isolate is examined from
each specimen, the identity of serotype may not
be observed.
A test has been developed for the direct detec¬
tion of C. perfringens enterotoxin in faeces,
food, or culture supernates (Bartholomew et al
1985). A reverse passive latex agglutination kit
is now available commercially (Oxoid).
C. perfringens enterotoxin-associated colitis
A syndrome differing substantially from that of
C. perfringens food poisoning has been reported
by Borriello et al (1984). Features include
abdominal pain and diarrhoea with blood or
mucus in the stools. Vomiting sometimes occurs.
Patients are usually elderly; an association with
current antibiotic therapy is common but not
invariable.
Large numbers of C. perfringens (107— 10'°/g)
are excreted in the stool, predominantly in spore
form, along with the enterotoxin which can often
be detected in high titre. The enterotoxin
produces a cvtopathic effect on Vero cells and
can be neutralized by specific antiserum raised
against it.
Enteritis necroticans: Clostridium perfringens
type C
Enteritis necroticans caused by type C strains of
C. perfringens (originally designated type F) was
recognized in Germany in the late 1940s. The
form of the disease associated with pork feasting
in the highland natives of Papua New Guinea,
called 'p'S t>e' < has been studied in detail
(Egerton & Walker 1964). There is segmental
involvement of small bowel that may be thick¬
ened and tender on palpation; loops of dilated
intestine with subsequent fibrinopurulent peri¬
tonitis and adhesions and intestinal obstruction
develop. The disease is a common cause of death
in the native children. C. perfringens type C (see
Table 37.1) produces heat-resistant spores,
which are not so markedly heat-resistant as the
original type F German strains, but resist 95CC
wet heat for some minutes. The organism
produces a-toxin. but it is the (3-toxin which
causes the disease when produced by organisms
multiplying and attaching to the villi of the small
gut; the toxin is protected from proteolytic diges¬
tion by the simultaneous ingestion of a sweet
potato vegetable which contains a protease
inhibitor. The low protein diet, and the conse¬
quent low intestinal protease activity of the
natives, further increase vulnerability to the (3-
toxin. The organism can be demonstrated in the
lesions by special immunofluorescence staining
and can be cultured from the intestinal content
of patients with the disease. It is also present in
the stools of healthy carriers and in environ¬
mental samples of soil from native cooking areas
where 'pig-bel' is endemic.
CLOSTRIDIUM DIFFICILE
Until recently, this organism was regarded as a
component of the normal faecal flora of 40-50%
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of neonates, but it was rarely isolated from
adults. Since 1977 it has been detected with
increasing frequency and is now accepted as a
cause of pseudomembranous colitis (PMC) and
antibiotic-associated colitis (AAC) (Bartlett
1979). The spectrum of disease caused by C.
difficile is still not fully known, but it appears to
range from PMC through AAC to antibiotic-
associated diarrhoea (AAD). and may also
include exacerbations of chronic inflammatory
bowel disease, post-operative diarrhoea and non-
antibiotic-associated diarrhoea (British Medical
Journal 1981: Brettle et al 1982). Evidence from
animal studies and from the observed clustering
of some cases favours the view that infection
may be exogenous with colonization of a
compromised gut.
Morphology and staining
Rod-shaped (4-8 x 0.5-1 /am) with subterminal
or terminal non-bulging oval spores. Gram
positive, becoming Gram negative in older
cultures. In wet films from cooked meat broth
(CMB) cultures it exhibits a characteristic oscil¬
lating motility. Electron microscopy shows
sparse peritrichous flagella.
Cultural characters
A strict anaerobe. Grows well on blood agar
(BA) and cefoxitin cycloserine fructose agar
(CCFA) at 37°C. On BA. colonies are glossy,
greyish, low convex, roughly circular with an
irregular edge sometimes becoming spreading;
non-haemolytic. On CCFA medium with blood,
colonies are similar to those on BA. On CCFA
with egg-volk and neutral red. colonies at 24 h
appear large (2-5 mm), flat to low umbonate.
yellow, with a ground-glass appearance and a
slightly filamentous edge. In films from this
growth, organisms may appear much longer,
sometimes almost filamentous, and spores are
absent; motility is much reduced. Colonies on
CCFA are very susceptible to oxygen and must
be subcultured without delay. In solid and liquid
media. C. difficile produces a characteristic farm¬
yard smell which is unlike that of any other Clos¬
tridium species.
Biochemical reactions
The biochemical reactions of C. difficile are
summarized in Table 37.4. Most strains ferment
glucose, fructose and mannitol. although we
have isolated an asaccharolytic strain of C'. diffi¬
cile. Aesculin is hydrolysed and some strains
produce gelatinase. All are indole negative and
lecithinase negative. Gas chromatography (GC.
see Methods. Ch. 3b) of the volatile fatty acid
metabolic products after culture in proteose
peptone yeast extract glucose (PPYG) medium
gives a characteristic profile (Fig. 38.2) which is
diagnostic for an organism that can grow on
CCFA medium. C. difficile produces p-cresol
from p-hydroxyphenyl acetic acid and this is
exploited in the indicator medium developed bv
Phillips & Rogers (1981) for use with GC.
Toxins
A cytotoxin (toxin B) that causes a cytopathic
effect on most tissue cell monolayers is neutral¬
ized by certain batches of C. sordelli antitoxin.
An enteroto.xin (Sullivan et al 1982). probably
produced by all enteropathogenic strains of C.
difficile, is only weakly cytotoxic but provokes
haemorrhagic dilatation when injected into
ligated ileal loops of rabbits: this (toxin A) is
thought to be the major virulence factor. In
1987. it was not yet practicable to detect the
enterotoxin in the diagnostic laboratory. Detec¬
tion of the cytotoxin is readily performed;
although a few enterotoxin positive, cytotoxin
negative strains may be missed, it is a worthwhile
addition to culture in investigating a possible C.
difficile infection (see below).
Sensitivity to chemical and physical agents
Vegetative cells of C. difficile are sensitive to
oxygen. Spores are resistant to oxygen, to heat
(75CC for 10-20 min) and to alcohol, which can
be used for their selection. Cresols and phenols
have been used as selective agents (e.g.
0.2-0.4T p-cresol) but this approach is not
recommended (see George et al 1979).
Sensitivity to antimicrobial agents
Most strains are sensitive to low concentrations
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Fig. 38.2 Gas chromatograms of volatile fatty acid metabolic products from 18 h PPYG cultures of a typical and an
asaccharolytic strain of C. difficile on columns of SP 1220 (see Poxton 1982). Sole: The small peak between acetic and
iso-butvric acids represents propionic acid.
of metronidazole, benzylpenicillin. ampicillin
and vancomycin (MIC usually <4 /zg/ml. but
some up to 32 pig/ml). Most strains are also
sensitive to clindamycin, tetracycline and erythro¬
mycin. but some are resistant to high levels of
these antibiotics. Relatively resistant to amino¬
glycosides, cephalosporins and cephamycins.
Typing
No generally accepted typing method was avail¬
able in 1987 when this chapter was written.
Various biotypes can be distinguished by a range
of simple biochemical tests (Poxton 1982). but
this approach is not promising. An immuno¬
logical fingerprinting method based on visualiz¬
ation of cell surface antigens, after separation on
polyacrvlamide gel electrophoresis (PAGE), by
immunoblot transfer and immunoperoxidase
labelling appears more satisfactory (Poxton et al
1984; Sharp & Poxton 1985). A typing method
based on PAGE of "S methionine-labelled
proteins has been described bv Tabaqchali et al
(1986).
Animal pathogenicity
Several investigations of the pathology and
epidemiology of C. difficile have employed a
hamster model. A fatal enterocaecitis can be
induced in hamsters if C. difficile and antibiotics
are given concomitantly. C. difficile alone does
not usually cause disease but antibiotics alone
can result in disease; C. difficile is apparently-
acquired from the environment and then from
other animals (Larson et al 1980).
Most strains produce soluble products in broth
cultures that are lethal for most laboratory
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animals. Intramuscular injection of washed live
organisms kills mice. Animal tests are not used
for diagnostic purposes at present.
Laboratory diagnosis of C. difficile infection
Send a fresh specimen of faeces or diarrhoeal
fluid for examination. The vegetative organisms
are sensitive to oxygen and are probably unlikely
to survive transportation on a swab. Faeces
should be investigated for the presence of cyto-
toxin*. A direct presumptive diagnostic test
(API) based on latex particle agglutination can
be applied to a faecal supernate.
The primary assignment is to examine the
specimen microscopically and to culture the
organism. The introduction of CCFA medium*
greatly facilitated the selective isolation of
C. difficile.
1. Prepare a Gram film and note the presence
of any Gram-positive sporing rods. Also prepare
a wet film and look for sporing rods showing
typical oscillating motility when viewed with
phase contrast microscopy. Note the presence of
polymorphonuclear leucocytes and red blood
cells.
2. Plate out the specimen on fresh CCFA
medium, with a large initial inoculum to ensure
detection of small numbers of organisms. Incu¬
bate the seeded plate anaerobically without
delay.
3. Increased yields of C. difficile may be
obtained by the use of CCFA with reduced
concentrations of antibiotics (cefoxitin 8 pg/ml,
cycloserine 250 Mg/ml) if the sample is previously-
treated with alcohol to reduce the numbers of
non-sporing vegetative commensal species in the
inoculum (Borriello & Honour 1981; Levett
1985). The original method used absolute
ethanol and homogenized samples were allowed
to stand at room temperature for 1 h before
plating to selective medium. In our experience,
satisfactory results are obtained when a pea-sized
sample is homogenized in c. 1 ml of industrial
methylated spirit; the sample may be plated out
within 1-2 min; this makes the method suitable
for routine use in the diagnostic laboratory. This
* Refer to Methods at end of this chapter.
procedure gives a significantly higher isolation
rate than direct culture on full-strength CCFA.
4. Enrichment culture. In addition to primary
selective culture, an enrichment procedure may
also be employed. Inoculate a portion of the
specimen into CMB. or into cycloserine cefoxitin
fructose broth (CCFB) which is CCFA medium
omitting agar and egg-yolk; O'Farrell et al
(1984) recommend including sodium tauro-
cholate 1 g litre in CCFB for enrichment of non-
faecal specimens. Incubate anaerobically for 24 h
at 37°C and subculture on fresh CCFA as above.
5. Examine plates after anaerobic incubation
for 24 h at 37°C. The CCFA medium is highly
selective, but an occasional yeast or lactobacillus
may grow. On CCFA medium, or on CCFA in
which the egg-yolk has been replaced by blood,
C. difficile colonies show a yellow/green fluor¬
escence in long wave (365 nm) UV light. Re-
incubate plates for a further 24 h before
discarding. The use of an anaerobic cabinet for
incubation of CCFA plates is particularly valu¬
able since it allows reincubation of plates after
inspection at 24 h without exposure to air.
6. Subculture any suspect colony to BA and
incubate anaerobically without delay. Subculture
to PPYG medium; after 24 h at 37°C prepare a
specimen from the PPYG culture for GC (see
Ch. 36, Methods). A more rapid GC confir¬
mation of this organism is done by demon¬
strating the presence of p-cresol and caproic acid
in cores of agar beneath suspect colonies on
CCFA medium supplemented with p-hydroxy-
phenyl acetic acid and DL nor-leucine (Phillips
& Rogers 1981).
7. If GC is not available, do a range of
biochemical tests as indicated in Tables 36.1 and
37.4.
8. Consider a biotyping or serotyping
approach if this is available for the investigation
of any suspected C. difficile outbreak. Isolates
may also be assessed for cytotoxin production.
CLOSTRIDIUM BOTULINUM
Botulism is a rare but often fatal intoxication of
man and animals. C. botulinum spores are
widely distributed in nature and botulism is the
\
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result of ingesting food in which C. botalinum
has multiplied and produced toxin. The disease
is characterized by pronounced toxic effects on
the peripheral cholinergic nervous system in
which the release of acetylcholine at peripheral
synapses is irreversibly blocked. After ingestion
of the toxin, within 24 h or less, there is
progressive paralysis, often initially affecting
oculomotor and oropharyngeal muscles. Death
usually results from paralysis of the muscles of
respiration. C. botulinum types A-G are differ¬
entiated on the basis of their antigenicaliy
distinct but pharmacologically identical toxins.
Types A. B and E are most frequently associated
with human cases of botulism, but all types can
cause disease in man.
Infant botulism is a recently recognized disease
in which ingested C. botulinum spores multiply
in the immature infant gut and produce toxin
which is absorbed and produces a spectrum of
disease ranging from a mild failure to thrive to
paralysis and a sudden infant death syndrome
(Arnon 1980).
Wound botulism is an extremely rare disease
arising from contamination of a wound or
devitalized tissue with C. botulinum. The toxin
gives rise to neurological symptoms after an
incubation period of 4-14 days.
Morphology and staining
Straight or slightly curved rods. 4 x 1 gim but
ranging from 2-10 x 0.5-2 gm, arranged singly
or less commonly in pairs or short chains. Spores
oval, subterminal and may slightly distend the
cell; some highly toxigenic strains produce few
spores. Motile with peritrichous flagella. Gram
positive, but become Gram negative when
sporulating.
Cultural characters
Strict anaerobe. Grows well on most rich
laboratory media. The different toxin types also
differ in their cultural characters and there
is some variability within each toxin type. Smith
(1977) divided the species into four groups
(I—1V. see Table 38.1) based on cultural charac¬
ters. Optimum temperature 30-37°C. depending
on strain. Colonies on solid media after incuba¬
tion for 48 h are irregularly circular, large
(3 mm), smooth, greyish, translucent, with a
fibrillar edge that often becomes spreading. Most
strains are haemolytic on horse blood agar.
Proteolytic strains (A. B. F and G) produce
partial clearing on heated blood agar. All types
except G produce restricted opalescence and a
pearly lipolytic effect on egg-yolk agar (Willis
1977). Recent experience with selective egg-yolk
agar containing cycloserine, sulphamethoxazole
and trimethoprim indicates that this is very
useful for the confirmation of botulism, especially
infant botulism (Hatheway & McCroskey 1981).
Biochemical reactions
The groups shown in Table 38.1 show different
biochemical reactions. Group 1 strains ferment
glucose and fructose and produce variable or
negative results with other sugars; group II
strains ferment fructose, glucose, mannose and
sucrose; group 111 strains ferment glucose,
mannose and ribose; and group IV (type G) is
asaccharolvtic. The proteolytic activities of the
various types are summarized in Table 38.1.
Most strains are indole negative. Tables
37.2. 37.4 and 37.5 indicate other biochemical
reactions of interest.
Table 38.1 Cultural groups of C. botulinum (after Smith
1977).
Characters of Cultural group
organism
1 II III IV
Fermentation of
glucose + + + _
Digestion of
coagulated protein + - J +
Hydrolysis of





A. B A. P. B A, iB.
B. iV
Toxin types A. B, F B. E. F C,. C;. D G
" Some strains show, weak proteolysis.
* Volatile fatty acids detected by gas chromatography
(GC): A. acetic; P. propionic; iB. iso-butyric; B. butyric;
iV. iso-valeric.
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C. sporogenes is biochemically indistinguish¬
able from C. botulinum group I. and C. novvi
type A is biochemically indistinguishable from C.
botulinum group III; differentiation of these
organisms depends on specific toxin testing
(Smith 1977).
Toxins
There are eight serologically distinct types - A.
B. Ci. C:. D. E. F and G. Slight cross-reactions
occur between C], C; and D. and between E and
F. Most but not all of these toxins are syn¬
thesized as non-toxic or slightly toxic protoxins.
Type A strains and some of the proteolytic type
B and F strains produce a protease that activates
the toxin; most type E strains and the non-
proteolytic B and F strains require an exogenous
protease to activate the toxin. Some strains of
types C and E produce fully active toxins. All
toxins are thermolabile and are inactivated by
formaldehyde. Specific phages are involved in
the production of toxin by C. botulinum types C
and D. which can be interconverted; similarly.
C. botulinum type C and C. novyi type A can
be interconverted by phages (Eklund & Poysky
1981).
Spores
C. botulinum spores are among the more
resistant bacterial spores. There is a descending
gradient of heat resistance from the most
resistant spores of group I to the less resistant
spores of group III. Spores of type A strains can
resist boiling at 100°C for some hours. Spores of
type E strains are said to be relatively heat
sensitive, but this may be misleading; the heated
spores of some type E strains do not germinate
until they have been treated with lysozyme or a
proteinase. Spores of C. botulinum are also
resistant to radiation. UV light, alcohols, and
phenolic and quaternary ammonium compounds.
They are relatively susceptible to hypochlorite,
ethylene oxide and formaldehyde. The reader is
referred to a review by Smith (1977, Ch. 3).
Typing methods
The specific toxin type is determined by
toxin, antitoxin neutralization tests in mice. Fluid
specimens are mixed with monovalent type-
specific antitoxins (Institut Pasteur. 28 Rue du
Docteur Roux. 75724 Paris) and injected intra¬
peritoneal^ into mice. Controls include heated
and unheated specimens without antitoxins.
The four groups of C. botulinum determined
on the basis of cultural and biochemical tests
appear to possess group-specific surface antigens.
Immunofluorescence procedures with fluorescein-
labelled antibodies (FA) can achieve partial
typing, but preparations have varied greatlv in
their usefulness (see Walker & Batty 1964).
Three FA reagents available from Wellcome are:
anti-type A with activity against A. B and F;
anti-type C which reacts with C and D; and anti¬
type E which reacts specifically with type E. A
polyvalent anti-ABF FA reagent is available in
the USA. Note that some immunofluorescence
reagents cross-react with C. sporogenes.
Animal pathogenicity
Intraperitoneal inoculation of culture fluid or
culture supernate into mice gives rise to respir¬
atory difficulty in the animals within a few hours.
Paralysis of abdominal muscles gives a wasp-
waist appearance. A flaccid or generalized para¬
lysis develops: death usually follows within
18-24 h but may take up to 4 days. The internal
organs are congested, and thromboses and
haemorrhages are seen at autopsy.
Laboratory diagnosis of botulism
Note that C. botulinum and materials that may
be contaminated with C. botulinum must be
handled under appropriate containment
conditions (Ch. 15). Guidelines for submission
of specimens to the Food Hygiene Laboratory.
CPHL. London, should be consulted (Report
1979).
Specimens to be investigated may include
faeces, food, vomit, gastric fluid, serum, en¬
vironmental samples and occasionally wound ex¬
udate or tissue. The most conclusive proof of
botulism is the detection and specific neutraliza¬
tion of toxin in the patient's serum by
toxin/antitoxin tests in mice. As direct toxin de¬
tection is not always possible, other investiga-
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tions are added as a routine, and these include
culture and identification of the organism from
specimens with subsequent detection of toxi-
genicity. Sometimes the organism may be
detected by direct immunofluorescence.
Detection of toxin in serum, food, vomit, faeces
or supernates
The following procedure is adapted from that
described by Willis (1977).
1. Prepare liquid extracts of solid specimens
by homogenization with an equal volume of
sterile saline and subsequent centrifugation.
2. As some toxins are activated by trypsin,
treat half of the extract with trypsin solution (1 c/c
Difco Trypsin 1:250 in distilled water) in the
proportions of 9 parts extract to 1 part trypsin
solution, held for 1 h at 37°C. The trypsin-
treated and untreated samples are again divided
into two; heat one portion of each sample to
100°C for 10 min to provide inactivated controls.
\'ote: when testing for toxin in serum, trypsin
treatment is unnecessary.
3. Add penicillin to each of the four speci¬
mens to give a final concentration of 200
units/ml.
4. Challenge three pairs of mice by intraperi¬
toneal inoculation of the untrypsinized material
as follows. Protect the first pair with intraperi¬
toneal polyvalent botulinum antitoxin (A. B and
E; Institut Pasteur) and challenge with 0.5 ml
doses of the unheated material. Challenge the
second pair, unprotected, in the same way. Chal¬
lenge the third pair, also unprotected, with 0.5
ml doses of the heated material.
5. Challenge a further three pairs of mice as
above but with the trypsinized material.
Five results are possible: (a) Unprotected mice
receiving unheated sample die. while protected
mice, and those receiving heated sample survive;
this confirms the presence of botulinum toxin.
(b) Increased toxicity of some toxins (e.g. type
E) by trypsinization may cause death of
protected animals - check by diluting sample.
(c) If none of the protected animals survives,
either toxin C. D or F. or a potent toxin of the
other types is present. Repeat with mice
protected with C, D and F antisera and use
diluted samples. Tetanus intoxication is another
possibility - use mice protected with tetanus anti¬
toxin. (d) All animals die including those
receiving heated sample - indicates a non¬
specific toxic substance, (e) All survive - indi¬
cates the absence of botulinum toxin.
Culture of C. botulinum
Direct detection of the organism in the specimen
by a fluorescent antibody (FA) procedure is
possible, but culture is often necessary and this
is generally regarded as technically difficult. See
Willis (1977) and Hatheway & McCroskey
(1981) for a fuller account.
1. If Gram-positive sporing rods are observed
in a specimen, try direct plating, especially in a
case of infant botulism. Egg-yolk agar (EYA)
has been the medium of choice; a new selective
EYA. C. botulinum isolation (CBI) medium*
will probably supersede it.
2. Attempt enrichment as follows after adding
sterile saline to the sample and homogenizing it
if necessary. Divide the sample into two. Add an
equal volume of absolute ethanol to one half,
and leave the other portion untreated. Take 1 ml
volumes of ethanol-treated and untreated
samples and add these to two sets of three tubes
of CMB. Hold one of each set in an 80°C water
bath for 10 min. and another pair for 20 min: the
final pair is left unheated. This procedure selects
for resistant spore-formers but also allows sensi¬
tive spores to survive in the untreated cultures.
3. Incubate these cultures anaerobically at
30°C and screen at intervals for toxin production
by mouse tests as above; FA tests may be of
value as a first screen (see Methods, Ch. 37). If
no toxin is detected after incubation for 3-5
days. C. botulinum should be considered not
present.
4. Plate any toxin-positive broth culture on to
EYA and CBI medium. An anaerobic chamber
should be used, especially if types C or D are
suspected. Incubate plates at 30°C for 36-48 h.
Colonies showing restricted opalescence and a
pearly layer (lipase activity) should be
subcultured to CMB and tested for specific toxin
in due course. If toxin was detected at the
enrichment stage and no opalescence or pearly
layer effect is observed on the EYA subcultures,
type G may be suspected. FA procedures may
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again he useful at this stage for rapid
confirmation.
METHODS
Cycloserine cefoxitin fructose agar (CCFA)
(George et al 1979)
Basal medium





Anhydrous MgS04 0.1 g
Fructose 6 g
Agar 20 g
1% ethanolic solution of
neutral red 3 ml
Distilled water l(HH) ml
Method. Sterilize basal medium at 121°C for
15 min in 1(30 ml portions. Add to 100 ml melted
base at 50°C: D-cycloserine (Sigma) to a final
concentration of 500/ag'ml. cefoxitin (MSD) to
a final concentration of 16 /ag/ml, and 5 ml of
50% Egg-yolk suspension (Oxoid). Alterna¬
tively, the egg-yolk may be replaced with 5 ml
of whole horse blood to make CCFA with blood.
Note that the concentration of antibiotics can
be halved when CCFA is used with an alcohol
procedure to select for spores of C. difficile (see
text).
Assay for C. difficile cytotoxin
The specimen may be a liquid stool, or the
homogenate of a solid stool in physiological
saline, or the supernate of a 5 day culture of C.
difficile in BHLPP broth (Brain heart infusion
(Oxoid) 3.7% w/v and Proteose peptone (Difco)
1% w/v). The supernate may be filter-sterilized,
but this is unnecessary.
Prepare four-fold serial dilutions of the test
liquid in physiological saline and add 10 /al
volumes to 90 /a! of Eagle's modified mainten¬
ance medium (Gibeo; Flow ) containing penicillin
(2(H) units/ml), streptomycin (2(H) /ag/ml), genta-
micin (10 jug ml) and amphotericin B (20 /ug'ml).
over monolayers of human embryo fibroblasts
(or a wide range of other cell lines) in Microtitre
plates (see Ch. 50). The highest dilution of the
test fluid that produces complete rounding of
more than 50% of the cells after incubation for
24 h at 37°C gives the cytotoxin titre. Neutral¬
ization is performed by adding 10 /al of a 25-fold
dilution of C. sordelli antitoxin (Wellcome) to a
duplieate series of wells. A positive control,
either a known positive stool extract or a
purified C. difficile cytotoxin. should be included;
we have found no loss in potency if the toxin
control is frozen and thawed several times.
Clostridium botulinum isolation (CBI) medium
(Dezfulian et al 19S1)
Antibacterial supplements. Prepare the following
solutions and sterilize by filtration: D-
cycloserine. 1% solution in water; sulpha-
methoxazole. 1.9% solution in water - add 10%
NaOH till dissolved; trimethoprim. 0.1% solution
in water - add 0.05 mol/litre HC1 till dissolved.
Basal medium
Trypticase peptone (BBL) 40 g
Na:HP04 5 g
NaCl - g
MgS04 5% aqueous solution 0.2 m
D-glucose ru rJO
Yeast extract (Difco) 5 g
Agar 20 g
Distilled water 9(H) ml
Method. Adjust to pH 7.4 and autoclave at
121CC for 15 min: cool to 55°C. Add 100 ml of
Egg-yolk suspension (50% in saline: Difco) and
antibacterial supplements prepared as above: D-
cycloserine. 25 ml (250 mg): sulphamethoxazole.
4 ml (76 mg): and trimethoprim. 4 ml (4 mg).
Store plates in an anaerobic chamber for at
least 4 h before use.
\
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1. Abstract
The reasons why anaerobes are studied by immunological methods include
the development of techniques for the diagnosis of disease, understanding
pathogenic mechanisms, epidemiological investigations, development of vaccines
and immunotherapeutic agents, in various biotechnological applications and
in taxonomic studies. The antigens of anaerobic bacteria are similar to those
of other Gram-positive and Gram-negative bacteria and these are described.
Two methods are given for the preparation of conventional polyclonal anti¬
serum. The various immunological methods that can be used for investigating
anaerobes are listed and several discounted as being of little use today. Modern
methods such as crossed immunoelectrophoresis, ELISA and immunoblotting
are described in some detail and the advantages and disadvantages of each
are described.
2. Introduction
It is perhaps those anaerobic bacteria of clinical importance that are most widely
known and this paper will tend to concentrate on these. However, before
beginning to describe the immunological methods that can be exploited, we
should question the reasons for doing so. This is not an active area of research,
perhaps because the work is fraught with difficulties and so few anaerobic
infections have a simple one organism-one disease relationship. Most anaerobic
infections have complex, poorly understood aetiologies. This paper will begin




anaerobes. This will be followed by a description of the antigens that can be
exploited and the methods for producing conventional polyclonal antiserum.
Finally, the immunological methods currently available will be discussed and
a selection of the most useful will be described.
3. Why Use Immunological Methods to Study Anaerobes?
The most obvious medical reason that one may first think of is serology: the
detection and measurement of specific antibodies in serum specimens. Is this
a useful approach? There are relatively few anaerobic infections with a well
established single pathogen and these include some of the clostridial infections
of man and animals. It may be in chronic infections, or deep abscesses, or
infections where the pathogen cannot be cultured, or infections with complex
microflora consisting of both commensals and pathogens, the latter also perhaps
originating from normal flora, that serological tests may be most useful. In acute
infections it is unlikely that an antibody response will be detectable early enough
and it is better to isolate and identify the organism.
An alternative approach in acute infections is to detect free antigen or, perhaps
more likely, to detect antigen bound to antibody, i.e. immune complexes.
These should both be detectable very early in the course of the infection
and their detection should be an accurate and sensitive way of making a
diagnosis, even if the infecting organism is non-viable because of the action
of the immune response or antibiotics, or it cannot be cultured. It is of course
possible to detect tetanus, botulinum and Clostridium difficile toxins by
toxin-antitoxin neutralization tests, but in the future it may be possible to detect
specific antigens in periodontal disease: perhaps, for example, spirochaete
antigens or Bacteroides gingivalis antigens. In vaginosis the detection of
Mobiluncus spp. antigens may be useful and it may be possible to detect specific
bacteroides antigens in serum or cerebral spinal fluid. For more details on the
detection and clinical significance of immune complexes see ref. 1.
In epidemiology a knowledge of the antigenic make up of an organism is of
obvious use. The candidate antigen tests range from traditional O and K
serotyping and toxin typing to immunochemical fingerprinting. It is possible
to serotype B. fragilis by use of O antigens but the clinical significance is not
yet apparent (2). Toxin typing is important for identifying C. perfringens and
for the investigation of botulism. Analysis of surface antigens of C. difficile
has proved most useful in epidemiological investigations of outbreaks of
antibiotic-associated pseudomembranous colitis and diarrhoea (3).
It is in studies of the pathogenic mechanisms of anaerobic infections that it
is most useful to have immunological probes and markers to investigate such
virulence factors as capsules, lipopolysaccharides, fimbriae, surface proteins
and toxins, and to be able to observe the effect of neutralization of these
components with specific antibodies or to observe their effects on complement
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action and phagocytosis. The knowledge gained from an understanding of the
pathogenic mechanisms can be made use of in the prevention and treatment
of infections.
Examples of active immunization are well known for tetanus and botulism, and
several other clostridial infections of animals. The value of passive immunization
for the two former conditions, along with gangrene, is debatable. Might
Figure 1. Diagrammatic representation of the cell envelope of (a) a Gram-positive and
(b) a Gram-negative bacterium. LP, lipoprotein; LPS, lipopolysaccharide; P, protein;
PL, phospholipid. (Figure reproduced from ref. 5.)
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Table 1. Antigens that can be exploited.
Gram-positive bacteria
Secondary wall carbohydrate (teichoic acid)
Membrane lipocarbohydrate (lipoteichoic acid)










immunization to prevent adhesion be useful for preventing any anaerobic infection?
The whole subject of immunotherapy is a new and exciting area of research and
it is possible that some anaerobic infections may be controlled in this manner.
In non-medical areas such as in biotechnology, anaerobes may produce commer¬
cially useful products. Antibodies, whether polyclonal or monoclonal, might be
used as probes for cloned gene products and as immunosorbents in product
purification. Finally, in taxonomy, antibodies are useful tools with which to
investigate relationships between organisms, and they have been used widely.
4. Antigens of Anaerobes
In all the work reported on the morphology, structure and chemistry of their
cell surfaces, anaerobes appear similar to the aerobes and facultative anaerobes
and can be thought of as typical Gram-positive and Gram-negative bacteria.
Diagrammatic representations of the surfaces are shown in Figure 1 and the
major antigens that can be exploited in any immunological investigation are
listed in Table 1. It should be noted that the production and fine structure of
most if not all antigens is very dependent on the conditions in which the organism
is cultured. The rich complex media employed for laboratory isolation and
identification are likely to produce antigens with a significantly different
chemistry from those grown in vivo and culture methods should attempt to
mimic the conditions in vivo as closely as possible. Methods for the isolation
and purification of antigens are described in refs4-5.
5. Antisera
In this paper only two methods are given for the production of polyclonal
antiserum. They have proved successful for many Clostridia and bacteroides.
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Details and recommendations for the preparation of monoclonal antiserum are
given in Chapter 18 by J. H. Reid.
5.1. Method for whole bacteria
Inject 109 bacteria in 1 ml buffered saline into the marginal ear vein of a rabbit
on days 1, 2, 3, 8, 9, 10 and 22. Test bleed on day 29 and exsanguinate by cardiac
puncture if sufficient antibody is present. A further boost is unlikely to increase
the levels more than two-fold. For Bacteroides spp., washed live cells can be
injected directly. For Fusobacterium spp., which tend to produce a more toxic
lipopolysaccharide than bacteroides, and for certain Clostridia that produce
potent exotoxins the number of cells should be reduced to 106—107 for the first
three injections and increased stepwise to 109. Cells from these genera should
also be killed by exposing a thin film of cell suspension in a glass petri dish
to short-wave ultraviolet light until no viable cells can be cultured. This has
to be checked by experimentation for each ultraviolet lamp.
5.2. Method for subcellular or purified antigens
Prepare injections containing 0.1-2.0 mg antigen (toxoided by treating with
0.5% formaldehyde for 18 h) in a total of 1 ml Freund's complete antigen (1 : 1
aqueous phase: adjuvant). Inject subcutaneously in several sites on the back
of a rabbit. Repeat after 2-4 weeks with incomplete Freund's adjuvant. Test
bleed after a further 1-2 weeks and boost if necessary.
Both of these methods can be used in the mouse if they are suitably scaled
down. Intravenous injections of 0.1 ml can be readily administered through the
tail vein and weights of antigen should be reduced 10- to 100-fold.
6. Methods for Immunological Analysis
The methods that have been or might be used for immunological analysis of
anaerobes are listed in Table 2. Those not in italic letters can probably be
discounted as they are out of date, insensitive, time consuming or of poor
specificity and have been largely superseded by more modern methods.
6.1. Enzyme-linked immunosorbent assay (ELISA)
This is probably the most useful and widely used immunoassay available at
present. It can be used for the detection of both antigen and antibody; it is
very sensitive and simple to use; in the standard 96-well format large numbers
of samples can be analysed; and it is suitable for automation. Monovalent
antigens can also be detected as long as the binding to the plate does not block
the epitope. The greatest disadvantage of ELISA is that if a mixture of antigens
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Italics, present-day methods of importance; Roman, out-dated
methods.
is used to coat the plate it is not possible to know which antibodies are binding
without performing an inhibition assay. More details of the applications of
ELISA can be found in refs 6-7.
6.2. Crossed immunoelectrophoresis (CIE)
Crossed immunoelectrophoresis (CIE) and its one-dimensional relative, rocket
immunoelectrophoresis, have been largely superseded by immunoblotting and
the much more difficult technique of radioimmunoprecipitation. There are,
however, several applications for CIE. This technique has the advantage that
the antigens are not denatured and the pore size of the agarose support matrix
allows extremely large antigens such as capsular polysaccharides to be analysed.
Rocket immunoelectrophoresis is a valuable technique for screening large
numbers of specimens or column fractions. Both of these techniques are
quantitative and sensitive but only precipitating antigens are detected and it
is rather expensive in antiserum. The methods for the techniques have been
described in detail elsewhere (8-10).
6.3. Immunoblotting (Western blotting)
This is a powerful modern technique that can resolve complex antigen mixtures.
It is fairly simple to perform and extremely sensitive. Its major drawbacks are
that the antigens must first be run on a denaturing polyacrylamide gel which
may result in the loss of epitopes, especially if monoclonal antibodies are used
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as probes, and antigens with a molecular mass of more than a few hundred
kilodaltons cannot enter the gel: it is therefore of little use in the analysis of
large molecular mass capsular polysaccharides. The methodology and some
applications of immunoblotting can be found in refs 11-13.
7. Conclusions
In conclusion, modern immunological methods have yet to be used widely in
the study of anaerobic bacteria. In our attempts to understand the complex
pathogenic mechanisms of anaerobic infections they have a major role to play.
Recently they have proved useful in epidemiological studies. It is perhaps in
rapid diagnostic techniques that a future role lies. Once we establish causal
relationships between specific pathogens and infection can we begin to develop
methods for the early detection of specific antigen. Candidate infections include
periodontal disease, infections of the female genital tract and deep abscesses.
It should not be forgotten, however, that one of the oldest and most useful of
diagnostic techniques in anaerobic bacteriology — the Nagler reaction — is a simple
demonstration of neutralization of phospholipase with a specific antiserum.
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As in any branch of modern bacteriology, immunological techniques are used for
a vast and increasing number of applications. The applications in the past were
mainly in medical microbiology, especially in the diagnosis of disease, in
epidemiological typing, and in the fundamental investigation of pathogenic
mechanism. In the future this trend is likely to continue, but the exploitation of
immunological methods for the detection and quantitation of any bacterial
component orproduct is likely to increase. In anaerobic bacteriology, however, it
is by no means an area of great activity. Many workers have been disillusioned by
the complexity of the subject, and it is true to say that much of the past work has
been greatly compromised by a lack of appreciation of the complexity of the
antigenic composition of anaerobes. They are no more complex than aerobes but,
especially for the Bacteroides spp., there are no traditional serotyping schemes
available as there were for the enterobacteria, and attempts ah extrapolating
from enterobacterial serology have been largely unsuccessful. Apart from certain
clostridial infections there is little evidence of a one organism one disease
relationship and again this has confused the unwary.
This chapter will give details of the immunological methods that will be of use
in the investigation of most problems likely to be encountered in anaerobic
bacteriology. Some examples of applications will be given where relevant and the
many problems and pitfalls highlighted.
2. Historical applications of immunological methods
Before beginning to describe the techniques and their applications, it is perhaps
worthwhile reviewing, and reminding the reader, of the immunological methods
used in the past. It is in clostridial identification that they have been most useful.
From the universally used Nagler reaction for the specific identification of
C perfringens on egg-yolk agar (see Chapter 3) to the definitive identification of
C. tetani and C. botulinum by toxin neutralization tests in mice (see Chapter 9),
the use of specific antibody neutralization tests has been wide. Immunofluores-
cent antibody methods have been developed for certain Clostridia. Capsular
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typing based on agglutination tests has been used for investigation of
C. perfnngens food poisoning strains. Several attempts have been made to
develop a somatic typing scheme for the Bacteroidesfragilis group, but these have
been largely unsuccessful and their relevance has been questioned.
3. Antigens of anaerobic bacteria
Anaerobic bacteria can be considered as typical Gram-positive and Gram-
negative bacteria (Figure I). As far as we know there are no fundamental
differences in structure between aerobes and anaerobes. The range of antigens
that can be exploited include both cell-surface components and extracellular
products (exotoxins and enzymes).
These antigens include
in Gram-positice bacteria
• secondary wall carbohydrate (teichoic acid)
• membrane carbohydrate (lipoteichoic acid)
• surface proteins (regular arrays and fibrillar proteins)
in Gram-negatice bacteria
• lipopolysacchande
• 'common antigens' (equivalent to the enterobacterial common antigen)




• capsular and other exopolysaccharides
• peptidoglycan
• flagella
• extracellular products (exotoxins and exoenzymes)
4. Preparation of some relevant antigens
The preparation of all the antigens just listed cannot be covered in this chapter.
Only those considered most important and relevant to anaerobes will be
described here. The investigator w ho requires more detailed information on the
preparation and characterization of bacterial antigens is referred to the book by
Hancock and Poxton (1). The extraction of antigens from the bacterial cell
usually begins with either the whole cell where extractants such as detergents or








(a) 3ram-?0si*:ve cell envelope
inner mem3rane
(b) GRAM-NEGATIVE CELL ENVELOPE
Figure 1. The cell envelopes of (a) Gram-positive and (b) Gram-negative bacteria,







subcellular components such as cell walls, cell envelopes, or membranes, and
then subsequent extraction methods are emploved on these fractions. For this
latter approach, cell breakage is necessary and is most important for Gram-
positive bacteria.
4.1 Cell breakage
Two methods will be described: (a) the French Press; and (b) sonication.
4.1.1 The French Press
The French Press (manufactured by Aminco, Slver Springs, Maryland. USA) is a
convenient method for breaking all types of bacteria It has the advantage that
the wall envelope remains largely intact and is not highly fragmented. The
bacteria are made into a suspension in a physiological buffer containing 1 mM
magnesium, and the cell density can range widely in concentration from very
dilute to 50% (wet w v). The suspension (5-40 ml) is poured into the pre-cooled
pressure cell and is assembled in the hydraulic press. Pressures in the range of
lCf Pa are required for breakage. Generally, Gram-negative rods break most
easily, while Gram-positive cocci are the most difficult, and may require several
passes through the cell for complete breakage The efficiency of breakage must be
monitored by microscopy and any unbroken cells are removed by two cycles of
low-speed centrifugation (5000 9 for lOmin). In very dense suspensions the
viscosity may rise alarmingly after breakage because of the release of nucleic
acids. If this is a problem 10-20 /jg of DNase and RNase can be added prior to
passage through the cell, and incubation at room temperature for 15 min or so
after breakage is usually sufficient to reduce viscosity.
4.1.2 Sonication
This technique is usually more widely available than the French Press, but suffers
from the disadvantages that only small volumes (usually 10 ml or less) are
handled. Heating is a problem and cooling in ice ethanol is necessary. Some
bacteria, especially Gram-positive cocci, can be difficult or impossible to break,
and, for those bacteria that can be broken, tiny fragments are often produced
which make subsequent fractionation difficult. A suspension is made up as
described in Section 4.1.1, and a 5-10% (wet w/v) concentration is usually ideal.
Depending on the type of bacteria, five 1-min bursts (with 30-sec cooling periods)
of peak power from the ultrasonic generator are often sufficient. Monitor
breakage by microscopy.
Once cells are broken, it must be recognized that most bacteria possess
autolytic enzymes w hich can greatly modify cellular components in a short time.
Subsequent steps must take account of this and procedures must involve
inactivation steps, or speed and low temperatures must be employed.
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Protocol 1. Wall preparation in Gram-positive bacteria
1. After cell breakage and removal of any unbroken cells, centrifuge the
suspension at 40000 g for 20 min. The cell wall envelope fraction forms a
dense layer at the bottom of the tube. For many anaerobic bacteria this layer
is often black in colour because of the presence of insoluble sulphides
produced in the highly reduced growth conditions.
2. Decant the supernate containing the cell membranes and cell contents and
retain for later Resuspend the wall pellet in water and wash once.
3. Resuspend the pellet in water and add an equal volume of 4% (w v) sodium
dodecyl sulphate (SDS) w hich has just boiled.
4. Stir the suspension for several hours (conveniently overnight) at room
temperature.
5. Wash the suspension free of SDS by at least six cycles of centrifugation
(40000 g) with water at room temperature (SDS precipitates in the cold). SDS
removal can be confirmed by the water not frothing. The cell w alls should now
appear white.
6. Resuspend in a small volume of water and lyophilize.
After the breakage of Gram-negative bacteria, the envelope fraction, i.e. inner
membrane, outer membrane, and associated peptidoglycan layer, is pelleted by
centrifugation at forces of 50000 g or greater.
4.2 Preparation of the outer membrane of Gram-negative
bacteria
Traditionally, the outer membrane (OM) was prepared from a whole envelope
fraction followed by density gradient centrifugation. Although this is probably
the most authentic method, an approximation to the method can be made using
the detergent sodium .V-lauroyl sarcosinate (Sarkosyl) which selectively
solubilizes the inner membrane from a broken cell suspension, leaving the OM as
an insoluble pellet.
Protocol 2. Outer membrane preparation
1. Break cells by either of the methods described in Section 4.1 and remove any
unbroken cells.
2. Add Sarkosyl (l vol of 24% (v v) solution of Sarkosyl (Sigma: 30% (w, v)
solution) to 9 vol. supernate) to give a final concentration of 0.7% by weight.
3. Centrifuge at 50000 g for l h to pellet insoluble outer membranes.
4. Resuspend pellet in distilled water and wash as in step 3.
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4.3 EDTA extraction of Gram-positive surface antigen
A method that has been used for the extraction of a surface antigen from various
Clostridia makes use of the chelating agent ethylenediamine tetraacetic acid
(EDTA). It appears that a range of surface proteins together with the
lipocarbohydrate membrane antigen can be released from Clostridia without the
lysis of the bacterial cell This soluble antigen is representative of the whole
surface of the bacterium. It has been used in a variety of applications such as in
the immunotaxonomy of Clostridia (2), especially C. botulinum and related
species (3), and in the immunological fingerprinting of C. difficile (4).
Protocol 3. EDTA extraction of whole bacteria
1. Harvest bacteria from 100 ml broth and wash three times in phosphate-
buffered saline (PBS: 50 mM phosphate buffer containing 0.15 M NaCl,
pH 7.4) by centrifugation at 10000 g for 10 min.
2. Resuspend pellet in 4 ml PBS containing 10 mM EDTA.
3. Incubate at 45 C for 30 min.
4. Remove cells by two cycles of centrifugation as in step 1.
5. The supernate, w hich will contain in the order of 1 mg, ml protein, can be used
without further treatment in ELISA and immunoelectrophoresis assays.
4.4 Secondary cell-wall carbohydrate antigens
The secondary cell-wall carbohydrate antigen or teichoic acid analogue is
probably, as in the aerobic Gram-positives, an important grouping antigen in
Clostridia. It has been investigated only in C. difficile (5).
Protocol 4. Preparation of secondary cell-wall carbohydrate
1. Prepare pure cell walls (see Protocol I).
2. Resuspend l g in 40 ml of either" 0.5 M NaOH or 0.1 M HC1 and stir at room
temperature for 1 h.
3. Neutralize with the equivalent concentration of HC1 or NaOH and remove
extracted walls by centrifugation (10000 g, 15 min).
4. Dialyse supernate against at least two changes of 5 1 of distilled water over
18 h.'
5. Concentrate by rotary evaporation and then freeze-dry.
* Although both have been used successful* with C difficile, it is well known for aerobes that,
depending on the nature of the glycosidic linkages. it is possible that either may depolymerize such




This polymer is analogous to the lipo- or membrane teichoic acid of aerobic
Gram-positives. where it is often an important antigen In aerobes it has been
investigated only in C. difficile and close relatives (6) and most recently in
C. tyrobutyricum (7).
Protocol 5. Preparation of lipocarbohydrate
1. The supemate prepared in step 2 of Protocol 1 is freeze-dned and used as the
starting point of the antigen extraction.
2. Dissolve the lyophilized cell supernate in chloroform methanol (2:1) at a
concentration of 20 mg ml and stir for several hours at room temperature.
After filtration through Whatman no. 1 paper, re-extract with another
volume of chloroform methanol by stirring overnight.
3. Air-dry the filtered, defatted material and then suspend to a concentration of
approximately 5% (w v) in distilled water. Add an equal volume of 80%
(w/w) aqueous phenol" and stir at room temperature for 1 h.
4. Centrifuge in phenol-resistant tubes at 10000 g for 20 min.
5. Remove the upper aqueous phase and dialyse against running water
overnight.
6. Remove any insoluble material by centrifugation (10000 <?. 10 min).
7. For many purposes it may be convenient to interrrupt the preparation at this
point and test the material for antigenicity. If a highly purified product is
required, it will be necessary to fractionate the material on a column of
Sepharose 6B w here it will elute in the void volume. Final purification may-
require immunoadsorbent chromatography (see references 5 and 6 for
details).
* Caution' Phenol is extremely caustic and toxic; handle with care.
4.6 Lipopolysaccharide
As in all Gram-negative bacteria, lipopolysacchande (LPS) is present in Gram-
negative anaerobes. It is usually considered less endotoxic than its aerobic
(Escherichia coli) equivalent, but only the clinically important Bacteroides and
Fusobacterium spp. have been investigated. Various serotyping schemes have
been developed for the B.fragilis group, but their relevance is uncertain. There is
confusion as to the relationship between capsular poly saccharide and LPS. There
is some debate as to the method for the extraction of LPS (8). The best starting
approach when investigating an unknown LPS is to use the proteinase K method
developed by Hitchcock and Brown (9).
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Protocol 6. Proteinase K method for LPS preparation
1. Harvest bacteria from broth or solid medium, wash once in PBS, and
resuspend in PBS to an 4}2S (absorbance of 525 nm) of between 0.5 and 0.6.
2. Centrifuge 1.5-ml volumes in a microcentrifuge at 10000 <7 for 3 min.
3. Suspend pellet in SDS-PAGE sample buffer and heat to 100:C for 5 min.
4. When cool add 25^1 proteinase K (Protease type XI. Sigma) in lO/il
SDS-PAGE sample buffer and incubate at 60C for 60 min.
5. Analyse 10-/B samples on 14% polyacrvlamide gels, omitting the SDS from
the stacking and separating gel buffers.
6. Stain gels with silver or transfer to nitrocellulose for immunoblotting (see
Protocol 14).
Once the chemotype of the LPS (i.e. rough or smooth) is established by the
proteinase K. method, it is possible to select the classical aqueous phenol method
for the preparation of smooth LPS or the phenol, chloroform petroleum method
for rough LPS (see reference 1 for methods). A combination of these methods has
been suggested by Weintraub et al. (10), but it should be noted that it is possible
that the smooth component of the LPS could inadvertently be discarded (8),
especially if the LPS only appeared rough because of the silver stain failing to
reveal the 'O' polysaccharide chains: these are sometimes penodate-resistant and
only revealed by specific antibody in immunoblots.
4.7 Exopolysaccharides
Capsules are found on a wide range of anaerobes, both Gram-positive and Gram-
negative. As described in Section 4.6 there is a certain amount of confusion
between the exo- or capsular polysaccharide of Bacteroides species and the O
antigen of the LPS. It is probably true to say that no definitive method exists for
the preparation of exopolysaccharide. In attempting to begin the preparation of
the capsule, mechanical methods of shearing off the capsule should be the first
approach.
Protocol 7. General method for capsule preparation
1. Harvest bacteria from solid medium by gently scraping with a glass rod and
suspend in PBS containing 0.5% formaldehyde.
2. Shear off capsule: gentle stirring to violent agitation in a blender or
homogenizer may be required. Monitor by microscopy with indian ink
staining.
3. Remove bacteria by centrifugation with forces >10000 g because of high




4. Add four volumes of ice-cold acetone to the supernate and allow the capsular
material to precipitate overnight at 4 C.
5. Wash precipitate several times in acetone, dissolve in water, and lyophilize
6. At this stage the material should be checked for antigenicity. It will almost
certainly be contaminated with proteins and other carbohydrates, especially
LPS in Gram-negative bacteria. The full purification will require often
difficult biochemical and immunological separation techniques which are
compounded by the high viscosity and high molecular mass of the material
4.8 Preparation of appendages
Bacterial appendages are well known antigens, but in anaerobes very little is
known of fimbriae or ptli. Only the preparation of flagella will be covered here.
They have been investigated in several Clostridia (11, 12).
Protocol 8. Preparation of flagella
1. Harvest motile bacteria from a log phase broth culture (l l) bv centrifugation
at lOOOOg for 15 min. Gently resuspend in 1 1 of PBS and recentrifuge.
2. Resuspend in 20 ml PBS and homogenize in a rotating blade blender at
maximum speed for 1-2 min.
3. Remove bacteria by at least two cycles of centrifugation at 10000g for
15 min.
4. Pellet crude flagella by centrifugation at 100000 g for 90 min. The pellet may
be extremely difficult to see, but it should be resuspended in a small volume of
PBS and monitored by electron microscopy (by shadowing or negative
staining).
5. Prepare a caesium chloride solution (1.3 g/ml) by dissolving optical grade
CsCl in pBS to give a refractive index of 1.3630 (cm 2.125 g is required). Add
this to the pellet of flagella and mix well. Centrifuge at 180000 g for 20 h in a
swinging bucket rotor.
6. The flagella form a band in the central region of the tube and are removed with
a fine-gauged syringe needle.
7. Recover the flagella by diluting the CsCl solution in the removed band in
about 10 ml distilled water and centrifuge at 100 000 g for 1 h.
5. Production of antisera
Only the preparation of conventional antiserum in rabbits will be described here.
The production of monoclonal antibodies is a much more specialized procedure
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and requires special facilities Nevertheless the immunization procedures
described here for rabbits can be scaled down 10- or 100-fold for the
immunization of mice prior to hvbridoma production.
Only two methods are given here for raising conventional polyclonal
antiserum—one for whole bacteria and the other for subcellular or soluble
antigens. The doses are based on New Zealand White rabbits of 2-2.5 kg. For the
smaller Dutch rabbits, w hich are becoming more common because of cage size
regulations, the dose should be scaled down on a weight for weight basis. As the
response to antigens can vary greatly from one animal to another it is usual to use
more than one animal for raising antisera.
5.1 Whole-bacteria vaccine
For most anaerobes, a washed suspension of live bacteria in PBS is all that is
required. All Bacteroides spp.. and many of the Clostridia, permit doses of 109 in
1 ml to be injected from day 1. For the more endotoxic Fusobacterium spp. and
the Clostridia w hich produce potent exotoxins, it is necessary to reduce the dose
to 106 organisms for the first three injections and irradiate the bactena (in a thin
film in a glass Petri dish) with a lethal dose of ultraviolet light. It is convenient to
prepare one batch of antigen for the w hole immunization series, storing v olumes
for each injection in individual tubes and deep freezing.
The procedure is as follows.
(a) Inject 1-ml doses of bacteria into the marginal ear vein on days 1,2, 3,8,9,10,
and 22.
(b) Test bleed from the ear on day 29 and, if antibody is of sufficient strength, ex¬
sanguinate the rabbit by cardiac puncture under terminal anaesthesia.
Boosting with more vaccine after day 29 is unlikely to result in a more than
twofold increase of titre.
5.2 Subcellular or soluble vaccine
Toxic antigens, such as powerful exotoxins, should be toxoided prior to injection
by treatment with 0.5% formaldehyde for 18 h at room temperature.
(a) Prepare vaccines containing 0.1-2.0 mg antigen in 1 ml amounts by mixing
equal volumes of the antigen in aqueous solution suspension and Freitl's
complete adjuvant. Thorough mixing in a small homogenizer or by pasang
from one syringe to another through a fine-bore tube is recommended to
produce a water-in-oil emulsion. This can be confirmed by placing a small
drop on water where it should remain without dispersing quickly.
(b) Inject the vaccine subcutaneously in several sites in the scapular region of the
back and massage firmly. Repeat after about 4 weeks using Freund's
incomplete adjuvant.
(c) Test bleed after 2 weeks and boost if necessary; then exsanguinate.
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The preparation of serum is conveniently accomplished by allowing the blood
to clot in a glass vessel overnight at 4 C. If more than one rabbit was used, the
serum should only be pooled after checking for an adequate response in each
rabbit. After pooling Sera should be divided up into convenient volumes and
stored deep frozen. Freezing and thawing should be kept to an absolute
minimum.
For some applications, such as crossed and rocket immunoelectrophoresis, a
much cleaner result can be obtained if the IgG fraction is prepared. Also, if an
antibody is to be labelled, it can be done to a much greater specific activity if it is
pure. Several methods exist for the preparation of IgG, but perhaps the simplest,
and the most suitable for most purposes, is by ammonium sulphate precipitation.
Protocol 9. Preparation of IgG
1. Prepare a saturated solution of ammonium sulphate in w ater and add 0.67 ml
dropwise at the rate of one drop per second to l.O ml serum which is stirred
gently in an ice bath.
2. Continue stirring for 15 min; then centrifuge the precipitated IgG at 3000 g
for 15 min.
3. Resuspend the pellet in 1 ml or less of 0.05 M Tris buffer, pH 8.0 and dialyse
against the same buffer. Alternatively a 10 kd cut-off ultrafilter may be used.
4. If the IgG is not to be labelled, it is recommended that bov ine serum albumin
is added to a final concentration of 1%.
6. Immunological methods
The last two decades or so have seen great advances in immunological
techniques. Before this, double gel diffusion, complement fixation tests, and
haemagglutination assays were the main techniques available. These have now
largely been superseded. In the early 1970s improvements in gel diffusion
techniques resulted in the widespread use of two-dimensional or crossed
immunoelectrophoresis. This was the first technique to permit resolution of
complex mixtures of antigens. It is a relatively difficult technique requiring a
certain degree of dexterity; it can only be done w ith a few samples at a time and
was only useful for precipitating antigens. The related rocket immunoelectro¬
phoresis allowed quantitation of multiple samples but did not give good
resolution. For most purposes immunoblotting has taken over these techniques.
The development of radioimmunoassays opened up the field to automation of
immunoassays and multiple specimen handling; however enzyme immuno¬
assays, especially enzyme-linked immunosorbent assays (ELISA), have super¬
seded this technique. For this chapter, precipitation in gel techniques will only be
covered briefly and most emphasis will be placed on ELISA, immunoblotting.
and immunogold electron microscopy.
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6.1 Precipitation in gels
Simple Ouchterlony-type gel diffusion is now largely superseded and will not be
described here. Rocket Immunoelectrophoresis is probably a more sensitive
substitute and is recommended for screening multiple samples containing
precipitating antigens. It is quantitative but it has poor resolution for complex
antigen mixtures. Crossed immunoelectrophoresis is recommended for complex
mixtures where resolution is required. It is only applicable to a relatively small
number of samples, but is useful for investigating large-molecular-mass antigens
which are impossible to analyse by the more recent immunoblotting technique
(see Section 6.3).
Protocol 10. Preparation of electrophoresis buffer and agarose gel
1. Prepare electrophoresis buffer solution l by dissolving in 2 l of distilled water
• Barbitone sodium 26 g
• Barbitone 4.14 g
2. Prepare solution 2 by dissolving in 2 I distilled water
• Glycine 112.5 g
3. Mix equal volumes of solutions l and 2 and confirm pH to be 8.8. Use this
buffer undiluted in buffer reservoirs.
4. Mix together
Heat with constant stirring in a boiling bath until agarose has dissolved. Triton
XlOO or other detergents can be added to a final concentration of l% at this
stage, if membranous or poorly soluble antigens are being investigated.
5. Cool to 55C before pouring gels.0
' It is convenient to prepare in bulk and dispense in suitable volumes for storage.
Protocol 11. Rocket immunoelectrophoresis
Up to 10 samples can be analysed on a 50 mm square of agarose. For more
samples a longer length of 50 mm width is required.
1. Cut a 50-mm square of Gelbond* and place it hydrophilic side up on to a
supporting glass plate on an absolutely level surface.
• Tris 90.4 g
• Agarose (low EEO)








2. Blank off two-thirds of the sheet with a glass plate and cast a layer of agarose
(see Protocol 10; ca. 1.3 ml required).
3. After setting, cut up to 10 3-mm diameter wells in a linear or staggered
pattern.
4. For many purposes it is convenient to show identity between antigens and, if
this is the case, the wells should be loaded at this stage with 10-ul volumes of
antigen and then left for 30 min in the cold to allow antigens to.fuse into the
agarose. This technique is then referred to as fused rocket immunoelectro-
phoresis. If show ing identity is not a concern then the wells may be loaded after
the next step.
5. Gently mix 2.2 ml molten agarose held at about 55C with 0.5 ml antiserum
which may be diluted in 1 :4-diluted electrophoresis buffer, and pour on to the
remaining two-thirds of the Gelbond*.
6. After setting, place the gel on to a horizontal electrophoresis tank with the
wells towards the cathode and connect the ends of the agarose to the
electrophoresis buffer (see Protocol 10) with presoaked filter paper wicks.
7. Apply 12 V/cm for 16 h at 4'C.
8. Press, wash, and stain with Coomassie blue as described in Protocol 13.
Protocol 12. Crossed immunoelectrophoresis
1. Prepare the first-dimension gel by pouring 15 ml molten agarose containing
1% Triton X100 (see Protocol 10) on to an 80-mm square glass plate.
2. After setting, place plate on the template (see Figure 2a) and cut out wells. Fill
with 10-15 g\ antigen.
3. Place in a horizontal electrophoresis tank with wells towards the cathode.
Connect to buffer with filter paper as described in step 6 of Protocol 11.
4. Apply 100 V/cm for 1-1.5 h at 4 C.
5. Remove gel from tank and replace on template. Cut out strips and transfer to
the edge of a 50-mm square of Gelbond^1, making sure the hydrophilic side is
uppermost as in Figure 2b.
6. Pour the second-dimension antiserum-containing agarose (0.5 ml of anti¬
serum, suitably diluted in 1 :4-diluted electrophoresis buffer, plus 3 ml
agarose at 55'C) against the first-dimension strip.
7. After setting, replace in the electrophoresis tank with the first-dimension strip
towards the cathode and connect the edges to the buffer with wicks.
8. Apply 12 V/cm for 16 h at 4:C.








Figure 2. Crossed Immunoelectrophoresis (CIE). (a) Template for first dimension—use an
80-mm square of glass, (b) template for second dimension—use a 50-mm square of Gelbond^;
(c) an example of CIE: an EDTA extract (see Protocol 3) of Clostridium difficile (10/rl) run
against whole cell antiserum (diluted 1 in 2).
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Protocol 13. Staining of gels
1. Place gels on a flat surface and carefully cover with a sheet of Whatman no. I
paper, avoiding air bubbles.
2. Cover with a stack of blotting paper and apply an even pressure with a weight
of about l kg (e.g. a glass plate and several books) for 15 min.
3. Remove gels, discard filter paper, and w ash in two changes ofO.Ol M NaCl for
15 min, followed by a 15-min water wash.
4. Repeat the pressing as in step 2, and then dry the gels in air or with a hot air
blower.
5. Place in Coomassie blue stain for 10 min
• Coomassie blue R250 5 g
• Ethanol 45 ml
• Acetic acid 10 ml
• Water 45 ml
6. Destain with two or three changes of the solution in step 5 from w hich the dye
is omitted.
An example of the use of CIE is shown in Figure 2c.
6.2 Enzyme-linked immunosorbent assay (EL1SA)
Since its development by Engvall and Perlmann in 1972 (13), this has become the
most useful and widely used of all immunological techniques. It has a vast
number of applications and many modifications and variations have been made.
Both antigen and antibody can be detected and it is extremely sensitive,
quantitative, and can readily be automated. The major disadvantage of the
technique is that, when it is used for complex mixtures of either antigens or
antibodies, it must be remembered that the final colour is proportional to the sum
of perhaps many individual antibody antigen reactions and results must be
interpreted with caution. For many complex applications it is perhaps worth
combining the technique with immunoblotting, which will resolve the individual
reactions (see Protocol 15). The technique described here is an example of the
most commonly used system where antigen is bound to the solid phase (plastic)
and specific antibody can be detected. After reaction of antigen and antibody, the
complex is detected with a second, antispecies antibody-enzyme conjugate. Its
applications range from monoclonal antibody screening to diagnostic serology.
In the latter case it must be remembered that the antigen is all important. If it is
impure, minor side-reactions can greatly distort the true picture. This is
especially true for anaerobes where, generally, the antigenic makeup of an
individual organism is uncertain and the degree of reaction and cross-reaction is
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extremely uncertain. Perhaps its safest use is the detection of antibodies to
purified toxins. For the detection of antigen the system must be inverted and the
antibody solid-phased for use as a capture for the antigen. A second antibody
which is enzyme-labelled is then used to create a 'sandwich'. One of the antibodies
should be monospecific polyclonal or monoclonal.
Protocol 14. A standard ELISA
1. Make dilutions of antigen in coating buffer (0.05 M sodium carbonate buffer
pH 9.6 containing 0.02% sodium azide) and add I00-/d volumes containing
10— 100 /zg antigen to wells ofmicrotitre plates. Cover and allow to incubate at
37:C for 4 h and then at 4=C overnight.
2. Wash three or four times with 0.9% NaCl containing 0.05% Tween 20.
3. Make dilutions of antibody in antibody/conjugate buffer (0.05 M phosphate
buffer, pH 7.4. containing 0.85% NaCl, 0.05% Tween 20, and 0.02% sodium
azide) and add to wells. Incubate for up to 4 h at room temperature or l h at
37°C.
4. Wash as in step 2.
5. Add 100-pl volumes of suitably diluted anti-first species antibody-enzyme
conjugate (dilutions of l in 500, to l in several thousand are typical) to the
wells and continue incubating for several hours (conveniently overnight) at
room temperature or an hour or so at 37~C. The most popular enzyme-
conjugates are alkaline phosphatase and horseradish peroxidase.
6. Wash as in step 2.
7. Add enzyme substrate diluted according to the manufacturer's instructions
and incubate at room temperature for 1 h. The results are conveniently read in
a purpose-made spectrophotometer.
6.3 Immunoblotting
Immunoblotting or Western blotting is the technique by which antigens, usually
proteins, are separated by polyacrylamide gel electrophoresis and are then
electrophoretically transferred to a nitrocellulose or similar membrane, where
they are subsequently probed with antibody to locate antigens. Since the transfer
method was first developed about 10 years ago by Towbin and colleagues (14) it
has become one of the most widely used of immunological techniques with an
ever-increasing range of applications and modifications. It has largely super¬
seded the Immunoelectrophoresis techniques such as crossed and rocket
immunoelectrophoresis. It is used in all areas of immunological research, in
diagnostic serology, and is becoming the standard method for the high-
resolution detection of any molecule against w hich an antibody is available. In
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anaerobic bacteriology it has been used for immunological fingerprinting of
Clostridium difficile (6) as well as in numerous other studies for investigating the
antigenic composition of anaerobic bacteria.
Protocol 15. Immunoblotting
1. Separate antigens on a conventional polyacrylamide slab gel, and place the
unfixed gel on the cathodic side of the transfer apparatus cassette.
2. Carefully overlay with a sheet of nitrocellulose which has been soaked in
transfer buffer, avoiding any air bubbles.
3. Assemble transfer cassette and place in a buffer tank containing a high pH
buffer (eg. Tns glycine methanol, pH 8.3: Tris I2g; glycine 57.68 g;
methanol l I; water 4 l, adjusting final pH with l M NaOH if necessary).
4. Connect to power supply and allow transfer to proceed. An overnight run of
10-12 V,40 mA is convenient, but faster runs can be made if higher voltages
are possible.
5. Remove the membrane and wash for 10 min in Tris-buffered saline (TBS:
Tris 4.84 g; NaCl 58.48 g; water 2 1, pH 7.5.
6. Block in 3% gelatin in TBS for 30-45 min.
7. Place in first antibody, suitably diluted in 1 % gelatin in TBS, for an hour or
more. Dilutions range from as low as 1 in 2 for human serum or monoclonal
antibody supernates to 1 in several hundred for hyperimmune rabbit
antisera.
8. Wash briefly in distilled water followed by two 10-min washes in TBS with
0.05% Tween 20.
9. Place in second antibody (enzyme-conjugate) diluted in 1% gelatin buffer
for at least 1 h. Dilutions of 1 in 500 to 1 in several thousand are usual for
most commercial conjugates.
10. Wash as in step 8.
11. Add colour development reagent (which must produce an insoluble
coloured product), made up according to the manufacturer's instructions,
and allow desired colour to develop.
12. Stop reaction by washing thoroughly in distilled water.
The recently developed semi-dry transfer apparatus with two flat graphite
electrodes is gaining in popularity. There are savings in buffer costs and the
transfer is more rapid because of the much steeper voltage gradient. An extension
to the original concept, where the electrophoretic transfer step is circumvented, is
by applying the antigen directly to the membrane as a dot (dot blotting). A
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further modification to this technique is the recently described "line blot' (15)
where the lines of antigen are applied with an ink pen point.
The main problems encountered with immunoblotting include: (a) a difficulty
in transfer or a lack of binding of the antigen; (b) the antigen losing its antibody-
binding capacity after separation and transfer, presumably by denaturation, and
the subsequent need for renaturation of the antigen; (c) the problems of high
background staining or non-specific binding, and the requirement of blocking
agents; (d) a lack of sensitivity when compared to ELISA; (e) the quantitation of
the technique; and (f) the inherent problem that the technique is difficult to
miniaturize for use in large-scale screening. Many of these problems have been
addressed recently with a limited amount of success, and the reader is encouraged
to see the recent review by Stott (16).
The final immunological method to be described here (immunogold electron
microscopy) is not commonly used, probably because of its complexity, but it is
proving invaluable for the detection and location of antigens on intact bacteria. It
has been used to great effect with Bacteroides by Patrick and colleagues (17).
Protocol 16. Immunogold microscopy'
1. Harvest and wash bacteria and resuspend in 0.01 M sodium cacodylate
buffer, pH 7.2.
2. Fix in cacodylate buffer containing 2% (w/v) paraformaldehyde and 0.1%
glutaraldehyde for 1 h at 4:C.
3. Wash in cacodylate buffer and dehydrate twice in graded alcohols and finally
twice in 100% ethanol w hich has been dried over anhydrous sodium sulphate.
4. Embed in LR (London resin) white resin as follows: mix in 50% resin, 50%
ethanol for 1 h at rom temperature. Next mix in 100% resin in open
containers in a fume cupboard overnight. After two further changes of resin at
2-3 h intervals, transfer the bacteria to gelatin capsules which have been dried
at 60"C for 3 h, fill the remaining space with 100% resin, seal, and polymerize
the resin in a 60:C oven for 18 h.
5. Cut thin sections, in an ultramicrotome and place on nickel grids.
6. Perform immunoassay at room temperature by placing sequentially in: (a)
1% bovine serum albumin (BSA) in PBS, pH 7.2 for 15 min; (b) antibody
suitably diluted inO. 1 % BSA in TBS (see Protocol 14 but adjust pH to 8.2); (c)
hold in TBS BSA prior to washing in a stream of 8 ml TBS coming from a
burette; (d) further block in 1% BSA in TBS for 15 min, followed by (e)
addition of an appropriate gold conjugate (15-20 nm particles from Janssen
Pharmaceuticals); (f) hold in BSATBS prior to washing as in (c); and (g)
finally rinse in distilled water.
7. Stain with saturated aqueous urany! acetate in the dark for 30 min.




several minutes before viewing in the electron microscope. To avoid the film of
resin disintegrating, anneal the section by play ing the electron beam over it at
low power before going to high power
' For negatively stained specimens, bacteria are suspended in distilled water and placed on
Formvar-coated nickel gnds The labelling is performed as in step 6 and negatively stained with l°«
aqueous ammonium molybdate.
7. Conclusions
The selected methods given in this chapter will be a useful initiation to those
wishing to investigate anaerobes by immunological methods. The techniques are
now well established in many laboratories, but a thorough awareness of the
complexity of the organism must alway s be borne in mind A final point, w hich
has not been covered elsew here in this chapter, cannot be stressed too much; that
is the need to recognize that the antigenic composition of any bacterium may be
strongly under the influence of its growth environment. This is as true for
anaerobes as for any other bacterium. Attempts must always be made to culture
the organism in a medium approximating as closely as possible its natural
habitat.
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GROUPING OF /LHAEMOLYTIC STREPTOCOCCI
BY ENZYME-LINKED IMMUNOSORBENT ASSAY
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Identification of /1-haemolytic streptococci (BHS) in the diagnostic laboratory has depended
traditionally on the use of presumptive tests in the first instance (Wilkinson, 1979). Definitive
group identification rests on extraction of group-specific carbohydrate antigens and their
reaction with specific antisera in capillary tubes or agar gel; counterimmunoelectrophoresis may
also be used (Hill et al., 1975). Other methods of identification include slide agglutination tests
(Christensen et al., 1973) and fluorescence staining (Moody, Ellis and Updyke, 1958).
The present study was undertaken to determine whether an enzyme-linked immunosorbent
assay (ELISA) could be adapted to provide a reliable system for grouping BHS. Although this
type of assay has been employed for detection of protein antigens and antibodies (Engvall and
Perlmann, 1972; Russell, Facklam and Edwards, 1976), many workers have been unable to
apply it to polysaccharide antigens, which have an overall negative charge that interferes with
adsorption to polystyrene surfaces (Dr B. M. Gray, Dept of Pediatrics and Microbiology,
University of Alabama in Birmingham, USA). In this paper we report that this difficulty can be
overcome by adsorbing whole cells to polystyrene plates. Results of a trial of the ELISA
procedure compared with a double-diffusion method in agar gel are presented.
Materials and methods
Streptococci were isolated from patients attending the Royal Infirmary, Edinburgh, or were
stock strains held in the laboratory. The 100 strains tested were; 20 group A, 35 group B, 15
group C, 15 group D, and 15 group G. Initially, strains were identified by the following
presumptive tests: gram-stained film, haemolysis on blood agar (Brown, 1919), bacitracin
sensitivity for group A (Maxted, 1953), the CAMP test for group B (Christie, Atkins and
Munch-Petersen, 1944) and the bile-aesculin test for group D (Facklam and Moody, 1970).
Preparation of extracts. The group-specific carbohydrates were extracted as described by
Lancefield (1933). Each strain was grown in 50 ml of Todd-Hewitt broth for 18 h at 37°C and
the culture was centrifuged at 1000 g for 15 min. The packed cells were extracted with 0-4 ml of
0 067m HC1 for 10 min. at 100°C, cooled, and neutralised with 0-5m NaOH. After centrifuga-
tion, the supernate was stored at 4°C.
Gel-diffusion test. Double diffusion in agar gel was performed by a modification of the
Ouchterlony method (Freimer, 1963).
Antisera. Grouping sera for groups A, C, D and G were obtained from Wellcome Reagents
Ltd, Hither Green, London SE13 6TL, and used for the ELISA and for the agar double-diffu¬
sion tests. Group-B antiserum was raised in rabbits in our own laboratory. Strain O90R
(Streptococcus Reference Laboratory, Colindale, London NW9 5HT) was grown in 250 ml of
Received 21 June 1979; revised version accepted 14 Sept. 1979
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Todd-Hewitt broth for 18 h at 37°C, washed twice in 0-9% (w/v) NaCl, killed by suspending in
2% (v/v) formalin for 3 h, and then resuspended in 25 ml of 0-9% NaCl.
An initial intravenous dose of 0-5 ml of vaccine was given and then 1 ml of vaccine was given
intravenously twice weekly for 1 month; test bleeds then showed that there had been a strong
homologous response by each animal. The rabbits were exsanguinated and the sera, divided
into 5-ml amounts, were stored at —20°C until use. Merthiolate (1 in 10 000) was used as a
preservative.
Cross-reacting antibodies were absorbed from each of the grouping sera by adding sequen¬
tially 10 ml of a 1 in 10 dilution of serum in PBS (0 05m sodium phosphate buffer containing
0-1 5m sodium chloride, pH 7-4) to packed PBS-washed bacteria from 100 ml ofovernight culture
of the prototypes representing the heterologous groups (group A strain NCTC8198, group B
NCTC9993, group C NCTC8543, group D Colindale strain and group G NCTC9603) and
incubating for 30 min. at room temperature.
Preparation of ELISA plates. Each strain was grown in 5 ml of Todd-Hewitt broth
incubated aerobically overnight at 37°C. After the cells had been washed once in saline, 0-5 ml
of005m sodium carbonate buffer at pH 9-6, containing 002% (w/v) of sodium azide (NaN3) was
added, and 50 pi of this suspension was dispensed into wells of a disposable flat-bottomed
polystyrene microtitration plate (Sterilin Ltd, 43-45 Broad Street, Teddington, Middlesex).
The plate was left open and placed in a drying cabinet at 60°C for 1 h to allow cells to adhere to
the polystyrene surface.
The ELISA technique was similar to that described by Voller, Bidwell and Bartlett (1976).
Each well was washed three times with phosphate-buffered saline containing 0 05% (v/v) Tween
20 (PBST), and shaken dry at the end ofeach wash; 50 p\ of a 1 in 400 dilution of the test serum in
PBST with 0 02% (w/v) NaN3 was then dispensed into the wells and allowed to incubate at 37°C
for 1 h. To prevent evaporation, each plate was sealed in aluminium foil. Washing with PBST
was repeated three times and the plate was shaken dry. Ten p\ of anti-rabbit antibody
conjugated with alkaline phosphatase (Miles Laboratories Ltd, Slough, Berks) was added to
5 ml of PBST containing 0 02% NaN3; 50 p\ of this mixture was dispensed into each well.
The plate was covered with aluminium foil and incubated for 1 h at 37°C. Again, wells were
washed three times with PBST, shaken dry, and 50 ^1 ofalkaline phosphatase substrate solution,
containing p-nitrophenylphosphate (Sigma Chemical Co., St Louis, Missouri, USA) 1 mg/ml of
0 05m carbonate buffer, pH 9-8 with 0 00 1m MgCL, was added to each well. The plate was then
left uncovered at room temperature.
Interpretation ofresults. Plates were read by eye within 45 min. of the addition of substrate;
a colour change from colourless to yellow was read as a positive result. Control wells containing
cells + substrate, and substrate alone were always included in the test.
Results
The following observations emerged from this study. (1) There was complete agreement
between the results obtained in agar precipitation tests and in the ELISA for the strains tested.
(2) The relative specificity of each of the grouping sera in the ELISA was assessed against known
prototype strains and only when complete specificity was obtained with these prototypes were
the unknown strains tested. It was necessary to do 5-9 absorptions on each of the sera before
this degree ofspecificity was achieved. (3) The commercial antisera could be used at a maximum
dilution of only 1 in 8 in the agar double-diffusion technique, whereas a dilution of 1 in 400
produced strong positive results in the ELISA. (4) An increase in incubation times for the
separate stages would permit the use of even higher dilutions of serum in the ELISA procedure.
However, plates should be read within the specified time to reduce the possibility of residual
cross-reacting antibodies affecting the results.
Discussion
Serological grouping of /Miaemolytic streptococci in service laboratories is commonly
performed by Lancefield's extraction of the carbohydrate antigen followed either by double
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diffusion in agar gel or capillary precipitation tests. These methods are not only time consuming
but, if tests are not performed with care, false-positive and false-negative results may occur. In
recent times, grouping kits have become available commercially; although these are rapid and
easily handled, they are without exception expensive, possibly precluding their use in some
laboratories.
The ELISA procedure described in this paper is simple, sensitive and quick to perform. It
has the same degree of reliability as gel-diffusion methods for grouping /1-haemolytic strepto¬
cocci, and is economical because antisera can be used in high dilutions. However, the fact that
there is a certain degree of complexity in the initial standardisation of the assay may make it
unattractive to laboratories dealing with only a few samples daily. The role of ELISA for the
serological grouping of streptococci may therefore be limited to laboratories dealing with large
numbers of specimens, and reference laboratories where quality control of sera may not be so
difficult.
Summary
A method of grouping /1-haemolytic streptococci serologically by enzyme-linked immuno¬
sorbent assay is described. A comparison of this method with double diffusion in agar gel
showed complete correlation of results when highly absorbed grouping sera were used.
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A polysaccharide antigen of group B streptococcus type lb was extracted from sodium
dodecyl sulphate-treated cell walls by trichloroacetic acid. In crossed immunoelectrophoresis
the polymer reacted with specific antisera to serotypes la, lb and Ic of group B streptococci
and with commercial grouping antiserum to give one precipitin line. However, the antigen did
not react with antisera to types II and III. The evidence suggests that this polymer confers the
group specificity to type lb of group B streptococci. The polysaccharide, after purification on
DEAE-cellulose, was shown to consist of rhamnose, glucosamine, galactose, glucose, sialic
acid and a trace of phosphorus.
introduction
The recognition that group B streptococci (GBS) play an important role in the
pathogenesis of neonatal infections has generated much interest in these organisms. Their
definitive identification is based on serological reaction of the group-specific carbohydrate
antigen which is extracted from the cell wall by hot hydrochloric acid (Lancefield, 1933). Early
reports indicated that the components of this antigen are polysaccharides of low molecular
size and consist mainly of rhamnose (Slade & Slamp. 1962; Curtis & Krause, 1964a;
Wittner & Hayashi, 1965). Immunochemical studies by sugar inhibition tests of the precipitin
reaction between the GBS antigen and specific antisera showed that rhamnose is the principal
immunodeterminant portion of the antigen; this suggests that it occupies a terminal position
in the polysaccharide (Curtis & Krause, 19646).
More recent studies have concentrated on the immunochemical characterization of the
type-specific, or capsular antigens of GBS, since these surface components are theoretically
most likely to be recognized immunologically by the infected host (Freimer, 1967; Wilkinson,
1975; Kasper et al., 1979). Capsular antigens extracted by the HC1 technique (Lancefield,
1934) have been shown to be partially degraded and immunologically incomplete (Baker et
al., 1976). Isolation of the complete native antigen by more subtle extraction procedures
allows an acid-labile terminal sialic acid determinant to be identified. Tai et al. (1979) were
able to isolate from whole cells the lb type-specific antigen which contained galactose,
glucose, A-acetylglucosamine and sialic acid in the approximate molar ratio 2:1:1:1. The
fact that this antigen cross-reacted with both type la and type Ic antisera is attributed to the
common determinant Iabc (Lancefield et al., 1975). Absorption studies suggest that the lb
specific determinant and the Iabc determinant are on the same molecule but that sialic acid is
not the cross-reactive determinant (Tai et al., 1979).
Various findings thus have shown that the character of GBS antigens is complex. The cell
surfaces contain a range of poorly characterized carbohydrate and protein antigens which
0022-1287/81/0000-9681 $02.00 © 1981 SGM
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have been extracted by a variety of techniques. In this study we have concentrated solely on
the carbohydrate antigen that is covalently linked to the cell wall of type lb GBS. Its chemical
composition and immunological profile have been examined.
METHODS
Strains of group B streptococci. The following strains, representative of the various serotypes, were obtained
from the Streptococcal Reference Laboratory, Colindale, London: 0903 (type la), H36B (lb), NCTC 11078 (Ic),
NCTC 11079 (II), NCTC 11080 (III).
Antisera. Specific antisera for types la. Ib, II and III were raised in New Zealand White rabbits by intravenous
injection of formalin-killed, trypsin-treated whole cell preparations. Heat-killed whole cells of strain NCTC 11078
were prepared to obtain antisera specific for type Ic bacteria. The immunization schedule has been described
previously (Cumming et al., 1980). Group B antiserum was purchased from Wellcome Reagents. Antisera were
not absorbed and their specificity was checked by capillary precipitin tests (Swift et al.. 1943) and double diffusion
in agarose gel against Lancefield extracts.
Preparation ofcell walls and extraction ofcarbohydrate. Saline-washed bacteria from overnight cultures (6 1) in
Todd-Hewitt broth were suspended in ice-cold water and disrupted by passing through a French press (Aminco
Inc.. Md.. U.S.A.) at 48 MPa (7000 lbf in-2). Cell walls and unbroken bacteria were collected by centrifugation at
52000 g for 15 min at 4 °C and then carefully separated. The suspension of cell walls was heated at 80 °C for 3
min to destroy autolytic enzymes, then washed in water at 4 °C. Protein and membrane components were
removed from the suspension by adding an equal volume of 5% (w/v) sodium dodecyl sulphate (SDS) and stirring
for 4 h at room temperature (Poxton et al.. 1978). To remove SDS, the cell walls were washed by centrifugation at
50000 g for 10 min in six successive changes of water at 20 °C. Carbohydrate was extracted from 75 mg
freeze-dried walls with 10 ml 10% (w/v) trichloroacetic acid (TCA) for 48 h at 4 °C. Walls were collected by
centrifugation at 50000 g for 10 min and TCA was removed from the supernatant fluid by six successive
extractions with 10 ml volumes of diethyl ether. Water was removed by rotary evaporation and the extracted
carbohydrate was dissolved in 1 ml water.
Purification of carbohydrates was performed by ion-exchange chromatography. Samples of carbohydrate in
5 ml water were applied to a column of DEAE-cellulose previously treated with 1 M-pyridinium acetate (pH 5-3)
and eluted by a linear gradient of 100 ml pyridinium acetate (pH 5-3) from 0 to 1 m concentration. Fifty fractions
were collected and samples were analysed for carbohydrate.
Lancefield extracts from whole cells. The group antigen extraction was performed by a modified method of
Lancefield and Freimer, described previously by Cumming et al. (1980).
Analytical techniques. Carbohydrate concentration was estimated by the method of Dubois el al. (1956),
phosphate analysis was done by the method of Chen et al. (1956). and sialic acid was determined by the
thiobarbituric acid method of Aminoff (1961).
Crossed Immunoelectrophoresis (CIE) techniques. Electrophoresis was carried out with a Shandon Southern
apparatus (Camberley, Surrey, U.K.). The technique used was similar to that described by Weeke (19736).
Antigen samples (10 pi, containing 1 mg carbohydrate ml-1) were applied to gels of 1% (w/v) agarose (BDH
electrophoresis grade). A barbital/glycine/Tris buffer. pH 8-8. described by Weeke (1973a) was used throughout.
Electrophoresis was at 12-5 V cm-1 for 2 h in the first dimension and at 12 V cm-1 for 16 h in the second
dimension, both at 4 °C. After washing, pressing and drying of the gels, precipitin lines were detected by
Coomassie blue stain (Weeke, 1973 a).
Acid hydrolysis. Samples eluted from the DEAE-cellulose column were hydrolysed in either 2 m-HCI for 4 h at
100 °C or 4 m-HCI for 18 h at 100 °C. Acid was removed by desiccation over NaOH and P2Os in vacuo and the
samples were dissolved in 0-5 ml water.
Paper chromatography. Descending paper chromatography was performed on Whatman no. 1 paper with a
pyridine/acetic acid/water (6 :4 :3, by vol.) solvent. Aminosugars were detected by ninhydrin and reducing sugars
by the alkaline silver nitrate reagents (Trevelyan et al., 1950).
Preparation of alditol acetates and gas-liquid chromatography (g.l.c.). Hydrolysed samples were converted to
alditol acetates as follows. Hydrolysates (1 ml) were reduced by 10 mg potassium borohydride for I h at 20 °C.
Excess borohydride was destroyed by addition of glacial acetic acid. Methyl borate was removed from the samples
by three successive distillations with methanol. The residue of each sample was then dissolved in 0-5 ml pyridine
plus 0-5 ml acetic anhydride and heated for 1 h at 100 °C. Pyridine and excess acetic anhydride were removed by
rotary evaporation with successive volumes of toluene until the acetate residues were dry. To remove impurities in
the residues, 2 ml chloroform was added followed by vigorous mixing with water using a vortex mixer. The
chloroform phase was subjected to rotary evaporation and the resulting samples were redissolved in 0-5 ml
chloroform and analysed by g.l.c.
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Alditol acetates were identified in a Pye Unicam series 104 chromatograph. A column (2-1 m x 4 mm)
containing 3% OV-225 on 100—120 mesh Gas Chrom Q was used for identification of amino sugars; hexoses were
identified on a column (1-5 m x 2 mm) of 3% SP-2330 on 100-120 mesh Supelcoport. Gas flow rates for the
OV-225 column were 35 ml N2 min-1, 35 ml H2 min-1 and 525 ml air min-1. Flow rates for SP-2330 were 20 ml
N2 min-1, 20 ml H2 min-1 and 525 ml air min-1. The temperature of both columns was 180 °C rising by 2°C
min-1 to 240 °C.
results
Cell wall and carbohydrate preparations
The yield of SDS-purified cell walls obtained from a 6 1 culture volume of type lb cells was
600 mg. Total carbohydrate extracted from the cell walls was approximately 6 mg. The
amount of reducing sugar in the sample was estimated as 3-0 mg by the phenol/sulphuric
acid assay.
CIE ofTCA-prepared wall antigens
Preliminary studies indicated that the optimum antigen concentration for electrophoresis
was 10 pi carbohydrate adjusted to 1 mg ml-1 estimated by the phenol/sulphuric acid assay
(Dubois et al., 1956). The optimum antiserum concentration to obtain clear precipitin lines in
the second dimension of CIE was 0-5 ml antiserum in 3 ml agarose.
Electrophoresis of the lb antigen extracted from cell walls was performed with sera raised
against the five main serotypes of GBS and with commercial grouping antiserum. Single
precipitin lines were observed with la, lb (Fig. 1) and Ic antisera and also with the Wellcome
grouping antiserum. No reaction was observed with type II or III typing antisera.
To check the specificity of the antisera, 'Lancefield' group antigens were prepared from
whole cells of the five serotypes of GBS and examined by the Ouchterlony technique. These
group antigen extracts resulted in one line of identity being produced between antigens from
all serotypes and the Wellcome grouping antiserum. However, when they were reacted
against the typing sera, la, lb and Ic extracts reacted with each other's typing antiserum but
not with antisera against types II and III, while group extracts from II and III reacted only
with their homologous typing antiserum. This showed that the typing antisera were devoid of
group antibodies.
Sialic acid determinations
Purified lb cell walls were treated with 0-02 m-HCI at 80 °C for periods up to 24 h to
extract sialic acid. From a sample (10 mg) of freeze-dried walls 120 gg sialic acid was
liberated after 4 h, whereas after 24 h only 81 gg sialic acid was detected. After TCA
treatment of walls, the sialic acid content of the extract was 63 gg mg-1; of this, 30-5 gg was
in the bound form. Control samples of sialic acid subjected to the same conditions as the test
samples showed that, after 4 h heating in HC1, there was a 30% loss of sialic acid, and after
24 h, a 70% loss. The results obtained from cell walls and TCA extract were corrected
accordingly for destruction of sialic acid.
Purification and analysis of TCA extract
Extracted carbohydrate preparations from cell walls were subjected to DEAE-cellulose
chromatography and eluted with increasing molarities of pyridinium acetate (pH 5-3).
Analysis of each sample from the column detected one carbohydrate fraction only, eluting
between 0'05 m- and 0-2 m-pyridinium acetate. Crossed immunoelectrophoresis of this
fraction showed it to be immunologically similar to the unpurified extract.
Paper chromatography of the purified sample hydrolysed in 2 m-HCI for 4 h at 100 °C
resulted in the detection of glucosamine and rhamnose; after hydrolysis in 4 m-HCI for 18 h
at 100 °C only glucosamine was detected. Confirmation of these results was obtained by





Fig. 1. Crossed Immunoelectrophoresis of TCA-extracted GBS type lb cell-wall antigen (10 pi) against
antiserum to GBS type lb (0-3 ml). This shows a single antigen which is heterogeneous for molecular
weight.












analysis of the derivatized hydrolysate by g.l.c. In addition to glucosamine and rhamnose,
small amounts of galactose and glucose were identified.
Analysis for phosphate in the sample detected trace amounts only. The complete chemical
profile of this antigen, expressed as molar proportions, is summarized in Table 1.
DISCUSSION
In this study an attempt has been made to examine the nature of an antigenic carbohydrate
polymer which is covalently bound to the peptidoglycan component of the cell wall of group
B streptococci (GBS) of type lb. Unlike previous reports in which antigens were extracted
from untreated whole cells, in this study cell walls were collected and purified by SDS
treatment, thereby removing all non-covalently bound polymers. Only one carbohydrate
fraction was extracted from the walls after prolonged treatment with TCA: this polymer
was shown to have a net negative charge by its binding capacity to DEAE-cellulose.
Chemical analysis of the extract resulted in the identification of rhamnose, glucosamine,
galactose, glucose, sialic acid and a trace of phosphorus. The relative proportions of these
compounds are essentially similar to the composition of the group-specific antigen isolated
from whole cells of GBS type la by Kane & Karakawa (1978). The presence of trace
amounts of phosphorus and the TCA lability of the bond between the isolated carbohydrate
and peptidoglycan suggest that a linkage unit containing phosphodiester bonds might be
present. This would be analogous to the peptidoglycan-teichoic acid linkage in other
Gram-positive bacteria (Coley et al., 1978).
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Specific antigen-antibody reactions were demonstrated by CIE. Single precipitin lines were
detected when the lb antigen was reacted with antisera raised against serotypes la, lb, Ic and
with the commercial grouping antisera. No reaction between the extracted antigen and typing
antisera for types II and III could be detected.
These findings indicate that type I strains of GBS possess a carbohydrate antigen which is
covalently linked to the cell wall peptidoglycan in type lb streptococci. This antigen does not
confer sub-type specificity (la, lb, Ic), and antibodies to this antigen do not appear to be
provoked by whole cell antigen preparations of types II or III. It is surprising that the
group-specific antigen of type I strains (i.e. the carbohydrate cell wall antigen) does not react
with typing antisera to types II or III, although grouping antigens of types II and III react
with commercially available group B serum. The type-specific antigens present in the
'Lancefield' extract are not covalently bound to the cell wall, as they can be removed by the
SDS procedure. These are probably capsular or membrane-bound in their location within the
B complex.
During preparation of this manuscript, Wagner et al. (1980) demonstrated by
immunoelectron microscopy that the group-specific polysaccharide antigen of GBS traverses
the whole of the cell wall. This is in complete agreement with the findings in this study, which
indicate that the group-specific polysaccharide is the secondary wall polymer covalently
bound to peptidoglycan.
We are grateful to Professors J. G. Collee and J. C. Southam for constant encouragement and advice
throughout this study.
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Further studies on the im¬
munochemical nature of the cell-
wall antigens of group - B
streptococcus, type la
C.G. Cumming, P.W Rosst and I.R. Poxtont
Departments of Oral Medicine and Oral Pathology,
and Bacteriologyt, University of Edingburgh,
Edingburgh, Scotland
Definitive identification of group-B streptococci (GBS)
is based on serological reaction of the 'group-specific'
carbohydrate antigen which can be extracted from the
cell wall by hot HC110. Early reports indicated that the
components of this antigen are polysaccharides of low-
molecular size and consist mainly of rhamnose7''2. Sugar
inhibition studies of the GBS antigen-antiserum reac¬
tion suggested that rhamnose forms the principal
immunodeterminant of the antigen and occupies a
terminal position in the polymer. In addition, the use of
more subtle extraction procedures made possible the
identification of acid-labile sialic acid in the cell-wall
antigen".
Recently, immunoelectron microscopy studies" have
demonstrated that the 'group-specific' antigen of GBS
traverses the whole of the cell wall, whereas the 'type-
specific antigen is found only on the outer surface of the
wall.
The aims of the present study were:
1) to extract and purify the carbohydrate antigen which
is covalentlv bound to peptidoglycan of GBS. type la
cell walls,
2) to examine the serological character of the antigen;
and
3) to perform a chemical analysis of the antigen.
Materials and methods
Batteriu. GBS. type la 09OR, were obtained from the
Streptococcus Reference Laboratory, Colindale,
London.
Antisera. Specific antisera for GBS types la. Ib, 1c, II
and III were raised in New Zealand white rabbits by a
method described previously5.
Preparation ofcell walls. Saline-washed bacteria from
a 10 litre overnight culture in Todd-Hewitt broth were
disrupted by passage through a French pressure cell
(Amino Inc., Maryland, USA) at 7000 p.s.i. Cell walls
were collected by centrifugation at 50,(XX)g. The suspen¬
sion of walls was heated at SOX for 3 min to destroy
autolytic enzymes, and washed in three successive
volumes of water. Protein and membrane components
were removed from the suspension by adding an equal
volume of boiling 5% (w/v) sodium dodecyl sulphate
(SDS) and stirring for 4 h at 20°C. SDS was removed by
washing the walls in six changes of water, and the
purified walls were freeze-dried.
Extraction of antigen. Cell walls were divided into
three portions and carbohydrate extraction was
performed by the following methods.
Walls (100 mg in 10 ml water) were suspended in 10 ml
of 10% (w/v) trichloroacetic acid (TCA) and stirred for 8
h at 4°C. The supernate containing carbohydrate as col¬
lected by certrifugation at 50,000 g for 10 min. TCA was
removed bv six successive extractions with 10 ml vol¬
umes of diethyl either. Concentration os carbohydrate
was adjusted to 1 mg/ml in water.
2. Walls (100 mg) were subjected to a similar proce¬
dure as above, except that extraction was performed
with TCA for 48 h at 4°C.
3. Carbohydrate was extracted from the third portion
of walls with 0.5 M NaOH for 2 h at 20°C by a method
described by Anderson & Archibald2. Sodium ions were
removed by ion exchange chromatography on a column
of Dowex 50 NH.»t form).
Purification of antigens. Free sialic acid was removed
from the TCA (48 h) extracted by fractioning on a col¬
umn of Sepharose G25 (Pharmacia). This antigen was
further purified with DEAE-cellulose. Material was
eluted from the column with a linear concentration gra¬
dient (0—>1 M) of 100 ml of pvridinium acetate buffer,
pH5.3.
The NaOH extract was purified by DEAE-cellulose
chromatography.
Serological techniques. Serological profiles of the un-
purified and purified extracts were performed against
'type-specific' GBS antisera using crossed
immunoelectrophoresis, described previously
(Cumming, Ross & Poxton, 1981).
Analytical techniques. Carbohydrate concentration
was estimated by the method of Dubois et al\ phosphate
analysis by the method of Chen, Toribara & Warner3,
and sialic acid was determined by the thiobarbituric acid
method'.
Sugars were identified by paper chromatography and
gas-liquid chromatography. Conditions and methods of
alditol acetate preparation were described prrcviously6.
Results
CIE of wall extracts. Serological reaction of the un-
purified NaOH cell wall extract with 'type-specific' la, Ib
and Ic GBS antisera resulted in the formation of single
precipitin lines (line i). No reaction was detected bet¬
ween the NaOH extract and antisera to tvpes II and III
GBS.
Two precipitin lines (i and ii) were observed when the
unpurified TCA (8 h) cell wall extract was reacted with
la 'type-specific' antiserum. Against types Ib and Ic
antisera single precipitin lines (line i) were produced.
There was no reaction with antisera types II and III. CIE
of the unpurified TCA (48 h) cell wall extract with la
antiserum resulted in two precipitin lines (i and ii),
although this extract consisted predominantly of antigen
forming line ii. No reaction was detected with Ib anti¬
serum, whereas there was a faint reaction with Ic 'type-
TableChemical composition of NaOH and TCA cell wall extracts (strain 090R)
Content (molar proportion of)
Extract
Galactose Glucose Glucosamine Rhamnose Sialic acid
NaOH (antigen (i) 0.6 0.2 1 2 0.06
TCA (48h) (antigen ii) 2 1 1 2.6 trace
specific' antiserum (line i). Again, no reaction occurred
with antisera of GBS serotypes II and III
Purification of wall extracts. Follow ing remov al of free
sialic acid from the TCA (48 h) extract by fractionation
on Sepharose G25. this extract and the NaOH extract
were further purified by DEAE-cellulose chromato¬
graphy. Analysis of the column fractions indicated that
one major carbohydrate polymer in each was extracted.
Serological testing by CIE showed that the purified
NaOH extract was identical with the unpurified extract.
1.e. gave rise to line i. The purified TCA (48 h) extract
contained only antigen, which reacted with acetate
preparation were described previously", homologous
antiserum to form precipitin line li.
Chemical analysis. Constituents of the NaOH and
TCA (48 h) extracts are expressed as molar proportions
in the table. In addition, traces of phosphorus were
found in both extracts.
Discussion
The NaOH extraction technique made possible the iso¬
lation of a single carbohydrate antigen from GBS. type
la cell walls. This sialic acid-containing polymer is
similar in composition to the 'group-specific' antigen
isolated from GBS type lb cell walls". Treatment of cell
walls by cold TCA for 8 h caused the release of an
antigenic complex, predominantly similar to the NaOH
extract, but containing a partially degraded polymer,
lacking sialic acid, and exhibiting a different electropho-
retic mobility. An increase in the duration of TCA treat¬
ment to 48 h resulted in further destruction of sialic acid,
producing an antigenic complex which is serologically
distinct from the NaOH-extracted antigen. Chemical
analysis of the antigens indicated that the main differ¬
ence between the two is the absence of sialic acid in the
TCA (48 h) extract.
The presence of trace amounts of phosphorus and the
TCA-lability of the bond between the isolated carbohy¬
drates and peptidoglycon suggest that a phosphodiester
bond analogous to the peptidoglycan-teichoic acid
linkage described in other Gram-positive bacteria4 may
be present in GBS. type la.
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Summary. Two distinct carbohydrate antigens were isolated from the
cell surface of group B streptococcus, type II. One antigen was
extracted from SDS-purified cell walls by cold trichloroacetic acid and
contained galactose, glucose, rhamnose, glucosamine and sialic acid in
the approximate molar proportions T7:T0:3-4:0-9:0-21 respectively.
The serological activity of this polymer indicated that it is the
group-specific antigen common to all group B streptococci. The second
antigen was extracted by phenol from cell membranes and contained
galactose, glucose, glucosamine, phosphorus and fatty acid in a molar
ratio of l-6:10:0-35:2-6:0016 respectively. This antigen was shown to
be specific for type II, group B streptococcus.
Introduction
Lancefield (1933) demonstrated that beta-haemolytic streptococci could be
differentiated into several serological groups, labelled A-E, by the presence of a
group-specific carbohydrate antigen or C-substance. Further studies by Lancefield
(1934, 1938) divided group B streptococci (GBS) into four serological types by the use
of acid extracts of type-specific surface or capsular polysaccharide antigens. These
types were designated la, lb, II and III, and later type Ic was identified by the detection
of the type Ibc protein antigen on the surface of strains possessing a la polysaccharide
antigen (Wilkinson and Eagon, 1971).
Early reports on the immunochemical character of GBS antigens indicated that the
group-specific antigen is composed mainly of rhamnose (Slade and Slamp, 1962;
Wittner and Hayashi, 1965). In addition, rhamnose was shown to be the principal
immunodeterminant in the antigen, suggesting that it occupied a terminal position in
the polysaccharide (Curtis and Krause, 1964). Recently, the chemical profile of the
group-specific antigen from GBS lb was determined (Cumming, Ross and Poxton,
1981).
In laboratory animals, GBS have been shown to elicit the production of multiple
populations of protective antibodies, particularly against the surface type-specific
antigens (Lancefield, McCarty and Everly, 1975). When extracted with hot HC1, these
Received 7 Apr. 1982; accepted 16 Jun. 1982.
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antigens are partially degraded and immunologically incomplete (Baker, Kasper and
David, 1976). Extraction of GBS type II polysaccharide antigen with cold
trichloroacetic acid (TCA) gave a polymer containing two serological determinants,
whereas a partial antigen with only one of the determinants was obtained by extraction
with boiling HC1 (Freimer, 1967). D-galactose was identified as the determinant of the
HCl-extracted polysaccharide. The second determinant, present only in the TCA
extract was not identified. Recent studies have identified sialic acid as the important
second immunodeterminant (Kane and Karakawa, 1978; Tai, Gotschlich and
Lancefield, 1979; Kasper et al., 1979).
The numerous reports on the immunochemical nature of the cell surfaces of GBS
have indicated a complexity of antigenic structure only partially understood. The
present study investigated two distinct classes of antigen extracted from GBS type II.
The purified cell-wall carbohydrate antigen was examined serologically and chemi¬
cally, and the first investigation of the cell-membrane polymer (teichoic acid or
analogue) was undertaken.
Materials and methods
Strains ofgroup B streptococci. The following strains, representing the various serotypes,
were obtained from the Streptococcus Reference Unit, Division of Hospital Infection, Central
Public Health Laboratory, Colindale, London: 090R (type la), H36B (lb), NCTC11078 (Ic),
NCTC11079 (II), NCTC11080 (III).
Antisera. Specific antisera for GBS types la, lb, II and III were raised in New Zealand white
rabbits by intravenous injection of formalin-killed, trypsin-treated whole cells. Heat-killed
(56 C for 30 min) whole cells of strain NCTC11078 were prepared to obtain antisera for type Ic
GBS. The immunisation schedule has been described previously (Gumming et al., 1980). Group
B antiserum was purchased from Wellcome Reagents, Beckenham, Kent. Antisera were not
absorbed and their specificity was checked against homologous and heterologous Lancefield
extracts of GBS by double diffusion in agar gel.
Preparation of type II cell-wall extracts. Saline-washed bacteria from overnight cultures
(10L) in Todd-Hewitt broth were suspended in ice-cold water and disrupted by passing through
a French press (Aminco Inc., Silver Spring. MD, USA) at 48MPa (7000 lbf in 2). The
suspension from the French press was centrifuged at 50 000 g for 15 min at 4°C. The supernate
containing membranes was removed, freeze-dried and retained for subsequent extraction of
antigen, while the upper layer of cell walls was carefully separated from the small pellet of
unbroken cells. The suspension of cell walls in water was heated at 80°C for 3 min to destroy
autolytic enzymes, then washed in water at 4°C. Non-covalently-linked protein and
membranes were removed from the suspension by adding an equal volume of 5% (w/v) sodium
dodecyl sulphate (SDS) and stirring for 4 h at room temperature. To remove SDS, the cell walls
were washed by centrifugation at 50 000 g for 10 min in six successive changes of water at 20°C.
Carbohydrate was extracted from the walls with 10% (w/v) trichloroacetic acid, as described
previously by Cumming et al. (1981). Purification of carbohydrate was performed by
ion-exchange chromatography. Samples in 2 ml of water were applied to a column (30 cm x 1-5
cm) of DEAE cellulose previously treated with lM-pyridinium acetate (pW 5-3) then equilibrated
with water and eluted with 50 ml of water and 50 ml of 1m pyridinium acetate (pH 5-3) to give a
linear gradient from 0-1 m concentration. Fifty fractions of 2 ml were collected and samples
were analysed for carbohydrate.
Preparation of type II cell-membrane extracts. After French pressing, unbroken bacteria
and cell walls were removed by centrifugation and the supernatant fluid containing cell
membranes was freeze dried and weighed. Membranes (1 g) were de-fatted by stirring for 18 hat
room temperature in 200 ml of chloroform-methanol (2:1 v/v). The membranes were filtered,
rinsed with 200 ml chloroform-methanol mixture, and dried in air. Lipocarbohydrates were
extracted from the membranes with cold 80% aqueous phenol as described by Coley, Duckworth
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and Baddiley (1975). Nucleic acids were removed by incubation of the extract with RNase A
and DNase I (Sigma Chemical Company, London) at concentrations of 10 pg/ml in 0-2 m
sodium acetate-acetic acid buffer (pH 5-0) containing 10~3 m MgCb, under toluene for 48 h at
37 C. To ensure complete removal of contaminants, the aqueous phenol extraction procedure
was repeated. Further purification of the extract was performed on a Sepharose 6B (Pharmacia
Fine Chemicals, Sweden) column (60 cm x 1 -6 cm). Fractions (3 ml) were eluted by an upward
flow of 0-2 m ammonium acetate buffer, pH 6-9, containing sodium azide001%. Fractions were
analysed for carbohydrate and assessed for antigen content with GBS antisera by fused rocket
immunoelectrophoresis.
Analytical techniques. Carbohydrate was estimated by the method of Dubois et al. (1956),
phosphate analysis was by the method of Chen, Toribara and Warner (1956), and sialic acid was
determined by the thiobarbituric acid method of AminofT (1961).
Immunoelectrophoresis techniques. Electrophoresis was carried out with a Shandon
Southern apparatus (Camberley, Surrey, UK). Fused rocket immunoelectrophoresis
(Svendsen, 1973) against GBS type II antiserum in the gel was used to assess the antigen content
of cell-wall and membrane fractions from the chromatography columns. Pooled antigen-
containing fractions were subjected to crossed immunoelectrophoresis (CIE) techniques,
described previously by Cumming et ai (1981). Simple immunodiffusion experiments in agar
gel were performed by the method of Ouchterlony (1948).
Acid hydrolysis. Purified cell-wall and membrane samples were hydrolysed in 2 m HC1 for 4 h
at 100 C. Acid was removed by desiccation over NaOH and P2O5 in a vacuum and the samples
were dissolved in 0-5 ml water.
Paper chromatography. Descending paper chromatography was performed on Whatman
no. 1 paper with a butan-l-ol/pyridine/water (6:4:3, by volume) solvent. Aminosugars were
detected by ninhydrin and reducing sugars by the alkaline silver nitrate reagents (Trevelyan,
Procter and Harrison, 1950).
Preparation ofmethyl esters offatty acids. Methyl esters of the fatty acids of the lipid portion
of the cell-membrane extract were prepared by heating in 0-5m HC1 in methanol at 65 C for 2 h.
The methyl esters were partitioned into ether and the constituents were analysed by gas-liquid
chromatography (GLC) on columns of SP2330 3% on Chromosorb W.
Preparation ofalditolacetates. Hydrolysed carbohydrates were converted to alditol acetates
using methods described by Cumming et al. (1981).
Results
Cell-wall and carbohydrate preparations
The yield of SDS-treated GBS type II cell walls from 10L of culture was 950 mg.
Total carbohydrate extracted with trichloroacetic acid was approximately 10 mg.
Purification and analyses of cell-wall extract
Fractions eluted from the DEAE-cellulose column were collected and assayed for
carbohydrate. One major peak (W1) was eluted between 0-2m and 0-26m pyridinium
acetate buffer (fig. 1). Two additional peaks (W2 and W3) were detected; they were
eluted between 0-38m-0-58m and 0-62m-0-82m pyridinium acetate buffer, respectively.
Chemical analyses were performed on material from peaks W1 and W2 only.
Examination of acid hydrolysates of W1 by descending paper chromatography
showed the presence of galactose, glucose, glucosamine and rhamnose. These
constituents were confirmed by GLC of alditol acetate derivatives from which molar
proportions were calculated. In addition, significant amounts of sialic acid and trace
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Fig. 1.—Purification of a TCA extract of SDS-treated cell walls of GBS, type II by ion exchange
chromatography on a DEAE-cellulose column. Fractions (2 ml) were eluted with a linear gradient (0
to 1 m) of pyridinium acetate, pH 5-3. Carbohydrate was assayed by the method of Dubois et at.
(1956).
amounts of phosphorus were identified in the fraction. The complete chemical
composition of the polymer Wl, expressed as molar proportions, is shown in table 1.
Analyses of W2 showed the presence of ribose and trace amounts of those
constituents found in extract Wl, except sialic acid which was not detected.
CIE of cell-wall fractions
The antigenic nature of the cell-wall fractions was assessed with 'type' and
'group-specific' GBS antisera by CIE. Material from peak Wl produced a single
precipitin line in gel with type II and commercial GBS grouping antisera. No reaction
occurred with type la, lb, Ic or III 'type-specific' antisera. Similar results were
obtained with peak W2 and the GBS antisera. There was however, a slight difference
table i
Chemical composition ofmaterialfrom peak Wl from DEAE chromatography ofa TCA extract of
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Fig. 2.—Purification of a phenol extract of the cell membranes of GBS, type II on a Sepharose 6B column.
Fractions (3 ml) were collected and assayed for nucleic acid at 260 nm (•) and carbohydrate (O).
in electrophoretic mobility in gel between the two fractions when they were run in
tandem gels against commercial grouping antiserum.
No reaction was detected between material from peak W3 and the GBS antisera.
Cell-membrane preparation
The yield of freeze-dried cell membranes from an overnight culture of GBS type II
in 10L of Todd-Hewitt broth was 1-26 g. Following phenol-extraction procedures,
47-5 mg of extract was collected.
Analyses of cell-membrane extract
Material extracted by phenol from type II cell membranes was applied to a
Sepharose 6B column and the fractions assayed for carbohydrate, phosphorus and
nucleic acid. The elution profile is shown in fig. 2. Three distinct carbohydrate peaks
Table ii
Carbohydrate composition ofmaterialfrom peak MI from Sepharose 6B chromatography ofa cold
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Table III
Lipid composition ofmaterialfrom peak Ml from Sepltarose 6B chromatography ofa cold aqueous
phenol extract of eelI membranes of GBS type II
Percentage of
Component total lipid
Palmitic acid (C: 16) 74
Stearic acid (C:18) 17-5
Oleic acid (C: 18.1) 8-5
(Ml, M2and M3) were detected. Analysis of peak Ml for carbohydrate and lipid was
performed (tables 2 and 3). Sialic acid was not detected. Chemical analyses of
material from peaks M2 and M3 were not performed.
CIE of cell-membrane fractions
Material from peak Ml reacted only with antiserum against type II GBS to
produce one characteristic precipitin line in agar gel, but material from M2 reacted
with type II antiserum and with commercial grouping antiserum forming single
precipitin lines. Simple immunodiffusion experiments indicated that with both type 11
and grouping antisera, material from peak M2 formed precipitin lines of complete
identity with material from cell-wall peak W1. Lines of identity were not detected with
either of these extracts or material from peak Ml.
Discussion
The results described in this study indicate that two distinct antigenic carbohydrate
polymers can be isolated from cell walls and membranes of GBS, type II. The
chemical composition of the main antigenic peak (Wl) from the TCA extract of SDS
treated cell walls is qualitatively similar to the group-specific antigen isolated from
GBS type lb (Cumming et al., 1981). The second antigenic cell-wall polymer (W2)
differed chemically from the material in peak Wl only in its lack of sialic acid. The
absence of sialic acid in this polymer almost certainly accounted for the difference in
electrophoretic mobility between the two antigens. In simple immunodiffusion
experiments, however, the two antigens produced lines of partial identity when reacted
with commercial group-specific antiserum. This pattern of serological activity is
similar to that of the group-specific extracts from GBS, type la (Cumming, Ross and
Poxton, 1982).
The fact that type-specific antigens were removed from cell walls by SDS treatment
indicates that these antigens are not covalently bound to peptidoglycan. This opposes
the view of Tai et al. (1979) who suggested that the capsular type-specific antigens are
covalently bound to the cell wall.
Two distinct antigenic polymers were detected in material extracted from type II
membranes by cold phenol. Serological reaction of material from peak M1 showed its
specificity for GBS type II only, whereas peak M2 produced the same serological
profile as the group-specific cell-wall polymer (Wl). Immunodiffusion experiments
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with material from the two peaks (W1 and M2) confirmed their serological similarity.
This agrees with the observation of Coley etal. (1975) that wall teichoic acids ofcertain
gram-positive bacteria are often found in the second peak eluted from a Sepharose 6B
column.
Chemical analysis of the type-specific antigen (M1) showed it to be a phosphorus
containing lipocarbohydrate. This polymer should not be classified as a teichoic acid,
however, since it does not contain ribitol or glycerol phosphate. The composition of
the carbohydrate portion of the molecule is similar to the type-specific antigen of GBS
type II described by Freimer (1967), except for the absence of sialic acid in the
membrane polymer. This result implies that the GBS type-specific antigens,
commonly referred to as capsular, surface, or cell wall associated antigens, are indeed
membrane bound structures.
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THE ISOLATION OF A LECTIN-LIKE MOLECULE
FROM CORYNEBACTERIUM PARYUM (NCTC 10390)
J. Bagg, I. R. Poxton and D. M. Weir
Department of Bacteriology, University Medical School, Teviot Place, Edinburgh EH8 9AG, Scotland
(Received 12 December 1980)
SUMMARY A mannose specific lectin has been isolated by affinity chromatography from the cell wall
of C. parvum. Polyacrylamide gel electrophoresis indicates that the lectin molecules lie in the molecular
weight range 57,000-72,000. It appears that C. parvum like E. coli and salmonellae express lectins that
bind to cells expressing mannose in their membranes. This may partly account for the interaction
between C. parvum and the macrophage leading to the various immunological phenomena associated
with C. parvum administration.
Introduction
For some time it has been known that anaerobic coryne-
forms including Corynebacterium parvum (C. parvum) are
able to bring about activation of the cells of the mono¬
nuclear phagocyte system (1) and the process appears to
be causally related to enhanced resistance to tumour
growth in animals (2). The characteristics and conse¬
quences of the binding of C. parvum to mouse peritoneal
macrophages have been studied in detail (3, 4). A "lectin-
like" receptor specific for bacterial cell wall sugars was
found in the macrophage membrane and was responsible
for binding C. parvum. Binding was also associated with
changes in phospholipid metabolism prior to activation.
Amongst the bacterial cell wall sugars recognised by
the lectin-like receptor is D-mannose. The involvement
of this sugar was of interest in view of earlier findings
that D-mannose could inhibit the haemagglutinating
activity of various strains of enteric bacteria (including
Salmonella, Klebsiella, Shigella and Proteus) which, in the
absence of D-mannose, will produce haemagglutination
(5, 6, 7). It therefore seemed necessary to investigate the
possibility that C. parvum binding to macrophages might
in part be due to a lectin-like binding site present in the
cell wall of the bacterium itself.
The present paper provides evidence for such a mech¬
anism of attachment, involving a lectin-like molecule on




C. parvum (10390) obtained from the National Collection of Type
Cultures Colindale was used throughout. The bacteria were grown in
Correspondence: Dr. D. M. Weir, address as above.
stationary, anaerobic culture for 48 hr at 37°C in horse digest broth
containing 3 % (w/v) glucose. The cells were harvested by sedimentation
at 12,000 g for lOmin and washed once in 0-5 %NaCl at 4°C.
Agglutination Assay
Cells of Saccharomyces cerevisiae were prepared as described by
Eshdat et al. (8). The assay was performed on a microscope slide by
mixing Wpl of the solutidn under test with 5 pi of phosphate buffered
saline (PBS) (pH7-4) and 10/d of the yeast cell suspension. Agglutin¬
ation was monitored by the naked eye.
Preparation of the Lectin-containing Extract
The lectin was extracted using the technique of Eshdat et al. (8). The
washed cells (41 g) were homogenised in 200 ml of PBS containing
850mM sodium chloride and 0-03 mM phenylmethanesulphonyl fluor¬
ide, in a Sorvall Ontnimixcr (30 min, 0°C). The cells were sedimented by
centrifugation at I0,000g for 20min, then resuspcnded in 100ml of the
homogenisation buffer and rehomogenised and resedimented under
the same conditions. The combined supernate (300 ml) was centrifuged
twice at 5000g for lOntin to remove any remaining bacteria. This
yielded a pale straw-coloured solution which was cenliifuged at 48,000g
for 3 hr to produce a pellet below a straw-coloured supernate. The pellet
was suspended in 5 ml of PBS.
Protein Assay
The protein assays were performed according to the method of
Lowry et al. (9).
Affinity Chromatography of the Crude Extract
Yeast mannan was linked to Sepharose 4B as described by Uy and
Wold (10). The prepared Mannan-Sepharose 4B was used to pack a
7cm x ljcm column, which was equilibrated in PBS (pH 7-4) contain¬
ing 0-2% sodium azide. The crude extract from C. parvum (2 ml) was
centrifuged lightly to remove any solid material from the solution. The
column was loaded with 660pi of this solution (containing 2mg of
protein) and washed through with 18 ml of PBS. The eluate was
collected in 1 ml fractions, each of which was screened for protein. A
further eighteen 1 ml fractions were then collected with 0-1 M a-methyl-
D-mannoside (aMM), in 0-9% sodium chloride solution as the eluting
buffer. These were also analysed for protein. The fractions eluted with
aMM were dialysed against PBS overnight, and then against distilled
water for a further 5hr, to remove the iMM. The fractions were con¬
centrated by freeze-drying prior to carrying out the agglutination assay.
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Polyacrylamide Gel Electrophoresis (P.A.G.E.)
P.A.G.E. of selected fractions was performed in the presence of 1 %
sodium dodecyl sulphate (SDS) on 10% polyacrylamide slab gels using
the discontinuous buffer system of Laemmli (11).
Table 1 Data relating to samples run on SDS -P.A.G.E.
Approximate mass Agglutination
Fraction ofprotein Assay
3 230 pg Negative
4 and 5 240pg Negative
6 and 7 210/tg Positive
15 and 16 100 /rg Very strong
27 50 /rg Very weak
i—*■
6 12 18 24 30 36 fraction no.
t
a MM added
Fig. 1. Protein assay from affinity chromatography of 2 mg of crude
extract from C. parvum on mannan-linked Sepharose 4B.
The results of SDS-P.A.G.E. (fig. 2) gave an indication
of the protein bands associated with agglutination of the
mannan-expressing yeast cells. Repeated gel analysis
resulted in the finding that agglutinating activity was
confined to two doublet protein bands and possibly a
third band in the molecular weight range 57,000-72,000
which were consistently associated with agglutinating
activity. Also of interest is the finding that in the fraction
eluted with aMM, three further bands of approximate
molecular weights, 12,000, 16,000 and 30,000 appear
though they are not, apparently, associated with strong
agglutination of yeast cells.
Electron microscopy of a preparation of C. parvum
negatively stained with 2% PTA showed that many of
the cells possess structures resembling fimbriae projecting
from the cell surface (fig. 3).
Electron Microscopy
A broth culture of C. parvum was fixed with 0-25% formaldehyde,
and the bacteria harvested at 1000 g for 14min. The cells were gently
washed in distilled water and resedimented. The pellet was resuspended
in distilled water to produce a milky suspension, one drop of which was
placed on a microscope slide. Two Formvar-coated copper grids were
placed onto the suspension and left for 1 min. Excess suspension was
removed with a piece of filter paper, and the grids inverted. 2% phos-
photungstic acid (PTA) was applied for 20s and excess PTA removed
with filter paper. The grids were dried in a desiccator before examin¬
ation in a Hitachi HU 12A electron microscope.
Results
The crude extract produced by high speed centrifugation
(48,000g) of the homogenate did not show agglutinating
activity with glutaraldehyde-treated yeast cells. Fraction¬
ation of the crude extract on the Mannan-Sepharose
affinity column as shown in Figure 1 led to several
protein peaks with that at fractions 15 and 16 containing
strong agglutinating activity for the yeast. In an attempt
to elute further agglutinating material aMM was added
to the column but this treatment failed to elute a protein
peak that contained strong agglutinating activity (fig. 1).
This suggested that the lectin was not firmly bound to the
column and that the majority of the material capable of
agglutinating yeast comes off in the buffer eluate.
Table 1 shows fractions and combined fractions used
in P.A.G.E. analysis. They were freeze-dried and re-
dissolved in 100/d of distilled water (except fraction 27
which was dissolved in 50/d distilled watei), and re-
checked for agglutinating activity. The table shows that




Fig. 2. SDS -P.A.G.E. in a 10% polyacrylamide gel slab of fractions
from affinity chromatography of C. parvum extract: (a) molecular
weight marker; (b) fraction 3; (c) fractions 4 and 5 combined; (d)
fractions 6 and 7 combined; (e) fractions 15 and 16 combined; (f)
fraction 27; (g) crude extract.
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Fig. 3. Electron micrograph of cells of C. parvum (10390) negatively
stained with 2% P.T.A. x 75,000.
Discussion
Whole C. parvum (10390) organisms will agglutinate
Saccharomyces cerevisiae cells. The results indicate that
material containing the agglutinating activity can be
extracted from the organism by mild homogenisation
and affinity chromatography fractionation. The crude
extract itself did not agglutinate yeast cells prior to purifi¬
cation. After fractionation a highly active component was
obtained that increased in agglutinating activity along
with increasing homogeneity. Thus the fraction shown
in band (E) (fig. 2) gave the strongest reaction of the
fractions tested. It would therefore appear that the
presence of contaminating proteins interferes with the
binding reaction between the lectin molecule on the
bacterial surface and the mannan residues on the yeast
cell.
The results of SDS-P.A.G.E. indicate that the active
lectin molecules are proteins in the molecular weight
range 57,000 72,000. Invariably lectin activity was shown
to be associated with two or three bands, which appear
as "doublets" after electrophoresis (fig. 2). A possible
explanation for this is that the mannose-specific activity
is present as distinct iso-lectins, a finding not uncommon
among molecules of this type. A further phenomenon
revealed by the SDS-P.A.G.E. is the presence of three
lower molecular weight bands in the fractions eluted with
aMM. These bands, in the molecular weight positions of
12,000, 16,000 and 30,000, may represent sub-units of the
active agglutinin, especially since lectin-like molecules
can often exist in several forms, each of differing valency.
In order to produce agglutination of the yeast cells, the
lectin molecule must obviously be at least divalent. It is
interesting that when these bands were present in the
absence of the higher molecular weight agglutinin mol¬
ecules, agglutination was very weak. This might in part
be due to the inhibitory effect of contaminating aMM
that was not removed even after extensive dialysis.
The hair-like projections from the cell surface, revealed
by electron microscopy, may act as probes which can
carry the lectin molecules across the high potential energy
barrier which exists at a short distance between the
bacterial cell and the cell to which it is attaching. Unless
this barrier is overcome, there can be no interaction
between the bacterial lectin and a mannose residue on,
for example, a yeast cell or macrophage membrane, and
thus no adhesion can take place (12). The present find¬
ings extend our earlier observations that the binding of
C. parvum to mouse macrophages can be blocked by
pretreatment of the bacterium with mannose (13) in
the same way that E. coli and salmonellae binding
to epithelial cells has been shown to be inhibited by
mannose (8). It seems likely that this type of binding to
cells bearing mannose in their membranes may help
to explain the adjuvant and anti-tumour properties of
C. parvum mediated through macrophages (14).
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BINDING OF TYPE-III GROUP-B STREPTOCOCCI
TO BUCCAL EPITHELIAL CELLS
J. Bagg, I. R. Poxton, D. M. Wf.ir and P. W. Ross
Department of Bacteriology, Medical School, Teviot Place, Edinburgh EH8 9AG
Summary. A binding assay was used to study the attachment of
type-Ill group-B streptococci (GBS) to buccal epithelial cells. Results
indicate that an adhesin, with the characteristics of a protein, is the
molecule at the streptococcal cell surface responsible for attachment to
the buccal cells. The bacterial adhesin probably recognises a sugar on
the surface of the mucosal cell, because periodate oxidation of the buccal
cells caused a significant reduction in subsequent adherence of GBS. A
sonicate of type-Ill GBS blocked the binding of the organism to buccal
cells. The effects of physical and chemical modifications of the sonicate
on its ability to prevent bacterial attachment are described; these
corroborate the evidence gained from heat and periodate treatments of
the buccal cells and GBS. Results suggest a lectin type of attachment
mechanism for type-Ill GBS which can be blocked by n-acetyl-d-gluco-
samine, rather than attachment by means of a lipoteichoic acid as
described for group-A streptococci.
Introduction
It is widely accepted that adherence of bacteria to mucosal cells is important in the
initiation of many types of microbial disease (Gibbons and van Houte, 1971).
Group-B streptococci (GBS) are an important cause of serious neonatal illness
(Anthony and Okada, 1977), which has been related to vaginal colonisation with these
organisations (Ferrieri, Cleary and Seeds, 1977); several authors have reported the
kinetics of the binding reaction between isolated vaginal epithelial cells and GBS
(Mardh and Westrom, 1976; Zawaneh et al., 1979). It has also been shown that the
degree of attachment between bacteria and vaginal cells is related to the hormonal
status of the vaginal-cell donor, reaching a maximum near the time of ovulation
(Botta, 1979). At present, little is known of the particular bacterial cell-surface
components concerned in the binding of GBS to epithelial cells. In group-A
streptococci, membrane lipoteichoic acid (LTA) at the surface of the bacteria, is
responsible, at least in part, for their adherence to buccal epithelial cells (BEC)
(Beachey, 1975). This paper describes features of the binding of GBS to BEC and
indicates the nature of the adhesin on the GBS cell surface that mediates attachment of
the organism to BEC.
Received 30 Nov. 1981; accepted 18 Jan. 1982.
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Materials and methods
Bacteria. Type-Ill GBS (strain NCTC11080) and group-A streptococcus (strain
NCTC10085) were from the National Collection of Type Cultures, Colindale Avenue, London
NW9 5HT and were grown in static culture for 18 h at 37°C in Todd-Hewitt Broth (Oxoid
CM 189).
Buccal cells were gently scraped with a wooden spatula from the inside of the cheek of a
healthy male donor and suspended in 10 ml of Dulbecco's Phosphate-buffered Saline (PBS;
Oxoid BR 14a). The suspension was placed in a thin-walled test tube and treated in a sonic water
bath (Model 6441 A, Dawe Inst. Ltd, Concord Road, Western Avenue, London W3 OSD) for 1^
min to aid the removal of background commensal organisms. The cells were then sedimented at
200 g for 10 min and washed twice more in PBS. The washed pellet was suspended in 2 ml of
PBS and a cell count performed in a Neubauer counting chamber. The suspension was finally
adjusted to a concentration of 2-6 x 104 cells/ml by dilution with PBS.
Adherence assay. The extinction at 650 nm of the 18-h culture of GBS was adjusted to
0-43 which, from a previously determined calibration curve, yielded 108 cfu/ml. The volume was
noted. The bacteria were sedimented at 900 g for 20 min, washed once in PBS, then resuspended
to 108 cfu/ml in the previously noted volume of Dulbecco's PBS + Dulbecco "B" solution (Oxoid
SR39) 0-5 ml/100 ml of PBS.
Samples of bacterial suspension (1 ml) were mixed with equal volumes of buccal-cell
suspension in small, flat-bottomed sample tubes; the stoppered tubes were rotated at 30 rpm at
37°C for 45 min. After incubation, each mixture was filtered through a 10-pm filter (Gelman
Sciences Inc., 600 S. Wagner Road, Ann Arbor, Michigan; polypropylene filter, 13-mm
diameter) held in a Millipore filter holder, mounted on the end of a 10-ml syringe. Each filter
was washed with 30 ml of PBS, carefully removed from the filter holder and inverted onto a drop
of PBS on a clean microscope slide. The filters were lifted off the slide after approximately 2
min. The slides were air-dried, fixed in methanol for 5 min, and finally stained by Gram's
method. The stained smears were mounted in DPX (dibutyl thallate xylol) under coverslips.
Each mixture of bacteria and buccal cells was prepared in duplicate and the results were
averaged. Counting was performed at a magnification of 400 and for each experiment the
bacteria adherent to each of 100 separate buccal cells was counted. Statistical significance was
tested by Student's t test.
Preparation ofsonicatefrom GBS. GBS were grown for 18 h in 3 L ofTodd-Hewitt broth, at
37°C. Bacteria were harvested by centrifugation at 20 000 g for 10 min, washed once in PBS (pH
7-4, 0 01m) and suspended in 20 ml of PBS. The resulting suspension was treated in 5-ml
portions in the sonic waterbath for 5 min and the cells were then sedimented at 20 000 g for 10
min. The supernate was collected and dialysed against 0-005m tris-HCl buffer (pH 7-4) for 3j h
at 4°C. The material was then lyophilised.
Heat-treated sonicate was prepared by autoclaving at 121 °C for 15 min. For periodate
oxidation of the sonicate, a 2-ml sample (protein 140 pg/ml in 001 m PBS, pH 7-4) was made 0-1 m
in sodium metaperiodate and left overnight at room temperature, in the dark. Excess periodate
was destroyed by treatment with ethylene glycol, followed by lyophilisation. The sample was
then re-dissolved in 2 ml of distilled water. A control sample was treated in the same way except
that periodate was not added.
Preparation of membrane lipoteichoic acid. LTA was extracted from the cytoplasmic
membrane of type-Ill GBS with cold 80% aqueous phenol and purified on a column of
Sepharose 6B by the method of Coley, Duckworth and Baddiley (1975).
Pretreatment of GBS. Bacterial suspensions were treated with periodate for 5 min at room
temperature in 4 ml of acetate buffer, pH 4-6, containing sodium meta-periodate 10 mg/ml.
Control organisms were suspended in the same buffer but which did not contain periodate. The
bacteria were then washed once in PBS before being resuspended in Dulbecco's PBS + "B" to the
required concentration. Bacteria were either heated in a 75°C water bath for 30 min or in an
autoclave to 121°C for 15 min.
Bacteria were treated with trypsin (E.C. 3,4,21,4, Type III Sigma Chemical Co.) at a
concentration of 10 000 n-benzoyl-l-arginine ethyl ester units/ml in 46 mM tris-HCl (pH 7-5)
containing 11-5 mM CaCL for 1 h at 37°C by the method of Saunders and Miller (1980).
Pretreatment ofbacteria with various sugars was by incubation, at 37°C, of washed cells with
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the relevant sugar, dissolved in Dulbecco's PBS + "B". Bacteria were washed once in
Dulbecco's PBS + "B" before the adherence assay.
Pretreatment of buccal cells. Washed BEC were treated with streptococcal sonicate by
mixing the cells with the sonicate on a tube rotator at 37°C for 1 h. The buccal cells were then
sedimented by centrifugation at 200 g for 10 min.
Buccal cells were treated with LTA 0-7 mg/ml in the same manner as was the sonicate.
Periodate treatment of the buccal cells was performed in the same way as for the GBS.
Analytical procedures. Protein concentration was estimated by the method of Lowry et al.
(1951).
Polyacrylamide-gel electrophoresis (PAGE) was done in the presence of 1% sodium dodecyl
sulphate (SDS) on 10% polyacrylamide slab gels with the discontinuous buffer system of
Laemmli and Favre (1973). The gels were stained for protein with Coomassie brilliant blue R.
A mixture of reference proteins (BDH, Poole, Dorset BH12 4NN) containing cytochrome C
(mol. wt 12 300), myoglobin (17 200), chymotrypsinogen A (25 700), ovalbumin (45 000),
albumin (66 200) and ovotransferrin (76-78 000) was used as an indicator of molecular weights.
Results
In preliminary experiments to confirm that GBS would adhere to BEC, their
adherence was compared with that of group-A streptococci, which previously have
been shown to become bound to BEC (Alkan, Ofek and Beachey, 1977). There was no
statistically significant difference (p > 0-1) between the number of these two organisms
binding to BEC (table I).
Table I
Adherence ofgroup-A streptococci and type-Ill GBS to human BEC
Bacterial cells
Mean* number of bacteria attached
per epithelial cell +2 SEM
None (background) 2-3 + 0-6
Type-Ill GBS 13-9 + 2-5
Group-A streptococci 15-7 + 3-2
GBS = group-B streptococci; BEC = buccal epithelial cells.
* Of count on 100 epithelial cells.
The kinetics of the binding reaction between BEC and type-Ill GBS, determined by
incubating mixtures of GBS and BEC for 5, 15, 25, 35, 45, 60 and 90 min respectively,
are shown in fig. 1. Maximum adherence was reached after 45 min with no significant
increase after incubation for 90 min.
Periodate treatment of BEC
Treatment of BEC with sodium meta-periodate caused a significant decrease
(p< 0-001) in the binding of type-Ill GBS to the cells (table II).
Pretreatment of bacteria
Periodate treatment of type-Ill GBS did not cause a decrease in binding to BEC.
Mild heat treatment of bacteria, 75°C for 30 min, did not decrease the binding either
but autoclaving at 121 °C for 15 min reduced binding to a very low level; the difference
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Fig. 1.—Effect of incubation time on adherence of type-Ill GBS to BEC. Each point represents the
geometric mean ( + 1 SE) of results from 100 buccal cells.
was statistically highly significant (p < 0 001). Treatment of GBS with trypsin caused
a significant decrease (p<001) in their subsequent adherence to BEC. These results
are shown in table III.
Blocking of adherence with sonicate from type-Ill GBS
Preincubation of BEC with the sonicate preparation blocked the binding of
type-Ill GBS in a dose-response fashion (fig. 2).
Treatment of the sonicate at 121°C for 15 min significantly reduced its ability to
block bacterial binding (p < 0-001), but periodate oxidation of the sonicate affected its
blocking capacity much less (table IV). Because there was no significant difference
(p > 01) between the activities of the periodate-treated sonicate and the periodate-con-
trol sonicate, it seems unlikely that a carbohydrate on the bacterial surface is concerned
in adhesion.
table ii
Effect ofperiodate treatment of BEC on subsequent adherence of type-Ill GBS
Cells
Mean* number of bacteria attached











Footnotes as in table I.
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Table III
Effect ofpretreatment of type-Ill GBS on their adherence to BEC
Bacterial cells
Mean* number of bacteria attached
per epithelial cell ±2 SEM
None (background) 19-9 + 3-4
GBS 26-5 + 3-2
Periodate-treated GBS 30-0 + 4-4
None (background) 21-4 + 3-2
GBS 30-5 + 3-4
Mildly heatedf GBS 35-4 + 3-5
None (background) 19-2 + 2-6
GBS 30-5 + 3-4
Autoclavedj GBS 20-0 + 2-0
None (background) 24-5 + 3-2
GBS 40-8 + 5-9
Trypsinised GBS 30-8 + 3-6
t 75 C for 30 min.
J 121°C for 15 min.
Other footnotes as in table I.
Inhibition of adherence by sugars
Of all the sugars tested (0-2m d-galactose, 0-2m l-fucose, 0 05m lactose, 0-2m
D-glucose, 0-2Ma-methyl-d-mannoside, 0-2m maltose, 01m n-acetyl-d-galactosamine
and 01m n-acetyl-d-glucosamine), only n-acetyl-d-glucosamine produced a
Concentration of sonicate (mg protein/ml)
Fig. 2.—Dose-response curve of inhibition of binding by type-Ill GBS sonicate. Each point represents the
geometric mean ( + 1 SE) of results from 100 buccal cells. = background.
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Table IV
Effect ofheat andperiodate oxidation on the capacity of type-Ill GBS sonicate to block binding of
type-Ill GBS to BEC
Epithelial and
bacterial cells
Mean* number of bacteria attached per
epithelial cell +2 SEM
Untreated BEC (background)
Untreated BEC + GBS




treated BEC + GBS
Unoxidised control sonicate-







t 121°C for 15 min.
Other footnotes as in table I.
100
Concentration of N-acetyl-D-glucosamine (mM)
Fig. 3.—Dose-response curve of inhibition of binding of type-Ill GBS to BEC by n-acetyl-d-glucosamine.
Means of three counts.
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Table V
Effect ofpretreatment ofBEC with type-Ill GBS membrane LTA on subsequent adherence of type
III-GBS
Epithelial and Mean* number of bacteria attached
bacterial cells per epithelial cell +2 SEM
Untreated BEC (background) 22-2 + 2-6
LTA-treated BEC + GBS 28-9 + 3-8
Untreated BEC + GBS 33-0 + 3-2
LTA = lipoteichoic acid.






Fig. 4.—SDS-polyacrylamide-gel electrophoresis of sonicate preparation from type-Ill GBS. Lane A,
molecular-weight markers; lane B, sonicate from type-Ill GBS.
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significant decrease (p< 0-001) in subsequent attachment of type-Ill GBS to BEC. A
dose-response curve is shown in fig. 3.
Pretreatment of BEC with membrane LTA
No significant difference in binding was evident between treated and untreated cells
(p >0-05) (table V).
Polyaery lamide-gel electrophoresis
SDS-PAGE of the sonicate preparation revealed several protein bands, with one
major band of low molecular weight (c. 17 000) as shown in fig. 4.
Discussion
Buccal epithelial cells have been widely used as target cells in experiments designed
to study the adherence of many different bacteria to epithelial surfaces (Alkan, Ofek
and Beachey, 1977; Atkinson and Trust, 1980; Craven et al., 1980; Saunders and
Miller, 1980; Yamazaki, Ebisu and Okada, 1981). Although a large proportion of
buccal cells are non-viable, as judged by trypan-blue exclusion, several layers of dead
cells are present in the buccal mucosa (Beachey, 1981). In view of this, it seems
appropriate to use them as a target cell for in-vitro assays. The mechanism of
attachment ofgroup-A streptococci has been studied with the help of BEC-attachment
assays (Beachey, 1975) and it was found that, in the assay described in this paper,
group-A streptococci and type-Ill GBS were bound to BEC to the same extent.
Sodium meta-periodate cleaves the C-C bond between vicinal hydroxyl groups of
sugars and when BEC were treated with periodate there was a highly significant drop in
the number of GBS that adhered to the cells. Conversely, treatment of the GBS with
periodate did not reduce the subsequent binding, suggesting that a sugar molecule on
the surface of the buccal cells plays a role in the binding mechanism. Inhibition studies
with various simple sugars indicate that n-acetyl-d-glucosamine may be concerned in
this.
Mild heat treatment of the bacteria did not reduce binding but heating at 121 °C for
15 min markedly reduced the degree of attachment; in both instances the bacteria were
killed. Possibly the adhesin on the bacterial cell wall is a lectin, a thermostable protein
not affected by a temperature of 75°C but denatured at 121°C.
Results obtained with the sonicate from type-Ill GBS also support the view that a
protein rather than a carbohydrate on the bacterial cell surface is the relevant adhesin.
Heat treatment of the sonicate greatly reduced its efficiency as a blocking agent
whereas the periodate had very little, if any, effect. SDS-PAGE of the sonicate
preparation indicated its heterogeneity although there was one dominant protein band
of low molecular weight (c. 17 000). It now seems likely that many bacteria, including
such diverse organisms as Escherichia coli (Ofek, Beachey and Sharon, 1978), Eikenella
corrodens (Yamazaki et al., 1981), Aeromonas hydrophila (Atkinson and Trust, 1980)
and Fusobacterium nucleatum (Mongiello and Falkler, 1979) rely on lectin-type
interactions for their adherence to mucosal surfaces. Work in our laboratories has
also shown that Corynebacterium parvum may attach to macrophages through a
lectin-like binding site in the cell wall of the bacterium (Bagg, Poxton and Weir, 1981).
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The suggestion (Botta, 1979) that some characteristics of adhesion of GBS to human
vaginal epithelial cells may be explained by a lectin-type interaction, is supported by
our findings. Work recently published (Elbein et al., 1981) describing the binding of
GBS to influenza viral glycoproteins that have been inserted into the cell membrane of
infected MDCK cells, also supports this view. In the system that we studied, in which
type-Ill GBS attach to BEC, it seems that an n-acetyl-d-glucosamine specific lectin on
the bacterial cell surface is involved in attachment of the organism to the eukaryotic
cell.
Beachey (1975) has identified membrane LTA as being responsible for binding of
group-A streptococci to epithelial cells. Preincubation of BEC with LTA extracted
from the cytoplasmic membrane of type-Ill GBS failed to block significantly the
attachment of GBS, so that it seems that the mechanism of their adherence differs from
that of the group-A streptococci. This agrees with the finding that loss of LTA from
GBS cell walls, caused by treatment with penicillin, did not inhibit adherence of the
bacteria to vaginal cells (Zawaneh et al., 1979).
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Cells of Pasteurella haemolytica serotypes A1 and A6 were extracted with sodium salicylate and
the chemical and antigenic composition of both extracts determined. The extracts were
concentrated by ultrafiltration and the serotype antigen, measured by the indirect haemagglu-
tination test, was estimated to have a molecular weight between 100000 and 300000. The
chemical composition of sodium salicylate extracts (SSEs) from both serotypes was similar,
having protein, carbohydrate, fatty acid and phosphorus present in the ratio 10:1:0-5:01.
SDS-PAGE of both SSEs gave similar profiles with at least 48 bands present. These results
suggest that sodium salicylate removes the outer membrane of P. haemolytica. Crossed
immunoelectrophoresis indicated that a major serotype-specific antigen was present in SSEs of
both strains. This antigen was extracted from the SSE with hot phenol/water and analysed by
gas chromatography. The sugar composition of A1 and A6 phenol/water extract (PWE) was
qualitatively identical although some differences in proportions were observed. A1 and A6
PWE antigens protected mice against homologous serotype challenge and A6 PWE protected
against heterologous (Al) challenge.
INTRODUCTION
Pasteurella haemolytica is the causal organism of enzootic pneumonia and septicaemia in
sheep. There are at least 15 serotypes of P. haemolytica (Fraser et al., 1982) and these fall into the
two biotypes described by Smith (1961).
Antigens from a number of A biotype strains have been obtained by extraction of cells with
sodium salicylate (Gilmour et al., 1979) and vaccines containing these antigens have been shown
to confer protection against homologous but not heterologous serotype challenge in sheep
(Gilmour et al., 1979, 1983) and in mice (Evans & Wells, 1979).
Burrells et al. (1983) reported considerable cross-reactivity in ELISA between sodium
salicylate-extracted antigens from different serotypes and Donachie et al. (1983), using the same
method, demonstrated that serotype specificity resided in the polysaccharide antigens. Apart
from these reports very little is known about the chemical, physical and antigenic composition of
sodium salicylate extracts.
We describe here the results of chemical and in vitro immunological analyses of sodium
salicylate extracts from P. haemolytica serotypes Al and A6.
METHODS
Bacteria. Pasteurella haemolytica biotype A, serotypes 1 and 6 (Al and A6), strains FA1 and FA6, were isolates
from sheep with pneumonic pasteurellosis. They were stored lyophilized or in nutrient broth at — 70 °C.
Abbreviations: IHA, indirect haemagglutination; KDO, ketodeoxyoctonic acid; PWE, phenol/water extract;
SSE, sodium salicylate extract.
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Preparation ofsodium salicylate extracts (SSEs). Strains of P. haemolytica A1 and A6 were removed from storage,
checked for purity and serotype identity and inoculated into 50 ml Oxoid no. 2 broth. After incubation at 37 °C for
18 h with agitation, 15 ml of the resultant culture were inoculated into 1-5 1 of the same medium and further
incubated at 37 °C for 6 h with agitation. Optical density measurements were made with a nephelometer,
previously correlated with viable counts, to check that growth had reached approximately 109 live bacteria ml"'.
The bacteria were sedimented by centrifugation at 4200 # for 40 min at 4 °C and resuspended in one tenth of the
broth culture volume in 1 M-sodium salicylate. This suspension was shaken at 37 °C for 3 h and the bacteria were
removed by centrifugation at 28000# for 40 min at 4°C. The clear supernate was dialysed against a dilute
phosphate/saline buffer (PBS: 0 02 M-sodium phosphate, 0 03 M-sodium chloride; pH 7-6) for 48 h. It was then
concentrated by ultrafiltration through Diaflo (Amicon, Lexington, Mass., USA) XM300 and XM100A
membranes and any slight sediment removed by centrifugation. From a 3 1 culture approximately 30 ml of an
opalescent and slightly viscous concentrate was obtained. All concentration procedures were carried out at 4 °C
and the final concentrated extract stored at — 20 °C or lyophilized. In later preparations the SSE was concentrated
before dialysis without any apparent effect on the final product.
Preparation ofphenol/water extracts (PWEs). SSEs were further extracted with phenol by a method similar to
that described by Westphal et al. (1952). SSE (20 mg) was suspended in 4 ml distilled water and added to an equal
volume of 90% (v/v) phenol. The mixture was heated at 68 °C for 10 min with shaking, cooled in an ice bath and
then centrifuged at 28000# for 30 min. The aqueous layer was removed, dialysed against running tap water for
24 h and lyophilized.
Antisera. Antisera were raised against washed whole cells of P. haemolytica Al and A6 in New Zealand White
rabbits using the procedure described by Fraser et al. (1982).
Indirect haemagglutination (IHA) test. A sample of the concentrated SSE or PWE was diluted in PBS in 1 0 ml
volumes. Ox red blood cells, fixed in 1 % glutaraldehyde in PBS (v/v) (Shirai et al., 1975), were added to the sample
dilutions to give a final concentration of 0-5% (v/v) and the suspensions incubated at 37 °C for 30 min. The cells
were washed three times in PBS and resuspended to their original 2-0 ml volumes. A homologous rabbit antiserum
at a previously determined optimal dilution was dispensed in 25 pi volumes into the wells of a U-bottomed micro-
titre plate (Cookes Engineering Co., Alexandria, Va., USA). After addition of 25 pi sensitized cell suspension
per well the plate was allowed to stand at room temperature for 2 h and examined for haemagglutination. Positive
and negative controls were included. IHA titres were expressed as reciprocals of the highest dilution of SSE or
PWE which produced haemagglutination.
Crossed Immunoelectrophoresis (CIE). The procedure was essentially that described by Weeke (1973a). The SSE
and PWE antigens were examined by CIE on 5 x 5 cm squares of Gelbond film (FMC Corporation. Marine
Colloids Division, Bio Products, Rockland, Me., USA) using barbital/glycine/Tris buffer pH 8-8 (Weeke,
19736). Buffer was used undiluted (ionic strength 0 08) in the electrode reservoirs, but in gels and in sample buffer
it was diluted 1 in 4 with distilled water. Electrophoresis was at 20 V cm"1 for 45 min in the first dimension and
4 V cm" 1 for 18 h in the second. Gels were pressed, washed and stained with Coomassie blue as described by
Weeke (19736).
Chemical assays. Total dry weight of the SSE and PWE was determined by freeze drying after complete dialysis
against water. Total protein was estimated by the Lowry method with bovine serum albumin as standard. Total
carbohydrate was determined by the phenol/sulphuric acid method described by Dubois et al. (1956) with glucose
as standard. Total phosphorus was determined by the method of Chen et al. (1956). For the estimation of fatty acid
content freeze-dried samples of SSE (10 mg) were hydrolysed with 6m-HC1 (2 ml) at 105 °C for 4 h. The
hydrolysates were then repeatedly extracted with diethyl ether (Clarke et al., 1967), the residue dissolved in
chloroform, and the fatty acid content determined by the copper colorimetric method of Duncombe (1963) with
palmitic acid as standard.
Ketodeoxyoctonic acid (KDO) and heptose were measured by the method of Osborn (1963).
Vaccines. Aqueous suspensions of SSE (1-18 mg ml"1) and PWE (0-44 mg ml" 1) of A1 and A6 were emulsified
with equal volumes of Freund's complete adjuvant (Difco).
Vaccination and challenge. Six-week-old C57 black mice randomly allocated to groups of ten, were inoculated
subcutaneously with 01 ml vaccine at day 0 and 14. For each serotype, vaccinated and unvaccinated groups of
mice were challenged at 28 d after the initial vaccination according to the method of Evans & Wells (1979), except
that no mice were killed immediately after challenge. Briefly, mice were challenged intraperitoneally with 0-5 ml
of a mixture of bacterial cell suspension in mucin (1 :4, v/v). The challenge doses for Al and A6 were 1-3 x 106
colony forming units (c.f.u.) mland2-9 x 10s c.f.u. ml" 1 respectively. The mice were killed 6 h after challenge,
their livers removed and the number of bacteria in each liver assessed by viable counting (Miles et al., 1938).
Counts from the livers of vaccinated and control mice were compared by the Mann-Whitney ranking test
(Snedecor & Cochran, 1967).
Gas chromatography (GC). PWEs were hydrolysed with 2 M-hydrochloric acid at 100 °C for 3 h. The
monosaccharides were analysed as alditol acetates prepared by the method of Poxton & Cartmill (1982) on a Pye
Unicam 104 chromatograph using a column containing 3% (w/w) OV-225.
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SDS-PAGE. This was done on 10% (w/v) acrylamide slab gels with the buffer system of Laemmli (1970) by the
method described by Poxton & Brown (1979).
RESULTS
SSE was prepared from P. haemolytica serotype A1 (strain FA 1) and serotype A6 (strain FA6)
by the ultrafiltration method. Antigenic activity for Al, estimated as the IHA titre against
homologous rabbit antiserum, was determined at each step in the concentration procedure.
Samples were titrated in serial doubling dilutions from 1 in 5 to 1 in 640 in 1 ml volumes of PBS.
Loss of antigenic activity in sediments during clarification by centrifugation was less than 1 % of
the total activity. Table 1 shows the specific IHA titres of the dialysed SSE before ultrafiltration,
the ultrafiltrate, and the concentrated preparation of two different Al SSE preparations passed
through Diaflo XM100A or XM300 membranes. Antigenic activity was almost completely
retained by the XM100A filter but appreciable amounts of antigen passed through the XM300
filter.
Both Al and A6 SSE had a high degree of antigenicity when titrated against their respective
homologous antisera in the IHA test. At a concentration of 2-5 mg ml~1 the SSEs of A1 and A6
had titres of 1 in 1000 and 1 in 5000 respectively.
The chemical analyses for Al and A6 SSEs (Table 2) indicate a strong similarity in chemical
composition with both preparations containing protein, carbohydrate, fatty acid and
phosphorus in roughly the same ratio (10:1:0-5 :0-1).
The antigens of P. haemolytica Al and A6 SSE were visualized by CIE. The homologous
antibody/antigen reactions for Al and A6 SSE were similar in that one major antigen was
present in each of the SSEs (Fig. 1 a, b). When the loading of the A6 SSE was increased to that of
the Al SSE (50 pg) three other precipitin lines were observed in the homologous antiserum gel.
However, this resulted in a very diffuse and distorted precipitin line for the major antigen (result
not shown). SSE antigens were also run in CIE with an intermediate gel containing heterologous
antiserum between the antigen and the homologous antiserum-loaded gel. The major antigen for
both SSEs passed through the intermediate gel and precipitated only in the homologous
antiserum gel (Fig. 1 c, d). The major antigens would appear to be serotype-specific. When A6
Table 1. IHA titrcs of two different SSE preparations from P. haemolytica AI before and after
ultrafiltration through XM300 and XM100A membranes
Specific titre = titre/sample volume (ml): titres were determined as described in Methods. The XM300
and XM100A fractions were derived from different preparations.
Specific titre of fraction
A
( \
Fraction XM300 membrane XM100A membrane
Dialysed SSE before 0-39 2-6
ultrafiltration
Concentrate 100 >490
Ultrafiltrate 0-245 <0 021
Table 2. Composition ofsodium salicylate and phenolIwater extract prepared from P. haemolytica
serotypes AI and A 6
Values are expressed as percentage of total dry weight; ND, not done.
Serotype Al Serotype A6
Component SSE PWE SSE PWE
Phosphorus 0-4 1 1 2-8
Protein 57-9 6-3 56 0-4
Carbohydrate 6-0 14-8 5-4 12-4
Fatty acid 2-8 10-8 3-4 5-8
Heptose ND 6-6 ND 2-4
KDO ND 0-6 ND 0 01
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Fig. 1. CIE of (a) A1 SSE (50 gg)run against 100 |Al A1 antiserum, with blank intermediate gel (IG); (b)
A6 SSE (12-5 |rg) run against 100 (ul A6 antiserum with blank IG. CIE patterns obtained with (c) A1
SSE (50 |xg) run against 100 pi A1 antiserum with IG containing 50 pi A6 antiserum; (d) A6 SSE
(12-5 pg) run against 100 pi A6 antiserum with IG containing 50 pi A1 antiserum.
SSE at an equivalent loading to A1 SSE was run with an intermediate gel the three minor
antigens were held back by the intermediate gel indicating that these antigens are common to A1
and A6 (result not shown).
The PWEs of both A1 and A6 had comparable levels of antigenicity when measured by IHA
(1 in 1000 and 1 in 2000 respectively at concentrations of 1 mgml"1).
Both A1 and A6 PWEs were rich in polysaccharide and had little protein compared to their
respective SSEs (Table 2). Both contained heptose and small amounts of KDO. When the PWEs
of A1 and A6 were examined by GC the sugar compositions were similar, with glucose,
galactose, mannose, glucosamine, galactosamine and two presumptive heptoses present in the
molar ratios 1-8:1-5:0-15:1-0:1-5:1-5:2-4 for A1 PWE and 3-3:1-3:2-1:1 -0:0-4:0-4:0-35 for
A6 PWE. The presumptive heptoses were later confirmed by mass spectrometry.
PWEs of SSE were also run on CIE. The antigenic profiles obtained when these preparations
were run through a blank intermediate gel into a homologous antiserum gel were similar to those
found for the SSE preparations. One major peak was visible for each serotype (Fig. 2a, b). In
addition two minor peaks were present in the intermediate gel of the A1 PWE run and one
minor peak was visible at the interface of the two gels in the A6 PWE run. When the
intermediate gel contained heterologous antiserum the major antigens of both serotypes were
unaffected and precipitated in the homologous antiserum gel (Fig. 2 c, d). One of the two minor







Fig. 2. CIE of (a) A1 PWE (10 |ig) run against 100 (tl A1 antiserum, with blank intermediate gel (IG);
(b) A6 PWE (10 (ig) run against 100 pi A6 antiserum with blank IG; (c) A1 PWE (10 (ag) run against
100 |tl A1 antiserum with IG containing 50 pi A6 antiserum and (d) A6 PWE (10 pg) run against 100 pi
A6 antiserum with IG containing 50 pi A1 antiserum.
A 1 A6
Fig. 3. SDS-PAGE of sodium salicylate extracts (300 pg) of P. haemolytica serotypes A1 and A6 on
10% acrylamide gels stained with Coomassie blue.
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Table 3. Viable counts ofP. haemolytica A1 or A6 in the livers ofcontrol mice and mice vaccinated
with SSE or PWE from P. haemolytica A1 or A6
log10Viable count
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A6 (2-9 x 105)
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* Significant at 0-001 level (Mann-Whitney ranking test),
t Significant at 0-01 level.
I Significant at 0-05 level.
antigens of A1 PWE was apparently unaffected and the other antigen failed to precipitate (Fig.
2c). The minor antigen present in A6 PWE was precipitated within the intermediate gel
indicating some reaction with the heterologous antiserum (Fig. 2a).
Analysis of the proteins present in A1 and A6 SSE by SDS-PAGE (Fig. 3) showed that the
two serotypes contained a similar pattern of polypeptides. At least 48 bands were present with
one major band at around 51000.
Table 3 shows that PWE from both serotypes conferred significant protection on mice
challenged with homologous serotype culture. When challenged with the heterologous serotype,
A6 PWE protected against A1 (P = 0-05) but A1 PWE did not protect against A6. The degree of
protection against homologous serotype challenge afforded by SSE (significant at 0-001 level) in
each case was greater than that of the PWE (both significant at 0-01 level).
DISCUSSION
Sodium salicylate may remove a whole complex of lipopolysaccharide (LPS) and protein from
the outer surface of P. haemolytica cells. As the antigenic activity determined by IHA titres is
high in the supernate after extraction and this activity is retained after ultrafiltration through
an XM100A membrane but not an XM300 membrane (Table 1) it is possible to suggest an
apparent molecular size of between 100000 and 300000 for the antigenic complex in the A1 and
A6 serotypes. Chemical analyses of both SSEs showed them to be similar.
SDS-PAGE analysis of the SSEs further illustrates the close similarity of the two serotypes in
structure as there are no major differences between them in the number or migration of
polypeptide bands present. This contrasts with a previous study by Thompson & Mould (1975)
where proteins extracted with phenol/acetic acid and water from the two serotypes produced
different profiles on electrophoresis in polyacrylamide gels.
The profiles obtained by SDS-PAGE indicate that the SSE of both serotypes contains a large
number of proteins. The exact origin of these proteins is unknown but it is likely that outer
membrane proteins are present.
CIE of the SSEs from A1 and A6 detected a number of antigens. In each case a dominant
serotype-specific antigen was present and in A6 SSE three minor antigens which were also
common to A1 were sometimes observed by precipitation with heterologous antiserum in an
intermediate gel. The serotype-specific antigen, as detected by CIE and IHA, of each serotype
was extractable with hot phenol/water and shown to be largely polysaccharide. The presence of
heptose and KDO, which are generally regarded as markers for LPS, make it likely that the
LPSs of P. haemolytica A1 and A6 are present in the PWE preparations and visualized in CIE.
The identical monosaccharide composition of A1 and A6 PWEs revealed by GC suggests that
the antigenic differences seen in CIE and IHA are a result of either the linkages between sugars
or the proportion of sugars in the polysaccharides, and are not due to completely different
components.
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However, CIE indicated that the PWEs were not pure preparations of the serotype antigens
as, for each serotype, minor antigenic peaks were held back in intermediate gels containing
heterologous antiserum. These cross-reacting antigens may be present in the small amount of
contaminating protein or may be distinct polysaccharide components. Further purification of
the serotype antigen with immunosorbent techniques has so far been unsuccessful.
The finding that the PWEs of both A1 and A6 were protective in mice against homologous
challenge and, in the case of A6 PWE, against heterologous challenge indicates that the
serotype-specific protection reported for SSE vaccines by Evans & Wells (1979) probably resides
in the serotype antigen extracted by the phenol/water. The one-way cross-protection seen with
A6 PWE against A1 challenge could be explained by the presence of antigenic determinants
within A6 PWE which are shared with A1 PWE and important in protection against Al. Other
determinants which are not shared may be important in protection against A6.
The degree of protection afforded by PWE was less than that provided by SSE which may
indicate that the immunogenicity of the serotype antigen is enhanced by close association with
other outer membrane components such as proteins. Karch & Nixdorff (1981) have shown that a
combination of outer membrane protein and LPS from Proteus mirabilis gave rise to increased
immune responses to both components compared to those obtained when they were injected
individually into mice.
The possibility that antigens other than the serotype antigens are important in protection is
supported by the work of Biberstein & Thompson (1965) and Knight et al. (1969) who showed
that cross-protection unrelated to the serotype antigen does occur between P. haemolytica
serotypes. Non-specific protection against Salmonella typhimurium by rough LPS preparations
of P. haemolytica A7 has been reported by Rimsay et al. (1981). On the other hand, available
evidence suggests that, in sheep, protection is serotype-specific (Gilmour et al., 1979).
If the components involved in the immune response to P. haemolytica can be identified and
characterized it may be possible to select strains which produce a more effective antigenic
complex for inclusion in pasteurella vaccines.
We thank Dr J. A. Lomax of the Rowett Research Institute, Aberdeen, for analysis of heptoses by mass
spectrometry.
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Identification of
non-haemolytic pasteurellae
cultured from the lungs of
cattle
M. Z. Abdullahi, N. J. L. Gilmour, I. R. Poxton
Veterinary Record (1989) 125, 154
PASTEURELLA multocida is the cause of haemorrhagic septicaemia
of cattle and buffalo in the tropics and subtropics (Bain 1963) and is
one of the causes of respiratory disease of cattle throughout the world
(Jensen and others 1976. CTilmour 1978).
Carter (1963) demonstrated four serological types designated A. B.
D and E in an indirect haemagglutination (iha) lest. Serotype A is the
most common isolate from mammals and birds (Carter 1957. Pcrreau
and others 1962) and can be distinguished from the other varieties of P
multocida by the hyaluronidase decapsulation (uyd) test (Carter
1955. 1972).
Madsen and others (1985) reported certain mucoid Pmultocida-UVe,
organisms (Taxon 13) which are also hyd test positive. However,
unlike P multocida. these organisms do not produce indole and do not
convert mannitol and sorbitol to acid.
This investigation sought to use the API20E and conventional tests
to identify presumptive P multocida strains isolated from pneumonic
lungs of cattle.
The 93 presumptive P multocida strains used in this study were sent
to Moredun Research Institute by vies throughout the uk. They were
all non-haemolytic thus excluding P haemolytica. Each isolate was
cubcultured on dextrose starch agar (dsa) (Gibco Europe, Paisley.
Scotland), harvested in skimmed milk and lyophilised.
Lyophilised cultures were reconstituted in brain heart infusion
broth (bhib) (Oxoid, Basingstoke, Hampshire) and subcultured on
dsa plates that were then incubated at 37°C overnight. Three or four
isolated colonies were picked with a sterile cotton wool swab, em¬
ulsified in 1 per cent yeast extract, and tested in the API20E system
(API Laboratory Products, Basingstoke, Hampshire) according to
the manufacturer's instructions.
Rabbit antiserum to P multocida type A was kindly supplied by Dr
V. Norrung, Staatens Veterinaere Serum-laboratorium. Denmark.
Isolates were tested by iha (Carter 1955, 1972), and by the hyd test
using hyaluronidase-producing Staphylococcus aureus (Carter and
Rundell 1975).
Of the 93 strains examined 37 were identified as P multocida in the
API20E tests, and eight were Pasteurella species strains in that they
produced indole in the API20E reactions. Seven strains conformed to
Madsen's Taxon 13 classification on a combination of API21IE and
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conventional biochemical tests. Forty-one did not fall into any of the
above categories.
The results of the iha and hyd tests are summarised in Table 1.
Thirty-three of the 37 typical P multocida strains were classified as
type A in the hyd test but only 21 on the iha test. All seven Taxon 13
strains were hyd positive and 17 of 41 biochemically unidentified
strains reacted to both tests for serotype A.
TABLE 1: Reaction of the isolates in the hyd and iha tests
Biochemical test Number of Number of positive strains
group strains hyd iha
Typical P multocida 37 33 21
Pasteurella species 8 0 0
Taxon 13 7 7 0
Unidentified * 41 17 17
* 17 of these strains were API20E negative but all reacted to both the hyd and
iha tests
The results indicate a diversity both in the strains of P multocida
and in other pasteurclla like organisms recovered from cattle with
respiratory disease. Their identification presents considerable prob
lems to the clinical bacteriologist.
Seventeen of the iiia positive strains examined did not react in the
API20E system, possibly because they were fastidious and the 1 per
cent yeast extract was not rich onough to give sufficient growth (Ob
erhofer 1981, Porres and Porter 1975).
Madsen and others (1985) found during biochemical investigations
of 61 isolates of P multocida from pneumonic calf lungs, that 67 per
cent of the isolates in Denmark belonged to Taxon 13. In contrast,
only 7-5 per cent of the strains examined by the present authors could
be regarded as Taxon 13. The reason for this lower prevalence in the
uk is unknown.
Only 38 of the 93 strains gave reactions with anti-A serum. The 38
positive strains comprised 2l of the 37 typical P multocida strains and
17 of the unidentified strains. It is likely that some of the non reactor
strains had dissociated and lost their capsules during storage and
would not be identified by the iha test. Other strains could have
belonged to the other Carter serotypes B, D and E. An interesting
observation from this study was that none of the Taxon 13 strains was
positive in the iiia test, although Taxon 13 strains have not previously
been examined by this technique (Madsen and others 1985). In this
study also, 57 of the 93 cultures examined wore iiyd positive including
all the seven Taxon 13 strains. Like the iha test, the hyd test can be
used only to type mucoid, capsulated strains.
It is clear that a number of P multocida-like organisms are present
in the respiratory tracts of cattle and further work is necessary to
elucidate the role of such strains in respiratory infections. The results
also highlight the need for a practical scheme of classification for the
clinical veterinary bacteriologist.
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Use of the egg hatch assay on
sheep faecal samples for the
detection of benzimidazole
resistant nematodes
K. R. Hunt, M. A. Taylor
TABLE 1: ED50 values (ng/ml) and resistance factors for resistant and
susceptible strains of Ostertagia circumcincta (O/C) and Haemonchus con¬
tortus (H/C) after different storage times
Susceptible strains Resistant strains Resistance factor
O/C Fresh 0053 0-748 14-1
5 days 0067 0-576 8-6
7 days 0 087 0-543 6-2
H/C Fresh 0043 0-334 7-8
5 days 0-045 0-309 6-9
7 days 0037 0-363 9-8
Veterinary Record (1989) 125, 153-154
ANTHELMINTIC resistance in nematodes of grazing livestock is of
increasing concern in a number of areas throughout the world, be¬
cause genes for resistance are present in most of the important genera
of nematodes that affect grazing animals. It is in countries where Hae¬
monchus contortus of sheep and goats is endemic that the major prob¬
lems with anthelmintic resistance are generally encountered.
Many reports of resistance involve the benzimidazole group of an¬
thelmintics and several techniques have been developed to detect the
presence of parasites resistant to this group. These techniques have
been reviewed by Presidente (1985) and more recently by Taylor and
Hunt (1989). The most widely used in vitro test for detecting ben¬
zimidazole resistance is the egg hatch assay. There are several vari¬
ations of the assay but they are all based on the ovicidal properties of
the benzimidazole drugs and the ability of eggs from resistant strains
to develop and hatch at higher concentrations of the anthelmintic than
their susceptible counterparts. The need for undeveloped eggs (Coles
and Simpkin 1977) has been a major obstacle to the application of in
vitro egg hatch assays in routine diagnosis.
Several techniques have been described to overcome the problems
of using the egg hatch assay to screen for benzimidazole resistance in
the field. One method described by Whitlock and others (1980) in¬
volved the recovery of nematode eggs by sugar flotation, and their
incubation with a range of concentrations of anthelmintic in McCart
ney flasks before transportation back to tho laboratory. A different
approach was to prevent the development of nematode eggs in transit
to the laboratory by storing faecal samples on ice (Smith-Buijs and
Borgsteede 1986). This paper describes a simple anaerobic storage
system that can be used for the submission of faecal samples from the
field to the laboratory up to seven days after collection.
To provide the nematode eggs required for the development of
storage techniques and for the egg hatch assays, parasite-free Dorset
horn lambs were infected with third stage larvae of either ben¬
zimidazole resistant or susceptible strains of H contortus or Ostertagia
circumcincta. The resistant strains were originally isolated from the
field and maintained in the laboratory by passage through worm-free
lambs. Anthelmintic sensitivity to bonzimidazole anthelmintics had
been previously determined by slaughter trials and egg hatch assay
(Cawthorne and Whitehead 1983, Cawthorne and Cheong 1984). Sus¬
ceptible strains had been maintained in tho laboratory for over 20
years in a similar manner and had not experienced any anthelmintic
selection pressure.
Faeces samples were examined from 21 days after infection for the
presence of nematode eggs. When egg counts had risen above 500
epg, approximately 20 g of faeces were taken from each infected ani¬
mal and divided into two subsamples, A and B. Sample A was
screened immediately by using the egg hatch method described by
Cawthorne and Whitehead (1983). Sample B was stored under an¬
aerobic conditions for up to seven days at 27°C. The method of stor¬
age involved adding 10 g of faeces to approximately 90 ml of water in a
100 ml screw-top plastic bottle containing 10 glass balls. The bottle
was shaken vigorously for one minute to break up the pellets and
release the eggs into suspension, and then placed in an incubator at
27°C. Anaerobic conditions, verified with an oxygen meter (Camlab
Schott-Gerate), developed within three hours.
Faecal samples were stored at 27°C for up to 14 days before the eggs
were recovered and screened for benzimidazole resistance using the
K. R. Hunt, M. A. Taylor, Central Veterinary Laboratory, New Haw,
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method described above. Seven days was the longest time that eggs
could be stored before their mortality exceeded 5 per cent of the
population.
ED50 values (the concentration of thiabendazole in p.g/ml required
to kill 50 per cent of eggs) obtained from the in vitro egg hatch assays
using three replicates of fresh and anaerobically stored samples are
given in Table 1. The corresponding dose response lines for ben¬
zimidazole susceptible and resistant strains of O circumcincta and H
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FIG 1: Comparative dose-response lines for fresh and anaerobically
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FIG 2: Comparative dose-response lines for fresh and anaerobically
stored eggs of benzimidazole susceptible and resistant strains of Hae¬
monchus contortus
The results demonstrate that the anaerobic storage of nematode
eggs for up to seven days had no significant effect on ED50 values when
compared with the values from fresh samples. Although there was
some variation in ED5() values and the resistance factors with storage,
they remained within the normal variations encountered with the egg
hatch assay technique (Boersma 1983, Waller and Prichard 1986).
The use of this anaerobic storage method should make it possible to
apply the egg hatch assay more widely for screening for benzimidazole
resistance in the field.
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Outer membrane proteins of bovine strains of
Pasteurella multocida type A and their doubtful role as
protective antigens
M. Z. ABDULLAHI*, N. J. L. GILMOUR and I. R. POXTONt
Moredun Research Institute, 408 Gilmerton Road, Edinburgh EH17 7JH, and tDepartment of Bacteriology,
University of Edinburgh Medical School, Teviot Place, Edinburgh EH8 9AG
Summary. Outer membranes were prepared by the Sarkosyl method from 30 strains
of Pasteurella multocida and the closely related Taxon 13, which had been isolated
from cattle. The patterns of the outer membrane proteins (OMPs) on SDS-PAGE
were generally similar to one another, though the four major proteins (a-d) varied
somewhat in molecular mass; these patterns allowed the strains to be arranged into
12 groups. Taxon 13 strains and typical P. multocida strains were indistinguishable,
both types being found within the same group. Mice were vaccinated with heat-killed
bacteria of three strains and challenged with 10 LD50 of homologous and heterologous
live bacteria, representing groups based on OMP patterns; the best protection was
afforded by strain W674, which protected against nine of the 17 challenge strains;
but there was no correlation between protection and PAGE pattern. Pre-vaccination
and pre-challenge sera were used in immunoblotting to probe OMPs from protective
and non-protective strains. All three vaccines produced antibody to proteins a and d\
these proteins appeared to be common to all strains, varying in molecular mass but
not in overall antigenic expression. The antibody response to the other two major
OMPs appeared to be PAGE-group specific. There was no correlation between
protection and the antigen pattern seen by immunoblotting.
Introduction
Pasteurella multocida is a small gram-negative,
saccharolytic, indole-positive, facultatively anaer¬
obic cocco-bacillus. Carter's capsular serotype A is
associated with several animal diseases of world¬
wide importance such as bovine and porcine pneu¬
monia, fowl cholera and rabbit septicaemia.1-3
Type A can be distinguished from other types4'5 by
indirect haemagglutination (IHA) and hyaluroni-
dase decapsulation (HYD). Similar organisms6 that
do not produce indole and are unable to ferment
mannitol and sorbitol have been designated Taxon
13.
Many studies of the pathogenic mechanisms and
immunogenicity of surface extracts of P. multocida
serotypes have been made with the aim of devel¬
oping vaccines.7-11 However, effective vaccines
have been developed only for types B and E, the
haemorrhagic septicaemia serotypes.12 Lugtenburg
et a/.13'14 have shown a correlation between cell-
Received 27 Sep. 1989; accepted 6 Nov. 1989.
* Present address: Department of Biological Sciences, Usmanu
Danfodiyo University, PMB 2346, Sokoto, Nigeria,
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envelope-protein type and pathogenicity of strains,
presumably type D,15 isolated from swine atrophic
rhinitis. For type A strains, an experimental vaccine
for rabbits has been reported recently. It is based
on a potassium thiocyanate extract of whole
bacteria16 and the protective immunogen has been
identified as a 37-5-Kda outer membrane protein
(OMP).17
The aim of this study was to analyse the OMP
profiles of P. multocida type A and the related
Taxon 13 strains isolated from bovine pneumonia,
to determine the heterogeneity of this group, and to
attempt to define a protective immunogen in a
mouse septicaemia model, by investigation of the
immunogenicity of the OMPs.
Materials and methods
Bacteria
With the exception of the reference strain NCTC
10322 which was obtained from the National Collection
of Type Cultures, London N W9 5HT, all the strains were
isolated at Veterinary Investigation Centres from the
lungs of calves with pneumonia, and were identified
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provisionally as P. multocida. They were sent to the
Moredun Research Institute (MRI) on blood-agar plates,
and subcultured there once on plates of Dextrose Starch
Agar (DSA; Gibco). After overnight incubation, pure
cultures were suspended in skimmed milk and stored by
freeze drying. Strains were typed by IHA and HYD,20
and identified further by biochemical reactions in a
combination of conventional tube tests and API 20E test
strips. The IHA technique was similar to that of
Carter,4' 18 except that glutaraldehyde-fixed sheep eryth¬
rocytes were used instead of human group O cells.19 Tests
were performed in 50-^xl volumes in U-shaped wells of
microtitration plates (Sterilin) with rabbit antiserum
kindly supplied by Dr V. Norring (Statens Veterinaire
Serum Laboratorium, Denmark). From the 93 strains
submitted, 30 were selected for this study: 24 of P.
multocida type A, and six of Taxon 13. More details of
the bacterial identification have been published else¬
where.21
Vaccine strains and preparation ofvaccine
In a preliminary study,22 vaccine preparations from
nine strains, containing capsule, Iipopolysaccharide,
formalin-killed bacteria or heat-killed bacteria, were
tested for protective ability against homologous and
heterologous challenge with 10 LD50 of live bacteria.
The heat-killed cell vaccines of P. multocida strains W674
and W829 afforded the best heterologous protection.
These two strains, and a Taxon 13 strain (XI20) which
gave no protection, were selected for the present study.
Preparation of vaccine. Freeze-dried bacteria were
plated on DSA and incubated overnight at 37°C in a
moist sealed chamber to enhance hyaluronic acid produc¬
tion.23 Several iridescent colonies, which represent the
wild-type (virulent) phenotype, were inoculated into
30 ml of Brain Heart Infusion Broth (BHIB; Oxoid) and
incubated overnight at 37°C in an orbital shaker. The
culture was transferred to 1 F of BHIB in a 2-L conical
flask and kept for 6 h at 37°C in an orbital incubator.
The cells were harvested by centrifugation at 12 000 g for
20 min at 20°C, washed once in phosphate buffered saline
pH 7-4 (PBS) and finally resuspended in 10 ml of PBS.
They were killed in a water bath at 68°C for 90 min and,
after sampling for sterility, they were freeze-dried.
Vaccine consisted of dried bacteria (final concentration
5 mg/ml) in equal volumes of water and Bayol F (Esso)
containing Arlacel (Sigma) 10%.
Immunisation and challenge ofmice
Swiss white mice of both sexes, bred at MRI, were 4-6
weeks old at the beginning of an experiment. Groups of
10 mice were given two doses of 0-2 ml of vaccine
subcutaneously, 14 days apart. Vaccinated mice and non-
vaccinated controls were challenged intraperitoneally
with 10 FD50 of a 6-h broth culture of the organism, 14
days after the second vaccination; and deaths were
recorded up to 48 h after challenge. The FD50 was
determined previously by the method of Reed and
Muench;24 it ranged from 7-5 x 106 to 1-2 x 108 orga¬
nisms.
A 50-/xl sample of blood was collected from the tail
vein of each mouse pre-vaccination and pre-challenge.
The blood from each group was pooled, and the serum
was stored at — 20°C.
Isolation ofouter membrane (OM)
A modification of the method of Filip et al.,25 for the
preparation of OM from E. coli, was used. Confluent
growth from each of five DSA plates was washed offwith
5 ml of 0 01 M HEPES buffer, pH 7-4. The bacteria were
deposited by centrifugation (20 000 g, 15 min), resus¬
pended in 20 ml of buffer, and disrupted in a French
pressure cell (Aminco, Silver Springs, MD, USA) at
6000 psi. After removalofunbrokencells by centrifugation
(10 000 g, 15 min), c. 400 p\ of Sarkosyl (sodium N-lauroyl
sarcosinate; Sigma; 30% w/v) was added to give a final
concentration of 0-7%. The OM was deposited by
centrifugation at 50 000 g for 1 h, washed in distilled
water, resuspended in 1 ml of distilled water, and stored
at — 20°C.
SDS-PAGE and immunoblotting
OM proteins were analysed on slab gels 10% with
Faemmli buffers,26 and stained with Coomassie Blue.
The method of Hancock and Poxton27 was used for
immunoblotting. Separated proteins were transferred to
nitrocellulose membranes (Sartorius, 0-2 /xm pore-size),
allowing transfer to proceed for 16 h at 12 V. For
immunodetection by the BioRad system, the mouse sera
were diluted 1 in 100, and the rabbit anti-mouse IgG-
horseradish peroxidase conjugate (ICN Immunochemi¬
cals) was diluted 1 in 500.
Results
SDS-PAGE ofouter membrane protein (OMP)
Fig. 1 shows the Sarkosyl OM preparations from
30 strains of P. multocida type A and Taxon 13,
analysed by SDS-PAGE, and stained with Coo¬
massie Blue. Overall, the patterns are very similar,
revealing two, three or four major proteins (labelled
a, b, c and d) with molecular masses (Mr) in the
range 36-5—19 Kda, though each protein varied in
Mr over a limited range. By visual examination, the
strains could be arranged in 12 groups based on the
mobility of these major OMPs (table I).
Proteins b and d were the most strongly stained
and were present in all strains. The Mr of protein b
was in the range 34-5-29-5 Kda. Protein c showed
the most constant Mr—26 Kda in the majority of
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Table I. Grouping of 24 strains of P. multocida and six strains of Taxon 13
with patterns produced by major OMPs on SDS-PAGE as shown in fig. 1
Group Tracks (fig. 1) Strains of P. multocida or Taxon 13
1 123 X200 W829X1113
2 467 W571 X1016X195
3 89 W599 W674
4 10 X1043*
5 5 11 X198 NCTC10322
6 12 13 W819* X969
7 14 W590*
8 15 16 17 18 19 W833X109X12X9 W828
9 20 21 W669X1122
10 22 23 24 25 X918 XI053 XI10 XI20*
11 26 W577*
12 27 28 29 30 X483 X971 W820* W1049
* Six strains of Taxon 13.
resolved in strains X200, W829, XI113, W571,
X198, X1016, X195 and NCTC 10322; where
present, its Mr ranged from 36-5 to 33-5 Kda. The
Mr of protein d ranged from 21 to 19 Kda.
There were no features in the OMP patterns
which allowed differentiation between the typical
P. multocida and the Taxon 13 strains.
Mouse protection
Groups of mice were vaccinated with heat-killed
cells of strains W674 and W829 (P. multocida) and
strain XI20 (Taxon 13). Vaccinated mice and non-
vaccinated controls were challenged with 10 LD50
of the homologous strain and 16 heterologous
strains representing most of the groups defined by
SDS-PAGE of the OMPs (table II). Strain W674
appeared to afford the best protection—at least
50% protection against nine of the 17 challenge
strains. Strain W829 gave this degree of protection
against four strains, but the Taxon 13 strain XI20
protected only against strain X9. Strain X120 was
also the only strain that did not afford homologous
protection at this level. There was no apparent
correlation between the SDS-PAGE group pattern
and protection.
Demonstration ofantibody response to the major
OMPs in vaccinated mice by immunoblotting
For each of the three groups of vaccinated mice,
seven strains (against some of which vaccination
was protective and some non-protective) were
selected for investigation by immunoblotting with
pre-vaccination and pre-challenge sera. With the
pre-vaccination sera, immunoblots showed no
reaction. In the pre-challenge sera, however, the
mice had responded to at least two of the major
OMPs; but there was no correlation between
immunoblot pattern and protection. Proteins a and
d were the most immunogenic. Immunoblots with
pre-challenge sera from mice vaccinated with strain
W829 are shown in fig. 2b. There was a relatively
uniform response to both a and d proteins; but this
did not depend upon the Mr being the same as that
of the vaccine strain. It appears that there are
common epitopes on all the a proteins and similarly
on all the d proteins. The response to the other two
major proteins was much more variable and
appeared to be PAGE-group specific, e.g., strains
W829 and XI113 in tracks 1 and 3 of fig. 2 both
belong to PAGE group 1 (table I). There was,
however, no correlation between the patterns and
protection: vaccine W829 protected against the
strains in tracks 1, 2, 3 and 6, but not against the
strains in tracks 4, 5 and 7, although the immuno¬
blots in tracks 4 and 6 are indistinguishable.
Discussion
The patterns produced on SDS-PAGE by Sar-
kosyl extracts of P. multocida are similar to the
patterns produced by the OMPs of other gram-
negative bacteria, in which there are a small
number of major proteins and several minor ones.28
The four major proteins which we have labelled
a-d have allowed us to arrange strains of P.
multocida into groups (table I). It is apparent from
this grouping that strains of Taxon 13 share profiles
of major OMPs with strains of P. multocida, and we
suggest that these taxa cannot be distinguished on
this basis.
TableII.Percentageprotectionfmi ei groups10vaccinat dw hh at-k ll do ga ismsnchal eng dits r if.mu toci arTax3
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Fig. 2. (a) SDS-PAGE gels of Sarkosyl OM preparations from strains of P. multocida and Taxon 13* against which mice were or
were not protected by vaccination with strain W829 (see table II). Track 1, strain W829 (protected); 2, W674 (protected); 3, XI113
(protected); 4, X12 (not protected); 5, W577* (not protected); 6, X9 (protected); 7, X120* (not protected), (b) Corresponding
immunoblot probed with pre-challenge serum from mice vaccinated with heat-killed cells of strain W829. (a, b, c, d represent major
OMPs).
When mice were vaccinated with heat-killed
cells they produced an antibody response to two or
more of the major OMPs (fig. 2b). This response
was a combination of species-specific and PAGE-
group-specific antibodies, but the latter did not
correlate with protection. The proteins were anti¬
genic in mice but not protective. Moreover,
although proteins may differ from one another in
Mr, they did not necessarily differ antigenically.
This finding applies also to other groups of closely
related species, e.g., some of the major OMPs of
Enterobacteriaceae share epitopes but differ in
Mr.29
Our conclusion is that, in this mouse model of
pasteurellosis, the major OMPs are not protective
antigens, and therefore may be unlikely candidates
for vaccines. However, this appears to contradict
the findings of Lu et aid1 who showed that the
37-5 Kda OMP (presumably our protein a) was
protective against homologous challenge in a rabbit
model; but in a mouse model, protection was
afforded against heterologous challenge only if the
challenge strain was shown, by probing with a
monoclonal antibody, to express the 37-5-Kda
antigen.30 Protection was not provided against
strains lacking this antigen. Thus, they showed that
this OMP can be a protective immunogen in the
strains that possess it; but they concede that other
antigens may be more important as vaccine
candidates, because only 24% of their strains of P.
multocida expressed this antigen.
We acknowledge the award of a scholarship to MZA by the
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Production of mouse monoclonal antibodies to
Pasteurella multocida type A and the immunological
properties of a protective anti-lipopolysaccharide
antibody
THULAG. WIJEWARDANA*, CHRISTINA F.WILSON, N. J. L. GILMOUR and I. R.POXTONt
Moredun Research Institute, 408 Gilmerton Road, Edinburgh EH 17 7JH and tDepartment of Bacteriology,
University Medical School, Teviot Place, Edinburgh EH8 9AG
Summary. Eight monoclonal antibodies (M Abs) were produced from mice immunised
with whole cells of heat-killed Pasteurella multocida type A which had been cultured
under iron-restricted conditions. The MAbs were selected by an enzyme-linked
immunosorbent assay (ELISA) in which the antigen consisted of whole bacteria of
the immunising strain. Their reactivity was investigated further by immunoblotting,
indirect haemagglutination, a complement-mediated bactericidal assay and passive
protection of mice. One of the eight MAbs was shown by immunoblotting to react
with lipopolysaccharide (LPS), was bactericidal, and completely protected mice
against homologous challenge with 10 LD50 of live bacteria. This MAb was selected
for further study. Its reaction with LPS of 17 type-A strains and of single strains of
types B, D and E was investigated by immunoblotting. Strains that reacted with the
anti-LPS MAb in immunoblots were susceptible to its bactericidal activity and gave
high ELISA absorbances. Those that did not react were not susceptible to its
bactericidal activity and gave low ELISA readings. The relation between bactericidal
activity and ELISA absorbance was highly significant (p < 0001). Five of the strongly
reacting heterologous strains and one non-reacting strain were selected as challenge
organisms in a passive protection experiment: only the mice receiving the reacting
strains were protected.
Introduction
Pasteurella multocida is the cause of various
diseases in mammalian and avian species.1 Capsu¬
lar type-A strains cause fowl cholera, pneumonia
in cattle, sheep and pigs, and "snuffles" in rab¬
bits ;1 '2 strains of types B and E cause haemorrhagic
septicaemia in cattle and buffaloes;3 and type-D
strains cause pneumonia in cattle and atrophic
rhinitis in pigs.1'4
Capsular polysaccharides of P. multocida types B
and E are protective against haemorrhagic septi¬
caemia.5 However, non-capsulate and capsulate
organisms are equally effective in immunising birds
against fowl cholera.6 Lipopolysaccharide (LPS) of
P. multocida, which is considered to be responsible
for the somatic serotype specificity,7 was poorly
Received 9 May 1990; accepted 25 June 1990.
"Present address: Veterinary Research Institute, PO Box 28,
Gannoruwa, Peradeniya, Sri Lanka.
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immunogenic in mice in its purified form, but
protective in chickens.8 A protein-LPS complex
protected mice, rabbits and chickens.9'10 LPS has
been recognised as the major immunogen in
ribosomal vaccines.11'12 The role of outer mem¬
brane proteins (OMP) in protection against P.
multocida infections is unclear. In mice, protection
by whole-cell type-A vaccines was unrelated to
their content of OMP;13 in rabbits, however, a
37-5-KDa OMP has been identified as a protective




P. multocida strain W674, a calf pneumonia isolate,
was used to immunise mice for MAb production. The
National Collection of Type Cultures supplied strains of
capsular serotypes A (NCTC 10322), B (NCTC 10323),
D (NCTC 10325) and E (NCTC 10326). All other strains
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were of P. multocida type A, isolated from calves at
Veterinary Investigation Centres and submitted to the
Moredun Institute for identification as described previ¬
ously.16
Immunisation procedure andproduction of
monoclonal antibodies
Five 6-week-old BALB/c mice were immunised with
108 heat-killed (60°C, 90 min) cells ofstrain W674, grown
in nutrient broth (NB; Oxoid) containing 2,2'-dipyridyl;
the iron-restricted medium probably increased the resem¬
blance of the bacteria to those grown in vivo. A suspension
of washed bacteria (8-0 x 109/ml in PBS) was emulsified
with an equal volume of Bayol/Arlacel adjuvant. One
volume of the emulsion was mixed with 3 volumes of a 1
in 10 dilution of alhydrogel. Each mouse received 0-1 ml
of this mixture intraperitoneally (i.p.) on days 0 and 14.
Blood was taken from the tail vein of each mouse on day
22 and the antibody response was measured by ELISA
(see below) with an antigen consisting of whole cells
grown in the presence of 2,2' dipyridyl. The mouse with
the highest antibody titre was selected for fusion. Three
days before fusion (day 30 + ) the mouse was inoculated
intravenously with heat-killed P. multocida (10s cells) in
01 ml of saline. Fusion with NS-0 cells was made by the
method ofKohler and Milstein17 except that polyethylene
glycol was used as the fusion agent. Hybridomas
producing specific antibody were detected by a whole-
cell ELISA (see below) and were cloned and sub-cloned
by limiting dilution.
Ascitic fluid was produced in adult BALB/c mice
which had been primed i.p. with 0-5 ml of pristane
(Sigma) 3 days before an injection by the same route of
107 hybridoma cells. Fluid was collected 7-10 days later.
Characterisation ofMAbs
lsotype determination. The class and subclass of the
MAbs in culture supernates were determined by means
of a mouse monoclonal-antibody isotyping kit (RPN29:
Amersham International pic) according to the manufac¬
turer's instructions.
Enzyme-linked immunosorbent assay (ELISA). An
ELISA was used (a) to detect the antibody response of
mice to vaccination, (b) to screen hybridomas for the
production of specific antibody, and (c) to test the
reactivity of MAbs against heterologous strains of
bacteria. For purposes (a) and (b), P. multocida strain
W674 was grown in NB containing 2,2'-dipyridyl for 6 h
at 37°C, washed once in phosphate-buffered saline (PBS)
and resuspended in carbonate-bicarbonate buffer,
pH 9-6, to a concentration (107 cfu/ml) previously shown
by chess-board titration to be optimal for coating. For
(c), an overnight culture of each strain was grown in NB,
washed once in PBS and resuspended in formol saline
0-5% to c. 107 cfu/ml (A420 = 0T). The wells of the
microtitration plates were coated with 100 pi of bacterial
suspension by incubating overnight at 4°C. The primary
antibody (100 pi) was either undiluted hybridoma culture
supernate or doubling dilutions of mouse serum, after an
initial 1 in 50 dilution, in PBS containing Tween 20
0-05% (PBST). After incubation for 1 h at 37°C and
washing four times in PBST, 100-pl volumes of horse¬
radish peroxidase-sheep anti-mouse Ig conjugate (Scot¬
tish Antibody Production Unit, Carluke) diluted 1 in 200
in PBST were added and incubated for 1 h at 37°C. After
washing as previously, 100-pl volumes of substrate
solution (ortho-phenylenediamine, Sigma; 0-4mg/ml in
citrate phosphate buffer, pH 5, with 30% hydrogen
peroxide 4 pi/10 ml) were added and after 1 h at 37°C the
colour was read at 492 nm in a Titertek Multiscan.
Immunoblotting. Whole-cell lysates of P. multocida
strain W674 and Sarkosyl-extracted outer membranes
prepared as described by Abdullahi et al.13 were separated
on polyacrylamide 10% gels with the buffer system of
Laemmli.18 LPS was prepared from several strains by
the Proteinase K method of Hitchcock and Brown19 and
separated on polyacrylamide 14% gels with the same
buffer system as that for the 10% gels except that sodium
dodecyl sulphate was omitted from the separating and
stacking gel buffers. Separated antigens were transferred
to nitrocellulose membranes (Schliecher and Schuell;
pore size 0-2 pm) and probed with undiluted hybridoma
culture supernates for 4 h at room temperature. Immune
complexes were detected with anti-mouse Ig-horseradish
peroxidase conjugate and the BioRad HRP colour
reagent.20
Indirect haemagglutination (IHA). This was performed
essentially by the method of Carter.21 Doubling dilutions
of MAb (ascitic fluids), from 1 in 2 to 1 in 128, were
tested against sheep red cells sensitised with capsular
antigen prepared from the homologous strain W674 and
several heterologous strains.
Bactericidal assay. MAbs were tested for their bacteri¬
cidal capacity by the method of Wijewardana and
Sutherland.22 Briefly, triplicate samples (20 pi) of MAb
(ascitic fluid) were incubated with 100 pi of a suspension
of strain W674(2000 cfu/ml) in modified barbitone buffer
(Sigma) for 10 min at room temperature in microtitration
plates (tissue culture grade; NUNC, Denmark). After
the addition of 80 pi of undiluted fresh complement
(serum from new-born calves or gnotobiotic lambs) to
each well the plates were incubated for a further 30 min
at 37°C. From each well, triplicate 10-pl samples were
removed and plated on 7% sheep blood agar. The number
of colonies (T30) was counted after overnight incubation
at 37°C. The initial bacterial inoculum was confirmed
retrospectively by plate counts23 and the assay count (T0)
was calculated as 0-5 x the mean cfu/ml. The percentage
killing (K%) was then calculated by the formula:
K%= 1 —
mean cfu/ml at T3(
mean cfu/ml at T0
x 100
Hyperimmune rabbit serum against strain W674 and
fetal bovine serum were included as standard positive
and negative sera respectively. The bactericidal capacity
of the MAbs against heterologous strains was tested by
the same method.
Passive protection of mice. The protective capacity of
MAbs was investigated in BALB/c mice. Each MAb
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(0-2 ml) in the form of ascitic fluid was inoculated into
five mice. Ascitic fluid (0-2-ml volumes) of an irrelevant
MAb (MAb E7, raised against louping-ill virus and
kindly supplied by Mr M. Hussein of the Moredun
Research Institute) was inoculated into five control mice.
One hour later, all mice were challenged with approxi¬
mately 10 LD50 of homologous or heterologous bacte¬
ria.13 Mice were observed for 48 h after challenge, deaths
were recorded and the percentage protected was calcu¬
lated.
Results
Production and characterisation ofmonoclonal
antibodies
Of 97 hybridoma supernates tested in ELISA, 20
gave optical densities (OD) at 492 nm of greater
than 0-5. However, only eight continued to produce
specific antibody after cloning and these were
characterised further.
Isotype determination. Four MAbs (1/2.16.8,
1/15.9.1, 1/18.13.5 and 1/20.10.15) were of the IgM
isotype, two (1/4.1.6 and 1/19.12.13) were IgG[,
one (1/13.6/12) was IgGib and one (1/8.16.11) was
IgG3.
a
Immunoblotting. By this technique, only two
MAbs were shown to react with separated, trans¬
ferred antigens of the immunising strain W674.
When the outer membranes were probed, only
MAb 1/4.1.6 reacted (with a 77-Kda band; fig. la).
However, when LPS was used, another MAb,
1/8.16.11, reacted strongly with the material at the
gel front, which corresponded to LPS. This is
shown in fig. lb. Included in this figure are tracks
probed with pre-cloned and pre-subcloned super-
nates.
Indirect haemagglutination. Only one MAb,
1/2.16.8, demonstrated haemagglutinating activity
(titre of 64) and was considered to be reactive with
a component of the capsule. Subsequently, when
this MAb was tested with heterologous strains, it
was found to be specific for the immunising strain.
Bactericidal activity. Complement-mediated bac¬
tericidal activity was demonstrated only by the
anti-LPS MAb (1/8.16.11). There was 80% killing
of the homologous strain.
Passive protection ofmice. The group of mice that
received the anti-LPS MAb (1/8.16.11) resisted
challenge with 10 LD50 of strain W674 and
remained well during the 48-h observation period,
b
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Fig. 1. Immunoblots of surface antigens of P. multocida strain W674 probed with undiluted hybridoma culture supernates. (a)
Sarkosyl-prepared outer-membrane proteins: the only tracks showing positive reactions compared with the negative control (track
16, uninoculated culture medium) are 14 and 17, which correspond to MAb 1/4.1.6 and the positive control (serum from the mouse
used for fusion) respectively, (b) LPS: the tracks showing strong, positive reactions were probed with MAb 1/8.16.11 (track 5), and
supernates from the uncloned primary hybridoma culture well (track 3) and the first cloning of this culture (track 4); the serum from
the mouse chosen for fusion is in track 14, and shows a weak positive reaction.
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indicating 100% protection; all the control mice
died. In the groups of mice inoculated with MAbs
1/19.12.13 and 1/20.10.15, two and five animals
respectively were alive at the end of the observation
period but they were severely ill. After killing the
surviving mice by cervical dislocation, heart blood
was plated on sheep blood agar. P. multocida was
recovered from the sick mice but not from the mice
protected with the anti-LPS MAb.
Reaction ofanti-LPS MAb with heterologous strains
From the results described above, it was evident
that the anti-LPS MAb (1/8.16.11) protected mice
against homologous challenge and promoted com¬
plement-mediated killing. Therefore, this MAb was
tested against heterologous strains in the whole-cell
ELISA, in immunoblotting with LPS preparations,
in bactericidal assays and by passive protection
tests in mice.
The whole-cell ELISA results and the bactericidal
capacities are shown in table I. The absorbances of
Table I. Bactericidal capacity of the anti-LPS MAb
(1/8.16.11) against strains of P. multocida and the
corresponding ELISA absorbances
Reactions of anti-LPS MAb with
P. multocida strains
Strain of P. multo¬ Bacterial ELISA absorbances
cida killing (%) (%)t
X1056* 1000 916
A36* 1000 970









Type A (10322)f 00 14-3
Type B (10323)$ 50 14-9
Type D (10325)$ 00 12-4






*Strains that reacted with MAb in immunoblotting.
fELISA absorbance values relative to the homologous
(strain W674) reaction.
tNCTC numbers.
heterologous strains are expressed as percentages
of the OD492 of the homologous strain. Correlation
between percentage killing and percentage absorb¬
ance, determined by the Spearman-Jackson rank
correlation test, was highly significant (p <0 001).
Immunoblots of LPS from 20 heterologous strains
showed that 10 strains reacted strongly with the
anti-LPS MAb and 10 did not (fig. 2). These
reactions correlated with the ELISA and the
bactericidal results. Fig. 3 shows that silver-stained
polyacrylamide gels of the LPS preparations were
all similar and resembled rough LPS of the
enterobacteria.
The passive protection afforded by the anti-LPS
MAb against six heterologous strains—five of
which reacted in ELISA and in immunoblotting
and one (strain A848) which did not—is shown in
table II. The only strain against which no protection
was obtained was A848; this strain was not killed
by complement-mediated bactericidal activity. Pro¬
tection was 60-100% against the other strains.
Discussion
Of the eight MAbs that reacted in ELISA to
whole bacteria, three were characterised further
and shown by immunoblotting to be specific for
LPS, capsule and an OMP respectively. The other
five MAbs did not react in immunoblotting or IHA
and were probably directed against protein epitopes
which were irreversibly denatured during separa¬
tion on polyacrylamide gel electrophoresis or on
transfer to nitrocellulose.24 As these MAbs were
shown subsequently not to be protective in mice
they were not investigated further.
The MAb that reacted only with the homologous
capsular antigen in IHA did not mediate comple¬
ment-dependent killing of bacteria in vitro. It did
not protect mice against challenge with live
organisms and was probably directed against a
strain-specific surface antigen rather than to the
type-specific hyaluronic acid capsule common to all
type-A strains of P. multocida.
Similarly, the anti-77 Kda OMP MAb did not
protect mice and was not bactericidal. Lu et a/.14
found that hyperimmune rabbit antiserum contain¬
ing a high titre of IgG antibody to a 37-5-Kda OMP
was protective in rabbits. However, they used a
polyclonal serum containing antibody to several
epitopes in a single molecule rather than a MAb
defining a single epitope.
The most significant finding of the present study
was that anti-LPS IgG3 MAb protected mice
against homologous and heterologous challenge by
a mechanism associated with complement-depend-
1
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Fig. 2. Examples of immunoblots of LPS from homologous (track 9) and heterologous strains of P. multocida type A probed with
anti-LPS MAb 1/8.16.11 diluted 1 in 2. Track 1, strain A757; 2, A36; 3, XI10; 4, X1056; 5, A848; 6, W666; 7, QUO; 8, X1016;
9, W674; 10, X120.
1 23456789 10
Fig. 3. Silver-stained LPS from 10 strains of P. multocida type A
on polyacrylamide 14% gels. The order is as in fig. 2.
ent antibody-mediated bacterial killing. An inves¬
tigation of the bactericidal activity of serum from
vaccinated mice22 suggested that a cell-surface
antigen was associated with this mechanism of
immunity, because the bactericidal capacity of
mouse polyclonal serum was closely correlated (p <
0 001) with whole-cell ELISA titres. It is clear that
anti-LPS antibodies play a major role in immunity
in mice by participating in complement-mediated
bacteriolysis. This agrees with earlier views.25'26
In addition, the LPS of P. multocida type A has
been identified as an important immunogen when
Table II. The activity of the anti-LPS MAb




Number of survivors in
groups of five mice
A36 4-8 x 106 3
X110 3-6 x 105 3
XI053 8-8 x 106 3
A341 6-3 x 105 5
A1174 61 x 106 4
A848 1-9 x 103 0
Mice were challenged with c. 10 LD50.
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conjugated with protein in chickens, mice and
rabbits.8~10, 27-30 To induce immunity, ribosomal
vaccines should contain LPS.1112 An LPS-ribo-
some complex gave an enhanced humoral but not
cell-mediated immunity in chickens.12
The epitope recognised by the anti-LPS MAb
was found to be present on the surface of about
50% of the capsule type-A strains investigated. It
will be of interest to define the chemical structure
of this epitope and to determine whether it is
specific to one or more O serotypes in capsule type-
A strains.
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1. SUMMARY
Pasteurella haemolytica organisms grown in vivo
were examined for their susceptibility to ovine
immune mechanisms in vitro. Compared with in
vitro grown organisms they were less susceptible
to opsonophagocytosis and, in contrast, suscep¬
tible to complement-dependent killing in the ab¬
sence of exogenous antibody. These differences
were not associated with phenotypic changes in
the surface of the bacterial cell. However, over¬
production and de novo synthesis of proteins was
observed in in vivo grown organisms. Also, bound
host-immunoglobulin was observed on in vivo
grown organisms and a role for this in modifying
the interaction with immune mechanisms is dis¬
cussed.
2. INTRODUCTION
Pasteurella haemolytica is the causative organ¬
ism of pneumonic pasteurellosis in sheep [1] and
cattle [2]. There are two biotypes (A and T) of P.
haemolytica, within which there are 16 serotypes.
Biotype A serotype 2 is the commonest serotype
Correspondence to: A.D. Sutherland, Moredun Research In¬
stitute, 408 Gilmerton Road, Edinburgh, Scotland, U.K.
isolated from field cases of pneumonic
pasteurellosis in sheep [3,4],
Sera from lambs which have recovered from
experimental infection with P. haemolytica A2
("convalescent" sera) and from lambs vaccinated
with serotype A2 antigens contain antibodies
which can variously opsonise P. haemolytica A2
thus increasing its uptake by sheep bronchoalveo-
lar macrophages (BAM) [5,6], activate comple¬
ment-dependent bacterial killing [7], and neu¬
tralise the activity of the specific leukotoxin pro¬
duced by P. haemolytica [6,8].
In vitro assays to measure these mechanisms of
immunity correlated with resistance to infection
[6-8] and immune sera passively protected recipi¬
ent lambs against experimental infection [9]. To¬
gether, these findings suggest that the effector
activities and titres of serum antibodies are im¬
portant in immunity to P. haemolytica and that in
vitro assays can be used to determine these criteria.
In vivo-grown bacteria can differ phenotypi-
cally from bacteria grown in vitro, differences
including the in vivo expression of outer mem¬
brane proteins (OMPs) involved in iron acquisi¬
tion [10-12] and changes in lipopolysaccharide
(LPS) composition. Growth in vivo can also result
in resistance to the bactericidal effects of serum.
Sensitive Neisseria gonorrhoeae became resistant
to human serum when grown in chambers im¬
planted in the peritoneal cavity of guinea pigs, but
0920-8534/90/S03.50 © 1990 Federation of European Microbiological Societies
reverted to the sensitive state on sub-culture in
vitro [14],
The possibility that similar phenotypic changes
may occur in P. haemolytica led to the studies
reported here of the interaction of P. haemolytica
grown in vivo in intraperitoneal chambers, with
bactericidal and opsonophagocytic mechanisms.
3. MATERIALS and METHODS
3.1. Bacterial strains
Strain T884 of P. haemolytica A2, originally
isolated from a field case of ovine pneumonic
pasteurellosis, was used in all procedures.
3.2. Preparation, implantation and recovery of peri¬
toneal growth chambers
Chambers for the in vivo growth of P. haemo¬
lytica A2 were prepared from silicone tubing (19.0
mm internal diameter and 25.4 mm outer diame¬
ter) (Altec, Alton, U.K.). Approximately 50 mm
lengths of tubing were closed at one end by seal¬
ing in place a 25 mm diameter, 0.45 jam pore
diameter filter membrane (Millipore, U.K.) using
medical-grade silicone type A adhesive (Dow
Corning, U.K.). The chambers, and a second filter
membrane to be used subsequently to close the
other end of the chamber, were sterilised by auto-
claving.
Inocula for the chambers were prepared by
centrifuging an 18 h culture of strain T884 in 10
ml nutrient broth (NB) at 10,000 X g for 30 min,
washing the pellet once in phosphate buffered
saline (PBS) pH 7.2, and resuspending the bacteria
in 50 ml of PBS. Approximately 10 ml vols were
pipetted aseptically into the chambers, which were
then sealed with a sterile filter membrane. Retro¬
spective plate counting showed the inocula to con¬
tain 2.0 X 107 and 5 X 106 cfu ml-1 on two sep¬
arate occasions.
Two chambers were each implanted aseptically
into the peritoneal cavity of anaesthetised sheep.
The peritoneal opening was closed with surgical
suture and the animals allowed to recover. Seven
days later the animals were killed and the cham¬
bers recovered.
The contents of the chambers (approximately
10 ml per chamber) were centrifuged at 10,000 X g
for 30 min at 4°C and pelleted bacteria washed
once in PBS before resuspension in the required
diluent (see below). The washed bacteria were
tested for susceptibility to bactericidal activity and
phagocytosis without further treatment. Aliquots
of pelleted bacteria and supernatant fluid were
also stored at — 70 °C or lyophilised for later
analysis.
3.3. Susceptibility of in vivo-grown P. haemolytica
A 2 to phagocytosis
The susceptibility of in vivo-grown organisms
to phagocytosis by BAM after opsonisation with
either naive (standard negative) or "convalescent"
(standard positive) SPF lamb serum was assessed
by a plate-counting method. In vitro-grown
bacteria were similarly tested as controls.
The washed in vivo-grown bacteria were resus-
pended in Hanks' balanced salt solution (Hanks')
supplemented with 10% heat-inactivated (56 °C
for 30 min) foetal bovine serum (FBS, Gibco
Paisley, U.K), 2% 30 mM Hepes buffer (Sigma),
1% sodium bicarbonate and adjusted to pH 7.2
with 1 M NaOH (Hanks' medium). In vitro-grown
bacteria were prepared by inoculating 100 /xl of
strain T884 taken from storage at — 70 ° C into 10
ml of nutrient broth (Oxoid, U.K.). The broth was
incubated at 37 °C for 18 h, then centrifuged at
10,000 X g for 20 min. The pelleted bacteria were
washed twice by centrifugation in Hanks' and
finally resuspended in Hanks' medium.
Sheep BAM recovered from lungs obtained at a
slaughter house by lung lavage [15] were sedi-
mented at 100 X g for 20 min. The cells were
washed twice in Hanks' and resuspended in 5 ml
of Hanks' medium. A 10 /xl aliquot of cells was
added to 90 /xl of 0.4% trypan blue dye in PBS
(Sigma, U.K.) and the total cell count and BAM
viability were assessed using an improved Neu-
bauer cell counting chamber. BAM suspensions
were used only if > 90% were viable and if BAM
represented > 80% of the cell population as as¬
sessed by morphological criteria. BAM were fi¬
nally adjusted to 2.5 X 106 viable cells • ml-1 by
dilution in Hanks' medium.
The opsonophagocytosis assay was performed
on two separate occasions. Volumes (500 /xl) of in
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vivo- or in vitro-grown P. haemolytica A2 were
mixed with 100 jul of the standard positive or
negative serum in duplicate 1 ml polypropylene
vials (NUNC, Denmark). Sera used for opsonisa-
tion were heat-inactivated at 56 °C for 30 min
before use. Tubes were incubated at 37 °C for 30
min on a roller apparatus (Luckham Laboratories)
to allow opsonisation to occur. Then, 400 pi of
BAM suspension was added to each suspension
and the tubes further incubated for 30 min on the
roller apparatus to allow phagocytosis to occur.
BAM were then sedimented by centrifugation at
100 X g for 5 min at 4 ° C, washed three times in
Hanks' to remove extracellular bacteria, resus-
pended in 1 ml of 0.1% Triton X100 (Sigma) and
finally vortexed vigorously to lyse BAM and re¬
lease intracellular bacteria. The lysed BAM sus¬
pensions were then titrated in ten-fold dilutions in
peptone water (Gibco) and each dilution plated
for bacterial counting.
The mean percentage of P. haemolytica A2
phagocytosed in duplicate sample tubes was
calculated from the formula:
mean % phagocytosis = 100 X (mean cfu • mh1
in lysed BAM suspensions/0.5 X mean cfu ml"1
in assay inoculum).
An opsonic index (OpI) [5] was calculated for
each suspension using the formula:
OpI = 100 X (Cs -Cc/Ct),
Where Cs = mean count of phagocytosed
bacteria in sample suspensions opsonised with the
standard positive serum, Cc = mean count of
phagocytosed bacteria in sample suspensions
opsonised with the standard negative serum and
Ct = 0.5 X mean count of total bacteria in the
assay inoculum.
3.4. Assay of the susceptibility of in vivo-grown P.
haemolytica A2 to bacterial killing mechanisms
In vivo-grown bacteria were tested on two sep¬
arate occasions for their susceptibility to anti-
body-mediated, complement-dependent bacterial
killing by the method described previously [7]. In
vitro-grown organisms were tested in the same
assay and considered as susceptible organisms [7].
"Convalescent" lamb serum and naive SPF lamb
serum were used as the standard positive and
negative sera.
The inocula for in vivo-grown organisms were
prepared by resuspending organisms in modified
barbitol buffer (MBB). Retrospective plate count¬
ing showed these to contain 1.7 X 104 and 1.1 X
104 cfu • ml-1 on the two separate assay occasions.
The in vitro-grown bacteria were prepared as
described previously from 3 h cultures [7]. Retro¬
spective plate counting showed these to contain
1.0 X 104 and 1.8 X 104 cfu • ml"1 on the two sep¬
arate assay occasions.
3.5. Examination of proteins from in vivo-grown P.
haemolytica A2 by SDS-PAGE
SDS-PAGE for the detection of proteins was
carried out on 10% gels by the method of Laemmli
[16]. Lyophilised whole bacterial cells (300 pg)
from either peritoneal chambers or 18 h cultures
in NB were resuspended in solubilising buffer and
loaded onto 10% SDS-PAGE gels. Gels were
stained with Coomassie blue dye [17] to visualise
protein bands.
3.6. Detection of host-immunoglobulin bound to in
vivo-grown organisms
Immunoglobulin bound to in vivo-grown P.
haemolytica A2 was detected by Western blotting.
Resolved proteins were transferred to nitrocellu¬
lose by the method of Burnette [18] as modified by
Herring and Sharp [19] and reacted directly with
donkey anti-sheep immunoglobulin conjugated
with horse radish peroxidase (HRP, Scottish Anti¬
body Production Unit, Law Hospital, Scotland).
3.7. Examination of LPS from in vivo-grown P.
haemolytica A2 by SDS-PAGE
LPS from both in vivo- and in vitro-grown cells
was examined by SDS-PAGE of proteinase K
(Sigma) digested whole bacterial cells prepared by
the method of Hancock and Poxton [20]. Lyophi¬
lised bacterial cells (300 jag) treated with pro¬
teinase K were loaded onto 12.5% gels. Gels were
stained with silver stain [21] to visualise LPS.
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3.8. Detection of bacterial capsule by Maneval stain
Detection of capsule was carried out retrospec¬
tively after the finding of phagocytosis studies. In
vivo-grown organisms were therefore examined for
capsule either after storage at — 70 °C or upon
recovery of organisms from a third chamber im¬
plant. Capsule was detected by the Maneval stain
[22], In vitro-grown P. haemolytica A2 cells were
recovered from 10 ml vols of NB incubated at
37 °C for 6, 18 or 24 h. Bacteria were harvested
from 1 ml vols by centrifugation at 11,000 X g for
5 min and pelleted bacteria resuspended in 1 ml of
PBS, pH 7.2. Similarly, in vivo-grown bacteria
were pelleted from chamber fluid by centrifuga¬
tion followed by resuspension in 100 /xl of PBS,
pH 7.2. A loopful of each bacterial suspension was
mixed on a microscope slide with a loopful of a
1.0% aqueous solution of Congo red stain (BDH
Chemicals), spread thinly and air dried. The smears
were then counter-stained with a 1.0% aqueous
solution of acid fuchsin suspended in Maneval
solution A (30 ml of 5% aqueous phenol, 8 ml of
20% aqueous glacial acetic acid and 4 ml of 30%
aqueous ferric chloride) for 2 min, drained and
blotted dry. By this method capsules appear as
negatively-stained structures surrounding red
staining bacterial bodies presented on a pale blue
background.
4. RESULTS
Fig. 1. Photograph of chamber implants in the peritoneum of a
sheep. A fibrinous capsule from which the chambers were
removed is arrowed.
organisms respectively on the two separate assay
occasions. Results of the phagocytosis assays (Ta¬
ble 1) showed that BAM phagocytosed a mean of
At necropsy, implanted chambers were found
to be completely enclosed by a thick fibrinous
capsule (Fig. 1). Considerable areas of ecchymosis
were noted in the peritoneum surrounding the
chambers. White blood cells were not detected on
any occasion in the chamber contents. This was
taken as an indication that the chambers had
remained intact. However, a small fibrinous clot
was always present, and was removed, with sterile
forceps. The pooled chamber contents contained
3.45 X 107 and 2.0 X 107 cfu -ml-1 P. haemolytica
A2 in pure culture on two separate occasions.
The P. haemolytica inocula used for phagocyto¬
sis assays contained 2.9 X 107 and 1.0 X 107 cfu •
ml-1 of in vivo-grown organisms and 3.9 X 107
and 1.0 X 107 cfu ml-1 of in vitro-grown
Table 1
The mean percentage phagocytosis of P. haemolytica A2 grown








1 in vivo positive a 9.65 7.8
negative b 1.9 0
in vitro positive 21.8 21.8
negative 0.002 0
2 m vivo positive 8.1 3.4
negative 4.7 0
in vitro positive 21.5 20.8
negative 0.7 0
Standard positive serum taken from a "convalescent" specific
pathogen-free lamb.
b




21.8% and 21.5% of the in vitro-grown bacteria on
two separate occasions in the presence of the
standard positive serum and 0.002% and 0.7% in
the presence of the standard negative serum. This
percentage phagocytosis was similar to levels ob¬
served for P. haemolytica A2 previously [5,6]. The
mean percentage phagocytosis of in vivo grown
bacteria was also increased in the presence of the
standard positive serum (9.65 and 8.1%) when
compared to the standard negative serum (1.9 and
4.7%), but to a significantly lower degree (P <
0.05). The mean OpI for in vivo-grown P. haemo¬
lytica over the two assays was therefore 5.6%,
compared with a mean OpI of 21.3% for in vitro
grown bacteria.
These results indicated that in vivo-grown P.
haemolytica A2 organisms were less susceptible to
antibody-mediated opsonophagocytosis than in
vitro-grown organisms and suggested that pheno-
typic changes might occur in organisms grown in
vivo which reduce their susceptibility to opsono¬
phagocytosis.
In the bactericidal assay 100% and 89% (means
of triplicate samples) of in vitro-grown bacterial
inocula were killed in the presence of the standard
positive serum, on the two assay occasions,
whereas no loss of viability (0% bactericidal activ¬
ity) was detected with the standard negative serum.
In contrast 97% and 100% of in vivo-grown
bacteria were killed in the presence of the stan-
Table 2
The mean percentage killing (%K) of in vitro- and in vivo-grown
P. haemolytica A2 in the bactericidal assay
Assay Bacterial growth
conditions
Serum Mean % K
1 in vivo positive a 97
negative b 91
in vitro positive 100
negative 0
2 in vivo positive 100
negative 90
in vitro positive 87
negative 0
a
Standard positive serum taken from a "convalescent" specific
pathogen-free lamb.
b





Fig. 2. Western blot of P. haemolytica A2 whole cells grown: in
vitro (lane 1); in vivo (lane 2) and molecular mass markers
(lane 3). Samples were reacted directly with donkey anti-sheep
immunoglobulin conjugated with horseradish peroxidase to
detect sheep immunoglobulin.
dard positive serum and 91% and 90% in the
presence of the standard negative serum (Table 2).
These results suggested that either phenotypic
changes in in vivo-grown organisms induced sus¬
ceptibility to the alternative complement pathway
or that host-derived immunoglobulin was bound
to the cell surfaces of in vivo grown bacteria. On
examination, host-derived immunoglobulin which
was bound to in vivo-grown P. haemolytica A2
was detected on immunoblotting by direct interac¬
tion of the immunoglobulin with donkey anti-
sheep immunoglobulin conjugated with HRP. A
thick band of 53 kDa was detected by the con¬
jugate on the track containing in vivo-grown
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organisms. In vitro-grown organisms did not show
this protein band (Fig. 2). Its molecular mass and
reaction with the conjugate indicate this band to
be the heavy chain of sheep IgG [6].
SDS-PAGE analysis showed extra protein
bands and enhanced production of some other
proteins in in vivo-grown cells compared to in
vitro-grown cells (Fig. 3). These bands were 105,
100, 95, 70, 66, 53 and 23 kDa in molecular mass.
Conversely, protein bands of 36 and 24 kDa were
expressed in in vitro-grown organisms which were
not detectable in in vivo-grown organisms. Ex¬
amination of the SDS-PAGE patterns of pro¬
teinase K LPS preparations indicated that both in
vivo- and in vitro-grown cells possessed rough
type LPS (results not shown) which gave an iden¬
tical profile to the serotype A2 LPS shown
elsewhere [6]. No phenotypic change in the A2
LPS structure was therefore detectable after in
vivo growth.
In vivo-grown bacteria were compared with
early and late log phase in vitro-grown organisms















Fig. 3. SDS-PAGE of: molecular mass standards (lane 1); in
vitro-grown (lane 2) and in vivo-grown (lane 3) P. haemolytica
A2 whole cells.
organisms from 6 h in vitro cultures (Fig. 4A)
were found to have visibly thicker capsules than
bacteria from 18 and 24 h cultures (Fig. 4B and
4C, respectively). In vivo-grown organisms taken
from storage at — 70 °C (Fig. 4C) or taken di¬
rectly from peritoneal chambers (not shown) had
no more capsule than was seen on organisms from
18 h cultures. In vivo-grown organisms were, how¬
ever, found to be aggregated into clusters of
bacteria (Fig. 4D).
5. DISCUSSION
Intraperitoneal chamber-implants were success¬
fully used in these studies to grow pure cultures of
P. haemolytica A2 organisms in vivo. Relatively
large numbers of viable bacteria free of contami¬
nant host cells were recovered.
Day et al. [23] found that the formation of a
fibrinous capsule around peritoneal implant
chambers was associated with virulent strains of
Staphylococcus aureus and considered that the
phenomenon was probably due to chemotaxis,
since the fibrinous capsule was composed mainly
of neutrophils. In the present work, implanted
chambers containing P. haemolytica A2 were also
found to induce the formation of an enveloping
capsule, suggesting that chemotactic factors are
similarly produced by this bacterium. Areas of
ecchymosis noted on the peritoneum adjacent to
the chambers further suggest the production of
soluble toxin(s) such as proteases [6,24] by the
bacteria in the chambers.
The finding that in vitro-grown bacteria re¬
quired the presence of both antibody and comple¬
ment for bacterial killing to occur confirmed pre¬
vious findings [7]. In vivo-grown organisms were
as susceptible to antibody-mediated complement-
dependent bacterial killing as in vitro-grown
organisms, but were also killed in the absence of
added specific antibodies. The detection of surface
adherent (host-derived) antibodies on in vivo
organisms may explain this finding. LPS has been
identified previously as a target antigen for anti¬
bodies involved in bactericidal mechanisms against
P. haemolytica A2 [7]. The finding that in vivo-
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changes in LPS antigens compared with in vitro-
grown organisms further supports the conclusion
that host-bound immunoglobulin was responsible
for the change in the susceptibility of in vivo
organisms to bactericidal activity in the absence of
exogenous antibody rather than this effect being
due to phenotypic changes in LPS structure. The
presence of surface-adherent, host-derived anti¬
bodies may also have been responsible for the
slightly elevated levels of phagocytosis observed
for in vivo grown organisms in the presence of the
standard negative serum when compared to simi¬
lar suspensions of in vitro-grown organisms. The
binding of IgG to 5. epidermidis grown in peri¬
toneal dialysate has been observed by others [25],
The production of a capsule in S. aureus was
associated with avoidance of opsonophagocytosis
through the prevention of opsonin phagocyte-re¬
ceptor interaction [26], Early log-phase cultures of
P. haemolytica A1 have been shown to produce
more capsule than late log-phase cultures [27] and
it is reported that early log-phase P. haemolytica
A1 are less susceptible to opsonophagocytosis than
late log-phase cultures [28]. The size of the P.
haemolytica capsule has therefore been implicated
as a factor in the avoidance of phagocytosis by
this organism.
In vivo-grown organisms were opsonophagocy-
tosed to a lesser degree than similarly treated in
vitro organisms on two separate occasions. The
thickness of the capsules produced by in vitro-
and in vivo-grown organisms was therefore com¬
pared to determine if this factor might be im¬
plicated in the observed variations in susceptibility
to opsonophagocytosis. In vivo-grown organisms
were however found to possess similar amounts of
capsule when compared to in vivo-grown organ¬
isms from 18 h cultures, which were employed for
phagocytosis studies. Thus capsular size was not
considered responsible for the observed reduction
in susceptibility of in vivo-grown organisms to
phagocytosis. In vivo-grown organisms were, how¬
ever, found to be aggregated and this may have
afforded some resistance to phagocytosis. Aggre¬
gation may indicate a change in cell-surface hy-
drophobicity which may be measureable in aggre¬
gation tests [29,30], or involve the interaction with
host-derived factors such as fibrin, fibronectin.
laminin and collagen which can cause clumping of
other bacteria [31]. Alternatively, surface bound
immunoglobulin may have caused aggregation
through cross-linking. It is uncertain however,
whether this aggregation would occur in natural
infection or was an artefact of chamber growth.
The finding that early log-phase P. haemolytica
A2 (6 h) cultures possessed larger amounts of
capsule than organisms from 18 or 24 h cultures is
in agreement with the observations on the A1
serotype [27],
Donachie and Gilmour [32] detected outer-
membrane proteins in P. haemolytica A2 organ¬
isms obtained from the pleuritic fluid of experi¬
mentally infected lambs which were not detectable
in in vitro-grown organisms. Similar expression of
these antigens in organisms obtained from peri¬
toneal chamber implants was therefore taken as
evidence of phenotypic change occurring in the
bacterial chamber inoculum in response to the in
vivo environment. Organisms from chambers ex¬
pressed increased amounts of 100 and 70 kDa
antigens. These antigens were also detected by
Donachie and Gilmour [32] in in vivo-derived
organisms and were shown by them to be iron-reg¬
ulated proteins (IRPs) that were inducible in vitro
by growth in iron-depleted medium. In the present
studies, two further proteins were detected in in
vivo-grown organisms, these being 95 and 105
kDa in molecular mass. It is interesting to note
that recombinant P. haemolytica cytotoxin has
been found to consist of either a 102 kDa antigen
[33] or of a 105 kDa antigen which reduces to a 95
kDa degradation product in older cultures [34].
The increased presence of 95 and 105 kDa pro¬
teins in the chamber-grown bacteria could there¬
fore represent increased amounts of intracellular
cytotoxin. Proteins of 53, 23 and 66 kDa were also
detected as supernumerary in in vivo cells. The 53
kDa protein may have been heavy chain IgG,
since bound IgG was detected on in vivo cells as a
53 kDa band. Purified ovine IgG has been shown
to consist of a 53 kDa heavy chain and a 26 kDa
light chain [6], The 66 kDa protein was possibly
sheep albumin bound to the in vivo cells.
Kelly et al. [13] have recently found that the
LPS from in vivo grown P. aeruginosa organisms
had additional polysaccharide bands which they
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suggested enhanced the virulence of that organism.
When examined for their LPS phenotype by
SDS-PAGE, in vivo-grown P. haemolytica A2
organisms were found not to differ from in vitro-
grown organisms.
No attempt was made to detect extracellular
cytotoxin production by in vivo-grown organisms
since substantial indirect evidence of toxin pro¬
duction in vivo has already been reported [6,35-
38],
Two proteins (36 kDa and 24 kDa) produced
by in vitro organisms were not expressed by in
vivo organisms. These proteins may be useful in
distinguishing between animals which have been
vaccinated with in vitro-derived products and
those which have undergone natural infection.
The findings that in vivo-grown organisms are
susceptible to antibody-mediated bactericidal
mechanisms and, to some extent opsonophago-
cytosis, further validate previous conclusions that
these mechanisms play an important role in im¬
munity against ovine pneumonic pasteurellosis (5
to 9) and that the in vitro assays for detecting
these mechanisms may therefore help in analysing
the protective potential of vaccines.
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SUMMARY
Tne surface structure ot Pasteureila multociaa is typical of a t>ram-
negative bacterium ana any of the component macromoiecuies might oe
considered to have the potential to corner protection. Two approacnes
have heen usea in an attempt to define protective antigens m Type a
strains:
ij Whole. Killed oacteria or cell surtace fractions (outer-memorane,
capsular extract and LPS) were usea for active immunisation, attempts
were made to reiate specific antibody levels to protection. A degree 01
protection was inaucea with every vaccine usea, with neat-Killea cens
being marginally superior. As all vaccines, with the possiole exception
of LPS, contained more than one macromoiecuiar species the speciric
protective antigen could not he defined directly. EL1SA and lmmunooiot-
ting were usea to quantify the specinc antioody levels to outer-mem¬
brane proteins and LPS. No correlation was ohservea oetween lmmunogenic-
lty of outer-memorane proteins ana protective capacity, wniie Lro ap¬
peared to be very poorly immunogenic and an antibody response could not
be readiiy aetectec.
iij Monoclonal antibodies imAbsj were produced to defined cell surtace
components and used for passive immunisation. Of the mAbs seiectea
several different speciricities were identified. The oniy type to give a
high degree or protection to homologous ana neteroiogous challenge
strains was shown oy immunoblotting to bind LPS. It gave protection
against only hair the heterologous strains ana this was airectly reiatea
to LPS Dinding capacity. The LPS from the immunising strain nas been
fractionated and the protective epitope shown by inhibition or llISA to
be in the Lipid A region of the molecule.
We Have concluded that LPS is a protective antigen nut, at least in
mice, is only weaKiy immunogenic.
INTRODUCTION
Pasteurella muitocida is a smaii Gram-positive saccnaroiytic, faculta¬
tively anaerobic roo-snapeo bacterium whicn is associated witn several
animai diseases of world-wide importance. Strains are conveniently
classiliec into rour capsular serotypes (1) and lb O-serotypes izj.
There is a partial relationship cetween capsular type and disease type:
type A strains cause pneumonia in cattle, sheep and pigs, and "snufries
in ranbits, strains of B and E types cause naemorrnagic septicaemia in
cattle and nuffaloes, and type D strains cause atrophic rhinitis m pigs
and pneumonia in cattle (3). Vaccines are not available for all types,
and those developed for protection against haemorrhagic septicaemia (hb)
suffer from a protective capacity of short duration requiring re-vacci-
nation at least yearly, an impractical proposal m many regions where lib
is endemic.
When considering the candidate vaccine components for a Gram negative
Bacterium, molecules which might he included are capsular polysaccha¬
rides, lipopolysaccharide, outer membrane proteins, exotoxins and en¬
zymes. The literature abounds with mention or an or these (,4j.
In the studies reported here, type A strains or P. multociaa were cnosen
to investigate the identification of possible protective antigens in a
mouse septicaemia modei. Type A strains are characterised ny possessing
a capsule of hyaluronic acid, a poorly or non-immunogemc molecule i4i.
The two approacnes used involved: i) vaccinating with whole oactena or
semi-deimed celi surtace constituents and attempting to relate antioody
levels produced against a certain component to protection, and nj
producing monoclonal antioodies imAPsi to defined surtace molecules and
using these mAbs to immunise mice passively against challenge with live
bacteria.
An important point to consider in such studies is an awareness tnat
protective antigens might be oniy pooriy expressed or not expressed at
aii on oacteria cultured in normal laboratory media. Tne expression in
vivo mignt be significantly different from m vitro, bucn factors as tne
concentration of iron are Known to effect expression or botn surtace
factors and toxins. Conditions in tne host are usually extremely defi¬
cient in iron (5).
riuch of the work presented in tnis paper nas already been puniished as
detailed papers (b, 7; and tnese snouid be consulted for metnodology.
THE CELL SUHFACE OF PASTEUkELLA flULTOCIDA.
This small Gram-negative organism nas tne typical cram-negative cell
surtace morphology: an inner and outer memorane are seen in the electron
microscope, and a capsule is usually present. Tne classic
mucoid/smootn/rough variation with tne added pnenomenon of iridescent or
non-iridescent smootn types gives a range of pnase variants. The Oasis
of this phase variation is not totally understood but it is certainly
related to virulence and capsulation.
As in many non-enterobactenal Gram-negatives tne LPb is not the classi¬
cal polymer with iong, heterogeneous chains of O-poiysaccnaride, out is
a rough or perhaps semi-rougn type and is probabiy more correctly termed
a iipo-oiigosaccharide or LOS (.7, 8).
ACTIVE IMUNISATiOh.
Various crude vaccines were prepared from o viruient Type A strains,
iridescent colonies were subcultured for 6h in brain-Heart iniusion
broth, and vaccines produced were: whole, beat-Kiiied cells (68°C for yu
mini; formann-killed ceiis (,0.3% formalin in saiine for 16b); capsuie'
(a 2.5% NaCl extract, 5b°C, lh); and lipcpoivsaccharide (an aqueous-
pnenol extract). Ail were formulated with oil adjuvants: 5mg/mi antigen
in water, mixed with an equal volume of Bayoi F (Esso) containing Aria-
cel (Sigma) 10%. Alter two intraperitoneal (IP) injections (u./i mi) 14
days apart, Swiss white mice were challenged IP with lu LbSU or a o n
brotn culture 14 days alter tne last injection. Deaths were recorded ror
up to 48 h. Pesuits showed that with homologous challenge it was possi¬
ble to confer a degree of protection witn all vaccine preparations (see
table 1). The heat-Killed (H-K) and formalin-kiiled (F-K) were nowever
superior to the more defined preparations. It showed however, mat
components present in the LPS and capsule" might be protective anti¬
gens .
In a further experiment the heat-Killed vaccine was tested for cross-
protection after challenge with heterologous strains (table 2). Pesuits
show that some strains conferred good cross-protection whiie others did
not.
Table 1. Homologous protection after vaccination
Challenge strain Survival alter vaccination witn:
H-K i'-K Capsule LPS No vaccine
W674 9/1U 9/10 3/10 6/10 0/10
W829 iU/10 10/10 8/10 7/10 4/10
Type A 10/10 9/10 4/10 5/10 5/10
X109 10/10 10/10 6/10 9/10 2/10
W828 7/10 3/10 2/10 2/10 1/10
W599 10/10 9/10 4/10 2/10 1/10
"Number surviving at 48 h/number challenged with 10 LD50
Table 2. Cross-protection by tne neat-Kiliea cell vaccine.
H-K vaccine Percent protection after challenge with heterologous strain
w o /' 4 Xluy W599 wb
W674 60 70 30 50
X109 1U 40 30 10
w599 60 yO 30 0
W629 60 40 10 90
SEROCONVERSION AND PROTECTION.
A major difficulty in defining protective antigens is that it is often
difficult to prepare a pure antigen. Minor, but immunologically mgniy
reactive contaminants can give a raise impression. We attempted to get
round this problem by assaying production of antibodies to specific
antigens using lmmunoblotting (Western blotting).
Initial screening of seroconversion was performed by ELISA, but this
tecnnique, although sensitive, suffers from the same problem or knowing
if the antigen on the plate is pure. Wnole outer memnranes were cnosen
as the initial screening antigen as this snouic contain outer-memnrane
proteins, LPS and possibly capsular material. The method of Filip et ai
(9), whicn uses the detergent Sarkosyi, was chosen to prepare outer
membranes. When the outer-membranes were analysed by polyacrylamide gei
electrophoresis (PAGE) and stained for proteins with Coomassie blue it
was observed that four of the proteins (a, b, c, and d) were present in
major amounts but or slightly varying molecular mass: strains could oe
grouped according to the pattern of these bands. Fig 1 shows PAGE pro¬
tein patterns or io Type A strains. Of the 24 strains investigated so
far, 12 different patterns have been recognised. In an attempt to cneck
if a strain with tne same outer-membrane pattern as another conferred
cross-protection, lmmunonlotting, together with mouse protection was
performed. Of the tnree strains selected tne best protection was afford¬
ed by W674, which protected against 9 of the 17 challenge strains. The
mice before vaccination bad no antibodies detectable by immunoblotting
to any outer-membrane antigen. After vaccination, all three produced a
response to proteins a and d of all strains: they have shared antigenic
determinants but are of varying molecular mass. The antibody response to
the other two tanas appeared to be PAGE-group specific. An example 01 the
Coomassie biue stained PAGE and the corresponding immunobiot is shown in
Fig 2. There was no correlation between protection ana the antigen
pattern seen by immunobictting.
By ELISA, when purified LPS was coated to plates, there appeared to be
an anti-LPS response. However, despite being able to visualise LPS on
gels by silver-stain (Fig 3), it was not possible to detect any reaction
to LPS by immunoblotting. The conclusions from this part of the worn
were that it was possible to protect mice against a range of strains
with a vaccine produced from a single strain, that the pattern of major
outer-membrane proteins was not correlated with protection ana that it
was difficult to observe a specific anti-LPS response by immunoblotting.
MONOCLONAL ANTIBODIES AND PA36l\/E PROTECTION.
Because of the difficulties encountered above, a second approach was to
prepare monoclonal antibodies (mAbs) to ceil surface components and
attempt to use these to protect mice passively against live challenge. A
heat-killed cell preparation of strain W674 was selected as the immuno-
gen as this nad been found to be the best at conferring wide protection
in the active immunisation model. Bacteria were grown m an lrcn-re-
stricted medium to mimic growth in vivo. After immunisation, the mouse
with the highest antibody level (by ELIbA) to whole iron-restricted
bacteria was selected for fusion, riybriaomas were screened by whole cell
EL1SA, ana eight were finally selected as stable clones producing anti¬
bodies which bound to wnole ceils.
CHARACTERISATION OF MONOCLONAL ANTIBODIES
By immunobiotting only two mAbs snowed reaction, one binding to an
outer-membrane protein and another to purified LPS. One further mAb
reacted in the indirect haemaggiutination assay suggesting that it may
be anti-capsuie. in a complement-mediated bactericidal model cniy the
anti-LPS antibody showed activity: there was 80% killing of the homolo¬
gous strain.
In passive protection of mice, those animals receiving the anti-LPS mAo
were 100% protected when challenged with 10 LD50 or the homologous
strain, and remained well throughout. Two of the other mAbs, which had
only reacted in the whole ceil EL1SA, showed some homologous protection,
but the mice which remained alive at the end of the 48h observation
period were severely ill.
THE ANTI-LPS llONOCLONAL ANTIBODY.
As this antibody was shown to protect passively against homologous
challenge, it was studied for reaction with heterologous strains. In
whole cell EL1SA it reacted strongly with 10 of 2u strains tested. The
LPS from the same 10 strains reacted in immunobiotting with the mAb,
producing a band at the gel front (Pig. 4j, ana in the bactericidal
assay the same 10 strains were effectively kiiied: between 72 and 100%
killing compared to Between 0 and 12% for the other strains, in the
passive protection model the antibody protected between 60 and 100% of
mice challenged with heterologous reacting strains but not against a
ncn-reactor. We have so far been unable to perform "neddieston typing
on our strains to see if reaction correlates with O-serotype.
In an attempt to determine the position of the protective epitope, the
LPS was chemically fragmented and the fragments used in an EL1SA lnnihi-
tion reaction. The results are shown in Pig 5. The suggestion is tnat
the lipid A portion is the site recognised by the antibody. This however
assumes that the LPS of Pasteureila muitocida behaves in acetic acid in
an analogous way to enterobacterial LPS. It might however be diiierent,
and the results simply suggest the epitope is acid labile. This requires
further investigation.
CONCLUSIONS
Lipopoiysaccharide, or lipo-oligosaccharide as it is more accurately
described, is a protective antigen, in whoie bacterial vaccines, or
complex sub-ceiluiar vaccines, it may be the lipopoiysaccharide wnicn is
the important immunogen. in pure lorm however it is poorly immunogenic.
The vaccine potential of this complex moiecuie shouid be investigated
further, especially from the point of view of immunogenicity, adjuvanti-
city and T-cell dependency.
Although our experience has been restricted to type A strains in a mouse
model, tne approaches used couid be applied to ali types. It snouia oe
noted nowever that the capsuie or Type A strains is hyaluronic acid
which is not usually immunogenic. Types b ana £ are different in tnis
respect.
REFERENCES
1. Carter, G.R. (.1963) Vet Record 75, 1264.
2. Heddleston, K.L., Gallagher, J.E. and Rebers, P.A. (19721 Avian Lis
16, 925-936.
3. Adlam, C. and Rutter, J. 11. (eds) 1989. Pasteureila and Pasteureiio-
sis. Academic Press, London
4. Rimier, R.B. and Rhoades, K.R. (1989). In: Adlam, C. and Rutter, J.fl.
(eds). Pasteureiia and Pasteureliosis. Academic Press, London
Chapter 3.
5. Bullen, J.J. and Griffiths, E. (eds) 1987. Iron ana Inrection.
Wiley, Chichester.
6. Abdullahi, II.Z., Gilmour, N.J.L. and Poxton, i.R. (1990) J Med Micro¬
biol 32, 55-61.
7. Wijewardana, T.G., Wilson, C.F., Giimour, N.J.L. and Poxton, I.R.
(.1990) J (lea Microbiol 33, 217-222.
8. Rimier, R.B. (1990) J Clin Microbiol 28, 654-659
9. Fiiip, F., Fletcher, G., Wulft, J.L. and Earhart, C.F. (1973)
J Bacterioi 115, 717-722.
LEGENDS FOR FIGURES
Figure 1. SDS-PAGE of SarKosyi-prepared outer memorane proteins from id
strains of Type A Paszeureila multocida stained with Coomassie blue, a,
b, c, and d are the major outer membrane proteins usea tor grouping the
strains.
Figure 2. a) SDS-PAGE of Sarkosyl outer-membrane preparations from seven
strains or Pasteurella muitociaa against wmcn mice were protected
(tracks 1, 2, 3, 6) or not protected (tracks 4, 5, 7) by vaccination
with strain wts29 i tracK 1). b; corresponding lmmunooiot probea with
pooled pre-chaiienge serum from mice vaccinated with heat-killed cells
of strain W829.
Figure 3. SDS-PAGE of 1lpopoiysaccharide preparations from ib strains or
Pasteurella multocida stained with silver.
Figure 4. Immunobiots of LPS prepared from 10 strains of Type A Pasteu¬
rella multocida probed with the anti-LPS monoclonal antioody. uniy 7
preparations gave reactions. This reflected the reactions in whole ceii
ELISA, the bactericidal model and in animal protection tests.
Figure 5. Inhibition of EL1SA to show the iocation of tne binding site
of the anti-LPS monoclonal antibody. A cell envelope traction was oound
to the plates and the monoclonal antibody was preincubated with poten¬
tial inhibitors. Lipid A, as well as the whole LPS and cell envelope
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ABSTRACT
McCourtie, J., Poxton, I.R., Spence, J.A. and Aitchison, G.U., 1989. Preliminary study of the
anaerobic bacteria isolated from subgingival plaque from sheep. Vet. Microbiol., 21: 139-146.
A preliminary study was made to determine the genera of cultivable anaerobic bacteria which
could be isolated from subgingival plaque of sheep. Samples were taken from 10 sheep on farms
with a known record of broken mouth periodontitis. For assessment of the sampling technique,
samples were also taken from freshly exposed tooth roots in killed sheep. The bacteria isolated on
several selective and non-selective media were identified to genus level by a combination of Gram
reaction, colony morphology and gas chromatographic analysis of volatile and non-volatile fatty
acid metabolic end products. At least 10 different genera were isolated and these findings are
discussed in relation to the bacteriology of human periodontitis and recent studies of sheep broken
mouth periodontitis.
INTRODUCTION
Broken mouth periodontitis in sheep is an international economic problem
for sheep farmers. The condition is in many ways similar to human periodon¬
titis (Hatt et ah, 1968; Cutress, 1976; Spence et ah, 1980) with the formation
ofperiodontal pockets and subsequent premature tooth loss. Histological stud¬
ies of sheep have shown that subgingival plaque is associated with periodontal
lesions (Cutress, 1976; Spence et ah, 1980; Page and Schroeder, 1982), but
little is known about the bacterial flora from these sites. Hatt et ah (1968)
sampled with swabs plaque from broken-mouthed sheep isolating haemolytic
and non-haemolytic streptococci, and fusiform bacilli together with small
numbers of micrococci, Neisseria spp. and Candida albicans. However, no sam¬
pling or bacteriological details were given. In more recent studies (Frisken et
ah, 1986, 1987), black-pigmented Bacteroides spp. similar to Bacteroides gin-
0378-1135/89/$03.50 © 1989 Elsevier Science Publishers B.V.
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givalis have been found in increased levels in diseased sheep and a study (Fris-
ken et al., 1988) was designed specifically to look in sheep for the suspected
periodontopathic microorganisms commonly associated with human perio¬
dontitis. Black-pigmented Bacteroides spp., Fusobacterium nucleatum and Fu-
sobacterium necrophorum, Eikenella corrodens, and Capnocytophaga spp. were
isolated from sheep classified into groups according to severity of periodontal
destruction.
This pilot investigation was aimed to determine the full range of genera of
cultivable subgingival anaerobic bacteria that could be isolated from sheep at
different stages of development of broken mouth periodontitis and to compare
the information obtained with that known about the human condition. This
should enable us to define the best sampling and cultural methods for more
detailed study of sheep subgingival plaque.
MATERIALS AND METHODS
Sample collection
Two groups of five sheep were used, one from a farm with a bad record of
broken mouths and the other from a farm with a low incidence of the disease.
Before sampling, any food debris was removed with a gauze swab and the base
of the tooth cleaned with a jet of air. Subgingival plaque samples were taken
with sterile dental nerve broaches (Produits Dentaires S.A. Verey, Switzer¬
land) from the disto-labial site on the central right incisor. The dental nerve
broaches were pre-cut to fit the transport sample chamber described below. In
addition samples were obtained at the Moredun Research Institute from four
freshly killed sheep (killed for other purposes) by cutting a flap of gum away
from the central incisor and scraping plaque directly from the labial surface of
the tooth root, with sterile dental nerve broaches. One healthy site, one small
pocketing and two deep pocketing sites were chosen and samples were taken
from just below the gingival margin and from the base of the pocket. In addi¬
tion, from the two deep pockets, a third sample was taken from between these
two sites.
Sample transport and treatment
After sampling, the dental nerve broaches were immediately placed into the
anaerobic conditions of the Anatube Type II transport system (Dept. Anaer-
obics, Microbiology, Ziekenhuis, Sint-Pieter, Brussels), In this system, a glass
tube containing oxygen-removing catalyst pellets is fitted with a bored rubber
stopper. A sample chamber is fitted into the underside of the stopper, and a
plunger into the top side, which when depressed sends the sample chamber
into the tube and coincidentally seals the tube. The sample chamber contains
0.2 ml of VMGII transport medium (shown to give good recovery rate of oral
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B. melaninogenicus; Holbrook et al., 1978) containing 0.3% Ionagar, which is
reduced by overnight incubation in an anaerobic cabinet (Forma Scientific,
OH). The tubes are assembled and packed in anaerobic jars (B.T.L.) in the
cabinet for transport to the farms.
On returning to the laboratory the tubes were immediately placed into the
anaerobic cabinet, the samples recovered and diluted in pre-reduced volumes
(1.8 ml) of nutrient broth. The samples were manually dispersed by repeated
expression from pasteur pipettes. Volumes (20 fil) of 10-fold serial dilutions
(from 101 to 104) were plated onto the pre-reduced culture media described
below. All plates were incubated anaerobically in an atmosphere of 80% N2,
10% H2 and 10% C02 at 37 °C for 5 days. From each plate, one colony of every
morphological type was picked and plated out twice on CBA plates. One of the
plates was incubated anaerobically as previously described for 2 days, while
the second was incubated aerobically to rule out any organisms which might
be facultative. Only the strictly anaerobic isolates were chosen for gas chro¬
matographic (GC) analysis.
Culture media
Five agar isolation media were used, one non-selective: combined blood agar
[CBA: Columbia agar base (Oxoid) with horse blood, 4%; lysed horse blood,
1%; haemin, 5 fig ml-1; menadione, 1 //gml"1] and four selective: (1) Bacter-
oides-selective agar (BSA; Holbrook et al., 1978) containing kanamycin (75
fig ml-1) and vancomycin (2.5 fig ml-1); (2) Rogosa Veillonella agar (RVA:
Rogosaet al., 1958); (3) tryptic soy serum bacitracin vancomycin agar (TSBV;
Slots, 1982), selective for Actinobacillus actinomycetemcomitans; (4) genta-
micin combined blood agar (GCBA), as CBA with, in addition, 20 fig ml-1
gentamicin.
GC samples
Isolates were grown in PPYG medium (proteose-peptone, yeast extract me¬
dium supplemented with 1% glucose; Deacon et al., 1978) for 48 h, or for up to
4 days for slower growing organisms. After acidification to^pH 2 with 50%
H2S04, and centrifugation, the culture supernates were used directly for anal¬
ysis of volatile fatty acids, or methylated at room temperature for 18-24 h by
the method of Holdeman et al. (1977) for analysis of non-volatile fatty acids.
Samples (1 fi\) were injected into 1.8-mX4-mm glass columns packed with
Supelco SP1220 (15%), H3P04 (1%) on 100/120 mesh chromosorb WAW.
The columns were heated isothermally at 147.5 °C in a Pye Unicam Series 104
Chromatograph fitted with dual F.I.D., with oxygen-free nitrogen as the carrier
gas, set at a rate of 35 ml min-1. Temperatures for the injector and detector
were 147.5 and 250 °C, respectively, and the attenuation was 103. The recorder
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speed was 300 mm h-1. Before use, the columns were conditioned at 170 °C for
16-18 h with the carrier gas set at 20 ml min-1.
Identification and approximate quantitation of the acids found in the test
samples was achieved by comparing their retention times and peak heights
with those obtained from standard mixtures of acids of known concentration.
A concentration of<0.2 mol 1_1 acid was considered negative, 0.2-1.0 mol 1_1
as trace, between 1.0 and 10 mol l-1 as a minor amount, and> 10 mol 1_1 was
considered a major amount (Deacon et al., 1978).
Identification ofgenera
Isolates were identified, as far as possible, to genus level using Gram-stain
reaction, colony morphology and GC analysis of volatile and non-volatile fatty
acid metabolic end products (Holdeman et ah, 1977; Brown et ah, 1989).
RESULTS AND DISCUSSION
The purpose of this study was to investigate the range of genera of cultivable
anaerobic bacteria in sheep subgingival plaque and to compare this with the
information known about human periodontal plaque. Sheep were chosen to
cover different stages of disease development from relatively healthy mouths
to ones near to tooth loss. As single samples only were taken, no attempt was
made to assess clinically the condition of the sheep or to quantitate the bac¬
terial genera. Investigations of plaque from various animals have demon¬
strated a flora similar to that of humans (Dent and Marsh, 1981; Laliberte and
Mayrand, 1983). Samples were obtained from subgingival plaque taken from
five sheep on each of two farms; one with a low incidence of broken mouth
periodontitis and one with a bad record. On the five media used, the genera of
anaerobic bacteria isolated are shown in Table 1. Actinobacillus actinomyce-
temcomitans was not recovered from any of the samples on the TSBV plates,
and only one isolate of Veillonella species grew on RVA. The BSA grew a va¬
riety of different genera; however, the recovery of asaccharolytic black-pig-
mented Bacteroides spp. was found to be greater on the non-selective media.
Indeed, van Winkelhoff and de Graaff (1983) found vancomycin at a concen¬
tration of 3.5 fug mi-1 (2.5 fig ml-1 was used here) to be inhibitory to Bacter¬
oides asaccharolyticus. It was noticeable that every genus identified grew on
GCBA except Veillonella-, gentamicin was added to reduce aerobic growth and
was particularly useful in two cases where the CBA, BSA and RVA plates were
overgrown by an aerobic swarming Gram-negative bacillus (Proteus sp.).
The genera found in this study were Bacteroides (including black-pigmented
spp.), Fusobacterium, Lactobacillus, Clostridium, Peptostreptococcus, other an¬
aerobic cocci, Actinomyces, Propionibacterium, Eubacterium, Bifidobacterium
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TABLE 1
Genera of anaerobic bacteria isolated from sheep subgingival plaque on different media
Genus Growth on1
CBA GCBA BSA RVA TSBV
Bacteroides + + + + +
Fusobacterium + + + + +
Lactobacillus + + + — +
Clostridium + + + — -
Peptostreptococcus + + - - -
Other anaerobic cocci + + — — -
Actinomyces + + + - —
Propionibacterium + + - - -
Eubacterium + + + — —
Bifidobacterium — + - - -
Veillonella — — — + —
'CBA, combined blood agar; GCBA, gentamicin combined blood agar; BSA, Bacteroides-selective
agar; RVA, Rogosa Veillonella agar; TSBV, tryptic soy serum bacitracin vancomycin agar.
and Veillonella. Although spirochaetes were not cultured they were observed
by dark-ground microscopy in every sample taken. These results compare well
with recent human studies (Moore et al., 1982; Dzink et ah, 1988) except that
no Eikenella, Selenomonas, Capnocytophaga or Wolinella spp. were detected in
the study reported here. Frisken et al. (1988), however, found Eikenella cor-
rodens-\ike organisms and a few Capnocytophaga spp. in sheep plaque using
media selective for these species.
The Clostridium spp. isolated are likely to have originated from food or soil
contamination; it was noted that compacted food could be found at the base of
the pockets. Tanner et al. (1979), however, describe the isolation of Clostri¬
dium ramosum from human periodontal sites.
Actinobacillus actinomycetemcomitans has been found in elevated numbers
in active sites of localized juvenile human periodontitis (Slots and Genco, 1984)
and was found to occur naturally in 69% of a population of squirrel monkeys
(Clark et al., 1988). A selective medium for this organism was included in this
study as it has been suggested that the clinical signs of broken mouth perio¬
dontitis resemble those of localized juvenile human periodontitis (Cutress and
Ludwig, 1969). However, this organism was not detected here, nor in the stud¬
ies of Dreyer et al. (1986) or Frisken et al. (1988).
To determine whether the sampling procedure used was removing a repre¬
sentative sample of the microbial flora of the subgingival plaque, samples were
taken directly from the base of the pocket after excision of the gum in freshly
killed sheep. This also enabled sampling from different parts of the pocket, to
look at the distribution of genera along the tooth root surface. Single sites in
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each of four different sheep were used, one healthy site and three with loss of
attachment.
We found that the genera of organisms were constant in samples scraped
from teeth at various depths of the periodontal pocket, and no differences were
evident between sheep or between healthy and diseased sites. The number of
samples taken was too small to make any conclusions from this, and the indi¬
vidual species involved need to be identified. The incidences of genera obtained
from the samples taken from live sheep and from those scraped directly from
exposed teeth are compared in Table 2. The genera and their incidences are
comparable, indicating that similar plaque samples were obtained with the two
sampling methods. There are also no obvious differences between the inci¬
dences of genera isolated on the two farms used in this study (Table 2).
Although this study was not quantitative, it was observed that most of the
isolates belonged to the Bacteroides or Fusobacterium genera. Further identi¬
fication of the Fusobacterium spp. (results not shown) revealed that the ma¬
jority were F. nucleatum-Yike or F. necrophorum-like, as demonstrated by Fris-
ken et al. (1988). However, few of the Bacteroides spp. fit into the recognized
species except for the asaccharolytic black-pigmented spp., which were mostly
B. asaccharolyticus-like or B. gingivalis-like (results not shown). Frisken et al.
(1988) have shown increased incidence of B. gingivalis-Bke organisms in bro-
TABLE 2
Incidence of genera of anaerobic bacteria isolated from subgingival plaque samples obtained from
periodontal pockets or samples obtained directly from tooth roots
Genus No. of samples from which genera were isolated
Periodontal pocket samples1 Root sample2
Farm A3 Farm B4 Total
Bacteroides 3 5 8 10
Fusobacterium 4 5 9 10
Lactobacillus 3 3 6 4
Clostridium 2 4 6 4
Peptostreptococcus 1 1 2 2
Other anaerobic cocci 1 1 2 5
Actinomyces 1 1 2 3
Propionibacterium 2 3 5 5
Eubacterium 0 2 2 3
Bifidobacterium 1 2 3 4
Veillonella 1 0 1 0
Subgingival plaque samples were taken from five sheep on each of two farms.
Subgingival plaque samples were taken directly from freshly exposed tooth roots.
'Farm A: designated as having a low incidence of periodontal disease.
4Farm B: designated as having a high incidence of periodontal disease.
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ken mouth periodontitis-associated sites compared with healthy ones, and
Dreyer et al. (1986) found that antibody titres against the human isolates of
B. intermedius and B. gingivalis were raised in diseased sheep in comparison
with their flock controls. These observations indicate the possible involvement
of the black-pigmented spp. in the pathogenesis ofbroken mouth periodontitis.
In addition, in squirrel monkeys, the presence of black-pigmented Bacteroides
spp. was associated with increased age, increased gingival index and the pres¬
ence of calculus (Clark et al., 1988).
As all of the genera isolated in this study grew on GCBA (except Veillonella
spp., of which only one colony was found) it is proposed that this medium is
used in an extended study to examine the species of anaerobic bacteria asso¬
ciated with subgingival plaque during the development of broken mouth per¬
iodontitis in sheep.
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A longitudinal study of the cultivable subgingival
anaerobic bacteria isolated from sheep during the
development of broken mouth periodontitis
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Department of Bacteriology, University of Edinburgh Medical School, Teviot Place, Edinburgh EH8 9AG and
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Summary. In a longitudinal bacteriological study of the cultivable subgingival
anaerobic flora isolated from developing broken mouth periodontitis in sheep,
samples were taken from five sheep on each of three farms on seven occasions over a
period of 2-5 years. Ten different bacterial genera were isolated regularly but with
fluctuating frequencies. Bacteroides and Fusobacterium organisms accounted for
nearly 70% of the isolates. The Bacteroides and Fusobacterium isolates studied in detail
from one farm were identified to species level. The fusobacteria comprised F.
nucleatum-like organisms (68-6%). F. necrophorum (29-6%) and F. naviforme (T8%).
The Bacteroides spp. were divided into 11 main groups and included black-pigmented
species similar to B. asaccharolyticus and B. gingivalis. On the farm studied in detail,
the sheep could be allocated to two groups according to progression of periodontal
disease. Most of the B. gingivalis-like isolates were from sheep with actively
progressing disease, indicating that this organism may play a role in periodontal
destruction in sheep.
Introduction
Periodontal disease (broken mouth) in sheep is
in many ways similar to human periodontitis.1-2 It
is a chronic inflammatory disease of the periodon¬
tium associated with alveolar bone loss which
results in premature loss of the incisor teeth. The
association of subgingival plaque with periodontal
lesions has been shown histopathologically.1-3
Recently, several bacteriological studies in sheep
have indicated the presence of anaerobic bacterial
species similar to suspected periodontopathic or¬
ganisms associated with periodontal disease in
man.4"6 However, a study of the complete cultiva¬
ble anaerobic subgingival flora of sheep has not
been made. As histopathological studies show that
2-3 years elapse between the first evidence of severe
gingivitis and tooth loss,7 a longitudinal study of
the anaerobic flora isolated from subgingival plaque
during this period may indicate the organisms that
are important in periodontal disease of sheep.
The aim of this study was to perform such a
longitudinal study of the subgingival flora of
Received 3 Aug. 1989; accepted 8 Sept. 1989.
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developing broken mouth periodontitis of sheep
over a 2-5 year period and to relate the results to
studies in man and other animals. A preliminary
study, investigating the range ofgenera ofanaerobic
bacteria cultivable from the gingival crevices of
healthy and diseased sheep8 provided information
on suitable sampling procedures and cultural




From 15 flocks included in an epidemiological survey
of broken mouth periodontitis in the South-east of
Scotland, three flocks of Scottish Blackface sheep were
selected. The flocks, on three separate farms, represented
high, intermediate and low incidences of broken mouth
periodontitis. Five ewes, each approximately 2-5 years
old, were chosen at random from each flock at the first
visit. Duplicate samples were collected by means of
dental nerve broaches (Produits Dentaires S.A. Verey,
Switzerland) from the same site (disto-labial site on the
central right incisor) on three separate occasions through¬
out the year as previously described,8 for a period of 2-5
years: the first sample was examined for cultivable
bacteria, the other by dark ground microscopy.
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Clinical examination
Each sheep was examined clinically and pocket depth,
crown height, tooth movement, recent recession, gingiv¬
itis and occlusion were measured and scored as described
by Spence and Aitchison.9,10
Sample treatment
After sampling, the dental nerve broaches were
immediately placed into 0-2 ml of pre-reduced VMGII
transport medium11 under the anaerobic conditions of
the Anatube Type II transport system.8 On return to the
laboratory, samples were recovered inside an anaerobic
cabinet (Forma Scientific, OH, USA) and diluted in pre-
reduced 1-8-ml volumes of nutrient broth. Samples were
dispersed by repeated expression from pasteur pipettes
(sheep plaque is not calcified). Volumes (20 /tl) of five¬
fold serial dilutions from 10' to 1-56 x 105 were plated on
to pre-reduced Gentamicin Combined Blood Agar
(GCBA : Columbia agar containing horse blood 4%, lysed
blood 1%, gentamicin 20 /rg/ml, haemin 5 /tg/ml and
menadione 1 /ig/ml). This medium has been shown to
support growth of the majority of anaerobic bacterial
genera commonly isolated from sheep subgingival
plaque.8 Plates were incubated anaerobically in an
atmosphere of N2 80%, H: 10%, C02 10% at 37°C for 5
days. For total anaerobic and aerobic counts, duplicate
CBA plates (GCBA plates without gentamicin) were
inoculated similarly and one set was incubated anaero¬
bically as before, while the other set was incubated
aerobically at 37°C for 2 days.
For an accurate analysis of the bacterial composition
of the samples a predetermined number of colonies was
selected, in an unbiased manner, to obtain a representa¬
tive cross-section of the cultivable flora. From each
sample a plate containing approximately 300 colonies
was chosen and placed on a grid, consisting of 192
numbered hexagons. With computer-generated random
numbers, 30 colonies were subcultured from the corre¬
spondingly numbered hexagons, and plated out twice on
CBA plates. One set ofplates was incubated anaerobically
for 2 days, or up to 4 days for slower growing organisms,
while the duplicate plates were incubated aerobically.
Only strictly anaerobic isolates were investigated further
by gas chromatographic (GC) analysis and, where
selected, for identification to species level.
GC analysis
Sample preparation. Isolates were grown in PPYG
medium (proteose peptone, yeast extract medium supple¬
mented with glucose 1%12) for 2 days, or up to 4 days for
slower growing organisms. After acidification to pH 2 or
less with H2S04 50% (v/v) and centrifugation, the culture
supernates were extracted by a slightly modified method
of Thomann and Hill,13 and analysed for volatile fatty
acids (VFA) and non-volatile fatty acids (NVFA). For
the VFA, 0-2 ml of H2SC>4 50%, 0-4 g of NaCl and 1 ml
of methyl tert-butyl ether (MTBE) were added to 1 ml of
acidified centrifuged supernate, or to a standard mixture
of VFAs. Methylation of NVFAs was achieved by
overnight incubation at room temperature of 1-ml
volumes of acidified culture supernate with 0-2 ml of
H;S04 50% and 1 ml of methanol; 1 ml of water, 1 ml of
MTBE and 0-4 g of NaCl were then added. In each case
the tubes were mixed mechanically for 10 s and allowed
to stand for 10 min before the top MTBE layer was
removed for analysis. It was not found necessary to
centrifuge the samples.
GC conditions. MTBE extracts (0-5 p\ volumes) were
analysed isothermally at 148°C on a column of SP1220
15%, H3P04 1% on 100-120 mesh Chromosorb WAW in
a Perkin-Elmer 8410 gas chromatograph fitted with flame
ionisation detector, integrator and AS 8300 auto-sampler.
Identification schemes
Isolates were grown initially for 24-48 h in PPY
medium or BM-CMB (trypticase 1%, proteose-peptone
1%, yeast extract 0-5%, NaCl 0-5%, sodium succinate
0-25%). The pH was adjusted to 7-4 and menadione (1 pg/
ml), haemin (5 /ig/ml) and L-cysteine HC1 (0-075%) were
added. Three volumes of this broth component were
added to one volume of cooked meat particles,14 and the
complete medium was sterilised by autoclaving. Cultures
were diluted in pre-reduced PPY medium to just visible
turbidity before 0-9-ml inocula were added to predis-
pensed substrates in tubes, or 30-/d volumes were
inoculated onto agar media for the tests listed below, and
incubated anaerobically for 2 days. If growth was slow or
poor, incubation was extended up to a maximum of 5
days.
Tests for Fusobacterium spp. Lipase production (on egg
yolk agar); motility; aesculin hydrolysis; indole produc¬
tion; fermentation of glucose, lactose, sucrose, maltose,
mannose, trehalose, fructose and starch. In addition,
selected isolates were tested for fermentation of galactose
and utilisation of lactate and threonine.15
Testsfor Bacteroides spp. Pigment production (on CBA
plates); gelatin digestion; motility; nitrate reduction;
urease production; aesculin hydrolysis, indole produc¬
tion; bile tolerance; fermentation of glucose, lactose,
sucrose, maltose, xylose, rhamnose, trehalose, cellobiose,
xylan, aesculin, raffinose and starch.
Tests were performed as described by Brown et al.xb
For fermentation tests a pH drop in the test substrate of
greater than 0-5 units compared with the substrate-free
control was considered a positive result. These tests have
been successfully used in identification ofclinical isolates,
by comparison with results obtained with type cultures.
Statistical analysis
Spearman's rank correlation coefficients were calcu¬
lated, where indicated in the text, to determine signifi¬
cance; the 5% level was considered significant.
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Results
In periodontal disease in sheep, the first teeth
lost tend to be the central incisors. For this reason,
it was decided to sample from this area only, and
from as many animals as possible by limiting
samples to one per sheep as the animals would have
to be dropped from the study on tooth loss. Seven
visits were conducted over a period of 2-5 years,
with no bacteriological samples being taken at visit
number four. From the 15 sheep investigated, 1908
isolates of anaerobic bacteria from the subgingival
plaque were analysed by GC for VFA and NVFA
end-products of metabolism.
The incidence and range of the bacterial genera
isolated is shown in table I, in descending order of
prevalence. The majority of isolates were Bacter-
oides or Fusobacterium spp., comprising 49-2% and
17-5% respectively of the total number. Aerobic or
facultative organisms comprised 10-3% of the total
number of isolates, while 7-9% were unidentified
either because they could not be recovered by
subculture from the original isolate, or the GC
profiles were not recognised. The incidence of most
of the bacterial genera remained fairly constant,
with only slight fluctuations, over the period of the
longitudinal study. There were no significant
differences in the types of organisms isolated from
the flocks representing high, medium and low
incidences of broken mouth periodontitis. There
were significant negative correlations between the
proportions of isolates that were Lactobacillus,
aerobic organisms, and the combination of the less
commonly isolated genera on the one hand and the
visit number on the other. The latter group of less
common genera comprised Actinomyces, Propioni-
bacterium, Leptotrichia and Bifidobacterium; these
were analysed cumulatively because their individ¬
ual numbers were too low to test.
As the Bacteroides and Fusobacterium spp. ac¬
counted for nearly 70% of the organisms isolated,
these were identified further by a series of biochem¬
ical and fermentation tests. Because some sheep
were lost or removed from two of the farms for
veterinary reasons, the remaining farm was selected
for this part of the study: this one had an
intermediate broken mouth problem and complete
records.
The Fusobacterium isolates could be divided into
three species—F. nucleatum-\\ke (68-6%), F. necro-
phorum (29-6%) and F. naviforme (T8%). However,
the F. nucleatum-Y\ke isolates were unusual in that
most of them fermented glucose and fructose more
strongly than would be expected. This suggested
that they may be more like the oral isolates obtained
from monkeys, F. simiae,11 or from man, F.
periodontium.To try to verify this, 12 selected
isolates were further tested for fermentation of
galactose and utilisation of lactate and threonine
(indicated by an increase in the production of
propionate in the VFA GC profile when lactate or
threonine is present in the growth medium). None
of these isolates fermented galactose and was,
therefore, not F. periodonticum. However, of the
isolates tested, most utilised threonine and lactate
to varying extents, indicating the possibility that
they are more like the monkey isolate, F. simiae. As
there are no clear cut definitions for interpretation
of the tests for utilisation of lactate and threonine,19
it was difficult to distinguish between F. nucleatum
Table I. Incidence and range of bacterial genera isolated from samples obtained from visits to
three farms
Percentage of isolates representing each genus at
visit no. Total
numbers of Percentage of
Genus or group 1 2 3 5 6 7 isolates all isolates
Bacteroides 37-7 45-7 54-7 59-3 44-8 52-7 1047 49-2
Fusobacterium 21-7 7-7 10-2 13-0 26-7 33-0 373 17-5
Lactobacillus 8-6 10-0 3-3 0-7 11 0-3 94 4-4
Clostridium 1-2 5-5 5-6 4-3 5-9 0-9 85 4-0
Anaerobic cocci 3-9 3-2 3-3 5-0 3-0 2-4 73 3-5
Eubacterium 0 6-4 1-6 2-7 2-2 0 49 2-3
Actinomyces 0 1-6 0-4 0 0 0 9 0-4
Propionibacterium 0-9 0-5 0 0 0 0 5 0-2
Leptotrichia 0 0-2 0-2 0 0-4 0 3 0-1
Bifidobacterium 0-3 0-2 0 0 0 0 2 0-1
Unidentified 11-3 4-5 10-0 2-3 10-7 8-8 168 7-9
Aerobes 14-5 14-5 10-7 12-7 5-2 1-8 219 10-3
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and F. simiae by these criteria; for the purpose of
this study we have defined these isolates as F.
nucleatum-like.
The Bacteroides isolates were placed in groups
according to their biochemical characteristics. Any
group with fewer than five members, or in which
the majority of the members were isolated from one
subgingival plaque sample, were discounted.
Eleven groups were obtained, which are outlined
in table II.
It was difficult to assign the Bacteroides isolates
to the currently recognised species. Groups 1, 3, 5
and 6 bear little resemblance to any described
Bacteroides species, and possibly represent new
(sheep-specific) species. Group 2 is similar to B.
oris or B. buccae, whereas Group 7 resembles B.
disiens. The asaccharolytic isolates, groups 8-11,
could be described as B. asaccharolyticus-like, B.
nodosus-like, B. capillosus-\ike and B. gingivalis-like,
respectively.
The proportions of each Bacteroides group and
Fusobacterium sp. isolated at each farm visit are
shown in table III. The incidence of most of the
Bacteroides groups fluctuated between visits. How¬
ever, on examination of the overall trends, isolates
in groups 3, 5, 6, 7, 8 and 11 appeared to increase
in number as the study progressed. The numbers of
F. nucleatum-like isolates were very variable but
the numbers of F. necrophorum decreased with time.
No statistical analysis of these results was made as
the numbers of isolates involved at many of the
sampling times were too low to give a statistically
representative sample.
The degree of gingival inflammation, recorded
at each farm visit, is represented by the gingivitis
index (GI; fig. la); the pocket indices (PI) are
shown in fig. lb. During the period of the
longitudinal bacteriological study (visits 1-7) the
GI and PI rose steadily in two of the sheep (nos. 1
and 2) while the other three sheep showed more
fluctuation and lower values.
The periodontal health of the sheep can be
Table II. Biochemical characteristics of the Bacteroides spp. isolated from sheep on the farm with an intermediate
incidence of broken mouth periodontitis
Characteristic
Reaction of group no.
1 2 3 4 5 6 7 8 9 10 11
Pigment production _ - _ _ _ + _ _ +
Gelatin hydrolysis - — -( + ) ■ + - + /- + /- + /- -( + ) +
Nitrate reduction — - - - - - — — - - -
Urease production — - - — — — — — — — —
Aesculin hydrolysis - + + (-) -( + ) + - + /" - - + -
Indole production — - + - - - - + /- - - +
Bile tolerance — - - - - — — — — — —
Fermentation of:
glucose + + + + + + + - - - -
lactose + + + + - - - - - - -
sucrose — + + + + /- + — — — — —
maltose — + + + + (-) + + (") — — - -
xylose - + - - - - - - - - -
rhamnose — + (-) — — — - - — — — —
trehalose - — — — — — — — — — —
cellobiose — + -( + ) — + — — — — — —
xylan - + /- - - - - - - - - -
aesculin — + /- -( + ) + /" -(+ ) - - - — — -
raffinose - + + + (-) + /- -(+ ) - — — — —
starch - + + + + + + — - - —
GC profile aPib apLs apis apis als als alS apibb as (pib as (pib apbiv
ivLs (iv) (iv) (pibiv) (iv) (iv) ivls ivls) ivl) sph(l)
Number of isolates 60 47 35 13 27 13 23 39 27 9 22
+, > 90% of strains positive; -, > 90% of strains negative; + / -, 30-70% of strains gave each result; + (—) or - (+), 70-90% of
strains gave the first result.
a, Acetic acid; P/p, propionic acid; ib, isobutyric acid; b, butyric acid; iv, isovaleric acid; ph, phenylacetic acid; L/l, lactic acid;
and S/s, succinic acid. Upper case letters; >10mmol/L; lower case letters, 0-2-9-9 mmol/L. Letters in parenthesis represent
variable production.
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Table III. Distribution of Bacteroides and Fusobacterium spp. isolated from sheep on
a farm with an intermediate incidence of broken mouth periodontitis
Species or group
Percentage of all bacterial isolates at visit no.
1 2 3 5 6 7
Bacteroides group 1 2-7 11-4 17-3 3-3 4-0 2-5
2 2-7 0-7 4-0 200 2-7 1-7
3 0-7 5-7 40 60 0 8-3
4 2-0 1-4 1-3 1-3 0-7 2-5
5 0 1-4 1-3 0 11-3 50
6 0 0-7 0-7 1-3 2-0 50
7 0 0-7 2-0 2-7 4-7 6-7
8 0-7 4-3 3-3 3-3 8-7 7-5
9 0-7 21 40 7-3 2-7 1-7
10 0 0-7 1-3 20 1-3 0-8
11 0 0 4-7 0 3-3 8-3
F. nucleatum 15-3 0 0 40 29-3 35-0
F. necrophorum 10-7 7-9 60 60 0 3-3
F. naviforme 0-7 0 0-7 0 0-7 0
Total number of Bacter¬ 54 52 77 86 107 106
oides and Fusobacterium
spp.
assessed by the dental index (DI: fig. 2), which
represents the average of the indices for pocket
depth, gingival inflammation, gum recession and
tooth displacement measurements. Our previous
experience has shown that a DI of greater than 10
predisposes to tooth loss. Two of the sheep (nos. 1
and 2) had rapidly increasing DI; sheep 2 had lost
one central incisor at visit 7 (age 5 years) and sheep
1 had lost the central and second incisors by the
end of the study (age 5 years). The other three sheep
(nos. 3-5) appeared to have a more slowly progress¬
ing condition.
Unfortunately, we cannot compare the clinical
status of the sampled sites in relation to their
bacteriology because the samples were taken from
sites distinct from the clinically monitored sites.
This was to avoid any possible periodontal damage
or bacteriological changes that may be caused by
repeated probing for measurement of indices.
However, pocket depths at the sampling sites were
recorded and these followed the same trends as the
overall pocket indices shown in fig. 1 b.
When the Bacteroides and Fusobacterium isolates
were compared, according to the periodontal status
of the sheep from which they were isolated, only
Bacteroides group 11, which consisted of the B.
gingivalis-like isolates showed any differences (table
IV). The majority of B. gingivalis-\'\ke organisms
were isolated from the subgingival plaque of sheep
with active broken mouth periodontitis (high dental
indices); only one isolate of this type was from the
sheep with a slowly progressing condition (low
dental indices), and that was isolated during the
last visit.
Discussion
The range of genera isolated in this study was
similar to that obtained in a preliminary study of
the anaerobic bacteria isolated from the subgingival
plaque from sheep,8 except that no Veillonella spp.
were recovered as a Veillonella selective medium
was not used. The incidence of Eubacterium spp.
was higher than found previously, although this
was mainly due to a high incidence of this genus in
one single plaque sample. Capnocytophaga and
Eikenella spp. have also been isolated in low
numbers from subgingival plaque of sheep6 but
Table IV. Distribution of B. gingivalis-like isolates (Group
11) from sheep with high and low final cumulative dental
indices
Percentage of total bacteria isolated at
visit no.
Dental index* 1 2 3 5 6 7
High 0 0 11-7 0 8-3 15-0
Low 0 0 0 0 0 1-7
* Dental index was considered high when the final cumulative
dental index was > 10 and low when < 10 (see fig. 2). Data are
for the animals included in figs. 1 and 2.


















1 2 3 4 5 6 7
Visit number Visit number
Fig. 1. Changes in (a) gingivitis indices and (b) pocket indices in five sheep with sequential visits to a farm with an intermediate
incidence of broken mouth periodontitis, over a period of 4-5 years. Bacteriological samples were taken at visits 1-7, over a period
of 2-5 years. Sheep 1 -0-; sheep 2 -f-; sheep 3 -0-; sheep 4 —sheep 5 -0-.
these organisms were not found in this study. The
incidence of each of the more commonly isolated
genera or groups (Bacteroides, Fusobacterium, Clos¬
tridium, anaerobic cocci and Eubacterium) remained
relatively stable over the period of the longitudinal
study. Only Lactobacillus spp. and the less com¬
monly isolated genera were seen to reduce in
numbers over the 2-5 year project.
The three farms used were chosen initially for
the different records of periodontal disease so that
a range of periodontal conditions could be covered
throughout the longitudinal study. However, the
sheep used on each individual farm gave a range of
periodontal disease involvement. In the farm
chosen for detailed study of the Fusobacterium and
Bacteroides isolates, two of the sheep had rapidly
progressive periodontitis culminating in tooth loss,
while the dentition of the other three remained
relatively healthy over the 2-5 year study.
The dental health indices (GI, PI and DI) and
incidences of bacterial genera and bacterial groups
fluctuated considerably during the study. This
confirmed the results obtained in a year-long study
of the clinical development of broken mouth in a
single flock of sheep10 and could reflect the episodic
nature thought to occur with periodontitis in
man20-21 and in sheep.22 Broken mouth periodon¬
titis in sheep has also been shown to have seasonal
variation23 and may be affected by nutritional and
environmental factors.10 The sheep used in this
study were hill sheep, and only readily available for
sampling three times a year. There was no control
over environmental factors, and diets may have
varied, due to increased feeding of pregnant ewes,
especially those expected to produce twins.
Fusobacterium spp. are found commonly in
human subgingival plaque, and F. nucleatum is the
most frequently detected species.24 This species is
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Visit number
Fig. 2. Changes in dental indices in five sheep with sequential
visits to a farm with an intermediate incidence of broken mouth
periodontitis, over a period of 4-5 years. Bacteriological samples
were taken at visits 1-7, over a period of 2-5 years. Sheep 1
sheep 2 sheep 3 -D-; sheep 4 —sheep 5 -H-.
associated with both active and inactive periodontal
sites in man25,26 and it is thought that this might
indicate a heterogeneity within the species.24
Similarly, in this study there was no difference in
the incidence of F. nucleatum-Mke, isolates between
the two categories of periodontal status described.
The Fusobacterium isolates from sheep comprised
three species biochemically similar to the human
types. However, further examination of selected
organisms from the F. nucleatum-like group indi¬
cated that some of these may be F. simiae. These
two species have been shown to be closely related
by DNA homology studies.27 Clearly the isolates
from sheep merit a more detailed investigation.
In a bacteriological study with sheep allocated to
three groups according to degree of periodontal
destruction, F. necrophorum and F. nucleatum were
found commonly.6 In addition, F. nucleatum Type
II (separated from Type I by colony morphology on
selective medium)28 correlated with disease sever¬
ity. Indeed, a statistically significant increase in
Type II isolates with increasing levels of gingivitis
in human periodontal disease has been
demonstrated29 although the two types appeared to
be identical by double diffusion in agar and
similarity of polyacrylamide gel electrophoresis
protein patterns. In the study presented here, it was
difficult to distinguish between colony types (results
not shown) and, because of the possibility that
some of the isolates might have been F. simiae, this
was not investigated further.
A study of Fusobacterium spp. isolated from bite
wounds in cats indicated that F. russii predominates
in the oral Fusobacterium population with smaller
amounts of F. necrophorum, F. naviforme (found in
low numbers in this study) and F. nucleatum being
isolated.19 Those isolated were shown to be geneti¬
cally distinct from human oral strains.30
In studies of human periodontitis, spirochaetes
have been found more frequently and in higher
numbers in diseased sites compared with healthy
sites.31 Spirochaetes were observed in all plaque
samples in this study by dark ground microscopy,
and also in other studies.10'32 Our attempts to grow
sheep spirochaetes (not reported here) were largely
unsuccessful. However, spirochaetes from monkey
periodontal pockets have been shown to have
different nutritional requirements from human
isolates33 and this may account for the lack of
success in this study.
Many of the Bacteroides spp. isolated in this
study were very fastidious, and grew poorly in pure
culture on solid media. In many cases growth was
enhanced by deliberately seeding the agar media,
close to the Bacteroides inoculum, with an aerobic
organism. Growth was enhanced near to the
stimulating organisms, particularly with the black-
pigmented Bacteroides where pigment production
was just detected at the opposing edge. This implies
that these isolates require additional nutrients not
present in the media, and may be indicative of the
dissimilarity of these isolates from human strains.
The sheep Bacteroides isolates could be placed in
11 broad categories by the tests used in this study.
Groups 1, 3, 5, and 6 are likely to be new species of
Bacteroides. However, a full characterisation of
these isolates with guanine plus cytosine content of
the DNA and DNA-DNA homology studies would
have to be performed to confirm this. Under certain
growth conditions a small proportion of the cells of
two isolates of Group 4 were motile and this merits
further investigation. Group 7 was like B. disiens.
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Although this organism is commonly isolated from
the vaginal flora, it has also been recognised as a
common anaerobic isolate from bite-wound infec¬
tions.34
Although the isolation frequency of several
groups of Bacteroides spp. and F. nucleatum-\ike
organisms increased during the study, only the B.
gingivalis-\ike isolates appeared to be associated
with active periodontal disease. No statistical
analysis was carried out on these data as the large
number of zero values made this difficult, and the
number of sheep in the groups (two in the high
index group and three in the low index group) was
considered too low to provide significant results.
Frisken et al.5'6 have also shown increased
incidence of total black-pigmented Bacteroides
species and, in particular, B. gingivalis in periodon¬
tal^ affected sheep. However, the incidence of B.
gingivalis-like organisms was much lower than that
found in this study (up to 15% of the total number
of anaerobes in periodontally affected sheep) and
differences were not statistically significant. This
difference could be due to the longitudinal nature
of this study, with increased chances of sampling
during active episodes of disease progression, or to
the use of different isolation media.
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1. SUMMARY
Isolates of Bacteroides species obtained from a
longitudinal study of developing periodontal dis¬
ease in sheep were analysed by SDS-PAGE. Pro¬
tein profiles of Sarkosyl-insoluble outer membrane
extracts were compared within groups of isolates
which had already been defined by conventional
biochemical techniques. Heterogeneity was ex¬
hibited within most groups. Isolates of B. gingiva-
lis and B. asaccharolyticus shown to be similar to
human isolates by conventional biochemical tests,
gave different protein profiles from the respective
type cultures. The sheep B. gingivalis-like isolates
were however homogeneous, while the B. asac-
charolyticus-Mke organisms could be divided into 3
subgroups. SDS-PAGE appears to be a useful
tool for the examination of bacterial flora and
recognition of subgroups or subspecies.
2. INTRODUCTION
Periodontal disease in sheep (broken mouth) is
a chronic inflammatory condition of the support-
Correspondence to: I.R. Poxton, Bacteriology Department, Uni¬
versity of Edinburgh Medical School, Teviot Place, Edinburgh
EH8 9AG, Scotland, U.K.
ing tissues of the teeth and shows many similari¬
ties to periodontal disease in man [1,2]. However,
little is known about the bacteriology of the sheep
condition, although the genera of bacteria isolated
from sheep subgingival plaque have been shown to
be similar to those obtained from man [3,4], In a
longitudinal study of the subgingival anaerobic
bacteria isolated from sheep during the develop¬
ment of broken mouth periodontitis, almost half
of the isolates belonged to the genus Bacteroides.
Initial characterisation divided these isolates into
11 groups, of which at least 4 are likely to be new
sheep-specific species [5].
Classical identification of microbial species has
been based on morphological, biochemical, sero¬
logical, toxigenic and genetic characteristics. More
recently, cellular protein profiles, obtained by
sodium dodecyl sulphate-polyacrylamide gel elec¬
trophoresis (SDS-PAGE) have been employed to
distinguish closely related species, or strains within
a species. Genera studied have included Arthro-
bacter [6], cariogenic Streptococcus species [7],
Mycoplasma [8], Clostridium [9], Bifidobacterium
[10] and Veillonella [11]. PAGE protein profiles
also distinguish between Bacteroides species, sub¬
species and reveal minor strain differences [12,13].
Use of this method has been suggested for study¬
ing bacterial flora [14] and for rapid identification
of Gram-negative species involved in periodontal
disease [15] and in particular, asaccharolytic non-
0378-1097/90/S03.50 © 1990 Federation of European Microbiological Societies
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pigmented species which are difficult to differenti¬
ate from each other [16]. This method is particu¬
larly useful for distinguishing B. oris and B. buc-
cae [17].
Most of the studies utilise PAGE of total cell
protein. In this study detergent-insoluble outer
membrane proteins were employed to reduce com¬
plexity of the profiles, and to include proteins
likely to be antigenic in vivo. Protein profiles of
the major sheep Bacteroides groups, previously
described [5], were compared for similarity or
heterogeneity amongst the isolates, and where pos¬
sible to compare the sheep isolates with the rele¬
vant type culture.
3. MATERIALS AND METHODS
3.1. Organisms
Representative isolates of 8 groups of Bacte¬
roides species isolated during a longitudinal study
of developing periodontal disease in sheep, de¬
scribed elsewhere [5] were utilised. They were di¬
vided into groups according to their reactions in
the following tests: gas chromatographic analysis
of volatile and non-volatile fatty acid metabolic
end-products; pigment production; gelatin di¬
gestion; nitrate reduction; urease production;
aesculin hydrolysis; indole production; bile toler¬
ance; fermentation of glucose, lactose, maltose,
xylose, rhamnose, trehalose, cellobiose, xylan,
aesculin, starch.
Type cultures (all isolated from humans) in¬
cluded for comparisons were, B. disiens VPI 8047,
B. asaccharolyticus NCTC 9337 and B. gingivalis
ATCC 33277. These were obtained from NCTC,
London.
3.2. Growth conditions
Organisms were grown in PPY medium (Pro-
teose-peptone, yeast extract medium with ad¬
ditional growth factors [18]). Batches of medium
(500 ml) were inoculated with overnight starter
cultures (50 ml) and incubated in an anaerobic
cabinet (Forma Scientific, Ohio) in an atmosphere
of 80% N2, 10% H2 and 10% C02 at 37 °C for
48 h.
3.3. Outer membrane preparation
Cells were harvested and washed once in phos¬
phate buffered saline (pH 7.4; PBS). The bacteria
were resuspended in 5 ml distilled water and lysed
by sonication, on ice (MSE Soniprep 150) at an
amplitude of 8-10 jum until more than 90% of the
cells were broken (up to five 1 min bursts with 30
s intervals between bursts). Unbroken cells were
removed by centrifugation at 5000 X g for 10-min.
The lysed cell supernatant was mixed with 7%
sodium TV-lauroyl sarcosinate (Sarkosyl; Sigma) to
a final concentration of 0.7%. Outer membrane
preparations were sedimented by centrifugation at
50 000 X g for 1 h, washed with distilled water and
finally resuspended in 0.5 ml distilled water by
repeated passage through a 26-gauge needle. Sam¬
ples were stored at — 20 ° C.
3.4. SDS-PAGE
The protein content of the preparations was
determined by the Lowry method [19], Samples
were diluted to a protein concentration of 400
jug/ml, mixed with an equal volume of sample
buffer and boiled for 3 min. Gels were prepared,
run and stained as described by Poxton [20].
4. RESULTS AND DISCUSSION
The isolates in this study could not easily be
assigned to currently recognised species of
Bacteroides, and were grouped according to their
biochemical characteristics. Groups 1, 3, 4 and 5
are thought to be new (sheep-specific) species,
while group 2 is similar to B. oris or B. buccae and
group 7 resembles B. disiens. The asaccharolytic
isolates, groups 8 and 11, could be described as B.
asaccharolyticus-like and B. gingivalis-like, respec¬
tively [5]. Isolates were chosen to represent the 3
different farms from the longitudinal study and to
cover the time span of the study.
Sarkosyl-insoluble extracts were run on SDS-
PAGE gels, and the protein profiles compared.
Groups 7, 8 and 11 were compared with the
reference strains, B. disiens VPI 8047, B. asac¬
charolyticus NCTC 9337 and B. gingivalis ATCC
33277, respectively.
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Fig. 1. SDS-PAGE profiles of Sarkosyl-insoluble fractions obtained from Bacteroides group 1 isolates.
The table lists the number of distinct protein
profiles obtained for each Bacteroides group. Only
2 of the 8 groups are clearly homogeneous and
likely to represent a single species. The other
groups all have more than one protein profile and
with group 2, each isolate gave a different protein
profile. These results are further illustrated by the
figures. Fig. 1 represents group 1 Bacteroides,
which all gave similar protein profiles. The pro¬
files of group 3, which can be subdivided into 2
groups are represented in Fig. 2. The sheep B.
asaccharolyticus-like isolates could be divided into
3 groups according to protein profiles (Fig. 3) and
were distinct from the reference strain.
The results obtained for the B. gingivalis-like
isolates (group 11) are not shown, as the
Sarkosyl-insolublc catracts were not stable and
did not store well, possibly due to proteolytic
activity. However these isolates gave 1 distinct
profile but again differed from the type culture.
These results indicate that the asaccharolytic sheep
species are distinct from the human ones. It has
already been shown that human B. gingivalis iso¬
lates are serologically distinct from isolates ob¬
tained from other animals (cats, dogs, jaguars and
Fig. 2. SDS-PAGE profiles of Sarkosyl-insoluble fractions
obtained from Bacteroides group 3 isolates.
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Fig. 3. SDS-PAGE profiles of Sarkosyl-insoluble fractions
obtained from Bacteroides group 8 isolates (B. asaccharolyti-
cttt-like) compared with a reference strain (B. asaccharolyticus
NCTC 9337; Track 1).
Table 1
The distribution of protein profiles obtained by SDS-PAGE
of Sarkosyl-insoluble extracts of eight different groups of sheep
oral Bacteroides isolates
Bacteroides Number of Number of distinct










The Bacteroides groups have been described in detail previ¬
ously [5],
raccoons [21]). The heterogeneity of groups 2, 4, 5
and 7 suggest that biochemical tests alone are not
sufficient for identification of sheep Bacteroides
isolates. Use of an electrophoretic technique in
conjunction with classical taxonomic approaches
has been proposed to differentiate closely related
oral species [22]. This study indicates that SDS-
PAGE of Sarkosyl-insoluble preparations would
be useful for the screening of sheep oral bacterial
flora.
ACKNOWLEDGEMENTS
This work was funded by the Wellcome Trust
(Grant no. 14552/1.5). We are extremely grateful
to Robert Brown and Carol Whittaker for techni¬
cal assistance.
REFERENCES
[1] Spence, J.A., Aitchison, G.U., Sykes, A.R. and Atkinson,
P.J. (1980) J. Comp. Pathol. 90, 275-292.
[2] Ismaiel, M.O., Greenman, J., Morgan, K., Glover, M.G.,
Rees, A.S. and Scully, C. (1989) J. Periodontol. 60, 279-
284.
[3] McCourtie, J., Poxton, I.R., Spence, J.A. and Aitchison,
G.U. (1989) Vet. Microbiol. 21, 139-146.
[4] Frisken, K.W., Tagg, J.R., Laws, A.J. and Orr, M.B.
(1988) J. Periodont. Res. 23, 18-21.
[5] McCourtie, J., Poxton, I.R., Brown, R., Whittaker, C.R.,
Spence, J.A. and Aitchison, G.U. (1990) J. Med. Micro¬
biol. 31, 275-283.
[6] Seiter, J.A. and Jay, J.M. (1980) Int. J. Syst. Bacterid. 30,
460-465.
[7] Simonson, L.G. and Shklair, I.L. (1972) J. Dent. Res. 51,
488-491.
[8] Theodore, T.S., Tully, J.G. and Cole, R.M. (1971) Appl.
Microbiol. 21, 272-277.
[9] Cato, E.P., Hash, D.E., Holdeman, L.V. and Moore,
W.E.C. (1982) J. Clin. Microbiol. 15, 688-702.
[10] Biavati, B., Scardovi, V. and Moore, W.E.C. (1982) Int. J.
Syst. Bacterid. 32, 358-373.
[11] Mays, T.D., Holdeman, L.V., Moore, W.E.C., Rogosa, M.
and Johnson, J.L. (1982) Int. J. Syst. Bacterid. 32, 28-36.
[12] Poxton, I.R. and Brown, R. (1979) J. Gen. Microbiol. 112,
211-217.
[13] Brown, R. Hornett, K.E. and Poxton, I.R. (1989) J. Med.
Microbiol. 28, 267-273.
[14] Moore, W.E.C., Hash, D.E., Holdeman, L.V. and Cato,
E.P. (1980) Appl. Environ. Microbiol. 39, 900-907.
9
[15] Tanner, A.C.R., Dzink, J.L., Socransky, S.S. and Des
Roches, C.L. (1987) J. Periodont. Res. 22, 207-208.
[16] Tanner, A.C.R. (1986) J. Clin. Microbiol. 24, 562-565.
[17] Holdeman, L.V., Moore, W.E.C., Churn, P.J. and John¬
son, J.L. (1982) Int. J. Syst. Bacteriol. 32, 125-131.
[18] Deacon, A.G., Duerden, B.I. and Holbrook, W.P. (1978)
J. Med. Microbiol. 11, 81-99.
[19] Lowry, O.H., Rosebrough, N.J., Farr, A.L. and Randall,
R.J. (1951) J. Biol. Chem. 193, 265-275.
[20] Poxton, I.R. (1988) in Bacterial Cell Surface Techniques
(Hancock, I.C. and Poxton, I.R., eds.), pp. 277-280, Wi¬
ley, Chichester.
[21] Parent, R., Mouton, C., Lamonde, L. and Bouchard, D.
(1986) Infect. Immun. 51, 909-918.
[22] Kinder, S.A., Kornman, K.S. and Holt, S.C. (1989) Oral
Microbiol. Immun. 4, 52-56.
52
FEMS Microbiology Letters 27 (1985) 247-251 247
Published by Elsevier
FEM 02068
The association on SDS-polyacrylamide gels of lipopolysaccharide
and outer membrane proteins of Pseudomonas aeruginosa as
revealed by monoclonal antibodies and Western blotting
(Pseudomonas aeruginosa; monoclonal antibodies; Western blotting; lipopolysaccharides; outer membrane
proteins)
Ian R. Poxton, Graham T. Bell and G. Robin Barclay *
Bacteriology Department, University of Edinburgh Medical School, Teviot Place, Edinburgh, EH8 9AG, and * Edinburgh and S.E.
Scotland Regional Blood Transfusion Centre, Royal Infirmary, Edinburgh, EH 3 9HB, Scotland
Received 25 January 1985
Accepted 31 January 1985
1. SUMMARY
Monoclonal antibodies raised against single
serotype components of a Pseudomonas aeruginosa
vaccine have been shown to bind to the O antigen
region of lipopolysaccharide (LPS). Outer mem¬
brane (OM) proteins, prepared by detergent treat¬
ment of envelope fractions and by EDTA/sonica-
tion treatment of whole cells, were separated on
sodium dodecylsulfate-polyacrylamide gel electro¬
phoresis (SDS-PAGE), electrophoretically trans¬
ferred to nitrocellulose membrane and reacted with
LPS-specific monoclonal antibodies. The patterns
produced revealed that many of the protein bands
were in fact protein-LPS complexes.
2. INTRODUCTION
The OM of Gram-negative bacteria consists of
LPS, phospholipids and a range of OM proteins.
Several methods have been developed for the pre¬
paration of OM. One method depends on the
physical separation of inner and outer membrane
on a density gradient [1], while possibly the most
commonly used method involves the treatment of
envelope fractions with detergents which selec¬
tively leave the OM as an insoluble pellet. The
method developed by Schnaitman [2] makes use of
the detergent Triton X100 and has been used
widely for Escherichia coli [3] and for other
Gram-negative bacteria [4], A similar method, de¬
veloped by Filip et al., using the detergent Sarko-
syl, has also been employed [5]. Methods based on
extraction of whole cells with EDTA have also
been used, e.g., [6].
The OM of P. aeruginosa has been investigated
by several workers. For example, Hancock and
coworkers [7] used a gradient centrifugation
method for its preparation, while Meadow et al. [8]
used Triton. Both methods gave highly similar
patterns of OM proteins on SDS-polyacrylamide
gels.
The LPS of P. aeruginosa is the type-specific
antigen of the species, and there are at least 16
known serotypes [9], In a separate study, mono¬
clonal antibodies have been prepared to 2 sero¬
types of P. aeruginosa [10]. Several of these mono¬
clonal antibodies have been shown to be serotype-
specific and to react with the O antigen region of
0378-1097/85/S03.30 © 1985 Federation of European Microbiological Societies
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the LPS (G.R. Barclay et al., unpublished). In the
present study, we used LPS-specific monoclonal
antibodies as probes to demonstrate the distribu¬
tion of LPS molecules among the OM proteins on
SDS-polyacrylamide gels.
3. MATERIALS AND METHODS
3.1. Bacterial strains and growth conditions
P. aeruginosa Habs serotypes 1 and 4 were
kindly supplied by Dr. R.J. Jones, MRC Vaccine
Research Laboratories, Medical School, Bir¬
mingham, U.K. Overnight cultures were grown in
1-1 volumes of Oxoid No. 2 Nutrient Broth, in 2-1
conical flasks in an orbital incubator at 37°C for
16 h. Log-phase cultures were grown from a 10%
overnight culture inoculum under the same condi¬
tions as above, but for 4 h.
P. aeruginosa serotype 1 was also grown in
[32P]orthophosphate in an attempt to label the
LPS. A synthetic medium based on that of
Robert-Gero et al. [11] was used. An overnight
culture in Nutrient Broth (1 ml) was used to
inoculate 200 ml of synthetic medium, and was
incubated for 16 h. This culture was added to 800
ml of fresh medium and incubated for a further 1
h. Cells were harvested, washed once in saline and
resuspended in 100 ml synthetic medium, in which
the phosphate had been replaced with 50 mM
Hepes buffer, pH 7.2, containing 100 juCi of 32 P-
labelled orthophosphate (Amersham). After a fur¬
ther 2.5 h, incubation cells were harvested and
outer membranes separated by the Sarkosyl
method (see below).
3.2. Preparation of LPS
LPS was extracted from washed, freeze-dried
bacteria harvested from an overnight culture by
the 45% (w/v) aqueous phenol method developed
by Westphal and Luderitz [12], The LPS was
washed and purified by 2 cycles of centrifugation
at 100000 X g for 3 h, and stored freeze-dried.
3.3. Preparation of OM proteins
Log-phase bacteria (4 1) were harvested by
centrifugation at 16000 X g for 10 min and washed
once in 0.01 M Hepes buffer, pH 7.4, then sus¬
pended in 40 ml Hepes. Cells were broken by
passage through a French pressure cell (Aminco,
Silver Springs, MD, USA) at 6000-7000 p.s.i.
(42-48 MPa). Unbroken cells were removed by 2
cycles of centrifugation at 6000 X g for 10 min.
The suspension was divided into two; one part to
be used for Triton extraction and the other for
Sarkosyl.
Triton treatment was by the method of Die-
drich et al. [13], MgCl2-6H20 was added to a
final concentration of 1 mM. Envelopes were sedi-
mented at 50000 Xg for 1 h. The pellet was
resuspended in 20 ml Hepes buffer, containing 2%
(v/v) Triton X100, and incubated in a water-bath
for 10 min at 23°C. The OM proteins were sedi-
mented at 50000 Xg for 1 h, washed once in
water and resuspended in 2 ml water.
Sarkosyl treatment was by a modification of the
method of Filip et al. [5], Sarkosyl (30% w/v
solution of sodium A-lauroyl sarcosinate (Sigma
Chemical Co.)) was added to the broken cell sus¬
pension to a final concentration of 0.7% (w/v)
sodium A-lauroyl sarcosinate. The suspension was
centrifuged at 50000 X g for 1 h, and the pellet of
OM was washed once in water and finally sus¬
pended in 2 ml water (0.5 ml in the case of the
32P-labelled extract).
EDTA treatment was by the method of Poxton
and Brown [6].
3.4. Preparation of monoclonal antibodies
The preparation and characterisation of mono¬
clonal antibodies to P. aeruginosa vaccine (PV) is
the subject of a complete paper which is in pre¬
paration (Barclay et al., unpublished). Briefly, mice
were immunised with the serotype 1 or 4 compo¬
nent of polyvalent Pseudomonas vaccine (PPV)
[14], Hybridomas for each serotype were prepared
by standard techniques [15]. The majority of the
hybridomas obtained produced monoclonal anti¬
bodies which were serotype-specific and were
shown to bind to the O antigen region of the LPS.
Representatives of these monoclonal antibodies
were used in the present study.
3.5. SDS-polyacrylamide gel electrophoresis
This was performed on 10% slab gels with the
buffer system of Laemmli [16], by the method of
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Poxton and Brown [6]. Protein (50 fig), LPS (12.5
jug carbohydrate) or 32P-labelled Sarkosyl extract
(106 cpm) were run. Gels were stained with
Coomassie blue [17], silver [18] or used for electro-
blotting. Urea (4 M) was added to some gels.
3.6. Electroblot transfer and enzyme immunoassay
This was essentially by the method of Towbin
et al. [19] with BioRad Immunoblot immunoassay,
as described previously [20].
3.7. Carbohydrate and protein assays
These were by the methods of Dubois et al. [21]
and Lowry et al. [22], respectively.
3.8. Autoradiography
Electroblots of 32P-labelled Sarkosyl extract run
on SDS-PAGE and X-ray film (Fuji) were placed
in a cassette fitted with intensifying screens and










Fig. 1. SDS-polyacrylamide (10%) gels of (a) Sarkosyl, (b)
Triton, and (c) EDTA preparations from P. aeruginosa sero¬
type 1; (d) Sarkosyl preparation of serotype 4, stained with
Coomassie blue; (e) LPS of serotype 1, stained with silver.
4. RESULTS AND DISCUSSION
SDS-polyacrylamide gels of the OM protein
preparations, whether prepared by Triton or
Sarkosyl, were almost identical when stained with
Coomassie blue (Fig. la and b), and those pre¬
pared from P. aeruginosa serotype 1 were ex¬
tremely similar to those from serotype 4 (Fig. Id).
The major OM proteins are labelled to conform
with the scheme of Mizuno and Kageyama [23].
OM prepared by EDTA/sonication are signifi¬
cantly different, but most of the bands are present,
although in different proportions (Fig. lc). Silver-
stained gels of the LPS preparations showed the
characteristic ladder pattern, each band differing
in Mr by one repeating unit of O antigen. An
example of a silver-stained gel of P. aeruginosa
serotype 1 is shown in Fig. le.
Unstained gels similar to those described above
were transferred to nitrocellulose membranes and
probed with a series of monoclonal antibodies. 2
Monoclonal antibodies (Nos. 1.5 and 1.7) raised
against the serotype 1 vaccine, and previously
shown (by ELISA and inhibition of ELISA) to be
specific for the O antigen region of the LPS
(Barclay et al., unpublished), were reacted with
LPS, Triton, Sarkosyl and EDTA preparations.
With the serotype 1 LPS preparation, both mono¬
clonal antibodies produced the characteristic
ladder pattern. This was similar to the silver-
stained gel, except that there was no stain at the
bottom of the gel at the position corresponding to
rough LPS. With the Triton and Sarkosyl prepara¬
tions, a different pattern was produced. This closely
followed the pattern of the Coomassie blue-stained
gel. Most protein bands, with the notable excep¬
tion of the porin (F) band, were stained. There was
no significant difference between the Triton and
Sarkosyl preparations. The EDTA preparation
gave a pattern similar to the LPS pattern at the
lower part of the gel, but was more like the protein
pattern for the higher Mr bands. Fig. 2 shows
examples of the patterns produced when mono¬
clonal antibody 1.5 was reacted with (a) Sarkosyl,
(b) EDTA and (c) LPS preparations of P. aeru¬
ginosa serotype 1; and (d) Sarkosyl and (e) LPS
preparations of serotype 4. These reactions were
specific for serotype 1. Monoclonal antibodies
shown to be serotype 4-specific showed, the oppo¬
site pattern, reacting only with the serotype 4
extracts. Fig. 2f shows the pattern produced when
a Sarkosyl extract of serotype 4 was reacted with a








Fig. 2. Western blots of (a) serotype 1 Sarkosyl preparation; (b)
serotype 1 EDTA extract; (c) serotype 1 LPS; (d) and (f)
Serotype 4 Sarkosyl extracts; and (e) Serotype 4 LPS. Tracks
(a)-(e) were reacted with the monoclonal antibody specific for
the LPS of P. aeruginosa serotype 1, and track (f) was reacted
with the monoclonal antibody specific for serotype 4.
tern produced when this monoclonal antibody was
reacted with homologous LPS gave a pattern iden¬
tical to that in Fig. 2c. If 4M urea was incorpo¬
rated into the stacking and separating gels, no
differences in the patterns described above were
observed.
Several of the monoclonal antibodies produced
in each fusion were not species-specific, but cross-
reacted in the screening enzyme-linked immuno¬
sorbent assay with vaccine preparations from other
serotypes of P. aeruginosa. These antibodies were
not directed against LPS, and 2, one from each
fusion, were used as controls in the above series.
No reactions were observed between these cross-
reactive monoclonal antibodies and either LPS
preparation. The antibodies only produced reac¬
tions when the OM extracts, but not LPS, were
spotted directly onto nitrocellulose membranes and
treated with the immunoblot reagents. After sep¬
aration on SDS-PAGE no lines were seen. This
suggested that these cross-reactive monoclonal an¬
tibodies were directed against proteins that were
denatured irreversibly by the electrophoresis
and/or transfer procedures.
Monoclonal antibodies directed against the LPS
of P. aeruginosa have allowed us to define specifi¬
cally the location of LPS molecules among the OM
proteins after separation on SDS-polyacrylamide
gels. It is perhaps not surprising to find that the
LPS is associated with some of the OM proteins in
OM prepared by detergent insolubility, and is not
simply revealed as the ladder pattern superim¬
posed on the OM protein pattern. In the intact
OM, LPS and proteins are in intimate association.
The solubilisation procedure used on the samples
prior to electrophoresis involved heating to 100°C
for 6 min in 2% SDS and 1% 2-mercaptoethanol,
and in some experiments urea was incorporated in
the gels; the association withstands these treat¬
ments. These findings are in apparent contradic¬
tion to those for Salmonella spp., where OM pro¬
teins have been shown not to be associated with
LPS [24], In that study, however, OM were pre¬
pared by EDTA/sonication. In our similar pre¬
paration from P. aeruginosa, the subsequent blot
with LPS-specific monoclonal antibodies showed a
pattern more similar to that of pure LPS, but still
with some high-Mr LPS-associated protein.
In a control experiment, we attempted to label
the LPS with radioactivity by incubating growing
cells with [32P]orthophosphate (see materials and
methods). Autoradiographs of the Sarkosyl ex¬
tracts showed a picture similar to that obtained
with LPS-specific monoclonal antibodies in a
Western blot. Most of the 32 P had been incor¬
porated into phospholipid, which ran near to the
front of the gel, but weaker bands corresponding
to protein bands could be seen. No ladder pattern
was apparent.
We suggest that those methods for preparing
OM based on the insolubility in detergents work
by selectively leaving, and perhaps encouraging,
protein/LPS complexes which are highly resistant
to disaggregation.
Our findings have important implications. When
undertaking studies on antibodies directed against
OM antigens of P. aeruginosa, and possibly of
other Gram-negative bacteria, Western blotting
should be used with caution. The OM proteins
need not necessarily be pure proteins, but pro¬
tein/LPS complexes and antibodies detected may
be against either antigen. It has only been possible
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Changes in Anti-Endotoxin-IgG Antibody
and Endotoxaemia in Three Cases of
Gram-Negative Septic Shock
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Circulating endotoxin levels and IgG antibodies to a range of Gram-negative bacterial
lipopolysaccharides (LPS) (endotoxins) of different sizes and structures were
measured daily in three cases of septic shock. There was an inverse relationship
between endotoxin levels and cross-reactive antibodies to the core glycolipid (CGL)
region of lipopolysaccharide. This suggests that antibody to LPS-CGL was initially
consumed by a superabundance of endotoxin, and that a resurgence of intrinsic
anti-LPS-CGL antibody levels may be associated with a reduction of circulating
endotoxin. The implications of these findings for passive antibody therapy of septic
shock are discussed.
Keywords: LPS, anti-LPS, core glycolipid, ELISA
INTRODUCTION
The relationships between bacteraemia, endotoxaemia, and septic shock remain
unclear. Septic shock commonly occurs in patients with Gram-negative bacteraemia
but may also develop in patients with Gram-positive or fungal infections or even
when no obvious source of infection can be demonstrated [1-5]. Positive blood
cultures have been reported to be detectable in as few as one-third of patients in septic
shock [4]. Endotoxin appears to play a central role in the pathogenesis of septic shock
[6,7]. In cases of Gram-negative bacteraemia a source of endotoxin is apparent: in
other cases it presumably originates from the endogenous Gram-negative bacteria in
the gut [8,9].
Recent reviews of a variety of studies of the role of passive antibody therapy in
treatment of septicaemia and septic shock have concluded that while antibodies to the
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lipopolysaccharide (LPS) endotoxins of Gram-negative bacteria have potential for
immunotherapy in septic shock, the mechanism by which anti-LPS antibodies act and
their specificities for regions of the LPS molecule associated with therapeutic activity
remain unclear [10-12]. Thus, parameters for selecting antibodies with high
therapeutic activity have not been defined.
Serotype-specific antibodies to the O-polysaccharide outer chains of LPS of
different bacteria have been shown to be bactericidal in animal protection models
[13-15], but may not be protective in clinical bacteraemia [16]. Further, because of
inherent difficulties or delays in detecting bacteria and determining serotypes in
patients, serotype-specific immunotherapy may be inappropriate in septic shock.
Successful immunotherapy is likely to require cross-reactive antibodies to structures
common to LPS from different bacteria, without reference to serotype. Conserved
structural regions with which cross-reactive anti-LPS antibodies interact are available
within the CGL region of LPS [17-20]. The CGL terminates in lipid A, which, on its
own, expresses most of the toxic properties of endotoxin [18]. Anti-LPS-CGL
cross-reactive antibodies might therefore neutralise endotoxic activities of free LPS
by binding to and masking biologically active sites, as well as promoting opsonisation
and clearance of LPS. Such antibodies might not be efficient as bactericidal
antibodies if LPS-CGL structures are poorly exposed on bacterial surfaces and may
be less important in bacteraemia than serotype-specific antibodies to the more
exposed polysaccharide chain of LPS. This remains to be clearly established.
It is now known that there are differences in CGL structures between LPS from
different Gram-negative bacteria [17-20], and it is not apparent whether truly
pan-reactive anti-LPS-CGL antibodies exist or could be achieved by immunisation or
whether any such antibodies would be therapeutically active. High endogenous levels
of anti-LPS antibodies [21], and, in particular, anti-LPS-CGL antibodies [16,22],
appear to be associated with protection against bacteraemia and septic shock in at-risk
patient groups. However, information on the dynamics of anti-LPS antibody levels,
their range of specificities, and their possible interaction with circulating endotoxin
during septic shock is not available.
We have developed a sensitive immunoassay for anti-LPS IgG antibodies
employing a range of complete and incomplete (CGL-component) LPSs, which can
demonstrate anti-LPS-CGL cross-reactivity patterns in sera [20]. We have used this
assay to determine sequential changes in anti-LPS antibodies and endotoxin levels in
sera from three cases of septic shock and have found evidence of apparent interaction
between certain anti-LPS antibodies and serum endotoxin.
CASE REPORTS
All patients admitted to the Intensive Therapy Unit (ITU) were placed on a
continuous prophylactic regimen of antibiotics for selective decontamination of the
digestive tract (SDD), accompanied by regular microbiological screening of multiple
sites [23],
Patient B.S.
This 43-year-old woman in previous good health was admitted to the ITU in
septic shock having had a laparotomy for faecal peritonitis following a sigmoid
myotomy 7 days previously. She required massive colloid transfusion and inotropic
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support to maintain blood pressure and organ perfusion. After 3 days of gradual
deterioration following admission to the ITU, repeat laparotomy revealed no localised
collection of pus. A rise in core temperature to more than 42°C, increasing
cardiovascular instability, and worsening renal function prompted a third laparotomy
6 days after admission. A large perforation in the sigmoid colon was discovered with
infected free fluid in the abdomen, from which enterococci, Escherichia coli,
Pseudomonas spp, and Serratia spp were cultured. The defect was oversewn, and the
abdomen was irrigated. Her recovery from this operation was stormy with profound
hypotension and renal, respiratory, and liver failure. Clinical improvement was
obtained by repeated blood product replacement, inotropic infusion, and haemodial-
ysis. Despite maximal supportive treatment, her condition deteriorated inexorably
from the 15th day of her admission, and she died after 34 days in the ITU. Repeated
blood cultures were negative.
Patient M.C.C.
This 39-year-old man was admitted to the ITU for post-operative care after
laparotomy for faecal peritonitis caused by dehiscence of a colonic anastomosis.
Three days post-admission, he became floridly septic with hypotension and
respiratory and renal impairment. Supportive treatment with volume replacement,
inotropic agents, ventilation, and antibiotics led to a rapid improvement in his clinical
condition, and he was discharged from the ITU after 10 days. Repeated blood cultures
were negative.
Patient M.C.M.
This 32-year-old man was admitted to the ITU in septic shock from pneumo¬
coccal septicaemia, with hypotension, respiratory and renal failure, and disseminated
intravascular coagulation. He developed severe vasculitis in his lower legs leading to
gangrene of both feet. Gradual improvement was achieved with volume replacement,
inotropic support, ventilation, and dialysis. An abrupt deterioration with sudden
hypoxia and hypotension occurred 14 days post-admission, but re-institution of the
previous supportive therapy led to a rapid resolution of the illness. Following bilateral




All patients had blood samples taken on arrival in the ITU and daily thereafter.
The blood was taken aseptically after skin preparation with 2% povidone-iodine in
alcohol, and serum was removed to pyrogen-free tubes for storage at — 20°C for
retrospective analysis.
Immunoassay of IgG Anti-LPS Antibodies
Different LPS were complexed with polymyxin-B for coating on polystyrene
microplates for enzyme-linked immunosorbant assay (ELISA) of serum IgG
antibodies essentially as previously described [20]. Minor modifications were that
estimates were made of the different LPS molecular weights based on the reported
molecular weight of 3,100 for Salmonella minnesota Re595 LPS and a mean
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molecular weight of 15,000 for smooth LPS [24], to achieve approximately
equimolar concentrations (2.0 pM) of LPS for plate coating. Microplate frames were
assembled from 8-well strips (NUNC); each strip was coated with a different LPS. All
samples of a given patient's sera were assayed simultaneously as previously described
using urease-conjugated anti-human-IgG indicator antibody, and microplate optical
density (O.D.) readings were stored directly by a microcomputer for further analysis.
Results were processed by microcomputer by plotting each set if IgG anti-LPS O.D.
readings net of background (no LPS-polymyxin complexes; strips postcoated with
BSA only) on a Hewlett-Packard 7475A plotter.
In all, seven smooth LPS, 22 rough LPS of a range of chemotypes, strains, and
species of Gram-negative bacteria, and two lipid A preparations were used in ELISA
studies (these will be reported in full together with results of current studies in the
future). In this report, we describe the responses to series of LPSs of different sizes
from S. minnesota smooth and rough mutants, and from a variety of LPSs from
smooth strains and complete core rough types of E. coli (Table I). These results
represent the general trend of changes in IgG antibodies to different LPS chemotypes
that were observed in these patients, and are less complex to present than the full set
of results. S. minnesota LPS and E. coli 011LB4 LPS were purchased from List
biologicals (Campbell, CA): other S-LPS were prepared by the method of Westphal
et al. [25], and R-LPS were prepared by the method of Galanos et al. [26] as
previously described [27].
Endotoxin Assay
Serum endotoxin levels were measured by a microplate modification of a
chromogenic Limulus amoebocyte lysate (LAL) test kit (Coatest/Endotoxin, Kabi
Vitrum Diagnostica UK, Uxbridge, England). Serum samples (0.1 ml) were added to
water (0.9 ml) at 75°C and held at 75°C for 5 minutes before cooling rapidly in a 4°C
ice/water bath. Two 30 pi volumes of each diluted sample were transferred to
flat-bottom microplates. To the first (blank) 90 p.1 of water was added: to the second
TABLE I. Lipopoly.saccharides Used as Antigens in ELISA
Key Bacteria Strain Chemotypc
A Salmonella minnesota R5 Rc
B Salmonella minnesota R595 Re
C Salmonella minnesota (ex-R595) Lipid A
D Salmonella minnesota S
E Salmonella minnesota R60 Ra
F Escherichia coli R1 HF 4704 Ra
G Escherichia coli R2 EH 100 Ra
H Escherichia coli R3 F 653 Ra
I Escherichia coli R4 F 2513 Ra
J Escherichia coli K12 W 3110 Ra
K Escherichia coli 06 S
L Escherichia coli 016 S
M Escherichia coli 018 S
N Escherichia coli 086 S
O Escherichia coli 0111 S
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(test) 30 p.] of LAL was added, followed by 25 min incubation at 37°C, then 60 p.1
of S2423 chromogenic substrate was added followed by 3 min incubation at 37°C.
Acetic acid (60 (xl of 50% v/v) was added to both blank and test, and the O.D. was
read at 405 nm on a microplate reader relative to reagent blank (30 p,l water + 30 p.1
LAL + 60 pi substrate + 60 pi acetic acid). A standard curve was constructed with
E. coli 0111:B4 LPS (test kit standard) over a range of 7 doubling dilutions in water
from 2.4 endotoxin units (EU), using 30 pi of standard dilution in place of test serum
dilution. Results were calculated by subtracting each blank from test for each serum
sample, finding the equivalent EU concentration from the standard curve, and
multiplying by 10 for the initial serum dilution. Pyrogen-free sterile reagents and
equipment were used throughout, and work was performed in a sterile laminar-flow
hood.
RESULTS
The daily levels of serum endotoxin and antibodies to different LPS for patients
B. S., M. C. C. and M. C. M., together with timing and volume of transfused blood and
blood products that may have contributed extraneous antibodies to these patients, are
shown in Figures 1-3, respectively.
Patient B.S. showed low but detectable levels of endotoxin in initial samples,
which became borderline detectable between days 5 and 11, followed by a rise in
endotoxin to a peak of 6.9 EU at day 14, with further small peaks at days 22 and 32.
All antibodies to R-LPS and antibody to S-LPS E. coli 086 showed considerable
fluctuation over days 0-11, most synchronously but some asynchronously, perhaps
reflecting some contribution of anti-LPS antibodies by blood products given during
this time. All of the above antibodies except anti-S. minnesota Ra LPS showed a
major depression over days 11 to 14, preceding the major peak of endotoxaemia. All
anti-LPS antibodies showed a rise coinciding with the fall of the major endotoxin
peak, and most anti-S-LPS and anti-Ra-LPS antibodies (except anti-£. coli K12)
remained at elevated levels thereafter. Anti-lipid A antibody also remained elevated
but showed a wider range of fluctuation. Anti-S. minnesota Rc and anti-£. coli K12
antibodies showed depressions at days 10-21 and 28-30. Anti-S. minnesota Re
antibody became profoundly depressed before each peak of endotoxaemia and
recovered as endotoxin levels fell.
Patient M.C.C. showed high levels of serum endotoxin in the initial sample
which fell in the next 3, rose to a second peak on day 5, then fell to a low level with
a minor peak on day 9. All anti-LPS antibodies were low to negligible in the initial
sample and recovered to intermediate (or high, as for E. coli Rl, R2, R3, and R4)
levels as endotoxin decreased. Most anti-S-LPS and anti-Ra-LPS antibodies showed
an interim peak in their recovery on day 5. The recovery in anti-S. minnesota Re
antibody was latest, beginning at the second peak of endotoxaemia on day 5.
Patient M.C.M. showed no endotoxaemia until day 5, after which endotox¬
aemia fluctuated then rose to a peak at day 15 and remained elevated. This patient had
Figs. 1-3. Serum endotoxin levels (stippled shading), transfused antibody-containing blood products
(columns), and anti-LPS IgG antibodies expressed as net ELISA optical density (O.D.) readings
according to the letter key given in Table I, in sequential samples from patients. RBCC = red blood cell
concentrate. Fig. 1: Patient B.S.; Fig. 2: patient M.C.C.; Fig. 3: patient M.C.M.
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no appreciable levels of anti-R-LPS antibodies except for anti-S. minnesota Rc LPS
in the early samples, and anti-S-LPS antibodies were generally low. Most antibodies
showed a peak after blood transfusion on day 6; this may represent passive antibody.
All antibodies, including the anti-S. minnesota Rc LPS antibody, became depressed
before the peak of endotoxaemia and remained depressed in the presence of elevated
endotoxin levels.
DISCUSSION
Despite advances in monitoring and treatment of patients with septic shock, the
mortality remains high. Antibiotic treatment is universal in these presumably infected
patients, but positive bacteriology to guide treatment is available in only a minority
[4,5]. All three patients described here were on continuous SDD prophylactic
antibiotics [23] and had regular cultures of sputum, blood, and other secretions; the
only positive bacteriology was in patient MCM who had Streptococcus pneumoniae
grown from the blood. None of the patients showed detectable Gram-negative
bacteraemia. All were in septic shock at some stage, diagnosed by standard criteria
[28]. Since patients in this ITU on the SDD regimen of continuous antibiotics did not
show peaks of endotoxaemia if they were not septic (unpublished observations), it is
probable that these patients' endotoxaemias were associated with sepsis rather than
intercurrent administration of antibiotics.
Endotoxin is thought to play a central role in septic shock, whether or not
Gram-negative bacteria or other organisms can be isolated [7,9,29], Endotoxaemia
may, however, be transient. Initiation by endotoxin of cellular and humoral cascades
may result in the typical picture of septic shock without simultaneously detectable
levels of endotoxin [7,29]. Recovery from septic shock depends on effective
resuscitation during the acute episode, but ultimate survival depends on whether
multiple organ failure ensues [30] and the effectiveness of supportive treatment.
The three patients reported illustrate these points. Patient B.S. was in profound
septic shock on admission to the ITU and again 6 days later. Endotoxin levels were
low or undetectable at those times. On both occasions prompt resuscitation produced
clinical improvement. A peak of endotoxaemia on day 15 coincided with worsening
renal and hepatic impairment and the development of abnormal neurological signs
indicative of marked cerebral injury. She died after 1 month in the ITU owing to
chronic and irreversible organ failure. By contrast, patients M.C.C. and M.C.M.
survived. Peaks of endotoxaemia on days 5 and 15 coincided with marked clinical
deterioration. In both cases resuscitation was effective, and multiple organ
dysfunction was only transient.
Whether anti-LPS antibodies played some role in the different clinical outcomes
of these three cases cannot be determined. However, it appears that the temporal
variations in levels of individual anti-LPS antibodies were related to variations in
endotoxaemia, because depressions of certain anti-LPS antibodies occurred
immediately before peaks of endotoxaemia, and recovery of these anti-LPS antibody
levels preceded falls in circulating endotoxin. Although there was some evidence that
administration of blood products could have contributed to rising antibody levels at
certain times, our studies have shown that antibodies acquired from infused blood
products are detectable very soon after infusion (unpublished). In these cases, we
would expect to detect any antibody acquired passively in the next sequential daily
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sample. The rising anti-LPS IgG levels during and following endotoxaemia could not
be attributed directly to a contribution from administered blood products. Studies of
anti-LPS IgG antibodies in healthy blood donors show that different individuals
express different patterns of specific antibodies to different parts of the endotoxin
inner core [20]. The particular specificity pattern and general levels of antibodies are
stable over many months in healthy individuals [31]. In contrast in these patients,
wide fluctuations of anti-LPS antibody levels occurred from day to day with certain
antibodies, especially those to the inner core of endotoxin, virtually vanishing during
endotoxaemia resulting in marked alteration of the relative anti-LPS specificity
patterns for this range of LPS antigens. Similar depressions of anti-LPS-CGL
antibodies during endotoxaemia have been found by us in a number of other cases of
septic shock in shorter series of samples, where the trend of relationships between
anti-LPS antibodies and endotoxin levels over an extended time, i.e., whether falling
antibody tended to precede rising endotoxaemia and vice versa, could not be
established because the series were too short (not shown).
The inverse relationship between endotoxin levels and anti-LPS IgG antibodies
appears generally true for all of the range of LPS-specific antibodies expressed in
patients M.C.C. and M.C.M. Anti-lipid A antibodies tended to reflect the general
pattern of variation of the anti-LPS antibodies in these patients, and appeared less
sensitive to changes in endotoxin levels than the anti-Re and anti-Rc antibodies when
these are expressed. In patient B.S., anti-S. minnesota-Re LPS antibodies fluctuated
in response to minor changes in endotoxin levels, and antibodies to smaller R-LPS
also showed extensive changes, whereas antibodies to most of the range of larger
rough LPS (Ra chemotype) were depressed only before the major endotoxin peak on
days 14-15. In this case, little variation in anti-S-LPS antibodies was found except
for anti-£. coli 086 where the pattern of variation resembled that of antibodies to
complete core (Ra chemotype): this probably reflects anti-LPS-CGL antibodies bound
by this smooth LPS, and not specific anti-086 serotype activity. We have found that
a large component of serum IgG antibodies that react with S-LPS can be absorbed by
rough Gram-negative bacteria or inhibited by R-LPS in immunoassay [37], and
therefore appear to be specific for LPS-CGL, not O-polysaccharide.
We can speculate that the concerted changes in antibodies to a wide range of
different LPS, seen especially in patients M.C.C. and M.C.M., might reflect changes
in a limited spectrum of IgG anti-LPS antibodies with extensive cross-reactivity. The
different patterns of changes in antibodies to different LPS in patient B.S. might
indicate a more selective interaction between her endotoxaemia and a subset of her
LPS-cross-reactive antibodies, possibly only in the LPS inner core region.
Alternatively, in patients M.C.C. and M.C.M. the concerted changes in antibodies
with a wide range of anti-LPS reactivities might reflect endotoxaemia caused by a
mixture of LPS from different bacterial strains, while the more restricted specificity
of the changing anti-LPS antibodies in patient B.S. might reflect a more
homogeneous source of endotoxin. In these cases, in vitro absorption studies were not
carried out to attempt to identify the range of specificities of the anti-LPS-CGL
antibodies in these sera at different times. Definition of the specificities,
cross-reactivities, and range of anti-LPS antibodies that change in relation to
endotoxaemia in such cases might reveal antibodies whose protective properties
should be investigated.
Schedel [32] has reported that in Gram-negative bacteraemia low anti-LPS-CGL
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antibodies together with rising or constant endotoxaemia are associated with early
mortality. Other studies of anti-LPS-CGL antibodies in Gram-negative bacteraemia,
where endotoxin levels were not measured, also indicate a poor prognosis if
anti-LPS-CGL antibodies are low [33,34]. Our studies on these three cases of
endotoxaemia without detectable Gram-negative bacteraemia appear to indicate that
depression of circulating antibodies to the LPS-CGL may reflect consumption of
anti-LPS-CGL antibodies by endotoxin, followed by appearance of detectable levels
of endotoxin in the peripheral blood. These studies are supported by the observations
of Wessels et al. [35] following induction of shock in primates after infusion of E.
coli, where bacteraemia was short lived, but developing and sustained endotoxaemia
was accompanied by a sustained reduction in intrinsic plasma IgG anti-LPS
antibodies.
It also appears that the resurgence of certain anti-LPS-CGL antibodies may
occur during endotoxaemia and precedes rather than coincides with the disappearance
of circulating endotoxin. We may speculate that rising anti-LPS-CGL antibodies may
reflect stimulation of secondary humoral responses to endotoxin and that increased
output of such antibodies may contribute to the disappearance of circulating
endotoxin. While humoral immunity to LPS tends to be viewed as predominantly
T-cell independent and refractory to establishment of secondary memory responses,
it may be that this only applies to immunity to the repeating polysaccharide units of
the O-chain of smooth LPSs. Secondary immunity to cross-reactive components of
endotoxin cores, capable of rapid elicitation in response to endotoxin challenge, may
be a necessary component of the host defence against endotoxaemia [20]. We have
found that immunity to LPS-CGL can be established in rabbits immunised with either
rough or smooth Gram-negative bacteria and that rapid-recall anti-LPS-CGL IgG
antibody responses can be elicited following subsequent challenge with different
strains of Gram-negative bacteria [31]. In one of the above cases (patient B.S.), the
endotoxaemia was followed by irreversible multiple organ failure and death. In such
cases, supplementation of intrinsic immunity by passively administered antibodies of
appropriate anti-LPS-CGL specificity prior to or during endotoxaemia might result in
prevention or more rapid resolution of endotoxaemia and a consequent reduction in
sustained organ failure and mortality in septic shock. Our current studies, on
antibodies from "naturally immune" blood donors and on LPS-cross-reactive mono¬
clonal antibodies, aim to investigate the therapeutic potential of passively
administered antibodies for treatment of Gram-negative sepsis.
The LPS occurring naturally in Gram-negative bacteria is of heterogeneous
chain length, ranging from smooth forms of various chain lengths to complete
unsubstituted core (Ra chemotype). Smaller rough LPS, useful for serological
studies, occur in bacterial mutants that are too serum-sensitive to survive in a host, so
that the natural serology of anti-LPS antibodies arises as a response to these larger
forms of LPS. The serology of Gram-negative LPS is complex, and the precise
structures of these LPS have not been fully resolved. The relationship between size
and conformation of rough LPS and the effect of this on expression of
three-dimensional epitopes is not understood. The effects of purification and
presentation for immunoassay may also alter LPS epitope expression. Our novel
ELISA, in which LPS is complexed to polymyxin B, appears to counteract some of
the effects of LPS presentation in immunoassay. The LPS-polymyxin complexes
detect anti-LPS-antibodies not detected by ELISA based on purified LPS alone, and
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the complex may mimic LPS structures found when LPS is naturally complexed with
bacterial outer membrane proteins or serum proteins, which are the most likely form
of presentation of LPS to the host's immune system [20,36,37], Similar enhancement
of detection of anti-LPS antibodies in ELISA can be achieved with other cationic
proteins complexed with LPS [37]. Such assays may assist in determining the precise
specificities of any anti-LPS-CGL antibodies showing protection against the
physiological effects of endotoxins.
A number of reports have tended to emphasize the importance of anti-lipid A
antibodies in Gram-negative septicaemia [30,32] or have examined antibodies to
individual R-LPS [16,22], Our studies suggest that cross-reactive IgG antibodies to a
variety of epitopes in the endotoxin core are prevalent in normal sera [20,30,35] and
can be depressed during endotoxaemia in Gram-negative septic shock. While this
report is restricted to three well-documented cases, other recent studies by us of
different clinical conditions (to be published) have provided us with evidence that
depression of anti-LPS-CGL cross-reactive IgG antibodies during endotoxaemia may
be a common phenomenon. In these cases of septic shock, it appears probable that the
decrease in serum anti-LPS antibodies represents their consumption, equivalent to in
vivo absorption, either by endotoxin or source Gram-negative bacteria derived either
from an infective focus or endogenously from the gut [1,8,9].
This study's primary aim was to determine whether IgG anti-LPS antibodies
became reduced in septic shock, and to begin to investigate systematically the
appropriate specificities of antibodies that might be replaced by passively
administered IgG anti-LPS antibody of the same specificity, obtained from plasma of
selected blood donors who show high natural levels of such antibodies. Recent studies
have suggested that sera from humans or animals deliberately immunized to produce
antibodies to the S. minnesota Re LPS core are cross-protective against bacteraemia
and endotoxaemia when given passively to animals, but that the protection was
provided by the IgM component, and not the IgG component, of immune sera
[38,39]. Although these reports infer that the pursuit of a suitable gammaglobulin for
passive immunotherapy of septic shock from immunized donors may be in vain, it
may be that "naturally immune" IgG from selected blood donors may have a different
range of anti-LPS specificities and protective properties from "Re-immune" IgG or
IgM. However, these reports emphasise the need for further characterization of the
properties of anti-LPS antibodies and for determination of whether they offer
protection against endotoxic shock. Our study shows that certain IgG antibodies do
show changes that appear to be related to episodes of endotoxaemia and supports our
continuing investigation of the properties of "naturally immune" blood donor plasma
required for selection for preparation of hyperimmune anti-LPS-CGL gammaglobulin
for passive immunotherapy of septic shock.
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IgG Antibodies to Gram-negative endotoxin in human sera. I.
Lipopolysaccharide (LPS) cross-reactivity due to antibodies to
LPS core
Boyd B. Scott*1, G. Robin Barclay1, David G. E. Smith2, Frances McLoughlin2
and Ian R. Poxton2
1 Regional Blood Transfusion Centre and Department of Transfusion Medicine, Royal
Infirmary and ''-Department of Bacteriology, University of Edinburgh Medical School,
Edinburgh, Scotland, U.K.
A series of 700 blood donor sera were screened for IgG antibodies to the core of
Gram-negative bacterial endotoxin with a quantitative enzyme-linked immuno-
sorbent-assay (ELISA), based on a cocktail of incomplete-core R-LPS from four
different Gram-negative bacterial species, and further serum samples were obtained
from donors exhibiting a range of different reactivity for isolation of serum IgG.
Analysis of the different IgG samples by ELISA employing a panel of individual LPS
from 31 different Gram-negative bacteria covering a range of species, serotypes and
R-LPS chemotypes showed that high-titer sera from the screening ELISA expressed
IgG with multiple reactivity to LPS in the complex ELISA. We investigated this
multiple reactivity in three serum IgGs by inhibition and absorption of isolated serum
IgG ELISA reactivity to R-LPS, employing purified LPS and whole bacteria
respectively. In two cases the ELISA reactivity appeared to be predominantly
attributable to a single antibody component directed to the inner LPS core structure
in the lipid A to KDO region. For the third serum IgG, the results suggested that the
cross-reactivity may be attributable to more than one specificity-group of cross-
reactive antibodies, although still restricted to the LPS inner core structures.
Keywords'. IgG, endotoxin, LPS-core, ELISA.
Introduction
The potential of antibodies to Gram-negative bacterial outer membrane lipopolysac¬
charide (LPS) for passive immunotherapy of Gram-negative bacteraemia and endotox-
aemia has attracted many investigators1-2. While antibodies to LPS polysaccharide chain
(O-serotype specific) can be potently bactericidal3-4, their clinical usefulness is restricted
by the wide variation in LPS O-serotypes5. Antibodies to the relatively conserved core-
glycolipid region of LPS might show wide cross-reactivity, and might present the best
potential for immunotherapy by inhibiting the endotoxic activities of LPS, associated
predominantly with the lipid A region of the LPS core-glycolipid6'7.
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Three prospective sources of cross-reactive anti-LPS antibodies for passive immuno¬
therapy have been cited in the literature: (i) immune plasma for immunized volunteers6-7;
(ii) plasma of naturally immune blood donors8-13; and (iii) monoclonal antibodies raised
against the core-glycolipid3,14-18. The first two sources have been used with demonstrated
clinical benefit. However, immunization with LPS core, e.g. on rough (R) mutant
bacteria, can produce a dominant R-LPS specific antibody response instead of cross-
reactive anti-LPS responses20,21: this problem also arises in the production of monoclonal
antibodies. If suitable high-titer donors can be identified then 'natural' anti-LPS
antibodies obtained from healthy adults may represent a good source of therapeutic
antibodies. Current plasma fractionation techniques best support the production of
immunoglobulin G (IgG) antibodies from plasma, and we have therefore focused our
studies on this class of antibodies.
The relationship between cross-reactive antibody specificities and clinical efficacy
remains to be conclusively established. Neither the structures of the shared epitopes to
which cross-protective antibodies are directed nor the means by which they confer
protection, either intrinsically or as passive immunotherapy, in different clinical aspects
of Gram-negative bacteraemia and septic shock, are fully defined2. We have recently
demonstrated depression of intrinsic serum IgG antibody levels to structures in the inner
LPS core region during endotoxaemia in patients with Gram-negative septic shock,
while their antibodies to LPS structures in the outer core or O-polysaccharide region can
remain unaltered during these episodes19. Thus the passive administration of similar
cross-reactive IgG antibodies to LPS inner core during endotoxaemia might mediate
some clinical benefit by reducing the level or duration of endotoxaemia and its
subsequent clinical effects.
In a previous study we found that IgG antibodies with apparent LPS-cross-reactivity
and endotoxin core specificity were common in healthy adult human sera23. We now
report a study in which we investigated the extent of IgG reactivity to a panel of 31 LPS
from different Gram-negative bacteria, encompassing a range of rough chemotypes (R-
LPS) and a selection of smooth serotypes (S-LPS), to define the range of specificities to
the LPS core that exist in such sera. Random blood donor sera were screened in a
quantitative ELISA for levels of IgG antibodies to a cocktail of selected R-LPS. Follow-
up sera were obtained from 32 donors selected to show different levels of reactivity in the
screening ELISA, and IgG was isolated from sera and evaluated for reactivity to the
panel of 31 different LPS by ELISA.
Individuals' sera which showed strong reactivity in the screening ELISA tended to
show multiple LPS reactivity to most of the 31 LPS in the panel. To investigate whether
the multiple reactivity observed was due to cross-reactive antibody, we attempted to
define common structures in the LPS core to which the IgG reacted by absorbing out
reactivities from IgG isolated from three different individuals' multiply-reactive sera.
Absorptions were made with different Salmonella minnesota and S. typhimurium rough
mutant bacteria with R-LPS of different chain lengths ranging in size from lipid A to
complete core. These were employed sequentially in both ascending and descending
LPS-size sequence. ELISA inhibition studies were also performed with purified LPS. In
an accompanying paper, we report the effects of absorption of anti-LPS core antibodies
on serum reactivity with smooth (S) bacteria and LPS24.
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Materials and methods
Lipopolysaccharides
The 31 purified LPS used in ELISA are listed below. The smooth LPS were purified by
phenol extraction after the method of Westphal & Jann25 and the rough LPS were
purified by phenol-chloroform-petroleum extraction after the method of Galanos et
alP. Certain LPS, including lipid A, were purchased from List Biologicals (California,
U.S.A.).
The following LPS were prepared in the Dept. of Bacteriology, University of Edinburgh:
S. typhimurium smooth (O) E. coli R1 (HF4704) (Ra)
S. typhimurium 1542 (Ra) E. coli R2 (EH 100) (Ra)
S. typhimurium 119 (Rb) E. coli R3 (F 673) (Ra)
S. typhimurium 878 (Rc) E. coli R4 (F 2513) (Ra)
S. typhimurium 1032 (Rd) E. coli C62 (Ra')
S. typhimurium 1102 (Re) E. coli 06 (O)
E. coli 016 (O)
P. aeruginosa PAC605 (Rb) E. coli 018K1 (O)
P. aeruginosa 01 (O) E. coli 018 (K1-) (O)
E. coli 086a (O)
K. aerogenes M 1 Ob (Rb)
The following LPS were purchased (List Biologicals):
S. minnesota smooth (O) E. coli OHLB4 (O)
S. minnesota R60 (Ra) E. coli K12 mm294 (Ra)
S. minnesota R345 (Rb) E. coli K12 D31m4 (Re)
5. minnesota R5 (Rc) E. coli ex-K12 diphosphoryl- lipid A
S. minnesota R7 (Rd)
S. minnesota R595 (Re)
S. minnesota ex-R595 monophosphoryl-lipid A
Bacteria
The bacteria used in these studies were as follows:
S. typhimurium 1542 (Ra) S1. minnesota R60 (Ra)
S. typhimurium 878 (Rc) 5. minnesota R5 (Rc)
S. typhimurium 1102 (Re) S. minnesota R595 (Re)
These were grown in tryptic soy broth (Difco) overnight at 37°C in a shaking incubator
then washed in Hank's buffered salt solution (HBSS) (Flow Labs) and finally resus-
pended at the desired concentration in HBSS.
Lipid A bacteria were produced by acid hydrolysis of 5. minnesota (R595) and S.
typhimurium (1102) Re mutants. These were acid hydrolysed after preparation as above
by incubating at 100°C in 1% (v/v) acetic acid for 1 h followed by washing in HBSS.
ELISA methods
(a) Quantitative screening ELISA. This assay was developed for screening blood
donor sera for recruitment of anti-LPS hyperimmune plasma donors. In brief, the
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ELISA employed a cocktail of four incomplete core R-LPS from different species of
Gram-negative bacteria (E. coli, P. aeruginosa, K. aerogenes and S. typhimurium)
complexed with polymyxin as below and mixed in equimolar proportions for coating on
polystyrene microplates. Test serum results were compared with a dilution curve of a
reference serum known to contain high-titer LPS-cross-reactive IgG antibodies. Samples
were tested at a 1:400 dilution. All tests were performed in triplicate, with a single control
antigen-negative well (see below). The ELISA was developed by urease-conjugated
sheep anti-human IgG antibody followed by addition of urease substrate (Common¬
wealth Serum Laboratories, England), and results were expressed as a percent of the
reference serum reactivity, calculated from the standard curve by processing microplate
reader (Titertek Multiscan) optical density (OD 585 nm) readings fed directly into a
microcomputer and using computer programmes developed by us.
(b) Complex LPS panel ELISA. The LPS-polymyxin ELISA was performed
essentially as described previously26 except that the LPS-polymyxin complexes were
formed by reacting LPS and polymyxin together at 01 mM and 0-2 mM respectively,
using the molecular weight (MW) of polymyxin and the approximate MWs of the
various LPS as reported by Morrison & Jacobs27 as a guide for our own calculations of
the LPS MW. LPS and LPS-polymyxin complexes were sonicated for 30 s. Complexes
were coated on to polystyrene microplate 8-well strips (Nunc 'polysorb'). Coated strips
were stored at — 40°C prior to use, and the complex ELISA assay panel was constructed
by assembling the 31 different coated strips across three ELISA plate frames for each
complete panel set. All solutions used in the ELISA procedure were made up with
pyrogen-free water containing 0 05% sodium azide.
Samples were measured in ELISA at a 1:100 dilution in duplicate against test antigen,
with a single negative-control well for each sample, post-coated with bovine serum
albumin only, as previously described26. Except where stated samples were reacted
simultaneously against the full panel of 31 LPS listed, and results were processed and
stored by microcomputer. Results are expressed as or derived from mean OD minus
negative control OD.
Purification of IgG from sera
IgG was purified from serum by ammonium sulphate precipitation followed by DEAE
cellulose column chromatography. Solid ammonium sulphate was added to serum to
50% saturation, and dissolved by stirring. The resulting precipitate was collected by
centrifugation at 10 000 g for 60min. The pellet was resuspended initially in a small
volume of 10 mM potassium phosphate at pH 6-8 then adjusted to the original serum
volume. This solution was then reprecipitated, centrifuged and resuspended as before.
The salt was removed by ultrafiltration by vacuum dialysis (Sartorius Collodion,
Membrane size 12400 MW cut-off) against three volumes of 10 mM potassium phosphate
and readjusted to the original volume.
Purification of the IgG from this solution was performed on a DEAE cellulose column
(Whatman DE52) equilibrated to pH 6-8 of the 10 mM potassium phosphate buffer. The
IgG peak was monitored by measuring column effluent absorbance at 280 nm. The
remaining immunoglobulins and serum proteins on the column were eluted by increas¬
ing the ionic strength of the buffer by the addition of 1 -4 m NaCl. The IgG peak was
reconcentrated to the original volume of each serum by vacuum dialysis, to restore the
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approximate physiologic concentration of IgG. Purity of IgG preparations was
measured by immunoelectrophoresis, and concentration determined by laser nephelo-
metry.
Inhibition and serial absorption protocols
Inhibition ofELISA by LPS. IgG, diluted 1:100 in ELISA dilution buffer, was mixed
with a polymyxin-LPS-complex (dilution as specified and prepared as described above)
and preincubated at 37°C for 1 h with occasional shaking before adding to the ELISA.
The mixture was treated in ELISA in duplicate against S. minnesota R5 (Rc) LPS (and
negative control).
Serial absorption of IgG on whole bactt
ascending and descending order of LPS
(1) Descending series
(A) S. minnesota R60 (Ra)
(B) S. minnesota R5 (Rc)
(C) S. minnesota R595 (Re)
(D) 5. minnesota lipid A
IgG were absorbed serially by bacteria in
: size in the following series:
(2) Ascending series
(A) S. minnesota lipid A
(B) S. minnesota R595 (Re)
(C) S. minnesota R5 (Rc)
(D) S. minnesota R60 (RA)
(3) Descending series
(A) S. typhimurium 1542 (Ra)
(B) S. typhimurium 878 (Rc)
(C) S. typhimurium 1102 (Re)
(D) S. typhimurium lipid A
(4) Ascending series
(A) S. typhimurium lipid A
(B) S. typhimurium 1102 (Re)
(C) S. typhimurium 878 (Rc)
(D) S. typhimurium 1542 (Ra)
Serum IgG solutions (1 ml), diluted 1: 10 in HBSS containing 0 05% sodium azide,
were added to Minisorb tubes (Nunc) containing sedimented washed bacteria at 107 cells
ml-1. Bacteria were resuspended in the IgG solutions and incubated for 15 min at room
temperature. The bacteria were then centrifuged at 1500# for 5 min. The supernatants
were removed to fresh tubes of sedimented bacteria and the process repeated. This step
was repeated three times for each absorbing bacteria (sufficient to maximally absorb
antibody on each bacteria), and an aliquot of IgG solutions was removed after
absorption by each strain of bacteria in the serial sequence, for ELISA tests.
The reactivity in ELISA of IgG, further diluted in the ELISA dilution buffer26 to give a
final dilution of 1: 100, was measured in duplicate with a background control well after
each step in each series against a panel of LPS (S. minnesota O (smooth), Ra, Rc, Re,
lipid A; S. typhimurium O (smooth), Ra, Rc and Re).
Results
Reactivity of IgG isolated from sera of blood donors to a panel of 31 different LPS in
ELISA
Randomly selected blood donor sera (700) were evaluated by the R-LPS cocktail
quantitative ELISA. Figure 1 shows the distribution of the results. Donors selected
across this range of distributions, from high through intermediate to low, were
approached for further samples of sera. A total of 32 volunteers each donated a further
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Figure 1 The distribution of IgG antibodies to a cocktail of R-LPS from four different Gram-negative
bacterial species (LPS core glycolipids, LPS-CGL) in sera from 700 randomly-selected healthy adults (Blood
donors) measured by a quantitative ELISA. Results are given as the numbers of donors with different anti-LPS
IgG antibody levels (levels are expressed as a percentage of ELISA reactivity of a high-titre anti-LPS-core
cross-reactive serum, used as the reference serum in the quantitative assay).
50 ml blood sample from which serum IgG was purified for study in isolation from other
immunoglobulin classes.
Purified IgG solutions from the 32 different blood donors' sera were evaluated in
ELISA against 31 different LPS. The results shown in Ligure 2 represent typical reaction
patterns found in this ELISA, namely multiple reactivity (MR), partial reactivity (PR),
and weak reactivity (WR). IgG MR-1, MR-2 and MR-3 [Pig. 2(a)] show strong
reactions with most or all of the 31 LPS antigens, and were all derived from the high
region of the distribution (>200%, Pig. 1). IgG PR-1, PR-2 and PR-3 [Pig. 2(b)] show
weak reactions with many of the LPS antigens but also a small number of stronger
reactions to some of the LPS antigens, and were derived from the mid-range population
(30-60%, Pig. 1). IgG WR-1, WR-2 and WR-3 [Fig. 2(c)] show only weak reactions or
no reaction, and were derived from the low region of the population (< 10%, Fig. 1). No
IgG failed to show some reactivity with at least some of the rough LPS antigens at the
dilution tested.
Sequential absorptions by whole bacteria of ELISA reactivity ofpurified serum IgG
to a range of Salmonella LPS chemotypes
Three multiply-reactive IgG preparations (MR-1, MR-2 and MR-3) were absorbed
sequentially with whole bacteria in each of the patterns listed in the methods. The
residual reactivity in the ELISA of each IgG after each stage of each series of absorption
was measured against purified LPS from S. typhimurium wild-type, 1542 (Ra), 878 (Rc),
1102 (Re), S. minnesota wild-type, R60 (Ra), R5 (Rc), R595 (Re), and lipid A. The
results, shown in Figures 3-5, show the percentage residual ELISA reactivity after each
absorption.
The results of these absorbance studies reveal a number of complexities which will be
discussed. However, with regard to the inner core regions of Salmonella LPS, it
appeared that the specificities of antibodies in IgG preparations MR-2 and MR-3 were
ax ELISA LPS' antigens
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Figure 2. The ELISA reactions to 31 different individual LPS of IgG isolated from sera of different
individuals with (a) multiple anti-LPS reactivity, (b) partial anti-LPS reactivity, and (c) weak anti-LPS
reactivity. The bars represent net ELISA OD readings (mean of duplicates, minus background) for each LPS.
St: Salmonella typhimurium, Sm: Salmonella minnesota, Ec: E. eoli, Pa: Pseudomonas aeruginosa, Ka: Klebsiella
aerogenes. Unless strain is prefixed by 'O', the LPS is rough.
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similar and largely absorbed out on Re or lipid A bacteria, while IgG preparation MR-1
appeared to be only partially absorbed on Re and lipid A bacteria and required Rc
bacteria for more complete absorption. A simple interpretation is that MR-1 contains
antibodies to both the lipid A/KDO region and heptose region of the LPS core while
MR-2 and MR-3 contain predominantly antibodies only to the lipid A/KDO region.
Antibodies to Gram-negative endotoxin I 33
IgG:MR—3
$. minnesota S. typhimurium
Residual ELISA % Descending Ascending
ELISA LPS
antigens
Absorbant:lpA Re Rc Ra non IpA Re Rc Ra
Residual ELISA % Descending Ascending
Absorbent:IpA Re Rc Ra non IpA Re Rc Ra
Figure 5.
Figures 3-5. Serial absorbtion of different serum IgG preparations with rough S. typhimurium or S.
minnesota bacteria with different size LPS, which were used in sequential steps in both ascending and
descending LPS size to absorb IgGs. Residual ELISA reactivities to S. typhimurium or S. minnesota S-LPS and
R-LPS at each stage of absorption are expressed as a percentage of the reactivity in unabsorbed IgG.
Comparing IgGs MR-2 and MR-3 (Figures 4, 5), the 'lipid A' acid-hydrolysed bacteria
absorbs antibodies from MR-3 better than from MR-2 which requires in addition Re
bacteria for more complete absorption. Thus, MR-3 may contain antibodies which may
be predominantly lipid A region specific while antibodies in MR-2 may be more KDO-
region specific.
Other features which were noted were as follows.
(i) Maximal absorption of antibodies binding to Ra and smooth (O) LPS was achieved
only for MR-2 and MR-3 anti-S. minnesota Ra and O LPS, on both S. minnesota and S.
typhimurium bacteria expressing LPS of most sizes (Figures 4, 5). In contrast, the same
IgG preparations expressed antibodies to S. typhimurium Ra LPS which were not readily
absorbed even on S. typhimurium Ra bacteria.
(ii) In IgG MR-3 (Figure 5), maximal absorption of antibodies to S. typhimurium LPS
is achieved with lipid A and Re S. minnesota bacteria whereas antibodies to S. minnesota
LPS require in addition the Rc bacteria from the S. minnesota series. MR-3 antibodies to
S. minnesota Ra were poorly absorbed by S. typhimurium LPS of any size.
(iii) In IgG MR-1 antibodies to S. minnesota (Figure 3), anti-Ra and anti-lipid A were
absorbed least while anti-Re and anti-Rc were absorbed best, on either S. minnesota or
S. typhimurium LPS. In contrast, in the antibodies to S. typhimurium LPS, anti-Ra was
absorbed better than anti-Rc, and the Rc antibodies were not well absorbed until Re
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(iv) In general, there was little difference between ascending and descending sequences
in the final ELISA reactivity of an absorbed IgG preparation for a given LPS after a
complete absorption sequence.
Inhibition by purified LPS (as LPS-polymyxin complexes) of ELISA reactivity of
purified serum IgG to S. Minnesota Rc LPS
The three multiply-reactive IgG preparations were also studied by inhibition of their
ELISA reactivity to S. minnesota R5 (Rc) LPS, which we have previously shown to be
the smallest LPS chemotype with which antibodies in most human sera commonly react
in an IgG ELISA21. Inhibitions were carried out with LPS complexed with polymyxin,
which we have shown to be a more efficient ELISA inhibitor than purified LPS alone28.
Maximal inhibition of IgG preparations MR-1, MR-2 and MR-3 (Figure 6) was usually
observed at the 1:40 dilution of the stock 01 mM LPS-polymyxin complex and fell with
dilution. For MR-1, the greatest inhibition was caused by S. minnesota R5 (Rc) LPS.
Inhibitor dilution
Inhibitory LPS:
S.minn Ra :~A-S.minnRc -«-S. minnRe
Figure 6. Inhibition of ELISA reactivity of different IgG preparations to S. minnesota R5 (Rc) after
preincubation with different size R-LPS complexed with polymyxin. Residual ELISA reactivity in the presence
of LPS is expressed as a percent of reactivity with no LPS. LPS inhibitor dilutions are from an original
concentration of 0-1 mM.
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Inhibition by S. minnesota 595 (Re) LPS reached its maximum at the two lowest
concentrations of inhibitor tested, and was then apparently saturated with no further
inhibition occurring at higher concentrations. Inhibition of MR-1 by R60 (Ra) LPS
increased less steeply with increasing concentration than for Rc LPS, but achieved a
similar degree of maximal inhibition at the highest concentrations tested. For MR-2 and
MR-3, the inhibition curves were similar for all three LPS chemotypes, with inhibition
increasing as the concentration of each LPS complex increased. Each LPS-complex
reached different degrees of maximum inhibition.
Discussion
The healthy adult population displays a wide range of levels of antibodies to LPS core
(Figure 1), and it may be that the individuals who can be identified with high levels of
such antibodies could provide a source of plasma for preparation of a therapeutic anti-
endotoxin gammaglobulin. Purified IgG from the 32 sera selected from high, medium
and low positions in this distribution analysed in ELISA revealed a number of features.
Amongst this group of IgGs there were greatly contrasting ranges of reactivities. We
found some IgGs which had strong multiple reactivity with all or most LPS in the panel,
e.g. IgG MR-1, MR-2 and MR-3 [Figure 2(a)]. The majority of IgGs investigated
reacted strongly with only a minority of LPS and weakly with most other LPS, e.g. IgG
PR-1, PR-2 and PR-3 [Figure 2(b)]. A third minor group of IgGs showed only weak or
negligible reactivities to these LPS under the ELISA conditions used, e.g. IgG WR-1,
WR-2 and WR-3 [Figure 2(c)], No IgG lacked reactivity with at least some of the rough
LPS antigens in this ELISA. Under more sensitive assay conditions, some human serum
IgG antibody reactivity can be detected to most LPS from different Gram-negative
bacterial chemotypes and strains (not shown). This is in agreement with previous reports
of antibodies to LPS, which were found to be widespread and common in the adult
population13.
Although these IgGs prepared from individual donors' sera may contain antibodies
with a range of anti-LPS specificities, it appears that they contain a major component
which is LPS cross-reactive. Although it is difficult to define individual specificities in
polyclonal IgG we hoped to identify the region in the LPS core to which the antibodies
were directed. Three serum IgGs identified as having strong LPS multiple reactivity by
ELISA, MR-1, MR-2 and MR-3 [Figure 2(a)], were evaluated in inhibition and
absorption studies to confirm the presence of LPS cross-reactive antibodies with
specificity for LPS core.
Considering only the absorption of anti-S. minnesota LPS responses by different
R-mutants of S. minnesota (Figures 3-5) and inhibition of anti-S1. minnesota Rc LPS
responses by S. minnesota LPS (Figure 6), it appears that IgG MR-2 and MR-3 have a
single predominant group of LPS-core cross-reactive antibodies directed to the deepest
core lipid A and/or KDO region, while IgG MR-1 has both this type of antibody and
another group of antibodies with reactivity beyond the Re-LPS chemotype size,
probably to the heptose region expressed on Rc-LPS.
When we consider the differences in absorptions and anti-LPS reactivities between S.
minnesota and S. typhimurium, it was found that while the results support the above
interpretation of the predominant anti-LPS antibody groups in these IgG preparations,
there are apparent differences between the 'equivalent' R-chemotype LPS of these
strains of Salmonella. In IgG MR-2 this difference is expressed to the outer-core region
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as differences in Ra serology, where different S. minnesota R-LPS, including Ra-LPS, do
not absorb antibodies to S. typhimurium Ra-LPS, and vice versa. In this case, the anti-S.
typhimurium Ra LPS antibodies are not well absorbed even by S. typhimurium Ra LPS,
while antibodies to both S. typhimurium and S. minnesota smooth LPS are absorbed on
either species Re LPS.
Complete (Ra) core LPS is co-expressed with S-LPS in Gram-negative bacteria which
may be encountered by the host, and probably stimulates LPS core 'type' specific
antibody responses of limited cross-reactivity. Such antibodies may not be depressed
during endotoxaemia in septic shock while antibodies to the LPS inner core are
depressed19. Since it is difficult to distinguish different antibody activities in polyclonal
sera in assays such as Western blotting, we cannot tell at this stage whether these LPS
outer-core type-restricted antibodies react only with the Ra LPS component from
smooth bacteria or whether they react with complete S-LPS expressing ©-polysac¬
charide chains. Evidence from our studies with monoclonal anti-LPS antibodies
(unpublished) suggests that both R-LPS restricted and S-LPS cross-reactive Ra-specific
antibodies can arise.
The failure of S. typhimurium Ra bacteria to absorb the antibody to S. typhimurium
Ra LPS appears to indicate that the antibody binding site is better exposed under the
conditions of the ELISA than at the absorbing bacterial surface. This also appears to
operate for antibodies to 5". minnesota Ra LPS in MR-1 and MR-3 IgGs. These results
appear to indicate differences between these Salmonella species LPS in the outer core
region. It was also noted that antibodies to S. minnesota lipid A were incompletely
absorbed: this may also be due to better expression of antigen under ELISA conditions
than on absorbing bacteria. In each case it may be that these natural antibodies from
human sera may arise after exposure to endotoxin rather than complete bacteria, since
they are poorly absorbed on bacteria but react well in LPS-polymyxin ELISA.
Other studies by us of inhibition of ELISA by LPS have been described in detail
elsewhere28, where it was found that purified LPS was a poor inhibitor of anti-LPS
antibodies in this ELISA, whereas purified LPS complexed with polymyxin is a more
efficient inhibitor of this ELISA. Crude LPS still complexed with bacterial outer-
membrane proteins, and purified LPS complexed with different polycations, including
polymyxin, or complexed with serum high-density lipoprotein, are also better inhibitors
of this ELISA than purified LPS (manuscript in preparation). The experiments in this
inhibition study were therefore performed using LPS-polymyxin complexes. This
phenomenon appears to be related to observations made in the development of this LPS-
polymyxin ELISA technique, where the LPS appears more accessible to 'natural'
antibodies in human sera in the complexed form than in a completely free state23. LPS
complexed to polymyxin may allow the LPS to mimic its natural conformation where it
is complexed to protein in the bacterial outer membrane29-30 or complexed to various
host plasma constituents or cells31-34.
Although it may not be valid to draw general conclusions from an analysis of such a
small number of sera, the results support earlier observations that sera contain
predominantly one of two kinds of cross-reactive families of anti-LPS-core antibodies,
(i) reactive with both Re-LPS and Rc-LPS ('anti-lipid A/KDO') or (ii) with Rc-LPS but
not Re-LPS ('anti-heptose')23. The cross-reactive element of IgG MR-2 and MR-3 has
been shown to consist primarily of the 'anti-lipid A/KDO' family of antibodies. The
identification of two major antibody specificities in IgG MR-1 is not in agreement with
earlier observations of apparent mutual exclusivity of these families of antibodies.
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However, since this study was conducted on three highly selected sera with high-titer
anti-LPS cross reactive antibodies, from the high end of the population distribution
(Figure 1), this serum may be exceptional.
We have established that selected sera with high-titer natural IgG antibodies specific
for LPS inner core and cross-reactive for Salmonella LPS can be obtained from the adult
population. However, it is important to establish the reactivities of such sera with
smooth Gram-negative bacteria commonly encountered in bacteraemia leading to septic
shock, in particular Escherichia coli species. Studies of the interactions of natural LPS-
core cross-reactive antibodies are reported in the accompanying paper24.
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A comparison of immunoblotting, flow cytometry and ELISA
to monitor the binding of anti-lipopolysaccharide
monoclonal antibodies
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This study was designed to assess the use of flow cytometry to observe the binding, under physiological
conditions, of anti-lipopolysaccharide (LPS) monoclonal antibodies (mAbs) to whole bacteria, and to
compare this with the more conventional whole cell ELISA and immunoblotting techniques. The bacteria
consisted of two clinical isolates of E. coli 018:K1 and 06:K5 and two isogenic mutants of the 018 parent:
a non-capsulate (018:K~) and a rough mutant (018rf). Two cross-reactive anti-core mAbs and one 018
0-antigen-specific mAb were used. ELISA and flow cytometry showed that capsule and O-polysaccharide
influenced the binding of mAbs to the bacteria, whilst the latter technique demonstrated that sub-popula¬
tions existed. Immunoblotting showed the two anti-core mAbs to be different, one bound only to core
which was not substituted with O-antigen, whilst the other bound both to substituted and unsubstituted
core. This comparison for monitoring the binding of anti-LPS mAbs demonstrates the potential use of
flow cytometry in bacterial cell surface research, and complements results obtained by ELISA and
immunoblotting.
Key words: Flow cytometry; ELISA; Immunoblotting; Lipopolysaccharide; E. coli; Monoclonal antibody
Introduction
Lipolysaccharide (LPS) or endotoxin is a major
constituent of the outer membrane of all Gram-
negative bacteria and is known to be responsible
for the range of pathophysiological features of
endotoxic shock. In general, LPS consists of three
regions: the outer O-polysaccharide - the com¬
position of which varies with the serotype of the
organism, the core oligosaccharide - which is less
variable, especially in the inner part, and the inner
Correspondence to: I.R. Poxton, Bacteriology Department,
University of Edinburgh Medical School, Teviot Place, Edin¬
burgh EH8 9AG, U.K.
lipid A - a highly conserved structure, responsible
for the toxicity and many of the biological activi¬
ties of LPS (Rietschel et al., 1984).
Limitations of existing therapeutic agents for
endotoxic shock have led to active investigation of
protective antibodies. It is thought that antibodies
directed against the conserved elements of the
core oligosaccharide and lipid A region of LPS
may be cross-reactive and possess anti-endotoxic
properties (Chedid et ah, 1968). An area of great
debate is whether antibodies can bind to these
inner regions of LPS in its natural states either on
the bacterial cell surface or bound to serum com¬
ponents in the circulation (Pollack et ah, 1989).
Flow cytometry has been used extensively to
analyse eukaryotic cell populations (Melamed et
0022-1759/90/S03.50 © 1990 Elsevier Science Publishers B.V. (Biomedical Division)
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al., 1979; Muirhead et al., 1985), although its
application to bacteria has remained limited. This
study was undertaken to assess the use of flow
cytometry for monitoring the binding of different
anti-LPS monoclonal antibodies (mAbs) to whole
bacteria, and to compare this with the more con¬
ventional techniques of enzyme-linked immuno¬
sorbent assay (ELISA) and immunoblotting.
Materials and methods
Bacteria and culture conditions
Four strains of Escherichia coli were kindly
supplied by Dr. A.S. Cross, Walter Reed Institute
for Army Research, Washington, DC, U.S.A. They
consisted of two clinical isolates (018:K1 and
06:K5 serotypes) together with two isogenic
mutants from the 018 parents: a non-capsulate
mutant (018:KC) and a rough mutant (018rf).
Cultures were grown in 100 ml filter-sterilised
nutrient broth (Gibco) in 250 ml conical flasks at
37 °C for 16 h in an orbital incubator. Cells were
harvested and washed twice in phosphate-buffered
saline, pH 7.4 (PBS). Total counts were made in a
haemocytometer (Thoma ruling).
Monoclonal antibodies
Monoclonal antibodies (mAbs) were prepared
by fusing spleen cells from immune BALB/c mice
with NSO myeloma cells by standard techniques
(Kipps and Hertzenberg, 1986). The reactivity of
the mAbs was determined by an LPS-polymyxin
ELISA method as described by Scott and Barclay
(1987). The 018-specific mAb was screened by its
binding to 018 LPS, while a cocktail of four rough
LPS was used as a primary screen for the anti-core
mAbs, followed by a broad secondary screen of
both rough and smooth LPS. Full details of the
immunisation of mice, selection of hybridomas
and characterisation of the mAbs are to be pub¬
lished elsewhere. Three mAbs with known
specificities in LPS-polymyxin ELISA were
selected for this study: mAb 0-1 (specific for 018
O-antigen), and mAbs C-l and C-2 (both cross-
reactive with core epitopes). Supernatant fluids of
hybridoma cell cultures grown in RPMI 1640 sup¬
plemented with 5% foetal calf serum in 150 cm2
flasks were used throughout. Cell cultures were
grown to maximum cell density and harvested at
50% cell viability. These three hybridomas gave
yields of approximately 50 pg/ml.
Preparation of LPS
LPS was prepared from whole washed bacteria
by the Proteinase K method of Hitchcock and
Brown (1983). The method is described in detail
by Hancock and Pox ton (1988). Briefly, bacteria
grown overnight were washed twice in PBS and
adjusted to an A525 between 0.5 and 0.6. After
centrifugation, the pellet from 1.5 ml of the
bacterial suspension was suspended in 50 jul of
sample buffer (2% SDS, 4% 2-mercaptoethanol,
10% glycerol, 0.002% bromophenol blue in 1 M
Tris-HCl pH 6.8) and heated for 10 min at 100 °C.
Proteinase K (25 pg in 10 jal sample buffer: pro¬
tease Type XI, Sigma) was added, and the mixture
incubated at 60 °C for 60 min.
SDS-PAGE
SDS-PAGE was performed on 14% acrylamide
slab gels with the Laemmli buffer system (Laem-
mli, 1970). Samples (10 pi for silver stain, or 20 jul
for immunoblotting) of the proteinase K LPS ex¬
tracts were loaded on to the gels. The LPS separat¬
ing gels were stained with silver by a method
developed by Tsai and Frasch (1982), modified by
Hancock and Poxton (1988). Briefly, gels were
fixed overnight in 200 ml of 25% propan-2-ol, 7%
acetic acid followed by oxidation in freshly pre¬
pared periodic acid. After frequent washing over 4
h in distilled water, fresh ammoniacal silver nitrate
solution (1.4 ml of ammonia solution, 21 ml of
0.36% NaOH, 4 ml of 19.4% AgN03 and distilled
water to 100 ml) was added for 15 min. Following
at least four washes in distilled water over 40 min,
gels were transferred to fresh 0.005% citric acid in
200 ml of 0.019% formaldehyde at 25 °C. On
development gels were washed repeatedly in dis¬
tilled water.
Immunoblot analysis
This was based on the method of Towbin et al.
(1979) as described by Hancock and Poxton (1988)
with Bio-Rad buffers and substrate. Electro-
phoretic transfer of LPS to nitrocellulose sheets of
a 0.2 pm pore size (Schleicher and Schuell) was
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performed at 12 V in electroblotting apparatus for
16 h at 4°C. After transfer, the nitrocellulose
membrane was washed in Tris-buffered saline
(TBS) for 10 min and blocked with 3% gelatin to
prevent non-specific binding of antibodies. A 1 in
10 dilution of culture supernatant fluids (shown
previously to give optimum staining) was added
for 3 h, followed by two 10 min washes in Tween
Tris-buffered saline (TTBS). After a 60 min treat¬
ment with an anti-mouse IgG/M/A -horseradish
peroxidase conjugate (Zymed), diluted 1 in 500,
membranes were washed in TTBS as before.
Freshly prepared HRP colour development re¬
agent was added and left for 30 min before wash¬
ing in distilled water.
Flow cytometry
Washed, overnight cultures of E. coli were re-
suspended to an A525 of between 0.5 and 0.6,
equivalent to approximately 1 X 108 cfu/ml. Sus¬
pensions (1 ml) were centrifuged at 10,000 X g in
a Microfuge (Beckman) for 2 min and the pellets
resuspended in 1 ml of mAb culture supernate,
diluted 1 in 10 in dilution buffer (see ELISA
methodology), and incubated for 60 min at 37 ° C.
Samples were washed twice in PBS followed by
addition of 0.5 ml, sheep FITC-conjugated anti-
mouse IgG (ICN) diluted 1 in 100 in dilution
buffer. After a further incubation of 60 min at
37 °C, samples were washed twice in PBS and
resuspended in 1 ml PBS containing 0.5% for¬
maldehyde. Prepared samples, diluted 1 in 50 in
PBS, were analysed in an EPICS 'C' (Coulter
Electronics) flow cytometer equipped with a 5 W
argon ion laser operating at 500 MW output and
exciting at 488 nm. Cells were passed through the
beam at approximately 500/s from a standard 76
(im flow cell tip. With the use of gates on the log
forward angle light scatter (LFLS) signal, both
background noise and clumps of cells were ex¬
cluded from the analysis. Cells stained with FITC
conjugate but no primary antibody provided a
background staining level which was set at 1 % +
0.5% by adjusting the voltage applied to the green
fluorescence log (GFL) photomultiplier tube. A
total of 50,000 cells were analysed from each
sample and the percentage of cells exhibiting
positive staining on GFL was calculated by the
EPICS 'Stat Pack' programme.
ELISA
Whole cell ELISA was based on the method of
Scott (1988). ELISA strips (Immuno module Poly-
sorp F8, Nunc) were coated with washed bacteria
(100 jttl/well) from a 16 h culture diluted with
coating buffer (0.05 M carbonate/bicarbonate pH
9.6 containing 0.02% sodium azide) to a con¬
centration of 2 X 107 cells/ml. Coating was pro¬
moted by centrifugation at 630 X g for 4 min and
leaving overnight at room temperature. Plates were
washed four times with PBS pH 7.2, containing
Tween 20 (0.05% v/v) and sodium azide (0.02%
w/v) and were then post-coated with bovine serum
albumin (5% w/v BSA) and sodium azide (0.02%
w/v) in PBS at 100 /id/well followed by overnight
incubation at room temperature. After washing
12 3 4
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Fig. 1. Silver-stained PAGE of proteinase K digests of E. coli
grown in filter-sterilised nutrient broth at 37° C for 16 h in an
orbital incubator. Track 1, 018:K1; 2, 018:K3, 018rf; and
4, 06:K5.
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four times, plates were rinsed in distilled water
and stored at — 20 ° C until used.
Dilutions of mAb supernatant fluids and con¬
jugate were made in dilution buffer consisting of
PBS, with Tween 20 (0.05% v/v), BSA (0.5% w/v),
polyethylene-glycol 6000 (4% w/v) and sodium
azide (0.02%). Antibody dilutions were added to
coated plates at 100 jul/well in triplicate and
plates incubated at 37 ° C for 90 min before wash¬
ing four times. Urease-conjugated sheep anti-
mouse Ig (Seralab) was diluted 1 in 500, added at
100 jul/well and plates incubated for a further 90
min at 37 °C. Plates were washed four times and
rinsed with distilled water before addition of
urease substrate (Seralab) at 100 ju,l/well. Plates
were incubated at room temperature and reactions
stopped by addition of thimerosal (1%) in distilled
water (20 /rd/well). Absorbances (A) were read at
590 nm in a Titertek Multiscan.
Results
Silver stain
The silver-stained SDS-PAGE profiles of LPS
from the four E. coli strains are shown in Fig. 1.
The LPS from the three smooth strains showed
the characteristic ladder pattern, with each band
differing in Mr by one repeating unit of O-anti-
gen. The rough LPS lacked any of the high molec¬
ular mass bands which corresponded to LPS sub¬
stituted with O-polysaccharide chains.
Immunoblots on LPS
Fig. 2. shows the reaction of the anti-LPS anti¬
bodies with the four LPS preparations in im¬
munoblots. The 018, O-antigen-specific antibody
(mAb 0-1), bound strongly to the high Mr bands
of both the smooth 018 strains but not to the 06
LPS (Fig. 2a). It also revealed a small amount of
high molecular mass O-antigen leaking from the
rough mutant of 018. Of the two anti-core mAbs,
mAb C-l bound only to the fast migrating species
that corresponded to the core glycolipid demon¬
strated on silver-stained gels (Fig. lb). Staining
was strongest for the rough E. coli LPS and
weakest for the E. coli 06. The reactivity of mAb
C-2 again was to the fast migrating core region,
but there was also binding to the high Mr, O-anti-
gen bearing molecular species of the smooth strains
(Fig. 2c).
Fig. 2. Immunoblots of proteinase K extracts of E. coli strains arranged as in Fig. 1. probed with an anti-018-specific mAb, 0-1 (a),
and two cross-reactive, core-specific mAbs, C-l (b) and C-2 (c).
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Flow cytometry on whole bacteria
Fig. 3. shows the binding of anti-LPS mAbs to
whole cells by flow cytometry. The reactivity of
the 018-specific mAb, mAb 0-1 is shown in Fig.
3a. The percentage of bacteria exhibiting positive
fluorescence above background levels was in ex¬
cess of 70% for the two smooth 018 strains, whilst
the E. coli 06 cells showed negligible binding. The
non-capsulate 018 strain showed two distinct
populations of cells, indicative of differences in
amount of antibody bound. The presence of small
amounts of O-antigen on the rough mutant is
again evident. The three smooth strains bound
anti-core mAb C-l and mAb C-2 antibodies at
less than 10% above background levels (Figs. 3b
and 3c). However, binding of mAb C-l to 018:K~
was almost double that of 018:K1. Percentage
binding to the rough mutant by mAb C-l was 84%
compared to a much lower figure of 14% for mAb
C-2.
ELISA on whole bacteria
The binding activities of the three mAbs to
whole cells in a urease ELISA system are shown in
Fig. 4. Reactivity of the 018-specific mAb 0-1
mirrored results of immunoblotting and flow cy-
Fluorescence intensity channel number X 10
Fluorescence intensity channel number X 10
Fig. 3. Flow cytometry. Green fluorescence intensity histograms of culture supernates of three mAbs against whole cells of four E.
coli strains, (018:K1; 018:K~; 018rf and 06:K5). a, b and c represent binding of the anti-018-specific mAb 0-1, and two
cross-reactive, core-specific mAbs, C-l and C-2 respectively. Percentage values represent bacteria exhibiting positive fluorescence
above background levels (indicated by vertical dotted line).
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Fig. 4. Binding activities of culture supernates of three mAbs
against whole cells of four E. coli strains in ELISA: 018:K1;
018: K~; 018rf and 06:K5. a, b and c represent binding of the
anti-018-specific 0-1, and two cross-reactive, core-specific mAbs
C-1 and C-2, respectively.
tometry. Smooth 018 strains had the highest Asgo
readings, whilst binding to the rough mutant re¬
flected the presence of some leaking O-antigen.
The binding of the mAb at high concentrations
was much stronger to the non-capsulate strain
than to the capsulate parent. The three smooth E.
coli strains all showed lower A590 values compared
to the rough E. coli when probed with dilutions of
the two anti-core mAbs, C-1 and C-2. Again, the
018 non-capsulate strain showed stronger affinity
for the anti-core mAbs compared to its capsulate
parent.
Discussion
The individual techniques used in this study
provide a means of assessing the binding specific¬
ity of anti-LPS mAbs. In combination, a much
more comprehensive picture can be built up of the
accessibility of endotoxin sites to antibody. Im-
munoblot patterns of proteinase K LPS extracts
against mAbs provide general information regard¬
ing their specificity. Indeed, the different reactiv¬
ity patterns of the two anti-core antibodies was
only apparent by immunoblotting. The ladder pat¬
tern or single core band effect reflected the bind¬
ing of C-2 to substituted and unsubstituted core,
and C-1 to unsubstituted core material only. It
should be noted that the binding of mAbs to
blotted LPS does not suffer from the loss or
denaturation of epitopes in the same way as pro¬
teins.
Results obtained by flow cytometry and ELISA
on whole bacteria showed that the absence of
O-polysaccharide side chains on the rough mutant
appeared to increase the accessibility of core LPS
to antibodies, resulting in better binding than to
smooth strains. This shielding effect by O-anti-
genic chains of LPS was also demonstrated by
Gigliotti and Shenep (1985). A comparison of the
ability of 018:K1 and 018:KC to bind antibody
suggests that capsule may have a role in masking
LPS binding sites. Flow cytometry, however, also
reveals further information about antibody bind¬
ing to LPS not detected in ELISA. Within a
population of cells showing positive fluorescence
an indication of the affinity of an antibody for its
antigen can be obtained. The presence of two
distinct populations of E. coli 018:K~ cells when
probed with 0-1 indicates possible differences in
structure or amount of LPS.
Flow cytometry offers a means of investigating
surface properties of individual cells in large num¬
bers with great speed and efficiency. The tech¬
nique also has the added advantage of analysing
cells in their natural form, devoid of potential
distorting influences present in other methods.
However, despite the unequivocal potential of flow
cytometric analysis of bacteria, it remains an un¬
der-used tool, still in its infancy. Phillips and
Martin (1988) used flow cytometry for the specific
detection of bacteria in aqueous samples. Their
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work established problems with background noise
as a result of stray light scatter in the optical
system, or possibly signals from sub-micron par¬
ticles in sheath fluids and PBS which had not been
removed by filtration. Selective gating near the
origin of the cytogram was not feasible in Philips
and Martin's study, although it was used in our
study to eliminate background noise.
ELISA is an established method for the detec¬
tion of antibodies to bacteria, offering advantages
of speed, flexibility and quantitative accuracy. The
apparent higher binding of anti-LPS mAbs to
smooth cells in ELISA than to flow cytometry
may reflect the better sensitivity of the whole cell
ELISA. However, in contrast to flow cytometry,
recent data (not shown) suggested that in some
instances the expression of coated whole cells on
ELISA plates differs from whole cells in suspen¬
sion, probably due to their alteration during bind¬
ing manipulations. Our results suggest that ELISA
has tended to over-emphasise the binding of anti-
core mAbs to whole cells. Indeed, Aydintug et al.
(1989) established that both the physical state of
bacteria and type of assay used affect the cross-re-
activity of an antibody.
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Monoclonal antibody (IIAb) probes were used to investigate the expression
of lipopolysaccharide (LPS) on four Escherichia coli strains, grown
under a variety of conditions in batch culture which mimicked some of
the in vivo environmental conditions of an infected host. Techniques of
silver-staining, immunoblotting, whole cell ELISA and flow cytometry
were all used to monitor the expression of LPS on the bacteria and the
binding of the anti-LPS MAbs. Growth in heat-inactivated sheep serum and
magnesium depleted conditions demonstrated increased expression of LPS
core and subsequent increased binding of anti-core MAbs. Magnesium-
depleted conditions also resulted in decreased production of 0-
polysaccharide material. Iron-depleted bacteria showed only minor
changes in LPS expression, although increased binding of anti-core MAbs
was observed. Nitrogen deficient/high carbon conditions, chosen to
promote capsule production, resulted in increased expression of 0-
polysaccharide and decreased binding of anti-core MAbs. The significance
and possible implications of these observations in relation to the use




The potential of antibody therapy for the prevention and treatment of
Gram-negative sepsis and endotoxaemia with anti-lipopolysaccharide (LPS)
antibodies has been intensively investigated recently. Much attention
has been focussed on the production and characterisation of monoclonal
antibodies (MAbs) to common epitopes of endotoxin in the LPS core.
There are many reports in the literature of the development of such
MAbs (Ziegler et al., 1991; Jongh-Leuvenink, 1990; Mayoral & Dunn, 1990;
Pollack et al., 1989). The therapeutic potential of anti-LPS MAbs is
however open to much debate (Heumann et al., 1991; Aydintug et al.,
1989; Chia et al. 1989). Concern exists as to whether it is possible for
these antibodies to bind to sites deep within the LPS molecule, either
when the LPS is bound to the bacterium or to host components such as
high density lipoprotein and endothelial surfaces, or "free" in mi¬
celles. A further complication exists by which the heterogeneity of 0-
polysaccharide chain length and degree of substitution of the LPS core
may affect antibody accessibility (Gigliotti & Shenep, 1985).
We have shown recently that it is possible, with a combination of ELISA
and flow cytometry, to use monoclonal antibodies to detect LPS expres¬
sion on whole bacteria (Nelson et al., 1990). Results showed however,
that although anti-O-polysaccharide MAbs could readily be observed
binding to bacteria by both techniques, anti-core MAbs could be shown to
bind significantly only by the sensitive ELISA and not by flow
cytometry.
It is now well recognised that the growth environment of bacteria great¬
ly influences the phenotypic expression of surface characters (Smith et
al., 1991; McGroarty & Rivera, 1990; Kelly et al., 1989; Horse et al.,
1983). This study attempts to investigate with HAb probes the
expression of LPS on bacteria cultured in conditions which mimic those
in vivo.
HethocLs
Bacteria. Four strains of Escherichia coli were kindly supplied by
Dr.A.S. Cross, Walter Reed Institute for Army Research, Washington, DC,
U.S.A. They consisted of two clinical isolates (018:K1 and 06:K5 sero¬
types) together with two isogenic mutants from the 018 parent: a non-
capsulate mutant (018:K~) and a rough mutant (018Krf).
Culture conditions. The following growth media were used: a) Nutrient
broth (Gibco): filter-sterilised, b) Magnesium depleted: prepared as a
modification of the Halka minimal medium of Robert-Gero et al. (1979) as
follows: solution A, NaHPO^ (73.4 mg ml-*), KH2P04 (32.4 mg ml-*);
solution B, MgS04.7H20 (20.5 mg ml-*); solution C, 20% w/v glucose;
solution D, FeS04.7H20 (1.83 mg ml-*) in sterile distilled water to
which one drop of concentrated hydrochloric acid was added; solution E
(NH2)2S04 (50.0 mg ml-*). All chemicals were from BDH. Solutions were
prepared with sterile distilled water and were filter sterilised. All
solutions except C were stored over chloroform. To prepare one litre of
Malka, 20ml A, 20ml B, 20ml C, 1ml D and 20ml E added to 919ml sterile
distilled water. A magnesium depleted medium contained 0.17 mmol. L-*,
prepared by the addition of only 1% volume (0.2ml) of solution B used
for the standard minimal medium, c) Nitrogen deficient/high carbon
medium: prepared following the method of Sutherland & Wilkinson (1965)
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containing: lg yeast extract (Oxoid); lg casamino acids (Difco technical
grade); lOg Na2HP04; 3g KH2P04; 0.2g IIgS04.7H20; llg K2S04; lg NaCl;
O.Olg CaCl2; and O.Olg FeS04. The volume was made up to 1000ml with
sterile distilled water and autoclaved. To this, 20% w/v filter-
sterilised glucose solution was added to give a final concentration of
2% glucose w/v. d) Iron depleted: prepared by the addition of 150 pmol.
— 1 1
L 2,2 dipyridyl to Gibco nutrient broth, e) Heat inactivated sheep
serum (obtained from the Horedun Research Institute, Gilmerton Road
Edinburgh): serum was filter-sterilised (0.45pm pore size) and heat
inactivated at 56°C for 60 min and stored at -20°C.
Log phase starter cultures were prepared by growing in nutrient broth at
37°C for 4h before harvesting and washing twice in phosphate-buffered
saline, pH 7.4 (PBS). A 1% inoculum was added to each growth medium.
Cultures were grown at 37°C in 100 ml of each medium to early stationary
phase in an orbital incubator prior to harvesting and washing as above.
Monoclonal antibodies. riAbs were prepared by fusing spleen cells from
immune BALB/c mice with NS-0 myeloma cells by standard techniques (Kipps
and Hertzenberg, 1986). The reactivity of the MAbs was determined by the
LPS-polymyxin ELISA method of Scott and Barclay (1987) as described by
Nelson et al (1990). Full details of the immunisation of mice, selection
of hybridomas and characterisation of MAbs are to be published else¬
where. Three KAbs with known specificities in LPS-polymyxin ELISA were
selected for this study: MAb O-l, specific for 018 O-antigen, and two
cross-reactive anti-core MAbs (C-l and C-2), reactive to either core not
substituted with O-antigen (C-l) or to both substituted and unsubstitut-
ed core material (C-2) (for more details see Nelson et al., 1990).
Supernatant fluids of hybridoma cell cultures grown in RPHI 1640 supple-
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mented with 5% (v/v) fetal calf serum in 150 cm flasks were used
throughout. Cell cultures were grown to maximum cell density and har¬
vested at 50% cell viability. These three hybridomas gave yields of
approximately 50 pg/ml.
Preparation of LPS. LPS was prepared from whole washed bacteria by the
proteinase K method of Hitchcock and Brown (1983) as described by Han¬
cock and Poxton (1988). For each growth condition the density of washed
bacteria was adjusted to A525 of 0.5 prior to proteinase K treatment.
This allowed direct comparison of cells from each growth medium.
PAGE. PAGE was performed on 14% slab gels with the Laemmli buffer
system (Laeramli, 1970), except SDS was omitted from the stacking and
separating buffers. Samples (10 pi for silver stain, or 20 pi for immu-
noblotting) of the proteinase K LPS extracts were loaded onto the gels.
The LPS separating gels were stained with silver by a method developed
by Tsai and Frasch (1982), modified by Hancock and Poxton (1988).
Immunoblot transfer. LPS separated by PAGE was electroblotted to nitro¬
cellulose by the method of Towbin et al (1979) as described by Hancock
and Poxton (1988) with BioRad buffers and substrate. Nitrocellulose
membrane of 0.2 pm pore size was obtained from Schleicher and Schuell
and an anti-mouse IgG-Horseradish peroxidase conjugate used (ICN).
Antibody culture supernates were diluted 1 in 10.
Diluents and buffers used in ELISA. (1) Coating buffer consisted of
0.05M carbonate/bicarbonate, pH 9.6. (2) Post-coat buffer consisted of
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phosphate-buffered saline pH 7.2 (PBS) containing 5% (v/v) bovine serum
albumin (BSA) (ICN Biomedicals). (3) Wash buffer consisted of PBS con¬
taining 0.05% (v/v) Tween 20. (4) Dilution buffer consisted of PBS
containing 0.05% (v/v) Tween 20, 0.5% BSA and 4% (v/v) polyethylene
glycol 6000 (Sigma Chemicals).
All solutions contained 0.02% sodium azide.
ELISA procedure. ELISA strips (Immuno module Polysorp F8, Nunc) were
coated with washed bacteria after measuring optical density (OD) at
540nm and diluting with coating buffer to a concentration of 2x10 cells
ml~*. Coating was promoted by centrifugation at 630g for 4 min and
leaving overnight at room temperature. Plates were washed four times in
wash buffer, before post-coating with post-coat buffer at lOOpl per well
overnight at room temperature. After further washing, plates were rinsed
in distilled water and stored at -20°C until used.
HAb supernatant fluids were diluted in dilution buffer and added to
coated microplates at 100pl per well in triplicate. Plates were incubat¬
ed at 37°C for 90 min before washing four times with wash buffer.
Urease-conjugated sheep anti-mouse IgG (Seralab) was diluted 1 in 500,
added at 100^1 per well and plates incubated for a further 90 min at
37°C. Plates were washed four times and rinsed in distilled water before
urease substrate (Sera Lab) at lOOpl per well was added. Plates were
incubated for 60 min at room temperature and reactions stopped by adding
1% v/v thimerosal (Sigma) in distilled water (20pl per well). The OD of
wells was read at 590nm on an automated microplate reader Titertek
Hultiscan (MC, Flow Laboratories). Final results were expressed after
subtraction of the OD of negative control wells (coated with BSA post-
coat only) for each MAb.
Flow cytometry. Flow cytometry was based on the method described by
Nelson et al (1990). Briefly, washed cultures of bacteria were resus-
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pended to a concentration of ca. lx 10 cells ml . Pellets from 1 ml
were resuspended in 1 ml of MAb culture supernate, diluted 1 in 10 in
dilution buffer (see ELISA methodology), and incubated for 60 min at
37°C. After washing twice in PBS, 0.5 ml sheep FITC-conjugated anti-
mouse IgG (ICN), diluted 1 in 100 in dilution buffer, was added and
incubated for 60 min at 37°C. After further washing in PBS, the pellet
was resuspended in PBS containing 0.5% formaldehyde. Samples were dilut¬
ed 1 in 50 in PBS and analysed in an EPICS "C" (Coulter Electronics)
flow cytometer with a 5 watt argon ion laser operating at 500 mW and
exciting at 488 run. 50,000 cells at 500 cells.min-1 were passed through
the beam from a 76 pm tip. Background noise and clumps of cells were
excluded by a gate on the log forward angle light scatter. Percent cells
exhibiting positive staining were calculated with the EPICS "Stat Pack"
programme.
Results
Silver-staining and Immunoblot Analysis of Lipopolysaccharide.
Figs. 1-3 represent silver-stained PAGE profiles of LPS and their corre¬
sponding immunoblots from four E. coli strains grown under different
batch culture growth conditions. The three smooth strains showed the
characteristic ladder pattern, each step up representing LPS substituted
with a progressively increasing number of 0-polysaccharide repeating
oligosaccharide units. These were missing from the rough mutant. The
effect of each growth condition on the expression of LPS was compared
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with nutrient broth. Silver-stained profiles of LPS of proteinase K
digested whole cells grown in nutrient oroth, iron-depletea ana nitrogen
deficient/glucose enriched media are shown in Fig. la. LPS from iron-
depleted cells show only minor changes compared to the LPS from nutrient
broth grown cells, whilst cells grown in a nitrogen deficient/glucose
enriched medium showed an increased expression of both mid-range and
high molecular mass bands. Immunobiotting of transblotted gels against
HAb 0-1 (Fig.lb), demonstrates the specificity for the O-antigen of E.
coli 018 and small amounts of high molecular mass O-antigen leaking from
the rough mutant of 018. The immunobiot again illustrates greater ex¬
pression of O-antigen as well as an overall increase in O-polysaccharide
chain length for cells grown under nitrogen aeticiency. Probing with C-
2, an anti-core HAb reactive against both substituted and unsubstituted
core material showed no significant differences between growtn condi¬
tions (Fig.lc). PAGE of LPS from the four magnesium-depleted E. coli
strains show a significant increase in the expression of unsubstituted
core-glycoiipid material and other low molecular mass bands (Fig.2a).
Immunobiotting with HAb 0-1 showed similar expression of O-antigen for
both nutrient broth and magnesium-depleted conditions (fig 2b), whilst
probing with HAb C-2 further highlights a pronounced increase in core
LPS (Fig.2c). Growth in sheep serum resulted in greater expression of
both the fast migrating core region, as well as hign H , O-antigen
bearing molecular species of the smooth strains compared to growth in
nutrient broth (Fig.3a). Immunobiot analysis with HAb C-l, reactive only
with unsubstituted core material, and C-2 , demonstrates better expres¬
sion of predominantly rough form LPS when grown in serum (Figs.3b,c).
ELISA on whole bacteria.
The binding activities of the three MAbs to whole ceils of E. coli
strains 018:K1 and 018:K~, cultured under various growth conditions are
shown in (.Fig.4). No significant differences in binding of the anti-0
MAb to E. coli 018:K1 were detected for the different growth conditions
(Fig.4a). However, the non-capsuiate mutant E. coll 018:K~ snowed a
significant decrease in binding of MAb 0-1 to ceils grown under both
iron and magnesium limitation (Fig.4b). The 018 non-capsuiate strain
showed stronger affinity for both anti-core MAbs compared to its capsu-
late parent when grown under each growth condition Figs. 4c-f. Growth of
both E. coli strains in the nitrogen deficient/glucose enriched medium
resulted in lower binding of the two anti-core MAbs compared to growtn
in nutrient broth. Significant increases in 0DS9Q when both strains were
grown in serum and magnesium limitation and probed with MAbs C-l and C-2
were observed. A similar, yet slightly lower increase in binding of
anti-core MAbs was seen for growth under iron-limitation compared to
nutrient broth.
Flow cytometric analysis.
The effect of growth conditions on the expression of LPS on wnoie
bacteria was also investigated by flow cytometry. Flow cytometric
profiles, which relate to the intensity of fluorescence signal (,ie
antibody binding to bacteria), were obtained consistently in three
separate experiments. Examples of representative profiles are
illustrated in Fig. 5. The histograms produced by the interaction of the
018-specific MAb, 0-1, and cells grown in nutrient broth and a magnesium
depleted medium are shown in Fig. 5a. A 41% decrease in magnesium-
depleted bacteria exhibiting positive fluorescence above background
i u
levels compared to nutrient broth cells was observed. The biphasic
fluorescence pattern produced by magnesium-depleted cells demonstrated
the presence of two distinct subpopulations of E.coli 018:K1 on the
basis of differential binding by MAb 0-1. Probing the same cells with C-
1; a MAb reactive against unsubstituted core LPS, resulted in positive
fluorescence levels of 5% for nutrient broth and 29% for magnesium
depletion (Fig. 5b). Significant increases in the binding levels of both
anti-core MAbs, C-l and C-2 (a MAb reactive against both substituted and
unsubstituted core LPS) were also observed when E.coli 018:K~ cells were
grown in serum compared to nutrient broth (figs. 5c,d).
Flow cytometry data, showing the effect of growing all four E.coli
strains under the different growth conditions on MAb recognition of LPS
associated epitopes is presented in Table 1. Although relative differ¬
ences between growth conditions remained constant, day to day variation
in percentage labelling within a given sample was evident. Smooth cells
grown under serum and magnesium-depleted conditions again showed the
largest increases in binding of anti-core MAbs. Iron-depleted and nitro¬
gen deficient cells showed only minor differences compared to nutrient
broth grown cells. Probing cells with the O-antigen specific MAb result¬
ed in similar binding levels for most conditions, whilst magnesium
depleted cells, notably 018:K~ showed a significant decrease. Enhanced
binding of both anti-core MAbs, especially C-l, was observed against the
rough mutant, 018:Krf, compared to the smooth strains. Minor variations
between growth conditions of 018:Krf cells reacted with anti-core MAbs
favoured higher percentage labelling for bacteria grown in magnesium-
depleted conditions.
Discussion
The environmental modulation of cell surface components of both Gram-
positive and Gram-negative bacteria has been intensively investigated
(Brown & Williams, 1985). Among the environmental factors that commoniy
influence the properties of microbial cells, the availability of
essential nutrients assumes particular importance (Harder & Dijkhuizen,
1983). LPS is a major ceii surface component of all Gram negative
bacteria, and implicated as a cause of endotoxic shock (Ryan, 1985).
This study has examined the effects of a number of nutrient growth
conditions relating to those in vivo, on the accessibility and expres¬
sion of LPS antigens using flAbs.
Our results indicated that the expression of E.coli core LPS was in¬
creased when grown in magnesium depleted conditions (0.17 mmol. L , cf.
0.65-1.0 mmol. L-1 in serum). This was reflected in greater binding of
anti-core MAbs using techniques of immunoblotting, whoie cell ELISA and
flow cytometry. Magnesium is important in maintaining the stability of
the structural arrangement of larger molecules such as LPS within the
outer membrane of Gram-negative bacteria (Costerton et al., 1974). Cell
walls of magnesium-limited cells of bacillus subtilis showed an in-
creased Mg binding affinity over magnesium-sufficient cells (Meers &
Tempest, 1968). Thus, certain organisms may respond to magnesium limita¬
tion by improving their ability to bind the ions by increasing negative¬
ly charged cell surface components such as LPS. Using ooth batch and
continuous culture Day & Marceau-Day, 1982, also reported compositional
changes in Pseudomonas aeruginosa LPS in response to magnesium ion
concentration, reflecting functional alterations in the LPS. Data indi¬
cated a change in core size of LPS relative to the O-antigen component,
suggesting the possibility of magnesium having a regulatory role on one
or more of the LPS biosynthetic enzymes. An increased production of low
molecular mass LPS was seen for E. coli grown at intermediate growtn
rates under magnesium limitation (Doads et ai. 1987). The amino-sugar,
2-aminohexose was also found to be absent from the O-polysaccharide.
Flow cytometric analysis of E.coli 018:K1 grown under magnesium-depieted
conditions and probed with an 0-antigen specific MAb revealed two popu¬
lations of bacteria. Possible reasons for this include: differences in
the structure or amount of LPS; the amount of capsule (shown to be
inhibited under these conditions by Taylor et al. 1981), or morphologi¬
cal heterogeneity of bacteria grown under magnesium-depletion. The
composition of LPS from E. coli 018:K~ LPS was shown to differ from
nutrient broth grown LPS using nuclear magnetic resonance spectrometry
(unpublished data). As well as a decrease in the amount of O-polysaccha-
ride, rhamnose, a constituent of the 018-0-antigen, was found to be
replaced by an as yet unidentified sugar.
The low availability of iron is acknowledged as a key determinant or
virulence (Griffiths, 1987). Alterations in the outer membrane of many
bacterial species under conditions of iron-deprivation include the
production of high molecular mass, iron regulated outer membrane
proteins (Neilands, 1982). Little effect of iron-depletion on LPS
production was observed by silver-staining and immunoblotting. However,
increasing the degree of iron-deprivation led to a greater expression or
rough core at the expense of high molecular mass O-polysaccharide LPS
(data not shown). Indeed, binding of anti-core HAbs to wnole cells was
shown to improve by whoie cell ELISA (Fig. 2), although not
significantly using flow cytometry (Table 1). This may be partly
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explained by differences in the two techniques. Whilst ELISA may ofrer
greater sensitivity, flow cytometry allows the analysis of cells without
exposure to distorting influences present in other methods such as
ELISA, leading to improved accessibility to LPS antigens. Although
changes in the expression of LPS per-se have oeen illustrated, growth
under stress conditions such as iron and magnesium are likely to alter
the structure and composition of other components of the outer membrane.
Therefore, LPS core determinants normally showing limited accessibility
may become better exposed on the cell surface. Although this study
attempted to assess the binding of anti-LPS IlAbs to whole cells, release
of membrane fragments from cells must also be considered, indeed, varia¬
tions in growth conditions could alter the extent and nature of the
excretion of such fragments (Hoekstra et al. 1976).
The present findings also show a significant increase in binding of
anti-core IlAbs when smooth E. coll, especially the non-capsulate 018:K~,
were grown in heat-inactivated sheep serum (HSS). Immunoblotting, ELISA
and flow cytometry all showed marked increases in binding of IlAbs to the
core region, despite an apparent increase in the expression of O-antigen
as revealed by siiver-staining. The possible presence of endogenous
anti-LPS antibodies within the serum may have caused a false impression
of MAb binding. However, since MAbs were raised in a different species
to the serum used, antibody conjugates would only recognise mouse IlAbs,
and removing any anti-LPS antibodies from the serum by absorption had no
effect on results (data not shown). Thus HSS appears to alter the anti¬
genic expression of LPS to permit binding of IlAbs to the core region.
Chedid et al. 1968, proposed an enzymatic process within serum capable
of attacking ceil wall components, thereby unmasking the conserved rough
i <•i
antigenic structures.
Although capsule piays an important role in the serum resistance of many
bacteria (Leying et ai. 1990), it has been reported not to provide a
barrier function for binding of anti-0 antibodies to Klebsiella (Wil¬
liams et al. 1988) and some E. coli including 018 (Cross et al. 1986).
Indeed, binding of the anti-018 MAb to capsulate and non-capsulate
strains of E. coli 018 showed no effect due to the presence of capsule.
However, greater binding of anti-core MAbs to the non-capsulate strain
indicates capsules may have a function as a barrier for the penetration
of anti-core LPS antibodies. Growth under nitrogen-deficient/high carbon
conditions has previously shown to promote capsule formation (Sutherland
and Wilkinson, 1965). Reduced binding of anti-core HAbs to both capsu¬
late and non-capsulate bacteria grown under these conditions suggested
another factor, other than capsule exerting an influence. Indeed, an
observed increase in chain iength and production of O-polysaccharide was
revealed by silver-staining and immunoblotting (Fig. 1). Since 0-poiy-
saccharide is Known to reduce accessibility to core LPS (Gigliotti &
Shenep, 1985), a change in both its production and possible arrangement
may have strengthened this effect. A variety of growth conditions have
been shown to alter the expression of O-antigenic LPS molecules.
HcGroarty & Rivera (1990) demonstrated a dramatic decrease in the iength
of the O-specific LPS grown under a number of stress conditions, whilst
growth phase (Day & harceau-Day 1982) and growth rate (Dodas et al.
1987) have also influenced its expression. Such variability in the
expression of LPS polysaccharide formation may contribute towards a
bacterium's ability to adapt to changes in its environment. Since varia-
i 5
bles other than nutrient limitation have been shown to influence the
expression of LPS, it is acknowledged that in using the batch culture
model, the significance of altering one variable can not be divorced
with certainty from the influence of others.
The diversity of phenotypic responses to environmental conditions by
individual bacteria indicates that the expression of a microbe's genome
is selective (Koch, 1976). Microbes generally express only that part of
their genome that enables them to become structurally and functionally
adjusted to a certain set of conditions (Harder & Dijkhizen, 1983).
Implicit in this is the role of DNA supercoiling and its involvement in
the environmental regulation of gene expression, reviewed by Dorman
(1991).
Variation in the expression of LPS and other outer membrane components
in response to a changing environment has important implications for the
usefulness of anti-LPS MAbs as immunotherapeutic agents against
endotoxic shock. Exposure of increased numbers of specific antigenic
epitopes on the bacterial cell surface may increase the potential of
MAbs targeted towards conserved regions of the LPS molecule. However, in
vivo, LPS is thought to be present in a number of different forms
(Pollack et al. 1989), and the complex environmental conditions in the
infected host will be quite different from most laboratory conditions
(Brown & Williams. 1985). Whilst caution is always needed when relating
effects of in vitro growth to those in vivo, the possibility of similar
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Legends
Fig.l. (a) Silver stained LPS profiles of proteinase K whole cell di¬
gests of 4 E. coli strains, (018:K1, 018:K~, 018:Krf and 06:K5) separat¬
ed by PAGE (14% w/v acrylamide). (b,c) Immunoblots of the 4 E. coli
strains transferred to NIC paper and probed with (b) an anti-018 specif¬
ic liAb, 0-1, and (c) a core-specific liAb, C-2. Tracks 1-4, 5-8 and 9-12
represent 4 E. coli strains grown to early stationary phase in nutrient
broth, an iron-depleted medium and a nitrogen-deficient medium respec¬
tively.
Fig.2. (a) Silver stained LPS profiles of proteinase K whole cell di¬
gests of 4 E. coli strains, (018:K1, 018:K~, 018:Krf and 06:K5) separat¬
ed by PAGE (14% w/v acrylamide). (b,c) Immunoblots of the 4 E. coli
strains transferred to NIC paper and probed with (b) an 0-18 specific
liAb, 0-1, and (c) a core specific liAb, C-2. Tracks 1-4 and 5-8 represent
the four E. coli strains grown to early stationary phase in nutrient
broth and a magnesium depleted medium respectively.
Fig.3. (a) Silver stained LPS profiles of proteinase K whole cell
digests of 4 E. coli strains (018:K1, 018:K~, 018:Krf and 06:K5), sepa¬
rated by PAGE (14% w/v acrylamide). (b,c) Immunoblots of the 4 E. coli
strains transferred to NIC paper and probed with two core-specific liAbs,
C-l (b) and C-2 (c). Tracks 1-4 and 5-8 represent 4 E. coli strains
grown to early stationary phase in nutrient broth and heat inactivated
sheep serum respectively.
Fig.4. ELISA activity of three anti-LPS MAbs against whole cells of E.
coli 018:K1 (a,c and e), and 018:K~ (b,d and f), grown under different
growth conditions, a and b represent binding of an anti-018-specific
MAb, 0-1, and (c and d), and (e and f) represent binding of two core-
specific HAbs, C-l and C-2 respectively. Cells were grown to early
stationary phase in nutrient broth,H ., nitrogen deficient medium, a,
iron depleted medium, magnesium depleted medium, \l/a , and heat
inactivated sheep serum, a. Each histogram bar represents the mean
optical density value of three separate experiments carried out in
triplicate.
Fig.5. Green fluorescence intensity histograms of two anti LPS KAbs
against whole cells of 018:K1 grown to early stationary phase in nutri¬
ent broth and a magnesium depleted medium (a and b), and 018:K~ grown in
nutrient broth and a heat-inactivated sheep serum medium (c and d). a
represents the binding of a 018-specific MAb , 0-1; and b and c, a
core-specific MAb C-l; and d, a second core-specific KAb, C-2. Percent¬
age values represent bacteria exhibiting positive fluorescence above
background levels.
Table 1. Flow cytometric analysis of anti-LPS HAb binding to whole cells
of four E. coli grown under different conditions. Percentage values
represent the mean positive fluorescence of bacteria above background
levels from three separate experiments. MAbs include an anti-018, 0-
polysaccharide (0-1), and two anti-core HAbs (C-l and C-2).
* = mean ±SD































Table 1. Flow cytometric analysis of anti-LPS MAb binding to whoie cells
of four E. coh grown under different conditions. Percentage values
represent the mean positive fluorescence of bacteria above background
levels from three separate experiments. MAbs include an anti-018, 0-
polysaccharide (0-1), and two anti-core MAbs (C-l and C-2).
Percentage of cells showing positive fluorescence*
MAb Growth medium
Escherichia coli strain
018:K1 018:K- 018:Krf 06:K5
Nutrient Broth 70(±19) 62(±14) 2 (±1) ND
Nitrogen Deficient/ 73(±10) 68(±7) 13(±6) ND
High Carbon
0-1
Iron-Depleted 74(±6) 50(±3) 3(±1) ND
Serum 68(±15) 67(±8) 8 (±1) ND
Magnesium-Depleted 49(±9) 39(±9) 7 (±0) ND
Nutrient Broth 3(±1) 3 (±2) 68(±11) 7 (±1)
Nitrogen Deficient/ 2(±0) 2(±1) 56(±12) 1(±0)
High Carbon
c-l
Iron-Depleted 10(±7) 7 (±4) 66 (.±7) 7 (±3)
Serum 28(±16) 61(±11) 43(±14) 26(.±12)
Magnesium-Dep1eted 21(±4) 24(±5) 75(±13) 18(±8)
Nutrient Broth 2(±1) 6 (±1) 26(±11) 3 (±2)
Nitrogen Deficient/ 2(±0) 3(±1) 16(±6) 2(±1)
High Carbon
C-2
Iron-Depleted 3(±2) 8 (±3) 20(±5) 14(±9)
Serum 16(±5) 34(±11) 20(±12) 32(±8)
Magnesium-Depleted 12(±4) 18(±2) 28(±7) 10(±2)
* = mean ±SD ND = not done
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Isolation and purification of bacterial antigens have
been invaluable in a number of areas. These tech¬
niques have been used in both human and veterinary
medicine to help define the role of bacterial products
and cellular components in the pathology of infectious
diseases. Identification of antigens that elicit a protec¬
tive immune response is necessary for development of
effective vaccines. Many clinical diagnostic techniques
are based on detection of bacterial antigens, and
development of new methods continues, particularly
those for organisms that are difficult to culture
(brucellosis, legionnaires' disease) or for which there is
no suitable artificial medium (syphilis), and for early
detection of infective agents in paediatric medicine.
Development of methods for screening or epidemi¬
ological studies of infectious diseases requires highly-
purified, specific, antigens to reduce the possibility of
cross-reactions with antigens of closely related but
non-pathogenic species. Alterations in antigens fol¬
lowing exposure to antibacterial agents can provide an
insight into the mechanism by which the substance
kills or inhibits bacteria. Comparison of similar
antigens purified from closely related species can also
be ofuse to taxonomists in their classification schemes.
There are two general categories of bacterial
antigens: soluble products such as enzymes and toxins;
and those antigens that form part of the cellular
structure. Table 4.1 lists examples of these structural
components in Gram-positive and Gram-negative
bacteria and the mycobacteria. Fig. 4.1 is a diagram¬
matic representation of the surface layers of Gram-
positive and Gram-negative bacteria.
The body of this chapter is organized into three
main sections. The first section includes general con¬
siderations regarding growth of bacteria for antigen
production and cell fractionation, and a review of the
methods available for isolation of the different types of
antigens. In the second section there is a review of
methods available for identification of the different
chemical classes of antigens. The last section contains
specific recommendations for the application of these
methods.
Methods for isolation of bacterial antigens
Growth of bacteria
General considerations
The conditions under which micro-organisms are
grown markedly influence the production of extracel¬
lular products and their structural components. The
essential pH, temperature, oxygen requirements, and
nutritional characteristics must all be considered;
therefore a review of the physiology of the organisms
under investigation is highly recommended. Growth
in a simple synthetic medium may result in a low yield
of bacteria, or growth in different complex media may
alter the composition of antigens [1,2,3,4], There are
some microbes such as Mycobacterium leprae for
which there is no satisfactory artifical medium, and
bacteria must be collected from human or animal
tissues [5,6].
Production ofextracellular proteins
It is often difficult to produce extracellular enzymes
and toxins in laboratory media. Either yields are low
or there are problems in purification due to the
complex mixtures of protein digests and meat or yeast
extracts required for their production. Several
methods have been employed to overcome these
problems. Hollander [7] reported a method for pro¬
duction of large quantities of staphylococcal toxins on
solid media and Holme & Wadstrom [8] devised a
continuous culture method for these toxins. Other
methods include batch liquid culture with totally
diffusible media and media in which complex growth
requirements are added within a dialysis membrane to
facilitate subsequent purification [9].
4.1
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Table 4.1. Examples of structural bacterial antigens
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Fig. 4.1. Diagrammatic representation of the cell-surfaces of (a) Gram-positive and (b) Gram-negative bacteria. LP,
lipoprotein; LPS, lipopolysaccharide; P, protein; PL; phospholipid.
Production ofstructural proteins
Culture on solid medium, liquid batch cultures, and
continuous culture have been used successfully for
growing large quantities of bacteria for analysis of
structural components. The continuous culture
method provides carefully controlled conditions so
that the effects of nutrients [10] or dissolved oxygen
[11] on components can be assessed. It may also be
useful for investigating antigenic differences observed
between actively growing and synchronized resting
cells [12],
Radiolabelling of cells
Oeschger [13] has formulated a rich medium that
supports rapid growth and efficient radiolabelling of
proteins and nucleic acids that can be used for
auxotrophic mutants. Addition of yeast extract
treated with tyrosine carboxylase to a defined medium
was used to prepare a rich medium from which at least
98% of the tyrosine was removed. Tyrosine is not
usually an intermediate in any microbial metabolic
pathway and the labelled tyrosine added to the
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Tyrosine is rapidly taken up and used by prototrophic
strains of Escherichia coli. The enzyme tyrosine decar¬
boxylase is active at mild conditions (pH 5.5) and has
no requirements such as a metal cofactor. It is present
in the medium in minute amounts and does not
contribute significantly to its composition. Tyrosine is
commercially available as a radiochemical with high
specific activity.
Both radiolabeled uridine and thymidine can be
used in this medium to label RNA and DNA. It is
suggested that similar depletion of a specific com¬
ponent in a complex medium could be employed for
the labelling of fastidious bacteria and those
organisms for which there are as yet no defined media.
It is also possible to label the surfaces of bacteria
with radioactive iodine. Exposed tyrosine or histidine
residues may be iodinated with 125I-lactoperoxidase.
For an example of an application of this technique see
Lambert & Booth [157],
Isolation ofantigens
Introduction
The methods described below are, in the opinion of the
authors, the most suitable that are currently available.
There are, however, few defined recipes for the
preparation of bacterial antigens. A technique that is
well tried for one organism may not be satisfactory for
another closely related microbe.
Most methods are concerned with releasing the
antigen from the bacterial cell. Once this is released,
the purification steps are similar to those for any
biological molecule and standard biochemical sepa¬
ration techniques are employed. However, as a result
of their special properties as antigens, affinity chroma¬
tographic techniques based on antibody-antigen
binding (immunoadsorbent chromatography) are
recommended whenever feasible.
Cell breakage
It is often desirable to disrupt the bacterial cell and
fractionate sub-cellular particles before isolation of
antigens. Fractionation of Gram-positive cells tends
to be relatively straightforward as long as the presence
of the sometimes highly active autolytic enzymes is
acknowledged. Gram-negative bacteria are more diffi¬
cult because of their more complex cell surface. Many
different methods exist for cell disruption, but they can
be conveniently divided into four types. Detailed
accounts of these methods have been published
[14.15]. Equipment and materials are listed in Table
4.2.
Table 4.2. Commercially available equipment and
















* See appendix for addresses.
Mechanical methods
These methods include grinding with alumina in a
pestle and mortar, shaking with glass beads in a Braun
homogenizer [ 16] or Mickel Disintegrator [17], passing
the cells through a pressure cell. e.g. Hughes press [ 18],
X-press [19] or French-press [20], The grinding or
shaking methods often result in extensive fragmen¬
tation of the walls and membranes. As a consequence,
some particles are difficult to sediment by centrifuga-
tion. The advantage of the pressure cells is that the
whole envelope remains largely intact.
Ultrasonic treatment
A variety of apparatus is available for this treatment.
The resultant particles tend to be fragmented most by
this method.
In the two methods above, much kinetic energy is
given to the system, and efficient cooling is necessary.
This can be achieved by using pre-cooled containers or
placing the apparatus in ice/water or ice/ethanol
mixtures. Also, giving the system short bursts of
energy rather than continuous exposure is useful. The
Braun homogenizer incorporates a CCL cooling sys¬
tem. Freezing, except in the cases of the Hughes and
X-press, should be avoided so that agitation is not
impaired. A general rule is that coccal-shaped bacteria
tend to require much more energy for breakage than
rod-shaped cells.
Enzymatic methods
These include naturally occurring autolytic enzymes
which can be either purified and used specifically, or
allowed to work without purification in a controlled
manner. This latter method must be used with caution,
as modification of antigens often occurs. For most
purposes it is not recommended. Other enzymatic
4.4 Antigens
methods include the use of the peptidoglycan solubi-
lizing enzymes, lysozyme and lysostaphin. These treat¬
ments are recommended when protoplasts of Gram-
positive or spheroplasts of Gram-negative bacteria are
required, e.g. when preparing intracellular or mem¬
brane bound antigens. Protection against osmotic lysis
must be maintained during the treatment. However,
one of the major uses of such enzymes is not in antigen
preparation, but in the preparation of DNA or other
intracellular components or membranes for use in
biosynthetic studies.
Chemical methods
These include detergents and chelating agents. Their
action results in the destabilization of the membranes
of the bacteria allowing release of membrane com¬
ponents. As the peptidoglycan layer tends to remain
intact, there is no cell lysis; however, the combination
of lysozyme and EDTA is useful for lysing Gram-
negative cells. This method is described more fully
below.
Fractionation of the cell envelope
Depending on the scale of the purification scheme, for
economic reasons it is often necessary initially to
employ crude fractionation and concentration steps
followed by finer, often more expensive techniques. It
is difficult to make generalizations; each preparation
must be judged individually. Techniques, equipment,
materials, and applications of methods for cell frac¬
tionation are listed in Table 4.3.
Method for Gram-positive bacteria
Once the bacteria have been broken open, the cell-
envelope components can be fractionated. In Gram-
positive organisms, this is relatively straightforward.
The walls are collected from cells which have been
broken, preferably by one of the methods listed under
'Mechanical methods', by centrifugation at 20 000 g
for 15 min. The dense pellet of unbroken cells is easily
distinguished from the lighter cell wall layer above.
This wall layer is removed by careful washing with a jet
of water or by gentle scraping. The autolytic enzymes
must then be inactivated. It should be noted that this
inactivation will also destroy any surface proteins
present on the wall. A method for their preparation is
given below (page 4.6). Inactivation of autolytic
enzymes is accomplished by heating a suspension of
walls to 80 °C for a few minutes. The method ofchoice
is treatment of the suspension of walls at room
temperature with an equal volume of boiling 4-5%
(w/v) sodium dodecyl sulphate (or decyl sulphate),
followed by stirring for several hours at room tem¬
perature [21]. This inactivates the autolytic enzymes
and also solubilizes any non-covalently bound pro¬
teins,- lipids or carbohydrates from the wall. The walls
are washed free ofsodium dodecyl sulphate with water
by several cycles of centrifugation (20 000 g) at room
temperature. The sodium dodecyl sulphate is insoluble
at low temperatures, but the decyl sulphate is very
soluble and can be washed from the walls at low
temperatures.
The cytoplasmic membrane of Gram-positive bac¬
teria can be prepared in parallel to the walls if
necessary. The bacteria are disrupted by mechanical
methods, ultrasonic treatment or enzymatic methods.
It is necessary to have the concentration of divalent
cations (Mg2+ or Ca2+) at 25 mM throughout the
entire preparation in order that the integrity of the
membranes is maintained. After the walls have been
removed by centrifugation (20 000 g for 15 min), the
membranes are pelleted from the supernate by centri¬
fugation at 100000 g for 1 h. The pellet consists of
membranous vesicles of varying sizes.
Methods for Gram-negative bacteria
The fractionation of the envelope of Gram-negative
bacteria is more complex than that of the Gram-posi¬
tive. The separation of the rigid layer (peptidoglycan
and associated molecules) makes use of the inert
nature of this component. One method [22] involves
treating whole cells sequentially with 0.03 M-NaOH,
0.4% SDS shaken with glass beads, 90% phenol, and
finally more 0.4% SDS and glass beads. After extensive
washing the peptidoglycan and covalently bound
lipoprotein remain. If proteolytic enzymes are in¬
cluded in the preparation, pure peptidoglycan
remains. Another method [23] uses disrupted cells
which are treated with 2% SDS at 60 °C for 30 min.
This leaves insoluble peptidoglycan, covalently linked
lipoprotein and 'tightly associated' proteins which are
not covalently linked (see page 4.6).
Membranes from Gram-negative bacteria can be
prepared by two different approaches: one is based on
cell disruption by treatment with EDTA and lyso¬
zyme; the other depends on the differential solubiliza¬
tion of the membrane in detergents.
The original method for separating inner and outer
membranes of Gram-negative bacteria was developed
by Miura & Mizushima [24] and later modified by
Osborn et aL [25]. The first step involves the prep¬
aration of spheroplasts by treatment of log-phase
bacteria with lysozyme and EDTA at 4°C. The
resulting spheroplasts are lysed osmotically or by
ultrasonic treatment and the membranes are separated
on a sucrose density gradient. The resultant bands
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Affinity chromatography (F) Main supplier of supports—
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Chromatofocussing'™' (F) Pharmacia Proteins 126
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1 C = crude method, suitable for initial steps and large scale preparations.
F = fine, high resolution techniques, often expensive and difficult to use on large scale.
2 See appendix for addresses of suppliers.
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consist of a heavy band which contains lipopolysac-
charide and is the outer membrane and a series of two
or three lighter bands which are inner membranes. A
further modification which is said to be more repro¬
ducible and can be used on a large scale is that of
Yamato et al. [26]. After treatment of cells at high
density with lysozyme and EDTA, they are broken by
passage through a French pressure cell. The washed
membranes are layered on to 44% (w/v) sucrose and
ultracentrifuged. The inner membrane does not enter
the sucrose and forms a band above it. The pellet is
then layered on to a two-step sucrose gradient (52%
and 56% w/v). The band that forms between the two
concentrations is the outer membrane.
One of the authors (I.R. Poxton) has found that a
simple and satisfactory method of preparing outer
membranes from Gram-negative anaerobes is to sub¬
ject bacteria to 10 mM-EDTA at pH 7.3 at 45 °C for 30
min. The suspension is treated for 60 s in an ultrasonic
cleaning bath to detach the outer membranes. The cell
bodies are removed by centrifugation (20000# for 10
min) leaving the outer membranes as vesicles in the
supernate. The outer membranes can be recovered by
ultracentrifugation, or concentrated by ultrafiltration
or dialysis [27]. A similar method has been used by
Hofstra & Dankert for a range of enterobacteria [28].
The other commonly used method for preparation
of outer membrane proteins is based on that developed
by Schnaitman [29]. A crude membrane fraction is
prepared by EDTA/lysozyme or disruption of cells in
a pressure cell. The membrane pellet is extracted with
Triton X-100. The cytoplasmic membrane is solubi-
lized leaving the outer membrane as the insoluble
phase together with the peptidoglycan if the cells were
disrupted without lysozyme. This method has been
used widely for E. coli [30] and many other Gram-
negative bacteria [31,32].
A similar method was developed using the detergent
sodium lauryl sarcosinate (Sarkosyl) rather than Tri¬
ton. This solubilized E. coli cytoplasmic membranes
and allowed the outer membrane to be recovered by
centrifugation [33]. It has been used successfully to
prepare membranes of Pseudomonas aeruginosa (P.A.
Lambert, personal communication) and Bacteroides
J'ragilis (I.R. Poxton, unpublished results).
It has been noticed recently that outer membrane
proteins of Pseudomonas aeruginosa, which have been
prepared by detergent methods, are complexed with
LPS even after separation on SDS-polyacrylamide
gels. Some of the OM protein bands that stain with
Coomassie Blue can also be visualized with monoclon¬
al antibodies which are specific for LPS [161]. It is




These consist of the antigenic extracellular proteins
that are released into the culture medium during or
after growth of bacteria. 1 n the main they are enzymes,
but some proteins have properties which interfere with
biological processes of the host, e.g. neurotoxins and
those that inhibit enzyme reactions. Extracellular
proteins which have an adverse pharmacological effect
on the host are often referred to as toxins or aggres-
sins.
The isolation of extracellular proteins is compli¬
cated by the fact that they have to be purified from the
culture medium which normally contains a complex
mixture of protein digests and meat or yeast extracts
(see 'Production of extracellular proteins', where
methods and references for overcoming this problem
are listed).
The first step in purification of an antigen from the
culture fluid is almost always one of concentration.
The two most commonly used methods are
ammonium sulphate precipitation or ultrafiltration. If
apparatus for ultrafiltration is not available, concen¬
tration in a dialysis bag and drawing out water and
small molecules with Sephadex (Pharmacia), polyeth¬
ylene glycol or by evaporation may also be used. Once
concentrated, any of the standard biochemical tech¬
niques for protein purification can be used. To obtain
a high degree of purity with minimum effort, one or a
few of the most modern separation techniques for
proteins should be used. These methods include
affinity (or immunosorbent) chromatography, isoelec¬
tric focussing, Chromatofocussing (Pharmacia) or
Fast Protein Liquid Chromatography (Pharmacia)
(Table 4.3).
Bound protein antigens
Such proteins can be bound covalently or non-cova-
lently to components of the bacterial cell. The former
group include those covalently linked to peptidogly¬
can, e.g. Braun's lipoprotein [34] in the Gram-negative
enterobacteria and the antigens A and B of Strepto¬
coccus mutans [35]. Both of these can be recovered
from SDS-treated cell envelope preparations. The
non-covalently bound proteins include those present
on the outer surface of the wall of Gram-positive
bacteria and in the membranes of both Gram-positive
and Gram-negative bacteria. The former antigens can
be removed by a variety of treatments, depending on
how strongly they are bound to the surface. EDTA
treatment (10 mM) of whole cells has proved useful for
releasing weakly bound proteins [36] while 8 M-urea or
5 M-guanidine-HCl is required for removing proteins
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forming regular arrays on detergent-treated envelope
fractions of several Gram-positive organisms [37].
One of the major problems in isolating proteins
from membranes is to solubilize them without causing
denaturation. Various detergents have been tried. A
general rule is that non-ionic detergents produce less
denaturation than ionic detergents. Triton X-100 has
been used extensively. The detergent Empigen BB has
recently been used successfully for the isolation of
gonococcal outer membrane protein I [38] and for an
antigenically active protein from membranes of Borde-
tella pertussis [39], This detergent appears to be
particularly useful for the isolation of protein antigens
which are easily susceptible to denaturation.
Another problem inherent in the purification of
biologically active proteins (enzymes or toxins) is that
inactivation often parallels purification. Associated
molecules either in the culture fluid or structural
components appear to exert a protective influence.
Toxins often become toxoids, retaining their antigeni¬
city but losing their toxic properties.
Carbohydrate antigens
Exopolysaccharides
This term includes any polysaccharide polymer that is
found outside the wall of the Gram-positive bacteria
or outside the outer membrane of the Gram-negative
bacteria. The polymer can be a discrete capsule, of
varying dimension, which can be visualized in the light
microscope with India ink [40] or in the electron
microscope by staining with Ruthenium Red [41], It
can also be found as an extracellular slime layer, which
is readily sloughed off the surface into the surrounding
medium.
The ease by which exopolysaccharides can be
isolated and purified can vary greatly. The limiting
factors tend to be how much polymer is produced and
how firmly it is bound to the cell surface. The yield of
exopolysaccharide, probably more than any other
antigen, is greatly influenced by the conditions under
which the bacteria are grown.
For reviews on exopolysaccharides see refs. 42 and
43. Brief guidelines will be given here for their
production and isolation. To obtain maximum yield it
is usually worthwhile to attempt to prolong the
incubation time; many exopolysaccharides are pro¬
duced in stationary phase. Usually a rich medium is
better than a minimal medium; one with an increased
carbon source and a reduced nitrogen source. Passag¬
ing the organism in the peritoneum of a mouse prior to
culture is useful for selecting cells that produce
exopolysaccharide, because they are less readily in¬
gested by the peritoneal phagocytes. Growth on solid
medium rather than liquid medium often results in
higher yields of exopolysaccharide and also facilitates
subsequent purification.
Isolation of exopolysaccharide involves harvesting
the bacteria from solid medium by gently scraping the
cells into a suspension of physiological saline contain¬
ing 0.1% formaldehyde which fixes the cells and
inhibits autolysis. The exopolysaccharide must then be
removed from the cells. In the case of loosely attached
slime, this step is almost unnecessary as most of it
readily sloughs off. For more firmly attached capsular
material, blending in a liquidizer or blender is
required; the time depends on how firmly attached the
polysaccharide is to the cell. Monitoring is done by the
India ink method. Additional treatment with heat and
dilute sodium hydroxide is sometimes suggested; but,
if possible, their use should be avoided as subsequent
purification is made more difficult due to the release of
other macromolecules. The bacteria are removed from
the blended suspension by centrifugation; high g
forces (> 10 000 g) are often required due to the high
viscosity of the suspension. The exopolysaccharide is
precipitated from the supernate by the addition of four
volumes of ice-cold acetone or ethanol. Depending on
the nature of the polymer, complete precipitation may
require 16 h. The precipitate is sometimes collected by
winding it onto a glass rod; otherwise, low-speed
centrifugation is required. The precipitate is usually
washed several times in acetone, suspended in distilled
water, and lyophilized. Further purification may be
required and the reader should refer to the techniques
discussed by Sutherland [43], None of these techniques
have proved generally satisfactory. The large relative
molecular mass and the viscosity of the polysacchar¬
ides in solution hinders the development of satisfac¬
tory purification. Immunoabsorbent chromatography
or immunoprecipitation of phenol-extracted capsule
(see method for phenol extraction of lipopolysacchar-
ide on page 4.8) are possibly the methods of choice,
especially if an antiserum free of LPS antibodies or a
monoclonal antibody preparation for the polysac¬
charide is available.
Teichoic acids (also teichuronic acids and other
secondary cell wall polymers of Gram-positive bac¬
teria)
These polymers are defined as the carbohydrates that
are covalently linked to the peptidoglycan of the
Gram-positive cell wall. Many of these polymers are
true teichoic acids; they contain ribitol phosphate or
glycerol phosphate. Analogous polymers are found in
most, if not all, Gram-positive bacteria: the group-spe¬
cific carbohydrate antigen of Lancefield group B
streptococci [44], and the cross-reactive cell wall
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antigen of several Clostridia [45]. Traditionally such
polymers were extracted by treatment of whole cells
with cold 10% trichloroacetic acid (TCA), dilute
NaOH, dilute AW-dimethylhydrazine, and several
lytic enzymes [46], Now that the nature of the linkage
of the teichoic acid to peptidoglycan has been deter¬
mined [47], it is probable that hydrolysis of cell walls
with weak acid or alkali will result in the release of the
polymer.
The method of choice for their isolation is as
follows. Cell walls purified by SDS treatment (see page
4.4) at a concentration of 2-5% (w/v) are extracted
with either acid (10% (w/v) TCA for 48 h at 4 °C) or
alkali (0.5 m-NaOH 4 h at room temperature). The
TCA is removed by six extractions with equal volumes
of diethyl ether and the NaOH by de-salting on a
column of Dowex 50 (NH4+ form) resin. Initially,
extractions should be performed on a small scale to
check that the polymer is not labile to either acid or
alkali. Depending on the stability of the polymer one
or other method is chosen for large scale preparation.
Once extracted the polymers are purified by the
methods described for TCA extracted pneumococcal
C-carbohydrate [21] or NaOH-extracted teichoic acid
of Bacillus stearothermophilus [48].
Peptidoglycan
The preparation ofpeptidoglycan from Gram-positive
bacteria is performed by preparing pure cell walls by
extensive SDS treatment, followed by solubilization of
the secondary wall polymers as above. If the sole aim
of the treatment is to prepare peptidoglycan, it does
not matter which technique is used and it is preferable
to use NaOH (0.5 m for 16 h at room temperature is
probably sufficient). After extensive washing, pure
peptidoglycan remains.
Preparation of peptidoglycan from Gram-negative
bacteria has been described (page 4.4).
Lipocarbohydrates
Method for lipopolysaccharide (LPS)
The most widely used method for LPS preparation is
based on the aqueous phenol extraction which was
developed by Westphal, Luderitz & Bister [49],
1 Dried whole bacteria are suspended to an approxi¬
mate concentration of 5% (w/v) in distilled water and
heated to 68 °C. An equal volume of90% (w/w) phenol
also at 68 °C is added to the bacterial suspension. The
mixture is stirred at 68 °C for 15-20 min, cooled in ice
to aid phase separation, and centrifuged in glass or
polypropylene tubes in a swing-out rotor for 15 min at
a minimum of 3000 g. The upper aqueous phase
contains LPS, nucleic acids, and other polysacchar¬
ides. This solution is dialysed free of phenol against
running water for at least 16 h at 4 °C. If any
precipitate is produced, it is worth removing it at this
stage by low-speed centrifugation (10 000 g). The LPS
is recovered from solution by concentrating the extract
to about 10-20% of its original volume by rotary
evaporation; this encourages micelle formation of the
LPS. It is then collected by high-speed centrifugation
(100 000 g for 3 h) as a gelatinous pellet. The pellet is
washed in water by one or two cycles of high-speed
centrifugation and then lyophilized. Although this is a
standard method for LPS preparation, it should be
noted that the product is often contaminated with
nucleic acids and capsular polysaccharides. Further
purification, preferably by immunoaffinity techniques,
should be considered.
2 Some LPS molecules tend to be more hydrophobic
than the classical O-specific LPS of enterobacteria for
which the method above was developed. These hydro¬
phobic molecules have a higher proportion of lipid or
TV-acetylated sugars and would partition into the
phenol phase. Examples of such LPS molecules are
those from rough (R) mutants of enterobacteria or
some Neisseria spp. A method for the isolation of
rough mutants was developed by Galanos et al. [50].
Whole dry bacteria are homogenized with 90% (w/v)
phenol, chloroform, light petroleum (2:5:8) at
5-20 °C for 2 min. After removal of the bacteria by
centrifugation in glass tubes (3000 g for 20 min), the
chloroform and petroleum are removed from the
solution by rotary evaporation and the LPS precipi¬
tated by dropwise addition of water. The product of
this extraction is usually less contaminated with
nucleic acid and capsular polysaccharide than the
classic penol-water method. Glycolipids are, however,
likely to be present.
3 A combination of the phenol-water and phenol-
chloroform-petroleum methods has been used to
obtain 'pure' LPS [51]. The crude dialysed aqueous
phase obtained after initial phenol-water extraction
was lyophilized and re-extracted with phenol-chloro¬
form-petroleum as above. This produced a supposedly
pure LPS. The technique requires further investigation
and comparison with the preparation of the entero¬
bacterial common antigen discussed below.
Enterobacterial common antigen (ECA)
Although the presence of an enterobacterial common
antigen has been recognized since its discovery by
Kunin in 1962 [52], it has been isolated only recently
and its structure has been only partially determined. It
appears to be a hydrophobic carbohydrate made up of
a basic repeating unit of TV-acetylglucosamine and
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TV-acetylmannosaminouronic acid with 0-acetyl and
possibly some fatty acid substituents [53]. It is included
in this section on lipocarbohydrates because of its
hydrophobic nature and because it often co-purifies
with LPS when extracted by phenol-water.
1 From Salmonella minnesota by the method of
Mannel & Mayer [54]. The aqueous phase from a
phenol-water extraction ofwhole cells (see LPS above)
is dialysed and lyophilized. It is then extracted with
phenol, chloroform, and petroleum spirit as described
for rough LPS. After the LPS has been precipitated
from the phenol by the addition of water, the ECA
remains in solution in the water-saturated phenol. The
ECA is recovered after extensive dialysis, lyophiliza-
tion, solubilization in water, and clarification by
ultracentrifugation and chromatography on DEAE
cellulose, eluting with 1.0 m-ammonium acetate in
methanol.
2 From Shigella sonnei, ECA has been isolated by
the method of Lugowski & Romanowska [55]. Whole
cells are extensively disintegrated ultrasonically for 12
min in a buffer containing EDTA. Lysozyme is added
and ultrasonic treatment is continued for 6 min. After
stirring overnight at room temperature the suspension
is centrifuged. The supernate is retained and the pellet
re-extracted with water. Ethanol is added to both
supernates to a final concentration of 85% by volume.
Crude ECA is precipitated by the addition of acetone
and is finally purified by silica gel chromatography and
Sephadex LH20 chromatography (Pharmacia) with
organic solvents as eluants.
Lipoteichoic acids (LTA) and other membrane asso¬
ciated lipocarbohydrates of Gram-positive bacteria
All Gram-positive bacteria appear to possess a mem¬
brane associated lipocarbohydrate. The true LTA is
based on a poly-(glycerol phosphate) backbone with
glycosyl and alanyl substituents [46]. Other lipocarbo¬
hydrates are known, e.g. the lipomannans of several
Micrococcus spp. [56]. Although the lipid portion of
the molecule is integrated into the cytoplasmic mem¬
brane, the carbohydrate is expressed outside the cell
wall, both as an antigen [57] and as a component
involved in adherence to surfaces [58],
An extraction technique similar to the isolation of
LPS has been developed and evaluated by Coley et al.
[59]. Cells which have been defatted by treatment with
chloroform-methanol (2:1) overnight are extracted
with 40% (w/w) aqueous phenol at 4 °C or 60 °C. The
aqueous fraction is purified by nuclease treatment and
fractionation on Sepharose 6B (Pharmacia). The LTA
elutes from the column in the void volume. The
conclusion from this study [59] was that there was no
single general method available and that the polymer
was still contaminated with nucleic acids. However,
we have found that the membrane lipocarbohydrate
from such diverse organisms as Clostridium difficile
and Group B streptococcus can be isolated by the cold
phenol method [59] followed by treatment with DNase
and RNase at pH 5.0 in acetate buffer, partial
fractionation on Sepharose 6B, and final purification
on an immunoabsorbent column [45,60],
Appendages
Flagella
Parton's method for isolation of flagella from Sal¬
monella minnesota is given here as an example of this
technique. Sixteen-hour broth cultures (Oxoid
Nutrient Broth no. 2) grown at 37 °C were collected by
centrifugation at 4 °C, washed once in saline, and
resedimented. Growth at 44 °C prevents production of
flagella. Cells from one litre were resuspended in 50 ml
cold saline and blended in an MSE homogenizer at full
speed for 2 min with the flask cooled in an ice water
bath. The sheared cells were removed by centrifuga¬
tion at 10 000 g for 30 min at 4 °C. Flagella were
concentrated from the supernate by dialysis against
polyethylene glycol 4000 (British Drug House) or
collected by centrifugation at 100 000# for one hour
[61].
Further purified preparations can be obtained by
enzyme digestion of the flagella with trypsin and
ribonuclease followed by equilibrium density centrifu¬
gation [62].
Pili or fimbriae
Isolation of pili from Neisseria gonorrhoeae is given
here as an example. Organisms were grown on trays of
clear typing medium (GC Medium, Difco) at 36 °C in
an atmosphere of 5% (v/v) CO2. Colony types 1 and 2
are pilate but colony types 3 and 4 are not. A plate of
clear typing medium inoculated at the same time as the
trays can be examined by means of a stereomicroscope
with a double system of substage lighting [63] for the
presence of pilate colony types. Gonococci were
harvested into ice-cold ethanolamine/HCl (0.15 m, pH
10.5) and subjected to mild shearing in an Ultra-
Turrax homogenizer (Vortex Mixers, Hampton, Mid¬
dlesex) for 2 min. The organisms were removed by
centrifugation at 23 000 g for 30 min. The pili were
precipitated from the supernate by adding saturated
ammonium sulphate (made alkaline by the addition of
0.1 volume of tenfold concentrated ethanolamine
buffer) to give a final saturation of 10%. Pili were
recovered by centrifugation at 10 000 g for 1 h and
purified by further cycles of repeated disaggregation in
ethanolamine buffer and precipitation with
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ammonium sulphate to remove contaminants of outer
membrane bleb material. Pili were finally washed in 2
m-NaCl and stored at 4 °C in 1 m-NaCl containing 8
mm-sodium azide.
The purity of the preparation was assessed by
sodium dodecyl sulphate-polyacrylamide gel electro¬
phoresis on a separating gel of a linear 10-25%
acrylamide gradient [64,65]. Gels were deliberately
overloaded and no contaminant protein bands were
detected on staining with Coomassie Brilliant Blue
R250.
A number of fimbrial antigens have been associated
with pathogenesis of intestinal diseases caused by E.
coli: colonization factors, CFA I and CFA II, in
humans; K88 in piglets; and K99 in calves. Production
of these antigens is temperature dependent. Cells
grown below 18 °C do not express the fimbriae and
these have been used to produce specific antisera
against the fimbrial antigen by absorbing antisera
produced against the same strain grown at a higher
temperature. Lysine in the growth medium represses
the production of K99 and a minimal casein medium,
'minca' medium, is recommended [66], Minca medium
is composed of: KFI2PO4, 1.36 g; Na2HP04"2H20,
10.1 g; glucose, 1 g; trace salts solution 1 ml; casamino
acids (Difco) 1 g; agar (Difco) 12 g; distilled water,
1000 ml. Trace salts solution contained:
MgS04-7H:0, 10 g; MnCl2-4H20, 1 g; FeCl3-6H20,
0.135 g; CaCl2-2H20, 0.4 g; distilled water 1000 ml.
Extraction and purification ofeach of these antigens
has been described by a number of groups. Methods
for extraction are listed in Table 4.4. Altmann et al.
[67] report that all three antigens—K99, K88, and
CFA—as well as pili from Bacteroides (Fusiformis)
nodosus (the bacterium causing foot rot in sheep) were
extractable by their KSCN method.
Purification usually involves concentration of the
extracted pili by acid or ammonium sulphate precipi-
Table 4.4. Extraction methods for fimbrial antigens
Antigen Extraction method Refer¬
ence
CFA 3 m-KSCN, pH 7.1; 67
heating 60 °C, 20 min, followed by
homogenization 68
Homogenization in Waring blender.
4 °C, 4 min 69
K88 3 m-KSCN, pH 7.1; 67
shearing in Virtis mixer 30 min in
ice 70
K99 Heating broth culture 60°C; 71
homogenization; 72
3 m-KSCN, pH 7.1 67
Table 4.5. Purposes for which fimbrial antigens have been
isolated
Antigen Use Reference




molecular mass of pili 68
Serological properties and
chemical purification 73
K88 Determination of amino-acid
composition 70
K99 Chemical purification and
amino-acid analysis 67
Structure-function relationship






Heterogeneity of K99 antigens 76, 77
tation, followed by fractionation on Sephadex col¬
umns. Purity is assessed by SDS-PAGE and isoelectric
focussing. Table 4.5 lists three fimbrial antigens, the
purposes for which they have been isolated, and the
reference to the specific method.
Mycobacterial antigens
Janicki and co-workers from several independent
laboratories devised a system of identification and
nomenclature for mycobacterial antigens. The system
employs immunoelectrophoresis and polyacrylamide
gel electrophoresis and utilizes small quantities of
readily available reagents. The immunoelectrophor¬
esis reference reagents and nomenclature are some¬
times called United States-Japan reagents because
their production was sponsored by the United States-
Japan Co-operative Medical Sciences Program
through the National Institutes of Allergy and Infec¬
tious Diseases. They have been used by many investi¬
gators to identify their products and/or to relate their
methodologies to a common reference point. Arabic
numeral designations of antigens refer to the nomen¬
clature of Janicki et al. [78], Table 4.6 relates the early
fractions described by Seibert [79] to the United
States-Japan system.
There is no standard starting material for the
isolation of these antigens. Sterile filtrates of old,
autolysed cultures are available in large quantities and
these have been used for antigen preparation. Whole
cells or cell walls extracted to decrease their lipid
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Table 4.7. Growth factors affecting compo¬
sition of mycobacterial antigens
Age [80,81,82,83,84,85,86]
pH and medium [87, 88]
Temperature [83]
content are used for preparations from which cell wall
polysaccharides are to be recovered. Disruption of the
cells can be accomplished by grinding, pressure or
sonication; few antigenic differences in these cell
extracts could be detected [79]. Variations in growth
conditions result in differences in the antigenic compo¬
sition of culture filtrates. These are mainly quantita¬
tive rather than qualitative differences (Table 4.7).
The reader is referred to the excellent review of
Daniel & Janicki [78] for details of purification and
isolation of mycobacterial antigens. Methods for
purification of a number of these are listed in Table
4.8.
Ribosomal vaccines
The efficacy ofearly ribosomal vaccines was attributed
to the double-stranded RNA they contained, but
subsequent studies showed that they contained im¬
munogenic amounts of cell surface antigens. At least
part of their protective effects has been ascribed to
these contaminants [108,109], The mechanisms by
which these preparations induce a protective immune
response are not yet clear [110]. Three hypotheses have
been suggested: (1) all protection is due to contamina¬
tion with cell surface antigens; (2) ribosomal RNA
induces protective immunity in an as yet unidentified
manner; (3) the ribosomes act as adjuvant for cell
surface antigens [111],
Studies on ribosomal vaccines have had two pur¬
poses: to prepare a protective vaccine; and to identify
the protective component. The second aim is impor¬
tant in that if the first hypothesis is true, energies
would be better used in isolation of antigenic surface
components. The use of genetically defined strains of
organisms presents opportunities to prepare riboso¬
mal vaccines from which certain antigens can be
eliminated [108],
Monomeric ribosomes are usually required for
vaccines. Maintaining the isolated ribosomes in the
appropriate solution is vital for preventing their
dissociation or disruption into small subunits or
fragments. Purification of the monomers requires
balancing the removal of adsorbed or absorbed com¬
ponents with maintaining the integrity of the mono¬
meric ribosomes.
Disruption of cells by chemical lysis provides less
opportunity for cell wall components to adsorb to the
ribosomes. Chemical lysis of Pasturella multocida cells
resulted in less LPS contamination of ribosomes than
mechanical disruption [112], Lysis with specific
enzymes, such as the phage-associated lysin for speci¬
fic disruption of Streptococcus pyogenes [113], may be
effective in eliminating particular cell wall com¬
ponents.
Procedures for isolation of ribosomes for immuno¬
genic purposes are basically identical to those for
preparations used for biochemical and biophysical
analysis. A number of methods have been used for the
isolation of ribosomes and the removal ofcontaminat¬
ing material. Differential centrifugation was used in
early studies to preferentially remove the ribosomes
from the cellular extract [114,115]. Gel filtration and
electrostatic disruption were used as gentle methods
for purifying and maintaining the integrity of the
ribosomes [ 116,117,118,119],
A number of techniques have been used to remove
contaminating antigens from the ribosomes. Electro-
phoretic methods have not been successful because
many of the undesired antigens have net charges
similar to those of the ribosomes. Treatment with
specific enzymes, such as a phage-associated gly-
canase, has been used to degrade and remove capsular
carbohydrates from ribosomal preparations of Kleb¬
siella pneumoniae. Of particular value are techniques
of affinity chromatography using specific ligands for
adsorption of minute quantities of antigens. Ribo¬
somes are eluted over columns to which monoclonal
antibodies to the contaminating antigen have been
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Table 4.8. Selected major purification method for mycobacterial antigens
Antigen(s) Method Reference
Preparation of PPD; PPDs from
mycobacteria other than M. tuberculosis
Proteins A, B, C, and D and poly¬
saccharides I and II, none highly purified
Highly purified antigenic arabinogalactan
and arabinomannan; non-antigenic mannan
and glucan
Protein- and polysaccharide-rich
fractions, none highly purified
Protein- and polysaccharide-rich
antigenic fractions, none highly
purified
Protein- and polysaccharide-rich
antigenic fractions, none highly purified
Purified tuberculin-active peptide
Highly purified antigenic proteins,
low yields




Antigenic proteins. Highly purified
antigen 5
Glycolipid antigen




Alkaline extraction, ethanol 90,91
precipitation, ion-exchange
chromatography




Acid solubility, molecular 94
exclusion chromatography
Hydrochloric acid extraction 95, 96
and picric acid precipitation,
gel filtration, ion-exchange
chromatography
Serial ammonium sulphate 82, 97, 98,
precipitation, gel filtration, 99, 100
ion-exchange chromatography,
zonal electrophoresis
Acrylamide gel electrophoresis 101, 102
Concanavalin A affinity 103
chromatography
Immunoabsorbent affinity 104, 105, 106
chromatography
107
coupled. This has been successfully applied to the
removal of LPS from P. multocida ribosomes [120], It
has also been suggested that new methods may be
developed in which lectins are successfully used as the
immobilized ligand to remove carbohydrate contain¬
ing components.
Methods for determining the chemical content of
ribosomes with particular reference to analysis of cell
wall and membrane contaminants are described by
Gregory & Schechmeister [121], Phillips & Rimler
[120] have also described a formaldehyde fixing pro¬
cedure for the stabilization of ribosomal preparations
that also enhanced their role as immunomodulators.
The most recent recommendations for the prep¬
aration of ribosomal vaccines are those that minimize
contamination of the ribosomes by cell wall or
membrane antigens (chemical rather than mechanical
disruption) and removal of undesired components by
affinity chromatography procedures with specific
monoclonal antibodies. The limitations of these pro¬
cedures lie in providing conditions for affinity reac¬
tions to occur so that unwanted antigens are removed
but the integrity of the ribosomes is preserved.
Methods for the identification of bacterial antigens
This section is restricted to methods that may be used
for the identification and quantification of antigens
during and after their preparation. The methods used
for routine detection of free or bacteria-bound
antigens in the diagnosis of bacterial infections or in
epidemiological investigations by reference labora¬
tories are excluded. Details of these methods are found
in Volume IV.
Review ofmethods and their applications
A great variety of methods are available for the
identification of bacterial antigens. Early methods
included immunoprecipitation in gels and tubes, agg¬
lutination and haemagglutination tests, complement
fixation tests, and simple forms of immunoelectro-
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(1) Direct immunodetection on





High resolution method for detecting precipitating
antigens; quantification of antigens in complex mixtures
Intermediate gels used for detecting cross-reacting
antigens or antibodies
Initial screening for precipitating antigens
Screening column fractions
Quantification of pure antigens
Monitoring antibody response in experimental animals and 142, 143,
antibody production by hybridomas; highly sensitive
technique for detecting antigens; quantitative
inhibition of ELISA useful for detecting cross-reactive
antigens and showing how purified antigens contribute
to a complex reaction (see Fig. 4.3)
Suitable for any antigen that can be separated on PAGE;
extremely sensitive; both types of technique rely on
SDS removal prior to immunoassay; slab gels useful for
screening large numbers of samples; becoming
increasingly used for monoclonal antibody studies
Monitoring purification procedures












1 SGIP = SDS gel immunoperoxidase; GIRA = gel immunoradioassay.
phoresis. It is questionable whether any of these tests
still have a place today. Although often sensitive and
quantitative, their inherent lack of specificity and low
resolving power make them largely unsuitable. There
are several reports which show that antigen prep¬
arations once thought to be pure are in fact complexes
of antigenic and non-antigenic molecules. It is only
when high-resolution separation techniques are used
in their preparation and subsequent analysis that these
problems become apparent; see refs. cited by Wad-
strom [9].
The range of immunological techniques that are
most applicable to the identification of bacterial
antigens are listed in Table 4.9. These methods have
been divided into three basic types: immunoelectro-
phoretic methods for precipitating antigens; indirect
ELISA methods for antigens that can be bound to
polystyrene or similar material; and immunodetection
of antigens that have been separated on polyacryla¬
mide gels. Examples of these are shown in Figs.
4.2-4.5.
It should be stressed that immunological methods
should not be used alone. Other sensitive analytical
techniques should be included so that non-antigenic
molecules can be detected. The various forms of
polyacrylamide gel electrophoresis and isoelectric
focussing are ideal for these purposes. It is important
that gels are deliberately overloaded so that minor
contaminants may be detected. The highly sensitive
silver stain which can be applied to both proteins and
carbohydrates is especially useful [122,123].
Recommendations
Purpose for which antigen is prepared
Before starting to prepare an antigen, careful consider¬
ation must be given to the purpose for which it is being
isolated. If it is to be used as a vaccine, care must be
taken to ensure that its native immunogenic properties
are retained. Extensive fractionation is often unnecess¬
ary. If, however, an analysis is to be made to determine
the chemical composition or immunologic specificity,








Fig. 4.2. Crossed Immunoelectrophoresis of Bacteroides fragilis antigens, (a) EDTA-extracted outer membrane (OM)
complex of a reference strain (20 /<g protein in 10 /il) was run into the first dimension for 1.5 h at 12.5 V cm and into the
second dimension, containing homologous antiserum raised to whole cells (0.25 ml antiserum in 3.5 ml agarose), for 16 h at
12 V cm~'. The gel was stained by Coomassie Blue, (b) The same method as (a) was used but the OM complex was heated
to 121 °C for 15 min before running in the first dimension, (c) A 45% (w/v) aqueous phenol extract of whole cells of the B.
fragilis reference strain (50 /<g carbohydrate in 10 /d) was run in the first dimension against homologous antiserum, (d)
EDTA-extracted OM complex from a clinical isolate (20 fxg protein in 10 /il) was run against antiserum to the reference
strain. The results demonstrate the presence of a heat-stable, aqueous phenol-extractablc common antigen in the two
strains. (Photograph kindly supplied by G. Cousland).
should be preserved, loss of immunogenicity is often
inevitable.
Culture of bacteria
As the growth conditions of the organism can mark¬
edly affect the expression of antigens, factors such as
medium composition, pH, incubation temperature,
oxygen tension, phase of growth at harvesting, and the
choice between batch or continuous culture need to be
considered. A compromise must usually be made
between a medium approximating the situation in the
Fig. 4.3. Fused rocket Immunoelec¬
trophoresis of a 40% (w/v) aqueous
phenol extract of cytoplasmic mem¬
branes from Clostridium difficile frac¬
tionated on an immunosorbent col¬
umn (antiserum to whole cells of C.
difficile linked to CNBr-activated
Sepharose 4B) by elution with 50%
(v/v) ethylene glycol in 5 mM-lysine,
140 mM-KCl (pH 11.5). Volumes (5
/il) of each fraction were placed in
wells, allowed to diffuse for 1 h at 4°C
and electrophoresed into antiserum to
whole cells of C. difficile (200 /il serun
in 5 ml agarose) for 16 h at 12 V
cm~'. Two distinct antigens were
demonstrated.
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Dilution of inhibitor (I in 2")
Fig. 4.4. Determination of the chemical nature of the major surface antigens of Bacleroides fragilis by inhibition of
ELISA. An uninhibited indirect ELISA was performed to obtain the 100% value ( ). B. fragilis outer membrane (OM)
complex was coated on to wells of a polystyrene multi-well plate and reacted with doubling dilutions of antiserum raised in
rabbits against whole cells of B. fragilis. The coated wells were reacted with anti-rabbit IgG-alkaline phosphatase conjugate
followed by p-dinitrophenyl phosphate. The endpoint of the reaction was the highest dilution (titre) of antiserum that gave
an absorbance reading of greater than 1.0 at 405 nm.
To determine the chemical nature of the major antigens detected above, an inhibition of ELISA was performed. B.
fragilis OM complex was coated onto wells. Before the antiserum was added, doubling dilutions of potential inhibitors were
mixed with an equal volume of antiserum diluted to twice the titre determined in the uninhibited assay and incubated at
37 °C for 30 min. Inhibitors were a positive control of untreated OM complex (•), OM complex heated at 121 °C for 15
min (O), OM complex treated with 0.01 M-NaI04 (pH 5) for 16 h at 20 °C (□), and lipopolysaccharide (■). After
incubation with the inhibitors, the antiserum was added to the antigen coated wells and the assay completed as above.
The results showed that heat-stable, periodate-labile components of the OM complex are the major antigens detected by
ELISA and that these are predominantly lipopolysaccharide [155].
host animal that may give high yields of an antigen but
results in difficult purification. A simple synthetic
medium provides a low yield but purification is easier.
Fractionation of the bacteria
When fractionating the bacterial cell the following
points must be considered: (1) maintain efficient
cooling during cell breakage as overheating may result
in proteins being denatured; (2) minimize the action of
autolytic enzymes, either by maintaining low tempera¬
ture and rapid processing if heat-labile antigens are to
be prepared or by inactivation by heat or formalde¬
hyde if the antigens are heat stable; and (3) consider
using chemical or enzymatic methods such as EDTA
detergents or lysoyme for cell lysis in certain prepara-
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Fig. 4.5. SDS-polyacrylamide gel electrophoresis and corresponding electroblot transfers of EDTA-extracts of strains of
C. botulinum, C. novyi, and C. sporogenes. Approximately 50 pg protein in 50 ^1 sample buffer were run on each track of a
10% acrylamide gel. Fig. 4.5a Coomassie blue stained gel: track 1, C. novyi type A NCTC 538; track 2, C. botulinum Al;
track 3, C. botulinum pB25; track 4, C. botulinum npB188; track 5, C. botulinum C205; track 6, C. botulinum D154; track 7,
C. botulinum E34; track 8, C. sporogenes NCTC 8594. Fig. 4.5b. Electroblot transfer of Fig 4.5a reacted with antiserum to
C. sporogenes NCTC 8594. Fig. 4.5c. Electroblot transfer of Fig. 4.5a reacted with antiserum to C. novyi NCTC 538.
SDS-PAGE was performed as in [136] and electroblot transfer as in [150]. Full details are as in [156].
tions—outer membrane preparations or ribosomal
vaccines.
Purification
The newly developed high-resolution biochemical
separation techniques should be used whenever poss¬
ible. Immunoabsorbent affinity methods are especially
useful. As many bacterial antigens of current interest
are located at the cell surface, they are often firmly
associated with membrane components. This necessit¬
ates the inclusion of detergents (Triton X-100 or
sodium deoxycholate) in the purification schemes.
These detergents often pose problems. They can
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denature antigens and, more importantly, are often
difficult to remove from the purified antigen. These
points must be considered and those detergents that
are recognized as causing extensive denaturation
(sodium dodecyl sulphate) should be avoided
whenever possible. Recently, Pierce and Warriner
have introduced an affinity chromatography medium
for removal of detergents from protein solutions.
Identification ofantigens
Avoid the older immunological methods that have low
resolving power. As pointed out above, detergents are
often necessary for the purification of membrane
antigens. These detergents are often included in
identification systems to avoid reaggregation and
complexing of antigens. For example, it is routine to
include 1% Triton in crossed immunoelectrophoresis
gels when membrane antigens are investigated.
Non-immunological analytical techniques should
also be included to detect the presence of non-anti-
genic contaminants. When using either technique, it is
worthwhile overloading the system with antigen to
determine minor contaminants.
Sources of technical information
As well as the references listed in this chapter, the
reader is encouraged to consult other sources for
general descriptions of methods and techniques. The
various 'Methods in . . .' series (Academic Press,
London and New York) are useful, i.e. 'Methods in
Microbiology' and 'Methods in Enzymology'. The
catalogues and pamphlets issued free of charge by
many of the chemical manufacturers are invaluable
sources of technical information; those produced by
Pharmacia, BioRad, LKB, and Miles are especially
worthy of note.
Appendix
Addresses ofsuppliers ofequipment and materials
Albright and Wilson, Whitehaven, Cumbria, U.K.
Amicon Corporation, Lexington, MA, U.S.A.
Aminco, American Instrument Company Inc., Silver
Springs, MD, U.S.A.
B.D.H. Chemicals, Ltd., Poole, Dorset BH12 4NN,
U.K.
Bio-Rad, 32nd and Griffin Ave., Richmond, CA
94804, U.S.A.
Braun Melsungen Int. Gmbtt., Schwarzenberger Weg
23, D3508, Melsungen, W. Germany.
Dawe Instruments, Ltd., Concord Road, Western
Ave., London W3 05D, U.K.
Difco Laboratories, Detroit, MI, U.S.A.
Dupont Company, Newton, CT. 06470, U.S.A.
L.K.B. Products AB, Box 305, S-16126 Bromma,
Sweden.
Miles Laboratories Ltd., P.O. Box 37, Stoke Poges,
Slough SL2 4LY, U.K.
Millipore Corporation, Bedford, MA 01730, U.S.A.
M.S.E. Scientific Instruments, Manor Royal, Craw¬
ley, W. Sussex, U.K.
Oxoid Ltd., Wade Road, Basingstoke, Hants. RQ24
0PW, U.K.
Pharmacia Fine Chemicals AB, Box 175, S-75104
Uppsala 1, Sweden.
Pierce and Warriner (U.K.) Ltd., 44 Upper Northgate
Street, Chester, U.K.
Sigma Chemical Co., St. Louis, MO 63178, U.S.A.
Vortex Mixers, Hampton, Middlesex, U.K.
Waring Products Division, Route 44, New Hartford,
CT, U.S.A.
Whatman W. and R. Balston (Modified Cellulose
Ltd.), Springfield Mill, Maidstone, Kent, U.K.
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Introduction
Lmmunoblotring or western blotting is the technique by
which macromolecules, usually proteins, are separated
by pofvacrylamide gel electrophoresis and are then elec-
trophoreucally transferred to a nitrocellulose or similar
membrane, ■where they are probed with antibody to lo
cate antigens. Since the transfer method was first devel
oped about 10 years ago by Towbin et al (Proc Satl
Acad Sci USA 1979, 76:4350-4354), it has become one of
the most •widely used immunological techniques with an
ever-increasing range of applications and modifications.
It has largely superseded the traditional Immunoelectro¬
phoresis techniques such as crossed and rocket immuno-
electrophoresis. It is used in all areas of immunological
research, in diagnostic serology, and it is becoming the
standard method throughout the biological sciences for
the high resolution detection of any molecule for which
an antibody is available. In this review, I shall attempt to
describe the current state of the technique and then go
on to discuss some of the most recent applications; it is
not possible to cover all of these here, so I shall concen¬
trate on those in the fields of immunology and microbiol¬
ogy. For an extensive, recent 'state-of-the-art review', see
[1],
The state of the technique
In immunoblotting, antigens are electrophoretically trans¬
ferred, after separation, to nitrocellulose or to one of
the more expensive, but much more robust, cationic ny¬
lon membranes, which have higher binding capacities for
most protein antigens (Miribel and Arnaud, J Immunol
Methods 1988, 107:253-259). The binding of the pro¬
tein to the membrane is thought to be mediated largely
by hydrophobic interactions. The transfer apparatus was
originally a large tank of several litres capacity in which
the gel and transfer membrane were mounted in a cas¬
sette between platinum wire electrodes. Large volumes
of relatively expensive buffer were required for this ap¬
paratus. However, the more recently developed semi-dry
transfer apparatus with two flat graphite electrodes is
gaining popularity There are savings in buffer costs and
the transfer is more rapid because of the much steeper
voltage gradient. An extension to the original concept in
which the electrophoretic transfer step is circumvented is
the application of the antigen directly to the membrane
as a dot (dot blotting) [ 1 ]. A further modification to this
technique is the recently described line immunobinding
assay [2], in which several narrow lines of different anu
gens are sprayed horizontally across a sheet of nitrocellu¬
lose membrane. The sheet is then cut into vertical strips
before probing with serum. This technique has been sue
cessfully applied to the serological investigation of several
viral infections. An extremely similar, but more appealing,
'line blot' in which lines of antigen are applied with an
ink pen point, has also been described [3],
The main problems encountered with immunoblotting
include: (1) difficulty with the transfer or lack of bind¬
ing of the antigen; (2) the antigen losing its antibody-
binding capacity after separation and transfer, presum¬
ably by denaturation, and the subsequent need for renat-
uration of the antigen; (3) high background staining or
non-specific binding, and the need for blocking agents;
(4) lower sensitivity than enzyme linked immunosorbent
assays (EUSAs); (5) quantification of the results; and (6)
the difficulty of miniaturising the technique for use in
large-scale screening. Many of these problems have been
addressed recently, with a limited amount of success [ 1 ].
Of these problems, the two areas that are still subject to
the most debate and confusion are the denatu ration and
renaturation of antigens, and the role of blocking agents
and detergents.
In the standard transfer method in a large tank, any ioruc
detergent, such as sodium dodecyi sulphate (SDS), used
in the polyacryiamide gel electrophoresis is removed or
at least greatly diluted. Otherwise, the SDS would inhibit
the binding of the antigen to the membrane and, subse
quently, of the antibody to the antigen. In the semi dry
system, therefore, the gel must first be washed. The step
aifter transfer is usually to block any unbound sites on
the membrane with a protein such as gelatin or bovine
serum albumin to prevent non-specific antibody binding
All subsequent buffers usually contain the non ionic de
tergent Tween 20 to prevent non specific binding. Re
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cently, it has been suggested that a blocking agent and
a blocking step are unnecessary if Tween 20 is simply
included in all steps after transfer [4). Contrary to this
is the report [5] lhat Tween 20 mediates a non specific
binding of enzyme-labelled or radio-labelled IgG to aller¬
genic extracts of oak pollen. The authors admit that this
may be specific to pollen proteins but suggest caution.
Others have suggested that the use of Tween 20 can re
suit in the loss of protein from nitrocellulose (Hoffman
and Jump, J Immunol Methods 1986, 194:191-196).
Many workers are still adamant that blocking is essential,
especially v.hen working at the limits of the technique,
where high concentrations of serum and long incuba¬
tion times are needed to detect low levels of antibody. In
addition, blocking is often necessary where background
staining is a problem, especially with some of the non
nitrocellulose membranes. If blocking is considered nec¬
essary, then it is important not to overdo it. As the anti¬
gens bind through hydrophobic interactions, it is thought
that the blocking protein slowly exchanges with the
bound antigen, resulting in a loss of antigen. The extent
of the loss is directly proportional to the concentration
of blocking protein and to the length of time of expo¬
sure to it. In a recent quantitative investigation [6], us¬
ing powdered low fat milk, an extremely inexpensive and
very popular blocking agent, it was shown that as much
as 25% of the antigen could be lost in a 24 h period. The
authors recommend the use of 0.5% milk for 30 min with
0.2 pm pore size nitrocellulose as a suitable blocking pro¬
cedure.
Turning to the problem of denaturation, it is perhaps
not surprising that some protein antigens lose their abil¬
ity to bind antibody after hearing at 100"C in an SDS-
solubilizing buffer, followed by separation and transfer.
This is especially apparent when blotting with mono¬
clonal antibodies. It is thought, however, that a consid¬
erable degree of renaturarion occurs during the transfer
and subsequent washing and blocking. Some outer mem¬
brane proteins of the meningococcus require incubation
with zwitterionic detergents or ionic detergents contain¬
ing substituted quaternary ammonium or amino groups,
or with specific meningococcal lipopohsaccharide (LPS)
to restore antibody binding. Non-ionic detergents such
as Triton X100 or Tween 20 do not work well [7],
In summary, it seems sensible that for any new system of
antigen, antibody binding the simplest technique is tried
first, viz. using no blocking agent but only Tween 20
throughout, subsequent to transfer. If problems are en¬
countered with high background, then the use of defat¬
ted powdered milk as a blocking agent should be con¬
sidered. If problems are still experienced, other blocking
agents or ways of making the assay more sensitive should
be tried.
As with all immunoassays, many amplification methods
have been used to increase the sensitivity of immunoblot-
ting. Most of these methods involve streptavidin-biorin
binding [ 1 ]. Recently, two other approaches have been
investigated. The first [8] is extremely simple and involves
using a mixed chromogenic substrate for the horseradish
peroxidase conjugate. Mixing the two commonly used
substrates, 3. 3' diaminobenzidine tetrahydro-chlonde
(DAB) and 4 chloro-l-naphthol (CN). results in a 10-
fold increase in sensitivity and the product is much eas¬
ier to record by photography. Ikegaki and Kennet [9]
claim that their method also allows a significant increase
in sensitivity. After incubation of the first antibody, the
antigen antibody complex on the nitrocellulose is treated
with glutaraldehyde. A several fold increase in sensitivity
was observed with concentrations of glutaraldehyde in
the range 0.1-0 25%; this was accompanied by a decrease
in non-specific binding of secondary or tertiary reagents.
Concentrations of 0.5% glutaraldehyde and above re¬
sulted in loss of sensitivity.
Non electrophoreric affinity immunoblotting is a recently-
developed technique (Knisley and Rodkey, J Immunol
Methods 1986. 95:79-87). A sheet of nitrocellulose is
soaked in specific antigen and, after drying and block
ing, is placed in direct contact with isoelectrofocused im
munoglobulins to allow the binding of specific antibodies
by capillary attraction. This method has been used mainly
for the analysis of clonotype distribution. An example of
its application in the investigation of congenital human
immunodeficiency vims (HIV) infection is described be¬
low.
Applications in immunology
The areas of immunology in which immunoblotting is ad¬
vancing our knowledge to the greatest extent are autoim¬
mune disease and allergy. Both of these areas involve the
identification of specific antigens among complex mix¬
tures, something that has, until recently, been difficult to
achieve.
Autoimmune disease
The detection and quantification of autoantibodies in
the diagnosis and pathogenesis of autoimmune diseases
such as rheumatoid arthritis, systemic lupus erythemato¬
sus (SLE) and primary immune neutropenia are obviously-
important. Only with the advent of immunoblotring have
investigations such as those described below been pos¬
sible.
Nuclear antigens are important markers in rheumatoid
arthritis, SLE and connective tissue disease in general.
Well known antigens such as the Sm and ribonucleopro-
tein (RNP) nuclear antigens have been investigated by im¬
munoblotting [10], Antibodies to Sm are highly specific
to SLE, whereas anti-RNP antibodies are associated with
mixed connective tissue disease. Using immunoblotring,
De Keyser et al [ 11 ] have detected a new anti nuclear
antibody in patients with rheumatoid arthritis.
Immunoblotring has been used in an interesting way
in the investigation of T-cell activation in SLE [12], Nu
clear protein antigens were first located by immunoblot
ring. The areas of nitrocellulose containing the antigens
were then dissolved in dimethyl sulphoxide and nitro-
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cellulose/antigen particles were precipitated with carbon¬
ate bicarbonate buffer The particles were then used in
T cell-enriched lymphocyte proliferation assays. Immuno-
blotting has also allowed the identification of neutrophil
antibodies in autoimmune neutropenia [13].
Allergy
The identification of allergens has been greatly facilitated
by immunoblotting (Tovey and Baldo, Electrophoresis
1987, 8:452). IgE, as well as other immunoglobulins di¬
rected against specific allergens, can be easily detected
and quantified by immunoblotting. Two recent exam¬
ples demonstrate the technique's value. In the first, an
investigation of farmers' lung (extrinsic allergic alveoli¬
tis) caused by Micropolysptora faeni showed that patients
characteristically have high antibody levels to three spe¬
cific fungal proteins, which may be useful in diagnosis
[14]. In the second example. IgE and IgG in patients suf¬
fering from Type 1 allergy to birch pollen were investi¬
gated by immunoblotting [ 15]. Of the 58 patients, 56 had
IgE antibodies that were reactive with a 17 kD Bet v I anti¬
gen. In 33 of these 56 patients, it was the only antigen to
which IgE was directed. All the pollen proteins were rec¬
ognized by IgG antibodies, but only weakly in the case of
the 17 kD antigen. The authors suggest that low or absent
IgG may facilitate the allergic reaction.
Other applications
Two other papers are worthy of note in the general field
of immunology. One describes the analysis of comple
ment Factor B activation by immunoblotting [16], allow¬
ing analysis in complex biological fluids without purifi¬
cation. The other highlights the use of the immunoblot¬
ting technique in clinical chemistry [17], where a method
has been developed for a subclass typing of human IgG
myeloma paraproteins.
Applications in microbiology
There is a vast literature on immunoblotting applications
in microbiology. The areas on which I shall concentrate
are the serodiagnosis of infectious disease, particularly
HIV diagnosis, and the use of immunoblot fingerprinting
in epidemiological studies of bacterial and fungal infec¬
tions.
Immunoblot analysis is a valuable confirmatory test for
the detection of antibodies to HIV. Its use is recom¬
mended for sera giving positive or borderline results in
enzyme immunoasays. Nitrocellulose strips of separated
HIV antigens permit simultaneous detection of antibodies
to distinct HIV antigens. Those antigens considered im¬
portant include the transmembrane glycoprotein (gp41)
and the core proteins p55 and p24. Several licensed com¬
mercial test strips are now available that avoid some of
the earlier problems of non-uniform antigen prepara¬
tions. Despite this, there are frequent false-positive or in
termediate' or 'indeterminate' immunoblot results (Meyer
and Pauker. .V Engl J Med 198", 31T238-2-H ). Because
of the ethical, medico-legal and emotive consequences
of false positives, especially in bkxxl donor screening, a
great effort is being made to clanfy the immunoblot as
say [18-20]. Aw (this issue, pp 892-89") discusses HIV
surveillance in more detail.
In infants delivered to HIV-positive mothers it is impor
tant to be able to detect congenital infections. Using con
ventional serological techniques, infections cannot be de¬
tected in infants of less than 15 months of age because of
the difficulty in discriminating between passively acquired
maternal antibody and actively produced antibody, but
affinity immunoblotting has been developed to detect in¬
fants' antibody as early as 2 months [21 ].
Since immunoblotting was first used to fingerprint
Clostridium difficile isolates involved in an outbreak of
antibiotic-associated pseudomembranous colitis (Poxton
et al, J Med Microbiol 1984, 1"*:31~—32-t). its use has
been extended to many hospital pathogens, both bacte
rial and fungal, which have been difficult to type by other
means (Burnie and Matthews,/ Immunol Methods 198".
100:41—46). The technique has proved especially use
ful for methicillin-resistant Staphylococcus aureus [22],
where exported proteins (culture supernatants) provide
a good source of antigen. A recent example of the use of
the technique in a fungal infection is described bv Bumie
etal. [23].
Conclusions
Immunoblotting is an extremely powerful technique
which in the past 10 years has revolutionized the detec
tion of both antigens and antibodies. The high resolving
power of this immunoassay permits applications to ex¬
tremely complex mixtures of antigens which were hith¬
erto impossible. Like many such separation techniques,
it is almost more of an art than a science and some of
the mysteries of the binding mechanisms invoked in im¬
munoblotting and the use of detergents and blocking
agents have still to be explained. It still has some way
to go to reach its full potential.
Annotated references and recommended
reading
• Of interest
• • Of outstanding interest
1. stott DI: Irnmunoblotting and dot blotting J Immunol
• • Methods 1989, 119153-187.
A comprehensive critical review Includes methodology, design of
equipment, types of gel, membrane transfer buffers, blocking agents,
probes, a discussion of denaturation of proteins, detection methods,
quantification and special applications.
2. Aeppu RE, Bakcetzi MJ. Binz H: Diagnostic screening of mul-
• tiple antigen antibody reactions in a new single assay on
nitrocellulose the line immunobinding assay (LIBA). J 1m
munol Methods 1989, 120 93-98
Immunological techniques
Using a fine spray, several different antigens are applied as lines horizon
tally across nitrocellulose Vertical stnps are probed with serum for the
detection of antibodies. This technique has been applied to the serol
ogy of rubella, measles and mumps. Compares favourably with EUSA
3. Raollt D, Dasch GA. The line blot an immunoassay for
• monoclonal and other antibodies. Its application to the
serotyping of Gram negative bacteria ] Immunol Methods
1989, 125:57-65.
Extremely similar to the technique descnbed in [2] but much simpler
to use. A simple ink pen and a ruler are used to draw lines of anugen
across a sheet of nitrocellulose. Uses less than 0 25 pg antigen per assay-
It has been applied to serotyping the following Gram negative genera
Proteus. Rickettsia. Rochalimaea and Legionella.
4 Mohammad K. Esen A A blocking agent and a blocking
• step are not needed in EL1SA immunostaining dot-blots
and western blots J Immunol Methods 1989, 117:141-145.
If Tween 20 at 0.05% is included in all steps subsequent to transfer, sig
nificant savings in time and money are made, without loss of sensitivity
5. Loria RC, Prange JO, Wedner HJ: Immunoblotting of pollen
• proteins: Tween 20 mediates nonspecific binding of gam¬
maglobulins to immunoblots of oak-pollen proteins. J Al¬
lergy Clin Immunol 1988, 82 834—841.
Claimed to be the first report of non specific binding in immunoblotting
of an allergenic extract, this paper confirms that Tween 20 results in
non specific binding. It binds to pollen grains and allows binding of
labelled probes—both horseradish peroxidase and '-'I labelled anti-
human IgE. This also occurs with Triton X100 Bovine serum albumin
and gelatin led to a marked reduction in non-specific binding .Although
admitting that this phenomenon may be restricted to pollen proteins,
the authors rightly suggest caution.
6. DenHouander N, Be fas D: The loss of antigens from
• immunoblotting membranes. J Immunol Methods 1989,
122 129-135.
Blocking with low fat milk powder can result in the non selective loss
of antigen from membranes. The loss is probably due to the simple
exchange of one protein for another.
7 Wedege E, Bryn K, Froholm lo: Restoration of antibody
• binding to blotted meningococcal outer membrane pro¬
teins using various detergents. J Immunol Methods 1988,
11351-59-
Some heat denatured meningococcal outer membrane proteins do not
bind antibody if immunoblotted. Binding can be restored if zwitterionic
and ionic detergents with substituted quaternary ammonium or amino
groups with a minimum of 10 carbon atoms in the alkyl chain are used.
Meningococcal LPS can also restore binding to a class 2 porin (outer
membrane) protein, but other LPSs cannot
8. Young PR Enhancement of immunoblot staining using a
• mixed chromogenic substrate. J Immunol Methods 1989,
121 295-296.
One horseradish peroxidase substrate, D.AB, is a sensitive substrate but
the coloured product is pale and photographs poorly The other com¬
monly used substrate, CN, although giving a better contrasting purple
colour, is slightly less sensitive. A combination of the two results in a
synergistic increase in sensitivity and a high-contrast black colour that
is suitable for photography. Just before use, the substrates are mixed
with phosphate buffered saline and hydrogen peroxide.
9. Ikegaki N, Kennet RH Glutaraldehyde fixation of the pri-
• mary antibody antigen complex on nitrocellulose paper in¬
creases the overall sensitivity of immunoblot assay. J Im
munol Methods 1989, 124 205-210.
A simple additional step to any standard immunoblot assay. The au
thors recommend a 15 min incubation with 0 25% glutaraldehyde in
phosphate-buffered saline immediately after incubation with the first
antibody.
10. Combe B, Rucheton m, Graafiand H, Lussiez v, Brunei. C,
• Sany j: Clinical significance of anti-rnp and anti-Sm autoan¬
tibodies as determined by immunoblotting and immuno-
precipitation in sera from patients with connective tissue
diseases. Clm Exp Immunol 1989. 75:18-24.
Immunoblotting can be used as a highly sensitive method for detec¬
tion of anu Sm and anu RNP unubodies. Ann Sm anubodies are highly-
specific for SLE, being found in ^6% of SLE patients. Anti-RNP antibod
ies are associated with mixed connective tissue disease, which may be
considered a distinct clinical entity associated with a specific serological
marker
11. De Keyser F. Verbri ggen G, Veys EM. Identification of a
• new antinuclear antibody by immunoblotting Lancet 1989,
ii:92T
Use of immunoblotting to screen for anti nuclear antibodies in patients
wtih rheumatic diseases. .Antibodies that are not detectable by immuno-
precipitation in gels are identified by immunoblotting
12. Pham BN. Prcv D. Gosset D, Hatron PY. Devulder B. Gapron
• A Dessaint JP T-lymphocyte activation in systemic lupus
erythematosus analysed by proliferative response to nucle¬
oplasms proteins on nitrocellulose immunoblots. Clin Exp
Immunol 1989, 77:168-174.
Suggests that activated T cells contribute to fine modulation of B cell
reactivity in SLE. .Antigens are solubilized as nitrocellulose particles.
13. Rothko K, Kjckler TS, Clay MC, Johnson RJ, Stroncek
• DF Immunoblotting characterization of neutrophil anti¬
genic targets in autoimmune neutropenia Blood 1989,
74:1698-1703.
Demonstration that immunoblotting may be used to identify antigenic
targets in autoimmune neutropenia that are not definable by other sero¬
logical tests.
14. iranttalab m, j.arollm e, rumpold h. steiner r ebner h,
• Feldner H. Scheiner O, Kraft D Characterization of Mi-
cropotyspora faeni antigens by human antibodies and im¬
munoblot analysis. Allergy 1989, 44 314-321.
Identification of fungal antigens from patients with farmers' lung by
measuring IgG, IgM and IgA antibodies. Stresses the need for Af. faeni
antigens of 11, 25, and 60 kD for in vitro diagnosis.
15. Jarollm E, Rumpold H, Endler AT, Ebner H, Breitenbach M,
• Scheiner O. Kraft D: IgE and IgG antibodies of patients
with allergy to birch pollen as tools to define the allergen
profile of Betula verrucosa Allergy 1989, 44 385-395.
Results of two-dimensional electrophoresis, immunoblot demonstrates
heterogeneity in birch pollens. Suggestion that IgG directed against mi¬
nor allergens may function as trapping antibody in healthy individuals.
16. Doran M. Reen DJ .Analysis of complement Factor B acti-
• vation by PAGE immunoblotting. J Immunol Methods 1989,
118237-243.
A sensitive and quantitative tool for the analysis of Factor B in com¬
plex biological fluids. Uses rabbit anti human complement Factor B
antiserum.
17. Fasullo FJ, Frjtche HA Liu FJ, Hamilton RG: IgG heavy-chain
• subclass typing of myeloma paraproteins by isoelectric fo¬
cusing immunoblot analysis. Clin Chem 1989, 35 364-368.
Use of IgG]_, monoclonal antibodies. Allows the monitoring of pi and
subclass of an IgG paraprotein over the course of a patient's therapy-
programme.
18. Genesca J, Jett BW, Epstein JS, Shih JWK, Hewlett IK, Alter
• HJ: What do western blot indeterminate patterns for hu¬
man immunodeficiency virus mean in ELA negative blood
donors' Lancet 1989, ii: 1023—1025.
It is prudent to continue to exclude blood units that are enzyme-im
munoassay positive and indeterminate, and to follow up donors. How¬
ever, indeterminate donors who have no history of exposure to HIV 1
and whose indeterminate pattern does not become positive in 6 months
are unlikely to have HIV infection.
19. zolla p.azner s, gornay mk, honnen wj, pinter a Reinter-
• pretation of human immunodeficiency virus western blot
patterns. A Engl J Med 1989, 320:1280-1281.
Viral antigens on commercial nitrocellulose strips with apparent molec
ular masses in the 120-160 kD range are not the gpl20 envelope gfy
Immunoblotting techniques Poxton 909
coprotein or the gpl60 envelope precursor, but are pnmarv multimers
of the gp4l transmembrane glycoprotein.
20 La-ntcs JP. Grae I, Frei PC Serological diagnosis of HI\' in-
• fectiom incidence, outcome and significance of partial re¬
actions in western blot analysis. Gin Exp Immunol 1989
76332-336
Investigates intermediate western blot patterns (1-3 'specific' bands)
Similar findings to [18], Stresses the importance of further testing 3
months later.
21 SlaDE HB, Pica rv, P.ahw.a SG: Detection of HTV-specific
• • antibodies in infancy by isoelectric focusing and affinity
immunoblotting. J Infect Dts 1989, 160:126-130
Nitrocellulose was coated with synthetic gp41 antigen and used to
affinity blot serum separated by isoelectric focusing. The presence or
absence of clonotypically distinct bands of IgG correlated with infec
tion status
22 Thomson Carter FM. Pennington TH Characterisation of
• methicillin resistant isolates of Staphylococcus aureus by
analysis of whole-cell and exported proteins J Med Micro¬
biol 1989. 28 25-32
Immunoblots of culture supernatants were preferable to whole cell pro
terns in discrimination between stains. Pooled human plasma known to
contain antibodies to many 5. aureus polypeptides was used as the pri¬
mary probe
23. Blrnte JP. Matthews RC. Clark I, Milne LJRi Immunoblot
• finger-printing of .Aspergillus fumigatus J Immunol Methods
1989, 118:179-186
First immunologically based typing system for Aspergillus fumigatus
Uses rabbit antiserum to detect up to 16 antigenic bands and gives












A. R. Archibald, D. R. Bundle, G. Dougan, B. Glauner, J. E. Heckels,
P. A. Lambert, P. Messner, D. E. Minnikin, D. C. Old, D. Parratt,
R. R. B. Russell, U. Schwartz, U. B. Sleytr, M. Virji
A Wiley-Interscience Publication
JOHN WILEY & SONS






Chapter 1: Structure of Bacteria and their Envelopes 1
With U. B. Sleytr, P. Messner, D. E. Minnikirt, V. E. Heckels and
M. Virji
A. Introduction—bacterial cell walls 1
B. Walls based on peptidoglycan 1
(i) Peptidoglycan 3
(ii) Walls of Gram-positive eubacteria 6
(iii) Walls of Gram-negative eubacteria 16
(iv) The periplasm in Gram-negative eubacteria 20
C. Envelopes of eubacteria without peptidoglycan 20
(i) Mollicutes 20
(ii) Ancient budding eubacteria 21
(iii) Bacteria with walls that contain insufficient
peptidoglycan to form a complete sacculus 21
D. Walls of archaebacteria 22
(i) Walls containing pseudomurein 23
(ii) Polysaccharide walls 23
(iii) Walls consisting of protein or glycoprotein subunits 23
E. Superficial wall components 24
(i) Protein S-layers 26
(ii) Capsules and glycocalyces 26
F. Surface appendages 28
(i) Pili and fimbriae 28
(ii) Flagella 30
Chapter 2: Culture of Bacteria 33
A. Selection of conditions for batch culture 33
(i) Growth rate 33
v
vi Contents
(ii) Medium composition 34
(iii) Other culture conditions 35
(iv) Defined media 36
B. Continuous culture-growth kinetics and wall turnover 37
A. R. Archibald
(i) Introduction 37
(ii) Media for continuous culture 37
(iii) Techniques 41
(iv) Effects of nutrient limitation 42
(v) Effects of growth rate 43
(vi) Use of the chemostat to study the kinetics of synthesis
and turnover of cell wall 43
(vii) Use of chemostat culture to study wall assembly and
the regulation of wall polymer synthesis 45
(viii) Kinetics of growth in continuous culture 46
(ix) Kinetics of synthesis of wall polymer 47
(x) Rate of incorporation of new material into the wall 48
C. In vivo radiolabelling of cell wall components 51
(i) Labelling of peptidoglycan by growth in the presence
of N-acetyl [ MC]glucosamine 54
Chapter 3: Isolation and Purification of Cell Walls 55
A. Introduction 55
(i) Mechanical cell disruption 55
(ii) Purification of walls and outer membrane 56
(iii) General precautions for wall isolation 58
B. Methods 59
(i) Wall purification without mechanical disruption 59
(ii) Procedures for cell disruption 62
(iii) Purification of the wall fraction 63
(iv) Purification of walls with attached outer membrane
from Gram-negative bacteria 64
Chapter 4: Separation and Purification of Surface Components 67
A. Detection and preparation of surface appendages 67
(i) Pili (fimbriae)
}. E. Heckels and M. Virji
(ii) Flagella 73
B. Peptidoglycan 75
(i) Isolation of peptidoglycan from Gram-negative
bacteria 76
(ii) Isolation of cross-linked, insoluble peptidoglycan fro:
Gram-positive bacteria 76
(iii) Isolation of cross-linked peptidoglycan from
mycobacteria 77
Contents vii
(iv) Preparation of soluble, uncross-linked peptidoglycan 78
C. Teichoic acids and other accessory carbohydrates from
Gram-positive bacteria 79
(i) Extraction with acid 80
(ii) Extraction of teichoic acids with alkali 81
(iii) Extraction with N,N' dimethylhydrazine (DMH) and
phenylhydrazine (PH) 82
(iv) Enzymic wall degradation 82
(v) Purification of accessory polymers isolated chemically
or enzymically from cell walls 83
D. Lipoteichoic acid and other lipocarbohydrates from Gram-
positive bacteria 88
(i) Extraction and purification of lipoteichoic acid 89
E. Preparation of lipopolysaccharide and enterobacterial
common antigen 90
(i) Extraction of LPS by aqueous phenol 91
(ii) Extraction of 'rough' LPS 91
(iii) Proteinase K digestion method for the preparation of
LPS 92
(iv) Deionization of LPS by electrodialysis 93
(v) Preparation of lipid A 95
(vi) Preparation of enterobacterial common antigen (ECA) 96
F. Isolation and purification of surface proteins 97
(i) Separation and purification of S-layers from Gram-
positive and Gram-negative bacteria 97
P. Messner and U. B. Sleytr
(ii) Isolation and purification of proteins linked to the
cell wall in Gram-positive bacteria 104
R. R. B. Russell




(ii) Preparation of porins 113
(iii) Purification of lipoproteins 118
(iv) OmpA protein of Escherichia coli 120
(v) Other outer membrane proteins 121
H. Isolation of exopolysaccharides 121
(i) General method for capsular polysaccharides 123
(ii) High-molecular-weight exopolysaccharide 124
(iii) Low-molecular-weight exopolysaccharide 124




(ii) Mycolic acid extraction and purification 127
(iii) Free lipid extraction and purification 133
Chapter 5: Chemical Analysis of Envelope Polymers 137
A. Analysis of polysaccharides 137
(i) Hydrolysis of carbohydrate polymers 138
(ii) Smith degradation of polysaccharides 139
(iii) Separation and quantitation of sugars as their alditol
acetates, by gas chromatography 140
(iv) Separation of sugars by HPLC 141
(v) Methylation analysis 142




(i) Investigation of murein structure and metabolism by
HPLC 158
B. Glauner and U. Schwartz
(ii) Determination of the average chain length of
peptidoglycan 171
C. Lipopolysaccharides 174
(i) Demonstration of heterogeneous chain length 174
(ii) Demonstration of polymeric O-antigen in some E. coli
strains 176
(iii) Separation of core and O-antigen 178
D. Accessory polymers of Gram-positive bacteria 179
(i) Introduction 179
(ii) Acid hydrolysis of teichoic acids 181
(iii) Cleavage with hydrofluoric acid 182
(iv) Alkaline hydrolysis of teichoic acids 183
(v) Chromatography of hydrolysis products 183
(vi) Determination of chain length of teichoic acids 187
(vii) Teichuronic acids 189
Chapter 6: Immunochemistry of Cell Surfaces 191
A. Preparation of antisera 191
(i) Whole bacteria 191
(ii) Subcellular fractions of soluble antigens 192
(iii) Preparation of IgG from antiserum 193
B. Preparation of monoclonal antibodies 194
(i) Purification of IgG monoclonal antibodies from
ascites fluid 194
(ii) Radiolabelling of monoclonal antibodies 194
-A
Contents ix
C. Precautions for working with human sera 196
D. Immunochemical methods 196
(i) Gel diffusion 196
(ii) Immunoelectrophoresis methods 197
(iii) Immunoblotting (electroblotting'Western blotting) 202
(iv) Enzyme-linked immunosorbent assay (ELISA) 207




(ix) Immunoelectron microscopy 220
(x) Immunoadsorbent chromatography 221
Chapter 7: Present and Future Applications of Knowledge of
Bacterial Surfaces 227
A. Bacterial cell envelopes in adhesion 227
D. C. Old
(i) Pili of Neisseria gonorrhoeae 228
(ii) Enterobacterial fimbriae 230
(iii) Adhesins in urinary infection 232
(iv) Adhesins in diarrhoeal disease 235
(v) Concluding remarks 239
B. Development of defined bacterial vaccines 240
G. Dougan
(i) Requirements of modern vaccines 240
(ii) Live attenuated bacterial vaccines 241
(iii) Multivalent live vaccines 243
(iv) Subunit vaccines 245
(v) Polysaccharide vaccines 249
(vi) Bacterial outer-membrane proteins as vaccines 250
(vii) Conclusions 250




(ii) The pattern of the serological response to infection 252
(iii) Traditional tests for antibody 254
(iv) Modern serological assays 259
(v) Assays of immune complexes 264
(vi) Conclusions 267
Appendix 1: General Methods 269
1 Estimation of pentoses and hexoses 269
2 Estimation of uronic acids 269
X Contents
3. Detection of hexosamines in glycans using MBTH 270
4 Estimation of hexosamines 271
5. General colorimetric assay for periodate-oxidizable
polysaccharides and related compounds 272
6. Estimation of 3-deoxy-D-manno-octulosonic acid (KDO) in
lipopolysaccharide 272
7. Estimation of organic phorphorus 274
8. Measurement of bound sulphate in polysaccharides 275
9. Quantitative measurement of protein 276
10. Polyacrylamide gel electrophoresis 277
11. Staining of polyacrylamide gels 279
12. Electron microscopy of bacteria 281
Appendix 2: Specialist Suppliers 287
References 289
Index 317
1.13 Determinants of bacterial 60
virulence
I, R. Poxton and J, P. Arbuthnott
Surface virulence determinants 332




Teichoic acids and related polymers 338
Protein virulence factors 340
Outer membrane proteins 343
Other surface proteins 343
The association of plasmids and bacteriophage
with virulence 344
The phenotypic expression of virulence
determinants 345
Bacterial exotoxins in virulence 345
Toxins acting on the gastrointestinal tract 346
Toxins causing subepithelial or systemic
damage 346
Toxic damage to internal organs 350
Conclusion 351
References 351
332 1.13 Determinants of bacterial virulence
Bacterial virulence determinants can he defined as the
components and products of the bacterial cell which
confer on the bacterium the potential to harm the host.
In very few instances is it possible to define a single such
factor. This is perhaps possible only in certain of the
classic bacterial intoxications (e.g. botulism) where the
powerful exotoxin may be considered to be the sole deter¬
minant of virulence. In most cases the damage suffered
by the host is multifactorial, the factors involved includ¬
ing those of host origin as well as bacterial factors. For
example, in certain Escherichia coli-induced diarrhoeas in
piglets, the organism requires two virulence determinants:
the surface fimbria! antigen to allow adherence to the
mucosa, and the ability to secrete one or more entero-
toxins. The animal host must be of a certain genotype
to express the receptors for the adherence factor and its
age is often important. Examples of these, together w ith
many others illustrating the complexity of bacterial viru¬
lence. are described in more detail later in this chapter.
The virulence determinants of bacteria are con¬
veniently divided into those that are cell associated (i.e.
cell surface components) and those that are extracellular
(i.e. the classic exotoxins and extracellular enzymes). It
should be stressed that many of the virulence
factors described here have functions other than those of
damaging the host. Most have a role, which is often
primary, in the anatomy or physiology of the bacterial
cell, and that of a virulence factor is purely coincidental.
Useful reviews on virulence and pathogenesis include
those of Roth (1988) and Brubaker (1985); for a more
historical perspective, see Howie and O'Hea (1955) and
Arbuthnott er al. (1983).
Surface virulence determinants
Before discussing the various surface virulence deter¬
minants. it is appropriate to describe the stages of the
pathogenic processes, particularly those at which surface
factors may be important. For a detailed review of patho¬
genesis. the reader is referred to the monograph by Mims
(1987). Rev iews more specifically relating to surface viru¬




Once a pathogenic bacterium is in or on a susceptible
host, it must become established at a suitable site. For
example, at mucous membranes it is usual for the patho¬
gen to penetrate the mucous blanket and subsequently to
adhere to the epithelium. Movement through the mucus
to the epithelial cells may be dependent on chemoat-
tractants in host tissue, and the bacterium may require
flagella and possibly mucus-degrading enzymes. Adher¬
ence to the tissue is then usual to avoid the mechanical
action of the cilia or the flushing action of the body fluids.
Surface factors involved in adherence include fimbriae
(pili), lipoteichoic acids, exopolysaccharides (capsules and
slime) and outer membrane proteins. These factors may
act in conjunction with host-derived polymers and those
from other bacteria to produce a glycocalyx or biofilm.
e.g. in dental plaque (see Chapter 12). The binding of the
receptor on the host cell surface and the bacterial adhesin
is often a highly specific 'lock and key" association. The
host cell surface protein, fibronectin. is a receptor for
several pathogens and is discussed later.
Once the organism is located in the host, subsequent
factors in the pathogenic process include evasion of the
host defence system and the ability of the pathogen to
compete with the commensal flora for nutrients and
space. Bacterial factors for the former step include pos¬
session of a capsule, which can be both antiphagocytic
and a camouflaging mechanism if it mimics host tissue.
The long polysaccharide chains of 'smooth' lipo-
polvsaccharide as well as of capsular polysaccharide
allow the fixation of complement at a site distant from
the bacterial cell membrane, thus making the bacterium
resistant to the lethal lytic effect of normal serum. Some
bacteria are classically intracellular and thus evade the
defence mechanisms by their internal location. Factors
which confer virulence on pathogens by allowing them
to compete with the normal flora include the ability to
secrete antibacterial substances (e.g. bacteriocins. organic
acids, alcohols) and their ability to express scavenging
mechanisms such as iron-binding proteins.
Subsequent steps in pathogenesis involve the mech¬
anisms by which the host is harmed. It is at this stage
that toxins - both the classic exotoxins and. in the case
of gram-negative bacteria, the lipopolysaccharide (endo¬
toxin) - exert their main influence. Their effects can be
either local or systemic. The actions of the toxins are
described in detail later. Tissue damage can also result
from direct invasion of tissue, from inflammation or from
harmful immune responses, which include anaphylaxis,
complement-mediated cytolysis. immune-complex reac¬
tions and cell-mediated reactions (see Chapters 14—17).
Finally, to complete the cyclic process of pathogenesis,
the organism is released from the host and is disseminated
to other susceptible hosts. The ability to survive outside
the host could be taken as contributing to virulence. The
waxy coat of the mycobacteria, the ability to form spores
and the possession of a highly hydrated capsule are
obvious examples of survival mechanisms but are not
considered further in this chapter.
From this brief description of pathogenesis it is appar¬
ent that virulence factors are involved at all stages of the
disease process and often the same component can be
involved in more than one stage. Furthermore, the viru¬
lence determinants encompass the w hole range of surface
components. Table 13.1 summarizes the role of surface
components as determinants of virulence.
The bacterial cell surface components w ill be described
in the first part of this chapter. A brief description of
their structures is followed by a discussion of their roles
as virulence determinants, with special reference to the
relationship, at the molecular level, between chemical and
physical structure and virulence mechanisms.
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Structure Exopolysaccharides include the discrete
capsules of many pathogenic bacteria and the loosely
associated slime produced by mucoid bacteria. They are
the classic K. antigens of the enterobacteria. Capsules
were among the first known bacterial virulence deter¬
minants. The first demonstration of bacterial trans¬
formation by Griffiths! 1928) involved the transformation
of rough (non-capsulate. non-virulent) pneumococci to
the smooth (capsulate. virulent) form.
Exopolysaccharides form highly hydrated. water-
insoluble gels. They can be readily demonstrated in the
light microscope by negative staining with indian ink. In
the electron microscope a ruthenium red stain, which
binds to negatively charged polymers, is usually used to
reveal capsules (Hancock and Pox ton 1988). The chemical
composition of exopolysaccharides can be of two types:
homo- and heteropolysaccharides. consisting respectively
of a single sugar monomer, (e.g. the levans and dextrans
of many oral streptococci) or of repeating oligosaccharide
units of more than one monomer. Many exopoly¬
saccharides are acidic due to the possession of carboxyl
groups, either from acidic sugars such as uronic acids or
neuraminic acid, or from non-sugar substituents such as
pyruvyl. acetyl and formyl groups. Their acidic nature is
reflected in many of their properties. A few of the bacilli
(e.g. Bacillus anthracis) have a capsule made up of a single
amino acid, poly-D-glutamic acid. In physical chemistry
and function, however, it is similar to the polysaccharide
capsules. Examples of the basic structures of the exopoly¬
saccharides of several pathogenic bacteria are shown in
Table 13.2, and the appearance of a capsulate bacterium
is shown in Fig. 13.1. For more details of the structures
of exopolysaccharides. see Sutherland (1977, 1985).
A relatively recent observation is that the long poly¬
saccharide chains of some E.coli capsules terminate at
their reducing end in a phosphodiester-linked lipid
residue, which is often phosphatidic acid. It also seems
likely that the terminal reducing sugar is 2-keto-3-deoxy-
mannosoctontc acid (KDO: 3-deoxy-D-wun/jo-2-octu-
losonic acid) whether or not this sugar is part of the
structure of the oligosaccharide repeating unit. This ques¬
tion is reviewed by Jann and Jann (1983). It is probable
that the lipid is involved in a hydrophobic interaction
with.the outer membrane, or other surface component,
and anchors the capsule to the cell.
Biological activities As virulence factors, exopoly¬
saccharides have two major roles. The first is in adhesion
and is particularly obvious in Streptococcus mutans.
the cariogenic organism. The bacterium can synthesize,
from dietary sucrose, a branched, water-insoluble homo-
polymer of glucose which is dextran-like. It forms a glu¬
tinous layer on the surface of the tooth and contributes
to the matrix of dental plaque. It also forms a metabolic
substrate for acid formation. Recent evidence shows that
coagulase-negative staphslococci adhere to prosthetic
devices and catheters by means of an exopolysaccharide
slime (Christensen etal. 1982. 1987).
The second main role of capsular polysaccharide in
virulence is protection of the organism from the host
defence systems. Since the classic work on the pneumo-
coccus it has been recognized that capsules prevent bac¬
teria from being engulfed by phagocytes. There are
several possible reasons. Capsulate or slime-producing
bacteria usually grow in microcolonies in vivo and engulf-
ment is difficult on purely steric considerations. Fur¬
thermore. complement (see below) and opsonic
antibodies cannot get access to the cell env elope. Another
general observation is that the more hydrophilic the
surface of a bacterium - and this can be related to the
amount of polysaccharide - the less readily it can be
phagocytosed. A good example of a potential virulence
determinant with some of the above properties is the
alginate slime of mucoid Pseudomonas aeruginosa in the
lungs of children with cystic fibrosis.
Several species of bacteria produce a capsule with a
chemical structure that mimics host tissue. This camou¬
flages the organism from the immune system by appear¬
ing to the host as 'self' (Jann and Jann 1987). Perhaps
the best known examples are the K1 capsule of E. coli and
the immunologically and structurally identical capsule of
Seisseria meningitidis group B. These organisms have
capsules of a-2.8-linked .Y-acetylneuraminic acid which
is partially O-acetylated. It cross-reacts immunologically
with neonatal neural cell adhesion molecules (Hoffman
et al. 1982). Capsules of similar composition are found
in the important sheep pathogen Pasteurella haemolytica
type A2 (Adlam et al. 1987). Another example of a
capsule mimicking host tissue is provided by the hyal¬
uronic acid capsules of Str. pyogenes and of Past, mul-
tocida type A. Many of these capsules also confer
>
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Data compiled from Jarm and Westphal (1975). Lmdberg (1977). Sutherland (1977). Robbms (1973) and De Voe (1982)
Abbreviations' Ac, acetyl' Gai, galactose GalNAcUA A-acetylgalactosaminurcnic acid. GaiU, galacturonic acid. Glc glucose
GlcNAc. iV-acetyiglucosamme ManNAc-I-P Af-acetylmannosamme phosphate NeuNAc A-actylneuramimc acid Rha rhamnose. Rib
ribose Rib-P, ribitol phosphate
a Partial structure only
b Not all the sugar residues are O-acetylatea
c An example of a teichoic acid polymer in a gram-negative organism
d Internal ester bridges are also present.
resistance to the bactericidal effect of serum, and this is
discussed further below.
As mentioned earlier, the capsule allows the bacterium
to evade the immune system by making it resistant to the
lytic action of complement. It is well known that, for
lipopolysaccharide (LPS), which is described later, the
longer the chains of O polysaccharide, the more resistant
they are to complement. This is thought to be because
the complement cascade is activated at a distance from
the bacterial membrane so that no lysis occurs. It has
been recognized for many years that the capsular poly¬
saccharide also confers this property of serum resistance
(Glynn and Howard 1970), especially the K1 antigen of
E. coli. There was, however, a certain amount of con¬
fusion as to which component was most important in
bacteria possessing both LPS and capsule. This problem
has been largely clarified by the work of Cross and co¬
workers (1986), who concluded that serum resistance
is multifactorial. The LPS of some E. coli serotypes is
incapable of protecting against serum lysis. For these
strains the capsule, which is most commonly Kl. confers
protection. For other serotypes of E. coli (e.g. 06) the
capsule is much less important. This serotype often pos¬
sesses the K5 capsule, which is as non-immunogenic as Kl.
but does not confer resistance to serum on the bacterium.
Finally, it should be noted that the anticomplementary
and antiphagocytic effects of capsules of £. coli and many
other species are usually overcome by opsonization of
the bacterium with capsule-specific antibodies.
There is a possible connection between the ability of
the organism to resist the action of complement and its
ability to invade the host: again, in £. coli the K! antigen
is important. Most bacterial pathogens found outside
the gut and inside functional barriers, e.g. those causing
bacteraemia, meningitis and urinary tract infections -
especially pyelonephritis - are capsulate. One of the most
\
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Fig. 13.1 Electron micrograph of a capsulate Klebsiella sp stained with ruthenium red Bar marker = 0 2/im. (Photograph kindly-
supplied by Dr J R. W. Govan)
invasive of bacteria is Salmonella Typhi. In this species
the most important virulence determinant is the Vi
antigen. This capsular antigen, which has a unit structure
of partially O-acetylated. 2-1,4-linked A'-acetyl-
galactosaminuronic acid monomers, is important in
invasion. The invasive, but non-capsulate, shigellae and
enteroinvasive E. coli(EIEC) have unusual acidic ©-poly¬
saccharides which are proposed as functional analogues
of the acidic capsule and as being important in the mech¬
anism of invasion.
The capsule of Bacteroidesfragilis and possibly of other
Bacteroides spp. is said to have a role in inhibiting the
phagocytosis and intracellular killing of facultative
anaerobes (predominantly E. coli) in mixed anaerobic
and aerobic infections. This conclusion is from a series
of observations, both in vitro (Ingham et al. 1981. Reid
and Patrick 1984. Jones and Gemmell 1986, Patrick
1988) and in vivo (Onderdonk et al. 1976. 1977, Kelly
1984. Patrick et al. 1986) that Bad. fragilis acts syner-
gistically with the aerobe. The mechanism is obviously
multifactorial, with LPS. proteins, metabolites, chemo-
taxis of neutrophils and the redox potential of the system
all possibly having an influence. It appears that a surface
polymer is likely to be involved in the process; but, as
the experiments in vitro were performed with capsular
polysaccharide contaminated with LPS and vice versa, it
is not possible to be precise as to the mechanisms involved
(Poxton and Brown 1986).
Li popolysaccha rides
It is considered that, more than other cell-surface com¬
ponents, lipopolysaccharide (LPS, endotoxin) is associ¬
ated with virulence. This amphipathic molecule, which
is anchored in the outer membrane of the gram-negative
bacterium and forms an essential constituent of the cell
envelope, confers on the organism a wide range of bio¬
logical properties. Much of the work on the structure-
function relationships of LPS has originated in lab¬
oratories in Freiburg and Borstel in West Germany. The
recent review by Brade et al. (1988) is recommended as a
comprehensive summary of the current knowledge in this
field.
Structure In structure, LPS consists of two main
regions: a hydrophobic glycolipid - the lipid A - and
a hydrophilic polysaccharide. In many bacteria with a
smooth-form LPS the polysaccharide can be subdivided
into the core oligosaccharide and the O-polysaccharide
or O-antigen. Rough mutants lack the O-polysaccharide.
Some bacteria (e.g. Neisseria spp.) possess a naturally
rough-form LPS which is sometimes referred to as a lipo-
oligosaccharide. The smooth, rough structure of LPS is
summarized diagrammatically in Fig. 13.2.
The lipid A is the toxic part of the molecule. In E. coli
it consists of a >9-1,6-linked glucosaminyl-glucosamine
disaccharide backbone which is substituted with phos-
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L'pid A Core oligosaccharide 0-polysaccharide
Rough *ype Repeat ng unit
Smooth *ype
Fig. 13.2 Diagrammatic representation of lipopolysaccharide
phate groups at the 1-position of the reducing end and at
the 4-position of the non-reducing sugar. Each sugar
monomer is substituted at the 2- and 3-positions with 3-
hydroxymyristic acid residues through amide and ester
linkages respectively. The fatty acids on the non-reducing
sugar are themselves substituted with lauric and myristic
acid. Figure 13.3 shows the structure of the lipid A mol¬
ecule of E. coli. This structure is more or less common to
all LPS molecules that are endotoxic. the variations being
in the length of the substituted fatty acid residues, the
type and distribution of the substituents of the fatty
acids and the additional substituents of the phosphoryl
residues.
The structure of the core oligosaccharide consists of
11 or so monosaccharide units. The inner region of the
core (i.e. the part proximal to the lipid A) is characterized
by being made up of the unusual sugars 3-deoxy-D-
wa/i«o-2-octulosonic acid (KDO) and L-glycero- or D-
glycero-D-manno-hepiose (heptose) together with phos¬
phate and ethanolamine. This inner region of the core is
largely conserved in a wide range of species. The outer
part, consisting typically of glucose, galactose and glu-
Flg. 13.3 The structure of lipid A from Escherichia cell.
(Adapted, with permission, from Brade etal (1988))
cosamine is w here a limited amount of variation between
and within species occurs. For example, there are prob¬
ably about six core-types for E. coli and only one for
Salmonella. Examples of core types are shown in Table
13.3; it should be stressed, however, that the structures
presented here are the best estimates from the data avail¬
able. Microheterogeneity certainly exists in the core,
especially in the non-sugar substituents. It is likely that
modifications of the structures will be made in the light
of results obtained from the increasing use of high-
resolution nuclear magnetic resonance spectrometric
analyses. In some species (e.g. Vibrio cholerae), it is often
difficult to demonstrate the presence of KDO because of
unusual substitution or linkage patterns: in other gram-
negative bacteria (e.g. a strain of Acinetobacter cal-
coaceticus) it appears to be absent, but an analogous
sugar is present (Brade el al. 1988).
It is in the O-polysaccharide where variation can be
almost infinite. This is the part of the molecule in which
the O-serotype specificity resides. The structure consists
typically of long chains of repeating units of oligo¬
saccharides, usually made up of three or four mono¬
mers. There are over 160 serotypes in E. coli whereas in
Salmonella there are over 60 types and in Ps. aeruginosa
only 17. Examples of the repeating unit structure of some
O-polysaccharides are shown in Table 13.4.
A feature of the O-polysaccharide that has become
apparent in recent years is its considerable variability in
chain length. A smooth bacterium possesses a range of
O chain lengths ranging from unsubstituted core oligo¬
saccharide to 30 or more repeating units. This is best
demonstrated by analysis of LPS by sodium dodecyl
sulphate-polyacrylamide gel electrophoresis (SDS-
PAGE) and staining with silver (Hancock and Poxton
1988). An example of this is shown in Fig. 13.4. This
variability in chain length influences the biological prop¬
erties of the LPS.
Certain serotypes of E. coli (e.g. 0111) produce some
of their O-polysaccharide in a form which is not linked
to core and lipid A. but is polymerized to form a capsular
polysaccharide resembling a K antigen. This has been
investigated in detail by Peterson and McGroarty (1985)
by separation of LPS fractions by ael filtration followed
by SDS-PAGE.
Biological activities The toxic part of the LPS mol¬
ecule resides in the lipid A region. This part alone can be
shown to express all the toxic biological properties of
endotoxin. The core and O-polysaccharide component,
however, have a marked influence on the fate of LPS in
the host (Fig. 13.5) and on the mechanisms of virulence
and pathogenicity of the bacterium. Table 13.5 sum¬
marizes the biological properties of LPS. In the host, the
culmination of the effect of LPS is endotoxic shock, the
main features of which are hypotension, a fall in cardiac
output and disseminated intravascular coagulation,
which lead to death (Morrison and Ryan 1987). Some
bacteria (e.g. Bact.fragilis) possess an LPS oflow endo-
toxicity and this is reflected in the structure of lipid A,
especially the fatty acid composition and phosphate sub¬
stitution (Weintraub el al. 1985).
\
Surface factors and pathogenesis 337






a 11.2 a I 1,6 I 1.7 I
Z 1.2 1.3 1.3 " 1.3 1,5 '
Salmonella Glc Gal Glc Hep Hep KDO —*- Lipid Aa a a^a^u r
Gal UL. Gal
a I 1.2




r- , 1,2 1.3 1.3E. coll R2 Glc —— Glc —— Glc ——
Glc GlcNAc
a I 1,2 P I 1.4
Z, 12 Z , i :
E coli R3 Glc Gal Glc
Gal Gal
3
a I 1.2 a 1 1,4
Z , 1.2 _ 1.3 Z, 1.:
E coh R4 - Gal —1— Glc —— Glc
GlcNAc
•I(3 J 1.6 1.2 1.3 1.3
E coli K-12 Glc Glc Glc
Rha Glc
a I 1.6 a I 1.7
P^eudomoras 1.3 * 1,? 1.4/5 2.4/5rseuao on
Q| Gjc GalN Hep — KDO —- KDO ■
aeruginosa u Q " 0
t 2
Ala
Abbreviations Ac. acetyl. Ala. alanine. Gal, galactose. GaiNAcUA, A'-acetylgalactosammuronic acid. GalN, galactosamme GaiU.
galacturonic acid; Glc. glucose GlcNAc, iV-acety[glucosamine Hep, heptose: KDO, 3-deoxy-o-ma/ino-2-octulosonic acic ManNAc-1-
P. AAacetylmannosamme phosphate, NeuNAc. N-actylrieurammic acid. Rha. rhamnose. Rib. nbose. Rib-P. ribitol phosphate
Data from Rowe and Meadow (1983) and Jann and Jann (19S4).
The exact mechanisms by which LPS harms the host
are by no means clearly understood, but the structure of
lipid A in relation to fatty acid and phosphate substitution
is of great importance. As a virulence determinant the
form of the LPS greatly affects the potential of the bac¬
terium to harm the host. Rough, isogenic mutants are
usually 1000 times or so less virulent than their smooth
parents, and even minor changes in the composition of
the sugar substituents of O-polysaccharide can markedly
influence the virulence for mice. As described previously
for capsular polysaccharide, the long O-polysaccharide
chains confer on the bacterium resistance to the lytic
action of serum and protects against engulfment by
phagocytes. LPS is a good activator of complement by
both the alternative pathway - independent of antibody -
and the classical pathway (Morrison and Kline 1977). It
is presumed that the long chains protect the inner region
of the LPS which is associated with the bacterial outer
membrane (Tomas el al. 1988). Anti-O antibodies may.
however, be bactericidal. Furthermore, the longer the
polysaccharides, the more hydrophilic is the cell. It is
likely that the degree of heterogeneity in chain length
may be of paramount importance to the balance of the
interaction between the host defence system and the
gram-negative bacterium: the greater the preponderance
of long chains, the greater the virulence. This factor is
no doubt influenced by the growth environment of the
bacterium, so predictions based on cells grown in vivo
may be false. N. gonorrhoeae with naturally rough LPS
(sometimes termed lipo-oligosaccharide) is usually sen-
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sitive to the lytic action of serum. However, strains iso¬
lated from disseminated gonococcal infections are serum-
resistant. In these strains the LPS appears to he altered
in an unknown way (Stephens and Shafer 1987).
In the previous section on capsules, it was noted that
the small group of serotypes of shigellae and entero-
invasive £. coli characterized by possessing acidic O-
polysaccharides act in a manner analogous to that of
invasive bacteria with acidic capsules, the acidic surface
structure being necessary for the mechanism of invasion.
Furthermore, in a way equally poorly understood, certain
LPS types (serotypes) are associated with other patho¬
genic mechanisms. For example, the enterotoxigenic £.
coli (ETEC) are confined to a small number of
serotypes, the enteropathogenic £. coli (EPEC) belong to
another small group, and the same is true of entero-
haemorrhagic £. coli (see below). There is thus a cir¬
cumstantial link between surface chemistry and patho¬
genicity. Whether this has any thing to do with recognition
of host tissue or perhaps susceptibility to infection by a
bacteriophage or plasmid (in the way that other virulence
determinants are phage or plasmid-encoded) is not
known.
Teichoic acids and related polymers
Structure The surface of the gram-positive bacterium
typically has two structurally related, negatively charged
components. One is covalently linked to the pep-
tidoglycan and is usually referred to as the teichoic acid
or the secondary (or accessory) cell wall polymer. Under
conditions of phosphorus limitation this can be replaced
by teichuronic acid. The other is anchored in the cyto¬
plasmic membrane and protrudes through the wall. This
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Fig. 13.4 The heterogeneity of lipopolysaccharide (LPS)
demonstrated by poiyacrylamide gel electrophoresis and silver
staining Samples of LPS from six blood-culture isolates prepared
by the proteinase K method and run on a 12°o polyacrylamide
gel Track 1, Escherichia cch 075: track 2. E coll 018: tracks 3
and 4, Pseudomonas aeruginosa, track 5, £ coll01. track 6, £ coli
06 See Hancock and Poxton (1988) for technical details
(Photograph kindly supplied by Dr A. P Gibb)
is the lipo- or membrane-teichoic acid, or lipocarbo-
hydrate. The terminology is complex because a teichoic
acid is. by definition, a polymer containing ribitol phos¬
phate or glycerol phosphate with phosphodiester link¬
ages, usually with hexose and D-alanine substituents
(Baddiley 1972). The lipoteichoic acids are usually based
on glycerol phosphate and have at their terminus a glyco-
lipid. Teichoic acids in this strict sense are not found
in all gram-positive bacteria, but there is usually a func¬
tionally analogous molecule. If phosphate is absent,
acidic sugars can contribute a negative charge, and the
polyol is sometimes replaced by a hexose. Examples of
this family of molecules are shown in Fig. 13.6.
Biological activities To discuss the secondary wall
polymers first: they are not well known as virulence
factors. Functionally their most important role is possibly
in sequestration of divalent cations. They are immu¬
nogenic and are the group antigens in many streptococci,
staphylococci and lactobacilli. Some may have a role in
inflammation, an example being the C substance (C-
teichoic acid) of Str. pneumoniae which binds to the acute
phase (C-reactive) protein.
The lipocarbohydrates have been proposed as ana¬
logues in gram-positive bacteria of the LPS in gram-
negative organisms. Many of the endotoxic properties of
LPS are said to be mediated by lipoteichoic acids, but





Fig. 13.5 The fate cf smooth and rough hpopoiysaccharide (LPS)
in the host (Data from Freudenberg and Galanos v 1986))
Table 13.5 The biological properties of
lipopolysacchanae
Pyrogenic for man and rabbits
Lowers temperature in mice
Lethal toxin
Activation of complement
Activation of clotting cascades
Limulus amoebocyte lysate gelation
B-cell mitogen (T-independent)
Local Shwartzman reaction
Induction of tumour necrosis factor
Induction of interleukin-1
Induction of colony-stimulating factor
Induction of prostaglandins and leukotrienes
Induction of non-specific resistance to infection
Date from Morrison ana Ryan (1987) and Brade era." (1988)
be responsible for much of the confusion. Lipoteichoic
acids have a role in channelling divalent cations to the
cytoplasmic membrane and are involved in cell division
as substrates for autolysins. They are probably anti¬
complementary and are phage receptors. They may be
responsible for cross-reactions between a range of gram-
positive bacteria; some false positive results in the Kahn
test for syphilis may be due to the cross-reaction between
cardiolipin and the phosphorylglycerol phosphate group¬
ing. Perhaps the major role for lipoteichoic acids in viru¬
lence is in adhesion. One proposal is that lipoteichoic
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acids and deacylated lipoteichoic acids interlink through
cationic bridges at their phosphate groups to bind Sir.
mutans to the tooth surface. Another is that adhesion of
Sir. pyogenes to the epithelium of the pharynx involves
a combination of M protein (see later) and lipoteichoic
acid in a fibrillar meshwork, which binds to fibronectin
on the host cell surface through the lipid moiety of the
lipoteichoic acid (Beachey and Courtney 1987).
Protein virulence factors
Proteins associated with the bacterial cell surface are in
two main forms; those that form appendages discernible
in the electron microscope - the fimbriae (or pili) and
flagella - and those present on the surface as a layer,
which often form a regular array, or are embedded in or
are associated with the gram-negative outer membrane.
Many of these proteins have well defined roles in
virulence, most commonly involving adherence. For a
recent review on adhesins of the bacterial cell envelope
the reader is referred to Old (1988).
Fimbriae (pili)
These synonymous terms describe the filamentous
protein appendages found on a variety of bacteria. In
this chapter the term 'fimbriae' will be used for all such
appendages with the exception of those of the gonococcus
in which they are conventionally referred to as pili. The
structurally similar, but functionally different, sex pilus
used in conjugation (see Chapters 2 and 6) is not described
further here.
Fimbriae of Enterobacteriaceae It is in the Entero-
bacteriaceae that fimbriae are best characterized. The
pioneering work of Duguid more than 30 years ago estab¬
lished the presence of fimbriae by agglutination of red
blood cells from a range of species. This fimbria-mediated
haemagglutination could be resistant or sensitive to
blocking by D-mannose (Duguid et al. 1955. 1966). The
mannose-sensitive (MS) fimbriae are usually termed
common or (type 1) fimbriae, and are widespread in most
species of enterobacteria. Structurally they are made up
of about 1000 protein subunits of mol.wt 17000 which
form a straight, tubular structure about 1 pm in length
and 7-8 nm in diameter with a central hole (Brinton
1965). These fimbriae bind to a w ide range of cell types
from many different species. Antigenically they do not
show much cross-reaction with each other and are even
distinct within a species. It is still, however, usual to
group them together as they react with an a-D-mannosyl-
containing receptor. Recent evidence tends to suggest
that this approach is perhaps too simplistic (Old 1988).
Orskov and Orskov (1983) studied the serology of E. coli
fimbriae. Expression of fimbriae by bacteria is dependent
on cultural conditions, and temperatures must be above
20°. Type 1 fimbriae are optimally produced at 37° in
static broth cultures. Some of the M R fimbriae and gono¬
coccal pili require solid medium for their expression.
Generally, the expression of fimbriae is better on minimal
than on rich media.
Until recently it was thought that type 1 fimbriae were
not virulence determinants. It was in fact considered that
their possession is detrimental to the bacterium. They
promote better binding to polymorphonuclear leucocytes
and are therefore better phagocytosed; moreover, as
potential urinary tract pathogens, they bind to Tamm-
Horsfall glycoprotein (in urinary mucus) and are flushed
out with the urine (Orskov et al. 1980). This concept has.
however, been challenged by Kuriyama and Silverblatt
(1986). who have shown that type 1 fimbriate bacteria are
resistant to phagocytosis when coated with the Tamm-
Horsfall glycoprotein. Furthermore, type 1 fimbriate E.
coli colonize the epithelium of the bladder better than
non-fimbriate types, and receptor analogues protect
against experimental infections (Old 1988). There
remains much to be clarified in the role of these common
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Table 13.6 Strains of Escherichia col: that cause diarrhoea





Data from Qrskcv (1978; Levine . ISS7; and Law (1968''
The role of another fimbria, the mannose-resistant P
fimbria, has a much less debatable role in urinary tract
infections. More than 90% off. coli strains isolated from
non-obstructive pyelonephritis in young children possess
P fimbriae. They were so named because they bind to the
P blood group antigen. P fimbriae recognize and can bind
to a D-gal-:x-( 1,4)-o-gal structure on epithelial cells as well
as on red cells (Kallenius ei al. 1980). This structure is
abundant in the glvcolipids of the upper ureter and
kidney. It has been proposed that secretor status may
influence individual susceptibility to urinary tract infec¬
tions. Women with recurrent urinary tract infections and
scarring of the kidney tend to be non-secretors (Lomberg
et al. 1986). It has been suggested that non-secretors may
have more receptors available for binding P-fimbriate
bacteria.
Similarly, other fimbriae designated X. S and M fimb¬
riae have been described and their receptors identified;
e.g. the S fimbriae bind to vascular endothelium through
a NeuAc-a-(2-3)-gal./?-( l-3)-galactosamine receptor and
may be an important virulence determinant in strains of
E. coli found in neonatal meningitis. A review by Lind-
berg et al. (1988) on protein-carbohydrate interactions
in bacterial pathogenicity is recommended for further
information on receptors for fimbriae.
Another well known group of fimbriae and fimbria-like
structures is found on E. coli strains causing diarrhoea in
man and domestic animals (reviewed recently by Levine
1987). The types of £. coli recognized as causing diar¬
rhoea are listed in Table 13.6. However, not all of these
types produce fimbria] adhesins. Classically, fimbriae are
associated with the enterotoxigenic f. coli (ETEC) and
the adhesins are often referred to as colonization factors.
They include the mannose-resistant K88, K99. 987P and
F41 antigens that cause diarrhoea in animals, and CFA I.
CFA II and E8775 found in human strains. In structure,
some (e.g. CFA I and 987P) resemble common fimbriae,
whereas others (e.g. K.88 and K99) appear as more flexible
and much thinner fibrils with a diameter of 2-3 nm. These
are sometimes referred to as fibrillae. The CFA II and
E8775 antigens consist of families of adhesins. The
CFA II strains carry CS1, CS2 and CS3 antigens (Smyth
1982). Almost all strains carrry CS3. usually with CS1 or
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CS2. CS1 and CS2 are like the typical type 1 fimbriae,
and CS3 is of the thin, flexible type. Similarly. E8775
strains carry combinations for CS4 and CS5 (rigid) and
CS6 (flexible) types.
The possession of different types of fimbriae is closely
related to the O-serotype of the organism. ETEC strains
belong to a small group of O-serotypes and it is probable
that all these serotypes possess a fimbrial adhesin. The
role of fimbriae in causing diarrhoea is to localize the
pathogen on the brush border of the mucosa of the
anterior ileum, usually in the first metre or so. Here
the organisms deliver the other major virulence factor
of ETEC strains: a heat-labile (LT) enterotoxin.
a heat-stable (ST) enterotoxin. or both. The entero-
toxins and adhesin are encoded on the same virulence
plasmid. These features of ETEC are described in detail
later.
The receptor for the colonization factor is usually
found in a narrow range of hosts. Some organisms tend
to bind only to the ileum of man, and others only to that
of certain animals. For example. E. coli carrying the K88
antigen seems to be found only adhering to the mucosa
of porcine ileum, and K.99 strains are found usually in
calves and lambs. After experimental inoculation. K88
and K99 strains do not produce diarrhoea in calves and
pigs respectively. Even within a host species, certain indi¬
viduals are resistant to infection. In piglets there are five
recognized phenotypes of brush border, one of which is
totally resistant to colonization by K88. This resistance
is transferred genetically by mendelian inheritance. The
chemical basis of the host receptors is not well under¬
stood. The age of the host is also important in sus¬
ceptibility to diarrhoea. Calves are susceptible to K.99
only during the first 2 days after birth, whereas piglets
are susceptible to 987P strains only in the neonatal period
but to K88 at two different ages: when younger than 6
days and during the post-weaning period (3-9 weeks). A
mechanism for resistance to 987P after the neonatal
period has been proposed by Dean et al. (1989). The
brush border expresses the 987P receptor in both neonatal
and older pigs, but in the latter it is released into the
lumen of the intestine and facilitates bacterial clearance.
For a detailed review of the host specificity of fimbrial
06.08 011.015 020.025 027.063.078.
080. 085, 0115 0128. 0139. 0148 0149
0153. 0159. 0167
020. 044. 055. 086 0111 0114. 0119. 0125
0126.0127 0128 0142 0158
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adhesins in diarrhoea! disease, see Gaastra and de Graaf
(1982).
Of the other E. coli strains w hich cause diarrhoea, only
the uncommon enterohaemorrhagic (EHEC) strains are
recognized as possessing fimbriae. In man. E. coli
0I57:EP is the serotype associated with the bloody diar¬
rhoea of haemorrhagic colitis. This syndrome is dis¬
tinguished from dysentery by the lack of fever and by the
copious volumes of stool. The strain is also associated
with haemolytic uraemic syndrome which, together with
haemorrhagic colitis, is being increasingly reported in
North America (Levine 1987). The strains are char¬
acterized as possessing a plasmid of mol.wt 60 x 10"
which codes for the fimbriae involved in binding the
bacteria to cells.
Fimbriae of Neisseria The last type of fimbria to be
described in detail in this chapter is that produced by A.
gonorrhoeae. The convention is that they are termed 'pili'
rather than 'fimbriae', and this will be observed here.
They are similar in appearance to the type 1 fimbriae of
enterobacteria.
Fresh isolates of .V. gonorrhoeae are invariably piliate.
but on repeated subculture on solid medium they lose
their pili and undergo phase variation, the non-piliate
forms giving rise to a different colonial morphology
(Brinton 1965). Differences in colonial opacity can also
result from variations in outer membrane proteins but
this point will be discussed later. Like the fimbriae of
enterobacteria. gonococcal piii are made up of identical
subunits of pilin. with a mol.wt of c. 20000. At least 12
antigenic variants of pili have been recognized in gono-
cocci (Swanson and Berrera 1983) but a single strain
which might have the capacity to produce up to seven
types possesses only a single type at any one time. On
genetic evidence there is potential for the production of
many more types than 12 (Haas and Meyer 1986). The
variant pili from a single strain differ slightly in the mol¬
ecular mass of their pilin subunits and in their antigenic
cross-reactivity. When antibodies were raised to four
different types of pilus isolated from a single strain, there
was only 10-20% cross-reactivity between heterologous
strains (Virji et al. 1982). These antigenic variations also
occur in vivo, as demonstrated by analysing sequential
isolates from a single patient (Heckels 1984).
The molecular basis for this variation has been deter¬
mined by sequencing the pilin subunit. The N-terminus
of the molecule consists of a highly conserved region of
about 50 amino acids. This region is not immunogenic.
The C-terminus consists of a highly variable region, and
it is this portion that is immunodominant and gives rise
to the antigenic variation (Hagblom et al. 1985). This
finding makes the possibility of an antipilus vaccine
unlikely.
The function of the pili of the gonococcus is mainly
one of adherence. They stick to a w ide range of cell types.
It is thought, however, that they are also antiphagocytic,
preventing binding to polymorphonuclear leucocytes.
Certain of the outer membrane proteins are also involv ed
in adherence and will be discussed later.
The closely related N. meningitidis possesses pili
structurally and antigenically related to those of the
gonococcus (Stephens et al. 1985). The fimbriae of
Pseudomonas and Moraxella spp. are also related to the
pili of Xeisscrta (Froholm and Sletten 1977. Saastrv et al.
1983).
Fimbriae of other bacteria The fimbriae (pili)
described above are the best known examples of their
role as virulence factors. There are. however, many other
examples in bacteria (usually gram-negative) that possess
fimbriae. In Haemophilus influenzae, fimbriae are
involved, possibly in conjunction with capsules, in adher¬
ence. For a recent review of the mechanisms of patho¬
genicity of H. influenzae investigated from a genetic point
of view, see Wilson and Moxon (1988). Fimbriae are
also found in Bordetella pertussis. Ps. aeruginosa, certain
Bacteroides spp. and Corynehacterium diphtheriae. and
are putatively involved in adherence.
Flagella
Structure These whip-like appendages are the com¬
ponents of the bacterial cell responsible for movement.
Not all bacteria possess the ability to move. When
present, however, the arrangement of the flagella on the
cell is species-dependent. Some species possess a single
polar flagellum (monotrichous). whereas others have
polar tufts (lopotrichous) and in some the surface is
completely covered with flagella (peritrichous). The flag¬
ellum is primarily a long filament made up of strands of
flagellin subunits of molecular weights in the range
33 000-66000. The final structure is a fairly rigid tube of
10-20pm in length and 12-20 nm in diameter with a hole
of diameter c.3nm in its centre. Some bacteria have a
sheathed flagellum. e.g. those of Vibrio and Pseudomonas
spp. The base of the flagellum is anchored into the bac¬
terial envelope by means of a hook-like organelle attached
to a basal body. The structure and function of the bac¬
terial flagellum were reviewed by Doetsch and Sjoblad
(1980); see also Chapter 2.
Biological activities As antigens, the flagella are
usually strongly immunogenic. They are the classic H
antigens of the Enterobacteriaceae. As candidate viru¬
lence factors they are. however, probably not of great
significance in many motile organisms. This is despite
their potential for aiding the pathogen to traverse mucus
and to penetrate cells, although their role in propelling
bacteria towards chemoattractants may be of import¬
ance.
It is in V. cholerae that flagella are best known as a
putative virulence factor. The main virulence factor of
this pathogen is cholera toxin which is described later,
but the penetration of the mucus blanket of the small
intestine is a necessary first step, and this might be fol¬
lowed by adherence and localisation at the epithelial
surface. Attridge and Rowley (1983) showed that a flag¬
ellum is necessary for attachment in vitro: however, a
functional flagellum is not required, as flagellate, non-
motile organisms bind to cells as well as flagellate, motile
\
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organisms. Furthermore, in an infant mouse model of
cholera the flagellum enhanced virulence by facilitating
the initial colonization of the ileum. Similar observations
have been made for Campylobacter jejuni but in this
instance it is acknowledged that many other adhesins
may play a part (Walker et al. 1986).
It has been reported (Weinstein et al. 1984) that the
flagella of Salm. Typhimurium help the organism to
survive in murine macrophages by protecting it from
intracellular killing or by enhancing its ability to multiply.
The axial filaments found in some of the spiral organ¬
isms. viz. Treponema. Leptospira and Borrelia spp..
resemble flagella in structure. In some cases they appear
to be protective antigens, but their role in virulence is
uncertain.
Outer membrane proteins
Structure The outer membrane (OM) of the gram-
negative bacterium appears as a typical bilayer in the
electron microscope. It is made up of phospholipids,
protein and. in its outer leaflet, lipopolysaccharide. When
analysed by PAGE the number of proteins appears
initially to be rather small because there are only a few-
dominant major OM proteins. There are. however, many
minor polypeptides. Some of the major proteins can form
transmembrane channels (porins) or may be part of either
the inner or the outer leaflet. The functions of OM pro¬
teins are numerous and include ion binding, transport
systems, a few enzymatic functions, receptors for phage
and bacteriocins. and adhesins. The structure of the OM
is described briefly in Chapter 2; for more detailed
accounts, see Vaara and Nikaido (1984) or Nikaido and
Vaara (1985) and. for OM proteins. Osborn and Wu
(1980).
The LPS component of the OM was described earlier
in this chapter, but here it should be stressed that LPS
and OM proteins are extremely closely associated and
the role of one might be closely influenced by the other. In
the isolation and analysis of OM proteins it is extremely
difficult to obtain them free of LPS (Poxton et al. 1985).
Biological activities Perhaps the function of OM
proteins as adhesins is the best recognized of their roles
in virulence, and. as for the other classic adhesins. the
fimbriae, it is in diarrhoea-causing E. coli and the gono-
coccus that they have been studied most. The types of E.
coli that cause disease are listed in Table 13.6. and. as
described earlier, the ETEC and EHEC are known to
have fimbriae as their major adhesins. In the EPEC
strains, however, an OM protein is probably an adhesin.
The identification of this adhesin followed the recognition
by Cravioto et al. (1979) of a plasmid of mol. wt c. 60 x 106
which encoded for adherence to HEp-2 cells and was
termed the EPEC adherence factor (EAF). This plasmid
was subsequently shown to code for an OM protein of
mol. wt 94000 (Levine et al. 1985) which is found in all
the important EPEC serogroups (Levine 1987). A DNA
probe has been developed for the detection of the EAF
(Nataro et al. 1985). A critical review of the virulence
factors of EPEC strains has been made by Law (1988).
The EIEC and shigellae are characterized as invasive
gut pathogens. After entering the epithelial cells of the
colon they multiply and kill the cell. A plasmid of mol. w t
140 x 106 appears to code for several OM proteins pro¬
posed as being involved in the invasion process (Harris
et al. 1982. Hale et al. 1983). Furthermore, in other
invasive organisms (e.g. Yersinia spp.) several plasmid-
coded OM proteins - along with other factors - have
been proposed as important in invasion. The mechanism
of invasion is not clearly understood. Apart from the
initial attachment of the bacterium to the host cell, the
OM proteins may also be involved in survival and mul¬
tiplication of the bacterium within the host. For a recent
review on enteroinvasive bacteria, see Sansonetti er al.
(1988).
The observation that non-piliated gonococci can still
bind to cells led to the identification of a second adhesin.
the OM protein II. or PII. Colonial variants, differing in
opacity, are commonly observed when a single strain is
grown on solid medium. This variation is due to variation
in expression of PI I. A total repertoire of about six differ¬
ent types of P11 is found in each strain (Sw anson 1978).
In common with the pili of the gonococcus. antigenic
variation of PII can occur in a single strain during the
course of a disease in a single patient (Schwalbe et al.
1985).
Another class of OM proteins recognized as important
virulence factors are the iron-regulated membrane
proteins. These are known to be expressed under con¬
ditions of iron limitation by a number of bacteria, and
more are being recognized. They act as virulence deter¬
minants by being able to compete for iron in the iron-
depleted environment of the host. This feature will be
covered in more detail later in the sections of phage-
associated virulence and on expression of virulence deter¬
minants.
Other surface proteins
The other proteins found on the surfaces of bacteria
include the crystalline surface arrays found on many
gram-positive and gram-negative bacteria and were
described briefly in Chapter 2. The species most inves¬
tigated are not pathogenic and therefore no role in viru¬
lence has been proposed for these proteins. There are.
however, certain proteins on gram-positive bacteria -
notably the M-protein of Str. pyogenes - that have a
significant role in virulence; protein A of Staphylococcus
aureus may also play some part in enhancing infection.
Streptococcal M protein
The M protein along with the hyaluronic acid capsule
and the lipoteichoic acid are recognized as the surface
virulence determinants of Str. pyogenes. There are over
80 different serological types of M protein and they are
used in the serological classification of group A strep¬
tococci. M protein exists as a fibrillar surface layer and
each molecule consists of two a-helical protein chains in
a coiled-coil superstructure anchored to the cytoplasmic
membrane at its C-terminus. As described earlier, in the
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section on lipoteichoic acids, it has been proposed that
the two polymers combine to form an adhesin. The M
protein also protects the organism from recognition and
ingestion by phagocytic cells, but this can be overcome
by opsonic anti-M immunoglobulins (Lancefield 1962).
It is also known that M protein binds the C3 component
of complement, but this binding is blocked if the bac¬
terium first binds fibrinogen from plasma (Whitnack and
Beachey 1985). The hyaluronic acid capsule, which has
earlier been described as a camouflage mechanism for the
bacterium, is also said to bind fibrinogen and thus to
block C3 binding (LeBouef el al. 1986). By cloning Str.
pyogenes M protein into Str. sanguis, Poirier et al. (1989)
have reinforced the suggestion that binding of M protein
to fibrinogen allows evasion of the host defence system.
An alternative explanation of the antiphagocytic activity
of M protein was put forward by Fischetti et al. (1988).
who suggested that, in serum. M protein binds factor H.
the serum control protein of the alternative complement
pathway, and so prevents phagocytosis by depleting C3b
on the streptococcal surface. For details of the comp¬
lement system, see Chapter 16.
Protein A of 5. aureus and a group of similar proteins
(e.g. protein G) found on other gram-positive bacteria
have the property of binding the Fc fragment of immu¬
noglobulins. Protein A is found in most strains of 5.
aureus but the Cowan strain is usually used for its prep¬
aration. Molecules of this class have become of great
importance in recent years because of their use in the
isolation and purification of immunoglobulins. As viru¬
lence factors, most of their potential roles are hypo¬
thetical. The binding of immunoglobulins by their 'wrong
ends' may be an antiphagocytic property. Furthermore,
binding of the Fc region may result in the release of
inflammatory agents.
The association of plasmids and
bacteriophage with virulence
As mentioned earlier in this Chapter, there is often a
close association between virulence determinants and the
possession of plasmids; in fact, the more determinants
investigated, the more are shown to be plasmid-mediated.
These plasmids are referred to as virulence plasmids or vir
plasmids. Bacteriophages, as prophages, are also known
to code for virulence determinants in a few well recog¬
nized instances. (See also 'Virulence factors' in Chapter
6.)
Plasmids
In 1980, Elwell and Shipley (1980) reviewed the plasmid-
mediated factors associated with virulence. Since then
several advances have been made. The gram-negative
bacteria, especially E. coli. other enterobacteria and Yer¬
sinia spp.. have been the most studied. In E. coli causing
diarrhoea, both the enterotoxin genes and the col¬
onization factor genes are coded for by plasmids (see
earlier in this Chapter and Levine (1987)). In the entero-
invasive E. coli and shigellae. the plasmid of mol. wt
140x 106 codes for virulence and invasion, presumably
by encoding for several outer membrane proteins of
unknown function. Enteroinvasive E. coli and shigellae
do not usually invade the lamina propria of the gastro¬
intestinal tract. However, in the more invasive species -
the salmonellae and yersiniae. which often become sys¬
temic invaders - plasmids have been linked both to
invasion mechanisms and to resistance to the lytic action
of serum. In Salm. Typhimurium. Vandenbosch et al.
(1987) have shown that resistance to complement is
plasmid-mediated. The phenotypic change is unknown
but the LPS moiety is apparently unchanged. In Salm.
Dublin plasmid-coded virulence is independent of the
ability of the organism to cross the gut wall (Manning et
al. 1986).
The three species of Yersinia pathogenic for man - Y.
pestis, Y. enterocolitica and Y. pseudotuberculosis - are all
known to have plasmids associated with their virulence.
Again the mechanisms are by no means well understood
(Portnoy and Martinez 1985). The situation is com¬
plicated by the existence of multiple virulence deter¬
minants; and in Y. pseudotuberculosis the inv gene is
located on the chromosome and codes for a protein of
17000 mol. wt. This has been cloned in £. coli and shown
to permit the invasion of human cell lines (Falkow et al.
1987).
The best studied virulence plasmids are the ColV family
of E. coli plasmids, which code for the small protein
bacteriocin, colicin V (see "Bacteriocins' in Chapter 5).
The plasmid is invariably found in E. coli strains isolated
from septicaemias and other invasive infections, and is
strongly associated with virulence. The production of
colicin V itself does not endow the host bacterium with
virulence, but three other determinants coded for by the
plasmid are reported to be associated with virulence
(reviewed by Crosa 1984, 1987). These properties are: (1)
the ability to withstand the lytic action of normal human
serum. (2) the ability to adhere to mammalian cells
(Darken and Savage 1987) and (3) an enhanced ability
to assimilate iron. The importance of iron to pathogenic
micro-organisms is well recognized (Bullen and Griffiths
1987). Free iron is present in minute quantities in tissue:
most extracellular iron is complexed with iron-binding
proteins such as transferrin and lactoferrin. Bacteria must
obtain iron for growth and many do so with the aid of
iron-chelating agents or siderophores. the best known of
which is enterobactin (or enterochelin). synthesized by
most of the Enterobacteriaceae (Griffiths 1983. 1987).
The ColV plasmid codes for a siderophore - aerobactin.
an outer membrane protein of mol. wt 74000. It is uncer¬
tain how the possession of aerobactin confers an advan¬
tage on a bacterium which can already synthesize
enterobactin.
A plasmid similar to ColV and with the same properties
is found in the important fish pathogen V. anguillarum.
It codes for two outer membrane proteins.
Bacteriophage
The two best known examples of bacteriophage-
associated virulence determinants are those coding for
diphtheria toxin and for Clostridium bolulinum toxin. It
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has been known for many years that the /Tphage of C.
diphtheriae codes for toxin production. Crosa (1987) has
summarized our present understanding of the phage-
mediated expression of diphtheria toxin. The phage tox
gene can be expressed when in a prophage genome, in a
repressed genome or in replicating genomes during the
vegetative phage growth. The amount of iron in the
medium strongly influences the amount of toxin produced
by the bacterium. Production of toxin is maximal only
when the organism is growing under iron-limited con¬
ditions. The current hypothesis for the iron regulation of
diphtheria toxin is that an active repressor-iron complex
is formed in the presence of excess iron; this binds to the
operator locus (Murphy and Bacha 1979) and switches
off toxin production. In vivo, iron is present in such small
quantities that this mechanism is inactive.
The species CI. botulinum consists of eight different
serotypes which produce immunologically distinct, but
pharmacologically similar, toxins. It is now well recog¬
nized that types C and D. which are biochemically related,
produce toxins C, and D only when they possess the
TOX' bacteriophage. Strains cured of the phage do not
produce toxin. After reinfection with the phage, toxin
production is restored and type C can be converted to D.
and vice versa. Types C and D that do not produce
toxin are biochemically indistinguishable from CI. novvi.
This species also carries a TOX" phage which codes for
x toxin. It is possible to convert CI. botulinum type C to a
type D or to a CI. novvi by exchanging the bacteriophage
(Eklund and Poysky 1981). TOX' phages have not been
identified in any of the other types of CI. botulinum. but
recently it has been suggested that the production of toxin
G by type G strains is dependent on the possession of a
single plasmid of mol. wt 81 x 106 which, coincidentally,
also codes for a bacteriocin (Eklund et al. 1988).
The phenotypic expression of virulence
determinants
It is beyond the scope of this Chapter to cover in detail
this vast and topical area of medical microbiology. It
has long been recognized that the environment greatly
influences the properties of a pathogen. A bacterium
growing in a rich nutrient medium in a laboratory must
be very different from the same bacterium in an infection.
How often does a fresh isolate differ in virulence from a
laboratory-passaged strain? It is probably not the loss of
genetic information by the pathogen which results in loss
of virulence, but rather the loss of phenoty pic expression,
as passage in animals can often restore virulence.
Throughout this Chapter references have been made
to the variation in expression of virulence determinants,
e.g. the pili and PII of N. gonorrhoeae, the iron-regulated
membrane proteins of E. coli and exopolysaccharide pro¬
duction by various species. It is probable that any viru¬
lence factor is susceptible to variation. The conditions
that influence expression might include; growth tem¬
perature; growth rate; availability of nutrients; ionic
strength /osmolarity; oxygen tension; pH; association in a
biofilm glycocalyx; and host factors such as complement,
phagocytes, the flushing action of cilia and body fluids
and the possible influence of antibiotics. One or more of
these factors may be important in determining expression
of virulence.
In the laboratory , various attempts have been made to
control these variables and observe expression in the
bacterium. The development of the continuous culture
apparatus was one of the most significant steps forward.
See, for example. Ell wood and Tempest (1972) for one
of the first major studies on the use of a chemostat to
demonstrate how the composition of the culture medium
influences the chemical structure of the cell wall.
The reader is referred to Birkbeck and Penn (1986) and
Brown and Williams (1985) for accounts of our present
views on phenotypic expression of virulence deter¬
minants. and to Meynell and Gooder (1961) for a his¬
torical perspective.
Bacterial exotoxins in virulence
Bacterial pathogenesis requires that the pathogen is able
to colonize the human or animal host, to multiply on or
in host tissues and to avoid antibacterial defences. These
events lead to the establishment of a focus of infection
and often culminate in significant damage to the tissues;
such damage, which is often mediated by exotoxins, may
be localized at the site of infection or generalized at
distant sites. Bacterial protein exotoxins are thus import¬
ant determinants of bacterial virulence. However, the
galaxy of putative virulence determinants includes cell-
associated factors - considered earlier in this Chapter -
such as capsules, fimbrial adhesins. outer membrane pro¬
teins and extracellular enzymes and exotoxins.
The targets for toxic action are: (i) mucosal epithelial
cells, e.g. epithelial cells of the gastrointestinal tract; (2)
subepithelial tissues such as blood vessels, connective
tissue and leucocytes (systemic effects are often triggered
by toxins that act in this way); and (3) internal organs
such as the heart, liver, kidney, central nervous system
and neuromuscular junctions.
In classic bacterial toxinoses such as diphtheria,
tetanus and botulism, the exotoxin produced by the
causative organism is of paramount importance in patho¬
genesis. More commonly, pathogenesis depends on
complex interactions, cell-associated factors and extra¬
cellular enzymes combining with exotoxins to produce
infection and the clinical signs of disease. Indeed, it is
only as a result of recent advances in molecular biology
that the roles of individual virulence factors have been
determined for certain multifactorial pathogens. Even so.
the status of certain exotoxins remains only putative at
the present time.
The damaging effect of a toxin may result from direct
impairment of an essential metabolic function of the
target cell or it may be mediated indirectly through release
of mediators such as interferons, interleukins. leu-
kotrienes and prostaglandins. Moreover, toxicity does
not always involve death or lysis of the target cell: selec¬
tive impairment of phy siological and metabolic functions
can result from subtle non-lethal damage at the site of
action.
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In terms of mode of action, bacterial toxins fall into
two main classes: (1) cytolytic toxins that damage cell
membranes: and (2) bipartite (A-B) toxins that bind to a
specific receptor through the B (binding) region and then
release the toxic A region which causes cell damage,
usually at a site within the target cell.
The purification and molecular characterization of
bacterial toxins has advanced rapidly in recent years such
that the molecular properties of many important toxins
are now well established. Knowledge of the mode of toxin
action at the molecular level has also progressed rapidly.
In order to deal with this large topic economically, the
properties of a number of toxins produced by bacteria
pathogenic for man are summarized in Tables 13.7-13.9
in w hich toxins are arranged according to the target tissue
affected in the disease process. Some general features of
toxins acting on different target tissues are dealt with in
the accompanying text. The recent reviews of Sandvig
and Olsnes (1986). Gill (1988). Freer (1988). Robertson
(1988). Scotland 1988 and Arbuthnott (1988a. b) are re¬
commended as comprehensive sources of current infor¬
mation on the toxins listed here. In addition, some key
references are cited in Tables 13.7-13.9 for each category
of toxins.
Toxins acting on the gastrointestinal tract
(Table 13.7)
Several bacterial exotoxins are involved in the patho¬
genesis of intestinal disease and cause the symptoms of
watery diarrhoea, dysentery (bloody diarrhoea) or vomit¬
ing. Except when these symptoms result from the con¬
sumption of preformed toxin, as in the case of
staphylococcal food poisoning, the initiation of disease
requires entry of organisms into the intestinal tract and
colonization of the intestinal lumen through adherence
to mucosal cells, followed by elaboration of toxin.
Diarrhoea results either from direct or indirect stimu¬
lation of normal pathways of fluid and ion secretion or
from selective impairment of absorption.
Enterotoxins causing diarrhoea without
inflammation
Examples of this group of enterotoxins include cholera
enterotoxin (CT) and the heat-labile (LT) and heat-stable
(ST) toxins elaborated by enterotoxigenic (ETEC) strains
of E. coli. Once cholera vibrios or ETEC organisms have
established themselves in the proximal small intestine
through adhesin-mediated attachment, the secreted en¬
terotoxins perturb the normal processes of ion and w ater
absorption secretion across the intestinal epithelium.
This disruption is mediated by the elevation of intra¬
cellular levels of the cyclic nucleotides cAMP and cGMP
which are sy nthesized upon stimulation of adenylate and
guanylate cyclase respectively: these cyclic nucleotides act
as intracellular messengers in the complex sequence of
events that lead to net secretion of water and electrolytes
in the small intestine, which appears as watery diarrhoea.
CT and LT are very similar in molecular structure and
have an identical mode of action. Both are bipartite A-
B toxins, consisting of five binding (B) subunits and a
single active (A) subunit. The A subumt is readily nicked
proteolytically into two fragments (A, and A:). Frag¬
ment A: is part of the delivery system and is linked non-
covalently to the five B subunits. whereas fragment A,
is enzymically active and is responsible for toxicity. Bind¬
ing to susceptible target cells occurs through the appro¬
priate receptors (CT receptor = GM, ganglioside: LT
receptors = Gvti ganglioside and glycoprotein).
Enterotoxic activity results from the intracellular
action of fragment A,, which causes ADP-ribosylation
of the x-subunit of the GTP-binding regulatory com¬
ponent of adenylate cyclase. This results in activation of
adenylate cyclase and raised levels of c.AMP which, in
turn, trigger electrolyte secretion as described above.
Information from peptide sequencing of purified toxin
protein and DNA sequencing of cloned genes reveals a
high degree of homology between CT and LT. However,
slight differences do exist between LT from human ETEC
pathogens and LT from porcine ETEC strains. Fur¬
thermore. whereas LT genes are found on transmissible
plasmids. the gene for CT is located chromosomaUy.
The heat-stable enterotoxin (STa and STb) of ETEC
can be differentiated on the basis of methanol solubility.
STd toxins, which are produced by human and porcine
strains, comprise a set of small methanol-soluble peptides
w hich cause water and electrolyte secretion through acti¬
vation of guanylate cyclase in intestinal epithelial cells.
STb. a product of porcine ETEC strains, is methanol
insoluble and its mode of action does not involve cyclic
nucleotides.
Enterotoxins causing structural damage to intestinal
cells
A number of enteric pathogens affect the structural integ¬
rity of intestinal epithelial cells in the course of disease
leading to local inflammation. This occurs as a result of
direct toxin-mediated cytotoxity (e.g. CI. difficile. CI.
perfringens type A and B. cereus), from intimate contact
between the pathogen and brush border membranes (e.g.
enteropathogenic E. coli (EPEC)) or from cell damage
following invasion of intestinal epithelial cells and intra¬
cellular multiplication (e.g. Shigella and enteroinvasive
strains of E. co//(EIEC). In many cases the determinants
of adherence, penetration and multiplication are as
important as exotoxin production in the pathogenesis of
disease. It is interesting that EPEC. EI EC and entero-
haemorrhagic E. coli (EHEC) strains produce bipartite
toxins known as shiga-like toxins (SLTs) that are immu¬
nologically related but not identical to the shiga toxin of
Shigella dysenteriae.
Toxins causing subepithelial or systemic
damage (Table 13.8)
Establishment of a focus of infection in subepithelial
tissue by so-called extracellular bacterial pathogens (i.e.
pathogens that do not normally invade host cells) requires
that the pathogen can resist the barrage of defences at
the disposal of the host. There are several points at w hich
Table 13.7 Toxins that affect the intestine
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the extracellular products of such a pathogen can modify
the host response: (1) by inhibiting the inflammatory
response at an early stage: (2) by inhibiting the chemo-
tactic response of phagocytic cells; (3) by killing or
impairing the function of phagocytic cells that arrive at
the focus of infection; (4) by exerting toxic effects within
phagocytes after the pathogen has been phagocytosed;
and (5) by indirect toxic effects resulting from the action
of bacterial products on mediator cells. Once a focus of
infection is established, local tissue damage to connective
tissue cells, small blood vessels and muscle tissue may
result, leading to, for example, abscesses, wound infec¬
tions. necrosis and gangrene. The pathogens responsible
for such lesions (S. aureus, Sir. pyogenes and CI.
perfringens) are well endowed with an array of cytolytic
membrane-damaging toxins which are candidate deter¬
minants in such effects.
Typical membrane-damaging toxins such as sta¬
phylococcal a- and /Ttoxin. streptolysin O and strep¬
tolysin S. CI. perfringens 2- and 0-toxins all inhibit
leucocyte chemotaxis at subcytolytic concentrations; it
is of interest that some toxins are more active against
polymorphs, and others against macrophages.
At higher concentrations the same group of cytolytic
toxins are involved in necrosis and tissue damage. For
instance, type A strains of CI. perfringens are the most
common cause of gas gangrene, and this disease is an
example of a situation in which tissue damage probably
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Table 13.9 Toxins that attack internal organs
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nbcsylat.ng toxin its roie ,r.
disease .s unknown
Toxin causes spastic paralysis Established
due tc .nh.bition of release of
inhibitory neurotransmitter from
mh.bitory neurons Heavy
component binds tc membranes
Dut detailed mechanism still not
clear
Binding of B region to receptor Established
followed by nicking leads tc
entry of A fragment This causes
ADP ribosylatior. of elongation
factor 2 and inhibition of protein
synthesis
Damages heart, kidney, liver and
adrenals
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involves several factors. Pathological changes include
necrosis and oedema, with damage to connective tissue,
blood vessels and muscle tissue: systemic effects can
follow rapidly, with the development of a fatal toxaemia.
The x-toxin of CI. perfringens has been well characterized
and shown to be a phospholipase C. It is a cytolytic,
membrane-damaging toxin that exerts its haemolytic.
cytotoxic, dermonecrotic and lethal action through
degradation of membrane phospholipids. Auxiliary-
factors implicated along with x-toxin are 0-toxin (a thiol-
activated cytolysin), /c-toxin (collagenase) and u-toxin
(hyaluronidase).
Like CI. perfringens. S. aureus produces a large number
of toxins and auxiliary toxic factors, including a group
of membrane-damaging cytolysins (x-./?-, >•-. (5-toxins and
leucocidin). each of w hich is a candidate for involvement
in localized tissue damage or more subtle perturbation of
host defences. Work with animal model systems, together
with the very recent application of molecular cloning
techniques involving the creation of site-directed
mutants, has established an important role for sta¬
phylococcal x-toxin in the initiation of infection. This
agent is cytotoxic for a wide range of cells and tissues,
and acts by penetrating the hydrophobic interior of mam¬
malian membranes, forming transmembrane pores which
destroy the normal permeability properties of the target
cell.
The mechanism of cell damage is not always cytolytic.
For instance, in whooping cough, the bipartite toxin
(pertussis toxin) by its action on adenylate cyclase induces
a number of systemic effects including fever, lym¬
phocytosis, leucocytosis, increased sensitivity to his¬
tamine and impaired regulation of blood glucose. Such a
cascade of effects may, in some cases, result from the
action of the toxin on the levels of major regulatory-
mediators such as interleukins and tumour necrosis
factor. This appears to hold for staphylococcal toxic
shock syndrome toxin as well as for the staphylococcal
enterotoxins and streptococcal erythrogenic toxin.
By contrast, the unusual specificity of staphylococcal
epidermolytic toxin for cells in the stratum granulosum of
the epidermis strongly suggests that binding to a specific
receptor triggers an intracellular signal that initiates the
events of cell separation and epidermal splitting, which
in turn lead to blister formation or extensive exfoliation
of the epidermis typical of the scalded skin syndrome.
Even more complex is the systemic damage seen in
anthrax, in w hich the interaction of three distinct proteins
is required for lethality.
Toxic damage to internal organs (Table
13.9)
In some diseases, toxin absorbed across an epithelial
surface or diffusing out from a focus of infection pen¬
etrates through the blood stream and lymphatics or via
neurons to affect single or multiple targets in internal
organs at sites distant from the focus of infection.
Examples of this sort of damage include the classic tox¬
inoses diphtheria, tetanus and botulism.
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In classic diphtheria, local invasion of the naso¬
pharyngeal tissues b> toxinogenic strains of C. diphtherial•
leads to the formation of the pseudomembrane of
diphtheria, a tough fibrinous sheet containing fibrin,
necrotic epithelial tissue, lymphocytes, leucocytes, ervth-
rocytes and very large numbers of diphtheria bacilli.
Underlying the pseudomembrane is a necrotic haem-
orrhagic lesion. In addition to this local lesion, which
itself can be fatal due to occlusion of the airways, damage
to the internal organs such as the heart, lungs, liver,
kidney and nervous system results from uptake and sys¬
temic spread of diphtheria toxin. The diphtheria bacilli
themselves remain at the focus of infection and are not
present in the haemorrhagic. necrotic lesions found in
internal organs. As would be expected in such a toxinosis,
the presence of circulating antitoxin is protective and
toxoid immunization, now practised in all developed
countries, has been spectacularly successful in reducing
the incidence of the disease. The pathogenesis of tetanus
is also characteristic of a toxinosis, and again antitoxic
immunity confers protection. Here the site of infection
is a wound, where sporing tetanus bacilli grow in the
anaerobic conditions created by tissue trauma. Tetanus
toxin released at this site reaches its point of attack in the
central nervous system by passing along nerve axons.
The pathology of tetanus, namely convulsive spasms of
voluntary muscles, results from continual excitation of
the motor neurons of the central reflex apparatus in the
spinal cord. Tetanus toxin exerts this action by preventing
the release of the inhibitory neurotransmitters, glycine
and y-aminobutyric acid, that under normal conditions
would prevent overstimulation of the motor neurons.
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